data_1ija_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ija _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 10' ' ' ASP . 74.3 Cg_endo -76.6 122.46 6.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.647 1.564 . . . . 0.0 112.324 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -59.48 -7.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 12' ' ' SER . 2.6 m-20 -77.31 94.95 4.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.275 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -57.21 -5.68 0.31 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.261 -0.9 . . . . 0.0 109.793 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 10' ' ' ASP . 18.3 t -110.55 40.5 1.97 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.36 135.73 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.77 120.04 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.95 -19.98 19.1 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.28 -168.12 32.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.61 126.73 9.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.01 146.08 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' OE2' ' N ' ' A' ' 20' ' ' ILE . 8.8 tp10 -146.13 127.5 14.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.041 -1.037 . . . . 0.0 109.703 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.489 ' N ' ' OE2' ' A' ' 19' ' ' GLU . 44.7 mt -144.28 127.6 8.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.94 -46.19 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.726 1.617 . . . . 0.0 111.644 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.97 -25.33 3.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.79 9.03 10.62 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.485 -0.759 . . . . 0.0 109.397 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 42.27 38.75 1.24 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.424 0.63 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 ' O ' ' OE2' ' A' ' 19' ' ' GLU . 4.4 mt -92.72 146.44 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.88 0.848 . . . . 0.0 109.536 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -164.64 80.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -132.09 156.16 80.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.398 -0.814 . . . . 0.0 111.278 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -82.31 164.98 16.84 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.953 2.436 . . . . 0.0 112.332 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.0 127.03 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.385 -0.822 . . . . 0.0 109.066 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 4.9 m-85 -89.77 150.41 43.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.919 -1.113 . . . . 0.0 109.594 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.81 104.98 1.48 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.139 1.893 . . . . 0.0 111.605 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.08 -176.41 47.64 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.309 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' THR . 73.4 Cg_endo -79.16 117.94 3.92 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.323 . . . . 0.0 111.101 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -43.22 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.392 0.615 . . . . 0.0 110.455 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.587 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.8 p -105.69 153.47 39.92 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.03 -43.15 2.58 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.037 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.82 -21.41 66.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.9 OUTLIER -93.34 -62.39 1.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.0 mt -46.26 -18.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.389 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.5 m-20 -63.25 -25.28 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 89.2 mtt180 -83.27 -17.95 40.82 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 164.94 -130.92 2.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.295 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.34 165.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.574 -0.956 . . . . 0.0 109.213 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.431 ' CB ' HE22 ' A' ' 38' ' ' GLN . 3.3 t -162.09 159.1 25.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.157 -0.964 . . . . 0.0 109.065 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.94 164.85 2.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.84 -1.163 . . . . 0.0 109.396 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -76.79 -21.84 54.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.375 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -138.19 147.42 43.79 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.315 -0.866 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 -24.14 67.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.555 -0.716 . . . . 0.0 111.185 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -86.28 3.39 43.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.867 -1.146 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.87 161.88 20.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.048 -1.033 . . . . 0.0 109.3 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.1 m -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 4.5 mp -84.44 17.23 2.71 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -145.52 2.27 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.46 -0.775 . . . . 0.0 110.359 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASN . 50.7 t0 -57.29 126.49 27.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.64 -1.287 . . . . 0.0 109.292 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -42.31 -20.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.512 -0.743 . . . . 0.0 109.777 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 54' ' ' ASP . 14.7 t-20 -143.07 104.15 4.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 108.834 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.03 119.93 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.104 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.4 p -108.11 122.89 47.81 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 59' ' ' ILE . 68.9 mt -112.5 161.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.943 0.878 . . . . 0.0 110.952 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.62 125.49 25.71 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.86 153.31 21.04 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.622 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.569 ' O ' ' N ' ' A' ' 72' ' ' PHE . 19.2 m-70 -74.97 167.8 21.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.737 -0.86 . . . . 0.0 109.972 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.663 ' HG1' ' HZ1' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -153.06 87.36 1.27 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 108.913 179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -87.26 117.1 25.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 mt -59.85 -29.13 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.786 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.32 19.4 2.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.444 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.593 ' C ' ' H ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -150.05 70.01 9.2 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.748 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.496 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.2 Cg_exo -54.38 18.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 123.236 2.624 . . . . 0.0 113.564 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.593 ' H ' ' C ' ' A' ' 67' ' ' ARG . 17.2 m-80 -148.94 62.31 1.05 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.07 -153.9 0.6 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.459 -0.776 . . . . 0.0 110.068 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -62.46 -89.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 111.685 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.569 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.9 t80 -95.08 14.1 23.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.537 -0.727 . . . . 0.0 110.692 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.4 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 95.8 m -65.17 -49.45 69.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.4 -1.438 . . . . 0.0 110.829 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 5.0 m120 -83.1 -19.1 37.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.435 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -53.84 -27.94 32.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.851 -1.155 . . . . 0.0 109.059 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.663 ' HZ1' ' HG1' ' A' ' 63' ' ' THR . 20.6 mtmm -66.73 -27.83 67.94 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.06 62.67 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.08 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.3 170.22 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.549 -0.719 . . . . 0.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -150.06 168.0 25.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.264 -0.897 . . . . 0.0 109.069 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -51.32 150.98 3.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.546 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.66 -15.12 32.45 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.452 ' O ' ' SD ' ' A' ' 97' ' ' MET . 25.9 p -63.58 108.08 1.3 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.359 -1.083 . . . . 0.0 108.679 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.464 ' CE ' ' OH ' ' A' ' 85' ' ' TYR . 21.0 ptm -80.65 166.46 21.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.049 -1.032 . . . . 0.0 109.452 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.15 175.8 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.316 -0.865 . . . . 0.0 110.108 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' OH ' ' CE ' ' A' ' 83' ' ' MET . 73.8 m-85 -142.54 111.39 6.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.3 115.99 28.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -85.93 141.12 29.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.6 m -146.64 127.69 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.534 -0.729 . . . . 0.0 109.163 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.57 -115.83 2.06 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -116.16 53.92 0.85 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.606 -0.937 . . . . 0.0 109.399 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -166.84 153.4 8.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.048 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' A' ' 92' ' ' THR . 9.0 t -131.09 124.9 31.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.4 6.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 7.5 ptpp? -142.92 154.8 44.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.146 -0.971 . . . . 0.0 110.042 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.542 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 4.1 m-85 -138.25 177.77 7.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -140.23 110.45 6.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.26 135.21 17.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.05 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 p -153.11 18.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 109.991 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.432 ' HG ' ' CG1' ' A' ' 143' ' ' VAL . 0.6 OUTLIER -170.14 87.45 0.13 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.624 -1.297 . . . . 0.0 109.259 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.296 -1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.247 -179.973 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.3 m-20 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 118' ' ' ASP . 37.5 mtmt -38.52 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -154.7 157.37 37.98 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.183 -0.948 . . . . 0.0 110.053 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.7 tp -121.82 106.73 11.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.1 m -91.16 128.03 36.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.933 -1.104 . . . . 0.0 108.785 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.3 mp -103.43 145.27 30.24 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.22 -0.925 . . . . 0.0 110.161 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.6 mt -142.58 139.97 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.374 -0.829 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.07 166.11 11.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.013 -1.054 . . . . 0.0 108.787 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.473 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -149.86 102.49 3.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.04 -1.037 . . . . 0.0 109.754 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 1.8 p-10 -156.03 148.03 23.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 0.0 109.305 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.48 56.85 2.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 108.802 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -62.05 119.0 8.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.464 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 135' ' ' VAL . 2.6 p-10 -83.92 130.63 34.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.013 -1.054 . . . . 0.0 109.694 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.75 5.52 43.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 109.061 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -71.63 -61.43 1.78 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.464 -0.773 . . . . 0.0 108.936 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -100.49 -1.42 35.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 109.342 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.85 49.72 33.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 5.1 t -146.99 168.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -1.065 . . . . 0.0 109.417 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 91.6 m95 -73.82 113.64 11.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -40.28 -77.54 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -84.36 150.49 25.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.015 . . . . 0.0 108.584 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -151.03 79.48 1.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.862 -1.149 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -75.2 148.72 39.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.455 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 11.9 pt -135.87 149.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 122.12 0.962 . . . . 0.0 110.902 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -144.09 143.86 31.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 99' ' ' SER . 4.7 p -136.89 149.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.897 -1.127 . . . . 0.0 110.938 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -130.89 -178.03 4.63 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.7 t -148.05 148.54 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.002 -1.061 . . . . 0.0 109.651 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -51.11 144.03 9.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.86 . . . . 0.0 109.223 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.346 -0.846 . . . . 0.0 109.164 -179.497 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.3 mm . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 98.9 Cg_exo -42.33 150.58 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.627 1.551 . . . . 0.0 112.004 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.08 -11.52 18.8 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.13 103.0 6.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 0.0 109.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -56.5 -13.0 1.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -98.48 30.81 3.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.4 -0.812 . . . . 0.0 109.203 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.5 140.53 23.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 58.5 t -60.65 163.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.72 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -138.51 -3.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.452 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 177.34 -175.19 47.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 69.6 m-85 -149.81 121.46 8.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.084 -1.245 . . . . 0.0 110.087 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.8 tt -98.66 143.93 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -146.84 136.03 22.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.03 -1.044 . . . . 0.0 110.675 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.4 mt -144.88 125.02 7.26 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.5 Cg_endo -76.3 -42.55 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.691 1.594 . . . . 0.0 111.434 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -50.66 -17.24 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.048 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . . . -133.82 14.31 3.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.513 -0.742 . . . . 0.0 109.209 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.4 p-10 43.75 50.25 6.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 25' ' ' ILE . 43.3 mm -92.7 142.79 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.645 0.736 . . . . 0.0 109.888 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -168.97 81.35 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.0 158.49 61.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.738 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -86.07 169.74 8.68 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.184 2.589 . . . . 0.0 113.105 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.56 137.14 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 24.6 m-85 -92.41 149.84 39.0 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.907 -1.121 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 50.3 Cg_endo -81.46 79.37 3.25 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.806 2.338 . . . . 0.0 111.802 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.76 177.5 39.58 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.865 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 91.2 Cg_endo -79.86 121.66 4.62 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.824 2.349 . . . . 0.0 111.182 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . -40.85 87.75 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.906 -0.496 . . . . 0.0 110.918 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -111.54 167.28 9.32 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.52 -45.36 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.739 1.626 . . . . 0.0 111.833 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -62.28 -17.03 57.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.856 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.599 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -96.98 -69.36 0.76 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 0.0 108.642 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.2 mt -41.35 -24.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.799 -0.563 . . . . 0.0 110.51 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 38' ' ' GLN . 31.3 m-20 -63.61 -25.13 68.09 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.436 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.4 mtp180 -84.49 -14.58 48.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.535 ' C ' HE21 ' A' ' 71' ' ' GLN . . . 156.51 -143.92 10.22 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.882 -1.151 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.538 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.9 t -88.61 152.88 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 t -148.81 141.02 24.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 108.967 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -56.45 162.35 2.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 108.944 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.423 ' CB ' ' OG ' ' A' ' 58' ' ' SER . . . -79.31 -9.98 59.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.173 -0.954 . . . . 0.0 108.812 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -145.27 149.55 35.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.5 pt-20 -63.39 -41.84 98.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 111.152 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 8.2 p30 -89.65 17.81 6.11 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 111.222 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.87 95.77 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.866 -1.146 . . . . 0.0 109.839 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -89.75 173.31 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.536 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -82.44 0.13 43.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.089 -1.007 . . . . 0.0 108.647 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.91 -10.68 19.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.564 -0.71 . . . . 0.0 109.897 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.5 t70 -59.59 113.44 2.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.772 -1.205 . . . . 0.0 108.863 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -46.72 -14.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.133 -0.979 . . . . 0.0 109.56 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' ASP . 3.8 m120 -133.49 97.21 3.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -94.23 115.86 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.233 -0.917 . . . . 0.0 108.917 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.8 t -108.63 116.69 32.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.697 -0.627 . . . . 0.0 109.351 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 92.1 mt -109.37 164.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.601 0.715 . . . . 0.0 109.579 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -138.32 135.25 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.07 148.78 20.7 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.081 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -74.53 -169.29 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.639 -0.918 . . . . 0.0 110.07 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.84 99.99 0.47 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.27 122.45 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.162 -0.962 . . . . 0.0 108.918 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -64.65 -43.06 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.783 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.26 18.91 2.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.187 -0.945 . . . . 0.0 109.888 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.568 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -151.04 75.58 8.16 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 72.9 Cg_exo -51.78 24.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.92 3.08 . . . . 0.0 114.642 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 67' ' ' ARG . 10.4 m120 -151.7 62.92 0.86 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 108.55 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.435 ' O ' ' OG1' ' A' ' 73' ' ' THR . 36.8 t80 -141.7 90.24 2.26 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.235 -0.916 . . . . 0.0 110.498 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.562 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 1.5 mm100 65.03 -119.23 0.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.764 -0.585 . . . . 0.0 111.556 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.628 ' CD2' ' O ' ' A' ' 72' ' ' PHE . 29.5 t80 -87.44 33.35 0.69 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.318 1.056 . . . . 0.0 109.142 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 70' ' ' TYR . 21.6 m -69.13 -57.21 5.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.15 -1.594 . . . . 0.0 110.607 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.1 m-20 -90.43 -13.56 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.181 -0.949 . . . . 0.0 111.775 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mt -52.38 -29.63 24.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 108.281 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -1.77 21.36 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -99.37 -33.2 10.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.618 . . . . 0.0 109.337 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.25 163.23 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -129.03 162.73 26.97 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.595 ' HZ3' ' CB ' ' A' ' 80' ' ' LYS . 9.5 mtmp? -49.06 132.41 19.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 109.282 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.94 -24.3 15.03 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -64.36 114.23 4.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.206 -1.173 . . . . 0.0 108.065 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -73.35 -174.11 1.55 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.839 -1.163 . . . . 0.0 109.454 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.584 ' N ' ' SD ' ' A' ' 83' ' ' MET . 21.4 t -146.46 110.75 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.515 ' CD2' ' SD ' ' A' ' 83' ' ' MET . 53.0 m-85 -87.45 102.44 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -97.56 117.54 32.07 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -107.75 139.77 41.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.414 -0.804 . . . . 0.0 110.112 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.434 ' CG1' ' NH1' ' A' ' 93' ' ' ARG . 7.1 p -168.96 157.41 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.724 . . . . 0.0 109.484 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.85 -96.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -154.27 29.8 0.44 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -140.17 -175.25 4.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.355 -0.841 . . . . 0.0 109.201 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 m -149.83 111.57 4.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.536 ' NH2' ' CD1' ' A' ' 52' ' ' LEU . 7.6 mpt_? -89.07 163.53 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -141.43 122.9 15.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.384 -0.823 . . . . 0.0 109.63 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 17.1 m-85 -109.15 175.1 5.58 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.429 -0.794 . . . . 0.0 109.128 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.89 111.06 8.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.28 -0.887 . . . . 0.0 109.886 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.9 mtt -50.67 123.23 8.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.123 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 p -149.44 20.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 109.431 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.1 t -171.37 123.69 0.57 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.691 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.3 mt . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 -179.081 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 49.1 t0 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.468 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 83.0 mttt -60.83 145.08 51.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -143.83 160.58 40.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.057 -1.027 . . . . 0.0 108.953 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.1 tp -114.87 107.98 16.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.675 . . . . 0.0 110.962 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.7 t -97.54 107.72 20.29 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.0 156.38 21.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.003 . . . . 0.0 110.278 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.7 mt -140.37 143.78 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.513 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -91.78 155.89 17.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.934 -1.104 . . . . 0.0 108.512 179.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 2.0 m -149.29 85.03 1.44 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.944 -1.097 . . . . 0.0 109.886 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 20.3 p-10 -142.8 143.88 32.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.141 -0.975 . . . . 0.0 109.235 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.34 61.09 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.451 -0.78 . . . . 0.0 109.072 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -63.7 119.98 10.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -85.67 123.48 31.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 109.602 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 131' ' ' GLU . 1.7 pm0 -94.82 14.7 20.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.343 -0.848 . . . . 0.0 109.77 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -69.31 -35.5 76.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.0 108.57 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.0 p -140.99 1.92 1.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 109.037 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.63 3.03 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.3 t -146.99 133.72 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.225 -1.162 . . . . 0.0 109.642 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 53.3 m95 -53.11 113.65 1.19 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.07 -1.019 . . . . 0.0 108.493 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -36.96 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.291 0.567 . . . . 0.0 110.326 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 137' ' ' GLU . 19.2 ptmt -96.87 139.35 33.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -151.78 96.49 2.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.891 -1.131 . . . . 0.0 110.569 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -86.58 158.49 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.156 -0.965 . . . . 0.0 108.473 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.9 mm -129.25 140.29 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 25.8 m-85 -129.49 170.63 13.47 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.1 t -154.06 140.85 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.692 -1.255 . . . . 0.0 110.86 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.24 139.3 40.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.8 t -109.85 137.61 47.39 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.399 -0.813 . . . . 0.0 110.389 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.03 133.55 55.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 109.547 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 109.327 179.832 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 10' ' ' ASP . 93.1 Cg_endo -83.6 134.18 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.191 1.927 . . . . 0.0 112.432 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -60.21 0.76 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 12' ' ' SER . 13.2 t70 -76.49 91.18 3.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -64.76 38.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.557 ' H ' ' C ' ' A' ' 10' ' ' ASP . 43.3 t -146.9 25.26 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 108.885 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -141.67 141.88 33.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.64 118.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.66 -0.65 . . . . 0.0 110.885 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.96 -16.81 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.97 -177.48 38.74 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 121.31 8.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -1.223 . . . . 0.0 109.586 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -99.9 142.04 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' CD ' ' NZ ' ' A' ' 87' ' ' LYS . 23.7 mt-10 -146.79 135.24 21.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.968 -1.083 . . . . 0.0 110.737 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 20' ' ' ILE . 32.5 mt -144.84 127.06 8.12 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.07 -42.75 0.37 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.636 1.557 . . . . 0.0 111.599 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -52.16 -14.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.403 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.63 15.14 3.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.42 -0.8 . . . . 0.0 109.136 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 42.41 49.52 4.62 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.718 0.77 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 50.0 mm -91.76 141.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 25' ' ' ILE . 42.3 mttp -165.9 81.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -143.91 156.58 58.79 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 0.0 110.817 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -84.79 165.36 11.84 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.041 2.494 . . . . 0.0 112.531 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.22 119.43 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.565 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 7.9 m-85 -79.37 149.43 72.23 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.817 -1.177 . . . . 0.0 110.207 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.58 88.5 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.479 2.119 . . . . 0.0 111.86 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.31 -179.44 41.23 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.575 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 35' ' ' THR . 85.2 Cg_endo -78.09 119.17 4.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.861 2.374 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -43.63 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.383 0.611 . . . . 0.0 110.397 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -112.55 153.47 44.94 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.63 -43.43 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.09 1.86 . . . . 0.0 111.664 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.09 -22.98 67.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.565 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 7.1 tp60 -89.94 -66.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.235 -0.916 . . . . 0.0 109.54 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.2 mt -46.39 -15.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.918 . . . . 0.0 109.947 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' GLN . 40.0 m-20 -63.25 -25.19 68.21 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' C ' ' HH ' ' A' ' 30' ' ' TYR . 86.6 mtt180 -88.88 -11.24 45.18 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 158.15 -136.6 4.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.42 159.03 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.992 . . . . 0.0 109.862 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 p -153.58 156.73 38.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -57.99 175.67 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.797 -1.189 . . . . 0.0 109.946 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.95 -12.18 51.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -147.24 151.12 36.15 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.472 0.653 . . . . 0.0 109.935 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.39 -38.73 92.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.6 -0.687 . . . . 0.0 111.34 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -87.38 12.31 12.38 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.897 -1.127 . . . . 0.0 110.643 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.31 84.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 53' ' ' ASP . 48.2 m -92.56 147.46 22.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.03 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.635 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.41 -8.77 0.37 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -77.12 -30.82 55.37 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.508 -0.745 . . . . 0.0 109.615 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 15.8 m-20 -62.16 104.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.055 -1.028 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.31 -16.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 54' ' ' ASP . 27.6 t-20 -117.97 97.86 6.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.646 -0.659 . . . . 0.0 109.223 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.445 ' O ' ' OG1' ' A' ' 122' ' ' THR . 92.2 mt -98.49 150.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.376 -0.827 . . . . 0.0 109.325 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -140.46 114.45 9.02 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -101.69 161.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.326 -0.859 . . . . 0.0 110.362 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.438 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -140.27 131.17 26.02 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.23 154.24 24.89 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.537 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.676 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 19.9 m-70 -71.1 175.52 5.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.68 -0.894 . . . . 0.0 109.063 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.86 89.75 0.66 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.65 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.05 116.99 28.49 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.2 mm -59.59 -29.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.799 . . . . 0.0 110.097 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -87.54 19.51 3.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -149.71 70.56 9.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.536 -0.727 . . . . 0.0 109.191 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.88 14.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 123.442 2.761 . . . . 0.0 113.853 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.579 ' H ' ' C ' ' A' ' 67' ' ' ARG . 56.5 m-80 -147.9 60.95 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.216 . . . . 0.0 108.839 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -146.8 103.63 3.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 110.48 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.676 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 15.0 mt-30 55.81 -115.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 111.907 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.68 30.65 2.87 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 111.13 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.1 m -63.92 -49.16 73.71 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.128 -1.608 . . . . 0.0 109.611 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 77' ' ' ALA . 4.9 m-20 -93.95 -18.23 22.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.012 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.439 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 2.6 tm? -51.05 -39.07 55.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -68.91 -4.71 17.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -91.5 -27.99 17.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 162.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 109.742 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 166.36 24.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.348 -0.845 . . . . 0.0 108.807 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -50.18 137.31 18.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.54 13.19 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -64.19 119.7 10.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.407 -1.055 . . . . 0.0 108.269 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.7 mtp -82.96 137.12 34.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.0 -1.063 . . . . 0.0 110.102 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.02 114.12 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.607 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -93.26 102.46 14.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.151 -0.968 . . . . 0.0 109.544 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -97.13 114.63 26.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 0.0 108.755 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' NZ ' ' CD ' ' A' ' 19' ' ' GLU . 23.0 mtmm -106.12 142.08 36.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.94 123.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.79 -145.23 5.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 90' ' ' ASN . 28.0 t-20 -85.26 52.1 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.198 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 m -152.98 148.68 27.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.601 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 177.15 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -144.31 164.1 31.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.028 -1.045 . . . . 0.0 110.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 94' ' ' LYS . 23.7 m-85 -148.96 108.31 3.95 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.39 117.91 16.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.132 -0.98 . . . . 0.0 109.27 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -51.75 129.62 26.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.309 -0.869 . . . . 0.0 108.988 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -158.16 24.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.227 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.0 t -171.28 132.7 0.81 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.4 mt . . . . . 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -178.545 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 4.2 m-20 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -47.37 141.29 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 108.824 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -152.84 164.58 37.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 110.572 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.1 tp -127.23 116.59 20.81 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.067 0.46 . . . . 0.0 109.854 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -96.05 92.37 6.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.07 143.17 54.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 110.136 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mt -140.92 135.62 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.462 -0.774 . . . . 0.0 109.324 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.6 p -96.63 167.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.058 -1.027 . . . . 0.0 108.521 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 70.8 m -147.03 139.5 24.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.022 -1.049 . . . . 0.0 110.124 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 1.7 p30 179.59 136.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 61.5 64.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.0 109.201 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -62.98 126.5 27.53 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 109.142 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -85.96 118.36 25.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.038 . . . . 0.0 109.509 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.74 -0.56 54.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.425 -0.797 . . . . 0.0 109.918 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.77 -50.24 9.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.008 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.7 p -95.13 -10.69 29.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.236 -0.915 . . . . 0.0 109.233 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.76 39.94 54.08 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.89 158.89 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.333 -1.098 . . . . 0.0 109.636 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.427 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.8 m95 -62.78 111.76 2.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -35.79 -77.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.064 0.459 . . . . 0.0 110.627 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.446 -0.784 . . . . 0.0 109.227 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -169.79 131.62 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.709 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.51 166.83 13.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.14 -0.975 . . . . 0.0 108.845 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 22.6 mt -141.51 144.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 13.1 m-85 -140.1 168.93 18.66 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -150.05 141.8 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.626 -1.296 . . . . 0.0 110.745 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.19 171.27 14.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 147' ' ' VAL . 14.4 t -146.87 147.53 30.91 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.84 -1.163 . . . . 0.0 110.93 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.17 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' A' ' 145' ' ' THR . 1.7 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.181 -0.949 . . . . 0.0 108.99 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' PRO . 6.9 mm . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' ILE . 76.8 Cg_exo -47.27 -174.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.527 1.485 . . . . 0.0 112.509 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -120.66 -26.7 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 12' ' ' SER . 30.8 t70 -76.08 101.68 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -57.45 -2.67 0.13 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.6 p -115.59 43.98 1.97 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.499 -0.75 . . . . 0.0 109.345 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HZ3' ' CB ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -142.24 136.83 30.24 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 t -61.19 108.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.52 -0.738 . . . . 0.0 111.402 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.7 -5.03 49.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.43 -170.24 40.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.08 126.33 10.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -1.183 . . . . 0.0 109.073 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 tp -97.41 140.77 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -146.58 132.54 19.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.167 . . . . 0.0 110.748 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.6 mt -144.8 120.58 6.02 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.94 -37.99 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.629 1.553 . . . . 0.0 111.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.32 -19.9 1.48 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.408 -0.807 . . . . 0.0 109.293 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 24' ' ' ASP . . . -130.54 5.32 4.72 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.5 -0.75 . . . . 0.0 109.465 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER 56.16 29.61 15.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.831 -0.543 . . . . 0.0 111.372 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CD1' ' ND2' ' A' ' 74' ' ' ASN . 1.5 mp -85.33 142.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.658 -1.276 . . . . 0.0 108.404 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -165.64 86.3 0.37 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -142.13 160.62 54.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.75 158.18 24.68 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.514 2.143 . . . . 0.0 112.17 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.06 108.39 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.75 166.94 27.01 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.948 -1.095 . . . . 0.0 109.11 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -86.1 130.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.486 2.124 . . . . 0.0 112.177 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.02 168.94 30.88 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.012 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.9 Cg_endo -77.78 121.02 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 111.286 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . -39.78 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.33 0.586 . . . . 0.0 110.281 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 p -126.43 152.82 74.68 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.12 -43.0 12.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.187 1.924 . . . . 0.0 111.995 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -61.46 -21.98 64.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.576 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -95.29 -69.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.158 -0.964 . . . . 0.0 109.253 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.5 mt -45.58 -16.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -62.18 -24.84 67.43 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.6 -15.64 54.06 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.61 -109.69 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.924 -1.131 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.473 ' C ' ' HG ' ' A' ' 44' ' ' SER . 5.0 t -125.52 153.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.505 -0.997 . . . . 0.0 109.758 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 2.7 m -153.79 153.74 32.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -56.78 165.57 1.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.594 -1.317 . . . . 0.0 109.474 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -79.05 -5.12 53.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -150.9 146.42 26.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.519 -0.738 . . . . 0.0 109.591 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.49 -38.39 87.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 111.075 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -89.47 15.48 9.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.99 -1.069 . . . . 0.0 111.143 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.0 99.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.847 -1.158 . . . . 0.0 109.61 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.1 p -91.22 144.28 25.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 108.856 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.672 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.99 -7.1 0.95 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 51' ' ' SER . 20.5 t0 -96.01 -13.47 23.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.691 -0.631 . . . . 0.0 109.626 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' ASN . 46.4 t0 -58.97 105.08 0.28 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.02 -1.05 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.732 HE21 HE21 ' A' ' 120' ' ' GLN . 6.0 tm0? -44.49 -17.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.506 -0.747 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 54' ' ' ASP . 5.0 t-20 -122.3 92.75 3.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.1 mt -93.55 145.8 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 108.453 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 t -142.3 109.17 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 108.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 81.5 mt -95.27 162.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.181 -0.949 . . . . 0.0 110.162 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.401 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -134.02 131.78 39.3 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.03 145.47 15.44 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.844 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 18.1 m-70 -72.85 -169.95 0.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.685 -0.891 . . . . 0.0 109.304 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.48 94.15 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -89.44 113.09 24.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.923 . . . . 0.0 108.887 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mt -61.07 -31.67 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 110.12 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -84.27 15.47 3.56 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 109.302 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -151.49 74.23 8.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.466 ' C ' ' ND2' ' A' ' 69' ' ' ASN . 76.8 Cg_exo -52.38 24.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 123.861 3.041 . . . . 0.0 114.379 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.572 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.9 m-80 -151.26 63.44 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.0 108.551 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 36.2 t80 -150.77 99.85 2.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.071 -1.018 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.542 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.8 mt-30 59.66 -122.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.706 . . . . 0.0 111.454 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.648 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 12.2 t80 -92.75 36.66 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.402 1.096 . . . . 0.0 109.574 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.7 m -67.05 -56.65 9.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 119.908 -1.745 . . . . 0.0 110.299 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.2 p30 -110.82 7.14 21.84 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.232 -0.917 . . . . 0.0 111.409 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mt -57.8 -15.03 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.62 -12.35 59.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -81.54 -30.41 33.15 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.8 -179.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLY . 23.5 mmtp -139.76 153.48 47.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -51.39 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.83 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.7 -15.35 0.36 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -62.86 121.25 13.02 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.335 -1.097 . . . . 0.0 108.119 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtp -70.94 -175.06 1.04 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.336 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -146.51 109.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.39 101.88 14.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE2' ' CG2' ' A' ' 88' ' ' VAL . 16.7 t80 -98.74 112.45 24.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' CB ' ' NZ ' ' A' ' 87' ' ' LYS . 7.0 mtmp? -92.12 146.55 23.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.064 -1.023 . . . . 0.0 110.809 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 90' ' ' ASN . 68.3 t -139.55 155.25 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.77 41.2 0.25 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 88' ' ' VAL . 43.1 t30 -160.4 -34.29 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.229 -1.159 . . . . 0.0 110.028 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.441 ' OE1' ' NH1' ' A' ' 93' ' ' ARG . 29.8 tt0 -172.4 165.9 5.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 t -107.14 123.04 47.67 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.441 ' NH1' ' OE1' ' A' ' 91' ' ' GLU . 5.3 mmt180 -92.94 160.16 15.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 108.737 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -144.87 121.18 10.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -114.59 176.76 4.91 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.607 -0.683 . . . . 0.0 109.223 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -136.56 107.21 6.55 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 0.0 109.395 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 28.5 tpp -49.49 119.29 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.052 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 99' ' ' SER . 2.6 t -145.37 19.72 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.096 -1.002 . . . . 0.0 109.744 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 98' ' ' THR . 45.7 m -169.54 118.84 0.65 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 108.784 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 100' ' ' ILE . 92.3 mt . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.554 -0.716 . . . . 0.0 109.669 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 121.549 0.69 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -44.86 140.77 2.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.732 HE21 HE21 ' A' ' 55' ' ' GLN . 9.0 pt20 -152.21 173.4 15.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.997 -1.064 . . . . 0.0 110.08 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.7 tp -122.87 155.86 35.81 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.45 0.643 . . . . 0.0 110.122 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.0 m -141.98 88.96 2.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.77 149.44 49.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.378 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 96.8 mt -140.04 141.99 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.5 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -90.49 156.56 18.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.919 -1.113 . . . . 0.0 108.831 179.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.533 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 23.0 m -148.75 89.82 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.142 -0.973 . . . . 0.0 109.449 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -148.54 146.04 28.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.235 -0.916 . . . . 0.0 109.118 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 1.2 m-20 61.29 63.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 108.835 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.432 ' HH ' ' C ' ' A' ' 134' ' ' GLY . 28.4 t80 -63.24 122.11 15.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -85.17 121.69 28.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.85 13.77 19.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.853 . . . . 0.0 109.638 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -81.19 -26.16 36.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 p -141.98 5.59 1.73 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.355 -0.84 . . . . 0.0 109.168 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.432 ' C ' ' HH ' ' A' ' 129' ' ' TYR . . . 68.23 53.04 23.88 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.481 ' CG1' ' NH2' ' A' ' 139' ' ' ARG . 3.3 t -147.29 139.83 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.218 -1.166 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 56.9 m95 -56.09 115.39 2.4 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.38 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 12.6 tp10 -39.51 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.724 -0.61 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -81.28 146.92 30.16 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.481 ' NH2' ' CG1' ' A' ' 135' ' ' VAL . 26.8 ttm180 -158.76 75.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.872 -1.143 . . . . 0.0 110.482 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -75.27 163.59 27.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.47 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 6.9 mm -134.09 156.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.836 0.826 . . . . 0.0 110.426 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 21.3 m-85 -141.75 159.73 41.64 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.2 147.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.711 -1.243 . . . . 0.0 111.342 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.17 158.77 43.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.21 143.02 50.27 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.15 -0.968 . . . . 0.0 109.92 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 9.1 tm-20 -60.48 135.75 57.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.438 -0.789 . . . . 0.0 108.88 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.425 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.5 2.036 0 O-C-N 121.356 -0.84 . . . . 0.0 108.875 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.62 172.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.275 1.983 . . . . 0.0 112.345 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.57 2.08 12.33 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.57 -0.707 . . . . 0.0 109.514 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 12' ' ' SER . 63.2 t0 -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.98 3.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 10' ' ' ASP . 27.2 p -129.24 39.81 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.259 -0.9 . . . . 0.0 109.82 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -150.42 150.36 31.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.149 -0.969 . . . . 0.0 109.143 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 89.0 t -61.04 157.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.603 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -144.29 -30.09 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.82 -178.18 28.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -148.06 120.01 8.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -1.137 . . . . 0.0 108.963 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tp -94.37 143.67 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -147.43 132.55 18.3 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.155 . . . . 0.0 110.914 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.2 mt -145.72 123.71 6.35 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.7 -39.42 0.52 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.752 1.635 . . . . 0.0 111.895 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.48 -23.32 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' O ' ' OD2' ' A' ' 24' ' ' ASP . . . -127.35 4.38 6.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 109.42 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.3 p30 52.38 37.38 22.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.832 -0.542 . . . . 0.0 111.359 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.29 146.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.76 -1.212 . . . . 0.0 108.095 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -166.55 82.56 0.26 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -139.27 156.91 71.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 111.646 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.0 164.51 7.28 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.82 2.346 . . . . 0.0 113.308 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.86 129.72 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 2.0 m-85 -87.57 152.36 51.81 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 120.877 -1.139 . . . . 0.0 110.179 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.4 97.94 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.577 2.185 . . . . 0.0 111.43 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.77 -178.27 48.68 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.323 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.0 Cg_endo -80.61 117.78 3.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.867 2.378 . . . . 0.0 111.018 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.05 88.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.395 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.0 p -107.7 153.63 41.36 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.62 -41.35 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.191 1.928 . . . . 0.0 112.392 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.43 -22.22 66.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 109.678 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.4 tm0? -96.17 -53.74 3.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.9 mt -45.1 -23.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' GLN . 14.6 m-20 -64.03 -25.67 68.22 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.419 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 88.5 mtt180 -84.35 -16.0 44.45 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.0 -139.61 6.81 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.682 -1.246 . . . . 0.0 110.782 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.85 159.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.46 -1.023 . . . . 0.0 109.792 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -155.56 152.97 29.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.516 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 54.1 m-85 -58.68 160.21 5.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.522 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -75.39 -6.16 48.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.997 . . . . 0.0 109.413 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -154.37 149.56 26.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.509 ' OE2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -62.99 -35.86 81.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 111.612 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.509 ' ND2' ' OE2' ' A' ' 48' ' ' GLU . 13.9 p30 -87.88 15.5 7.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.858 -1.151 . . . . 0.0 110.979 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 12.0 tm-20 -64.86 145.06 56.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.991 -1.068 . . . . 0.0 109.062 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.725 ' HG ' ' H ' ' A' ' 53' ' ' ASP . 8.4 p -148.44 153.46 38.54 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.419 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -67.04 -4.64 10.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.725 ' H ' ' HG ' ' A' ' 51' ' ' SER . 39.2 m-20 -95.06 -17.42 21.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.9 t70 -59.15 115.56 3.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.944 -1.097 . . . . 0.0 108.846 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 9.3 tt0 -46.04 -19.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 109.607 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' ASP . 61.7 t-20 -131.88 113.48 13.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.692 . . . . 0.0 109.435 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.64 145.19 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 108.627 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.7 p -141.55 104.43 4.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -103.13 158.83 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.86 129.06 47.5 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.8 149.05 20.55 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.924 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 31.3 m-70 -74.28 -163.54 0.2 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.61 -0.936 . . . . 0.0 110.046 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 63' ' ' THR . 10.0 t -164.34 80.56 0.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.332 -0.855 . . . . 0.0 108.794 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -87.51 108.0 18.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.798 -1.189 . . . . 0.0 109.11 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.99 -29.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -82.38 12.31 4.6 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.805 0.812 . . . . 0.0 109.401 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.606 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -146.01 75.39 12.95 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.52 8.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.617 2.878 . . . . 0.0 113.988 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.606 ' H ' ' C ' ' A' ' 67' ' ' ARG . 12.2 p30 -142.93 59.36 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 0.0 108.085 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.435 ' O ' ' OG1' ' A' ' 73' ' ' THR . 27.9 t80 -143.46 102.91 4.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.381 -0.824 . . . . 0.0 110.177 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 51.62 -132.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.423 -0.798 . . . . 0.0 110.752 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.679 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 1.1 t80 -87.65 63.39 7.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.881 1.324 . . . . 0.0 108.779 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 70' ' ' TYR . 52.9 m -89.66 -32.69 16.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.657 -1.277 . . . . 0.0 108.377 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.556 ' N ' ' OD1' ' A' ' 74' ' ' ASN . 3.6 p-10 -140.03 10.06 2.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -10.53 0.72 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 74' ' ' ASN . 1.8 ptmm? -85.33 -23.48 28.05 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -67.33 -29.09 68.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.36 -157.15 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.7 ptmt -171.23 162.42 6.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -52.59 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.256 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 152.56 -25.09 0.85 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -63.41 113.66 3.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.1 mtp -63.24 -177.5 0.19 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.68 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.6 t -144.87 106.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.421 -0.8 . . . . 0.0 109.171 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.99 102.43 14.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.931 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -96.12 115.99 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -102.91 144.04 31.72 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.304 -0.873 . . . . 0.0 109.983 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -169.24 140.29 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.399 -0.813 . . . . 0.0 109.105 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.5 -97.71 0.15 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.88 18.9 0.89 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -1.14 . . . . 0.0 109.299 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -132.73 139.82 47.78 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.7 t -112.53 132.35 55.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.439 -0.788 . . . . 0.0 110.287 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 93' ' ' ARG . 7.4 mmm-85 -92.93 167.56 11.74 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -148.46 92.76 2.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.9 -1.125 . . . . 0.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -87.7 -178.16 6.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 108.185 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -138.39 105.33 5.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.252 -0.905 . . . . 0.0 109.769 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.7 ttm -50.06 115.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -157.59 24.76 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.1 m -164.69 119.53 1.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.428 -0.795 . . . . 0.0 109.63 -178.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' GLN . 34.7 m-20 . . . . . 0 N--CA 1.503 2.202 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' ASP . 42.4 mmtt -41.27 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.3 pm0 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.18 102.66 10.35 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -96.46 134.8 39.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.097 -1.002 . . . . 0.0 109.332 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.97 148.06 43.38 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.504 -0.748 . . . . 0.0 109.132 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.1 mt -133.77 143.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.43 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 p -91.13 153.23 20.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 109.335 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.515 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 10.6 m -149.31 92.18 1.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.327 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.416 ' OD2' ' OD1' ' A' ' 128' ' ' ASP . 6.5 p-10 -149.0 146.85 27.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.353 -0.842 . . . . 0.0 108.898 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.416 ' OD1' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-20 59.33 63.66 1.52 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.01 124.89 22.25 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.682 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 6.3 t-20 -85.11 115.1 22.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.947 . . . . 0.0 109.312 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -83.87 1.21 44.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 65.0 mmtt -79.86 -53.91 6.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.274 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.0 p -95.55 -9.8 31.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.52 42.94 31.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.22 152.26 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -1.118 . . . . 0.0 109.62 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.4 m95 -58.72 114.93 2.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.1 tt0 -38.3 -72.92 0.05 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 110.567 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HZ2' ' CB ' ' A' ' 138' ' ' LYS . 5.2 mtpm? -91.01 148.17 22.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.098 -1.001 . . . . 0.0 109.305 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -154.13 93.42 1.62 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.035 -1.041 . . . . 0.0 110.906 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.551 ' CB ' ' HZ1' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -94.7 164.59 12.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.0 mt -139.38 149.88 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.251 -0.906 . . . . 0.0 110.505 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.2 m-85 -137.27 164.5 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 99' ' ' SER . 72.5 t -152.66 118.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.655 -1.278 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -101.81 -176.48 3.14 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.0 t -153.9 131.37 11.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.873 -1.142 . . . . 0.0 110.022 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.54 109.85 1.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.87 0.843 . . . . 0.0 109.667 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 8' ' ' PRO . 5.7 mm . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 7' ' ' ILE . 74.2 Cg_exo -49.54 -140.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 121.96 1.773 . . . . 0.0 113.63 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -160.2 -30.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.882 -1.136 . . . . 0.0 109.783 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' SER . 26.3 t0 -74.96 112.6 11.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.496 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -57.8 -4.78 0.32 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 109.752 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.7 p -111.88 39.73 2.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.549 -0.719 . . . . 0.0 109.585 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.4 143.63 29.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.044 -1.035 . . . . 0.0 109.662 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.83 149.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.817 0.817 . . . . 0.0 110.846 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.87 10.45 1.78 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.66 176.05 38.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -147.96 117.27 6.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.305 -1.114 . . . . 0.0 109.437 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -97.76 141.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -146.34 138.89 25.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.996 -1.065 . . . . 0.0 110.45 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.4 mt -144.46 125.8 7.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.72 -41.14 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.477 1.451 . . . . 0.0 111.333 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -51.79 -16.6 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.835 . . . . 0.0 109.315 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' O ' ' OD1' ' A' ' 24' ' ' ASP . . . -137.29 14.88 3.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.81 . . . . 0.0 109.476 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 4.4 p-10 43.79 50.09 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.43 -0.794 . . . . 0.0 109.891 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 25' ' ' ILE . 49.6 mm -88.8 144.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.582 0.706 . . . . 0.0 109.664 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -168.9 81.25 0.14 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -140.83 152.5 65.77 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.239 -0.913 . . . . 0.0 110.33 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.14 166.92 10.95 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.827 2.351 . . . . 0.0 112.633 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.7 120.44 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -90.99 165.7 21.06 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.004 -1.06 . . . . 0.0 109.432 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.12 120.66 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.71 2.273 . . . . 0.0 112.569 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.28 168.46 20.57 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.566 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 69.3 Cg_endo -73.84 123.95 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.831 2.354 . . . . 0.0 111.195 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.95 87.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.781 -0.574 . . . . 0.0 110.654 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.0 p -112.21 151.65 43.83 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.22 -40.03 9.28 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.15 1.9 . . . . 0.0 111.636 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.61 -23.05 66.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.351 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -96.16 -58.92 1.95 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.301 -0.874 . . . . 0.0 108.791 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -47.13 -12.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.831 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.5 m-20 -60.93 -26.74 67.71 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -82.31 -16.84 47.88 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.24 -128.77 2.6 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.769 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 4.5 t -95.93 158.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.467 -1.019 . . . . 0.0 110.245 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -154.96 147.32 23.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.0 109.132 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -52.85 170.21 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.866 -1.146 . . . . 0.0 109.061 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -100.5 9.15 42.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.467 -0.771 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -167.91 132.24 1.75 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.003 . . . . 0.0 109.889 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 50' ' ' GLU . 10.2 pt-20 -55.07 -19.41 7.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.71 -0.619 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.86 25.86 0.89 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.909 -1.119 . . . . 0.0 108.568 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.3 145.56 53.44 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.2 p -154.36 144.94 22.3 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 mt -71.95 10.1 0.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.5 OUTLIER -127.76 -1.14 6.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.89 -0.506 . . . . 0.0 110.312 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' CG ' HE22 ' A' ' 55' ' ' GLN . 4.8 t70 -54.78 118.43 4.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.452 -1.405 . . . . 0.0 108.719 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.715 HE21 ' H ' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -45.52 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.715 ' H ' HE21 ' A' ' 55' ' ' GLN . 6.7 p-10 -144.88 110.82 5.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -93.31 116.82 35.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 109.134 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 27.8 m -107.76 111.53 23.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -115.06 162.78 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.6 121.63 37.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.36 140.37 13.38 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.6 m-70 -73.1 170.33 15.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -1.034 . . . . 0.0 110.027 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.459 ' C ' ' HG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -149.27 78.18 1.37 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.41 -0.806 . . . . 0.0 109.04 179.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.668 ' N ' ' HG1' ' A' ' 73' ' ' THR . 50.2 m-85 -86.53 110.19 19.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 109.291 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.1 mt -57.73 -27.21 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.485 -0.759 . . . . 0.0 110.055 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.9 14.45 3.27 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.569 ' C ' ' H ' ' A' ' 69' ' ' ASN . 80.9 mtt180 -148.21 72.37 11.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.45 25.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 123.33 2.687 . . . . 0.0 113.443 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.569 ' H ' ' C ' ' A' ' 67' ' ' ARG . 11.3 p30 -148.82 25.76 0.93 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 0.0 108.509 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.41 -152.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.691 0.758 . . . . 0.0 109.991 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -71.31 -81.89 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.781 -0.575 . . . . 0.0 111.411 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 34.4 t80 -94.36 -6.81 43.41 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.023 -1.048 . . . . 0.0 110.116 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.668 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 96.1 m -43.32 -39.52 3.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.96 . . . . 0.0 110.813 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 76' ' ' LYS . 6.0 m120 -94.17 -27.17 16.35 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.841 -1.162 . . . . 0.0 111.44 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.5 mt -51.74 -11.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.694 -1.254 . . . . 0.0 109.36 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 74' ' ' ASN . 3.3 ptmt -84.05 -2.71 57.2 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -103.76 -36.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.68 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.104 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' O ' ' SD ' ' A' ' 97' ' ' MET . 50.0 mttm -148.09 174.57 11.8 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -48.13 139.69 8.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 109.709 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.32 -15.19 62.65 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 97' ' ' MET . 53.2 p -64.22 98.18 0.22 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.262 -1.14 . . . . 0.0 108.486 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.487 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 11.3 ptm -67.63 178.08 1.79 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.32 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.2 t -144.24 117.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.487 ' OH ' ' SD ' ' A' ' 83' ' ' MET . 97.9 m-85 -93.82 102.71 14.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CZ ' ' CG1' ' A' ' 88' ' ' VAL . 37.1 t80 -95.87 110.83 22.95 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -99.69 146.52 26.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 90' ' ' ASN . 20.2 m -156.89 142.03 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.719 -0.613 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.35 -96.64 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.522 ' ND2' ' OE2' ' A' ' 91' ' ' GLU . 4.4 p-10 -140.17 19.2 2.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -1.141 . . . . 0.0 109.296 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.522 ' OE2' ' ND2' ' A' ' 90' ' ' ASN . 4.2 mp0 -120.03 167.11 12.52 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -152.64 118.92 5.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 110.16 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.482 ' HG2' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.85 169.86 10.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -143.8 117.29 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.876 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.28 176.19 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -138.89 106.44 5.58 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.442 -0.786 . . . . 0.0 109.867 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 36.7 ttm -48.26 124.93 8.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.085 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -153.83 0.21 0.22 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.033 -1.042 . . . . 0.0 109.81 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 143' ' ' VAL . 72.2 m -163.85 112.59 1.21 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.229 -0.919 . . . . 0.0 110.228 -177.472 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.7 t70 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 118' ' ' ASP . 66.2 mttm -36.79 132.58 0.64 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -148.32 -178.14 6.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.455 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.8 tp -134.99 111.31 9.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -96.04 87.54 4.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.27 -0.893 . . . . 0.0 108.716 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.72 121.04 23.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.12 -0.988 . . . . 0.0 109.145 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.2 mt -105.12 140.76 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.773 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -94.76 161.61 14.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.125 -0.985 . . . . 0.0 108.863 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 21.8 m -148.03 139.51 23.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -175.1 132.95 0.31 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.065 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.1 t0 61.83 66.01 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.812 . . . . 0.0 109.132 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -61.76 123.56 18.31 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.021 -1.049 . . . . 0.0 109.739 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -87.34 125.49 34.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.157 -0.965 . . . . 0.0 109.672 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.71 7.68 38.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.368 -0.833 . . . . 0.0 109.698 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -79.38 -58.65 3.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -0.924 . . . . 0.0 109.077 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.2 p -96.74 -3.9 41.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 109.3 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.82 35.98 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.15 157.37 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -1.073 . . . . 0.0 109.733 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.449 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.5 m95 -63.79 114.31 3.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 136' ' ' TRP . 31.0 tt0 -36.79 -81.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.244 0.545 . . . . 0.0 110.451 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.53 170.16 4.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.13 -0.981 . . . . 0.0 108.519 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -161.86 112.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 0.0 109.983 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.15 155.83 49.09 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 pt -150.78 160.52 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 111.187 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -138.11 157.37 46.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 99' ' ' SER . 96.5 t -144.24 111.68 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -99.3 175.08 6.0 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.1 t -138.88 133.89 32.54 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.035 -1.041 . . . . 0.0 109.706 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.22 127.68 33.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.441 -0.787 . . . . 0.0 109.706 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.282 179.823 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.456 HD11 HG23 ' A' ' 7' ' ' ILE . 64.8 mt . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.23 167.39 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.078 1.852 . . . . 0.0 112.5 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.81 -12.95 12.66 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 12' ' ' SER . 52.6 t0 -76.87 107.5 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -57.9 -5.39 0.41 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.404 -0.81 . . . . 0.0 109.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 10' ' ' ASP . 16.5 m -103.68 29.24 5.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.445 -0.784 . . . . 0.0 109.808 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -147.16 140.29 25.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.154 -0.966 . . . . 0.0 109.418 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 94.8 t -59.91 166.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.71 0.767 . . . . 0.0 110.656 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -140.3 -34.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -160.49 -165.68 17.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 31.3 m-85 -149.41 126.24 11.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.983 -1.304 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -96.31 142.75 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -145.63 146.08 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.955 -1.091 . . . . 0.0 110.304 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.88 131.42 7.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.48 -51.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.883 1.722 . . . . 0.0 111.752 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -50.55 -29.18 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.412 -0.805 . . . . 0.0 109.321 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.38 3.27 19.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.52 -0.738 . . . . 0.0 109.062 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 42.84 41.13 2.4 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.577 0.703 . . . . 0.0 109.894 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.82 150.07 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.777 0.799 . . . . 0.0 110.016 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -167.25 83.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -135.8 158.51 73.93 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.351 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.84 161.98 16.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.008 2.472 . . . . 0.0 113.154 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.47 130.82 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 12.6 m-85 -85.77 148.84 49.65 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.845 -1.159 . . . . 0.0 109.993 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.37 82.73 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.647 2.231 . . . . 0.0 111.398 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.64 -173.96 35.48 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.187 -1.482 . . . . 0.0 110.897 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.8 Cg_endo -82.38 121.4 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.961 2.44 . . . . 0.0 111.406 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -43.53 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.851 -0.53 . . . . 0.0 110.576 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.1 p -110.47 151.33 42.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.51 -41.71 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.227 1.951 . . . . 0.0 112.04 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.64 -21.38 66.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' ASN . 1.6 tt0 -96.73 -60.68 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' GLY . 24.0 mt -45.16 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.69 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' GLN . 38.7 m-20 -64.35 -26.47 68.49 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.429 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 23.4 mtt-85 -79.93 -19.55 47.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 162.48 -144.12 9.36 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.75 163.62 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.297 -1.119 . . . . 0.0 108.874 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.459 ' CB ' ' NE2' ' A' ' 38' ' ' GLN . 4.4 t -158.41 155.28 28.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 109.202 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -60.02 164.84 3.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.075 -1.016 . . . . 0.0 109.419 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.81 -19.16 55.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.176 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.77 150.5 41.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.397 -0.814 . . . . 0.0 110.248 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.44 -36.52 84.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.589 -0.694 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.17 9.27 15.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.891 -1.131 . . . . 0.0 110.989 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -65.02 138.53 58.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 0.0 109.391 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.616 ' HG ' ' H ' ' A' ' 53' ' ' ASP . 2.8 t -147.23 169.42 19.41 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 108.986 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.485 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -10.19 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.616 ' H ' ' HG ' ' A' ' 51' ' ' SER . 4.3 m-20 -81.92 -29.35 32.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.483 -0.761 . . . . 0.0 109.213 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.6 m-20 -64.4 100.7 0.37 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.73 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' A' ' 55' ' ' GLN . 2.8 pm0 -48.33 -15.92 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.982 -1.074 . . . . 0.0 109.012 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' ASP . 19.6 t30 -110.45 100.04 8.94 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.55 148.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.212 -0.93 . . . . 0.0 109.548 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -145.82 107.88 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 79.1 mt -110.79 165.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.588 -0.695 . . . . 0.0 110.134 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -149.55 138.75 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.461 -0.775 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.55 157.73 27.49 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.29 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -73.11 -177.15 2.36 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.302 -1.116 . . . . 0.0 109.818 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.9 81.46 0.43 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -87.85 122.2 31.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.318 -0.863 . . . . 0.0 109.533 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 mm -58.9 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -0.894 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.72 20.53 2.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' ASN . 90.8 mtt180 -150.37 67.87 8.34 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.541 -0.725 . . . . 0.0 109.572 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.3 5.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 123.537 2.825 . . . . 0.0 114.124 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.567 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -146.13 61.24 1.24 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.89 -1.131 . . . . 0.0 108.638 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -152.86 121.0 6.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 110.509 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.578 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.4 -124.71 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.681 -0.637 . . . . 0.0 110.864 178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' ASN . 3.3 m-85 -97.82 12.51 33.68 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.72 -1.237 . . . . 0.0 110.15 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.0 m -46.41 -19.93 0.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.911 -1.118 . . . . 0.0 110.311 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 72' ' ' PHE . 5.5 m-20 -121.77 -21.74 6.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.442 -0.786 . . . . 0.0 109.971 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -55.96 -25.22 42.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.57 -13.64 60.06 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.52 -16.43 39.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.96 174.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.827 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 81' ' ' GLY . 53.5 mtmt -150.49 159.21 44.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.901 . . . . 0.0 109.114 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -52.84 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.2 -22.71 0.51 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -66.43 121.12 14.59 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.459 -1.024 . . . . 0.0 108.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.6 mtm -77.58 -177.82 4.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.962 -1.086 . . . . 0.0 109.801 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.4 t -145.65 159.51 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.808 . . . . 0.0 109.444 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -144.17 102.46 3.87 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 109.371 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -95.0 113.5 25.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 108.658 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -102.08 139.1 38.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -162.23 144.22 3.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 49.98 -151.65 4.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.601 ' N ' HD21 ' A' ' 90' ' ' ASN . 0.0 OUTLIER -92.94 59.33 3.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.197 -1.178 . . . . 0.0 109.297 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -168.36 163.37 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.335 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -144.86 151.78 39.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 159.38 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.47 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 37.5 pttt -143.1 164.82 29.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 3.1 m-85 -141.31 -174.62 4.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -141.95 115.03 8.75 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.16 -0.962 . . . . 0.0 108.964 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.41 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.2 mmt -49.36 110.09 0.33 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.598 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 p -139.46 20.69 2.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.436 -0.79 . . . . 0.0 109.14 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 143' ' ' VAL . 31.1 t -168.63 122.91 0.88 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.209 -0.932 . . . . 0.0 109.296 -178.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 120' ' ' GLN . 28.8 m-20 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 118' ' ' ASP . 4.3 mptp? -26.04 87.77 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 122.315 1.055 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 118' ' ' ASP . 5.9 pt20 -89.04 161.16 16.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.05 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.7 tp -133.35 109.01 9.06 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -94.24 92.18 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.949 . . . . 0.0 109.909 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.3 mt -74.98 148.02 40.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.131 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.1 mt -138.74 143.27 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.213 -0.929 . . . . 0.0 109.628 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -105.49 155.67 18.95 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.341 -0.85 . . . . 0.0 108.726 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 127' ' ' ASP . 66.7 m -145.81 155.92 43.23 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.93 -1.106 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER 170.49 140.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.89 . . . . 0.0 109.56 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 0.4 OUTLIER 56.89 63.16 2.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.688 -0.633 . . . . 0.0 109.334 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.71 120.57 10.91 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.872 -1.142 . . . . 0.0 108.525 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -85.14 111.41 19.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 109.896 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.4 4.83 9.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.357 -0.839 . . . . 0.0 109.751 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.34 -53.83 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.0 p -96.48 -8.19 32.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.866 . . . . 0.0 109.195 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.62 41.37 43.71 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.71 155.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.224 -1.162 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.442 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.0 m95 -61.85 112.6 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.4 tt0 -38.08 -78.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.702 -0.624 . . . . 0.0 110.016 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -89.92 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -152.54 108.24 3.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.909 -1.119 . . . . 0.0 110.524 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.415 ' CB ' ' HZ2' ' A' ' 140' ' ' LYS . 3.8 mtmp? -109.84 133.81 52.75 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.5 mm -104.81 129.53 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -117.4 160.09 21.72 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.5 t -145.72 149.75 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.715 -1.24 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.75 179.3 7.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -161.37 156.38 23.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.575 -1.328 . . . . 0.0 111.309 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.25 135.05 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.312 0.577 . . . . 0.0 110.059 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 122.01 0.909 . . . . 0.0 109.426 179.522 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.34 152.43 3.79 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.022 . . . . 0.0 112.667 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -93.08 -17.08 24.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 108.885 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 36.2 t0 -77.58 106.03 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.453 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 0.9 OUTLIER -58.01 -5.45 0.44 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 13.6 t -103.19 39.25 1.6 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.364 -0.835 . . . . 0.0 109.751 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -147.76 132.91 18.33 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.301 -0.874 . . . . 0.0 109.71 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 38.8 t -61.31 132.21 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.56 -16.3 20.12 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -176.7 -162.76 27.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -148.89 128.78 13.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.251 -1.146 . . . . 0.0 109.687 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.72 144.67 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -144.27 147.45 33.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.874 -1.141 . . . . 0.0 110.75 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mt -149.68 131.88 7.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -50.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.936 1.757 . . . . 0.0 112.0 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.19 -20.98 1.75 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.829 . . . . 0.0 109.406 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' ASP . . . -118.46 3.31 11.84 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ALA . 1.5 p30 40.91 38.86 0.72 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.542 0.687 . . . . 0.0 109.848 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -98.08 155.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.86 0.838 . . . . 0.0 110.47 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -162.49 69.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 71' ' ' GLN . 11.2 mt-10 -100.56 150.2 36.77 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.582 -0.699 . . . . 0.0 112.495 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -87.98 159.96 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.844 2.363 . . . . 0.0 111.608 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.71 130.55 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.117 -0.989 . . . . 0.0 109.646 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -94.42 155.92 39.2 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.881 -1.137 . . . . 0.0 108.888 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -81.59 95.12 0.92 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.311 2.007 . . . . 0.0 111.786 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.88 -177.66 39.86 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.336 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 89.0 Cg_endo -81.64 116.99 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.915 2.41 . . . . 0.0 111.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.46 87.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.331 0.586 . . . . 0.0 110.335 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -112.85 153.35 45.19 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.44 -45.04 19.63 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.07 1.847 . . . . 0.0 111.433 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.54 -19.04 64.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.417 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' ASN . 6.7 tp60 -93.02 -69.35 0.75 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -45.37 -17.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 109.754 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 38' ' ' GLN . 13.7 m-20 -61.81 -24.92 67.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.6 mtt180 -85.56 -12.97 50.3 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.76 -110.64 0.45 Allowed Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.737 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.9 t -131.64 156.79 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.383 -1.069 . . . . 0.0 109.395 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 t -153.04 154.33 34.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 108.749 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.31 171.69 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.926 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -78.46 -26.28 46.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 109.517 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -135.15 150.24 50.13 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -0.781 . . . . 0.0 109.635 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.52 -32.77 72.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.626 -0.671 . . . . 0.0 111.456 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -85.93 11.32 11.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.885 -1.135 . . . . 0.0 110.81 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.96 147.1 52.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 53' ' ' ASP . 2.7 p -147.99 151.76 36.32 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.481 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -65.94 -5.52 9.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 51' ' ' SER . 13.7 t70 -91.58 -22.51 20.28 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 52.7 m-20 -60.11 100.67 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.199 -0.938 . . . . 0.0 108.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 9.0 tt0 -42.98 -20.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.519 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 22.1 t-20 -116.89 97.64 6.07 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.8 146.8 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 46' ' ' ALA . 10.6 m -144.66 109.61 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mt -108.82 167.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.374 -0.828 . . . . 0.0 109.948 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.96 135.17 27.26 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.38 157.9 27.1 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.835 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' A' ' 72' ' ' PHE . 25.9 m-70 -73.67 -173.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.608 -0.937 . . . . 0.0 110.562 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.688 ' HG1' ' HZ1' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -174.9 77.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.7 119.05 28.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.133 . . . . 0.0 108.977 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.09 -26.62 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.453 -0.779 . . . . 0.0 110.365 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.15 14.78 2.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.628 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 69' ' ' ASN . 83.0 mtt180 -150.77 76.66 8.06 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.641 . . . . 0.0 109.407 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.6 12.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 123.657 2.905 . . . . 0.0 114.021 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.602 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -146.5 52.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.892 -1.13 . . . . 0.0 108.125 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 15.7 t80 -136.93 100.72 4.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.411 -0.805 . . . . 0.0 109.96 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 12.1 mp0 54.86 -125.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.625 -0.672 . . . . 0.0 110.722 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.537 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 4.9 m-85 -90.23 34.08 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.685 -1.259 . . . . 0.0 110.092 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.4 m -57.55 -26.65 61.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.357 -1.464 . . . . 0.0 109.477 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.4 p30 -140.55 4.15 1.94 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.2 tt -55.2 -21.63 14.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.853 -1.154 . . . . 0.0 107.929 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.688 ' HZ1' ' HG1' ' A' ' 63' ' ' THR . 14.2 mtmm -82.77 -18.54 40.29 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -62.29 -22.84 66.34 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -54.62 -169.9 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 81' ' ' GLY . 4.5 ptpt -154.58 157.52 38.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -0.961 . . . . 0.0 109.223 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.479 ' CB ' ' NZ ' ' A' ' 80' ' ' LYS . 5.3 ttpm? -52.2 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 109.543 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 153.42 -14.75 0.64 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -64.42 119.12 9.78 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.545 -0.974 . . . . 0.0 108.774 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.3 mmm -73.51 179.89 3.83 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.393 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.26 161.74 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.967 . . . . 0.0 109.231 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -147.67 103.13 3.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.345 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -94.58 111.99 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -95.55 144.83 25.69 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.1 96.83 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.52 -0.738 . . . . 0.0 109.134 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 48.62 -131.35 21.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -82.22 52.54 2.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.154 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.25 143.44 10.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.14 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.4 m -152.87 146.95 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.987 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 177.99 7.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.475 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 23.9 pttm -144.28 161.09 39.82 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.091 -1.006 . . . . 0.0 110.351 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 10.9 m-85 -141.35 -179.79 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -147.13 130.54 16.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.935 -1.103 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.443 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 12.9 mtt -48.51 150.86 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.394 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 97' ' ' MET . 14.9 m -166.28 1.34 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.161 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 t -168.5 124.08 0.96 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.25 -0.906 . . . . 0.0 109.141 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.68 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 119' ' ' LYS . 97.6 m-20 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' ASP . 57.5 mttp -44.69 126.78 5.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.837 . . . . 0.0 109.334 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.589 ' OE1' ' N ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -149.37 168.24 23.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.983 -179.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.8 mt -116.71 154.0 31.37 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.552 0.691 . . . . 0.0 110.321 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.0 m -140.48 86.41 2.06 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.45 159.68 19.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 111.175 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.9 mt -140.14 126.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 p -90.31 118.7 30.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.767 -1.208 . . . . 0.0 109.025 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.534 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 23.1 m -99.1 154.2 18.31 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.619 -0.676 . . . . 0.0 110.129 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.1 t70 179.87 132.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 109.073 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.2 t0 59.76 72.27 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 109.331 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -65.27 122.27 16.73 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 10.0 p30 -85.7 129.47 34.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.893 -1.129 . . . . 0.0 109.476 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -91.25 4.84 51.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 108.962 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -71.96 -62.44 1.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.807 . . . . 0.0 109.088 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 p -98.49 -3.16 37.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.472 -0.767 . . . . 0.0 109.314 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.67 47.78 19.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.54 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 2.9 t -146.79 169.57 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -1.076 . . . . 0.0 109.329 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.534 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 73.4 m95 -73.2 114.19 11.11 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.177 -0.952 . . . . 0.0 108.943 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.6 tp10 -35.55 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.081 0.467 . . . . 0.0 110.727 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.13 150.42 40.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.608 -0.682 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.1 OUTLIER -166.96 164.91 16.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -130.41 133.19 46.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.499 -0.75 . . . . 0.0 109.1 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 141' ' ' ILE . 15.4 mm -94.54 146.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.46 140.93 25.41 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 5.9 t -133.07 147.15 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.271 -0.893 . . . . 0.0 110.752 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.41 144.65 33.19 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.7 t -118.3 148.89 42.0 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 147' ' ' VAL . 7.7 tp10 -61.93 137.24 58.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.62 -0.675 . . . . 0.0 109.407 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.52 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 4.3 m . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.95 . . . . 0.0 109.358 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.21 118.94 1.86 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.595 1.53 . . . . 0.0 112.065 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -73.68 -18.61 60.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.945 . . . . 0.0 109.371 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -77.94 106.38 9.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.354 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -57.04 -10.6 1.19 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -94.26 27.2 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 109.771 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -141.52 131.64 24.77 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.317 -0.865 . . . . 0.0 109.481 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 44.7 t -61.84 142.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.472 -0.768 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.55 -23.78 14.97 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.496 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -174.2 -163.25 27.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 34.7 m-85 -149.88 130.84 14.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 0.0 109.539 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tt -95.62 144.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -146.04 142.09 28.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.037 -1.039 . . . . 0.0 110.343 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.5 mt -150.13 132.23 7.87 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.09 -49.28 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.883 1.722 . . . . 0.0 111.882 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -51.75 -30.02 21.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.601 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.67 3.29 26.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.371 -0.83 . . . . 0.0 108.895 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.1 p30 43.61 30.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.28 147.66 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.898 0.856 . . . . 0.0 109.79 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -165.35 84.51 0.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.458 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 18.9 mt-10 -132.84 159.36 72.88 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.327 -0.858 . . . . 0.0 111.052 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.21 163.59 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.273 2.649 . . . . 0.0 113.32 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.79 132.54 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 42.2 m-85 -87.44 146.18 39.12 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.818 -1.176 . . . . 0.0 109.872 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.52 88.83 1.23 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.909 1.739 . . . . 0.0 111.365 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.19 -170.97 34.41 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.522 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 95.6 Cg_endo -81.11 117.97 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.883 2.389 . . . . 0.0 111.513 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.03 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.301 0.572 . . . . 0.0 110.724 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.7 OUTLIER -110.6 155.76 41.62 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 56.8 Cg_endo -69.93 -44.15 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.223 1.949 . . . . 0.0 112.036 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -62.93 -26.2 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.618 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -84.12 -62.62 1.52 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.159 -0.963 . . . . 0.0 109.039 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -49.28 -11.99 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.3 m120 -61.93 -27.75 69.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' C ' ' HH ' ' A' ' 30' ' ' TYR . 49.2 mtp180 -91.4 -10.88 39.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' C ' HE22 ' A' ' 71' ' ' GLN . . . 164.12 -139.45 5.86 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.259 -1.448 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 t -110.67 164.59 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.438 -1.037 . . . . 0.0 109.329 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -158.86 157.14 30.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.182 -0.949 . . . . 0.0 108.623 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.536 ' CE2' ' OE1' ' A' ' 50' ' ' GLU . 46.9 m-85 -58.04 175.92 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.863 -1.148 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -89.0 -3.35 58.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.457 -0.777 . . . . 0.0 109.126 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -153.97 145.82 23.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.287 -0.883 . . . . 0.0 109.966 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -62.49 -31.17 71.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -86.86 6.94 29.33 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.953 -1.092 . . . . 0.0 110.893 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 11.9 tm-20 -61.79 152.19 32.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 53' ' ' ASP . 76.5 p -146.32 163.38 35.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.666 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -74.54 10.64 1.25 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.9 OUTLIER -124.0 -6.25 7.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.838 -0.539 . . . . 0.0 109.751 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.7 t70 -59.73 113.9 2.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.859 -1.15 . . . . 0.0 109.308 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -45.4 -18.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.277 -0.889 . . . . 0.0 109.631 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' OE1' ' A' ' 55' ' ' GLN . 4.0 m120 -133.27 98.66 4.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.498 -0.751 . . . . 0.0 109.051 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 57' ' ' ILE . 96.1 mt -96.68 113.31 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.698 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.5 m -108.6 120.23 41.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 87.1 mt -107.21 164.45 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.473 -0.767 . . . . 0.0 110.226 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -135.99 124.61 23.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.65 152.4 22.07 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 119.932 -1.128 . . . . 0.0 110.748 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 72' ' ' PHE . 34.0 m-70 -72.72 -179.93 3.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.758 -0.848 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 88.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.02 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -87.51 123.68 32.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 109.06 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 mt -63.76 -33.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.563 -0.71 . . . . 0.0 110.589 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -82.97 8.17 13.43 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 110.122 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.594 ' C ' ' H ' ' A' ' 69' ' ' ASN . 21.7 mmt180 -140.72 75.28 25.92 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 87.7 Cg_exo -48.64 5.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.621 2.881 . . . . 0.0 113.844 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.594 ' H ' ' C ' ' A' ' 67' ' ' ARG . 6.8 p30 -143.64 59.42 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.95 -1.094 . . . . 0.0 108.165 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.66 95.97 3.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.582 -0.699 . . . . 0.0 110.355 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.468 HE22 ' C ' ' A' ' 42' ' ' GLY . 1.1 mm100 61.0 -114.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.851 -0.53 . . . . 0.0 111.815 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 62' ' ' HIS . 2.3 t80 -91.93 26.85 2.29 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.138 -0.976 . . . . 0.0 110.803 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -69.22 -38.74 78.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.87 -1.144 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 15.6 m-20 -108.49 -17.0 14.09 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.226 -0.921 . . . . 0.0 111.072 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -25.33 13.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.729 -1.232 . . . . 0.0 108.36 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -81.88 -14.35 56.34 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -78.4 -16.57 57.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.03 -162.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -174.32 174.97 2.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -48.85 149.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 -11.27 7.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 57.8 m -62.21 94.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.117 -1.225 . . . . 0.0 108.64 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptm -66.32 162.19 20.75 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.195 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.82 174.3 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.865 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -144.71 108.83 4.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -0.899 . . . . 0.0 110.001 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -95.09 113.37 25.06 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -96.49 144.37 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 110.301 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 18.3 t -143.02 86.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.36 -133.37 42.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.86 37.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -1.223 . . . . 0.0 109.587 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 88' ' ' VAL . 21.1 mp0 -138.81 151.98 47.5 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.268 -0.895 . . . . 0.0 108.916 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.6 m -152.97 143.82 22.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.005 . . . . 0.0 110.099 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.406 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -144.33 170.61 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.413 -0.805 . . . . 0.0 108.98 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 24.8 pttm -142.87 162.0 36.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 5.9 m-85 -139.35 -175.67 4.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -136.79 110.58 8.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.457 ' C ' ' HG1' ' A' ' 98' ' ' THR . 36.0 tpp -50.89 104.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.431 -0.793 . . . . 0.0 109.05 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.457 ' HG1' ' C ' ' A' ' 97' ' ' MET . 3.1 m -143.84 35.32 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 143' ' ' VAL . 16.5 t -173.67 131.91 0.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.2 mt . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 109.008 -179.3 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 121.371 0.605 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 119' ' ' LYS . 12.2 mptt -46.29 162.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -157.18 145.0 19.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.154 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.2 tp -103.57 107.56 18.46 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 57' ' ' ILE . 10.5 m -92.54 146.76 23.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.62 152.24 50.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.284 -0.885 . . . . 0.0 110.489 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 mt -141.3 134.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 140' ' ' LYS . 1.1 p -92.21 160.61 15.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.932 -1.105 . . . . 0.0 108.423 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 56.6 m -144.97 140.1 27.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.06 -1.025 . . . . 0.0 109.943 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 2.0 p30 175.65 139.39 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.43 58.76 1.65 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.26 -0.9 . . . . 0.0 108.887 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.99 126.62 27.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 109.444 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -85.9 116.99 24.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.131 -0.981 . . . . 0.0 109.695 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -84.18 1.38 44.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -81.22 -52.18 7.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.328 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.6 p -95.65 -15.06 22.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.27 42.31 15.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -147.14 153.24 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.345 -1.091 . . . . 0.0 109.509 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 69.2 m95 -59.25 112.55 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 23.1 tt0 -35.24 -84.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -107.06 157.45 17.82 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.394 -0.816 . . . . 0.0 109.473 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -174.84 161.02 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' H ' HG21 ' A' ' 125' ' ' THR . 41.5 mttp -127.67 153.31 46.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 35.0 mm -115.91 139.12 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.583 0.706 . . . . 0.0 110.61 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -136.57 159.12 42.76 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 99' ' ' SER . 59.4 t -148.08 149.29 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.776 -1.202 . . . . 0.0 110.896 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.67 134.24 30.11 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.3 t -95.68 143.43 26.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 3.3 tm-20 -60.22 145.76 46.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 1.8 t . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 0.0 109.337 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.85 136.37 7.16 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.844 1.696 . . . . 0.0 112.196 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -87.44 -28.72 21.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.04 113.28 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -58.2 -11.78 2.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.328 -0.857 . . . . 0.0 109.626 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -79.95 21.04 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -147.51 136.16 21.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.057 -1.027 . . . . 0.0 109.659 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 61.3 t -60.36 161.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.699 0.761 . . . . 0.0 110.223 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.401 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -136.13 -9.58 2.01 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.05 -179.16 42.8 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.6 120.11 7.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.3 . . . . 0.0 109.172 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 tt -97.04 140.33 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -146.23 138.89 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.105 -0.997 . . . . 0.0 110.081 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 8.3 mt -146.4 127.13 7.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.6 -44.22 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.742 1.628 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.24 -17.67 0.75 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.293 -0.88 . . . . 0.0 109.819 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.406 ' O ' ' CG ' ' A' ' 24' ' ' ASP . . . -134.36 17.55 3.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.168 -0.958 . . . . 0.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.71 48.4 4.81 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.682 0.753 . . . . 0.0 109.912 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.3 mm -88.89 141.42 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.655 0.741 . . . . 0.0 109.543 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.31 82.69 0.17 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -143.13 156.78 61.39 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.139 -0.976 . . . . 0.0 110.561 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -83.49 165.72 14.12 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.888 2.392 . . . . 0.0 112.301 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.1 109.23 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.439 ' O ' ' OG ' ' A' ' 44' ' ' SER . 30.8 m-85 -65.84 139.51 96.88 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.705 -1.247 . . . . 0.0 109.1 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.53 109.23 2.59 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.824 1.682 . . . . 0.0 111.904 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.54 -174.47 39.76 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.135 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' THR . 74.3 Cg_endo -76.75 113.93 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.576 2.184 . . . . 0.0 110.969 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.58 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.438 0.637 . . . . 0.0 111.151 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.24 169.35 8.08 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.56 -27.53 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.632 1.555 . . . . 0.0 112.42 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.48 -33.66 75.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.647 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.85 -51.7 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 109.231 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.8 mt -46.88 -30.45 2.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.473 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -65.01 -27.32 68.74 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' GLN . 89.0 mtt180 -84.5 -19.61 32.98 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.67 -140.77 6.35 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.754 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.32 164.69 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.708 -0.878 . . . . 0.0 108.799 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.647 ' CB ' HE22 ' A' ' 38' ' ' GLN . 35.5 t -163.24 157.53 20.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.959 -1.088 . . . . 0.0 109.194 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 37.3 m-85 -59.67 161.86 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.354 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -86.56 5.28 36.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.39 142.03 9.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.717 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 -23.64 67.54 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.645 -0.659 . . . . 0.0 111.529 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -87.1 4.84 40.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.878 -1.139 . . . . 0.0 110.728 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -62.68 157.15 21.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 109.429 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.534 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -143.99 179.51 7.15 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -83.75 4.24 29.75 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -146.07 16.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.512 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.2 t70 -58.26 115.24 2.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.681 -1.262 . . . . 0.0 108.779 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -43.51 -19.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 54' ' ' ASP . 21.6 t-20 -135.17 97.24 3.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -94.85 151.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 109.347 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' ALA . 38.7 m -143.64 116.84 8.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 96.7 mt -112.59 162.57 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.738 0.78 . . . . 0.0 110.601 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -132.78 131.76 41.48 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.24 148.3 19.98 Favored Glycine 0 N--CA 1.505 3.286 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.323 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.716 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 41.5 m-70 -76.3 -169.89 1.31 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.646 -0.914 . . . . 0.0 110.422 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.519 ' O ' ' CG2' ' A' ' 63' ' ' THR . 14.7 t -158.82 83.44 0.81 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.75 0.786 . . . . 0.0 108.971 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.56 108.51 19.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.712 -1.243 . . . . 0.0 109.462 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 mm -60.06 -28.4 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 110.44 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -86.97 16.52 4.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 69' ' ' ASN . 33.2 ttm180 -150.56 72.99 9.02 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.81 14.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 123.909 3.073 . . . . 0.0 114.325 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 67' ' ' ARG . 8.8 p30 -148.47 62.63 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.802 -1.186 . . . . 0.0 108.572 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -151.47 98.79 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 4.1 mt-30 60.99 -127.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 111.179 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.71 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -92.01 59.08 3.51 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.682 1.23 . . . . 0.0 109.574 -178.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 m -91.17 -24.77 19.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.202 -1.561 . . . . 0.0 108.632 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -136.77 -0.97 2.28 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 -178.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -10.22 0.28 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.403 -1.435 . . . . 0.0 108.042 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.48 -37.59 50.95 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -27.6 69.13 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.06 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -175.11 171.51 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 109.919 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -51.14 101.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.5 -29.85 2.46 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.444 ' OG ' ' CG2' ' A' ' 20' ' ' ILE . 14.1 t -62.81 108.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.2 mtp -62.83 174.99 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.642 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.09 108.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.97 104.91 17.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 109.942 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -94.53 111.94 23.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -102.01 144.64 30.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 110.459 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 p -170.24 128.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.557 -0.714 . . . . 0.0 109.268 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.19 -120.42 19.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.19 35.05 4.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.956 . . . . 0.0 109.117 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.3 133.61 16.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 108.944 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.8 t -119.01 133.91 55.53 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.674 0.749 . . . . 0.0 110.172 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -94.89 172.07 8.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -147.53 96.51 2.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.915 -1.116 . . . . 0.0 110.226 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 24.7 m-85 -87.57 -173.72 4.47 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.015 -1.053 . . . . 0.0 108.594 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER -150.25 111.55 4.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.138 -0.976 . . . . 0.0 109.886 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtp -48.67 117.27 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.326 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -158.54 21.11 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.053 -1.029 . . . . 0.0 109.555 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 11.2 p -167.83 86.04 0.22 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.635 -1.291 . . . . 0.0 109.299 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 179.354 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 119' ' ' LYS . 33.2 t0 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 16.8 ttmm -34.54 132.79 0.28 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.91 175.03 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.6 tp -128.82 102.97 6.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -93.03 87.24 5.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.185 -0.947 . . . . 0.0 109.151 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.82 152.3 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.909 -1.119 . . . . 0.0 109.256 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -129.03 151.56 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.669 -0.645 . . . . 0.0 109.29 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.403 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 52.0 p -96.37 153.3 17.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.154 -0.967 . . . . 0.0 108.568 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.77 97.88 2.97 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.968 -1.083 . . . . 0.0 109.799 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 p30 -147.25 136.18 22.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 108.75 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 127' ' ' ASP . 1.5 m-20 70.84 64.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 109.576 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.99 125.75 25.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 0.0 109.865 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -86.87 125.74 34.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.135 -0.978 . . . . 0.0 109.399 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.72 4.5 47.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 109.811 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.67 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.408 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.8 p -95.21 -3.14 48.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.37 45.4 54.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 165.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -1.146 . . . . 0.0 109.24 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLU . 81.4 m95 -68.86 114.38 7.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.189 -0.945 . . . . 0.0 108.696 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.3 tp10 -35.42 -86.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.24 0.543 . . . . 0.0 110.325 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -103.76 148.86 25.58 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -157.19 138.9 14.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.792 -1.192 . . . . 0.0 110.618 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -99.76 166.35 11.14 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.3 132.84 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.435 -0.79 . . . . 0.0 110.157 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -141.34 147.25 37.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.529 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 19.2 t -135.94 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.077 -1.015 . . . . 0.0 111.296 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.15 -178.54 3.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.0 t -144.85 141.01 28.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.91 -1.119 . . . . 0.0 109.377 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -57.67 147.27 28.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.81 . . . . 0.0 109.555 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mm . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.08 168.56 0.36 Allowed 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.466 2.111 . . . . 0.0 112.446 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 -14.99 16.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.401 -0.812 . . . . 0.0 109.176 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 12' ' ' SER . 0.8 OUTLIER -76.71 107.45 9.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.587 ' CB ' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -60.52 -3.44 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.0 109.293 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 10' ' ' ASP . 80.9 p -116.69 44.23 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -150.46 128.13 11.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.32 -0.862 . . . . 0.0 109.262 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -55.33 158.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 111.278 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.7 2.39 1.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 173.68 -175.44 46.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 67.3 m-85 -150.34 126.74 10.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.109 -1.23 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 tt -95.66 147.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -149.84 134.88 17.94 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.807 -1.183 . . . . 0.0 110.95 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.4 mt -145.49 124.79 6.81 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.2 -41.19 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.65 1.567 . . . . 0.0 111.724 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.92 -17.95 1.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.6 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 24' ' ' ASP . . . -130.01 13.49 5.73 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.523 -0.736 . . . . 0.0 109.553 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.8 p30 42.23 36.4 0.72 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 mt -90.58 140.97 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -165.92 86.89 0.36 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.62 159.15 70.2 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.474 -0.767 . . . . 0.0 110.441 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.58 164.0 10.79 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.061 2.507 . . . . 0.0 112.952 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.18 113.5 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.29 168.34 13.75 Favored Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.776 -1.202 . . . . 0.0 109.801 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.91 124.49 4.47 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.894 2.396 . . . . 0.0 111.831 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.99 170.55 30.11 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.29 -1.434 . . . . 0.0 110.45 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 35' ' ' THR . 98.5 Cg_endo -78.43 117.29 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.79 2.327 . . . . 0.0 111.256 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.79 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.534 -0.729 . . . . 0.0 109.996 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -122.96 155.41 63.94 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 19.5 Cg_endo -58.25 -48.1 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.902 1.735 . . . . 0.0 111.191 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -63.01 -19.53 64.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.89 . . . . 0.0 109.205 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.569 ' C ' ' H ' ' A' ' 40' ' ' ASN . 19.5 tp60 -89.63 -69.51 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.006 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.1 mt -52.57 -3.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.569 ' H ' ' C ' ' A' ' 38' ' ' GLN . 16.5 m-20 -59.54 -28.62 67.26 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.906 -1.121 . . . . 0.0 108.744 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' CD ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -87.79 -18.94 28.23 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.38 -127.52 1.73 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.267 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.53 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.8 t -101.66 157.11 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.538 -0.978 . . . . 0.0 109.97 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' HG ' ' C ' ' A' ' 43' ' ' VAL . 6.3 m -155.58 151.82 28.02 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -56.53 170.2 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.751 -1.218 . . . . 0.0 109.829 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.43 -3.39 52.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.822 . . . . 0.0 109.06 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -153.57 150.49 28.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.0 109.874 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 13.1 pt-20 -62.73 -40.73 98.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.544 -0.722 . . . . 0.0 111.422 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 6.4 t-20 -88.44 18.64 4.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 7.7 tp10 -62.92 139.44 58.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.718 -1.238 . . . . 0.0 109.696 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 53' ' ' ASP . 16.1 m -146.51 152.51 39.1 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.568 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -60.39 -5.66 1.24 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 51' ' ' SER . 5.1 m-20 -75.85 -33.08 60.01 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.677 -0.639 . . . . 0.0 109.679 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 56' ' ' ASN . 51.3 m-20 -59.84 111.22 1.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.295 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.533 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -48.41 -14.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 108.819 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.6 t30 -125.69 108.02 11.13 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.39 117.65 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.009 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -108.6 108.96 20.04 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.66 161.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.475 -0.766 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -132.61 137.29 46.99 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.21 147.86 19.26 Favored Glycine 0 N--CA 1.5 2.965 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.998 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.73 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 18.7 m-70 -75.79 -165.52 0.46 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.885 -0.774 . . . . 0.0 110.278 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.95 88.86 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -88.15 108.97 19.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.055 -1.028 . . . . 0.0 109.084 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 mt -57.48 -27.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.465 -0.772 . . . . 0.0 109.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.6 12.1 5.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.007 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.606 ' C ' ' H ' ' A' ' 69' ' ' ASN . 87.1 mtt180 -150.94 74.79 8.42 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 80.9 Cg_exo -48.62 7.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 123.629 2.886 . . . . 0.0 113.927 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.606 ' H ' ' C ' ' A' ' 67' ' ' ARG . 44.8 p30 -142.21 58.81 1.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 71' ' ' GLN . 61.7 t80 -141.49 100.21 3.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.427 -0.796 . . . . 0.0 110.387 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.73 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 5.1 mt-30 60.75 -124.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.512 -0.742 . . . . 0.0 111.245 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.673 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -91.95 34.72 0.99 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 122.772 1.272 . . . . 0.0 109.297 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.9 m -73.6 -26.66 60.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.421 -2.049 . . . . 0.0 108.855 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 22.0 m-20 -133.55 -4.42 2.94 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.266 -0.897 . . . . 0.0 110.775 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.9 -23.42 7.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.733 -1.229 . . . . 0.0 108.775 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -2.09 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.949 -1.094 . . . . 0.0 108.388 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -91.56 -33.55 15.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.76 179.56 0.12 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.171 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -148.84 170.77 17.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.16 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -49.14 149.14 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 109.034 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.3 -23.13 23.15 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.9 t -62.45 103.08 0.37 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 58.2 mmm -62.01 171.25 1.79 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.162 -0.962 . . . . 0.0 110.149 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -141.38 110.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.44 102.44 15.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -95.42 113.7 25.39 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -85.78 143.22 28.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.565 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 t -148.2 84.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.42 -128.04 27.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -95.28 37.36 1.18 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.174 -1.192 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 92' ' ' THR . 1.2 tm-20 -163.17 114.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.076 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 91' ' ' GLU . 9.8 t -107.35 147.1 30.75 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.426 -0.797 . . . . 0.0 110.082 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 93' ' ' ARG . 9.2 mmm-85 -93.7 172.9 7.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.498 -0.751 . . . . 0.0 109.369 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -146.36 92.94 2.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.105 -0.997 . . . . 0.0 109.999 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.431 ' O ' ' SD ' ' A' ' 83' ' ' MET . 22.7 m-85 -87.38 -176.39 5.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.904 -1.122 . . . . 0.0 108.726 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -147.33 107.93 4.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.239 -0.913 . . . . 0.0 109.428 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 23.9 mtt -48.29 117.83 2.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.1 p -142.92 8.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.259 -0.901 . . . . 0.0 109.143 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 143' ' ' VAL . 30.9 t -164.87 107.98 0.87 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 108.646 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.522 -0.736 . . . . 0.0 109.544 -178.807 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 120' ' ' GLN . 14.3 t70 . . . . . 0 N--CA 1.501 2.102 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 18.7 mmmt -26.93 84.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.484 0.659 . . . . 0.0 110.842 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.8 pm0 -99.36 170.03 8.93 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.585 0.707 . . . . 0.0 110.664 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.97 102.5 8.04 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -94.93 87.55 5.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.131 -0.981 . . . . 0.0 109.355 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.5 132.53 35.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.89 -1.131 . . . . 0.0 109.367 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.7 mt -113.96 159.86 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.501 0.667 . . . . 0.0 109.534 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 p -97.2 167.24 11.16 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.62 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.551 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 1.7 m -149.96 84.59 1.4 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.153 -0.967 . . . . 0.0 109.348 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 128' ' ' ASP . 15.0 t70 -148.22 129.0 14.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.976 -1.078 . . . . 0.0 108.953 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 4.5 t0 78.92 60.72 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.85 127.71 33.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.817 -1.177 . . . . 0.0 110.067 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -85.79 123.71 31.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.07 -1.019 . . . . 0.0 109.501 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.487 ' N ' HD21 ' A' ' 130' ' ' ASN . 19.0 pt-20 -98.39 8.4 44.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.263 -0.898 . . . . 0.0 109.78 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.536 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 33.3 mtpt -86.89 -20.22 27.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.7 p -140.29 0.69 1.72 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.5 49.04 53.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.72 137.79 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -1.156 . . . . 0.0 109.305 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 51.5 m95 -52.6 112.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.934 -1.104 . . . . 0.0 108.43 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 136' ' ' TRP . 8.2 tp10 -37.6 -81.14 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.904 -0.498 . . . . 0.0 110.174 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -103.67 139.15 39.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.486 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.1 OUTLIER -147.25 114.21 6.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.896 -1.128 . . . . 0.0 110.415 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -95.53 166.69 11.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.2 pt -147.95 162.42 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.89 -1.131 . . . . 0.0 110.919 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.8 m-85 -137.41 150.49 47.69 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 99' ' ' SER . 21.7 t -132.62 111.73 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.179 -0.951 . . . . 0.0 111.161 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.75 177.59 4.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.7 t -144.66 139.35 27.96 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.978 -1.076 . . . . 0.0 109.726 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.08 144.81 44.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 m . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.603 -179.799 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.6 155.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.807 1.672 . . . . 0.0 112.525 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -102.65 -19.01 14.97 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.0 109.455 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.9 m-20 -77.22 110.31 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -58.0 -3.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.428 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.8 t -111.99 41.63 1.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.487 -0.758 . . . . 0.0 109.473 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -149.11 133.79 17.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 61.5 t -58.86 161.0 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 110.95 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -139.97 -0.8 1.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 172.73 -173.71 45.54 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 44.2 m-85 -150.09 128.68 12.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.294 -1.121 . . . . 0.0 109.923 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -95.0 146.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -149.79 119.6 7.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.819 -1.175 . . . . 0.0 111.171 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 mp -131.52 127.12 21.46 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 23' ' ' ALA . 71.9 Cg_endo -76.37 -42.71 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.53 1.486 . . . . 0.0 111.483 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 40.8 t0 -52.25 -10.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.423 -0.798 . . . . 0.0 109.473 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -140.59 15.45 2.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ALA . 2.3 p-10 41.68 49.6 3.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.078 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.2 mm -91.27 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.674 0.749 . . . . 0.0 109.71 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -170.27 80.94 0.1 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -142.03 157.52 63.77 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 110.536 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.03 162.0 15.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.099 2.533 . . . . 0.0 113.068 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.92 109.23 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.67 168.77 22.92 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 120.753 -1.217 . . . . 0.0 109.505 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -88.21 117.12 1.01 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 122.726 2.284 . . . . 0.0 112.032 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.6 175.92 40.91 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.108 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 80.6 Cg_endo -78.35 115.52 3.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.808 2.339 . . . . 0.0 111.271 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.95 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.611 -0.681 . . . . 0.0 110.084 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.5 p -120.15 152.99 55.29 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.39 -41.29 79.57 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.985 1.79 . . . . 0.0 111.745 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.13 -22.84 67.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 109.62 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -90.89 -70.31 0.69 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.489 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.1 mt -43.87 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 109.916 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 38' ' ' GLN . 19.6 m-20 -60.99 -24.17 65.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -90.95 -10.73 41.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.1 -115.72 0.68 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.6 t -126.16 154.95 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 5.1 m -150.68 155.13 38.72 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -56.28 173.88 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.65 -1.281 . . . . 0.0 109.391 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.01 -13.39 58.9 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -146.31 153.19 40.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.269 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -63.71 -41.24 98.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.525 -0.734 . . . . 0.0 111.394 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -86.92 12.61 10.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.037 -1.039 . . . . 0.0 111.012 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.57 90.78 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.96 -1.087 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 53' ' ' ASP . 17.4 m -89.37 151.64 21.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 108.671 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.4 0.67 1.4 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' SER . 45.3 m-20 -95.88 -14.37 23.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.651 -0.656 . . . . 0.0 109.339 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.9 t0 -58.35 119.28 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.039 -1.038 . . . . 0.0 109.571 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.99 -14.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.72 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' ASP . 40.5 t30 -145.56 109.95 4.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 0.0 108.97 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -95.29 154.9 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 108.98 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.6 t -143.67 123.28 13.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 90.2 mt -110.59 162.23 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.453 -0.779 . . . . 0.0 110.597 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.432 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -139.97 131.12 26.44 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.29 156.34 26.07 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 119.88 -1.153 . . . . 0.0 110.527 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -72.08 177.02 4.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.539 -0.977 . . . . 0.0 109.47 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.5 87.16 0.75 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.297 -0.877 . . . . 0.0 109.65 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.13 102.69 15.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.292 -0.88 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 mt -53.02 -23.69 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.218 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.03 13.96 3.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.115 -0.99 . . . . 0.0 109.451 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' ASN . 19.5 ttm-85 -152.66 74.95 7.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 109.282 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.43 20.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 123.911 3.074 . . . . 0.0 114.495 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.22 62.8 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.893 -1.129 . . . . 0.0 108.609 179.217 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -151.32 123.53 8.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.097 -1.002 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 61.1 mt-30 40.9 -115.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.812 -0.555 . . . . 0.0 111.357 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -98.03 9.22 43.34 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -49.34 -22.25 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.544 -1.347 . . . . 0.0 109.556 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 77' ' ' ALA . 4.0 t-20 -119.57 -22.35 6.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.863 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.423 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 2.7 tm? -53.26 -35.7 60.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.068 -1.02 . . . . 0.0 108.57 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -72.31 -4.37 29.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.308 -0.87 . . . . 0.0 108.689 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -89.81 -28.37 19.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.6 -172.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.767 . . . . 0.0 109.678 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.432 ' O ' ' OG ' ' A' ' 82' ' ' SER . 14.4 pttm -162.07 -177.64 5.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.882 . . . . 0.0 109.071 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 82' ' ' SER . 26.9 mtmm -49.78 155.89 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.005 -1.06 . . . . 0.0 109.288 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.75 -18.86 4.48 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 80' ' ' LYS . 73.7 m -63.89 98.93 0.22 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.327 -1.102 . . . . 0.0 108.437 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.7 mtm -62.24 -179.32 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.616 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -149.2 108.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.412 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.15 102.38 15.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.128 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.403 ' CZ ' ' CG1' ' A' ' 88' ' ' VAL . 43.4 t80 -95.66 111.99 23.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -95.89 134.22 39.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.159 -0.963 . . . . 0.0 111.384 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.403 ' CG1' ' CZ ' ' A' ' 86' ' ' PHE . 2.0 m -153.33 134.7 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.29 -138.95 26.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -101.62 43.98 1.04 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.31 -1.112 . . . . 0.0 109.665 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -162.24 136.44 6.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.315 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -117.28 140.53 49.44 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.521 -0.737 . . . . 0.0 110.081 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -93.26 168.29 11.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.572 -0.705 . . . . 0.0 109.301 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 15.5 pttp -145.8 118.89 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.995 . . . . 0.0 109.935 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.51 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 27.5 m-85 -116.44 168.48 10.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -130.22 108.98 10.44 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.239 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.421 ' O ' ' OG1' ' A' ' 98' ' ' THR . 32.5 tpp -50.89 135.09 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.514 -0.741 . . . . 0.0 109.237 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 97' ' ' MET . 2.5 m -166.28 19.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.883 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.8 t -164.88 92.34 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.887 . . . . 0.0 109.498 -179.397 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.5 m-20 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' ASP . 13.3 mptt -43.38 130.31 4.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.243 -0.911 . . . . 0.0 109.448 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.71 172.67 12.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.7 tp -118.51 156.34 29.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.661 -0.649 . . . . 0.0 110.019 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.503 ' HG1' HD22 ' A' ' 56' ' ' ASN . 53.1 m -134.77 88.38 2.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.51 145.54 52.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 110.883 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.5 mt -138.55 138.26 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.542 -0.724 . . . . 0.0 109.158 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -102.2 156.85 17.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 85.5 m -144.76 138.06 26.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.944 -1.098 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 4.3 t0 178.96 146.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 108.891 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 8.3 t70 60.59 54.3 3.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -61.68 121.25 12.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.116 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -86.25 121.88 29.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.757 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.5 pm0 -87.08 6.72 31.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.45 -50.83 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.4 p -97.67 -14.39 20.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 108.952 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.02 17.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.12 163.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -1.141 . . . . 0.0 109.717 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' O ' ' C ' ' A' ' 137' ' ' GLU . 73.4 m95 -68.24 114.71 6.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -37.18 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.218 0.532 . . . . 0.0 110.181 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -93.94 153.18 18.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -156.51 94.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.852 -1.155 . . . . 0.0 110.71 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -86.79 159.39 19.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 9.8 pt -145.82 159.57 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.842 -1.162 . . . . 0.0 110.685 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.4 m-85 -139.95 168.42 19.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.19 142.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.802 -1.186 . . . . 0.0 110.423 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.16 147.85 40.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 147' ' ' VAL . 13.0 t -108.63 140.36 42.12 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.51 ' OE1' ' CD2' ' A' ' 95' ' ' TYR . 3.2 tp10 -65.72 45.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.4 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.118 -0.988 . . . . 0.0 109.223 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -41.08 143.3 0.7 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.304 2.003 . . . . 0.0 113.356 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -87.19 -16.24 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.148 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 12' ' ' SER . 12.9 m-20 -77.7 105.62 8.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 109.451 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 1.9 mptp? -58.56 -2.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.443 -0.786 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 10' ' ' ASP . 39.7 m -113.94 43.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 134.41 25.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.942 . . . . 0.0 109.04 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.6 115.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.818 . . . . 0.0 110.932 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.76 -4.53 43.82 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.53 -168.85 41.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.54 124.77 10.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.178 -1.189 . . . . 0.0 109.071 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.7 tt -98.91 147.38 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.18 145.95 30.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.01 -1.056 . . . . 0.0 109.828 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -147.86 131.82 8.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -52.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.981 1.787 . . . . 0.0 111.833 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -50.88 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 109.301 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.55 3.08 17.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.521 -0.737 . . . . 0.0 109.073 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 43.39 37.1 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.573 -0.705 . . . . 0.0 109.646 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -92.91 152.19 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 122.214 1.006 . . . . 0.0 110.665 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -166.07 82.64 0.3 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -132.4 158.69 74.97 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.47 -0.769 . . . . 0.0 110.694 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.67 162.01 21.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.006 2.47 . . . . 0.0 112.654 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -138.16 104.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -76.65 166.13 47.23 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.785 -1.197 . . . . 0.0 109.377 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -89.77 120.04 0.89 Allowed 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.488 2.126 . . . . 0.0 111.818 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.09 -178.4 43.53 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 35' ' ' THR . 88.3 Cg_endo -81.22 116.63 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.919 2.413 . . . . 0.0 111.712 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.61 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.765 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -119.62 153.9 54.43 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 22.4 Cg_endo -60.35 -45.12 23.93 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.127 1.884 . . . . 0.0 111.803 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -63.28 -27.8 69.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 109.698 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -86.51 -68.33 0.75 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -46.82 -14.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.738 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.6 m-20 -63.89 -24.96 67.94 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -80.14 -20.92 43.8 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.085 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' OE1' ' A' ' 71' ' ' GLN . . . 159.29 -119.29 0.88 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.55 157.8 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.605 -0.938 . . . . 0.0 110.102 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 158.9 37.86 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -56.18 173.37 0.16 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.716 -1.24 . . . . 0.0 109.355 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.1 -14.48 55.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.895 . . . . 0.0 109.139 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -146.78 145.62 29.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 110.063 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -24.41 67.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.52 -0.737 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -88.75 3.24 51.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.0 150.3 45.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 109.758 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 45.9 m -149.04 159.6 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.483 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -69.64 -4.22 18.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -99.52 -15.34 18.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.683 . . . . 0.0 109.932 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 51' ' ' SER . 31.2 m-20 -60.14 107.61 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.716 -1.24 . . . . 0.0 109.203 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -45.75 -18.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.379 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.4 t-20 -127.81 98.31 5.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 57' ' ' ILE . 96.6 mt -94.51 154.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 109.277 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 46' ' ' ALA . 58.6 m -145.38 117.59 8.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.62 158.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 110.22 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.52 136.61 34.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.95 156.38 25.93 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -71.77 178.41 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.484 -1.009 . . . . 0.0 109.535 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.462 ' CG2' ' OD1' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -163.52 86.51 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.42 -0.8 . . . . 0.0 109.28 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -88.41 119.34 28.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.7 -30.9 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.074 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -82.9 15.94 2.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 109.566 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.592 ' C ' ' H ' ' A' ' 69' ' ' ASN . 54.7 ttt180 -150.32 70.97 9.17 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.19 18.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.843 3.028 . . . . 0.0 114.36 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.2 63.41 0.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.783 -1.198 . . . . 0.0 108.651 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -151.09 110.77 4.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 64.2 mt-30 54.81 -115.5 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.712 -0.618 . . . . 0.0 111.918 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 74' ' ' ASN . 3.1 m-85 -96.21 10.98 36.07 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.186 -0.946 . . . . 0.0 110.559 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.4 m -49.08 -18.01 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 77' ' ' ALA . 4.0 m-20 -122.05 -23.58 5.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.398 -0.814 . . . . 0.0 110.032 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.2 -29.0 44.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.768 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -75.4 -7.2 53.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -88.41 -24.0 23.17 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.73 -178.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.584 -0.697 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' CB ' ' HZ1' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -153.23 162.86 40.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -52.98 133.03 38.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.57 -5.06 66.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 83' ' ' MET . 25.8 t -63.33 -161.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.055 -1.262 . . . . 0.0 108.174 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.521 ' N ' ' OG ' ' A' ' 82' ' ' SER . 50.1 mmm -142.61 162.27 35.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 109.739 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 t -146.15 155.45 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.236 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.83 107.9 5.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.287 -0.883 . . . . 0.0 109.207 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -95.02 112.28 24.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -97.99 138.98 34.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.7 m -144.06 150.19 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.32 -14.83 0.06 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 88' ' ' VAL . 48.2 t30 -84.02 -58.48 2.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.035 -1.274 . . . . 0.0 109.999 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' H ' HG22 ' A' ' 88' ' ' VAL . 20.1 tt0 -172.08 171.68 4.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 108.904 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -97.61 149.7 21.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.202 -0.936 . . . . 0.0 110.037 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.65 169.5 17.52 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.524 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.78 156.49 44.99 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.05 -1.031 . . . . 0.0 110.911 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.527 ' CE2' ' OE1' ' A' ' 146' ' ' GLU . 6.5 m-85 -136.5 -178.07 5.01 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -145.68 116.45 7.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.164 -0.96 . . . . 0.0 109.054 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 40.2 mtt -51.03 111.98 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.438 -0.788 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -140.04 28.98 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.369 -0.832 . . . . 0.0 108.916 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 p -178.95 141.91 0.19 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -178.632 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 119' ' ' LYS . 4.4 mptp? -46.83 137.54 7.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 108.54 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -150.05 152.04 34.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 110.528 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.28 117.32 30.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.949 -0.47 . . . . 0.0 110.22 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 m -92.41 88.17 6.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.0 mt -68.28 138.33 55.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.697 . . . . 0.0 109.986 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.2 mt -137.87 148.31 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.391 -0.818 . . . . 0.0 109.604 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -102.94 169.01 8.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.427 -0.796 . . . . 0.0 108.907 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 34.5 m -148.49 138.93 22.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.993 -1.067 . . . . 0.0 109.619 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.462 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 0.3 OUTLIER 175.3 140.23 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 109.078 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 t0 59.86 66.36 1.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 108.986 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -65.52 127.53 32.23 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 109.668 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -84.77 124.94 32.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.027 -1.045 . . . . 0.0 109.759 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.3 6.25 48.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.461 -0.774 . . . . 0.0 109.228 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -88.36 -19.73 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.808 . . . . 0.0 109.681 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.7 p -137.29 -2.36 2.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.382 -0.824 . . . . 0.0 109.323 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.42 44.29 59.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.78 154.34 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.63 112.99 3.07 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.3 tp10 -37.96 -82.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.93 -0.481 . . . . 0.0 110.691 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' CB ' ' NZ ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -105.24 140.34 38.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.481 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -170.45 138.84 1.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.9 160.58 21.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.89 159.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.833 -1.167 . . . . 0.0 110.92 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 4.8 m-85 -132.66 177.45 7.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.4 t -150.66 133.61 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.852 -1.155 . . . . 0.0 110.586 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.57 15.03 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 147' ' ' VAL . 12.6 t -139.93 147.33 40.39 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.0 -1.063 . . . . 0.0 110.853 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.527 ' OE1' ' CE2' ' A' ' 95' ' ' TYR . 18.2 tp10 -65.51 48.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.778 -0.576 . . . . 0.0 109.459 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 145' ' ' THR . 2.0 t . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.084 -1.01 . . . . 0.0 108.961 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -41.39 130.58 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.818 1.679 . . . . 0.0 112.51 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -78.03 -29.27 49.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.503 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 12' ' ' SER . 40.3 m-20 -77.28 112.65 14.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -58.66 -2.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.524 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.2 m -105.68 38.84 1.89 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.345 -0.847 . . . . 0.0 109.543 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -142.51 126.37 17.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.302 -0.874 . . . . 0.0 109.261 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.435 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 24.9 t -59.62 132.34 24.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.914 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.07 -10.61 21.34 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 176.16 -161.13 29.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 66.0 m-85 -148.9 131.58 15.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.768 -1.43 . . . . 0.0 110.179 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -98.16 142.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -145.38 133.26 21.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.996 -1.065 . . . . 0.0 110.166 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 20' ' ' ILE . 53.5 mt -142.63 125.94 9.37 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.98 -44.35 0.21 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.707 1.604 . . . . 0.0 111.956 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -53.17 -20.48 3.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.087 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.6 8.33 10.09 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.4 p30 43.15 31.71 0.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.593 -0.692 . . . . 0.0 110.01 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 mt -91.08 143.2 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -164.2 85.89 0.46 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.4 159.6 68.76 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 110.624 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.06 162.01 26.28 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.048 2.499 . . . . 0.0 113.036 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -139.63 115.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.442 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.73 170.37 13.19 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 120.794 -1.191 . . . . 0.0 108.733 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -89.16 130.91 2.1 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.451 2.101 . . . . 0.0 112.194 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' PHE . . . 164.74 175.08 35.17 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.612 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 35' ' ' THR . 61.9 Cg_endo -85.95 128.01 3.17 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.909 2.406 . . . . 0.0 111.589 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . -38.84 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.662 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -118.79 154.13 52.71 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.76 -41.37 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.267 1.978 . . . . 0.0 111.89 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -63.08 -21.28 66.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 109.588 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -94.64 -70.08 0.72 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.296 -0.877 . . . . 0.0 109.269 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.7 mt -44.29 -26.29 0.31 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -61.11 -24.17 66.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 26.9 mtt-85 -89.13 -11.76 42.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.32 -122.33 1.14 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.222 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.438 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 18.2 t -122.3 151.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.61 -0.936 . . . . 0.0 109.094 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.481 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 m -151.23 151.01 31.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 32' ' ' GLY . 27.7 m-85 -55.4 155.78 4.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.544 -1.348 . . . . 0.0 108.41 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.43 4.88 25.74 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.265 -0.897 . . . . 0.0 109.04 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -149.99 130.83 14.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.403 -0.811 . . . . 0.0 110.109 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.76 -22.83 65.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.775 . . . . 0.0 110.486 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.0 -2.8 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.035 -1.041 . . . . 0.0 110.075 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -60.45 163.55 5.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 109.081 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -145.43 -167.97 2.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 108.893 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.441 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 4.4 mp -95.05 11.64 31.35 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.215 -0.928 . . . . 0.0 109.079 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.92 12.38 0.44 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.541 ' CG ' HE22 ' A' ' 55' ' ' GLN . 19.6 t0 -57.03 120.38 7.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.756 -1.215 . . . . 0.0 108.751 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.694 HE21 ' N ' ' A' ' 56' ' ' ASN . 1.1 pm0 -45.86 -15.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.694 ' N ' HE21 ' A' ' 55' ' ' GLN . 4.8 m120 -136.12 99.32 4.1 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.0 mm -93.26 153.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.03 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 t -142.02 103.29 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.3 mt -100.4 158.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.854 0.835 . . . . 0.0 110.336 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.12 134.7 34.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.87 27.43 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.684 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' PHE . 14.3 m-70 -76.49 178.4 6.65 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.585 -0.95 . . . . 0.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.48 90.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 108.74 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.556 ' N ' ' HG1' ' A' ' 73' ' ' THR . 5.3 m-85 -87.48 110.54 20.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.199 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 mm -58.32 -30.68 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 110.155 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -87.96 19.38 3.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.13 -0.981 . . . . 0.0 109.465 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.552 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -149.88 74.5 9.33 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.433 -0.792 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.1 Cg_exo -56.06 26.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 123.48 2.787 . . . . 0.0 113.524 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -150.57 29.21 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.835 -1.166 . . . . 0.0 109.073 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.8 t80 -89.28 -153.2 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -0.956 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.4 mp0 -71.29 -84.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.711 0.767 . . . . 0.0 110.808 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -94.78 19.45 10.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.677 -0.639 . . . . 0.0 109.968 -178.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.556 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 55.5 m -69.74 -38.19 76.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.326 -1.484 . . . . 0.0 109.93 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 77' ' ' ALA . 16.0 m-20 -103.92 -10.28 18.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.182 -0.948 . . . . 0.0 111.46 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.16 -29.27 30.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.406 -1.433 . . . . 0.0 108.365 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 10.6 pttp -80.36 -10.44 59.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -79.51 -23.37 42.98 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.85 -175.34 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLY . 34.3 mttm -150.53 154.98 38.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.029 -1.045 . . . . 0.0 109.686 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -51.06 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 109.734 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 150.84 -20.93 1.0 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.66 ' HG ' ' H ' ' A' ' 83' ' ' MET . 5.5 t -66.03 -165.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.104 -1.233 . . . . 0.0 108.185 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.66 ' H ' ' HG ' ' A' ' 82' ' ' SER . 45.3 mmm -137.88 171.65 14.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.14 108.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.0 109.145 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -93.37 109.37 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' O ' ' OG1' ' A' ' 92' ' ' THR . 39.9 t80 -94.76 116.89 29.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -85.24 139.11 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 111.115 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 4.3 m -147.78 124.98 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.53 -132.79 35.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.477 ' N ' ' OE2' ' A' ' 91' ' ' GLU . 49.8 t30 -97.95 35.98 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -1.198 . . . . 0.0 109.832 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.477 ' OE2' ' N ' ' A' ' 90' ' ' ASN . 1.2 pm0 -159.64 170.0 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -0.979 . . . . 0.0 108.955 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 86' ' ' PHE . 6.3 t -141.26 150.22 42.33 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.714 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -92.29 175.53 6.81 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -146.87 133.48 19.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 1.7 m-85 -138.85 126.84 22.42 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HZ2' ' CG2' ' A' ' 147' ' ' VAL . 4.1 ttpm? -93.95 120.39 34.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 109.399 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 85.2 mtp -48.13 120.64 3.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.791 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 p -149.83 31.62 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.37 -0.831 . . . . 0.0 109.304 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 m -171.54 86.95 0.09 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.834 -179.192 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.471 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 2.2 m-20 . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 118' ' ' ASP . 58.2 mttm -44.7 147.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -150.6 150.74 31.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.677 -1.265 . . . . 0.0 110.791 -178.036 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.38 111.9 24.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.88 -0.513 . . . . 0.0 109.753 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 m -98.04 120.79 39.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.201 -0.937 . . . . 0.0 108.696 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mp -104.43 147.11 27.92 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.471 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 77.3 mt -137.89 147.41 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.226 -0.921 . . . . 0.0 110.076 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -97.74 155.6 16.94 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.9 m -148.63 97.17 2.7 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.954 -1.091 . . . . 0.0 109.658 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.536 ' OD2' ' NZ ' ' A' ' 138' ' ' LYS . 4.9 p-10 -149.39 149.17 30.42 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.502 ' CB ' ' HZ2' ' A' ' 138' ' ' LYS . 8.5 t70 61.39 61.23 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.745 . . . . 0.0 109.282 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -64.38 118.87 9.34 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -86.72 118.04 25.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.051 -1.03 . . . . 0.0 109.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 5.1 pm0 -84.86 10.72 10.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -81.99 -54.53 5.24 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.8 p -96.29 -8.13 33.55 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.87 41.47 33.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -147.21 163.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.276 -1.132 . . . . 0.0 109.837 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.443 ' O ' ' C ' ' A' ' 137' ' ' GLU . 71.1 m95 -67.09 116.44 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' TRP . 16.4 tp10 -37.96 -86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.778 -0.576 . . . . 0.0 109.893 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.536 ' NZ ' ' OD2' ' A' ' 127' ' ' ASP . 1.9 pttp -89.0 152.06 21.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -157.45 89.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -79.28 167.99 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.493 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -148.58 151.38 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.756 -1.215 . . . . 0.0 110.023 -179.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 1.3 m-85 -143.09 162.52 35.31 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.1 t -148.68 152.72 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.764 -1.21 . . . . 0.0 110.929 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.41 160.96 38.19 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.3 t -127.91 135.43 49.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.97 105.61 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.52 -0.738 . . . . 0.0 109.677 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.485 ' CG2' ' HZ2' ' A' ' 96' ' ' LYS . 1.3 t . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 108.889 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mt . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.37 162.82 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.474 2.116 . . . . 0.0 112.753 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -103.32 -12.41 17.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.511 -0.743 . . . . 0.0 109.363 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.515 ' CG ' ' HZ2' ' A' ' 13' ' ' LYS . 2.6 m-20 -77.55 109.06 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 11.9 mptt -59.62 -0.32 0.17 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.892 . . . . 0.0 109.604 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ASP . 41.6 m -114.28 36.81 3.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.466 -0.771 . . . . 0.0 110.282 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HZ2' ' CG ' ' A' ' 10' ' ' ASP . 2.1 ttmp? -144.18 143.83 31.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.027 -1.046 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.19 145.12 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 110.098 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.46 11.79 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.87 173.54 34.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.75 119.98 7.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -1.175 . . . . 0.0 109.147 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -97.03 141.5 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -145.09 136.71 25.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 0.0 110.101 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.8 mt -144.37 127.05 8.47 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.9 Cg_endo -75.71 -43.23 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.524 1.483 . . . . 0.0 111.312 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.36 -15.24 0.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.464 -0.772 . . . . 0.0 109.128 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -137.1 13.6 3.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.46 52.4 4.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.454 -0.779 . . . . 0.0 109.944 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.46 146.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.864 0.84 . . . . 0.0 110.214 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -169.83 80.28 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -142.9 158.79 58.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.54 162.27 14.64 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.511 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.52 112.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 5.7 m-85 -73.11 146.48 87.21 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -79.93 97.36 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.571 2.181 . . . . 0.0 111.884 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.19 -174.13 46.49 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.671 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 93.7 Cg_endo -80.55 120.97 4.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.839 2.359 . . . . 0.0 111.431 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.5 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.696 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.1 p -103.67 152.11 38.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 53.5 Cg_endo -68.95 -44.31 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.958 1.772 . . . . 0.0 111.803 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.42 -24.68 67.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.701 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 40' ' ' ASN . 2.8 tt0 -88.59 -59.81 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.651 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -47.29 -15.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 5.9 m120 -58.63 -29.89 66.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 85.7 mtt180 -80.38 -19.7 45.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.9 -141.7 7.55 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.459 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.36 161.47 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.401 -1.058 . . . . 0.0 109.388 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.484 ' CB ' HE22 ' A' ' 38' ' ' GLN . 11.7 p -158.84 156.97 30.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.072 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -56.06 171.84 0.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -95.46 -2.43 48.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.97 140.41 18.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.024 -1.048 . . . . 0.0 110.62 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -62.56 -22.84 66.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.69 20.85 2.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 0.0 109.486 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.22 145.63 53.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.233 1.016 . . . . 0.0 111.116 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.561 ' C ' ' H ' ' A' ' 53' ' ' ASP . 3.3 m -155.33 136.32 13.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.506 ' CB ' HH22 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -60.87 -4.91 1.11 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 51' ' ' SER . 92.8 m-20 -93.73 -17.8 22.79 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.745 -0.597 . . . . 0.0 109.677 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 56' ' ' ASN . 42.0 t0 -58.94 109.84 0.91 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.777 -1.202 . . . . 0.0 109.286 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -47.56 -12.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 109.638 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' ASP . 50.0 t-20 -140.28 104.97 4.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.198 -0.939 . . . . 0.0 109.074 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 58' ' ' SER . 4.0 mp -95.07 159.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.9 p -145.43 123.15 11.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.3 mt -120.23 160.15 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.679 0.752 . . . . 0.0 110.396 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -134.28 134.28 41.72 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.76 22.37 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 72' ' ' PHE . 18.8 m-70 -71.66 176.48 4.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.983 . . . . 0.0 109.272 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.16 90.5 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.55 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.522 ' N ' ' HG1' ' A' ' 73' ' ' THR . 39.8 m-85 -89.42 111.42 22.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.908 . . . . 0.0 109.258 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 mm -60.47 -29.19 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.855 . . . . 0.0 110.627 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.44 15.97 4.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.912 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.55 ' C ' ' H ' ' A' ' 69' ' ' ASN . 51.5 ttt180 -152.18 77.56 6.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.6 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 30.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 123.128 2.552 . . . . 0.0 112.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.55 ' H ' ' C ' ' A' ' 67' ' ' ARG . 17.4 m-80 -150.95 63.46 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.085 -1.009 . . . . 0.0 108.622 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.612 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 3.0 t80 -137.83 -153.76 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.612 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 2.4 mp0 -58.43 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 62' ' ' HIS . 3.8 m-30 -94.61 16.61 15.11 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.522 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 75.8 m -49.14 -24.87 1.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.722 -1.236 . . . . 0.0 109.907 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.8 m-20 -115.31 -29.04 6.69 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.763 . . . . 0.0 110.006 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -50.81 -20.89 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -76.44 -18.1 58.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -82.15 -29.04 31.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.526 0.679 . . . . 0.0 109.338 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.67 123.86 7.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.802 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -102.67 177.57 4.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -0.831 . . . . 0.0 109.143 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -51.06 152.49 2.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.77 -19.72 19.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.5 m -62.97 95.66 0.08 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.339 -1.095 . . . . 0.0 108.579 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.74 165.75 9.95 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.49 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -143.89 121.5 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.948 . . . . 0.0 109.099 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 12.5 m-85 -95.09 110.57 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 88' ' ' VAL . 28.6 t80 -96.15 112.16 23.98 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -96.13 149.85 21.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.295 -0.878 . . . . 0.0 111.034 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' CZ ' ' A' ' 86' ' ' PHE . 74.1 t -155.42 103.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.93 -127.43 31.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -90.29 53.04 2.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -1.146 . . . . 0.0 109.692 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -155.1 146.23 22.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.2 m -151.31 109.94 3.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.506 HH22 ' CB ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -100.83 169.51 8.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.559 -0.713 . . . . 0.0 110.003 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 147.96 41.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 109.586 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 3.3 m-85 -134.1 175.36 9.55 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' THR . 59.5 tttp -131.66 106.7 8.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.0 ttm -49.01 98.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 108.876 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -133.65 24.17 4.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.851 . . . . 0.0 109.835 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.8 t -167.06 121.85 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.8 mt . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.415 -0.803 . . . . 0.0 110.203 -178.222 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 120' ' ' GLN . 2.3 m-20 . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' ASP . 19.1 ttpp -47.32 96.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.876 -1.14 . . . . 0.0 108.788 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.1 pm0 -95.89 174.54 6.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.844 0.83 . . . . 0.0 110.777 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.08 119.41 24.14 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -95.26 93.51 7.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 0.0 108.949 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 123' ' ' LEU . 3.1 mm? -76.45 148.34 37.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 16.9 mt -142.32 140.68 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -97.18 164.84 12.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.232 -0.917 . . . . 0.0 108.691 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.431 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 22.6 m -148.97 140.76 23.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.009 -1.057 . . . . 0.0 109.934 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 177.81 142.93 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 2.6 m-20 55.99 63.41 2.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.743 . . . . 0.0 109.101 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.34 125.4 24.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.104 -0.998 . . . . 0.0 109.393 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -86.7 124.03 32.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.084 -1.01 . . . . 0.0 109.562 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.17 4.22 46.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -78.44 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.164 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.0 p -95.6 -3.21 46.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.335 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.84 46.33 53.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 t -146.78 157.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -1.158 . . . . 0.0 109.374 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.9 m95 -63.86 111.63 2.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.165 -0.96 . . . . 0.0 108.596 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' TRP . 74.6 tt0 -32.49 -72.39 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.872 0.368 . . . . 0.0 111.309 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -134.03 146.52 50.45 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.269 -0.895 . . . . 0.0 109.853 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.69 ' H ' ' HE ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -167.38 -162.86 0.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.121 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -145.88 162.18 38.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.006 -1.058 . . . . 0.0 108.992 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.5 mt -133.78 138.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.42 -0.8 . . . . 0.0 109.843 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.7 m-85 -128.79 165.76 20.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 99' ' ' SER . 12.8 t -146.38 114.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.946 -1.096 . . . . 0.0 110.423 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.23 169.38 9.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.1 t -132.02 127.76 36.9 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.486 -0.759 . . . . 0.0 109.608 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 3.2 tm-20 -59.0 131.92 52.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.13 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.239 -0.913 . . . . 0.0 109.075 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 7' ' ' ILE . 45.6 mt . . . . . 0 N--CA 1.497 1.881 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.8 179.54 6.19 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.786 1.657 . . . . 0.0 112.313 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -103.77 20.8 17.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.469 -0.77 . . . . 0.0 109.578 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.7 m-20 -77.98 101.94 7.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.983 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 3.5 mptp? -62.29 7.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.383 -0.823 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 10' ' ' ASP . 75.6 p -141.37 41.85 1.76 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -147.66 142.0 26.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.023 -1.048 . . . . 0.0 109.827 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.35 122.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.595 -0.691 . . . . 0.0 110.67 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.81 -25.3 15.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -172.95 -161.64 23.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 13.0 m-85 -147.26 126.97 13.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.132 -1.217 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.04 138.44 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -145.23 141.29 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.652 -1.28 . . . . 0.0 111.836 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.0 mt -148.26 127.26 6.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 23' ' ' ALA . 73.8 Cg_endo -75.8 -43.65 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.567 1.511 . . . . 0.0 111.379 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.51 -11.33 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -0.857 . . . . 0.0 109.364 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -134.36 11.4 3.82 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.405 -0.809 . . . . 0.0 109.687 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ALA . 3.7 p30 42.26 36.31 0.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.457 -0.777 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.18 140.71 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 109.155 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -166.03 86.47 0.35 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -139.79 157.93 68.8 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.5 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -80.96 162.01 20.82 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.115 2.544 . . . . 0.0 113.108 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.76 134.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 5.3 m-85 -94.48 151.1 39.06 Favored Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 120.869 -1.144 . . . . 0.0 110.56 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.17 82.45 2.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.74 2.293 . . . . 0.0 111.442 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 178.84 39.75 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.128 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 35' ' ' THR . 87.3 Cg_endo -78.75 109.53 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.247 2.631 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.09 89.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 111.694 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' PRO . 10.3 p -121.41 152.26 57.56 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -40.13 65.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.36 1.374 . . . . 0.0 111.969 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -66.37 -34.66 78.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.751 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.565 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -88.64 -26.33 21.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.49 -1.381 . . . . 0.0 110.769 -178.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.94 -10.88 59.95 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.014 -1.054 . . . . 0.0 108.871 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -56.88 -29.3 62.82 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -79.04 -20.06 49.85 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.33 -135.23 4.75 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.9 t -84.79 169.18 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.567 -0.961 . . . . 0.0 110.235 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.565 ' CB ' HE22 ' A' ' 38' ' ' GLN . 1.6 t -167.78 152.97 6.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.0 109.096 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.63 155.4 26.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.817 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -72.49 -2.97 21.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -151.86 147.63 26.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 110.184 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.73 -39.11 93.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.727 -0.608 . . . . 0.0 111.54 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -88.01 20.75 2.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.119 . . . . 0.0 111.327 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.09 137.06 58.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.833 -1.167 . . . . 0.0 109.49 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 m -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 109.425 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 7.5 mp -61.15 -13.92 21.15 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.094 -1.004 . . . . 0.0 108.525 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.55 -27.41 51.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.546 -0.721 . . . . 0.0 109.623 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 56' ' ' ASN . 3.4 m-20 -61.78 112.43 2.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.155 -0.965 . . . . 0.0 109.862 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -65.9 6.63 0.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.083 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 54' ' ' ASP . 46.6 t-20 -147.04 95.14 2.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.5 115.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.505 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.482 ' H ' ' HG ' ' A' ' 58' ' ' SER . 0.6 OUTLIER -108.71 113.69 26.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 59' ' ' ILE . 69.0 mt -99.95 155.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.56 115.32 23.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.11 145.22 16.07 Favored Glycine 0 N--CA 1.503 3.153 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 72' ' ' PHE . 9.2 m-70 -72.88 175.95 6.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.502 -0.999 . . . . 0.0 109.761 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.48 79.73 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -88.01 129.6 35.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 109.885 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mt -64.33 -34.79 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.531 -0.73 . . . . 0.0 109.935 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.04 20.28 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 109.45 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.6 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -149.98 68.2 8.75 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.099 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 66.7 Cg_exo -52.27 15.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.187 0 C-N-CA 123.481 2.787 . . . . 0.0 113.915 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.2 p30 -151.29 63.75 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.894 -1.129 . . . . 0.0 108.217 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 33.5 t80 -148.02 99.42 3.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.7 mt-30 61.01 -110.89 0.45 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 35.6 t80 -91.14 0.16 57.59 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.111 -0.993 . . . . 0.0 111.55 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.9 m -49.17 -43.65 42.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.535 -1.353 . . . . 0.0 110.626 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ALA . 3.8 m120 -94.93 -21.51 18.59 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.027 -1.045 . . . . 0.0 112.028 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 77' ' ' ALA . 1.4 tm? -51.07 -32.28 21.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.562 -1.336 . . . . 0.0 108.279 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 1.11 2.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -105.96 -27.36 11.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.2 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.845 . . . . 0.0 109.543 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.648 ' H ' ' HG ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -170.04 175.23 5.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 110.02 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -49.37 135.68 17.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.1 -17.79 55.87 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 5.5 m -62.14 107.98 0.98 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.011 -1.288 . . . . 0.0 107.748 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mtp -70.23 176.27 4.02 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.287 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.69 154.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.22 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -145.65 104.88 3.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.06 111.8 23.56 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -99.21 148.23 24.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 0.0 110.453 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.1 p -167.09 107.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.86 -146.37 48.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -83.54 43.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 109.62 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.42 150.1 37.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.197 -0.94 . . . . 0.0 109.246 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.9 m -150.53 118.85 6.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -0.895 . . . . 0.0 109.704 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -92.7 164.16 13.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.414 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -145.61 118.89 8.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 109.587 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 16.7 m-85 -112.36 -171.49 1.86 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -143.61 101.67 3.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.16 -0.963 . . . . 0.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.6 mtp -48.94 116.58 1.71 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.326 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -161.54 29.9 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.089 . . . . 0.0 110.561 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 t -163.5 86.31 0.51 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.958 -1.089 . . . . 0.0 108.151 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 2.1 mp . . . . . 0 C--N 1.301 -1.507 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 13.1 t70 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 60.6 mttm -38.05 135.5 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.73 161.8 39.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.892 -1.13 . . . . 0.0 111.104 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.51 103.8 13.39 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.2 m -91.48 152.95 20.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.84 146.8 36.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.7 mt -136.76 142.02 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.3 p -91.84 169.67 10.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.866 -1.146 . . . . 0.0 108.815 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 m -147.8 106.41 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.08 -1.012 . . . . 0.0 109.803 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 128' ' ' ASP . 10.5 t70 -157.35 144.9 18.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.012 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 127' ' ' ASP . 70.6 m-20 53.69 64.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.476 -0.765 . . . . 0.0 109.135 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -65.27 124.11 21.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 110.056 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -86.76 127.52 34.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.937 -1.102 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.8 pm0 -94.6 12.19 28.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.454 -0.779 . . . . 0.0 109.649 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -85.61 -57.97 2.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 109.073 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.0 p -95.72 -9.95 30.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.834 . . . . 0.0 109.136 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.83 46.86 9.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -147.05 153.55 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -1.094 . . . . 0.0 109.551 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.426 ' O ' ' C ' ' A' ' 137' ' ' GLU . 72.5 m95 -61.44 112.29 2.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 136' ' ' TRP . 42.5 tt0 -38.68 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.247 0.546 . . . . 0.0 110.326 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -91.38 135.96 33.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.106 -0.996 . . . . 0.0 108.61 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.559 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -157.04 122.26 4.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.946 -1.096 . . . . 0.0 110.334 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -100.79 164.48 11.83 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 29.3 pt -148.35 151.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.832 -1.168 . . . . 0.0 110.481 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.28 172.2 14.23 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.65 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 43.0 t -147.32 129.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.856 -1.153 . . . . 0.0 110.961 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.19 -176.28 3.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.0 t -148.26 136.71 21.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.745 -1.222 . . . . 0.0 109.426 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.24 150.18 18.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.405 -0.809 . . . . 0.0 109.537 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.343 -0.848 . . . . 0.0 109.131 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -40.85 137.49 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.56 1.506 . . . . 0.0 112.248 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -82.46 -20.15 37.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.244 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 12' ' ' SER . 67.2 m-20 -77.87 108.89 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -62.68 -1.09 0.74 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 10' ' ' ASP . 22.6 p -120.49 47.33 1.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.667 -0.645 . . . . 0.0 109.517 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -144.8 136.04 25.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.3 -0.875 . . . . 0.0 109.274 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.47 114.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.767 . . . . 0.0 110.995 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.96 -17.33 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.26 -173.0 35.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.99 125.0 9.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.101 -1.235 . . . . 0.0 109.211 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -97.29 146.88 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -150.6 131.76 14.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.045 . . . . 0.0 110.476 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 20' ' ' ILE . 26.6 mt -144.29 126.47 8.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.45 -41.54 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.648 1.565 . . . . 0.0 111.572 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -51.38 -16.19 0.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.0 109.469 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.415 ' O ' ' OD1' ' A' ' 24' ' ' ASP . . . -136.13 15.32 3.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.2 p-10 44.23 48.51 7.81 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.404 -0.81 . . . . 0.0 109.875 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 25' ' ' ILE . 46.5 mm -90.31 138.64 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.208 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.08 84.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -144.67 151.99 51.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.039 -1.038 . . . . 0.0 110.5 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.05 161.71 18.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.575 2.183 . . . . 0.0 112.155 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.46 102.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' HH ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -80.69 171.49 12.17 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.761 -1.212 . . . . 0.0 109.109 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -86.39 137.11 4.94 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.592 2.194 . . . . 0.0 112.301 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.66 171.62 20.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' ' N ' ' A' ' 35' ' ' THR . 92.2 Cg_endo -78.01 117.88 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.587 2.192 . . . . 0.0 110.767 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -43.04 88.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.698 -0.626 . . . . 0.0 110.338 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -114.6 153.89 46.71 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.05 -41.9 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.944 1.763 . . . . 0.0 112.112 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 4.6 pm0 -63.04 -23.46 67.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.906 -1.121 . . . . 0.0 109.532 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -90.82 -66.82 0.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.013 . . . . 0.0 109.17 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -45.27 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -64.2 -24.45 67.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' C ' ' HH ' ' A' ' 30' ' ' TYR . 30.5 mtt-85 -87.34 -10.63 51.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 154.67 -129.47 2.59 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 t -112.67 156.63 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.613 -0.933 . . . . 0.0 109.907 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -150.68 154.84 38.18 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -58.56 169.96 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.593 -1.317 . . . . 0.0 110.068 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.64 -0.92 49.4 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -154.95 150.67 27.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.59 0.71 . . . . 0.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -63.9 -40.28 96.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 111.631 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.63 12.76 11.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.874 -1.141 . . . . 0.0 111.595 -177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -62.67 101.9 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.786 -1.196 . . . . 0.0 109.519 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 53' ' ' ASP . 8.6 p -93.61 141.85 28.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.154 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.5 ' H ' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -54.85 -9.91 0.41 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 51' ' ' SER . 7.8 t70 -95.16 -9.91 32.08 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.678 -0.639 . . . . 0.0 109.817 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.7 t0 -56.35 113.26 1.51 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.832 -1.167 . . . . 0.0 109.001 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 54' ' ' ASP . 1.1 tt0 -41.58 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.693 -0.629 . . . . 0.0 110.186 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 15.4 p-10 -137.34 115.21 11.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.27 -0.894 . . . . 0.0 108.772 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -97.72 152.26 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' ALA . 9.3 m -140.66 105.42 4.93 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 81.6 mt -100.28 161.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.773 0.797 . . . . 0.0 110.725 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -139.05 129.84 26.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.94 160.14 25.24 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.54 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.58 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 19.3 m-70 -77.25 179.11 6.58 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.585 -0.95 . . . . 0.0 109.791 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.426 ' OG1' ' NZ ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -153.49 91.75 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 108.734 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' N ' ' OG1' ' A' ' 73' ' ' THR . 7.3 m-85 -86.51 104.55 16.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.132 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.83 -32.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.24 17.05 2.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 0.0 109.059 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 69' ' ' ASN . 6.3 tpp180 -150.46 72.51 9.09 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.25 25.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 123.297 2.665 . . . . 0.0 113.522 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 18.3 p30 -149.78 39.21 0.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.829 -1.17 . . . . 0.0 109.093 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.74 -153.57 0.49 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.58 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 29.0 mt-30 -64.79 -89.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.657 -0.652 . . . . 0.0 111.776 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -93.97 22.54 5.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.0 110.191 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 92.7 m -72.8 -24.88 60.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.306 -1.496 . . . . 0.0 109.951 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.9 m-20 -119.37 -13.93 9.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.136 -0.977 . . . . 0.0 111.291 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 mt -51.74 -19.9 1.87 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.62 -1.3 . . . . 0.0 108.79 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' NZ ' ' OG1' ' A' ' 63' ' ' THR . 12.1 pttm -88.55 -8.4 54.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 108.563 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -85.69 -21.78 28.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.4 -174.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 109.362 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' GLY . 45.9 mtmt -150.23 155.23 39.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -51.4 89.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 148.19 -15.94 1.32 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.6 m -62.59 114.22 3.44 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.0 ptm -68.9 -179.59 1.52 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.48 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.06 153.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.0 109.593 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -132.74 103.28 6.03 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.36 111.7 23.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -90.65 150.81 21.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.6 t -150.01 151.3 12.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.45 -4.89 0.42 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 88' ' ' VAL . 55.0 m-20 -102.41 -45.96 4.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.311 -1.111 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -171.55 -156.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.985 -1.072 . . . . 0.0 109.106 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.4 m -132.88 120.3 21.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.345 -0.847 . . . . 0.0 109.941 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.512 ' CG ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -92.13 171.9 8.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.472 -0.768 . . . . 0.0 109.031 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.493 ' HZ1' ' CB ' ' A' ' 94' ' ' LYS . 8.5 mtmp? -144.84 152.32 40.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 11.4 m-85 -139.34 178.57 7.1 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -142.28 105.82 4.66 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.147 -0.971 . . . . 0.0 109.773 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 55.0 mtt -49.33 125.1 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.6 t -150.78 19.45 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 143' ' ' VAL . 3.4 p -174.69 122.87 0.26 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 C--N 1.298 -1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.286 -177.538 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' GLN . 11.2 m-20 . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.492 ' CB ' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -37.84 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.907 0.86 . . . . 0.0 109.323 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -95.47 147.15 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.411 0.624 . . . . 0.0 110.123 -178.213 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -102.74 155.16 18.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.516 -0.74 . . . . 0.0 109.407 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -139.64 87.85 2.2 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.04 145.31 44.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 0.0 110.75 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.481 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 50.0 mt -139.69 148.31 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.468 -0.77 . . . . 0.0 109.085 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.59 170.16 9.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -149.81 95.56 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -155.39 141.94 18.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 109.485 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.6 55.66 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 0.0 109.073 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -64.13 123.18 18.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 109.833 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -84.4 122.83 29.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.0 109.302 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -87.53 4.74 42.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -80.17 -55.85 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.9 p -95.7 -12.05 26.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 45.55 10.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.7 t -146.96 153.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.259 -1.142 . . . . 0.0 109.61 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.538 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 66.0 m95 -61.73 110.69 1.59 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.184 -0.948 . . . . 0.0 108.591 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 136' ' ' TRP . 2.8 tm-20 -42.37 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.487 -0.758 . . . . 0.0 109.859 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 144.13 27.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 108.248 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.483 ' HG2' HH11 ' A' ' 139' ' ' ARG . 0.5 OUTLIER -161.05 94.33 1.01 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.0 110.548 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -75.1 163.84 27.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.457 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 4.2 mt -144.28 155.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.058 -1.026 . . . . 0.0 110.791 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 38.5 m-85 -140.74 165.01 28.66 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 99' ' ' SER . 57.6 t -147.65 148.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.839 -1.163 . . . . 0.0 110.385 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.73 179.24 6.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 t -143.46 142.71 31.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.09 -1.006 . . . . 0.0 109.979 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -56.82 152.32 12.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.608 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.827 . . . . 0.0 109.297 179.763 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 114.36 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.388 2.058 . . . . 0.0 112.916 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -60.03 -11.09 5.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.24 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 12' ' ' SER . 34.8 m-20 -77.02 100.53 5.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -59.38 0.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.9 m -122.85 39.49 3.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -142.71 143.58 32.34 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.8 t -58.23 155.28 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.37 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.7 6.62 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 162.79 -172.8 38.92 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -146.72 125.52 12.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -1.071 . . . . 0.0 109.706 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -95.08 144.25 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -146.98 129.13 15.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.879 -1.138 . . . . 0.0 110.569 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mt -144.76 126.98 8.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.3 Cg_endo -76.9 -42.15 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.673 1.582 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -52.75 -12.96 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.05 10.74 3.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 40.95 39.86 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.475 0.655 . . . . 0.0 110.121 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 25' ' ' ILE . 7.0 mt -94.7 146.23 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.944 0.878 . . . . 0.0 110.024 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' CB ' ' HZ2' ' A' ' 26' ' ' LYS . 7.6 ttpm? -166.02 83.16 0.3 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -139.96 159.53 64.15 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.388 -0.82 . . . . 0.0 110.645 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.47 161.5 22.35 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.946 2.431 . . . . 0.0 112.579 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.5 113.21 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.32 171.29 12.53 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.756 -1.215 . . . . 0.0 109.181 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -95.32 136.99 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.546 2.164 . . . . 0.0 112.018 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.72 173.53 22.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 35' ' ' THR . 57.0 Cg_endo -71.88 115.43 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.731 2.287 . . . . 0.0 110.785 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.49 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.59 -0.694 . . . . 0.0 110.741 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -109.0 152.52 42.49 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.527 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 32.7 Cg_endo -63.52 -43.22 18.15 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.072 1.848 . . . . 0.0 112.153 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.07 -27.41 69.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.027 -1.045 . . . . 0.0 109.527 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -84.14 -63.72 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.207 -0.933 . . . . 0.0 109.54 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.6 mt -47.5 -13.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.472 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.7 m120 -59.02 -28.13 66.12 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.423 ' C ' ' OH ' ' A' ' 30' ' ' TYR . 26.6 mtt-85 -79.84 -17.72 52.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.17 -101.61 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.59 -1.29 . . . . 0.0 111.057 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.416 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 4.8 t -135.5 155.14 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -1.073 . . . . 0.0 110.217 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 t -151.22 152.04 32.71 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.55 171.32 0.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.546 -1.346 . . . . 0.0 109.346 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -80.52 -10.38 59.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -149.71 154.68 38.93 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.778 0.799 . . . . 0.0 109.96 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.8 pt-20 -64.48 -43.09 95.25 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 31.6 m120 -84.68 10.3 11.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.597 -1.314 . . . . 0.0 111.037 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 58' ' ' SER . 4.5 mm-40 -64.75 96.74 0.19 Allowed 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 110.354 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.497 ' HG ' ' H ' ' A' ' 53' ' ' ASP . 38.6 p -93.69 175.27 6.8 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.469 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -79.92 -10.64 59.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.497 ' H ' ' HG ' ' A' ' 51' ' ' SER . 63.6 m-20 -102.19 -4.12 26.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.694 . . . . 0.0 109.975 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 56' ' ' ASN . 10.3 t70 -58.72 125.56 23.99 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.848 -1.158 . . . . 0.0 109.337 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.555 HE22 ' N ' ' A' ' 119' ' ' LYS . 34.8 tp60 -39.28 -24.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.73 -0.606 . . . . 0.0 109.956 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 54' ' ' ASP . 52.4 t-20 -151.96 113.87 4.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -96.11 156.04 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.513 ' N ' ' OE2' ' A' ' 50' ' ' GLU . 34.0 t -143.21 123.41 13.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.4 mt -110.9 153.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.547 -0.721 . . . . 0.0 110.567 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -133.9 132.56 40.43 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.28 157.28 25.5 Favored Glycine 0 N--CA 1.503 3.13 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.995 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -70.61 176.38 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.73 -0.865 . . . . 0.0 109.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.34 93.83 1.15 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.13 105.51 17.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.166 -0.959 . . . . 0.0 108.915 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.74 -29.09 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 8.2 t70 -84.55 11.22 9.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.399 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' ASN . 24.5 ttm180 -151.62 79.75 6.46 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.277 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.25 24.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 123.702 2.935 . . . . 0.0 114.357 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' ARG . 40.6 m-80 -151.09 62.77 0.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 108.597 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.52 ' CD2' ' OE1' ' A' ' 71' ' ' GLN . 15.3 t80 -146.73 102.93 3.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.165 -0.959 . . . . 0.0 110.272 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 15.2 mp0 55.28 -113.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 111.796 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.4 m-85 -92.42 7.73 41.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.085 -1.01 . . . . 0.0 110.421 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.8 m -47.16 -33.65 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.74 -1.225 . . . . 0.0 109.698 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ALA . 8.1 m120 -100.28 -28.95 12.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -0.773 . . . . 0.0 110.472 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 77' ' ' ALA . 6.9 tp -54.11 -31.94 53.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.616 -1.303 . . . . 0.0 108.792 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -65.99 -3.28 5.02 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 75' ' ' LEU . . . -102.33 -28.5 12.21 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -44.75 168.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 110.017 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.78 160.76 39.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.372 -0.83 . . . . 0.0 108.94 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -49.99 137.08 17.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.03 -1.044 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 -23.94 32.28 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 m -62.68 115.9 4.71 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.211 -1.17 . . . . 0.0 108.057 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.83 176.7 4.73 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.971 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.9 t -142.81 109.27 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.405 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -93.67 102.84 15.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -96.99 112.17 24.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -93.89 154.32 17.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.036 -1.04 . . . . 0.0 110.74 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.6 m -151.15 160.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.36 46.38 0.26 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 22.7 p30 -160.33 -36.78 0.05 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 109.783 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.0 tt0 -174.24 -157.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 108.925 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 t -141.54 129.76 22.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.048 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -92.12 162.37 14.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.813 . . . . 0.0 109.212 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -144.36 93.98 2.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.086 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -93.23 179.34 5.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.076 -1.015 . . . . 0.0 108.8 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 98' ' ' THR . 36.1 ttpt -144.96 114.82 7.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.3 mtt -48.96 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 109.113 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.6 m -126.03 29.65 5.83 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.7 . . . . 0.0 109.538 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.3 86.98 0.08 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.15 -0.969 . . . . 0.0 108.499 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.4 mm . . . . . 0 C--N 1.298 -1.66 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.57 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.535 ' C ' HE22 ' A' ' 55' ' ' GLN . 16.7 t70 . . . . . 0 N--CA 1.501 2.076 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.555 ' N ' HE22 ' A' ' 55' ' ' GLN . 46.4 mttp -43.35 129.81 4.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -148.42 167.43 25.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.0 -1.062 . . . . 0.0 110.117 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.7 tp -118.8 122.2 41.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.651 -0.656 . . . . 0.0 110.35 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -100.63 94.13 5.94 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -73.78 147.4 43.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.923 . . . . 0.0 110.244 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.507 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 82.0 mt -138.13 148.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.578 ' HG1' ' H ' ' A' ' 140' ' ' LYS . 18.1 p -102.18 165.23 11.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 108.898 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.9 m -147.51 87.44 1.65 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.976 -1.077 . . . . 0.0 109.273 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 7.1 p30 -130.21 146.34 51.82 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.22 -0.925 . . . . 0.0 110.089 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 54.8 72.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.657 -0.652 . . . . 0.0 109.493 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -67.56 119.96 13.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.181 -0.949 . . . . 0.0 109.683 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -88.88 123.11 32.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.779 -1.201 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.3 pm0 -93.13 -13.01 29.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.847 . . . . 0.0 109.019 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -62.93 -49.72 73.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 46.7 p -97.35 -13.34 21.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 108.775 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 38.19 27.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.15 162.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.444 ' O ' ' C ' ' A' ' 137' ' ' GLU . 78.9 m95 -64.73 113.21 3.62 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.6 tp10 -36.99 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.947 -0.471 . . . . 0.0 110.418 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -111.12 137.72 48.44 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.49 113.85 5.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 109.753 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.578 ' H ' ' HG1' ' A' ' 125' ' ' THR . 44.5 mttm -75.45 166.84 22.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.107 -0.996 . . . . 0.0 108.517 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 pt -149.6 134.51 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.937 -1.102 . . . . 0.0 110.331 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -130.06 169.85 14.76 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 t -145.85 143.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.818 -1.176 . . . . 0.0 110.667 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -132.8 126.24 31.89 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.4 t -94.49 145.65 24.65 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -58.41 147.12 32.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.3 mt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -42.57 156.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.475 1.45 . . . . 0.0 112.179 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -103.38 -23.71 13.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 12' ' ' SER . 21.5 t0 -76.96 108.13 9.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.668 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -58.28 -3.61 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.267 -0.895 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 10' ' ' ASP . 42.3 m -115.27 43.43 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.487 -0.758 . . . . 0.0 109.349 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -147.6 145.86 29.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.72 149.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.857 0.837 . . . . 0.0 110.742 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.39 12.46 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 160.17 177.07 32.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.25 122.5 9.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.27 . . . . 0.0 109.055 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.7 tt -97.57 151.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.48 132.25 15.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 20' ' ' ILE . 50.3 mt -142.29 125.71 9.57 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.451 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.2 Cg_endo -76.1 -43.07 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.692 1.595 . . . . 0.0 111.511 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -51.05 -14.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.89 . . . . 0.0 108.867 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.451 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.4 12.52 3.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.661 -0.649 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 4.6 p-10 43.02 51.86 5.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.42 -0.8 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.6 mm -95.69 147.25 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.045 0.926 . . . . 0.0 111.04 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -168.75 80.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 10.0 mt-10 -139.3 158.57 68.73 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.299 -0.876 . . . . 0.0 110.944 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.25 160.44 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.986 2.457 . . . . 0.0 112.91 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 t -132.46 101.7 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.65 171.72 11.19 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.918 -1.114 . . . . 0.0 109.76 -178.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -86.59 116.02 1.34 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.142 2.561 . . . . 0.0 112.945 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.23 160.99 22.78 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.736 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 90.3 Cg_endo -76.59 126.77 9.17 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.702 2.268 . . . . 0.0 111.053 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -41.58 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.753 -0.592 . . . . 0.0 110.77 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.7 p -127.17 149.61 70.02 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.525 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 19.7 Cg_endo -58.21 -43.04 50.65 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.925 1.75 . . . . 0.0 112.185 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.22 -20.87 65.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.106 -0.996 . . . . 0.0 109.788 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -89.26 -68.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.16 -0.962 . . . . 0.0 109.378 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.2 mt -47.34 -11.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.979 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 38' ' ' GLN . 4.0 m120 -56.84 -28.88 62.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 19.9 mmt180 -81.12 -18.31 46.9 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 147.83 -124.51 1.92 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 2.3 t -97.6 160.66 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.288 -1.125 . . . . 0.0 109.825 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 p -165.22 153.62 11.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 108.778 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -53.54 167.19 0.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.954 -1.091 . . . . 0.0 108.802 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.4 11.14 40.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.394 -0.816 . . . . 0.0 109.055 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -156.16 134.3 11.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.988 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.61 -25.63 68.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -87.07 17.29 4.29 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.926 -1.109 . . . . 0.0 110.03 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 51' ' ' SER . 1.7 pp20? -62.43 165.63 5.94 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.732 0.777 . . . . 0.0 110.347 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.533 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 2.1 p -150.77 174.12 13.42 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.12 2.74 33.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.9 -1.125 . . . . 0.0 108.368 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -154.86 25.02 0.44 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.473 -0.767 . . . . 0.0 110.126 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' N ' ' HG ' ' A' ' 51' ' ' SER . 24.2 t70 -56.7 124.04 17.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.742 -1.224 . . . . 0.0 108.571 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.483 ' CD ' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -43.77 -22.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 41.9 t-20 -140.18 97.1 3.16 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -94.41 154.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.291 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 p -142.64 120.8 12.19 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 79.5 mt -114.59 164.88 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.846 0.831 . . . . 0.0 110.753 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -141.12 139.87 34.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.03 145.08 13.45 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.587 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.694 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 39.0 m-70 -73.16 -172.19 1.05 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.99 . . . . 0.0 109.42 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.23 88.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.848 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -89.1 121.82 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 0.0 108.734 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 mt -61.65 -32.34 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.449 -0.782 . . . . 0.0 110.67 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.69 17.45 2.27 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.716 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.6 ' C ' ' H ' ' A' ' 69' ' ' ASN . 53.5 mtp180 -150.11 73.26 9.34 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.56 -0.712 . . . . 0.0 109.393 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.57 12.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.285 2.657 . . . . 0.0 113.62 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.6 p30 -147.15 57.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.916 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -141.87 112.66 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.364 -0.835 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.694 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 7.5 mt-30 51.85 -127.78 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.469 -0.77 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -93.97 42.5 1.1 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.834 -1.166 . . . . 0.0 110.404 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.9 m -68.79 -16.48 63.81 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.445 -1.409 . . . . 0.0 109.091 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 77' ' ' ALA . 14.8 m-20 -125.82 -25.54 3.62 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.582 -0.699 . . . . 0.0 109.99 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.92 -25.29 19.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 0.0 108.591 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -74.35 -6.06 45.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -94.16 -28.61 15.57 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.377 0.608 . . . . 0.0 109.409 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.86 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.486 -0.759 . . . . 0.0 109.801 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' C ' ' SD ' ' A' ' 97' ' ' MET . 14.6 ptpt -155.37 179.36 9.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.95 . . . . 0.0 109.369 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.603 ' HZ2' ' N ' ' A' ' 100' ' ' ILE . 58.1 mmtt -47.4 138.32 7.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.17 -16.05 59.64 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -62.54 97.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.168 -1.195 . . . . 0.0 108.494 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 70.3 mmm -62.93 168.28 4.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.773 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 t -142.32 114.87 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.519 -0.738 . . . . 0.0 109.482 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.25 107.29 19.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.114 -0.991 . . . . 0.0 109.614 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -94.64 112.33 24.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -94.18 135.0 36.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.088 -1.007 . . . . 0.0 110.969 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -157.06 132.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 55.96 -148.33 28.25 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -94.61 50.67 1.35 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.195 -1.179 . . . . 0.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -171.24 140.26 1.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.036 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -120.8 133.14 55.33 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.543 -0.723 . . . . 0.0 110.303 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.525 ' CG ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.8 178.23 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.253 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 15.1 ptpt -145.66 152.3 39.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.147 -0.971 . . . . 0.0 109.861 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.49 ' O ' ' SD ' ' A' ' 83' ' ' MET . 26.6 m-85 -141.23 178.79 7.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.259 -0.9 . . . . 0.0 108.759 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -143.35 110.34 5.64 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.18 -0.95 . . . . 0.0 109.938 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 79' ' ' LYS . 37.3 ttm -48.19 127.05 12.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.495 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . 11.1 m -161.78 25.68 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.1 . . . . 0.0 110.269 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.419 ' N ' ' NZ ' ' A' ' 80' ' ' LYS . 2.2 m -163.27 87.43 0.55 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.672 -1.267 . . . . 0.0 108.636 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.603 ' N ' ' HZ2' ' A' ' 80' ' ' LYS . 1.3 mp . . . . . 0 C--N 1.303 -1.456 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 119' ' ' LYS . 3.1 m-20 . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 118' ' ' ASP . 1.6 mptm? -30.89 129.85 0.12 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.256 0.551 . . . . 0.0 110.043 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -147.3 168.37 21.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.059 -1.025 . . . . 0.0 109.962 -178.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.7 mt -124.31 111.81 16.25 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.742 -0.598 . . . . 0.0 109.911 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.3 m -91.68 88.07 6.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.041 -1.037 . . . . 0.0 108.243 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.16 154.51 31.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 18.4 mt -140.01 148.89 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 56.2 p -99.03 163.64 12.5 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.6 m -147.34 149.54 33.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 109.579 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.88 130.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 27.8 t0 60.34 71.24 0.58 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.011 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 130' ' ' ASN . 40.7 t80 -65.1 132.43 49.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.655 -1.278 . . . . 0.0 110.026 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.436 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 51.7 t30 -79.64 119.64 22.86 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.982 -1.074 . . . . 0.0 109.351 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -91.97 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.227 -0.92 . . . . 0.0 109.544 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -78.87 -64.66 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 p -94.84 -7.65 39.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 53.78 4.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.98 151.4 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.199 -1.177 . . . . 0.0 109.551 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.39 116.41 5.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 128' ' ' ASP . 7.0 mm-40 -37.76 -85.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.149 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -111.76 156.03 22.59 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -170.16 -160.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 109.963 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.481 ' N ' ' OG1' ' A' ' 125' ' ' THR . 59.7 mttp -152.05 160.46 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.5 mt -141.69 127.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.131 -0.981 . . . . 0.0 110.201 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -147.58 149.02 31.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.91 . . . . 0.0 108.715 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.4 t -125.47 136.22 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.463 -0.773 . . . . 0.0 111.142 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.73 174.85 5.71 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -140.26 135.95 32.83 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.87 131.12 49.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.888 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 -163.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.244 1.963 . . . . 0.0 112.168 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -126.41 -23.17 3.85 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 12' ' ' SER . 16.9 t0 -77.41 114.15 15.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.239 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -58.33 -2.55 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.85 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.2 p -112.39 41.78 1.94 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 109.618 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -146.24 137.25 24.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -1.0 . . . . 0.0 109.78 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.34 159.76 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 121.682 0.753 . . . . 0.0 110.762 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.65 1.4 1.91 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.67 -170.39 38.99 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -147.27 125.76 12.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.126 -1.22 . . . . 0.0 110.518 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 tp -95.51 140.13 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -145.15 145.49 31.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.827 -1.17 . . . . 0.0 110.822 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 mt -147.8 129.35 7.31 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.07 -53.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.86 1.707 . . . . 0.0 112.296 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.96 -27.89 6.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.742 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.37 5.91 20.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.43 -0.793 . . . . 0.0 109.163 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.4 p30 42.95 35.75 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.738 -0.601 . . . . 0.0 110.395 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt -90.5 146.39 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -0.834 . . . . 0.0 109.113 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -166.59 84.47 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.77 158.12 74.72 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.69 161.61 16.53 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 123.114 2.542 . . . . 0.0 113.083 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 t -125.01 123.35 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 2.5 m-85 -84.65 152.54 60.23 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.86 100.61 0.97 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.559 2.173 . . . . 0.0 111.844 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.46 179.12 47.56 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 35' ' ' THR . 71.5 Cg_endo -77.78 120.74 5.22 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.736 2.291 . . . . 0.0 111.097 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -40.33 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.34 0.59 . . . . 0.0 110.767 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -107.39 153.46 41.22 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.75 -41.88 7.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.232 1.954 . . . . 0.0 112.435 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -63.71 -19.79 65.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.005 . . . . 0.0 110.08 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -94.96 -63.61 1.15 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.101 -0.999 . . . . 0.0 109.117 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.08 -24.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.401 -0.812 . . . . 0.0 109.857 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' GLN . 21.4 m-20 -59.88 -24.77 64.53 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.5 mtt180 -89.11 -9.08 52.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.64 -136.03 4.99 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 6.1 t -101.42 157.25 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.485 -1.009 . . . . 0.0 109.586 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -151.74 147.94 27.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.277 -0.889 . . . . 0.0 108.85 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -55.13 168.89 0.28 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.864 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' OG ' ' A' ' 58' ' ' SER . . . -92.31 0.42 57.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -161.38 142.96 11.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.444 -0.785 . . . . 0.0 108.947 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.57 -37.44 78.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.492 -0.755 . . . . 0.0 111.222 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -89.72 -0.25 57.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.877 -1.139 . . . . 0.0 111.005 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 11.3 tp10 -63.24 89.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.853 -1.155 . . . . 0.0 109.749 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -89.4 177.0 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.347 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.84 -8.1 56.7 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 108.901 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.51 -19.39 29.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.462 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 40.7 t0 -59.43 111.44 1.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -44.88 -17.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 6.2 m120 -132.31 100.49 5.02 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -94.46 120.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 108.78 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.5 t -108.16 115.15 29.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.5 -0.75 . . . . 0.0 109.165 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.55 166.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.2 132.54 34.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.79 148.47 19.99 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.434 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.2 m-70 -72.31 168.06 19.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.28 88.57 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.0 109.352 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.644 ' N ' ' HG1' ' A' ' 73' ' ' THR . 15.7 m-85 -88.19 102.5 14.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 109.233 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.09 -29.93 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.32 -0.862 . . . . 0.0 110.094 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.29 12.4 6.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ASN . 23.5 ttm-85 -151.33 77.39 7.42 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.528 -0.732 . . . . 0.0 109.51 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.64 32.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 123.31 2.673 . . . . 0.0 113.319 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' ARG . 19.7 m-80 -149.41 61.11 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 0.0 108.376 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -130.94 -153.47 0.56 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 109.78 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -69.61 -83.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 111.715 -178.482 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 62' ' ' HIS . 28.5 t80 -93.56 -11.64 31.39 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.212 -0.93 . . . . 0.0 110.298 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.644 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 89.5 m -37.45 -40.71 0.39 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.671 . . . . 0.0 111.124 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.8 m120 -94.48 -21.61 18.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.131 -0.981 . . . . 0.0 111.605 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mt -53.42 -26.08 18.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.392 -1.443 . . . . 0.0 108.263 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 73' ' ' THR . 9.5 ptpt -75.53 -18.97 59.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -82.09 -14.41 55.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.15 -165.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -163.96 164.7 23.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.169 -0.957 . . . . 0.0 109.422 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -52.39 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 155.66 -26.83 0.59 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 p -63.07 117.83 7.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.352 -1.087 . . . . 0.0 108.252 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.0 mtp -70.91 179.26 2.77 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.008 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.8 t -145.17 111.65 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -93.89 106.33 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.272 -0.892 . . . . 0.0 110.072 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -94.7 112.5 24.24 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -89.44 151.92 21.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 111.111 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 90' ' ' ASN . 5.9 t -145.71 45.64 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.36 -80.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -53.08 -30.93 38.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.403 -1.057 . . . . 0.0 111.1 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -170.93 167.49 7.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.725 -1.234 . . . . 0.0 109.665 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 t -131.2 134.22 46.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.501 -0.749 . . . . 0.0 110.183 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.58 175.25 6.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.625 -0.672 . . . . 0.0 109.276 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -144.57 144.94 31.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.108 -0.995 . . . . 0.0 109.566 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 17.2 m-85 -131.56 177.19 7.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.439 -0.788 . . . . 0.0 108.926 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -133.71 104.32 6.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 109.601 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.9 mmt -48.59 120.03 3.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.35 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -161.82 28.81 0.12 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.289 -0.882 . . . . 0.0 109.42 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 7.7 m -165.58 133.33 2.99 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.279 -0.888 . . . . 0.0 108.674 -178.841 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.484 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 70.7 m-20 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 118' ' ' ASP . 34.2 ttmt -39.66 137.24 0.89 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.485 -0.759 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.75 155.6 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.274 -0.891 . . . . 0.0 109.202 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.4 mt -103.88 115.91 31.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.441 -0.787 . . . . 0.0 110.185 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.8 m -93.95 87.04 5.23 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.953 -1.092 . . . . 0.0 108.547 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.25 154.78 38.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.9 mt -140.02 140.98 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.467 -0.771 . . . . 0.0 108.973 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.3 p -94.24 162.13 13.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 109.493 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.479 ' SG ' ' CD1' ' A' ' 136' ' ' TRP . 51.3 m -146.9 137.11 23.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -173.3 134.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.123 -0.986 . . . . 0.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 55.09 69.63 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 108.916 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -62.28 122.11 14.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.04 -1.038 . . . . 0.0 109.844 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -84.99 122.42 29.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.1 -1.0 . . . . 0.0 109.355 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -86.03 5.89 31.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.294 -0.879 . . . . 0.0 109.749 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -79.93 -57.84 3.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 p -96.47 -4.27 41.89 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.232 -0.918 . . . . 0.0 109.354 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.53 46.86 53.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.66 155.42 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -1.116 . . . . 0.0 109.509 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CD1' ' SG ' ' A' ' 126' ' ' CYS . 65.1 m95 -63.13 112.15 2.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.198 -0.939 . . . . 0.0 108.651 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 136' ' ' TRP . 72.3 tt0 -39.03 -82.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.277 0.561 . . . . 0.0 110.037 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -77.45 120.67 22.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -134.98 137.13 42.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.339 -0.851 . . . . 0.0 109.827 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -140.5 134.33 30.51 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.3 mm -99.39 127.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.758 0.79 . . . . 0.0 111.22 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -129.99 154.52 47.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 p -161.88 151.3 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.223 -1.548 . . . . 0.0 111.853 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.39 175.92 7.84 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -138.16 142.38 40.08 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 10.1 tp10 -60.78 137.17 58.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.773 . . . . 0.0 109.192 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 4.6 m . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.397 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 mt . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.51 166.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.626 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -113.41 -13.25 12.88 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 105.02 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.157 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -56.44 -11.08 1.1 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.838 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m -102.48 30.72 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.317 -0.864 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 143.51 33.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.325 -0.859 . . . . 0.0 109.205 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.9 t -60.06 150.95 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.91 12.04 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.72 168.44 29.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.54 119.66 6.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.03 -1.277 . . . . 0.0 109.51 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.9 tt -99.05 141.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -146.2 136.27 23.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.18 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.3 mt -144.1 125.69 8.11 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 23' ' ' ALA . 74.4 Cg_endo -75.15 -41.26 0.66 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.633 1.555 . . . . 0.0 111.494 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.25 -15.42 0.37 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -0.878 . . . . 0.0 109.203 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . . . -137.81 15.46 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.808 . . . . 0.0 109.835 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 4.1 p-10 44.57 50.17 8.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.092 -1.005 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.6 mm -92.25 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.82 0.819 . . . . 0.0 109.983 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -169.65 82.74 0.12 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -142.69 150.3 53.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 0.0 110.68 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.78 165.05 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.848 2.365 . . . . 0.0 113.04 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.8 t -126.91 122.32 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.626 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 7.6 m-85 -82.59 150.36 62.84 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.007 -1.058 . . . . 0.0 110.247 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.87 100.04 1.36 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 111.681 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.26 178.78 45.37 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.616 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 72.9 Cg_endo -76.49 118.81 5.0 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.755 2.304 . . . . 0.0 111.029 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.49 88.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.453 0.644 . . . . 0.0 110.572 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.4 p -113.67 152.43 45.47 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -40.21 10.91 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.124 1.883 . . . . 0.0 111.945 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -62.24 -20.06 63.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.098 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.626 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 7.3 tp60 -96.04 -63.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -45.05 -15.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 0.0 110.275 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.6 m-20 -62.55 -25.14 67.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.429 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 25.2 mtt-85 -88.13 -12.0 45.32 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.09 -135.93 4.78 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.408 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.18 160.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -1.021 . . . . 0.0 109.619 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -151.42 152.68 33.4 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 50.4 m-85 -60.32 167.95 2.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.197 . . . . 0.0 109.745 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.16 -8.35 59.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.448 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -152.85 150.95 29.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -62.77 -35.82 81.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.563 -0.71 . . . . 0.0 111.102 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.65 16.42 6.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.99 -1.069 . . . . 0.0 110.905 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.535 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 14.5 tm-20 -63.23 98.44 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 109.84 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 53' ' ' ASP . 1.4 p -95.38 141.74 28.59 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.417 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -61.16 -3.73 0.93 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.756 -1.215 . . . . 0.0 107.881 179.422 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 51' ' ' SER . 23.1 m-20 -91.56 -17.7 25.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.594 -0.691 . . . . 0.0 109.861 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 38.6 p-10 -60.64 116.99 4.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.861 -1.149 . . . . 0.0 109.576 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -45.63 -15.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 38.2 t30 -132.6 108.58 9.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 109.673 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.0 mt -98.61 117.52 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.504 ' H ' ' HG ' ' A' ' 58' ' ' SER . 1.9 p -108.44 114.76 28.85 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 124' ' ' ILE . 61.2 mt -105.47 167.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.438 -0.789 . . . . 0.0 109.907 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.403 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -135.07 126.65 28.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.85 152.89 23.86 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.68 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.728 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 33.2 m-70 -72.85 -170.46 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.636 -0.92 . . . . 0.0 109.275 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.17 72.0 0.1 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 5.8 m-85 -87.6 114.11 23.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.91 -18.42 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -85.18 13.92 5.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.184 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.596 ' C ' ' H ' ' A' ' 69' ' ' ASN . 59.1 mtm-85 -151.41 74.35 8.13 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.29 14.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.673 2.915 . . . . 0.0 114.023 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -150.59 62.28 0.94 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.854 -1.154 . . . . 0.0 108.334 179.289 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.444 ' CE2' ' OE1' ' A' ' 71' ' ' GLN . 41.8 t80 -149.72 99.77 2.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.728 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 5.1 mt-30 61.09 -125.49 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.513 -0.742 . . . . 0.0 111.734 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 72' ' ' PHE . 86.2 t80 -92.48 38.88 1.02 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.186 -0.946 . . . . 0.0 110.37 -178.088 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.422 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 37.1 m -81.58 -65.21 1.04 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.995 -1.066 . . . . 0.0 109.034 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 76' ' ' LYS . 9.9 t-20 -81.18 -24.72 37.32 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.611 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.85 -3.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.913 -1.117 . . . . 0.0 108.617 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' H ' ' C ' ' A' ' 74' ' ' ASN . 46.1 mtpt -87.03 -21.47 26.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -80.78 -37.15 30.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -45.43 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' SD ' ' A' ' 97' ' ' MET . 48.3 mtmt -144.24 172.86 12.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -49.08 153.5 0.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -17.58 31.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 97.86 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.45 -1.029 . . . . 0.0 108.423 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.1 mtp -55.76 171.63 0.21 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.512 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -143.51 113.96 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.444 -0.785 . . . . 0.0 109.492 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.92 102.89 14.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 109.438 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -97.54 112.0 24.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.235 -0.916 . . . . 0.0 108.571 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -100.25 144.28 29.46 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -169.77 140.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.4 -110.68 3.54 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -137.69 45.89 2.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.475 -1.015 . . . . 0.0 109.282 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 92' ' ' THR . 3.9 tm-20 -163.66 138.83 6.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.089 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.445 ' N ' ' CD ' ' A' ' 91' ' ' GLU . 21.6 m -115.13 125.15 53.13 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.775 . . . . 0.0 109.801 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 172.43 7.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.396 -0.815 . . . . 0.0 108.863 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 17.0 pttm -141.34 150.2 42.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.278 -0.889 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 15.8 m-85 -138.96 179.39 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -134.89 107.88 7.6 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.528 -0.733 . . . . 0.0 109.885 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 31.8 ttm -49.61 128.84 18.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 108.849 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.418 ' O ' ' CG2' ' A' ' 98' ' ' THR . 73.0 m -159.23 3.56 0.09 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.752 -1.217 . . . . 0.0 110.679 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' VAL . 13.4 t -149.14 122.24 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.708 -1.245 . . . . 0.0 107.886 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -178.085 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 . . . . . 0 N--CA 1.501 2.123 0 CA-C-O 121.511 0.672 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 52' ' ' LEU . 46.7 tttp -47.04 157.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -157.98 161.86 38.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.008 -1.058 . . . . 0.0 109.847 -178.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.7 mt -114.95 103.39 10.87 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.603 -0.686 . . . . 0.0 110.0 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.9 m -99.34 149.2 23.39 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 tt -141.58 157.86 44.57 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.054 -1.029 . . . . 0.0 109.757 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 59' ' ' ILE . 44.9 mt -128.77 150.05 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 p -89.83 163.59 14.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.579 -1.325 . . . . 0.0 108.725 179.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -146.4 81.94 1.58 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.418 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 14.9 p-10 -137.48 133.97 35.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.407 -0.808 . . . . 0.0 109.127 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 69.06 62.01 0.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -62.62 126.23 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.273 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -85.89 118.56 25.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 1.36 45.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.68 -52.91 7.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.0 p -94.89 -8.28 37.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.34 41.45 52.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.04 162.56 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.24 -1.153 . . . . 0.0 109.599 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 68.2 m95 -66.29 114.87 5.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.303 -0.873 . . . . 0.0 108.674 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' TRP . 24.6 tt0 -38.96 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.264 0.555 . . . . 0.0 110.13 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -83.2 148.25 27.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -148.25 73.89 1.27 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.95 -1.094 . . . . 0.0 110.482 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -76.75 159.01 30.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.919 -1.113 . . . . 0.0 108.225 178.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.74 153.43 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.982 -1.074 . . . . 0.0 111.277 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -135.45 171.37 14.55 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 99' ' ' SER . 1.7 p -162.93 117.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.214 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -96.99 177.95 5.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -147.51 127.93 14.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.762 -1.211 . . . . 0.0 110.131 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -63.89 117.45 6.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.968 0 O-C-N 121.194 -0.941 . . . . 0.0 109.087 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mt . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.54 167.26 27.54 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.257 1.305 . . . . 0.0 112.032 -179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -102.09 -12.78 17.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 12' ' ' SER . 87.1 m-20 -77.16 102.4 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.681 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -58.22 -3.79 0.29 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 10' ' ' ASP . 15.1 t -115.59 44.63 1.84 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.589 -0.694 . . . . 0.0 109.331 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -141.11 133.28 27.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.341 -0.849 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.65 107.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.616 -0.678 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.73 19.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.44 -173.55 35.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.41 126.64 9.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.008 -1.289 . . . . 0.0 109.74 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -99.22 144.6 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -150.33 131.67 14.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.874 -1.141 . . . . 0.0 110.622 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 mt -144.25 125.88 8.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.09 -41.77 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.654 1.569 . . . . 0.0 111.458 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OG ' ' A' ' 82' ' ' SER . 47.5 t0 -50.98 -16.23 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.051 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.7 15.98 3.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.431 -0.793 . . . . 0.0 109.427 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.0 p30 41.78 48.96 3.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 mm -91.64 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.63 0.729 . . . . 0.0 109.635 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -169.13 84.98 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -145.48 157.19 52.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.063 -1.023 . . . . 0.0 110.33 -177.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.32 165.24 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.85 2.367 . . . . 0.0 112.425 179.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.37 112.92 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -85.98 158.31 56.08 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 109.449 -179.289 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.09 133.87 9.04 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.463 2.109 . . . . 0.0 112.398 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.6 176.89 24.0 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.217 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.589 ' O ' ' N ' ' A' ' 35' ' ' THR . 83.1 Cg_endo -79.14 118.01 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.758 2.305 . . . . 0.0 111.119 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.44 87.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.199 0.523 . . . . 0.0 110.61 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -108.3 152.89 42.15 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.19 -42.18 37.44 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.244 1.963 . . . . 0.0 112.092 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.89 -25.86 68.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.081 -1.012 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.8 -70.11 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.492 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.1 mt -42.06 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.565 -0.709 . . . . 0.0 110.113 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.11 -23.52 66.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -87.11 -11.71 49.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.81 -106.44 0.29 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 11.3 t -136.02 154.73 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.483 -1.01 . . . . 0.0 109.298 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 t -149.4 156.1 41.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -57.69 173.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.734 -1.228 . . . . 0.0 109.513 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -88.58 -3.24 58.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -155.04 148.61 25.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.524 -0.735 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.62 -29.89 70.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 111.733 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -88.49 -3.79 58.75 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.707 -1.245 . . . . 0.0 111.449 -177.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.27 114.59 3.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.729 -1.232 . . . . 0.0 109.673 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -91.53 -164.69 1.21 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 2.2 mp -102.72 17.9 22.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -144.42 4.27 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' ASN . 68.5 t0 -59.53 118.89 6.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.879 -1.138 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -13.55 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.998 -1.064 . . . . 0.0 109.899 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' ASP . 4.8 t-20 -131.42 93.81 3.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.425 -0.797 . . . . 0.0 109.08 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.42 145.61 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' ALA . 1.8 p -142.89 109.36 5.36 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.8 mt -103.81 159.19 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.664 0.745 . . . . 0.0 110.657 -178.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.36 124.31 38.31 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.85 146.04 17.68 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -178.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' PHE . 20.6 m-70 -73.16 174.87 7.35 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.41 -1.053 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.71 93.56 1.58 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.389 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.416 ' N ' ' HG1' ' A' ' 73' ' ' THR . 7.1 m-85 -89.06 113.49 24.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.962 . . . . 0.0 109.074 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 mt -60.47 -34.13 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.94 17.69 2.77 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.931 . . . . 0.0 109.291 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -150.66 73.7 8.82 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 63.9 Cg_exo -52.37 23.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 123.904 3.069 . . . . 0.0 114.219 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' ARG . 27.3 m-80 -153.55 63.53 0.74 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.603 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 12.8 t80 -148.29 100.46 3.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.102 -0.999 . . . . 0.0 110.953 -178.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 13.1 mp0 54.39 -109.04 0.46 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.671 -0.643 . . . . 0.0 112.57 177.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 62' ' ' HIS . 41.6 t80 -91.59 8.9 34.44 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.331 -0.855 . . . . 0.0 111.177 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.416 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 50.9 m -56.42 -45.35 80.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.465 -1.397 . . . . 0.0 110.921 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 77' ' ' ALA . 5.7 m120 -94.31 -22.09 18.58 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.04 -1.038 . . . . 0.0 111.498 -177.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -50.37 -36.82 34.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 108.777 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -60.72 -18.26 53.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -86.12 -23.78 26.5 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.331 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.52 167.61 5.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.412 -0.805 . . . . 0.0 110.0 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.557 ' H ' ' HG ' ' A' ' 82' ' ' SER . 56.4 mttm -149.66 175.67 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.86 158.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.86 -29.24 3.81 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.557 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 61.3 m -62.17 103.74 0.41 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.293 -1.122 . . . . 0.0 108.237 179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.4 mtp -63.36 176.11 0.87 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.777 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.4 t -144.15 114.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.482 -0.761 . . . . 0.0 109.17 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -93.64 107.29 19.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.22 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -94.99 113.9 25.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -85.69 151.04 24.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 110.644 -178.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.6 t -153.94 116.71 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.16 -102.86 0.05 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.02 34.98 4.87 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.545 -0.973 . . . . 0.0 109.499 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.84 119.89 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 108.797 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.6 t -111.2 132.87 53.98 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.52 -0.737 . . . . 0.0 110.253 -179.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -96.9 179.71 4.86 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.544 -0.723 . . . . 0.0 109.528 179.594 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -144.93 142.47 29.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 22.7 m-85 -128.82 178.92 6.02 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -135.32 110.36 8.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.275 -0.891 . . . . 0.0 109.755 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.7 mmt -52.13 118.43 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -151.05 31.21 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 109.717 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 t -164.89 86.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.028 -1.045 . . . . 0.0 109.338 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.435 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 p30 . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 121.329 0.585 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -47.66 139.27 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -151.61 158.61 43.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.007 -1.058 . . . . 0.0 110.099 -178.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.22 157.42 20.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.461 0.648 . . . . 0.0 110.214 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.2 m -139.22 88.34 2.26 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.89 147.08 52.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.523 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.8 mt -139.42 141.01 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -94.18 159.42 15.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.94 -1.1 . . . . 0.0 109.181 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -147.84 100.52 3.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -152.41 144.53 23.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.0 t0 60.53 58.7 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.07 119.41 8.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 11.1 p30 -86.96 124.04 32.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.066 -1.021 . . . . 0.0 109.988 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.9 14.22 10.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -71.5 -31.47 67.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -0.859 . . . . 0.0 109.163 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.2 p -140.64 3.2 1.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.36 53.1 6.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.4 t -146.95 159.42 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.087 -1.243 . . . . 0.0 109.912 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.551 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 70.6 m95 -72.77 116.1 12.86 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.239 -0.913 . . . . 0.0 108.626 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' TRP . 30.2 tt0 -40.29 -83.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.737 -0.602 . . . . 0.0 109.991 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.85 165.1 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 108.474 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.532 ' NE ' ' O ' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -167.08 76.61 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.904 -1.122 . . . . 0.0 110.12 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -88.97 156.88 18.61 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.8 pt -145.98 146.77 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.925 -1.11 . . . . 0.0 111.629 -178.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -128.98 165.98 20.07 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 78.3 t -149.14 143.61 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.653 -1.279 . . . . 0.0 110.339 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.75 163.94 30.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.2 t -140.91 141.14 34.58 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.07 -1.019 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.42 113.69 3.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 108.821 179.569 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 mm . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -42.75 121.34 2.14 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.708 1.606 . . . . 0.0 112.31 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -66.13 -32.59 74.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 12' ' ' SER . 9.7 m-20 -76.87 111.4 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -60.87 -0.95 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.0 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.6 t -111.21 42.75 1.59 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -142.92 133.38 24.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 t -58.75 120.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.44 -0.787 . . . . 0.0 111.263 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.12 -9.63 27.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.22 140.35 3.15 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.44 125.22 38.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -1.213 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 tp -95.29 143.04 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -148.07 138.81 23.07 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.712 -1.242 . . . . 0.0 110.936 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.0 mt -149.84 128.32 5.99 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.12 -44.06 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.825 1.683 . . . . 0.0 112.241 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -50.2 -28.3 7.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.4 7.07 17.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p30 43.54 30.25 0.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 109.888 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.12 145.2 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.102 0.953 . . . . 0.0 109.795 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -163.02 87.97 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -138.1 159.95 66.22 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.592 -0.693 . . . . 0.0 110.952 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.52 159.19 35.97 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.982 2.455 . . . . 0.0 113.229 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -135.64 98.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.52 170.74 14.68 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.119 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.46 164.21 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.072 1.848 . . . . 0.0 112.048 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.67 171.92 13.05 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.7 Cg_endo -78.56 120.37 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.758 2.305 . . . . 0.0 111.187 179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -41.6 87.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.235 0.54 . . . . 0.0 110.643 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.7 p -108.57 123.56 36.93 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.26 -43.57 7.74 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.804 1.669 . . . . 0.0 112.257 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.73 -16.49 61.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.081 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.563 HE21 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -97.07 -69.51 0.75 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.417 -0.802 . . . . 0.0 109.702 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.563 ' N ' HE21 ' A' ' 38' ' ' GLN . 22.5 mt -45.01 -18.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 109.796 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 38' ' ' GLN . 16.5 m-20 -62.15 -24.87 67.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -83.2 -13.7 54.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.69 -124.23 1.35 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.64 159.34 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.575 -0.956 . . . . 0.0 109.963 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.496 ' CB ' HE22 ' A' ' 38' ' ' GLN . 6.9 p -161.66 164.93 28.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 108.937 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.87 162.32 5.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.604 -1.31 . . . . 0.0 109.205 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -83.21 -9.09 59.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.387 -0.82 . . . . 0.0 109.366 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.53 144.31 29.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.147 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.98 -25.99 68.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -87.8 3.9 46.44 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.917 -1.114 . . . . 0.0 110.677 -178.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.447 ' C ' ' HG ' ' A' ' 51' ' ' SER . 6.0 tp10 -64.93 157.59 27.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.339 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 50' ' ' GLU . 17.3 m -148.0 -179.84 7.2 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.559 ' H ' ' CD1' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -91.11 17.19 8.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 13.0 p-10 -141.16 -0.73 1.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.492 -0.755 . . . . 0.0 110.178 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' ASN . 48.6 t0 -57.89 114.58 2.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.733 -1.229 . . . . 0.0 108.998 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -43.07 -20.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.439 -0.788 . . . . 0.0 109.479 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.3 p-10 -134.96 104.09 5.83 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.43 156.06 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 46' ' ' ALA . 50.7 p -141.66 102.08 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 109.133 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 94.8 mt -97.98 162.03 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -145.08 134.18 22.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.44 158.77 27.61 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.754 -1.213 . . . . 0.0 110.209 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 72' ' ' PHE . 10.7 m-70 -71.49 -179.84 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.952 . . . . 0.0 109.913 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.79 80.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' N ' ' HG1' ' A' ' 73' ' ' THR . 7.8 m-85 -87.94 107.53 18.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 109.118 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 mt -58.46 -29.35 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 110.141 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.36 12.63 5.18 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.791 . . . . 0.0 109.429 -178.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 69' ' ' ASN . 96.6 mtt180 -150.76 64.55 6.48 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -40.14 -19.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.701 2.268 . . . . 0.0 112.534 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' ARG . 28.6 p30 -98.29 28.72 3.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.605 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.9 t80 -89.68 -153.69 0.29 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.851 -1.156 . . . . 0.0 109.754 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -72.88 -96.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.619 -0.676 . . . . 0.0 111.322 -178.731 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.4 t80 -91.63 37.11 0.95 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.765 . . . . 0.0 110.327 -177.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.612 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 53.0 m -77.37 -49.04 15.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.859 -1.151 . . . . 0.0 109.706 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 77' ' ' ALA . 19.1 m-20 -93.79 -19.99 20.51 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.644 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.93 -29.18 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.804 -1.185 . . . . 0.0 108.869 -179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -80.6 -6.71 58.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 108.287 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -83.68 -21.0 32.54 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -55.71 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -0.756 . . . . 0.0 109.396 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -155.13 152.95 30.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 108.708 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -50.14 108.08 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 109.678 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.44 -16.37 3.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.5 m -66.5 -172.73 0.17 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -1.157 . . . . 0.0 108.355 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.9 mmm -129.34 176.79 7.67 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.12 108.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 109.242 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -95.49 105.81 17.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 110.389 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -94.98 111.74 23.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -107.15 143.87 34.71 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.28 -0.887 . . . . 0.0 110.997 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -168.13 129.57 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.541 -0.725 . . . . 0.0 109.531 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 -105.53 1.6 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.31 22.16 2.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.321 -1.105 . . . . 0.0 109.218 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.27 138.73 35.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -119.91 138.94 53.13 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.677 0.751 . . . . 0.0 110.721 -179.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.42 170.68 9.76 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -146.57 128.52 15.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.126 -0.983 . . . . 0.0 110.385 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -128.41 172.74 10.83 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 98' ' ' THR . 16.5 ttpt -141.85 117.24 10.19 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.17 -0.956 . . . . 0.0 108.941 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 51.3 mtt -50.61 89.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.517 -0.74 . . . . 0.0 109.478 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -118.89 25.71 10.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 98' ' ' THR . 6.1 m -174.41 138.14 0.53 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 100' ' ' ILE . 58.6 mt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.556 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.7 m-20 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.556 ' C ' ' O ' ' A' ' 118' ' ' ASP . 4.4 mmmt -21.23 131.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 CA-C-N 118.662 0.664 . . . . 0.0 110.34 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -135.69 179.95 6.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.909 -176.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.91 107.41 4.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.075 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 m -94.27 129.96 40.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.47 149.71 29.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.873 . . . . 0.0 109.209 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.4 mt -142.36 140.5 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 109.125 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -93.57 167.36 11.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.929 -1.107 . . . . 0.0 108.6 178.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.8 m -146.27 128.69 15.92 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.026 -1.047 . . . . 0.0 109.794 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -174.69 131.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.081 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 62.78 67.18 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.522 -0.736 . . . . 0.0 109.117 -179.824 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.09 128.41 35.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.943 -1.098 . . . . 0.0 109.51 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 10.4 t-20 -85.18 114.34 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 109.457 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.95 -3.09 58.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.849 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 51.2 mtmt -81.65 -46.56 14.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.6 p -96.13 -17.2 21.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 109.298 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.3 36.72 23.24 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.99 158.5 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -1.159 . . . . 0.0 109.528 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLU . 64.0 m95 -61.1 112.09 1.96 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.161 -0.962 . . . . 0.0 108.553 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.2 tp10 -39.01 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.163 0.506 . . . . 0.0 110.37 -179.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.39 150.8 19.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 0.0 109.087 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -172.75 156.94 3.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.984 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -130.11 162.95 27.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.03 130.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.466 -0.771 . . . . 0.0 111.273 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 -123.22 165.29 17.16 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.29 147.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.732 -1.23 . . . . 0.0 110.507 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.06 141.1 31.19 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 147' ' ' VAL . 12.0 t -98.68 146.52 25.78 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.244 -0.91 . . . . 0.0 109.918 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.46 34.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.607 ' H ' ' C ' ' A' ' 145' ' ' THR . 2.2 t . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.037 -1.039 . . . . 0.0 109.016 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.52 129.68 11.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.53 1.487 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -79.0 -18.92 52.8 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.054 -1.029 . . . . 0.0 108.971 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 12' ' ' SER . 28.1 t0 -78.15 101.43 7.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -58.29 -2.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.0 109.806 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 10' ' ' ASP . 12.6 t -108.95 40.52 1.8 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.458 -0.776 . . . . 0.0 109.578 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -146.46 139.91 25.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.16 119.41 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.858 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.71 -17.12 21.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.71 -169.18 34.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.45 121.69 8.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.312 -1.11 . . . . 0.0 109.041 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.53 143.02 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.39 134.51 22.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.006 -1.059 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.4 mt -145.04 126.55 7.77 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 23' ' ' ALA . 72.1 Cg_endo -76.68 -43.24 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.559 1.506 . . . . 0.0 111.375 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 15.7 t0 -53.58 -12.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.354 -0.841 . . . . 0.0 109.124 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -133.45 11.02 4.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.0 109.336 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 p30 41.89 34.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.633 -0.667 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -91.29 144.86 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.543 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -165.76 83.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -140.37 160.27 60.27 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 111.128 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.53 164.91 25.69 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 123.026 2.484 . . . . 0.0 113.0 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.59 107.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -72.56 155.59 90.94 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.821 -1.174 . . . . 0.0 109.515 -179.499 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.5 118.93 1.93 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.139 1.893 . . . . 0.0 111.668 178.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.3 -174.76 41.84 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.22 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 35' ' ' THR . 97.9 Cg_endo -80.7 117.63 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.77 2.313 . . . . 0.0 111.331 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -47.89 85.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.311 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.1 p -104.64 153.96 38.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 37.6 Cg_endo -65.57 -45.18 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.95 1.766 . . . . 0.0 111.616 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.43 -27.65 69.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.312 -0.868 . . . . 0.0 110.271 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.7 OUTLIER -82.73 -65.34 1.02 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.308 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' N ' ' NE2' ' A' ' 38' ' ' GLN . 17.5 mt -44.74 -17.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.9 m120 -58.23 -28.95 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.1 mtt180 -83.51 -15.35 49.73 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 160.25 -137.62 5.12 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.4 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.98 160.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.504 -0.998 . . . . 0.0 110.269 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 t -155.75 156.66 35.22 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -56.29 171.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.591 -1.318 . . . . 0.0 109.38 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -84.33 -9.06 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.597 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -151.77 145.57 25.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.99 -26.74 68.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.707 . . . . 0.0 110.972 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.638 HD21 ' N ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -86.57 1.08 52.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.856 -1.152 . . . . 0.0 109.886 -179.061 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.638 ' N ' HD21 ' A' ' 49' ' ' ASN . 9.4 tp10 -64.16 150.26 46.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.647 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 53' ' ' ASP . 51.8 p -147.48 159.77 43.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.401 ' HB2' HH12 ' A' ' 93' ' ' ARG . 0.4 OUTLIER -71.54 4.31 3.19 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' SER . 25.9 m-20 -112.57 -7.49 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t0 -60.32 114.02 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.003 -1.061 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.717 HE22 HE21 ' A' ' 120' ' ' GLN . 0.4 OUTLIER -47.72 -17.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 109.036 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.3 t-20 -133.04 104.74 6.68 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -95.05 150.66 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.1 p -144.41 115.21 7.77 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 78.5 mt -110.53 164.47 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.828 0.823 . . . . 0.0 110.629 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -141.92 139.15 32.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.66 153.36 25.12 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.895 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.724 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 20.7 m-70 -72.54 177.02 4.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.714 -0.874 . . . . 0.0 109.48 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.82 82.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.968 . . . . 0.0 109.416 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.461 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 10.3 m-85 -89.59 118.79 29.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.26 -0.9 . . . . 0.0 109.348 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mm -60.76 -23.05 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -0.817 . . . . 0.0 110.161 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -86.59 14.2 7.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.607 ' C ' ' H ' ' A' ' 69' ' ' ASN . 39.3 mtm-85 -150.76 74.36 8.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.569 -0.707 . . . . 0.0 109.243 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.13 13.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 123.403 2.735 . . . . 0.0 113.617 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.607 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -147.64 60.95 1.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 108.465 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -146.24 102.1 3.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.1 -1.0 . . . . 0.0 110.838 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.724 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 7.3 mt-30 58.46 -115.13 0.8 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.724 -0.61 . . . . 0.0 112.038 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.3 m-85 -95.17 19.36 10.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.097 -1.002 . . . . 0.0 110.938 -177.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -59.94 -20.11 55.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.422 -1.424 . . . . 0.0 109.492 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' ALA . 7.0 m-20 -121.92 -18.41 7.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 109.834 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 77' ' ' ALA . 2.4 tm? -53.51 -39.24 64.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.894 -1.129 . . . . 0.0 108.287 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -65.27 -3.19 3.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' LEU . . . -96.89 -29.37 13.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.01 -177.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.44 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.422 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -160.27 179.09 8.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.375 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.548 ' CB ' ' HZ1' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -49.58 149.9 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 109.104 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.81 -13.45 24.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 39.3 m -61.96 100.26 0.15 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.412 -1.052 . . . . 0.0 108.349 179.448 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mmm -67.35 170.07 7.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.669 -179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 t -145.16 110.95 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 109.194 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.19 108.45 19.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.826 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -94.71 111.9 23.65 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -100.74 146.24 27.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 t -132.93 167.64 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.654 -0.653 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.4 ' C ' ' ND2' ' A' ' 90' ' ' ASN . . . -45.23 -32.88 3.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.4 ' ND2' ' C ' ' A' ' 89' ' ' GLY . 7.2 m-80 -153.97 47.62 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.913 -1.345 . . . . 0.0 110.274 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -171.95 121.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.064 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.6 t -125.1 125.93 44.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.401 HH12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.37 175.51 9.22 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.545 -0.722 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -145.38 132.74 20.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.176 -0.953 . . . . 0.0 110.24 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.463 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 13.1 m-85 -102.93 -177.15 3.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.489 -0.757 . . . . 0.0 108.967 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -141.56 110.74 6.3 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.37 -0.831 . . . . 0.0 109.349 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.6 tpp -48.37 114.47 0.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -146.47 26.25 1.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 108.703 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 m -170.24 124.11 0.72 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 0.0 109.841 -179.038 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.0 t0 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 118' ' ' ASP . 20.5 tptt -17.11 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 122.361 1.077 . . . . 0.0 111.153 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.717 HE21 HE22 ' A' ' 55' ' ' GLN . 13.2 mt-30 -93.76 173.61 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.106 -177.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.95 98.31 2.43 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.3 m -92.09 91.73 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.4 147.34 48.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.001 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.518 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 47.0 mt -136.97 149.32 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.325 -0.86 . . . . 0.0 109.782 -179.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.23 158.81 15.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.0 137.87 23.82 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.927 -1.108 . . . . 0.0 109.603 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.3 t0 178.39 138.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 6.4 t0 65.1 60.09 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -64.59 121.78 15.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.161 -0.962 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 12.1 p30 -85.55 126.72 34.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.934 -1.104 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.06 6.11 41.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 109.471 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -76.68 -58.81 3.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.33 -0.856 . . . . 0.0 109.118 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 48.8 p -97.87 -4.37 36.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.365 -0.834 . . . . 0.0 109.245 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.04 46.99 33.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.7 t -146.91 167.27 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -1.1 . . . . 0.0 109.459 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 137' ' ' GLU . 70.4 m95 -72.32 113.63 9.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.194 -0.941 . . . . 0.0 108.944 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' TRP . 36.9 tt0 -36.25 -63.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.114 0.483 . . . . 0.0 110.733 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.2 149.85 44.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 109.163 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -173.96 139.63 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.746 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.53 -179.58 6.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.862 . . . . 0.0 109.21 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 141' ' ' ILE . 7.0 tt -151.31 144.7 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 8.9 m-85 -137.54 166.57 23.57 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 88.1 t -146.74 148.57 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.977 -1.077 . . . . 0.0 110.084 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.92 179.95 6.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.442 -0.786 . . . . 0.0 109.011 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.2 t -153.63 146.64 24.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.048 -1.032 . . . . 0.0 110.087 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.52 139.36 57.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 109.444 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.528 -179.992 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 mt . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -42.14 132.73 4.6 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.76 1.64 . . . . 0.0 112.442 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -83.85 -17.44 40.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 12' ' ' SER . 54.8 m-20 -77.01 106.63 8.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.58 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.58 -5.82 0.41 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 10' ' ' ASP . 67.4 p -110.83 42.14 1.67 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -146.6 134.17 20.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 38.3 t -61.64 133.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 111.097 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.97 -7.68 24.84 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . 171.65 -168.73 41.85 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 44.3 m-85 -146.88 126.81 13.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.937 -1.331 . . . . 0.0 109.679 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.93 141.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -145.27 137.01 25.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.92 -1.112 . . . . 0.0 110.431 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.67 128.77 7.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 23' ' ' ALA . 73.9 Cg_endo -75.39 -42.87 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.614 1.543 . . . . 0.0 111.403 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -54.13 -11.62 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.858 . . . . 0.0 108.959 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -131.5 6.49 4.44 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 42.19 31.72 0.27 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.648 -0.658 . . . . 0.0 109.935 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.99 147.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.061 0.934 . . . . 0.0 109.977 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -164.32 84.49 0.43 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -134.73 159.25 72.87 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.54 -0.725 . . . . 0.0 110.728 -176.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.88 159.51 15.98 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.974 2.45 . . . . 0.0 112.88 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.27 111.34 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 7.6 m-85 -74.41 148.76 86.14 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.855 -1.153 . . . . 0.0 109.765 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.72 112.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.254 1.969 . . . . 0.0 111.96 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.07 -176.12 43.27 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.472 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.7 Cg_endo -79.74 110.57 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 123.045 2.496 . . . . 0.0 111.501 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.63 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.418 0.628 . . . . 0.0 111.443 -178.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -104.18 173.25 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.992 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.22 -28.44 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.693 1.595 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.86 -35.57 80.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.48 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.618 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -81.6 -67.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 110.41 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 38' ' ' GLN . 33.5 mt -42.75 -25.14 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.059 -1.026 . . . . 0.0 110.232 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.03 -24.81 67.29 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -96.14 -17.72 20.65 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 177.57 -133.15 2.14 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.894 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.482 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.1 t -125.82 159.44 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.534 -0.98 . . . . 0.0 109.572 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.618 ' CB ' HE22 ' A' ' 38' ' ' GLN . 4.2 p -155.97 163.0 40.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.231 -0.918 . . . . 0.0 108.833 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 39.9 m-85 -59.43 169.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 109.19 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.66 -14.36 54.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -144.62 146.38 32.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.28 -0.887 . . . . 0.0 110.067 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -23.82 67.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.678 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -87.53 2.49 50.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 2.8 tm-20 -63.56 156.37 26.71 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.498 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.514 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 5.0 m -145.73 178.13 8.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.674 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -87.33 14.79 7.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 108.324 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -140.44 0.86 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.678 . . . . 0.0 109.904 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 14.3 t0 -56.77 118.7 5.16 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.823 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.682 HE22 ' N ' ' A' ' 119' ' ' LYS . 41.5 tp60 -37.52 -24.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.029 0.442 . . . . 0.0 110.322 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 54' ' ' ASP . 18.9 t-20 -133.68 117.27 16.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.354 -0.841 . . . . 0.0 108.944 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 mm -92.72 142.85 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 108.597 179.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.5 p -140.67 109.69 6.12 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 90.6 mt -111.15 161.2 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.646 0.736 . . . . 0.0 110.486 -178.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -137.8 130.41 29.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.96 154.91 25.66 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 72' ' ' PHE . 15.9 m-70 -72.61 170.45 14.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.588 -0.948 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.94 82.42 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 108.97 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.62 114.99 23.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 0.0 108.799 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 mt -56.68 -29.91 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 109.948 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.82 16.24 2.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.602 -178.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.59 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -144.49 69.43 15.41 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.536 -0.728 . . . . 0.0 109.251 179.691 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.42 17.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.068 2.512 . . . . 0.0 113.543 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.59 ' H ' ' C ' ' A' ' 67' ' ' ARG . 37.0 m-80 -148.95 62.77 1.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.926 -1.108 . . . . 0.0 108.558 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -133.3 -154.04 0.58 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 109.77 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 79.4 mt-30 -57.77 -98.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.539 -0.726 . . . . 0.0 111.19 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.7 m-85 -96.0 27.36 3.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.226 -0.921 . . . . 0.0 110.549 -178.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.2 m -65.76 -12.4 53.66 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.58 -1.325 . . . . 0.0 109.581 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' ALA . 11.4 m-20 -128.05 -20.58 3.78 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.269 -0.894 . . . . 0.0 110.47 -179.274 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.65 -33.57 55.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 108.278 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -71.44 -9.56 58.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -87.76 -24.49 23.78 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.377 0.608 . . . . 0.0 109.468 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 171.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.659 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -144.77 167.14 23.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 109.221 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -49.42 138.6 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.42 -20.96 47.01 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -62.43 100.52 0.18 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.368 -1.078 . . . . 0.0 108.119 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.28 173.17 0.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 t -143.13 113.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 109.069 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -95.15 102.6 14.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -95.71 112.08 23.88 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -96.59 152.12 18.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.236 -0.915 . . . . 0.0 111.251 -178.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG2' HH12 ' A' ' 93' ' ' ARG . 76.6 t -156.15 93.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.49 -105.83 1.09 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -118.3 38.84 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.472 -1.016 . . . . 0.0 109.577 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -146.05 108.5 4.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.915 . . . . 0.0 108.828 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.4 ' O ' ' CG2' ' A' ' 92' ' ' THR . 12.8 t -110.39 119.54 39.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.505 -0.747 . . . . 0.0 110.387 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.523 HH12 ' CG2' ' A' ' 88' ' ' VAL . 2.2 mpt_? -95.22 172.54 8.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 109.308 179.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -144.41 146.9 32.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.858 -179.661 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 12.8 m-85 -137.52 177.92 7.5 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -140.63 107.69 5.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 109.721 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 81' ' ' GLY . 64.7 mtp -51.86 120.68 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -153.09 28.66 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.264 -0.897 . . . . 0.0 108.904 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.2 t -166.46 121.58 1.16 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 61.3 mt . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.444 -0.785 . . . . 0.0 110.192 -178.207 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 119' ' ' LYS . 8.0 m-20 . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.682 ' N ' HE22 ' A' ' 55' ' ' GLN . 85.6 mttt -34.89 131.31 0.38 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.69 -0.631 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.79 162.24 38.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.052 -1.03 . . . . 0.0 110.263 -178.443 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.4 mt -109.18 120.47 42.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.706 -0.621 . . . . 0.0 110.497 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m -98.35 87.37 3.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.95 140.84 49.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.413 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -138.16 131.42 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -95.8 164.92 12.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.086 -1.009 . . . . 0.0 108.695 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 97.7 m -145.77 149.06 33.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.118 -0.989 . . . . 0.0 109.873 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.7 OUTLIER 176.79 132.09 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.306 -0.871 . . . . 0.0 109.35 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 0.8 OUTLIER 58.7 75.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.98 126.21 26.92 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.47 117.69 24.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.039 -1.038 . . . . 0.0 109.363 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -85.63 1.9 47.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.353 -0.842 . . . . 0.0 109.686 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -80.79 -55.88 4.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.6 p -94.66 -10.72 30.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.2 41.59 21.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.77 157.34 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 109.508 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.428 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.1 m95 -61.36 113.2 2.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.167 -0.958 . . . . 0.0 108.596 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' TRP . 35.2 tt0 -35.93 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.378 0.608 . . . . 0.0 110.759 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.591 ' CB ' ' HZ1' ' A' ' 138' ' ' LYS . 7.8 ttpm? -100.33 150.95 22.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 108.95 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -173.55 144.66 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.948 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -106.37 173.2 6.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.1 mt -145.69 130.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.09 -1.007 . . . . 0.0 109.868 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -128.32 168.43 15.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.4 t -149.57 147.71 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.778 -1.201 . . . . 0.0 110.978 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.12 175.48 9.58 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -146.75 139.15 24.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.929 -1.107 . . . . 0.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 15.8 tm-20 -60.75 112.51 2.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 10.9 m . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.845 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -65.79 143.15 57.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.571 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.527 ' O ' ' NE2' ' A' ' 2' ' ' GLN . . . -71.13 166.33 21.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 0.0 109.394 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -152.14 58.16 2.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.234 -0.916 . . . . 0.0 109.809 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.44 -160.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.395 2.063 . . . . 0.0 111.502 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -94.7 72.54 3.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.989 -1.069 . . . . 0.0 109.995 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.5 mt -89.22 113.43 56.31 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 10' ' ' ASP . 74.3 Cg_endo -76.6 122.46 6.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.647 1.564 . . . . 0.0 112.324 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -59.48 -7.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 12' ' ' SER . 2.6 m-20 -77.31 94.95 4.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.275 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -57.21 -5.68 0.31 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.261 -0.9 . . . . 0.0 109.793 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 10' ' ' ASP . 18.3 t -110.55 40.5 1.97 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.36 135.73 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.77 120.04 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.95 -19.98 19.1 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.28 -168.12 32.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.61 126.73 9.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.01 146.08 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' OE2' ' N ' ' A' ' 20' ' ' ILE . 8.8 tp10 -146.13 127.5 14.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.041 -1.037 . . . . 0.0 109.703 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' N ' ' OE2' ' A' ' 19' ' ' GLU . 44.7 mt -144.28 127.6 8.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.94 -46.19 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.726 1.617 . . . . 0.0 111.644 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.97 -25.33 3.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.79 9.03 10.62 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.485 -0.759 . . . . 0.0 109.397 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 42.27 38.75 1.24 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.424 0.63 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 ' O ' ' OE2' ' A' ' 19' ' ' GLU . 4.4 mt -92.72 146.44 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.88 0.848 . . . . 0.0 109.536 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -164.64 80.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -132.09 156.16 80.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.398 -0.814 . . . . 0.0 111.278 -176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -82.31 164.98 16.84 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.953 2.436 . . . . 0.0 112.332 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.0 127.03 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.385 -0.822 . . . . 0.0 109.066 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 4.9 m-85 -89.77 150.41 43.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.919 -1.113 . . . . 0.0 109.594 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.81 104.98 1.48 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.139 1.893 . . . . 0.0 111.605 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.08 -176.41 47.64 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.309 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' THR . 73.4 Cg_endo -79.16 117.94 3.92 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.323 . . . . 0.0 111.101 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -43.22 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.392 0.615 . . . . 0.0 110.455 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.587 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.8 p -105.69 153.47 39.92 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.03 -43.15 2.58 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.037 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.82 -21.41 66.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.9 OUTLIER -93.34 -62.39 1.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.0 mt -46.26 -18.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.389 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.5 m-20 -63.25 -25.28 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 89.2 mtt180 -83.27 -17.95 40.82 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 164.94 -130.92 2.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.295 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.34 165.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.574 -0.956 . . . . 0.0 109.213 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.431 ' CB ' HE22 ' A' ' 38' ' ' GLN . 3.3 t -162.09 159.1 25.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.157 -0.964 . . . . 0.0 109.065 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.94 164.85 2.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.84 -1.163 . . . . 0.0 109.396 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -76.79 -21.84 54.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.375 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -138.19 147.42 43.79 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.315 -0.866 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 -24.14 67.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.555 -0.716 . . . . 0.0 111.185 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -86.28 3.39 43.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.867 -1.146 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.87 161.88 20.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.048 -1.033 . . . . 0.0 109.3 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.1 m -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.509 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 4.5 mp -84.44 17.23 2.71 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -145.52 2.27 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.46 -0.775 . . . . 0.0 110.359 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASN . 50.7 t0 -57.29 126.49 27.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.64 -1.287 . . . . 0.0 109.292 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -42.31 -20.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.512 -0.743 . . . . 0.0 109.777 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 54' ' ' ASP . 14.7 t-20 -143.07 104.15 4.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 108.834 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.03 119.93 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.104 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.4 p -108.11 122.89 47.81 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 59' ' ' ILE . 68.9 mt -112.5 161.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.943 0.878 . . . . 0.0 110.952 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.62 125.49 25.71 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.86 153.31 21.04 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.622 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.569 ' O ' ' N ' ' A' ' 72' ' ' PHE . 19.2 m-70 -74.97 167.8 21.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.737 -0.86 . . . . 0.0 109.972 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.663 ' HG1' ' HZ1' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -153.06 87.36 1.27 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 108.913 179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -87.26 117.1 25.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 mt -59.85 -29.13 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.786 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.32 19.4 2.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.444 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.593 ' C ' ' H ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -150.05 70.01 9.2 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.748 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.496 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.2 Cg_exo -54.38 18.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 123.236 2.624 . . . . 0.0 113.564 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.593 ' H ' ' C ' ' A' ' 67' ' ' ARG . 17.2 m-80 -148.94 62.31 1.05 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.07 -153.9 0.6 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.459 -0.776 . . . . 0.0 110.068 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -62.46 -89.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 111.685 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.569 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.9 t80 -95.08 14.1 23.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.537 -0.727 . . . . 0.0 110.692 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.4 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 95.8 m -65.17 -49.45 69.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.4 -1.438 . . . . 0.0 110.829 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 5.0 m120 -83.1 -19.1 37.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.435 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -53.84 -27.94 32.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.851 -1.155 . . . . 0.0 109.059 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.663 ' HZ1' ' HG1' ' A' ' 63' ' ' THR . 20.6 mtmm -66.73 -27.83 67.94 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.06 62.67 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.08 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.3 170.22 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.549 -0.719 . . . . 0.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -150.06 168.0 25.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.264 -0.897 . . . . 0.0 109.069 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -51.32 150.98 3.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.546 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.66 -15.12 32.45 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.452 ' O ' ' SD ' ' A' ' 97' ' ' MET . 25.9 p -63.58 108.08 1.3 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.359 -1.083 . . . . 0.0 108.679 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.464 ' CE ' ' OH ' ' A' ' 85' ' ' TYR . 21.0 ptm -80.65 166.46 21.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.049 -1.032 . . . . 0.0 109.452 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.15 175.8 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.316 -0.865 . . . . 0.0 110.108 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' OH ' ' CE ' ' A' ' 83' ' ' MET . 73.8 m-85 -142.54 111.39 6.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.3 115.99 28.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -85.93 141.12 29.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.6 m -146.64 127.69 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.534 -0.729 . . . . 0.0 109.163 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.57 -115.83 2.06 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -116.16 53.92 0.85 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.606 -0.937 . . . . 0.0 109.399 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -166.84 153.4 8.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.048 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' A' ' 92' ' ' THR . 9.0 t -131.09 124.9 31.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.4 6.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 7.5 ptpp? -142.92 154.8 44.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.146 -0.971 . . . . 0.0 110.042 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.542 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 4.1 m-85 -138.25 177.77 7.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -140.23 110.45 6.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.26 135.21 17.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.05 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 p -153.11 18.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 109.991 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.519 ' OG ' ' NE ' ' A' ' 101' ' ' ARG . 0.6 OUTLIER -170.14 87.45 0.13 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.624 -1.297 . . . . 0.0 109.259 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.418 ' CG2' ' OD2' ' A' ' 102' ' ' ASP . 43.4 mm -81.33 136.51 22.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.247 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.0 OUTLIER -124.52 -8.85 7.43 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.393 -0.817 . . . . 0.0 109.353 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 103' ' ' VAL . 6.4 p30 -43.64 -16.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.239 -0.913 . . . . 0.0 110.236 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 101' ' ' ARG . 20.5 t -59.5 -112.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -70.65 135.39 85.97 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.31 -34.25 13.07 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.204 1.269 . . . . 0.0 112.292 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' A' ' 106' ' ' THR . 17.8 p -84.85 91.31 7.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 109.614 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -135.39 160.34 38.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.411 -0.805 . . . . 0.0 108.933 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.75 46.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.759 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 107' ' ' ASP . . . -161.7 38.6 0.39 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 t -65.98 -29.09 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.1 mt -139.99 -33.39 0.58 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.523 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 45.7 t0 47.62 41.94 14.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.185 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -114.29 -7.57 12.94 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 114' ' ' GLN . 2.2 mp0 -103.03 -9.21 19.96 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -64.68 -155.68 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.91 42.54 0.54 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -95.99 -121.61 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.252 -1.146 . . . . 0.0 109.434 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.3 m-20 -118.82 169.74 9.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.32 -0.863 . . . . 0.0 108.773 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 118' ' ' ASP . 37.5 mtmt -38.52 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.423 ' OE1' ' OD1' ' A' ' 112' ' ' ASP . 7.0 pt20 -154.7 157.37 37.98 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.183 -0.948 . . . . 0.0 110.053 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.7 tp -121.82 106.73 11.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.1 m -91.16 128.03 36.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.933 -1.104 . . . . 0.0 108.785 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.3 mp -103.43 145.27 30.24 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.22 -0.925 . . . . 0.0 110.161 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.6 mt -142.58 139.97 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.374 -0.829 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.07 166.11 11.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.013 -1.054 . . . . 0.0 108.787 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.473 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -149.86 102.49 3.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.04 -1.037 . . . . 0.0 109.754 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 1.8 p-10 -156.03 148.03 23.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 0.0 109.305 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.48 56.85 2.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 108.802 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -62.05 119.0 8.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.464 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 135' ' ' VAL . 2.6 p-10 -83.92 130.63 34.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.013 -1.054 . . . . 0.0 109.694 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.75 5.52 43.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 109.061 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -71.63 -61.43 1.78 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.464 -0.773 . . . . 0.0 108.936 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -100.49 -1.42 35.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 109.342 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.85 49.72 33.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 5.1 t -146.99 168.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -1.065 . . . . 0.0 109.417 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 91.6 m95 -73.82 113.64 11.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -40.28 -77.54 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -84.36 150.49 25.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.015 . . . . 0.0 108.584 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -151.03 79.48 1.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.862 -1.149 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -75.2 148.72 39.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.455 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 11.9 pt -135.87 149.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 122.12 0.962 . . . . 0.0 110.902 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -144.09 143.86 31.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.432 ' CG1' ' HG ' ' A' ' 99' ' ' SER . 4.7 p -136.89 149.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.897 -1.127 . . . . 0.0 110.938 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -130.89 -178.03 4.63 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.7 t -148.05 148.54 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.002 -1.061 . . . . 0.0 109.651 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -51.11 144.03 9.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.86 . . . . 0.0 109.223 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.1 t -91.97 -153.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.346 -0.846 . . . . 0.0 109.164 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 84.3 mttt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.45 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.51 ' OE1' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -154.56 146.67 23.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.259 -0.901 . . . . 0.0 109.515 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.85 158.36 18.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.249 -0.907 . . . . 0.0 109.702 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.56 ' O ' ' O ' ' A' ' 5' ' ' PRO . 1.6 pttm -71.07 153.43 94.56 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 109.015 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' O ' ' O ' ' A' ' 4' ' ' LYS . 66.1 Cg_exo -42.52 -125.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 123.047 2.498 . . . . 0.0 113.726 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -147.76 116.06 6.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.707 -1.246 . . . . 0.0 110.264 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.3 mm -85.27 114.0 53.69 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 98.9 Cg_exo -42.33 150.58 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.627 1.551 . . . . 0.0 112.004 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.08 -11.52 18.8 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.13 103.0 6.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 0.0 109.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -56.5 -13.0 1.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -98.48 30.81 3.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.4 -0.812 . . . . 0.0 109.203 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.5 140.53 23.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 58.5 t -60.65 163.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.72 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -138.51 -3.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.452 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 177.34 -175.19 47.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 69.6 m-85 -149.81 121.46 8.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.084 -1.245 . . . . 0.0 110.087 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.8 tt -98.66 143.93 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -146.84 136.03 22.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.03 -1.044 . . . . 0.0 110.675 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.4 mt -144.88 125.02 7.26 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.5 Cg_endo -76.3 -42.55 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.691 1.594 . . . . 0.0 111.434 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -50.66 -17.24 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.048 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . . . -133.82 14.31 3.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.513 -0.742 . . . . 0.0 109.209 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.4 p-10 43.75 50.25 6.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 25' ' ' ILE . 43.3 mm -92.7 142.79 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.645 0.736 . . . . 0.0 109.888 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -168.97 81.35 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.0 158.49 61.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.738 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -86.07 169.74 8.68 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.184 2.589 . . . . 0.0 113.105 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.56 137.14 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 24.6 m-85 -92.41 149.84 39.0 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.907 -1.121 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 50.3 Cg_endo -81.46 79.37 3.25 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.806 2.338 . . . . 0.0 111.802 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.76 177.5 39.58 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.865 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 91.2 Cg_endo -79.86 121.66 4.62 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.824 2.349 . . . . 0.0 111.182 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . -40.85 87.75 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.906 -0.496 . . . . 0.0 110.918 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -111.54 167.28 9.32 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.52 -45.36 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.739 1.626 . . . . 0.0 111.833 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -62.28 -17.03 57.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.856 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.599 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -96.98 -69.36 0.76 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 0.0 108.642 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.2 mt -41.35 -24.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.799 -0.563 . . . . 0.0 110.51 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 38' ' ' GLN . 31.3 m-20 -63.61 -25.13 68.09 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.436 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.4 mtp180 -84.49 -14.58 48.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.535 ' C ' HE21 ' A' ' 71' ' ' GLN . . . 156.51 -143.92 10.22 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.882 -1.151 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.538 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.9 t -88.61 152.88 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 t -148.81 141.02 24.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 108.967 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -56.45 162.35 2.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 108.944 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.423 ' CB ' ' OG ' ' A' ' 58' ' ' SER . . . -79.31 -9.98 59.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.173 -0.954 . . . . 0.0 108.812 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -145.27 149.55 35.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.5 pt-20 -63.39 -41.84 98.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 111.152 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 8.2 p30 -89.65 17.81 6.11 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 111.222 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.87 95.77 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.866 -1.146 . . . . 0.0 109.839 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -89.75 173.31 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.536 ' CD1' ' NH2' ' A' ' 93' ' ' ARG . 0.2 OUTLIER -82.44 0.13 43.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.089 -1.007 . . . . 0.0 108.647 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.91 -10.68 19.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.564 -0.71 . . . . 0.0 109.897 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.5 t70 -59.59 113.44 2.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.772 -1.205 . . . . 0.0 108.863 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -46.72 -14.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.133 -0.979 . . . . 0.0 109.56 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' ASP . 3.8 m120 -133.49 97.21 3.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -94.23 115.86 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.233 -0.917 . . . . 0.0 108.917 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.8 t -108.63 116.69 32.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.697 -0.627 . . . . 0.0 109.351 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 92.1 mt -109.37 164.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.601 0.715 . . . . 0.0 109.579 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -138.32 135.25 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.07 148.78 20.7 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.081 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -74.53 -169.29 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.639 -0.918 . . . . 0.0 110.07 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.84 99.99 0.47 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.27 122.45 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.162 -0.962 . . . . 0.0 108.918 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mt -64.65 -43.06 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.783 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.26 18.91 2.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.187 -0.945 . . . . 0.0 109.888 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.568 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -151.04 75.58 8.16 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 72.9 Cg_exo -51.78 24.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.92 3.08 . . . . 0.0 114.642 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 67' ' ' ARG . 10.4 m120 -151.7 62.92 0.86 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 108.55 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.435 ' O ' ' OG1' ' A' ' 73' ' ' THR . 36.8 t80 -141.7 90.24 2.26 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.235 -0.916 . . . . 0.0 110.498 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.562 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 1.5 mm100 65.03 -119.23 0.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.764 -0.585 . . . . 0.0 111.556 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.628 ' CD2' ' O ' ' A' ' 72' ' ' PHE . 29.5 t80 -87.44 33.35 0.69 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.318 1.056 . . . . 0.0 109.142 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 70' ' ' TYR . 21.6 m -69.13 -57.21 5.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.15 -1.594 . . . . 0.0 110.607 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.1 m-20 -90.43 -13.56 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.181 -0.949 . . . . 0.0 111.775 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mt -52.38 -29.63 24.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 108.281 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -1.77 21.36 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -99.37 -33.2 10.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.618 . . . . 0.0 109.337 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.25 163.23 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -129.03 162.73 26.97 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.595 ' HZ3' ' CB ' ' A' ' 80' ' ' LYS . 9.5 mtmp? -49.06 132.41 19.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 109.282 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.94 -24.3 15.03 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -64.36 114.23 4.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.206 -1.173 . . . . 0.0 108.065 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -73.35 -174.11 1.55 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.839 -1.163 . . . . 0.0 109.454 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.584 ' N ' ' SD ' ' A' ' 83' ' ' MET . 21.4 t -146.46 110.75 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.515 ' CD2' ' SD ' ' A' ' 83' ' ' MET . 53.0 m-85 -87.45 102.44 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -97.56 117.54 32.07 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -107.75 139.77 41.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.414 -0.804 . . . . 0.0 110.112 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.434 ' CG1' ' NH1' ' A' ' 93' ' ' ARG . 7.1 p -168.96 157.41 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.724 . . . . 0.0 109.484 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.85 -96.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -154.27 29.8 0.44 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -140.17 -175.25 4.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.355 -0.841 . . . . 0.0 109.201 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 m -149.83 111.57 4.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.536 ' NH2' ' CD1' ' A' ' 52' ' ' LEU . 7.6 mpt_? -89.07 163.53 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -141.43 122.9 15.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.384 -0.823 . . . . 0.0 109.63 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 17.1 m-85 -109.15 175.1 5.58 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.429 -0.794 . . . . 0.0 109.128 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.89 111.06 8.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.28 -0.887 . . . . 0.0 109.886 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.9 mtt -50.67 123.23 8.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.123 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 p -149.44 20.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 109.431 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.1 t -171.37 123.69 0.57 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.691 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.3 mt -138.82 128.78 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 101' ' ' ARG . 3.6 mtt-85 -86.54 -70.8 0.58 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.189 -0.944 . . . . 0.0 108.945 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 51.16 10.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.113 -0.992 . . . . 0.0 109.179 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 104' ' ' LYS . 10.6 t -91.05 -93.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.533 ' N ' ' CG1' ' A' ' 103' ' ' VAL . 52.0 mtpt -100.0 140.96 21.91 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.06 28.89 0.29 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.207 1.271 . . . . 0.0 111.879 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -178.56 75.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.397 -0.814 . . . . 0.0 109.544 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 106' ' ' THR . 49.5 t0 -61.77 -115.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -0.969 . . . . 0.0 108.81 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.436 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 6.4 m -104.14 22.34 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.33 -0.856 . . . . 0.0 109.126 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.48 103.85 0.84 Allowed Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.64 -15.25 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.214 -1.168 . . . . 0.0 108.337 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.4 mt -135.38 54.88 1.9 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -171.74 20.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.469 -0.77 . . . . 0.0 109.097 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 113' ' ' GLU . 10.2 tt0 -156.64 0.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 109.553 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.582 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 3.6 mp0 -94.37 15.73 16.9 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -96.16 44.55 1.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -92.44 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -145.91 -26.49 0.44 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 49.1 t0 -118.86 168.16 11.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.144 -0.973 . . . . 0.0 108.617 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.468 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 83.0 mttt -60.83 145.08 51.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -143.83 160.58 40.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.057 -1.027 . . . . 0.0 108.953 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.1 tp -114.87 107.98 16.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.675 . . . . 0.0 110.962 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.7 t -97.54 107.72 20.29 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.0 156.38 21.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.003 . . . . 0.0 110.278 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.7 mt -140.37 143.78 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.513 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -91.78 155.89 17.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.934 -1.104 . . . . 0.0 108.512 179.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 2.0 m -149.29 85.03 1.44 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.944 -1.097 . . . . 0.0 109.886 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 20.3 p-10 -142.8 143.88 32.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.141 -0.975 . . . . 0.0 109.235 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.34 61.09 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.451 -0.78 . . . . 0.0 109.072 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -63.7 119.98 10.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -85.67 123.48 31.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 109.602 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 131' ' ' GLU . 1.7 pm0 -94.82 14.7 20.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.343 -0.848 . . . . 0.0 109.77 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -69.31 -35.5 76.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.0 108.57 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.0 p -140.99 1.92 1.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 109.037 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.63 3.03 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.3 t -146.99 133.72 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.225 -1.162 . . . . 0.0 109.642 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 53.3 m95 -53.11 113.65 1.19 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.07 -1.019 . . . . 0.0 108.493 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -36.96 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.291 0.567 . . . . 0.0 110.326 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 137' ' ' GLU . 19.2 ptmt -96.87 139.35 33.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -151.78 96.49 2.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.891 -1.131 . . . . 0.0 110.569 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -86.58 158.49 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.156 -0.965 . . . . 0.0 108.473 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.9 mm -129.25 140.29 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 25.8 m-85 -129.49 170.63 13.47 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.1 t -154.06 140.85 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.692 -1.255 . . . . 0.0 110.86 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.24 139.3 40.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.8 t -109.85 137.61 47.39 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.399 -0.813 . . . . 0.0 110.389 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.03 133.55 55.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 109.547 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.2 m -91.63 148.17 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 109.327 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.7 pttp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.438 -179.998 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.309 0.575 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -74.43 91.25 2.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.913 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.19 60.08 2.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.409 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 5' ' ' PRO . 43.7 mttp -146.81 77.26 11.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.323 -0.861 . . . . 0.0 109.431 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' CD ' ' OD1' ' A' ' 53' ' ' ASP . 52.9 Cg_exo -54.58 -140.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.972 2.448 . . . . 0.0 112.495 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -67.37 91.84 0.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.765 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mt -149.46 95.57 3.75 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 10' ' ' ASP . 93.1 Cg_endo -83.6 134.18 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.191 1.927 . . . . 0.0 112.432 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -60.21 0.76 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 12' ' ' SER . 13.2 t70 -76.49 91.18 3.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -64.76 38.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.557 ' H ' ' C ' ' A' ' 10' ' ' ASP . 43.3 t -146.9 25.26 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 108.885 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -141.67 141.88 33.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.64 118.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.66 -0.65 . . . . 0.0 110.885 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.96 -16.81 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.97 -177.48 38.74 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 121.31 8.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -1.223 . . . . 0.0 109.586 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -99.9 142.04 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' CD ' ' NZ ' ' A' ' 87' ' ' LYS . 23.7 mt-10 -146.79 135.24 21.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.968 -1.083 . . . . 0.0 110.737 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG23 HD12 ' A' ' 20' ' ' ILE . 32.5 mt -144.84 127.06 8.12 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.07 -42.75 0.37 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.636 1.557 . . . . 0.0 111.599 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -52.16 -14.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.403 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.63 15.14 3.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.42 -0.8 . . . . 0.0 109.136 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 42.41 49.52 4.62 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.718 0.77 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 26' ' ' LYS . 50.0 mm -91.76 141.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 25' ' ' ILE . 42.3 mttp -165.9 81.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -143.91 156.58 58.79 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 0.0 110.817 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -84.79 165.36 11.84 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.041 2.494 . . . . 0.0 112.531 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.22 119.43 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.565 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 7.9 m-85 -79.37 149.43 72.23 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.817 -1.177 . . . . 0.0 110.207 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.58 88.5 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.479 2.119 . . . . 0.0 111.86 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.31 -179.44 41.23 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.575 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 35' ' ' THR . 85.2 Cg_endo -78.09 119.17 4.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.861 2.374 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -43.63 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.383 0.611 . . . . 0.0 110.397 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -112.55 153.47 44.94 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.63 -43.43 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.09 1.86 . . . . 0.0 111.664 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.09 -22.98 67.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.565 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 7.1 tp60 -89.94 -66.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.235 -0.916 . . . . 0.0 109.54 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.2 mt -46.39 -15.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.918 . . . . 0.0 109.947 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' GLN . 40.0 m-20 -63.25 -25.19 68.21 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' C ' ' HH ' ' A' ' 30' ' ' TYR . 86.6 mtt180 -88.88 -11.24 45.18 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 158.15 -136.6 4.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.42 159.03 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.992 . . . . 0.0 109.862 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 p -153.58 156.73 38.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -57.99 175.67 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.797 -1.189 . . . . 0.0 109.946 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.95 -12.18 51.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -147.24 151.12 36.15 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.472 0.653 . . . . 0.0 109.935 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.39 -38.73 92.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.6 -0.687 . . . . 0.0 111.34 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -87.38 12.31 12.38 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.897 -1.127 . . . . 0.0 110.643 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.31 84.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.52 ' C ' ' H ' ' A' ' 53' ' ' ASP . 48.2 m -92.56 147.46 22.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.03 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.635 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.41 -8.77 0.37 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -77.12 -30.82 55.37 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.508 -0.745 . . . . 0.0 109.615 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 15.8 m-20 -62.16 104.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.055 -1.028 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.31 -16.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 54' ' ' ASP . 27.6 t-20 -117.97 97.86 6.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.646 -0.659 . . . . 0.0 109.223 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.445 ' O ' ' OG1' ' A' ' 122' ' ' THR . 92.2 mt -98.49 150.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.376 -0.827 . . . . 0.0 109.325 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -140.46 114.45 9.02 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -101.69 161.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.326 -0.859 . . . . 0.0 110.362 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.438 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -140.27 131.17 26.02 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.23 154.24 24.89 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.537 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.676 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 19.9 m-70 -71.1 175.52 5.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.68 -0.894 . . . . 0.0 109.063 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.86 89.75 0.66 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.65 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.05 116.99 28.49 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.2 mm -59.59 -29.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.799 . . . . 0.0 110.097 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -87.54 19.51 3.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -149.71 70.56 9.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.536 -0.727 . . . . 0.0 109.191 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.88 14.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 123.442 2.761 . . . . 0.0 113.853 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.579 ' H ' ' C ' ' A' ' 67' ' ' ARG . 56.5 m-80 -147.9 60.95 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.216 . . . . 0.0 108.839 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -146.8 103.63 3.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 110.48 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.676 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 15.0 mt-30 55.81 -115.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 111.907 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.68 30.65 2.87 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 111.13 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.1 m -63.92 -49.16 73.71 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.128 -1.608 . . . . 0.0 109.611 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 77' ' ' ALA . 4.9 m-20 -93.95 -18.23 22.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.012 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.439 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 2.6 tm? -51.05 -39.07 55.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -68.91 -4.71 17.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -91.5 -27.99 17.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 162.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 109.742 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 166.36 24.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.348 -0.845 . . . . 0.0 108.807 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -50.18 137.31 18.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.54 13.19 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -64.19 119.7 10.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.407 -1.055 . . . . 0.0 108.269 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.7 mtp -82.96 137.12 34.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.0 -1.063 . . . . 0.0 110.102 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.02 114.12 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.607 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -93.26 102.46 14.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.151 -0.968 . . . . 0.0 109.544 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -97.13 114.63 26.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 0.0 108.755 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' NZ ' ' CD ' ' A' ' 19' ' ' GLU . 23.0 mtmm -106.12 142.08 36.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.94 123.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.79 -145.23 5.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 90' ' ' ASN . 28.0 t-20 -85.26 52.1 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.198 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 m -152.98 148.68 27.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.601 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 177.15 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -144.31 164.1 31.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.028 -1.045 . . . . 0.0 110.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 94' ' ' LYS . 23.7 m-85 -148.96 108.31 3.95 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.39 117.91 16.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.132 -0.98 . . . . 0.0 109.27 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -51.75 129.62 26.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.309 -0.869 . . . . 0.0 108.988 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -158.16 24.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.227 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.0 t -171.28 132.7 0.81 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 64.4 mt -142.1 166.74 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 101' ' ' ARG . 2.9 mtt-85 -140.35 -26.74 0.76 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.5 t0 42.68 20.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.678 . . . . 0.0 109.186 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -167.95 141.57 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' PRO . 38.8 tttm -65.66 -62.25 4.71 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.897 -1.127 . . . . 0.0 110.606 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 107' ' ' ASP . 28.0 Cg_exo -23.81 -109.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 123.788 2.992 . . . . 0.0 114.462 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 107' ' ' ASP . 31.0 p 50.34 -89.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.753 -1.217 . . . . 0.0 109.705 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.569 ' C ' ' H ' ' A' ' 109' ' ' GLY . 50.8 m-20 -96.73 169.35 9.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.6 m -72.79 33.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.076 -1.015 . . . . 0.0 108.962 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 154.67 122.16 0.81 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.541 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 60.9 t -68.09 -35.95 73.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.186 -1.185 . . . . 0.0 108.597 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.08 67.83 0.67 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -173.45 25.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.987 . . . . 0.0 110.187 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -155.02 22.87 0.44 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.866 -1.146 . . . . 0.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 110' ' ' VAL . 5.8 pt20 -146.34 13.79 1.25 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.433 -0.792 . . . . 0.0 109.121 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -80.35 31.81 0.28 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.679 -0.638 . . . . 0.0 109.551 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . -150.51 8.36 0.74 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -96.65 -125.1 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -1.22 . . . . 0.0 108.982 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 4.2 m-20 -116.45 168.37 10.21 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -47.37 141.29 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 108.824 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.419 ' OE1' ' OE1' ' A' ' 114' ' ' GLN . 6.8 pt20 -152.84 164.58 37.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 110.572 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.1 tp -127.23 116.59 20.81 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.067 0.46 . . . . 0.0 109.854 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -96.05 92.37 6.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.07 143.17 54.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 110.136 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mt -140.92 135.62 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.462 -0.774 . . . . 0.0 109.324 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.6 p -96.63 167.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.058 -1.027 . . . . 0.0 108.521 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 70.8 m -147.03 139.5 24.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.022 -1.049 . . . . 0.0 110.124 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 1.7 p30 179.59 136.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 61.5 64.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.0 109.201 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -62.98 126.5 27.53 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 109.142 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -85.96 118.36 25.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.038 . . . . 0.0 109.509 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.74 -0.56 54.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.425 -0.797 . . . . 0.0 109.918 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.77 -50.24 9.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.008 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.7 p -95.13 -10.69 29.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.236 -0.915 . . . . 0.0 109.233 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.76 39.94 54.08 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.89 158.89 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.333 -1.098 . . . . 0.0 109.636 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.427 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.8 m95 -62.78 111.76 2.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -35.79 -77.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.064 0.459 . . . . 0.0 110.627 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.446 -0.784 . . . . 0.0 109.227 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -169.79 131.62 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.709 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.51 166.83 13.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.14 -0.975 . . . . 0.0 108.845 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 22.6 mt -141.51 144.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 13.1 m-85 -140.1 168.93 18.66 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -150.05 141.8 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.626 -1.296 . . . . 0.0 110.745 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.19 171.27 14.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 147' ' ' VAL . 14.4 t -146.87 147.53 30.91 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.84 -1.163 . . . . 0.0 110.93 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.17 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.512 ' H ' ' C ' ' A' ' 145' ' ' THR . 1.7 t -148.1 175.17 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.181 -0.949 . . . . 0.0 108.99 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.4 pttt . . . . . 0 N--CA 1.499 2.007 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.377 179.888 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -164.41 143.91 7.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 109.242 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.76 143.67 1.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' PRO . 45.8 mttt -82.17 154.91 69.82 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' LYS . 99.8 Cg_exo -42.11 172.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.081 1.854 . . . . 0.0 112.062 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -92.32 113.04 25.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.907 -1.12 . . . . 0.0 111.252 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' PRO . 6.9 mm -87.82 118.52 69.82 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' ILE . 76.8 Cg_exo -47.27 -174.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.527 1.485 . . . . 0.0 112.509 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -120.66 -26.7 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 12' ' ' SER . 30.8 t70 -76.08 101.68 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -57.45 -2.67 0.13 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.6 p -115.59 43.98 1.97 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.499 -0.75 . . . . 0.0 109.345 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HZ3' ' CB ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -142.24 136.83 30.24 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 t -61.19 108.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.52 -0.738 . . . . 0.0 111.402 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.7 -5.03 49.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.43 -170.24 40.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.08 126.33 10.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -1.183 . . . . 0.0 109.073 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 tp -97.41 140.77 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -146.58 132.54 19.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.167 . . . . 0.0 110.748 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.6 mt -144.8 120.58 6.02 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.94 -37.99 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.629 1.553 . . . . 0.0 111.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.32 -19.9 1.48 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.408 -0.807 . . . . 0.0 109.293 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 24' ' ' ASP . . . -130.54 5.32 4.72 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.5 -0.75 . . . . 0.0 109.465 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER 56.16 29.61 15.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.831 -0.543 . . . . 0.0 111.372 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CD1' ' ND2' ' A' ' 74' ' ' ASN . 1.5 mp -85.33 142.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.658 -1.276 . . . . 0.0 108.404 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -165.64 86.3 0.37 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -142.13 160.62 54.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.75 158.18 24.68 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.514 2.143 . . . . 0.0 112.17 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.06 108.39 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.75 166.94 27.01 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.948 -1.095 . . . . 0.0 109.11 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -86.1 130.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.486 2.124 . . . . 0.0 112.177 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.02 168.94 30.88 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.012 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.9 Cg_endo -77.78 121.02 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 111.286 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . -39.78 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.33 0.586 . . . . 0.0 110.281 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 p -126.43 152.82 74.68 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.12 -43.0 12.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.187 1.924 . . . . 0.0 111.995 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -61.46 -21.98 64.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.576 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -95.29 -69.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.158 -0.964 . . . . 0.0 109.253 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.5 mt -45.58 -16.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -62.18 -24.84 67.43 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.6 -15.64 54.06 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.61 -109.69 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.924 -1.131 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.473 ' C ' ' HG ' ' A' ' 44' ' ' SER . 5.0 t -125.52 153.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.505 -0.997 . . . . 0.0 109.758 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 2.7 m -153.79 153.74 32.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -56.78 165.57 1.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.594 -1.317 . . . . 0.0 109.474 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -79.05 -5.12 53.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -150.9 146.42 26.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.519 -0.738 . . . . 0.0 109.591 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.49 -38.39 87.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 111.075 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -89.47 15.48 9.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.99 -1.069 . . . . 0.0 111.143 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.0 99.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.847 -1.158 . . . . 0.0 109.61 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.1 p -91.22 144.28 25.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 108.856 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.672 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.99 -7.1 0.95 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 51' ' ' SER . 20.5 t0 -96.01 -13.47 23.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.691 -0.631 . . . . 0.0 109.626 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' ASN . 46.4 t0 -58.97 105.08 0.28 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.02 -1.05 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.732 HE21 HE21 ' A' ' 120' ' ' GLN . 6.0 tm0? -44.49 -17.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.506 -0.747 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 54' ' ' ASP . 5.0 t-20 -122.3 92.75 3.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.1 mt -93.55 145.8 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 108.453 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 t -142.3 109.17 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 108.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 81.5 mt -95.27 162.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.181 -0.949 . . . . 0.0 110.162 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.401 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -134.02 131.78 39.3 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.03 145.47 15.44 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.844 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 18.1 m-70 -72.85 -169.95 0.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.685 -0.891 . . . . 0.0 109.304 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.48 94.15 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -89.44 113.09 24.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.923 . . . . 0.0 108.887 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mt -61.07 -31.67 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 110.12 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -84.27 15.47 3.56 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 109.302 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -151.49 74.23 8.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.466 ' C ' ' ND2' ' A' ' 69' ' ' ASN . 76.8 Cg_exo -52.38 24.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 123.861 3.041 . . . . 0.0 114.379 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.572 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.9 m-80 -151.26 63.44 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.0 108.551 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 36.2 t80 -150.77 99.85 2.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.071 -1.018 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.542 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.8 mt-30 59.66 -122.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.706 . . . . 0.0 111.454 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.648 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 12.2 t80 -92.75 36.66 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.402 1.096 . . . . 0.0 109.574 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.7 m -67.05 -56.65 9.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 119.908 -1.745 . . . . 0.0 110.299 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.2 p30 -110.82 7.14 21.84 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.232 -0.917 . . . . 0.0 111.409 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mt -57.8 -15.03 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.62 -12.35 59.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -81.54 -30.41 33.15 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.8 -179.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLY . 23.5 mmtp -139.76 153.48 47.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -51.39 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.83 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.7 -15.35 0.36 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -62.86 121.25 13.02 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.335 -1.097 . . . . 0.0 108.119 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtp -70.94 -175.06 1.04 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.336 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -146.51 109.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.39 101.88 14.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE2' ' CG2' ' A' ' 88' ' ' VAL . 16.7 t80 -98.74 112.45 24.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' CB ' ' NZ ' ' A' ' 87' ' ' LYS . 7.0 mtmp? -92.12 146.55 23.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.064 -1.023 . . . . 0.0 110.809 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 90' ' ' ASN . 68.3 t -139.55 155.25 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.77 41.2 0.25 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 88' ' ' VAL . 43.1 t30 -160.4 -34.29 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.229 -1.159 . . . . 0.0 110.028 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.441 ' OE1' ' NH1' ' A' ' 93' ' ' ARG . 29.8 tt0 -172.4 165.9 5.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 t -107.14 123.04 47.67 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.441 ' NH1' ' OE1' ' A' ' 91' ' ' GLU . 5.3 mmt180 -92.94 160.16 15.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 108.737 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -144.87 121.18 10.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -114.59 176.76 4.91 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.607 -0.683 . . . . 0.0 109.223 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -136.56 107.21 6.55 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 0.0 109.395 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 28.5 tpp -49.49 119.29 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.052 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 99' ' ' SER . 2.6 t -145.37 19.72 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.096 -1.002 . . . . 0.0 109.744 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 98' ' ' THR . 45.7 m -169.54 118.84 0.65 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 108.784 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 100' ' ' ILE . 92.3 mt -134.34 151.92 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.554 -0.716 . . . . 0.0 109.669 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.519 ' NH2' ' OE1' ' A' ' 113' ' ' GLU . 10.9 mpt_? -112.66 -65.43 1.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 101' ' ' ARG . 18.5 t70 37.68 54.57 1.5 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.339 0.59 . . . . 0.0 110.001 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.2 p -159.58 40.15 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.253 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 74.11 155.16 0.15 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.482 -0.761 . . . . 0.0 109.211 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -35.25 101.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.801 2.334 . . . . 0.0 112.484 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.652 ' HG1' ' N ' ' A' ' 107' ' ' ASP . 38.6 p -88.18 -42.82 12.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.5 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.652 ' N ' ' HG1' ' A' ' 106' ' ' THR . 30.3 t70 -98.83 160.79 14.02 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.69 32.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.086 -1.009 . . . . 0.0 108.88 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 157.12 134.4 1.76 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.168 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.9 m -69.75 -34.38 60.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.414 -1.051 . . . . 0.0 108.911 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 112' ' ' ASP . 19.8 mt -101.13 67.61 1.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.489 -0.757 . . . . 0.0 109.413 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.664 ' N ' HE21 ' A' ' 114' ' ' GLN . 1.8 m-20 -178.22 28.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.519 ' OE1' ' NH2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -160.88 25.14 0.14 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.664 HE21 ' N ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -137.96 16.94 2.84 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 116' ' ' GLY . 6.8 mtpm? -97.87 35.77 1.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 115' ' ' LYS . . . -48.35 -96.16 0.01 OUTLIER Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -154.79 -32.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -1.203 . . . . 0.0 110.647 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -104.99 149.96 25.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.207 -0.933 . . . . 0.0 110.442 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -44.86 140.77 2.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.732 HE21 HE21 ' A' ' 55' ' ' GLN . 9.0 pt20 -152.21 173.4 15.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.997 -1.064 . . . . 0.0 110.08 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.7 tp -122.87 155.86 35.81 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.45 0.643 . . . . 0.0 110.122 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.0 m -141.98 88.96 2.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.77 149.44 49.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.378 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 96.8 mt -140.04 141.99 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.5 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -90.49 156.56 18.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.919 -1.113 . . . . 0.0 108.831 179.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.533 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 23.0 m -148.75 89.82 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.142 -0.973 . . . . 0.0 109.449 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -148.54 146.04 28.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.235 -0.916 . . . . 0.0 109.118 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 1.2 m-20 61.29 63.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 108.835 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.432 ' HH ' ' C ' ' A' ' 134' ' ' GLY . 28.4 t80 -63.24 122.11 15.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -85.17 121.69 28.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.85 13.77 19.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.853 . . . . 0.0 109.638 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -81.19 -26.16 36.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 p -141.98 5.59 1.73 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.355 -0.84 . . . . 0.0 109.168 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.432 ' C ' ' HH ' ' A' ' 129' ' ' TYR . . . 68.23 53.04 23.88 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.481 ' CG1' ' NH2' ' A' ' 139' ' ' ARG . 3.3 t -147.29 139.83 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.218 -1.166 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 56.9 m95 -56.09 115.39 2.4 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.38 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 12.6 tp10 -39.51 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.724 -0.61 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -81.28 146.92 30.16 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.481 ' NH2' ' CG1' ' A' ' 135' ' ' VAL . 26.8 ttm180 -158.76 75.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.872 -1.143 . . . . 0.0 110.482 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -75.27 163.59 27.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.47 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 6.9 mm -134.09 156.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.836 0.826 . . . . 0.0 110.426 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 21.3 m-85 -141.75 159.73 41.64 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.2 147.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.711 -1.243 . . . . 0.0 111.342 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.17 158.77 43.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.21 143.02 50.27 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.15 -0.968 . . . . 0.0 109.92 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 9.1 tm-20 -60.48 135.75 57.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.438 -0.789 . . . . 0.0 108.88 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.425 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t -136.89 175.84 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.356 -0.84 . . . . 0.0 108.875 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.9 pttt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.085 -1.009 . . . . 0.0 109.459 179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.579 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.376 0.608 . . . . 0.0 109.393 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -69.9 111.32 5.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.624 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.18 154.97 41.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.17 -0.956 . . . . 0.0 109.363 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.3 pttp -56.15 143.82 62.32 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.14 -0.975 . . . . 0.0 109.159 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 4' ' ' LYS . 74.6 Cg_exo -49.25 -156.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.225 1.95 . . . . 0.0 113.21 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -67.5 101.66 1.02 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.016 . . . . 0.0 109.909 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.483 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . 11.8 mt -149.75 94.92 3.77 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 0.0 108.964 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.62 172.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.275 1.983 . . . . 0.0 112.345 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.57 2.08 12.33 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.57 -0.707 . . . . 0.0 109.514 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 12' ' ' SER . 63.2 t0 -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.98 3.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 10' ' ' ASP . 27.2 p -129.24 39.81 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.259 -0.9 . . . . 0.0 109.82 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -150.42 150.36 31.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.149 -0.969 . . . . 0.0 109.143 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 89.0 t -61.04 157.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.603 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -144.29 -30.09 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.82 -178.18 28.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -148.06 120.01 8.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -1.137 . . . . 0.0 108.963 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tp -94.37 143.67 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -147.43 132.55 18.3 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.155 . . . . 0.0 110.914 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.2 mt -145.72 123.71 6.35 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.7 -39.42 0.52 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.752 1.635 . . . . 0.0 111.895 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.48 -23.32 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' O ' ' OD2' ' A' ' 24' ' ' ASP . . . -127.35 4.38 6.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 109.42 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.3 p30 52.38 37.38 22.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.832 -0.542 . . . . 0.0 111.359 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.29 146.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.76 -1.212 . . . . 0.0 108.095 177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -166.55 82.56 0.26 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -139.27 156.91 71.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 111.646 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.0 164.51 7.28 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.82 2.346 . . . . 0.0 113.308 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.86 129.72 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 2.0 m-85 -87.57 152.36 51.81 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 120.877 -1.139 . . . . 0.0 110.179 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.4 97.94 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.577 2.185 . . . . 0.0 111.43 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.77 -178.27 48.68 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.323 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.0 Cg_endo -80.61 117.78 3.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.867 2.378 . . . . 0.0 111.018 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.05 88.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.395 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.0 p -107.7 153.63 41.36 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.62 -41.35 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.191 1.928 . . . . 0.0 112.392 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.43 -22.22 66.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 109.678 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.4 tm0? -96.17 -53.74 3.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.9 mt -45.1 -23.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' GLN . 14.6 m-20 -64.03 -25.67 68.22 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.419 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 88.5 mtt180 -84.35 -16.0 44.45 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.0 -139.61 6.81 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.682 -1.246 . . . . 0.0 110.782 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.85 159.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.46 -1.023 . . . . 0.0 109.792 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -155.56 152.97 29.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.516 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 54.1 m-85 -58.68 160.21 5.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.522 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -75.39 -6.16 48.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.997 . . . . 0.0 109.413 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -154.37 149.56 26.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.509 ' OE2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -62.99 -35.86 81.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 111.612 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.509 ' ND2' ' OE2' ' A' ' 48' ' ' GLU . 13.9 p30 -87.88 15.5 7.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.858 -1.151 . . . . 0.0 110.979 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 12.0 tm-20 -64.86 145.06 56.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.991 -1.068 . . . . 0.0 109.062 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.725 ' HG ' ' H ' ' A' ' 53' ' ' ASP . 8.4 p -148.44 153.46 38.54 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.419 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -67.04 -4.64 10.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.725 ' H ' ' HG ' ' A' ' 51' ' ' SER . 39.2 m-20 -95.06 -17.42 21.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.9 t70 -59.15 115.56 3.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.944 -1.097 . . . . 0.0 108.846 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 9.3 tt0 -46.04 -19.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 109.607 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.747 HD22 ' HZ2' ' A' ' 115' ' ' LYS . 61.7 t-20 -131.88 113.48 13.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.692 . . . . 0.0 109.435 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.64 145.19 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 108.627 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.7 p -141.55 104.43 4.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -103.13 158.83 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.86 129.06 47.5 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.8 149.05 20.55 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.924 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 31.3 m-70 -74.28 -163.54 0.2 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.61 -0.936 . . . . 0.0 110.046 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.476 ' O ' ' CG2' ' A' ' 63' ' ' THR . 10.0 t -164.34 80.56 0.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.332 -0.855 . . . . 0.0 108.794 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -87.51 108.0 18.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.798 -1.189 . . . . 0.0 109.11 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.99 -29.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -82.38 12.31 4.6 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.805 0.812 . . . . 0.0 109.401 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.606 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -146.01 75.39 12.95 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.52 8.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.617 2.878 . . . . 0.0 113.988 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.606 ' H ' ' C ' ' A' ' 67' ' ' ARG . 12.2 p30 -142.93 59.36 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 0.0 108.085 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.435 ' O ' ' OG1' ' A' ' 73' ' ' THR . 27.9 t80 -143.46 102.91 4.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.381 -0.824 . . . . 0.0 110.177 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 51.62 -132.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.423 -0.798 . . . . 0.0 110.752 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.679 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 1.1 t80 -87.65 63.39 7.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.881 1.324 . . . . 0.0 108.779 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 70' ' ' TYR . 52.9 m -89.66 -32.69 16.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.657 -1.277 . . . . 0.0 108.377 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.556 ' N ' ' OD1' ' A' ' 74' ' ' ASN . 3.6 p-10 -140.03 10.06 2.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -10.53 0.72 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 74' ' ' ASN . 1.8 ptmm? -85.33 -23.48 28.05 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -67.33 -29.09 68.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.36 -157.15 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.7 ptmt -171.23 162.42 6.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -52.59 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.256 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 152.56 -25.09 0.85 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -63.41 113.66 3.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.1 mtp -63.24 -177.5 0.19 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.68 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.6 t -144.87 106.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.421 -0.8 . . . . 0.0 109.171 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.99 102.43 14.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.931 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -96.12 115.99 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -102.91 144.04 31.72 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.304 -0.873 . . . . 0.0 109.983 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 p -169.24 140.29 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.399 -0.813 . . . . 0.0 109.105 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.5 -97.71 0.15 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.88 18.9 0.89 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -1.14 . . . . 0.0 109.299 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -132.73 139.82 47.78 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.7 t -112.53 132.35 55.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.439 -0.788 . . . . 0.0 110.287 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 93' ' ' ARG . 7.4 mmm-85 -92.93 167.56 11.74 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -148.46 92.76 2.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.9 -1.125 . . . . 0.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -87.7 -178.16 6.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 108.185 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -138.39 105.33 5.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.252 -0.905 . . . . 0.0 109.769 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 35.7 ttm -50.06 115.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -157.59 24.76 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.1 m -164.69 119.53 1.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 71.4 mt -130.49 166.97 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.428 -0.795 . . . . 0.0 109.63 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' A' ' 101' ' ' ARG . 4.1 mtt-85 -142.02 -71.85 0.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -0.828 . . . . 0.0 109.04 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 101' ' ' ARG . 2.7 p30 40.81 27.45 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.525 0.678 . . . . 0.0 109.645 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.473 ' O ' ' CG1' ' A' ' 103' ' ' VAL . 9.7 p -145.07 118.26 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 103' ' ' VAL . 11.4 mptt 52.24 97.09 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.117 -0.99 . . . . 0.0 108.628 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.61 74.6 4.25 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.582 1.521 . . . . 0.0 112.249 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 106' ' ' THR . 0.7 OUTLIER -178.22 41.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -82.16 -54.67 5.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -0.969 . . . . 0.0 109.768 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -145.0 33.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 109.498 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.85 102.04 1.5 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.37 -18.35 23.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.395 -1.061 . . . . 0.0 108.475 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.66 49.12 2.08 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.91 115.39 27.18 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.545 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 1.6 pm0 -87.79 20.49 3.01 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -149.7 24.33 0.87 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.747 ' HZ2' HD22 ' A' ' 56' ' ' ASN . 55.6 mttp -38.58 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.286 0.565 . . . . 0.0 110.191 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . 89.92 3.74 73.16 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -96.28 -138.91 0.26 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.193 -1.18 . . . . 0.0 109.652 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' GLN . 34.7 m-20 -118.81 169.21 10.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.154 -0.966 . . . . 0.0 109.226 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' ASP . 42.4 mmtt -41.27 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.3 pm0 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.18 102.66 10.35 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -96.46 134.8 39.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.097 -1.002 . . . . 0.0 109.332 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.97 148.06 43.38 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.504 -0.748 . . . . 0.0 109.132 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.1 mt -133.77 143.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.43 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 p -91.13 153.23 20.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 109.335 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.515 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 10.6 m -149.31 92.18 1.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.327 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.416 ' OD2' ' OD1' ' A' ' 128' ' ' ASP . 6.5 p-10 -149.0 146.85 27.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.353 -0.842 . . . . 0.0 108.898 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.416 ' OD1' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-20 59.33 63.66 1.52 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.01 124.89 22.25 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.682 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 6.3 t-20 -85.11 115.1 22.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.947 . . . . 0.0 109.312 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -83.87 1.21 44.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 65.0 mmtt -79.86 -53.91 6.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.274 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.0 p -95.55 -9.8 31.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.52 42.94 31.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.22 152.26 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -1.118 . . . . 0.0 109.62 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.4 m95 -58.72 114.93 2.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.1 tt0 -38.3 -72.92 0.05 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 110.567 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HZ2' ' CB ' ' A' ' 138' ' ' LYS . 5.2 mtpm? -91.01 148.17 22.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.098 -1.001 . . . . 0.0 109.305 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -154.13 93.42 1.62 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.035 -1.041 . . . . 0.0 110.906 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.551 ' CB ' ' HZ1' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -94.7 164.59 12.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.0 mt -139.38 149.88 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.251 -0.906 . . . . 0.0 110.505 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.2 m-85 -137.27 164.5 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 99' ' ' SER . 72.5 t -152.66 118.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.655 -1.278 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -101.81 -176.48 3.14 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.0 t -153.9 131.37 11.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.873 -1.142 . . . . 0.0 110.022 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.54 109.85 1.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 98.9 t -95.59 -14.65 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.87 0.843 . . . . 0.0 109.667 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.9 mttp . . . . . 0 C--N 1.29 -1.994 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.28 -179.488 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.307 0.575 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.42 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 18.9 mp0 -64.91 150.66 47.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.46 110.8 15.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.636 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.532 ' O ' ' O ' ' A' ' 5' ' ' PRO . 23.3 pttm -55.15 150.72 19.87 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 108.972 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' O ' ' O ' ' A' ' 4' ' ' LYS . 25.7 Cg_exo -36.44 -116.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 123.196 2.597 . . . . 0.0 113.858 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -148.19 109.72 4.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.631 -1.293 . . . . 0.0 110.77 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 8' ' ' PRO . 5.7 mm -85.43 124.02 72.16 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 7' ' ' ILE . 74.2 Cg_exo -49.54 -140.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 121.96 1.773 . . . . 0.0 113.63 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -160.2 -30.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.882 -1.136 . . . . 0.0 109.783 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' SER . 26.3 t0 -74.96 112.6 11.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.496 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -57.8 -4.78 0.32 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 109.752 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.7 p -111.88 39.73 2.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.549 -0.719 . . . . 0.0 109.585 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.4 143.63 29.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.044 -1.035 . . . . 0.0 109.662 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.83 149.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.817 0.817 . . . . 0.0 110.846 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.87 10.45 1.78 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.66 176.05 38.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -147.96 117.27 6.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.305 -1.114 . . . . 0.0 109.437 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -97.76 141.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -146.34 138.89 25.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.996 -1.065 . . . . 0.0 110.45 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.4 mt -144.46 125.8 7.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.72 -41.14 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.477 1.451 . . . . 0.0 111.333 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -51.79 -16.6 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.835 . . . . 0.0 109.315 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' O ' ' OD1' ' A' ' 24' ' ' ASP . . . -137.29 14.88 3.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.81 . . . . 0.0 109.476 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 4.4 p-10 43.79 50.09 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.43 -0.794 . . . . 0.0 109.891 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 25' ' ' ILE . 49.6 mm -88.8 144.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.582 0.706 . . . . 0.0 109.664 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -168.9 81.25 0.14 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -140.83 152.5 65.77 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.239 -0.913 . . . . 0.0 110.33 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.14 166.92 10.95 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.827 2.351 . . . . 0.0 112.633 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.7 120.44 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -90.99 165.7 21.06 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.004 -1.06 . . . . 0.0 109.432 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.12 120.66 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.71 2.273 . . . . 0.0 112.569 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.28 168.46 20.57 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.566 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 69.3 Cg_endo -73.84 123.95 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.831 2.354 . . . . 0.0 111.195 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.95 87.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.781 -0.574 . . . . 0.0 110.654 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.0 p -112.21 151.65 43.83 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.22 -40.03 9.28 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.15 1.9 . . . . 0.0 111.636 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.61 -23.05 66.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.351 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -96.16 -58.92 1.95 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.301 -0.874 . . . . 0.0 108.791 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -47.13 -12.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.831 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.5 m-20 -60.93 -26.74 67.71 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -82.31 -16.84 47.88 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.24 -128.77 2.6 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.769 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 4.5 t -95.93 158.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.467 -1.019 . . . . 0.0 110.245 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -154.96 147.32 23.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.0 109.132 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -52.85 170.21 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.866 -1.146 . . . . 0.0 109.061 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -100.5 9.15 42.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.467 -0.771 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -167.91 132.24 1.75 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.003 . . . . 0.0 109.889 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 50' ' ' GLU . 10.2 pt-20 -55.07 -19.41 7.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.71 -0.619 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.86 25.86 0.89 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.909 -1.119 . . . . 0.0 108.568 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.3 145.56 53.44 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.559 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.2 p -154.36 144.94 22.3 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 mt -71.95 10.1 0.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.559 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.5 OUTLIER -127.76 -1.14 6.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.89 -0.506 . . . . 0.0 110.312 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' CG ' HE22 ' A' ' 55' ' ' GLN . 4.8 t70 -54.78 118.43 4.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.452 -1.405 . . . . 0.0 108.719 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.715 HE21 ' H ' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -45.52 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.715 ' H ' HE21 ' A' ' 55' ' ' GLN . 6.7 p-10 -144.88 110.82 5.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -93.31 116.82 35.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 109.134 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 27.8 m -107.76 111.53 23.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -115.06 162.78 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.6 121.63 37.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.36 140.37 13.38 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.6 m-70 -73.1 170.33 15.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -1.034 . . . . 0.0 110.027 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.459 ' C ' ' HG1' ' A' ' 73' ' ' THR . 0.5 OUTLIER -149.27 78.18 1.37 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.41 -0.806 . . . . 0.0 109.04 179.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.668 ' N ' ' HG1' ' A' ' 73' ' ' THR . 50.2 m-85 -86.53 110.19 19.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 109.291 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.1 mt -57.73 -27.21 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.485 -0.759 . . . . 0.0 110.055 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.9 14.45 3.27 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.569 ' C ' ' H ' ' A' ' 69' ' ' ASN . 80.9 mtt180 -148.21 72.37 11.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.45 25.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 123.33 2.687 . . . . 0.0 113.443 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.569 ' H ' ' C ' ' A' ' 67' ' ' ARG . 11.3 p30 -148.82 25.76 0.93 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 0.0 108.509 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.41 -152.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.691 0.758 . . . . 0.0 109.991 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -71.31 -81.89 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.781 -0.575 . . . . 0.0 111.411 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.494 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 34.4 t80 -94.36 -6.81 43.41 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.023 -1.048 . . . . 0.0 110.116 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.668 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 96.1 m -43.32 -39.52 3.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.96 . . . . 0.0 110.813 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 76' ' ' LYS . 6.0 m120 -94.17 -27.17 16.35 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.841 -1.162 . . . . 0.0 111.44 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.5 mt -51.74 -11.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.694 -1.254 . . . . 0.0 109.36 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 74' ' ' ASN . 3.3 ptmt -84.05 -2.71 57.2 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -103.76 -36.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.68 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.104 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' O ' ' SD ' ' A' ' 97' ' ' MET . 50.0 mttm -148.09 174.57 11.8 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -48.13 139.69 8.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 109.709 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.32 -15.19 62.65 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 97' ' ' MET . 53.2 p -64.22 98.18 0.22 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.262 -1.14 . . . . 0.0 108.486 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.487 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 11.3 ptm -67.63 178.08 1.79 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.32 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.2 t -144.24 117.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.487 ' OH ' ' SD ' ' A' ' 83' ' ' MET . 97.9 m-85 -93.82 102.71 14.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CZ ' ' CG1' ' A' ' 88' ' ' VAL . 37.1 t80 -95.87 110.83 22.95 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -99.69 146.52 26.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 90' ' ' ASN . 20.2 m -156.89 142.03 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.719 -0.613 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.35 -96.64 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.522 ' ND2' ' OE2' ' A' ' 91' ' ' GLU . 4.4 p-10 -140.17 19.2 2.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -1.141 . . . . 0.0 109.296 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.522 ' OE2' ' ND2' ' A' ' 90' ' ' ASN . 4.2 mp0 -120.03 167.11 12.52 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -152.64 118.92 5.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 110.16 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.482 ' HG2' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.85 169.86 10.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -143.8 117.29 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.876 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.28 176.19 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -138.89 106.44 5.58 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.442 -0.786 . . . . 0.0 109.867 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 36.7 ttm -48.26 124.93 8.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.085 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -153.83 0.21 0.22 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.033 -1.042 . . . . 0.0 109.81 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 143' ' ' VAL . 72.2 m -163.85 112.59 1.21 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.0 pt -139.68 -166.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.229 -0.919 . . . . 0.0 110.228 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 101' ' ' ARG . 3.5 mtt-85 -146.6 -74.77 0.21 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.217 -0.927 . . . . 0.0 109.183 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 101' ' ' ARG . 1.7 p30 40.38 24.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.712 0.767 . . . . 0.0 109.323 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 101' ' ' ARG . 9.4 p -154.21 98.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 121.799 0.809 . . . . 0.0 109.069 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.65 62.97 10.69 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.765 -1.21 . . . . 0.0 109.254 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -39.53 131.29 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.967 2.445 . . . . 0.0 112.81 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 30.1 p -75.23 -21.21 58.78 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.492 -0.755 . . . . 0.0 109.351 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 106' ' ' THR . 5.3 t70 83.25 -2.28 1.21 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.84 -0.537 . . . . 0.0 109.921 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 m -79.9 16.4 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.006 -1.059 . . . . 0.0 109.158 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -161.5 44.43 0.39 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.11 -30.28 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 120.973 -1.31 . . . . 0.0 107.743 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.6 mt -137.35 -33.89 0.73 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.476 ' OD1' ' NE2' ' A' ' 120' ' ' GLN . 12.3 t70 50.29 55.57 9.26 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.409 -0.807 . . . . 0.0 109.562 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -108.89 8.11 26.36 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -147.0 1.81 0.77 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.352 0.596 . . . . 0.0 109.657 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 117' ' ' LYS . 54.6 mmtt -75.39 132.68 41.07 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 109.046 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.01 85.14 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 115' ' ' LYS . 58.2 mttp -145.69 -166.67 2.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.185 -1.185 . . . . 0.0 109.38 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.7 t70 -118.22 170.45 8.87 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 118' ' ' ASP . 66.2 mttm -36.79 132.58 0.64 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.476 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 5.0 pt20 -148.32 -178.14 6.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.455 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.8 tp -134.99 111.31 9.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -96.04 87.54 4.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.27 -0.893 . . . . 0.0 108.716 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.72 121.04 23.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.12 -0.988 . . . . 0.0 109.145 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.2 mt -105.12 140.76 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.773 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -94.76 161.61 14.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.125 -0.985 . . . . 0.0 108.863 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 21.8 m -148.03 139.51 23.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -175.1 132.95 0.31 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.065 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.1 t0 61.83 66.01 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.812 . . . . 0.0 109.132 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -61.76 123.56 18.31 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.021 -1.049 . . . . 0.0 109.739 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -87.34 125.49 34.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.157 -0.965 . . . . 0.0 109.672 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.71 7.68 38.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.368 -0.833 . . . . 0.0 109.698 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -79.38 -58.65 3.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -0.924 . . . . 0.0 109.077 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.2 p -96.74 -3.9 41.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 109.3 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.82 35.98 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.15 157.37 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -1.073 . . . . 0.0 109.733 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.449 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.5 m95 -63.79 114.31 3.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 136' ' ' TRP . 31.0 tt0 -36.79 -81.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.244 0.545 . . . . 0.0 110.451 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.53 170.16 4.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.13 -0.981 . . . . 0.0 108.519 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -161.86 112.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 0.0 109.983 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.15 155.83 49.09 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 pt -150.78 160.52 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 111.187 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -138.11 157.37 46.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 99' ' ' SER . 96.5 t -144.24 111.68 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -99.3 175.08 6.0 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.1 t -138.88 133.89 32.54 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.035 -1.041 . . . . 0.0 109.706 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.22 127.68 33.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.441 -0.787 . . . . 0.0 109.706 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.0 m -92.14 -169.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.282 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.408 179.881 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 tpp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -78.97 90.69 4.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.386 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.57 117.34 29.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.177 -0.952 . . . . 0.0 109.544 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -46.06 111.81 1.56 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.435 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.36 -141.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.018 1.812 . . . . 0.0 111.973 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -66.05 91.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.806 -1.184 . . . . 0.0 110.556 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.456 HD11 HG23 ' A' ' 7' ' ' ILE . 64.8 mt -145.62 94.5 5.11 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.23 167.39 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.078 1.852 . . . . 0.0 112.5 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.81 -12.95 12.66 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 12' ' ' SER . 52.6 t0 -76.87 107.5 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -57.9 -5.39 0.41 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.404 -0.81 . . . . 0.0 109.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 10' ' ' ASP . 16.5 m -103.68 29.24 5.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.445 -0.784 . . . . 0.0 109.808 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -147.16 140.29 25.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.154 -0.966 . . . . 0.0 109.418 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 94.8 t -59.91 166.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.71 0.767 . . . . 0.0 110.656 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -140.3 -34.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -160.49 -165.68 17.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 31.3 m-85 -149.41 126.24 11.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.983 -1.304 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -96.31 142.75 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -145.63 146.08 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.955 -1.091 . . . . 0.0 110.304 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.88 131.42 7.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.48 -51.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.883 1.722 . . . . 0.0 111.752 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -50.55 -29.18 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.412 -0.805 . . . . 0.0 109.321 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.38 3.27 19.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.52 -0.738 . . . . 0.0 109.062 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 42.84 41.13 2.4 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.577 0.703 . . . . 0.0 109.894 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.82 150.07 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.777 0.799 . . . . 0.0 110.016 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -167.25 83.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -135.8 158.51 73.93 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.351 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.84 161.98 16.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.008 2.472 . . . . 0.0 113.154 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.47 130.82 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 12.6 m-85 -85.77 148.84 49.65 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.845 -1.159 . . . . 0.0 109.993 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.37 82.73 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.647 2.231 . . . . 0.0 111.398 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.64 -173.96 35.48 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.187 -1.482 . . . . 0.0 110.897 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.8 Cg_endo -82.38 121.4 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.961 2.44 . . . . 0.0 111.406 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -43.53 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.851 -0.53 . . . . 0.0 110.576 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.1 p -110.47 151.33 42.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.51 -41.71 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.227 1.951 . . . . 0.0 112.04 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.64 -21.38 66.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' ASN . 1.6 tt0 -96.73 -60.68 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' GLY . 24.0 mt -45.16 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.69 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' GLN . 38.7 m-20 -64.35 -26.47 68.49 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 23.4 mtt-85 -79.93 -19.55 47.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 162.48 -144.12 9.36 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.75 163.62 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.297 -1.119 . . . . 0.0 108.874 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.459 ' CB ' ' NE2' ' A' ' 38' ' ' GLN . 4.4 t -158.41 155.28 28.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 109.202 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -60.02 164.84 3.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.075 -1.016 . . . . 0.0 109.419 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.81 -19.16 55.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.176 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.77 150.5 41.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.397 -0.814 . . . . 0.0 110.248 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.44 -36.52 84.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.589 -0.694 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.17 9.27 15.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.891 -1.131 . . . . 0.0 110.989 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -65.02 138.53 58.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 0.0 109.391 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.616 ' HG ' ' H ' ' A' ' 53' ' ' ASP . 2.8 t -147.23 169.42 19.41 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 108.986 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.485 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -10.19 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.616 ' H ' ' HG ' ' A' ' 51' ' ' SER . 4.3 m-20 -81.92 -29.35 32.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.483 -0.761 . . . . 0.0 109.213 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.6 m-20 -64.4 100.7 0.37 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.73 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.518 ' NE2' ' OE1' ' A' ' 114' ' ' GLN . 2.8 pm0 -48.33 -15.92 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.982 -1.074 . . . . 0.0 109.012 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' ASP . 19.6 t30 -110.45 100.04 8.94 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.55 148.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.212 -0.93 . . . . 0.0 109.548 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -145.82 107.88 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 79.1 mt -110.79 165.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.588 -0.695 . . . . 0.0 110.134 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -149.55 138.75 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.461 -0.775 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.55 157.73 27.49 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.29 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -73.11 -177.15 2.36 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.302 -1.116 . . . . 0.0 109.818 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.9 81.46 0.43 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -87.85 122.2 31.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.318 -0.863 . . . . 0.0 109.533 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 mm -58.9 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -0.894 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.72 20.53 2.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.567 ' C ' ' H ' ' A' ' 69' ' ' ASN . 90.8 mtt180 -150.37 67.87 8.34 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.541 -0.725 . . . . 0.0 109.572 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.3 5.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 123.537 2.825 . . . . 0.0 114.124 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.567 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -146.13 61.24 1.24 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.89 -1.131 . . . . 0.0 108.638 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -152.86 121.0 6.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 110.509 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.578 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.4 -124.71 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.681 -0.637 . . . . 0.0 110.864 178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 74' ' ' ASN . 3.3 m-85 -97.82 12.51 33.68 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.72 -1.237 . . . . 0.0 110.15 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.0 m -46.41 -19.93 0.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.911 -1.118 . . . . 0.0 110.311 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 72' ' ' PHE . 5.5 m-20 -121.77 -21.74 6.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.442 -0.786 . . . . 0.0 109.971 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -55.96 -25.22 42.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.57 -13.64 60.06 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.52 -16.43 39.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.96 174.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.827 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 81' ' ' GLY . 53.5 mtmt -150.49 159.21 44.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.901 . . . . 0.0 109.114 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -52.84 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.2 -22.71 0.51 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -66.43 121.12 14.59 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.459 -1.024 . . . . 0.0 108.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.6 mtm -77.58 -177.82 4.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.962 -1.086 . . . . 0.0 109.801 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.4 t -145.65 159.51 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.808 . . . . 0.0 109.444 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -144.17 102.46 3.87 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 109.371 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -95.0 113.5 25.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 108.658 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -102.08 139.1 38.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.4 p -162.23 144.22 3.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 49.98 -151.65 4.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.601 ' N ' HD21 ' A' ' 90' ' ' ASN . 0.0 OUTLIER -92.94 59.33 3.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.197 -1.178 . . . . 0.0 109.297 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -168.36 163.37 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.335 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -144.86 151.78 39.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 159.38 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.47 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 37.5 pttt -143.1 164.82 29.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 3.1 m-85 -141.31 -174.62 4.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -141.95 115.03 8.75 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.16 -0.962 . . . . 0.0 108.964 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.41 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.2 mmt -49.36 110.09 0.33 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.598 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 p -139.46 20.69 2.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.436 -0.79 . . . . 0.0 109.14 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 143' ' ' VAL . 31.1 t -168.63 122.91 0.88 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.9 mt -136.02 124.94 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.209 -0.932 . . . . 0.0 109.296 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 103' ' ' VAL . 22.5 mmm180 -79.42 -71.81 0.43 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 51.08 13.85 0.18 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.022 -1.049 . . . . 0.0 108.184 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.514 ' H ' ' C ' ' A' ' 101' ' ' ARG . 20.2 t -74.59 150.33 7.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.528 ' C ' ' H ' ' A' ' 106' ' ' THR . 46.4 tttp -63.52 -64.99 2.34 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.733 -1.23 . . . . 0.0 109.622 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' ASP . 37.9 Cg_endo -63.4 40.02 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.816 1.678 . . . . 0.0 111.057 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.528 ' H ' ' C ' ' A' ' 104' ' ' LYS . 6.6 t -48.36 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.192 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.568 ' C ' ' H ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER 171.82 -2.33 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 0.0 110.14 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.467 ' CG2' ' NH2' ' A' ' 101' ' ' ARG . 32.2 m -71.0 16.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.696 -1.252 . . . . 0.0 109.574 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 138.91 22.26 0.4 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.4 m -69.14 -34.94 65.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.979 -1.306 . . . . 0.0 108.604 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.1 mt -139.16 74.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -134.94 -109.27 0.22 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.468 -0.77 . . . . 0.0 109.058 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.541 ' C ' HE21 ' A' ' 114' ' ' GLN . 14.9 pt-20 -81.55 -175.47 5.54 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.187 -0.945 . . . . 0.0 108.775 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.541 HE21 ' C ' ' A' ' 113' ' ' GLU . 5.4 mm-40 -91.01 63.38 5.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.215 -0.928 . . . . 0.0 108.841 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -44.7 -53.22 7.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.354 -0.841 . . . . 0.0 109.242 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.578 ' O ' ' NE2' ' A' ' 120' ' ' GLN . . . -60.86 113.43 5.59 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -80.24 -6.59 58.1 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.839 -1.389 . . . . 0.0 108.401 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 120' ' ' GLN . 28.8 m-20 -119.14 136.99 53.9 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 118' ' ' ASP . 4.3 mptp? -26.04 87.77 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 122.315 1.055 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 116' ' ' GLY . 5.9 pt20 -89.04 161.16 16.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.05 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.7 tp -133.35 109.01 9.06 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -94.24 92.18 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.949 . . . . 0.0 109.909 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.3 mt -74.98 148.02 40.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.131 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.1 mt -138.74 143.27 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.213 -0.929 . . . . 0.0 109.628 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -105.49 155.67 18.95 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.341 -0.85 . . . . 0.0 108.726 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 127' ' ' ASP . 66.7 m -145.81 155.92 43.23 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.93 -1.106 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.5 OUTLIER 170.49 140.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.89 . . . . 0.0 109.56 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 0.4 OUTLIER 56.89 63.16 2.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.688 -0.633 . . . . 0.0 109.334 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.71 120.57 10.91 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.872 -1.142 . . . . 0.0 108.525 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -85.14 111.41 19.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 109.896 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.4 4.83 9.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.357 -0.839 . . . . 0.0 109.751 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.34 -53.83 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.0 p -96.48 -8.19 32.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.866 . . . . 0.0 109.195 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.62 41.37 43.71 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.71 155.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.224 -1.162 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.442 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.0 m95 -61.85 112.6 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.4 tt0 -38.08 -78.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.702 -0.624 . . . . 0.0 110.016 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -89.92 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -152.54 108.24 3.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.909 -1.119 . . . . 0.0 110.524 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.415 ' CB ' ' HZ2' ' A' ' 140' ' ' LYS . 3.8 mtmp? -109.84 133.81 52.75 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.5 mm -104.81 129.53 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -117.4 160.09 21.72 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.5 t -145.72 149.75 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.715 -1.24 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.75 179.3 7.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -161.37 156.38 23.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.575 -1.328 . . . . 0.0 111.309 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.25 135.05 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.312 0.577 . . . . 0.0 110.059 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.5 t -91.01 -18.33 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 122.01 0.909 . . . . 0.0 109.426 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt . . . . . 0 C--N 1.288 -2.078 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.539 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.328 0.585 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -50.14 143.86 7.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -0.958 . . . . 0.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.37 -170.19 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.0 109.263 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -54.65 142.44 52.75 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.915 . . . . 0.0 109.08 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.39 -110.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.299 1.999 . . . . 0.0 111.843 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -101.05 116.26 32.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.34 -0.85 . . . . 0.0 109.721 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 mt -149.41 95.06 3.83 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.34 152.43 3.79 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.022 . . . . 0.0 112.667 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -93.08 -17.08 24.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 108.885 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 36.2 t0 -77.58 106.03 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.453 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 0.9 OUTLIER -58.01 -5.45 0.44 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 13.6 t -103.19 39.25 1.6 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.364 -0.835 . . . . 0.0 109.751 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -147.76 132.91 18.33 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.301 -0.874 . . . . 0.0 109.71 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 38.8 t -61.31 132.21 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.56 -16.3 20.12 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -176.7 -162.76 27.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -148.89 128.78 13.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.251 -1.146 . . . . 0.0 109.687 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.72 144.67 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -144.27 147.45 33.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.874 -1.141 . . . . 0.0 110.75 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mt -149.68 131.88 7.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -50.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.936 1.757 . . . . 0.0 112.0 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.19 -20.98 1.75 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.829 . . . . 0.0 109.406 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' ASP . . . -118.46 3.31 11.84 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ALA . 1.5 p30 40.91 38.86 0.72 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.542 0.687 . . . . 0.0 109.848 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -98.08 155.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.86 0.838 . . . . 0.0 110.47 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -162.49 69.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 71' ' ' GLN . 11.2 mt-10 -100.56 150.2 36.77 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.582 -0.699 . . . . 0.0 112.495 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -87.98 159.96 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.844 2.363 . . . . 0.0 111.608 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.71 130.55 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.117 -0.989 . . . . 0.0 109.646 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -94.42 155.92 39.2 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.881 -1.137 . . . . 0.0 108.888 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -81.59 95.12 0.92 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.311 2.007 . . . . 0.0 111.786 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.88 -177.66 39.86 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.336 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 89.0 Cg_endo -81.64 116.99 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.915 2.41 . . . . 0.0 111.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.46 87.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.331 0.586 . . . . 0.0 110.335 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -112.85 153.35 45.19 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.44 -45.04 19.63 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.07 1.847 . . . . 0.0 111.433 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.54 -19.04 64.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.417 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' ASN . 6.7 tp60 -93.02 -69.35 0.75 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -45.37 -17.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 109.754 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 38' ' ' GLN . 13.7 m-20 -61.81 -24.92 67.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.6 mtt180 -85.56 -12.97 50.3 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.76 -110.64 0.45 Allowed Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.737 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.9 t -131.64 156.79 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.383 -1.069 . . . . 0.0 109.395 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 t -153.04 154.33 34.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 108.749 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.31 171.69 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.926 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -78.46 -26.28 46.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 109.517 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -135.15 150.24 50.13 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -0.781 . . . . 0.0 109.635 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.52 -32.77 72.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.626 -0.671 . . . . 0.0 111.456 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -85.93 11.32 11.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.885 -1.135 . . . . 0.0 110.81 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.96 147.1 52.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 53' ' ' ASP . 2.7 p -147.99 151.76 36.32 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.481 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -65.94 -5.52 9.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 51' ' ' SER . 13.7 t70 -91.58 -22.51 20.28 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 52.7 m-20 -60.11 100.67 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.199 -0.938 . . . . 0.0 108.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.466 HE22 ' H ' ' A' ' 117' ' ' LYS . 9.0 tt0 -42.98 -20.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.519 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 22.1 t-20 -116.89 97.64 6.07 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.8 146.8 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 46' ' ' ALA . 10.6 m -144.66 109.61 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mt -108.82 167.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.374 -0.828 . . . . 0.0 109.948 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.96 135.17 27.26 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.38 157.9 27.1 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.835 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' A' ' 72' ' ' PHE . 25.9 m-70 -73.67 -173.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.608 -0.937 . . . . 0.0 110.562 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.688 ' HG1' ' HZ1' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -174.9 77.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.7 119.05 28.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.133 . . . . 0.0 108.977 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.6 mt -61.09 -26.62 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.453 -0.779 . . . . 0.0 110.365 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.15 14.78 2.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.628 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 69' ' ' ASN . 83.0 mtt180 -150.77 76.66 8.06 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.641 . . . . 0.0 109.407 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.6 12.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 123.657 2.905 . . . . 0.0 114.021 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.602 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -146.5 52.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.892 -1.13 . . . . 0.0 108.125 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 15.7 t80 -136.93 100.72 4.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.411 -0.805 . . . . 0.0 109.96 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 12.1 mp0 54.86 -125.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.625 -0.672 . . . . 0.0 110.722 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.537 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 4.9 m-85 -90.23 34.08 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.685 -1.259 . . . . 0.0 110.092 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.4 m -57.55 -26.65 61.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.357 -1.464 . . . . 0.0 109.477 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.4 p30 -140.55 4.15 1.94 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.2 tt -55.2 -21.63 14.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.853 -1.154 . . . . 0.0 107.929 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.688 ' HZ1' ' HG1' ' A' ' 63' ' ' THR . 14.2 mtmm -82.77 -18.54 40.29 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -62.29 -22.84 66.34 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -54.62 -169.9 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 81' ' ' GLY . 4.5 ptpt -154.58 157.52 38.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -0.961 . . . . 0.0 109.223 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.479 ' CB ' ' NZ ' ' A' ' 80' ' ' LYS . 5.3 ttpm? -52.2 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 109.543 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 153.42 -14.75 0.64 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -64.42 119.12 9.78 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.545 -0.974 . . . . 0.0 108.774 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.3 mmm -73.51 179.89 3.83 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.393 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.26 161.74 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.967 . . . . 0.0 109.231 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -147.67 103.13 3.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.345 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -94.58 111.99 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -95.55 144.83 25.69 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.1 96.83 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.52 -0.738 . . . . 0.0 109.134 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 48.62 -131.35 21.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -82.22 52.54 2.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.154 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.25 143.44 10.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.14 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.4 m -152.87 146.95 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.987 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 177.99 7.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.475 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 23.9 pttm -144.28 161.09 39.82 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.091 -1.006 . . . . 0.0 110.351 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 10.9 m-85 -141.35 -179.79 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -147.13 130.54 16.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.935 -1.103 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.443 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 12.9 mtt -48.51 150.86 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.394 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 97' ' ' MET . 14.9 m -166.28 1.34 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.161 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 t -168.5 124.08 0.96 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.25 -0.906 . . . . 0.0 109.141 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mt -137.09 132.0 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 103' ' ' VAL . 82.5 mtt180 -100.62 -66.54 0.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.474 -0.766 . . . . 0.0 109.398 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 63.9 t0 46.9 17.06 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.221 -0.924 . . . . 0.0 109.214 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 101' ' ' ARG . 53.6 t -134.43 -10.12 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.544 ' HZ1' HH12 ' A' ' 139' ' ' ARG . 6.0 ttmm 55.72 56.53 10.12 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.454 -0.779 . . . . 0.0 109.856 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.0 -54.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.861 2.374 . . . . 0.0 111.425 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -84.56 -35.68 22.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 109.063 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 0.3 OUTLIER 65.54 -58.44 0.3 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.781 -0.574 . . . . 0.0 109.491 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 106' ' ' THR . 31.2 m -95.88 33.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.152 -0.967 . . . . 0.0 109.801 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' N ' ' HG1' ' A' ' 106' ' ' THR . . . -126.43 15.12 6.8 Favored Glycine 0 N--CA 1.502 3.078 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.465 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 60.9 t -71.76 -34.67 52.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 120.933 -1.334 . . . . 0.0 108.511 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mp -137.07 72.72 1.42 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -172.65 22.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -163.42 29.19 0.09 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 109.055 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 110' ' ' VAL . 35.0 mt-30 -134.4 8.93 3.69 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.43 -65.91 0.72 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.18 64.69 4.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.466 ' H ' HE22 ' A' ' 55' ' ' GLN . 33.3 tttt -143.95 -154.51 0.53 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.315 -1.109 . . . . 0.0 108.522 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 119' ' ' LYS . 97.6 m-20 -106.18 160.29 15.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.276 -0.89 . . . . 0.0 108.859 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' ASP . 57.5 mttp -44.69 126.78 5.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.837 . . . . 0.0 109.334 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.589 ' OE1' ' N ' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -149.37 168.24 23.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.983 -179.331 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.8 mt -116.71 154.0 31.37 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.552 0.691 . . . . 0.0 110.321 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.0 m -140.48 86.41 2.06 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.45 159.68 19.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 111.175 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.9 mt -140.14 126.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 p -90.31 118.7 30.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.767 -1.208 . . . . 0.0 109.025 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.534 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 23.1 m -99.1 154.2 18.31 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.619 -0.676 . . . . 0.0 110.129 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.1 t70 179.87 132.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 109.073 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.2 t0 59.76 72.27 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 109.331 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -65.27 122.27 16.73 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 10.0 p30 -85.7 129.47 34.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.893 -1.129 . . . . 0.0 109.476 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -91.25 4.84 51.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 108.962 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -71.96 -62.44 1.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.807 . . . . 0.0 109.088 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 p -98.49 -3.16 37.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.472 -0.767 . . . . 0.0 109.314 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.67 47.78 19.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.54 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 2.9 t -146.79 169.57 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -1.076 . . . . 0.0 109.329 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.534 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 73.4 m95 -73.2 114.19 11.11 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.177 -0.952 . . . . 0.0 108.943 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.6 tp10 -35.55 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.081 0.467 . . . . 0.0 110.727 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.13 150.42 40.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.608 -0.682 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.1 OUTLIER -166.96 164.91 16.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -130.41 133.19 46.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.499 -0.75 . . . . 0.0 109.1 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.415 HD11 HG23 ' A' ' 141' ' ' ILE . 15.4 mm -94.54 146.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.46 140.93 25.41 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 5.9 t -133.07 147.15 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.271 -0.893 . . . . 0.0 110.752 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.41 144.65 33.19 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.7 t -118.3 148.89 42.0 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 147' ' ' VAL . 7.7 tp10 -61.93 137.24 58.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.62 -0.675 . . . . 0.0 109.407 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.52 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 4.3 m -93.11 -175.46 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.95 . . . . 0.0 109.358 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.576 ' CB ' ' HZ1' ' A' ' 148' ' ' LYS . 9.6 mtmp? . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.427 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 mtm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -159.82 117.98 2.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.393 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.01 75.48 10.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 109.683 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.8 pttt -67.73 155.86 90.46 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 108.956 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 4' ' ' LYS . 71.0 Cg_exo -50.79 -160.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.053 1.835 . . . . 0.0 112.35 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -99.35 101.95 13.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.087 -1.008 . . . . 0.0 110.067 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 mt -88.38 113.39 55.1 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 109.255 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.21 118.94 1.86 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.595 1.53 . . . . 0.0 112.065 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -73.68 -18.61 60.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.945 . . . . 0.0 109.371 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -77.94 106.38 9.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.354 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -57.04 -10.6 1.19 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -94.26 27.2 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 109.771 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -141.52 131.64 24.77 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.317 -0.865 . . . . 0.0 109.481 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 44.7 t -61.84 142.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.472 -0.768 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.55 -23.78 14.97 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.496 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -174.2 -163.25 27.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 34.7 m-85 -149.88 130.84 14.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 0.0 109.539 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tt -95.62 144.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -146.04 142.09 28.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.037 -1.039 . . . . 0.0 110.343 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.5 mt -150.13 132.23 7.87 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.09 -49.28 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.883 1.722 . . . . 0.0 111.882 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -51.75 -30.02 21.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.601 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -106.67 3.29 26.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.371 -0.83 . . . . 0.0 108.895 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.1 p30 43.61 30.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.28 147.66 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.898 0.856 . . . . 0.0 109.79 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -165.35 84.51 0.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 18.9 mt-10 -132.84 159.36 72.88 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.327 -0.858 . . . . 0.0 111.052 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.21 163.59 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.273 2.649 . . . . 0.0 113.32 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.79 132.54 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 42.2 m-85 -87.44 146.18 39.12 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.818 -1.176 . . . . 0.0 109.872 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.52 88.83 1.23 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.909 1.739 . . . . 0.0 111.365 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.19 -170.97 34.41 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.522 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 95.6 Cg_endo -81.11 117.97 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.883 2.389 . . . . 0.0 111.513 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.03 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.301 0.572 . . . . 0.0 110.724 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.7 OUTLIER -110.6 155.76 41.62 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 56.8 Cg_endo -69.93 -44.15 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.223 1.949 . . . . 0.0 112.036 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -62.93 -26.2 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.618 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -84.12 -62.62 1.52 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.159 -0.963 . . . . 0.0 109.039 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -49.28 -11.99 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.3 m120 -61.93 -27.75 69.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' C ' ' HH ' ' A' ' 30' ' ' TYR . 49.2 mtp180 -91.4 -10.88 39.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' C ' HE22 ' A' ' 71' ' ' GLN . . . 164.12 -139.45 5.86 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.259 -1.448 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 t -110.67 164.59 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.438 -1.037 . . . . 0.0 109.329 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -158.86 157.14 30.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.182 -0.949 . . . . 0.0 108.623 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.536 ' CE2' ' OE1' ' A' ' 50' ' ' GLU . 46.9 m-85 -58.04 175.92 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.863 -1.148 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -89.0 -3.35 58.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.457 -0.777 . . . . 0.0 109.126 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -153.97 145.82 23.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.287 -0.883 . . . . 0.0 109.966 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -62.49 -31.17 71.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -86.86 6.94 29.33 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.953 -1.092 . . . . 0.0 110.893 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 11.9 tm-20 -61.79 152.19 32.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 53' ' ' ASP . 76.5 p -146.32 163.38 35.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.666 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -74.54 10.64 1.25 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.9 OUTLIER -124.0 -6.25 7.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.838 -0.539 . . . . 0.0 109.751 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.7 t70 -59.73 113.9 2.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.859 -1.15 . . . . 0.0 109.308 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -45.4 -18.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.277 -0.889 . . . . 0.0 109.631 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' OE1' ' A' ' 55' ' ' GLN . 4.0 m120 -133.27 98.66 4.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.498 -0.751 . . . . 0.0 109.051 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.416 HG23 HD13 ' A' ' 57' ' ' ILE . 96.1 mt -96.68 113.31 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.698 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.5 m -108.6 120.23 41.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 87.1 mt -107.21 164.45 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.473 -0.767 . . . . 0.0 110.226 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -135.99 124.61 23.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.65 152.4 22.07 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 119.932 -1.128 . . . . 0.0 110.748 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 72' ' ' PHE . 34.0 m-70 -72.72 -179.93 3.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.758 -0.848 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 88.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.02 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -87.51 123.68 32.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 109.06 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 mt -63.76 -33.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.563 -0.71 . . . . 0.0 110.589 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -82.97 8.17 13.43 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 110.122 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.594 ' C ' ' H ' ' A' ' 69' ' ' ASN . 21.7 mmt180 -140.72 75.28 25.92 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 87.7 Cg_exo -48.64 5.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.621 2.881 . . . . 0.0 113.844 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.594 ' H ' ' C ' ' A' ' 67' ' ' ARG . 6.8 p30 -143.64 59.42 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.95 -1.094 . . . . 0.0 108.165 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.66 95.97 3.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.582 -0.699 . . . . 0.0 110.355 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.468 HE22 ' C ' ' A' ' 42' ' ' GLY . 1.1 mm100 61.0 -114.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.851 -0.53 . . . . 0.0 111.815 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 62' ' ' HIS . 2.3 t80 -91.93 26.85 2.29 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.138 -0.976 . . . . 0.0 110.803 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -69.22 -38.74 78.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.87 -1.144 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 15.6 m-20 -108.49 -17.0 14.09 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.226 -0.921 . . . . 0.0 111.072 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -25.33 13.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.729 -1.232 . . . . 0.0 108.36 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -81.88 -14.35 56.34 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -78.4 -16.57 57.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.03 -162.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -174.32 174.97 2.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -48.85 149.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 -11.27 7.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 57.8 m -62.21 94.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.117 -1.225 . . . . 0.0 108.64 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptm -66.32 162.19 20.75 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.195 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.82 174.3 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.865 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -144.71 108.83 4.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -0.899 . . . . 0.0 110.001 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -95.09 113.37 25.06 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -96.49 144.37 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 110.301 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 18.3 t -143.02 86.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.36 -133.37 42.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.86 37.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -1.223 . . . . 0.0 109.587 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 88' ' ' VAL . 21.1 mp0 -138.81 151.98 47.5 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.268 -0.895 . . . . 0.0 108.916 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.6 m -152.97 143.82 22.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.005 . . . . 0.0 110.099 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.406 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -144.33 170.61 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.413 -0.805 . . . . 0.0 108.98 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 24.8 pttm -142.87 162.0 36.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 5.9 m-85 -139.35 -175.67 4.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -136.79 110.58 8.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.457 ' C ' ' HG1' ' A' ' 98' ' ' THR . 36.0 tpp -50.89 104.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.431 -0.793 . . . . 0.0 109.05 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.457 ' HG1' ' C ' ' A' ' 97' ' ' MET . 3.1 m -143.84 35.32 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 143' ' ' VAL . 16.5 t -173.67 131.91 0.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.2 mt -138.64 144.57 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 109.008 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.0 OUTLIER -119.83 1.04 10.98 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -67.88 45.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 108.757 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 101' ' ' ARG . 7.4 p -157.07 -21.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -166.48 62.2 0.7 Allowed Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' A' ' 107' ' ' ASP . 89.5 Cg_endo -76.4 -49.21 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.949 2.433 . . . . 0.0 113.053 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 108' ' ' VAL . 1.3 p 69.15 -27.58 0.15 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 105' ' ' PRO . 1.4 m-20 67.6 -43.27 0.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.157 -0.965 . . . . 0.0 109.505 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 106' ' ' THR . 26.9 m -76.33 26.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.193 -0.942 . . . . 0.0 109.26 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -153.18 -21.69 0.05 OUTLIER Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.407 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.5 t -67.51 -22.81 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.919 -1.342 . . . . 0.0 108.887 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.8 mt -138.67 79.95 1.76 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.624 -0.672 . . . . 0.0 109.243 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -162.65 -34.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.732 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -179.81 30.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.519 ' C ' ' H ' ' A' ' 116' ' ' GLY . 8.9 tt0 -91.55 23.77 3.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' C ' HE22 ' A' ' 120' ' ' GLN . 19.8 pttp -50.69 -9.68 0.05 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . 49.87 -97.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' LYS . 32.5 pttt -146.59 -45.03 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -1.112 . . . . 0.0 109.564 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -118.73 167.68 11.45 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.487 -0.758 . . . . 0.0 109.525 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 119' ' ' LYS . 12.2 mptt -46.29 162.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.522 HE22 ' C ' ' A' ' 115' ' ' LYS . 3.7 pt20 -157.18 145.0 19.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.154 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.2 tp -103.57 107.56 18.46 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 57' ' ' ILE . 10.5 m -92.54 146.76 23.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.62 152.24 50.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.284 -0.885 . . . . 0.0 110.489 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 mt -141.3 134.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 140' ' ' LYS . 1.1 p -92.21 160.61 15.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.932 -1.105 . . . . 0.0 108.423 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 56.6 m -144.97 140.1 27.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.06 -1.025 . . . . 0.0 109.943 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 2.0 p30 175.65 139.39 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.43 58.76 1.65 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.26 -0.9 . . . . 0.0 108.887 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.99 126.62 27.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 109.444 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -85.9 116.99 24.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.131 -0.981 . . . . 0.0 109.695 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -84.18 1.38 44.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -81.22 -52.18 7.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.328 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.6 p -95.65 -15.06 22.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.27 42.31 15.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -147.14 153.24 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.345 -1.091 . . . . 0.0 109.509 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 69.2 m95 -59.25 112.55 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 23.1 tt0 -35.24 -84.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -107.06 157.45 17.82 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.394 -0.816 . . . . 0.0 109.473 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -174.84 161.02 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' H ' HG21 ' A' ' 125' ' ' THR . 41.5 mttp -127.67 153.31 46.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 35.0 mm -115.91 139.12 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.583 0.706 . . . . 0.0 110.61 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -136.57 159.12 42.76 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 99' ' ' SER . 59.4 t -148.08 149.29 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.776 -1.202 . . . . 0.0 110.896 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.67 134.24 30.11 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.3 t -95.68 143.43 26.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 3.3 tm-20 -60.22 145.76 46.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 1.8 t -91.47 -142.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 0.0 109.337 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.464 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.6 mpp? . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.348 0.594 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' N ' ' OE1' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -159.74 91.07 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.841 . . . . 0.0 109.033 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.83 32.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.812 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.533 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 47.8 pttt -135.62 48.02 2.51 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.413 -0.805 . . . . 0.0 109.967 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 42.4 Cg_endo -66.0 -160.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.637 2.224 . . . . 0.0 111.802 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -79.58 119.62 22.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.617 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.9 mt -150.58 101.68 3.09 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.307 -0.871 . . . . 0.0 108.813 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.85 136.37 7.16 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.844 1.696 . . . . 0.0 112.196 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -87.44 -28.72 21.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.04 113.28 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -58.2 -11.78 2.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.328 -0.857 . . . . 0.0 109.626 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -79.95 21.04 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -147.51 136.16 21.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.057 -1.027 . . . . 0.0 109.659 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 61.3 t -60.36 161.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.699 0.761 . . . . 0.0 110.223 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.401 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -136.13 -9.58 2.01 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.05 -179.16 42.8 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.6 120.11 7.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.3 . . . . 0.0 109.172 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 tt -97.04 140.33 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -146.23 138.89 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.105 -0.997 . . . . 0.0 110.081 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 8.3 mt -146.4 127.13 7.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.6 -44.22 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.742 1.628 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.24 -17.67 0.75 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.293 -0.88 . . . . 0.0 109.819 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.406 ' O ' ' CG ' ' A' ' 24' ' ' ASP . . . -134.36 17.55 3.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.168 -0.958 . . . . 0.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.71 48.4 4.81 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.682 0.753 . . . . 0.0 109.912 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.3 mm -88.89 141.42 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.655 0.741 . . . . 0.0 109.543 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.31 82.69 0.17 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -143.13 156.78 61.39 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.139 -0.976 . . . . 0.0 110.561 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -83.49 165.72 14.12 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.888 2.392 . . . . 0.0 112.301 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.1 109.23 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.439 ' O ' ' OG ' ' A' ' 44' ' ' SER . 30.8 m-85 -65.84 139.51 96.88 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.705 -1.247 . . . . 0.0 109.1 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.53 109.23 2.59 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.824 1.682 . . . . 0.0 111.904 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.54 -174.47 39.76 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.135 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' THR . 74.3 Cg_endo -76.75 113.93 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.576 2.184 . . . . 0.0 110.969 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.58 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.438 0.637 . . . . 0.0 111.151 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.24 169.35 8.08 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.56 -27.53 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.632 1.555 . . . . 0.0 112.42 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.48 -33.66 75.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.647 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.85 -51.7 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 109.231 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.8 mt -46.88 -30.45 2.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.473 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -65.01 -27.32 68.74 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 38' ' ' GLN . 89.0 mtt180 -84.5 -19.61 32.98 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.67 -140.77 6.35 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.754 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.32 164.69 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.708 -0.878 . . . . 0.0 108.799 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.647 ' CB ' HE22 ' A' ' 38' ' ' GLN . 35.5 t -163.24 157.53 20.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.959 -1.088 . . . . 0.0 109.194 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 37.3 m-85 -59.67 161.86 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.354 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -86.56 5.28 36.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.39 142.03 9.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.717 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 -23.64 67.54 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.645 -0.659 . . . . 0.0 111.529 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -87.1 4.84 40.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.878 -1.139 . . . . 0.0 110.728 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -62.68 157.15 21.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 109.429 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.534 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -143.99 179.51 7.15 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -83.75 4.24 29.75 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -146.07 16.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.512 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.2 t70 -58.26 115.24 2.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.681 -1.262 . . . . 0.0 108.779 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -43.51 -19.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 112' ' ' ASP . 21.6 t-20 -135.17 97.24 3.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -94.85 151.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 109.347 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' ALA . 38.7 m -143.64 116.84 8.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 96.7 mt -112.59 162.57 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.738 0.78 . . . . 0.0 110.601 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -132.78 131.76 41.48 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.24 148.3 19.98 Favored Glycine 0 N--CA 1.505 3.286 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.323 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.716 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 41.5 m-70 -76.3 -169.89 1.31 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.646 -0.914 . . . . 0.0 110.422 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.519 ' O ' ' CG2' ' A' ' 63' ' ' THR . 14.7 t -158.82 83.44 0.81 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.75 0.786 . . . . 0.0 108.971 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.56 108.51 19.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.712 -1.243 . . . . 0.0 109.462 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 mm -60.06 -28.4 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 110.44 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -86.97 16.52 4.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 69' ' ' ASN . 33.2 ttm180 -150.56 72.99 9.02 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.81 14.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 123.909 3.073 . . . . 0.0 114.325 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 67' ' ' ARG . 8.8 p30 -148.47 62.63 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.802 -1.186 . . . . 0.0 108.572 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -151.47 98.79 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 4.1 mt-30 60.99 -127.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 111.179 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.71 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -92.01 59.08 3.51 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.682 1.23 . . . . 0.0 109.574 -178.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 m -91.17 -24.77 19.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.202 -1.561 . . . . 0.0 108.632 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -136.77 -0.97 2.28 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 -178.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -10.22 0.28 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.403 -1.435 . . . . 0.0 108.042 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.48 -37.59 50.95 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -27.6 69.13 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.06 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -175.11 171.51 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 109.919 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -51.14 101.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.5 -29.85 2.46 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.444 ' OG ' ' CG2' ' A' ' 20' ' ' ILE . 14.1 t -62.81 108.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.2 mtp -62.83 174.99 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.642 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.09 108.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.97 104.91 17.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 109.942 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -94.53 111.94 23.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -102.01 144.64 30.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 110.459 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.7 p -170.24 128.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.557 -0.714 . . . . 0.0 109.268 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.19 -120.42 19.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.19 35.05 4.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.956 . . . . 0.0 109.117 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.3 133.61 16.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 108.944 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.8 t -119.01 133.91 55.53 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.674 0.749 . . . . 0.0 110.172 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -94.89 172.07 8.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -147.53 96.51 2.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.915 -1.116 . . . . 0.0 110.226 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 24.7 m-85 -87.57 -173.72 4.47 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.015 -1.053 . . . . 0.0 108.594 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER -150.25 111.55 4.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.138 -0.976 . . . . 0.0 109.886 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtp -48.67 117.27 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.326 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -158.54 21.11 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.053 -1.029 . . . . 0.0 109.555 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 11.2 p -167.83 86.04 0.22 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.635 -1.291 . . . . 0.0 109.299 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.453 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 1.9 mp -79.28 166.29 2.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 102' ' ' ASP . 3.4 mmp_? -142.98 -5.45 0.88 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.798 -1.189 . . . . 0.0 109.89 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.598 ' CG ' ' H ' ' A' ' 103' ' ' VAL . 41.5 t0 -58.67 -151.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 108.896 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.598 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 60.6 t 54.18 -85.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 0.0 109.414 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 102' ' ' ASP . 17.5 tptm -126.8 89.26 52.55 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.65 -103.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.895 1.73 . . . . 0.0 112.028 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.6 p 44.51 52.97 7.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -0.918 . . . . 0.0 110.0 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -78.73 -118.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.113 -0.992 . . . . 0.0 108.735 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.61 26.51 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 147.04 106.6 0.46 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.23 -33.66 64.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.279 -1.13 . . . . 0.0 108.082 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.1 mt -137.82 76.67 1.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.528 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -131.02 179.5 5.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.505 -0.747 . . . . 0.0 109.367 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 14.4 mp0 -60.65 -123.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 109.498 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -86.45 86.74 7.34 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.461 ' CB ' ' NZ ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -43.3 -17.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 110.377 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . 141.12 32.8 0.13 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.451 ' CG ' ' H ' ' A' ' 118' ' ' ASP . 10.0 tptm -143.72 -145.04 0.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.254 -1.145 . . . . 0.0 110.495 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 119' ' ' LYS . 33.2 t0 -118.98 171.6 8.13 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 16.8 ttmm -34.54 132.79 0.28 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.91 175.03 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.6 tp -128.82 102.97 6.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -93.03 87.24 5.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.185 -0.947 . . . . 0.0 109.151 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.82 152.3 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.909 -1.119 . . . . 0.0 109.256 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -129.03 151.56 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.669 -0.645 . . . . 0.0 109.29 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.403 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 52.0 p -96.37 153.3 17.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.154 -0.967 . . . . 0.0 108.568 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.77 97.88 2.97 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.968 -1.083 . . . . 0.0 109.799 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 p30 -147.25 136.18 22.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 108.75 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 127' ' ' ASP . 1.5 m-20 70.84 64.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 109.576 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.99 125.75 25.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 0.0 109.865 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -86.87 125.74 34.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.135 -0.978 . . . . 0.0 109.399 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.72 4.5 47.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 109.811 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.67 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.408 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.8 p -95.21 -3.14 48.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.37 45.4 54.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 165.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -1.146 . . . . 0.0 109.24 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLU . 81.4 m95 -68.86 114.38 7.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.189 -0.945 . . . . 0.0 108.696 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.3 tp10 -35.42 -86.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.24 0.543 . . . . 0.0 110.325 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -103.76 148.86 25.58 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -157.19 138.9 14.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.792 -1.192 . . . . 0.0 110.618 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -99.76 166.35 11.14 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 102' ' ' ASP . 2.3 mt -138.3 132.84 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.435 -0.79 . . . . 0.0 110.157 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -141.34 147.25 37.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.529 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 19.2 t -135.94 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.077 -1.015 . . . . 0.0 111.296 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.15 -178.54 3.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.0 t -144.85 141.01 28.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.91 -1.119 . . . . 0.0 109.377 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -57.67 147.27 28.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.81 . . . . 0.0 109.555 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 148' ' ' LYS . 17.8 m -91.43 170.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 147' ' ' VAL . 37.6 pttt . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.47 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' CG ' HE22 ' A' ' 2' ' ' GLN . 11.9 tpt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.495 HE22 ' CG ' ' A' ' 1' ' ' MET . 6.4 mp0 -71.29 106.36 3.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.967 . . . . 0.0 109.292 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.08 120.08 24.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.384 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 40.7 pttt -141.67 41.39 0.4 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.362 -0.836 . . . . 0.0 110.39 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 29.8 Cg_endo -62.44 -157.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.325 2.017 . . . . 0.0 111.72 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -79.99 94.57 5.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.98 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mm -141.89 94.15 7.3 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.08 168.56 0.36 Allowed 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.466 2.111 . . . . 0.0 112.446 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 -14.99 16.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.401 -0.812 . . . . 0.0 109.176 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 12' ' ' SER . 0.8 OUTLIER -76.71 107.45 9.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.587 ' CB ' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -60.52 -3.44 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.0 109.293 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 10' ' ' ASP . 80.9 p -116.69 44.23 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -150.46 128.13 11.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.32 -0.862 . . . . 0.0 109.262 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -55.33 158.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 111.278 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -140.7 2.39 1.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 173.68 -175.44 46.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 67.3 m-85 -150.34 126.74 10.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.109 -1.23 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.3 tt -95.66 147.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -149.84 134.88 17.94 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.807 -1.183 . . . . 0.0 110.95 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.4 mt -145.49 124.79 6.81 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.2 -41.19 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.65 1.567 . . . . 0.0 111.724 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.92 -17.95 1.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.6 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 24' ' ' ASP . . . -130.01 13.49 5.73 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.523 -0.736 . . . . 0.0 109.553 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.8 p30 42.23 36.4 0.72 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 mt -90.58 140.97 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -165.92 86.89 0.36 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.62 159.15 70.2 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.474 -0.767 . . . . 0.0 110.441 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.58 164.0 10.79 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.061 2.507 . . . . 0.0 112.952 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.18 113.5 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.29 168.34 13.75 Favored Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.776 -1.202 . . . . 0.0 109.801 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.91 124.49 4.47 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.894 2.396 . . . . 0.0 111.831 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.99 170.55 30.11 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.29 -1.434 . . . . 0.0 110.45 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 35' ' ' THR . 98.5 Cg_endo -78.43 117.29 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.79 2.327 . . . . 0.0 111.256 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.79 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.534 -0.729 . . . . 0.0 109.996 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -122.96 155.41 63.94 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 19.5 Cg_endo -58.25 -48.1 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.902 1.735 . . . . 0.0 111.191 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -63.01 -19.53 64.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.89 . . . . 0.0 109.205 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.569 ' C ' ' H ' ' A' ' 40' ' ' ASN . 19.5 tp60 -89.63 -69.51 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.006 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.1 mt -52.57 -3.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.569 ' H ' ' C ' ' A' ' 38' ' ' GLN . 16.5 m-20 -59.54 -28.62 67.26 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.906 -1.121 . . . . 0.0 108.744 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' CD ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -87.79 -18.94 28.23 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.38 -127.52 1.73 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.267 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.53 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.8 t -101.66 157.11 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.538 -0.978 . . . . 0.0 109.97 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' HG ' ' C ' ' A' ' 43' ' ' VAL . 6.3 m -155.58 151.82 28.02 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -56.53 170.2 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.751 -1.218 . . . . 0.0 109.829 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.43 -3.39 52.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.822 . . . . 0.0 109.06 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -153.57 150.49 28.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.0 109.874 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 13.1 pt-20 -62.73 -40.73 98.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.544 -0.722 . . . . 0.0 111.422 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 6.4 t-20 -88.44 18.64 4.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 7.7 tp10 -62.92 139.44 58.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.718 -1.238 . . . . 0.0 109.696 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 53' ' ' ASP . 16.1 m -146.51 152.51 39.1 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.568 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -60.39 -5.66 1.24 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 51' ' ' SER . 5.1 m-20 -75.85 -33.08 60.01 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.677 -0.639 . . . . 0.0 109.679 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 56' ' ' ASN . 51.3 m-20 -59.84 111.22 1.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.295 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.533 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -48.41 -14.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 108.819 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.6 t30 -125.69 108.02 11.13 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.39 117.65 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.009 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -108.6 108.96 20.04 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.66 161.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.475 -0.766 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -132.61 137.29 46.99 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.21 147.86 19.26 Favored Glycine 0 N--CA 1.5 2.965 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.998 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.73 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 18.7 m-70 -75.79 -165.52 0.46 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.885 -0.774 . . . . 0.0 110.278 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.95 88.86 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -88.15 108.97 19.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.055 -1.028 . . . . 0.0 109.084 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 mt -57.48 -27.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.465 -0.772 . . . . 0.0 109.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.6 12.1 5.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.007 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.606 ' C ' ' H ' ' A' ' 69' ' ' ASN . 87.1 mtt180 -150.94 74.79 8.42 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 80.9 Cg_exo -48.62 7.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 123.629 2.886 . . . . 0.0 113.927 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.606 ' H ' ' C ' ' A' ' 67' ' ' ARG . 44.8 p30 -142.21 58.81 1.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 71' ' ' GLN . 61.7 t80 -141.49 100.21 3.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.427 -0.796 . . . . 0.0 110.387 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.73 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 5.1 mt-30 60.75 -124.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.512 -0.742 . . . . 0.0 111.245 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.673 ' O ' ' CG ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -91.95 34.72 0.99 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 122.772 1.272 . . . . 0.0 109.297 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.9 m -73.6 -26.66 60.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.421 -2.049 . . . . 0.0 108.855 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 22.0 m-20 -133.55 -4.42 2.94 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.266 -0.897 . . . . 0.0 110.775 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.9 -23.42 7.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.733 -1.229 . . . . 0.0 108.775 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -2.09 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.949 -1.094 . . . . 0.0 108.388 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -91.56 -33.55 15.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.76 179.56 0.12 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.171 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -148.84 170.77 17.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.16 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -49.14 149.14 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 109.034 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.3 -23.13 23.15 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.9 t -62.45 103.08 0.37 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 58.2 mmm -62.01 171.25 1.79 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.162 -0.962 . . . . 0.0 110.149 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.1 t -141.38 110.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.44 102.44 15.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -95.42 113.7 25.39 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -85.78 143.22 28.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.565 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 t -148.2 84.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.42 -128.04 27.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -95.28 37.36 1.18 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.174 -1.192 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 92' ' ' THR . 1.2 tm-20 -163.17 114.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.076 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 91' ' ' GLU . 9.8 t -107.35 147.1 30.75 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.426 -0.797 . . . . 0.0 110.082 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 93' ' ' ARG . 9.2 mmm-85 -93.7 172.9 7.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.498 -0.751 . . . . 0.0 109.369 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -146.36 92.94 2.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.105 -0.997 . . . . 0.0 109.999 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.431 ' O ' ' SD ' ' A' ' 83' ' ' MET . 22.7 m-85 -87.38 -176.39 5.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.904 -1.122 . . . . 0.0 108.726 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -147.33 107.93 4.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.239 -0.913 . . . . 0.0 109.428 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 23.9 mtt -48.29 117.83 2.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.1 p -142.92 8.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.259 -0.901 . . . . 0.0 109.143 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 143' ' ' VAL . 30.9 t -164.87 107.98 0.87 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 108.646 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 55.5 mt -119.51 166.47 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.522 -0.736 . . . . 0.0 109.544 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 103' ' ' VAL . 4.2 mmt-85 -131.11 -84.77 0.51 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 8.6 t70 44.53 18.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.467 -0.77 . . . . 0.0 109.217 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 101' ' ' ARG . 4.4 p -151.59 114.34 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.409 -0.807 . . . . 0.0 109.257 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt 45.09 60.55 13.02 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -37.25 102.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.935 2.423 . . . . 0.0 112.509 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 0.7 OUTLIER -57.25 -44.1 83.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 0.0 109.841 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 109' ' ' GLY . 4.4 t0 85.42 27.87 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 m -60.11 -6.67 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 157.58 85.37 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 m -68.54 -35.2 69.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.242 -1.152 . . . . 0.0 108.48 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.4 mt -139.29 42.45 2.05 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -92.7 125.28 37.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.104 -0.997 . . . . 0.0 109.647 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.576 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 1.1 pm0 -90.67 16.98 8.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.576 ' NE2' ' H ' ' A' ' 113' ' ' GLU . 1.7 pm0 -148.47 26.25 0.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -48.71 -9.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.604 -0.685 . . . . 0.0 110.117 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . 92.43 39.04 5.44 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -137.36 -164.25 1.56 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.494 -1.004 . . . . 0.0 109.415 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 120' ' ' GLN . 14.3 t70 -117.55 169.07 9.83 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 18.7 mmmt -26.93 84.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.484 0.659 . . . . 0.0 110.842 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.8 pm0 -99.36 170.03 8.93 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.585 0.707 . . . . 0.0 110.664 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.97 102.5 8.04 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -94.93 87.55 5.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.131 -0.981 . . . . 0.0 109.355 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.5 132.53 35.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.89 -1.131 . . . . 0.0 109.367 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.7 mt -113.96 159.86 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.501 0.667 . . . . 0.0 109.534 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 80.8 p -97.2 167.24 11.16 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.62 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.551 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 1.7 m -149.96 84.59 1.4 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.153 -0.967 . . . . 0.0 109.348 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 128' ' ' ASP . 15.0 t70 -148.22 129.0 14.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.976 -1.078 . . . . 0.0 108.953 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 4.5 t0 78.92 60.72 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.85 127.71 33.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.817 -1.177 . . . . 0.0 110.067 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -85.79 123.71 31.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.07 -1.019 . . . . 0.0 109.501 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.487 ' N ' HD21 ' A' ' 130' ' ' ASN . 19.0 pt-20 -98.39 8.4 44.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.263 -0.898 . . . . 0.0 109.78 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.536 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 33.3 mtpt -86.89 -20.22 27.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.7 p -140.29 0.69 1.72 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.5 49.04 53.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.72 137.79 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -1.156 . . . . 0.0 109.305 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 51.5 m95 -52.6 112.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.934 -1.104 . . . . 0.0 108.43 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 136' ' ' TRP . 8.2 tp10 -37.6 -81.14 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.904 -0.498 . . . . 0.0 110.174 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -103.67 139.15 39.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.486 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.1 OUTLIER -147.25 114.21 6.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.896 -1.128 . . . . 0.0 110.415 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -95.53 166.69 11.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.2 pt -147.95 162.42 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.89 -1.131 . . . . 0.0 110.919 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.8 m-85 -137.41 150.49 47.69 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 99' ' ' SER . 21.7 t -132.62 111.73 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.179 -0.951 . . . . 0.0 111.161 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.75 177.59 4.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.7 t -144.66 139.35 27.96 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.978 -1.076 . . . . 0.0 109.726 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.08 144.81 44.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 9.8 m -90.46 166.23 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.603 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.455 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mmm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -162.02 167.54 24.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.664 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.65 77.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 109.427 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -45.55 108.8 0.83 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 109.793 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.15 -148.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.192 1.928 . . . . 0.0 111.918 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -66.92 118.73 10.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.896 -1.128 . . . . 0.0 110.839 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.6 mt -152.3 98.38 2.91 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.6 155.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.807 1.672 . . . . 0.0 112.525 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -102.65 -19.01 14.97 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.0 109.455 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.9 m-20 -77.22 110.31 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -58.0 -3.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.428 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.8 t -111.99 41.63 1.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.487 -0.758 . . . . 0.0 109.473 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -149.11 133.79 17.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 61.5 t -58.86 161.0 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 110.95 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -139.97 -0.8 1.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 172.73 -173.71 45.54 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 44.2 m-85 -150.09 128.68 12.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.294 -1.121 . . . . 0.0 109.923 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -95.0 146.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -149.79 119.6 7.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.819 -1.175 . . . . 0.0 111.171 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 mp -131.52 127.12 21.46 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 23' ' ' ALA . 71.9 Cg_endo -76.37 -42.71 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.53 1.486 . . . . 0.0 111.483 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 40.8 t0 -52.25 -10.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.423 -0.798 . . . . 0.0 109.473 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -140.59 15.45 2.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ALA . 2.3 p-10 41.68 49.6 3.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.078 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.2 mm -91.27 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.674 0.749 . . . . 0.0 109.71 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -170.27 80.94 0.1 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -142.03 157.52 63.77 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 110.536 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.03 162.0 15.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.099 2.533 . . . . 0.0 113.068 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.92 109.23 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.67 168.77 22.92 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 120.753 -1.217 . . . . 0.0 109.505 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -88.21 117.12 1.01 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 122.726 2.284 . . . . 0.0 112.032 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.6 175.92 40.91 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.108 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 80.6 Cg_endo -78.35 115.52 3.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.808 2.339 . . . . 0.0 111.271 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.95 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.611 -0.681 . . . . 0.0 110.084 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.5 p -120.15 152.99 55.29 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.39 -41.29 79.57 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.985 1.79 . . . . 0.0 111.745 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.13 -22.84 67.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 109.62 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -90.89 -70.31 0.69 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.489 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.1 mt -43.87 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 109.916 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 38' ' ' GLN . 19.6 m-20 -60.99 -24.17 65.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -90.95 -10.73 41.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.46 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.1 -115.72 0.68 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.6 t -126.16 154.95 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 5.1 m -150.68 155.13 38.72 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -56.28 173.88 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.65 -1.281 . . . . 0.0 109.391 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.01 -13.39 58.9 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -146.31 153.19 40.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.269 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -63.71 -41.24 98.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.525 -0.734 . . . . 0.0 111.394 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -86.92 12.61 10.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.037 -1.039 . . . . 0.0 111.012 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.57 90.78 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.96 -1.087 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 53' ' ' ASP . 17.4 m -89.37 151.64 21.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 108.671 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.4 0.67 1.4 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' SER . 45.3 m-20 -95.88 -14.37 23.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.651 -0.656 . . . . 0.0 109.339 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.9 t0 -58.35 119.28 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.039 -1.038 . . . . 0.0 109.571 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.99 -14.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.72 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.618 ' ND2' HE22 ' A' ' 114' ' ' GLN . 40.5 t30 -145.56 109.95 4.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 0.0 108.97 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.6 mp -95.29 154.9 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 108.98 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.6 t -143.67 123.28 13.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 90.2 mt -110.59 162.23 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.453 -0.779 . . . . 0.0 110.597 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.432 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -139.97 131.12 26.44 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.29 156.34 26.07 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 119.88 -1.153 . . . . 0.0 110.527 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -72.08 177.02 4.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.539 -0.977 . . . . 0.0 109.47 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.5 87.16 0.75 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.297 -0.877 . . . . 0.0 109.65 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.13 102.69 15.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.292 -0.88 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 mt -53.02 -23.69 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.218 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.03 13.96 3.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.115 -0.99 . . . . 0.0 109.451 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' ASN . 19.5 ttm-85 -152.66 74.95 7.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 109.282 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.43 20.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 123.911 3.074 . . . . 0.0 114.495 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.22 62.8 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.893 -1.129 . . . . 0.0 108.609 179.217 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -151.32 123.53 8.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.097 -1.002 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 61.1 mt-30 40.9 -115.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.812 -0.555 . . . . 0.0 111.357 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -98.03 9.22 43.34 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -49.34 -22.25 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.544 -1.347 . . . . 0.0 109.556 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 77' ' ' ALA . 4.0 t-20 -119.57 -22.35 6.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.863 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.423 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 2.7 tm? -53.26 -35.7 60.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.068 -1.02 . . . . 0.0 108.57 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -72.31 -4.37 29.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.308 -0.87 . . . . 0.0 108.689 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -89.81 -28.37 19.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.6 -172.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.767 . . . . 0.0 109.678 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.432 ' O ' ' OG ' ' A' ' 82' ' ' SER . 14.4 pttm -162.07 -177.64 5.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.882 . . . . 0.0 109.071 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 82' ' ' SER . 26.9 mtmm -49.78 155.89 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.005 -1.06 . . . . 0.0 109.288 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.75 -18.86 4.48 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 80' ' ' LYS . 73.7 m -63.89 98.93 0.22 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.327 -1.102 . . . . 0.0 108.437 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.7 mtm -62.24 -179.32 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.616 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 74.2 t -149.2 108.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.412 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.15 102.38 15.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.128 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.403 ' CZ ' ' CG1' ' A' ' 88' ' ' VAL . 43.4 t80 -95.66 111.99 23.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -95.89 134.22 39.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.159 -0.963 . . . . 0.0 111.384 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.403 ' CG1' ' CZ ' ' A' ' 86' ' ' PHE . 2.0 m -153.33 134.7 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.29 -138.95 26.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -101.62 43.98 1.04 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.31 -1.112 . . . . 0.0 109.665 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -162.24 136.44 6.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.315 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -117.28 140.53 49.44 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.521 -0.737 . . . . 0.0 110.081 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -93.26 168.29 11.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.572 -0.705 . . . . 0.0 109.301 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 15.5 pttp -145.8 118.89 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.995 . . . . 0.0 109.935 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.51 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 27.5 m-85 -116.44 168.48 10.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -130.22 108.98 10.44 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.239 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.421 ' O ' ' OG1' ' A' ' 98' ' ' THR . 32.5 tpp -50.89 135.09 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.514 -0.741 . . . . 0.0 109.237 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 97' ' ' MET . 2.5 m -166.28 19.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.883 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.8 t -164.88 92.34 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 2.5 mp -97.7 162.31 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.887 . . . . 0.0 109.498 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 103' ' ' VAL . 74.8 mtt180 -136.33 -86.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 101' ' ' ARG . 3.3 p30 44.22 16.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.377 -0.827 . . . . 0.0 109.931 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 101' ' ' ARG . 3.8 t -94.39 -81.99 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.655 ' H ' ' CD ' ' A' ' 105' ' ' PRO . 9.1 ttpt -129.6 -42.76 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.441 -0.787 . . . . 0.0 109.958 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.655 ' CD ' ' H ' ' A' ' 104' ' ' LYS . 20.6 Cg_exo -65.62 66.8 0.37 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.218 1.945 . . . . 0.0 111.299 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 108' ' ' VAL . 22.2 p -89.17 89.64 8.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.101 -1.0 . . . . 0.0 110.714 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER 63.07 -1.26 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.412 -0.805 . . . . 0.0 110.294 178.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' A' ' 106' ' ' THR . 3.5 m -67.72 2.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.87 -1.144 . . . . 0.0 108.145 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 176.87 10.58 0.02 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.881 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.531 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 23.7 t -69.83 -37.51 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.636 -1.508 . . . . 0.0 108.334 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -98.85 58.48 1.16 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -176.04 23.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.499 -0.751 . . . . 0.0 109.52 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -156.69 14.41 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 109.143 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.618 HE22 ' ND2' ' A' ' 56' ' ' ASN . 7.5 mt-30 -101.49 6.05 42.18 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -75.78 30.06 0.11 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.703 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . -149.69 -14.78 0.09 OUTLIER Glycine 0 N--CA 1.498 2.815 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.655 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -93.27 -147.39 0.24 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.876 -1.367 . . . . 0.0 109.429 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.5 m-20 -116.2 168.87 9.73 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' ASP . 13.3 mptt -43.38 130.31 4.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.243 -0.911 . . . . 0.0 109.448 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.71 172.67 12.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.7 tp -118.51 156.34 29.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.661 -0.649 . . . . 0.0 110.019 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.503 ' HG1' HD22 ' A' ' 56' ' ' ASN . 53.1 m -134.77 88.38 2.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.51 145.54 52.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 110.883 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.5 mt -138.55 138.26 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.542 -0.724 . . . . 0.0 109.158 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -102.2 156.85 17.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 85.5 m -144.76 138.06 26.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.944 -1.098 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 4.3 t0 178.96 146.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 108.891 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 8.3 t70 60.59 54.3 3.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -61.68 121.25 12.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.116 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -86.25 121.88 29.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.757 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.5 pm0 -87.08 6.72 31.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.45 -50.83 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.4 p -97.67 -14.39 20.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 108.952 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.02 17.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.12 163.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -1.141 . . . . 0.0 109.717 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.445 ' O ' ' C ' ' A' ' 137' ' ' GLU . 73.4 m95 -68.24 114.71 6.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -37.18 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.218 0.532 . . . . 0.0 110.181 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -93.94 153.18 18.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -156.51 94.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.852 -1.155 . . . . 0.0 110.71 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -86.79 159.39 19.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.428 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 9.8 pt -145.82 159.57 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.842 -1.162 . . . . 0.0 110.685 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.4 m-85 -139.95 168.42 19.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.19 142.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.802 -1.186 . . . . 0.0 110.423 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.16 147.85 40.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 147' ' ' VAL . 13.0 t -108.63 140.36 42.12 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.51 ' OE1' ' CD2' ' A' ' 95' ' ' TYR . 3.2 tp10 -65.72 45.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.4 t -146.7 177.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.118 -0.988 . . . . 0.0 109.223 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.419 ' OXT' ' O ' ' A' ' 147' ' ' VAL . 29.3 mmtp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.329 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.457 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -66.75 155.48 38.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.902 . . . . 0.0 109.556 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.5 129.89 6.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.482 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -45.84 148.7 1.31 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.91 -152.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.43 2.087 . . . . 0.0 111.684 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -68.76 129.17 39.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.023 -1.048 . . . . 0.0 110.258 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.1 mt -150.63 96.56 3.37 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -41.08 143.3 0.7 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.304 2.003 . . . . 0.0 113.356 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -87.19 -16.24 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.148 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 12' ' ' SER . 12.9 m-20 -77.7 105.62 8.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 109.451 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 1.9 mptp? -58.56 -2.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.443 -0.786 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 10' ' ' ASP . 39.7 m -113.94 43.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 134.41 25.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.942 . . . . 0.0 109.04 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.6 115.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.818 . . . . 0.0 110.932 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.76 -4.53 43.82 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.53 -168.85 41.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.54 124.77 10.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.178 -1.189 . . . . 0.0 109.071 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.7 tt -98.91 147.38 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.18 145.95 30.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.01 -1.056 . . . . 0.0 109.828 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -147.86 131.82 8.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -52.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.981 1.787 . . . . 0.0 111.833 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -50.88 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 109.301 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.55 3.08 17.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.521 -0.737 . . . . 0.0 109.073 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 43.39 37.1 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.573 -0.705 . . . . 0.0 109.646 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -92.91 152.19 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 122.214 1.006 . . . . 0.0 110.665 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -166.07 82.64 0.3 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -132.4 158.69 74.97 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.47 -0.769 . . . . 0.0 110.694 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.67 162.01 21.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.006 2.47 . . . . 0.0 112.654 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -138.16 104.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -76.65 166.13 47.23 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.785 -1.197 . . . . 0.0 109.377 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -89.77 120.04 0.89 Allowed 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.488 2.126 . . . . 0.0 111.818 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.09 -178.4 43.53 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 35' ' ' THR . 88.3 Cg_endo -81.22 116.63 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.919 2.413 . . . . 0.0 111.712 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.61 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.765 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -119.62 153.9 54.43 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 22.4 Cg_endo -60.35 -45.12 23.93 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.127 1.884 . . . . 0.0 111.803 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -63.28 -27.8 69.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 109.698 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -86.51 -68.33 0.75 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -46.82 -14.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.738 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.6 m-20 -63.89 -24.96 67.94 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -80.14 -20.92 43.8 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.085 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' OE1' ' A' ' 71' ' ' GLN . . . 159.29 -119.29 0.88 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.55 157.8 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.605 -0.938 . . . . 0.0 110.102 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 158.9 37.86 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -56.18 173.37 0.16 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.716 -1.24 . . . . 0.0 109.355 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.1 -14.48 55.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.895 . . . . 0.0 109.139 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -146.78 145.62 29.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 110.063 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -24.41 67.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.52 -0.737 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -88.75 3.24 51.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.0 150.3 45.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 109.758 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 45.9 m -149.04 159.6 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.483 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -69.64 -4.22 18.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -99.52 -15.34 18.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.683 . . . . 0.0 109.932 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 51' ' ' SER . 31.2 m-20 -60.14 107.61 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.716 -1.24 . . . . 0.0 109.203 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.652 ' NE2' ' H ' ' A' ' 117' ' ' LYS . 10.8 tt0 -45.75 -18.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.379 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.4 t-20 -127.81 98.31 5.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 57' ' ' ILE . 96.6 mt -94.51 154.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 109.277 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 46' ' ' ALA . 58.6 m -145.38 117.59 8.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.2 mt -112.62 158.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 110.22 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.52 136.61 34.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.95 156.38 25.93 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -71.77 178.41 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.484 -1.009 . . . . 0.0 109.535 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.462 ' CG2' ' OD1' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -163.52 86.51 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.42 -0.8 . . . . 0.0 109.28 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -88.41 119.34 28.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.7 -30.9 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.074 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -82.9 15.94 2.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 109.566 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.592 ' C ' ' H ' ' A' ' 69' ' ' ASN . 54.7 ttt180 -150.32 70.97 9.17 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.19 18.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.843 3.028 . . . . 0.0 114.36 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.592 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.2 63.41 0.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.783 -1.198 . . . . 0.0 108.651 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -151.09 110.77 4.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 64.2 mt-30 54.81 -115.5 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.712 -0.618 . . . . 0.0 111.918 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 74' ' ' ASN . 3.1 m-85 -96.21 10.98 36.07 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.186 -0.946 . . . . 0.0 110.559 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.4 m -49.08 -18.01 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 77' ' ' ALA . 4.0 m-20 -122.05 -23.58 5.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.398 -0.814 . . . . 0.0 110.032 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.2 -29.0 44.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.768 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -75.4 -7.2 53.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -88.41 -24.0 23.17 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.73 -178.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.584 -0.697 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' CB ' ' HZ1' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -153.23 162.86 40.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -52.98 133.03 38.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.57 -5.06 66.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 83' ' ' MET . 25.8 t -63.33 -161.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.055 -1.262 . . . . 0.0 108.174 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.521 ' N ' ' OG ' ' A' ' 82' ' ' SER . 50.1 mmm -142.61 162.27 35.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 109.739 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 t -146.15 155.45 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.236 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.83 107.9 5.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.287 -0.883 . . . . 0.0 109.207 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -95.02 112.28 24.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -97.99 138.98 34.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.7 m -144.06 150.19 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.32 -14.83 0.06 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 88' ' ' VAL . 48.2 t30 -84.02 -58.48 2.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.035 -1.274 . . . . 0.0 109.999 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' H ' HG22 ' A' ' 88' ' ' VAL . 20.1 tt0 -172.08 171.68 4.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 108.904 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -97.61 149.7 21.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.202 -0.936 . . . . 0.0 110.037 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.65 169.5 17.52 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.78 156.49 44.99 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.05 -1.031 . . . . 0.0 110.911 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.527 ' CE2' ' OE1' ' A' ' 146' ' ' GLU . 6.5 m-85 -136.5 -178.07 5.01 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -145.68 116.45 7.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.164 -0.96 . . . . 0.0 109.054 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 40.2 mtt -51.03 111.98 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.438 -0.788 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -140.04 28.98 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.369 -0.832 . . . . 0.0 108.916 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 p -178.95 141.91 0.19 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 50.3 mt -140.76 164.2 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 104' ' ' LYS . 22.5 mmt180 -140.82 -9.08 1.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.426 -0.796 . . . . 0.0 109.157 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 103' ' ' VAL . 23.4 p30 -45.82 -22.47 0.19 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.228 -0.92 . . . . 0.0 109.713 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.521 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 8.9 p -83.51 -23.9 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.0 109.321 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 101' ' ' ARG . 19.1 pttm -149.36 61.97 5.62 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.585 ' C ' ' H ' ' A' ' 107' ' ' ASP . 58.6 Cg_endo -72.16 -69.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.392 2.061 . . . . 0.0 112.629 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.536 ' HG1' ' N ' ' A' ' 107' ' ' ASP . 1.5 p 65.83 -35.95 0.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.277 -0.889 . . . . 0.0 109.548 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER 71.03 -37.11 0.38 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.524 ' H ' ' C ' ' A' ' 106' ' ' THR . 15.3 m -75.81 25.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 109.214 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -159.6 -20.63 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.485 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.523 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 12.7 t -67.26 -38.64 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.902 -1.352 . . . . 0.0 108.823 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.9 mt -100.21 63.37 1.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.494 -0.754 . . . . 0.0 109.338 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -172.44 22.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.298 -0.876 . . . . 0.0 109.953 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -175.85 29.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.181 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.545 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 32.1 mt-30 -140.26 17.1 2.42 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' C ' ' NE2' ' A' ' 55' ' ' GLN . 21.6 pttm -104.82 13.46 31.21 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -128.86 45.15 1.16 Allowed Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.652 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 53.6 mttm -142.92 -131.9 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.316 -1.108 . . . . 0.0 108.795 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -106.77 164.13 12.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.244 -0.91 . . . . 0.0 108.593 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 119' ' ' LYS . 4.4 mptp? -46.83 137.54 7.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 108.54 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 8.2 pt20 -150.05 152.04 34.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 110.528 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.28 117.32 30.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.949 -0.47 . . . . 0.0 110.22 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 m -92.41 88.17 6.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.0 mt -68.28 138.33 55.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.697 . . . . 0.0 109.986 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.2 mt -137.87 148.31 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.391 -0.818 . . . . 0.0 109.604 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -102.94 169.01 8.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.427 -0.796 . . . . 0.0 108.907 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 34.5 m -148.49 138.93 22.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.993 -1.067 . . . . 0.0 109.619 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.462 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 0.3 OUTLIER 175.3 140.23 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 109.078 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 t0 59.86 66.36 1.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 108.986 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -65.52 127.53 32.23 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 109.668 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -84.77 124.94 32.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.027 -1.045 . . . . 0.0 109.759 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.3 6.25 48.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.461 -0.774 . . . . 0.0 109.228 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -88.36 -19.73 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.808 . . . . 0.0 109.681 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.7 p -137.29 -2.36 2.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.382 -0.824 . . . . 0.0 109.323 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.42 44.29 59.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.78 154.34 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.63 112.99 3.07 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.3 tp10 -37.96 -82.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.93 -0.481 . . . . 0.0 110.691 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' CB ' ' NZ ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -105.24 140.34 38.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.481 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -170.45 138.84 1.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.9 160.58 21.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.89 159.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.833 -1.167 . . . . 0.0 110.92 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 4.8 m-85 -132.66 177.45 7.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.4 t -150.66 133.61 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.852 -1.155 . . . . 0.0 110.586 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.57 15.03 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 147' ' ' VAL . 12.6 t -139.93 147.33 40.39 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.0 -1.063 . . . . 0.0 110.853 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.527 ' OE1' ' CE2' ' A' ' 95' ' ' TYR . 18.2 tp10 -65.51 48.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.778 -0.576 . . . . 0.0 109.459 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 145' ' ' THR . 2.0 t -146.64 177.05 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.084 -1.01 . . . . 0.0 108.961 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.0 pttp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.319 -179.715 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -82.36 142.52 31.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.842 . . . . 0.0 109.533 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.7 127.33 32.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 0.0 109.348 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' PRO . 38.4 mmtt -80.91 151.71 70.92 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 109.118 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 4' ' ' LYS . 66.8 Cg_exo -36.9 161.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.359 2.039 . . . . 0.0 112.464 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.481 ' N ' ' OE1' ' A' ' 6' ' ' GLN . 1.2 mp0 -70.73 119.38 14.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.617 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mt -83.59 115.18 58.21 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -41.39 130.58 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.818 1.679 . . . . 0.0 112.51 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -78.03 -29.27 49.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.503 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 12' ' ' SER . 40.3 m-20 -77.28 112.65 14.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -58.66 -2.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.524 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.2 m -105.68 38.84 1.89 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.345 -0.847 . . . . 0.0 109.543 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -142.51 126.37 17.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.302 -0.874 . . . . 0.0 109.261 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.435 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 24.9 t -59.62 132.34 24.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.914 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.07 -10.61 21.34 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 176.16 -161.13 29.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 66.0 m-85 -148.9 131.58 15.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.768 -1.43 . . . . 0.0 110.179 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -98.16 142.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -145.38 133.26 21.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.996 -1.065 . . . . 0.0 110.166 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 20' ' ' ILE . 53.5 mt -142.63 125.94 9.37 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.98 -44.35 0.21 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.707 1.604 . . . . 0.0 111.956 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -53.17 -20.48 3.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.087 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.6 8.33 10.09 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.4 p30 43.15 31.71 0.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.593 -0.692 . . . . 0.0 110.01 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 mt -91.08 143.2 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -164.2 85.89 0.46 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.4 159.6 68.76 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 110.624 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.06 162.01 26.28 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.048 2.499 . . . . 0.0 113.036 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -139.63 115.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.442 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.73 170.37 13.19 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 120.794 -1.191 . . . . 0.0 108.733 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -89.16 130.91 2.1 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.451 2.101 . . . . 0.0 112.194 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' PHE . . . 164.74 175.08 35.17 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.612 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 35' ' ' THR . 61.9 Cg_endo -85.95 128.01 3.17 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.909 2.406 . . . . 0.0 111.589 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 33' ' ' PRO . . . -38.84 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.662 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -118.79 154.13 52.71 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.76 -41.37 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.267 1.978 . . . . 0.0 111.89 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -63.08 -21.28 66.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 109.588 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -94.64 -70.08 0.72 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.296 -0.877 . . . . 0.0 109.269 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.7 mt -44.29 -26.29 0.31 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -61.11 -24.17 66.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 26.9 mtt-85 -89.13 -11.76 42.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.32 -122.33 1.14 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.222 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 18.2 t -122.3 151.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.61 -0.936 . . . . 0.0 109.094 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.481 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 m -151.23 151.01 31.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 32' ' ' GLY . 27.7 m-85 -55.4 155.78 4.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.544 -1.348 . . . . 0.0 108.41 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.43 4.88 25.74 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.265 -0.897 . . . . 0.0 109.04 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -149.99 130.83 14.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.403 -0.811 . . . . 0.0 110.109 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.76 -22.83 65.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.775 . . . . 0.0 110.486 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.0 -2.8 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.035 -1.041 . . . . 0.0 110.075 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -60.45 163.55 5.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 109.081 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -145.43 -167.97 2.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 108.893 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.441 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 4.4 mp -95.05 11.64 31.35 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.215 -0.928 . . . . 0.0 109.079 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.92 12.38 0.44 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.541 ' CG ' HE22 ' A' ' 55' ' ' GLN . 19.6 t0 -57.03 120.38 7.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.756 -1.215 . . . . 0.0 108.751 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.694 HE21 ' N ' ' A' ' 56' ' ' ASN . 1.1 pm0 -45.86 -15.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.694 ' N ' HE21 ' A' ' 55' ' ' GLN . 4.8 m120 -136.12 99.32 4.1 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.0 mm -93.26 153.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.03 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 t -142.02 103.29 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.3 mt -100.4 158.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.854 0.835 . . . . 0.0 110.336 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.12 134.7 34.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.87 27.43 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.684 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' PHE . 14.3 m-70 -76.49 178.4 6.65 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.585 -0.95 . . . . 0.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.48 90.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 108.74 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.556 ' N ' ' HG1' ' A' ' 73' ' ' THR . 5.3 m-85 -87.48 110.54 20.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.199 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 mm -58.32 -30.68 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 110.155 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -87.96 19.38 3.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.13 -0.981 . . . . 0.0 109.465 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.552 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -149.88 74.5 9.33 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.433 -0.792 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.1 Cg_exo -56.06 26.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 123.48 2.787 . . . . 0.0 113.524 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.552 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -150.57 29.21 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.835 -1.166 . . . . 0.0 109.073 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.8 t80 -89.28 -153.2 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -0.956 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.4 mp0 -71.29 -84.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.711 0.767 . . . . 0.0 110.808 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -94.78 19.45 10.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.677 -0.639 . . . . 0.0 109.968 -178.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.556 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 55.5 m -69.74 -38.19 76.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.326 -1.484 . . . . 0.0 109.93 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 77' ' ' ALA . 16.0 m-20 -103.92 -10.28 18.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.182 -0.948 . . . . 0.0 111.46 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.16 -29.27 30.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.406 -1.433 . . . . 0.0 108.365 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 10.6 pttp -80.36 -10.44 59.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -79.51 -23.37 42.98 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.85 -175.34 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLY . 34.3 mttm -150.53 154.98 38.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.029 -1.045 . . . . 0.0 109.686 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -51.06 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 109.734 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 150.84 -20.93 1.0 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.66 ' HG ' ' H ' ' A' ' 83' ' ' MET . 5.5 t -66.03 -165.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.104 -1.233 . . . . 0.0 108.185 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.66 ' H ' ' HG ' ' A' ' 82' ' ' SER . 45.3 mmm -137.88 171.65 14.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.14 108.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.0 109.145 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -93.37 109.37 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' O ' ' OG1' ' A' ' 92' ' ' THR . 39.9 t80 -94.76 116.89 29.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -85.24 139.11 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 111.115 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 4.3 m -147.78 124.98 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.53 -132.79 35.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.477 ' N ' ' OE2' ' A' ' 91' ' ' GLU . 49.8 t30 -97.95 35.98 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -1.198 . . . . 0.0 109.832 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.477 ' OE2' ' N ' ' A' ' 90' ' ' ASN . 1.2 pm0 -159.64 170.0 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -0.979 . . . . 0.0 108.955 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 86' ' ' PHE . 6.3 t -141.26 150.22 42.33 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.714 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -92.29 175.53 6.81 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -146.87 133.48 19.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 1.7 m-85 -138.85 126.84 22.42 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' HZ2' ' CG2' ' A' ' 147' ' ' VAL . 4.1 ttpm? -93.95 120.39 34.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 109.399 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 85.2 mtp -48.13 120.64 3.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.791 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 p -149.83 31.62 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.37 -0.831 . . . . 0.0 109.304 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 m -171.54 86.95 0.09 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.8 mm -89.13 125.93 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.834 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 103' ' ' VAL . 23.2 mmt180 -96.67 -116.02 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.9 t0 58.18 3.6 0.26 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.213 -0.93 . . . . 0.0 109.227 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.656 ' CG1' ' H ' ' A' ' 104' ' ' LYS . 85.7 t -114.3 -167.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.656 ' H ' ' CG1' ' A' ' 103' ' ' VAL . 1.6 mmmp? -39.36 -55.87 3.01 Favored Pre-proline 0 N--CA 1.499 2.025 0 O-C-N 120.805 -1.185 . . . . 0.0 110.896 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -43.28 88.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.009 1.806 . . . . 0.0 111.741 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 10.1 p -126.85 94.29 4.0 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.394 -0.816 . . . . 0.0 109.712 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 109' ' ' GLY . 3.6 t70 83.38 13.3 0.39 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.2 m -69.18 3.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 135.34 16.62 0.92 Allowed Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 m -66.91 -24.58 32.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.032 -1.275 . . . . 0.0 108.428 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.8 mt -100.91 33.04 2.94 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 114' ' ' GLN . 30.1 t0 -83.58 121.93 27.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.195 -0.941 . . . . 0.0 109.076 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -61.1 -5.26 1.38 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.031 0.92 . . . . 0.0 108.652 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.683 HE22 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -155.26 74.36 0.9 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.56 ' HZ2' ' HZ3' ' A' ' 117' ' ' LYS . 1.5 mmmm -41.98 -63.14 0.78 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.178 -0.951 . . . . 0.0 109.71 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.683 ' N ' HE22 ' A' ' 114' ' ' GLN . . . 148.99 -19.61 1.23 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.56 ' HZ3' ' HZ2' ' A' ' 115' ' ' LYS . 11.0 pttp -97.9 -106.42 0.18 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.165 -1.197 . . . . 0.0 110.823 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.471 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 2.2 m-20 -121.16 171.18 8.88 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.288 -0.882 . . . . 0.0 109.57 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 118' ' ' ASP . 58.2 mttm -44.7 147.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.541 ' OE1' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -150.6 150.74 31.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.677 -1.265 . . . . 0.0 110.791 -178.036 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.38 111.9 24.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.88 -0.513 . . . . 0.0 109.753 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 m -98.04 120.79 39.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.201 -0.937 . . . . 0.0 108.696 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mp -104.43 147.11 27.92 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.471 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 77.3 mt -137.89 147.41 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.226 -0.921 . . . . 0.0 110.076 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -97.74 155.6 16.94 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.9 m -148.63 97.17 2.7 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.954 -1.091 . . . . 0.0 109.658 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.536 ' OD2' ' NZ ' ' A' ' 138' ' ' LYS . 4.9 p-10 -149.39 149.17 30.42 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.502 ' CB ' ' HZ2' ' A' ' 138' ' ' LYS . 8.5 t70 61.39 61.23 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.745 . . . . 0.0 109.282 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -64.38 118.87 9.34 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -86.72 118.04 25.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.051 -1.03 . . . . 0.0 109.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 5.1 pm0 -84.86 10.72 10.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -81.99 -54.53 5.24 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.8 p -96.29 -8.13 33.55 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.87 41.47 33.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -147.21 163.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.276 -1.132 . . . . 0.0 109.837 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.443 ' O ' ' C ' ' A' ' 137' ' ' GLU . 71.1 m95 -67.09 116.44 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' TRP . 16.4 tp10 -37.96 -86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.778 -0.576 . . . . 0.0 109.893 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.536 ' NZ ' ' OD2' ' A' ' 127' ' ' ASP . 1.9 pttp -89.0 152.06 21.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -157.45 89.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -79.28 167.99 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.493 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -148.58 151.38 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.756 -1.215 . . . . 0.0 110.023 -179.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 1.3 m-85 -143.09 162.52 35.31 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.1 t -148.68 152.72 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.764 -1.21 . . . . 0.0 110.929 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.41 160.96 38.19 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.3 t -127.91 135.43 49.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.97 105.61 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.52 -0.738 . . . . 0.0 109.677 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.485 ' CG2' ' HZ2' ' A' ' 96' ' ' LYS . 1.3 t -93.02 176.97 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 108.889 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.9 mttm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.429 -179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mmt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 2' ' ' GLN . 4.1 mp0 -57.07 114.07 1.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.9 137.43 35.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.49 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 57.3 mttp -152.12 52.93 0.99 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 109.656 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 60.0 Cg_endo -70.51 -155.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.582 2.188 . . . . 0.0 111.869 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -75.36 96.99 3.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.095 -1.003 . . . . 0.0 110.271 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mt -149.5 94.21 3.94 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.37 162.82 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.474 2.116 . . . . 0.0 112.753 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -103.32 -12.41 17.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.511 -0.743 . . . . 0.0 109.363 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.515 ' CG ' ' HZ2' ' A' ' 13' ' ' LYS . 2.6 m-20 -77.55 109.06 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 11.9 mptt -59.62 -0.32 0.17 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.892 . . . . 0.0 109.604 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ASP . 41.6 m -114.28 36.81 3.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.466 -0.771 . . . . 0.0 110.282 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HZ2' ' CG ' ' A' ' 10' ' ' ASP . 2.1 ttmp? -144.18 143.83 31.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.027 -1.046 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.19 145.12 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 110.098 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.46 11.79 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.87 173.54 34.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.75 119.98 7.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -1.175 . . . . 0.0 109.147 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -97.03 141.5 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -145.09 136.71 25.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 0.0 110.101 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.8 mt -144.37 127.05 8.47 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.9 Cg_endo -75.71 -43.23 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.524 1.483 . . . . 0.0 111.312 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.36 -15.24 0.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.464 -0.772 . . . . 0.0 109.128 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -137.1 13.6 3.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.46 52.4 4.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.454 -0.779 . . . . 0.0 109.944 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 49.8 mm -92.46 146.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.864 0.84 . . . . 0.0 110.214 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -169.83 80.28 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -142.9 158.79 58.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.54 162.27 14.64 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.511 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.52 112.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 5.7 m-85 -73.11 146.48 87.21 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -79.93 97.36 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.571 2.181 . . . . 0.0 111.884 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.19 -174.13 46.49 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.671 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 93.7 Cg_endo -80.55 120.97 4.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.839 2.359 . . . . 0.0 111.431 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.5 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.696 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.1 p -103.67 152.11 38.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 53.5 Cg_endo -68.95 -44.31 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.958 1.772 . . . . 0.0 111.803 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.42 -24.68 67.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.701 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 40' ' ' ASN . 2.8 tt0 -88.59 -59.81 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.651 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -47.29 -15.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 5.9 m120 -58.63 -29.89 66.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 85.7 mtt180 -80.38 -19.7 45.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.9 -141.7 7.55 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.459 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.36 161.47 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.401 -1.058 . . . . 0.0 109.388 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.484 ' CB ' HE22 ' A' ' 38' ' ' GLN . 11.7 p -158.84 156.97 30.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.072 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -56.06 171.84 0.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -95.46 -2.43 48.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.97 140.41 18.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.024 -1.048 . . . . 0.0 110.62 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -62.56 -22.84 66.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.69 20.85 2.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 0.0 109.486 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.22 145.63 53.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.233 1.016 . . . . 0.0 111.116 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.561 ' C ' ' H ' ' A' ' 53' ' ' ASP . 3.3 m -155.33 136.32 13.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.506 ' CB ' HH22 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -60.87 -4.91 1.11 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 51' ' ' SER . 92.8 m-20 -93.73 -17.8 22.79 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.745 -0.597 . . . . 0.0 109.677 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 56' ' ' ASN . 42.0 t0 -58.94 109.84 0.91 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.777 -1.202 . . . . 0.0 109.286 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -47.56 -12.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 109.638 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' ASP . 50.0 t-20 -140.28 104.97 4.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.198 -0.939 . . . . 0.0 109.074 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.432 ' CG2' ' N ' ' A' ' 58' ' ' SER . 4.0 mp -95.07 159.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.9 p -145.43 123.15 11.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.3 mt -120.23 160.15 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.679 0.752 . . . . 0.0 110.396 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -134.28 134.28 41.72 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.76 22.37 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 72' ' ' PHE . 18.8 m-70 -71.66 176.48 4.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.983 . . . . 0.0 109.272 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.16 90.5 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.55 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.522 ' N ' ' HG1' ' A' ' 73' ' ' THR . 39.8 m-85 -89.42 111.42 22.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.908 . . . . 0.0 109.258 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 mm -60.47 -29.19 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.855 . . . . 0.0 110.627 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.44 15.97 4.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.912 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.55 ' C ' ' H ' ' A' ' 69' ' ' ASN . 51.5 ttt180 -152.18 77.56 6.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.6 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 30.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 123.128 2.552 . . . . 0.0 112.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.55 ' H ' ' C ' ' A' ' 67' ' ' ARG . 17.4 m-80 -150.95 63.46 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.085 -1.009 . . . . 0.0 108.622 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.612 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 3.0 t80 -137.83 -153.76 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.612 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 2.4 mp0 -58.43 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 62' ' ' HIS . 3.8 m-30 -94.61 16.61 15.11 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.522 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 75.8 m -49.14 -24.87 1.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.722 -1.236 . . . . 0.0 109.907 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.8 m-20 -115.31 -29.04 6.69 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.763 . . . . 0.0 110.006 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tt -50.81 -20.89 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -76.44 -18.1 58.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -82.15 -29.04 31.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.526 0.679 . . . . 0.0 109.338 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.67 123.86 7.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.802 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -102.67 177.57 4.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -0.831 . . . . 0.0 109.143 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -51.06 152.49 2.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.77 -19.72 19.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.5 m -62.97 95.66 0.08 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.339 -1.095 . . . . 0.0 108.579 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.74 165.75 9.95 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.49 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -143.89 121.5 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.948 . . . . 0.0 109.099 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 12.5 m-85 -95.09 110.57 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 88' ' ' VAL . 28.6 t80 -96.15 112.16 23.98 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -96.13 149.85 21.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.295 -0.878 . . . . 0.0 111.034 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' CZ ' ' A' ' 86' ' ' PHE . 74.1 t -155.42 103.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.93 -127.43 31.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -90.29 53.04 2.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -1.146 . . . . 0.0 109.692 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -155.1 146.23 22.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.2 m -151.31 109.94 3.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.506 HH22 ' CB ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -100.83 169.51 8.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.559 -0.713 . . . . 0.0 110.003 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 147.96 41.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 109.586 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 3.3 m-85 -134.1 175.36 9.55 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' THR . 59.5 tttp -131.66 106.7 8.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.0 ttm -49.01 98.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 108.876 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -133.65 24.17 4.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.851 . . . . 0.0 109.835 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.8 t -167.06 121.85 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.483 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 65.8 mt -131.48 167.4 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.415 -0.803 . . . . 0.0 110.203 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.571 ' NH1' ' N ' ' A' ' 103' ' ' VAL . 4.9 ttt-85 -137.45 -91.11 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 101' ' ' ARG . 1.9 p30 44.1 19.56 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.953 0.882 . . . . 0.0 108.935 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.571 ' N ' ' NH1' ' A' ' 101' ' ' ARG . 1.7 p -171.32 129.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.538 ' O ' ' O ' ' A' ' 103' ' ' VAL . 16.8 ttmm 59.5 134.52 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 107' ' ' ASP . 30.3 Cg_endo -62.99 8.3 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.727 0.938 . . . . 0.0 112.321 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.502 ' H ' ' C ' ' A' ' 104' ' ' LYS . 3.8 p 43.56 -90.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 0.0 109.849 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 109' ' ' GLY . 16.5 m-20 -118.33 144.82 45.58 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.1 41.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 108.964 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -150.33 55.45 0.47 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.03 -27.3 40.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.011 -1.288 . . . . 0.0 108.089 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.0 mt -137.8 64.81 1.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.537 ' CG ' HE22 ' A' ' 114' ' ' GLN . 9.8 t0 -96.12 -141.49 0.27 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.034 -1.041 . . . . 0.0 108.692 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.87 19.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.038 -1.039 . . . . 0.0 109.654 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.537 HE22 ' CG ' ' A' ' 112' ' ' ASP . 1.6 pm0 -152.08 19.97 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.379 -0.826 . . . . 0.0 109.841 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 109' ' ' GLY . 18.6 mmtp -43.05 127.77 4.27 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.378 -0.826 . . . . 0.0 109.61 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.47 58.75 0.18 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' LYS . 25.5 mtpp -143.15 -143.74 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.235 -1.156 . . . . 0.0 108.886 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 120' ' ' GLN . 2.3 m-20 -118.42 168.95 10.17 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.184 -0.948 . . . . 0.0 108.714 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' ASP . 19.1 ttpp -47.32 96.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.876 -1.14 . . . . 0.0 108.788 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.1 pm0 -95.89 174.54 6.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.844 0.83 . . . . 0.0 110.777 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.08 119.41 24.14 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -95.26 93.51 7.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 0.0 108.949 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 123' ' ' LEU . 3.1 mm? -76.45 148.34 37.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 16.9 mt -142.32 140.68 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -97.18 164.84 12.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.232 -0.917 . . . . 0.0 108.691 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.431 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 22.6 m -148.97 140.76 23.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.009 -1.057 . . . . 0.0 109.934 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 177.81 142.93 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 2.6 m-20 55.99 63.41 2.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.743 . . . . 0.0 109.101 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.34 125.4 24.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.104 -0.998 . . . . 0.0 109.393 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -86.7 124.03 32.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.084 -1.01 . . . . 0.0 109.562 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.17 4.22 46.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -78.44 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.164 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.0 p -95.6 -3.21 46.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.335 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.84 46.33 53.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 t -146.78 157.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -1.158 . . . . 0.0 109.374 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.9 m95 -63.86 111.63 2.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.165 -0.96 . . . . 0.0 108.596 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' TRP . 74.6 tt0 -32.49 -72.39 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.872 0.368 . . . . 0.0 111.309 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -134.03 146.52 50.45 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.269 -0.895 . . . . 0.0 109.853 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.69 ' H ' ' HE ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -167.38 -162.86 0.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.121 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -145.88 162.18 38.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.006 -1.058 . . . . 0.0 108.992 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.5 mt -133.78 138.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.42 -0.8 . . . . 0.0 109.843 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.7 m-85 -128.79 165.76 20.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 99' ' ' SER . 12.8 t -146.38 114.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.946 -1.096 . . . . 0.0 110.423 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.23 169.38 9.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.1 t -132.02 127.76 36.9 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.486 -0.759 . . . . 0.0 109.608 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 3.2 tm-20 -59.0 131.92 52.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.13 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t -93.68 176.32 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.239 -0.913 . . . . 0.0 109.075 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.543 179.923 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 1' ' ' MET . 4.2 mpp? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -72.15 158.84 35.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.34 42.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -152.04 60.06 3.39 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.263 -0.898 . . . . 0.0 109.023 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.14 -155.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.533 2.155 . . . . 0.0 111.355 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -83.44 71.93 10.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.92 -1.112 . . . . 0.0 109.803 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 7' ' ' ILE . 45.6 mt -148.52 108.98 3.59 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.8 179.54 6.19 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.786 1.657 . . . . 0.0 112.313 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -103.77 20.8 17.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.469 -0.77 . . . . 0.0 109.578 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.7 m-20 -77.98 101.94 7.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.983 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' CD ' ' N ' ' A' ' 11' ' ' LYS . 3.5 mptp? -62.29 7.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.383 -0.823 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 10' ' ' ASP . 75.6 p -141.37 41.85 1.76 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -147.66 142.0 26.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.023 -1.048 . . . . 0.0 109.827 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.35 122.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.595 -0.691 . . . . 0.0 110.67 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.81 -25.3 15.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -172.95 -161.64 23.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 13.0 m-85 -147.26 126.97 13.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.132 -1.217 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.04 138.44 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -145.23 141.29 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.652 -1.28 . . . . 0.0 111.836 -177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.0 mt -148.26 127.26 6.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 23' ' ' ALA . 73.8 Cg_endo -75.8 -43.65 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.567 1.511 . . . . 0.0 111.379 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.51 -11.33 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -0.857 . . . . 0.0 109.364 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -134.36 11.4 3.82 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.405 -0.809 . . . . 0.0 109.687 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ALA . 3.7 p30 42.26 36.31 0.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.457 -0.777 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.18 140.71 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 109.155 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -166.03 86.47 0.35 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -139.79 157.93 68.8 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.5 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -80.96 162.01 20.82 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.115 2.544 . . . . 0.0 113.108 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.76 134.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 5.3 m-85 -94.48 151.1 39.06 Favored Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 120.869 -1.144 . . . . 0.0 110.56 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.17 82.45 2.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.74 2.293 . . . . 0.0 111.442 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 178.84 39.75 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.128 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 35' ' ' THR . 87.3 Cg_endo -78.75 109.53 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.247 2.631 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.09 89.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 111.694 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' PRO . 10.3 p -121.41 152.26 57.56 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -40.13 65.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.36 1.374 . . . . 0.0 111.969 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -66.37 -34.66 78.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.751 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.565 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -88.64 -26.33 21.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.49 -1.381 . . . . 0.0 110.769 -178.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.94 -10.88 59.95 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.014 -1.054 . . . . 0.0 108.871 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -56.88 -29.3 62.82 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -79.04 -20.06 49.85 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.33 -135.23 4.75 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.9 t -84.79 169.18 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.567 -0.961 . . . . 0.0 110.235 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.565 ' CB ' HE22 ' A' ' 38' ' ' GLN . 1.6 t -167.78 152.97 6.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.0 109.096 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.63 155.4 26.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.817 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -72.49 -2.97 21.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -151.86 147.63 26.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 110.184 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.73 -39.11 93.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.727 -0.608 . . . . 0.0 111.54 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -88.01 20.75 2.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.119 . . . . 0.0 111.327 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.09 137.06 58.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.833 -1.167 . . . . 0.0 109.49 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 m -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 109.425 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 7.5 mp -61.15 -13.92 21.15 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.094 -1.004 . . . . 0.0 108.525 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.55 -27.41 51.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.546 -0.721 . . . . 0.0 109.623 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 56' ' ' ASN . 3.4 m-20 -61.78 112.43 2.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.155 -0.965 . . . . 0.0 109.862 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -65.9 6.63 0.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.083 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 54' ' ' ASP . 46.6 t-20 -147.04 95.14 2.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.5 115.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.505 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.482 ' H ' ' HG ' ' A' ' 58' ' ' SER . 0.6 OUTLIER -108.71 113.69 26.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 59' ' ' ILE . 69.0 mt -99.95 155.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.56 115.32 23.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.11 145.22 16.07 Favored Glycine 0 N--CA 1.503 3.153 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 72' ' ' PHE . 9.2 m-70 -72.88 175.95 6.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.502 -0.999 . . . . 0.0 109.761 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.48 79.73 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -88.01 129.6 35.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 109.885 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mt -64.33 -34.79 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.531 -0.73 . . . . 0.0 109.935 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.04 20.28 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 109.45 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.6 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -149.98 68.2 8.75 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.099 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 66.7 Cg_exo -52.27 15.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.187 0 C-N-CA 123.481 2.787 . . . . 0.0 113.915 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.2 p30 -151.29 63.75 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.894 -1.129 . . . . 0.0 108.217 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 33.5 t80 -148.02 99.42 3.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.7 mt-30 61.01 -110.89 0.45 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' O ' ' CD1' ' A' ' 72' ' ' PHE . 35.6 t80 -91.14 0.16 57.59 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.111 -0.993 . . . . 0.0 111.55 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.9 m -49.17 -43.65 42.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.535 -1.353 . . . . 0.0 110.626 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ALA . 3.8 m120 -94.93 -21.51 18.59 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.027 -1.045 . . . . 0.0 112.028 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 77' ' ' ALA . 1.4 tm? -51.07 -32.28 21.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.562 -1.336 . . . . 0.0 108.279 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 1.11 2.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -105.96 -27.36 11.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.2 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.845 . . . . 0.0 109.543 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.648 ' H ' ' HG ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -170.04 175.23 5.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 110.02 -179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -49.37 135.68 17.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.1 -17.79 55.87 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.648 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 5.5 m -62.14 107.98 0.98 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.011 -1.288 . . . . 0.0 107.748 179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mtp -70.23 176.27 4.02 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.287 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.69 154.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.22 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -145.65 104.88 3.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.06 111.8 23.56 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -99.21 148.23 24.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 0.0 110.453 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.1 p -167.09 107.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.86 -146.37 48.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -83.54 43.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 109.62 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.42 150.1 37.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.197 -0.94 . . . . 0.0 109.246 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.9 m -150.53 118.85 6.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -0.895 . . . . 0.0 109.704 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -92.7 164.16 13.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.414 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' O ' ' CG ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -145.61 118.89 8.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 109.587 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 16.7 m-85 -112.36 -171.49 1.86 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -143.61 101.67 3.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.16 -0.963 . . . . 0.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.6 mtp -48.94 116.58 1.71 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.326 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -161.54 29.9 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.089 . . . . 0.0 110.561 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 t -163.5 86.31 0.51 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.958 -1.089 . . . . 0.0 108.151 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 2.1 mp -82.64 158.3 3.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.529 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.1 OUTLIER -142.12 -15.72 0.77 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 141' ' ' ILE . 3.0 p30 -47.69 -30.19 3.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 109.372 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 11.9 p -82.2 -32.87 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.427 -0.796 . . . . 0.0 109.452 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -130.32 72.33 81.94 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 106' ' ' THR . 94.6 Cg_endo -79.41 -158.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.605 2.203 . . . . 0.0 112.147 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 105' ' ' PRO . 6.1 t 36.34 47.56 0.5 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.375 0.607 . . . . 0.0 110.624 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.56 -133.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.406 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.38 27.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.327 -0.858 . . . . 0.0 109.706 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 159.06 89.26 0.07 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.41 -31.2 51.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 mt -139.65 54.08 1.69 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.51 ' OD2' ' NE2' ' A' ' 114' ' ' GLN . 1.4 m-20 -78.52 115.92 18.55 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -83.51 16.87 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.51 ' NE2' ' OD2' ' A' ' 112' ' ' ASP . 2.1 pp0? -150.0 28.69 0.75 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' A' ' 117' ' ' LYS . 84.9 mttt -40.89 140.65 0.7 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.686 -0.634 . . . . 0.0 109.845 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.25 8.25 0.7 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 115' ' ' LYS . 63.9 mmtt -96.64 -145.91 0.29 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.147 -1.208 . . . . 0.0 109.685 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 13.1 t70 -118.86 169.71 9.63 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 60.6 mttm -38.05 135.5 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.73 161.8 39.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.892 -1.13 . . . . 0.0 111.104 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.51 103.8 13.39 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.2 m -91.48 152.95 20.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.84 146.8 36.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.7 mt -136.76 142.02 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.3 p -91.84 169.67 10.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.866 -1.146 . . . . 0.0 108.815 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 m -147.8 106.41 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.08 -1.012 . . . . 0.0 109.803 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 128' ' ' ASP . 10.5 t70 -157.35 144.9 18.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.012 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 127' ' ' ASP . 70.6 m-20 53.69 64.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.476 -0.765 . . . . 0.0 109.135 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -65.27 124.11 21.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 110.056 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -86.76 127.52 34.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.937 -1.102 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.8 pm0 -94.6 12.19 28.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.454 -0.779 . . . . 0.0 109.649 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -85.61 -57.97 2.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 109.073 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.0 p -95.72 -9.95 30.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.834 . . . . 0.0 109.136 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.83 46.86 9.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -147.05 153.55 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -1.094 . . . . 0.0 109.551 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.426 ' O ' ' C ' ' A' ' 137' ' ' GLU . 72.5 m95 -61.44 112.29 2.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 136' ' ' TRP . 42.5 tt0 -38.68 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.247 0.546 . . . . 0.0 110.326 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -91.38 135.96 33.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.106 -0.996 . . . . 0.0 108.61 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.559 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -157.04 122.26 4.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.946 -1.096 . . . . 0.0 110.334 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -100.79 164.48 11.83 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 102' ' ' ASP . 29.3 pt -148.35 151.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.832 -1.168 . . . . 0.0 110.481 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.28 172.2 14.23 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.65 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 43.0 t -147.32 129.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.856 -1.153 . . . . 0.0 110.961 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.19 -176.28 3.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.0 t -148.26 136.71 21.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.745 -1.222 . . . . 0.0 109.426 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.24 150.18 18.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.405 -0.809 . . . . 0.0 109.537 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t -90.48 -144.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.343 -0.848 . . . . 0.0 109.131 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.534 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 ttm . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.302 0.572 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -75.46 141.35 43.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.45 -168.51 1.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.855 . . . . 0.0 109.371 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.0 mptt -82.09 156.38 69.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.006 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' LYS . 90.0 Cg_exo -40.87 174.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.615 2.21 . . . . 0.0 112.835 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -67.24 152.06 46.4 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.118 -0.989 . . . . 0.0 109.386 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 mt -83.75 127.57 67.05 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 108.989 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -40.85 137.49 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.56 1.506 . . . . 0.0 112.248 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -82.46 -20.15 37.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.244 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 12' ' ' SER . 67.2 m-20 -77.87 108.89 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.403 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -62.68 -1.09 0.74 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 10' ' ' ASP . 22.6 p -120.49 47.33 1.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.667 -0.645 . . . . 0.0 109.517 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -144.8 136.04 25.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.3 -0.875 . . . . 0.0 109.274 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.47 114.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.767 . . . . 0.0 110.995 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.96 -17.33 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.26 -173.0 35.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.99 125.0 9.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.101 -1.235 . . . . 0.0 109.211 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -97.29 146.88 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -150.6 131.76 14.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.045 . . . . 0.0 110.476 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.419 HG21 HD11 ' A' ' 20' ' ' ILE . 26.6 mt -144.29 126.47 8.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.45 -41.54 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.648 1.565 . . . . 0.0 111.572 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -51.38 -16.19 0.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.0 109.469 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.415 ' O ' ' OD1' ' A' ' 24' ' ' ASP . . . -136.13 15.32 3.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.2 p-10 44.23 48.51 7.81 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.404 -0.81 . . . . 0.0 109.875 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 25' ' ' ILE . 46.5 mm -90.31 138.64 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.208 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.08 84.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -144.67 151.99 51.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.039 -1.038 . . . . 0.0 110.5 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.05 161.71 18.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.575 2.183 . . . . 0.0 112.155 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.46 102.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' HH ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -80.69 171.49 12.17 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.761 -1.212 . . . . 0.0 109.109 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -86.39 137.11 4.94 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.592 2.194 . . . . 0.0 112.301 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.66 171.62 20.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' ' N ' ' A' ' 35' ' ' THR . 92.2 Cg_endo -78.01 117.88 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.587 2.192 . . . . 0.0 110.767 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -43.04 88.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.698 -0.626 . . . . 0.0 110.338 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -114.6 153.89 46.71 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.05 -41.9 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.944 1.763 . . . . 0.0 112.112 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' OE1' ' N ' ' A' ' 37' ' ' GLU . 4.6 pm0 -63.04 -23.46 67.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.906 -1.121 . . . . 0.0 109.532 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -90.82 -66.82 0.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.013 . . . . 0.0 109.17 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -45.27 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -64.2 -24.45 67.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' C ' ' HH ' ' A' ' 30' ' ' TYR . 30.5 mtt-85 -87.34 -10.63 51.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 154.67 -129.47 2.59 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.5 t -112.67 156.63 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.613 -0.933 . . . . 0.0 109.907 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -150.68 154.84 38.18 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -58.56 169.96 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.593 -1.317 . . . . 0.0 110.068 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.64 -0.92 49.4 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -154.95 150.67 27.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.59 0.71 . . . . 0.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -63.9 -40.28 96.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 111.631 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.63 12.76 11.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.874 -1.141 . . . . 0.0 111.595 -177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -62.67 101.9 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.786 -1.196 . . . . 0.0 109.519 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 53' ' ' ASP . 8.6 p -93.61 141.85 28.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.154 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.5 ' H ' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -54.85 -9.91 0.41 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 51' ' ' SER . 7.8 t70 -95.16 -9.91 32.08 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.678 -0.639 . . . . 0.0 109.817 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.7 t0 -56.35 113.26 1.51 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.832 -1.167 . . . . 0.0 109.001 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 1.1 tt0 -41.58 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.693 -0.629 . . . . 0.0 110.186 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 15.4 p-10 -137.34 115.21 11.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.27 -0.894 . . . . 0.0 108.772 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -97.72 152.26 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 46' ' ' ALA . 9.3 m -140.66 105.42 4.93 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 81.6 mt -100.28 161.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.773 0.797 . . . . 0.0 110.725 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -139.05 129.84 26.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.94 160.14 25.24 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.54 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.58 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 19.3 m-70 -77.25 179.11 6.58 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.585 -0.95 . . . . 0.0 109.791 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.426 ' OG1' ' NZ ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -153.49 91.75 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 108.734 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' N ' ' OG1' ' A' ' 73' ' ' THR . 7.3 m-85 -86.51 104.55 16.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.132 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.83 -32.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.24 17.05 2.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 0.0 109.059 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 69' ' ' ASN . 6.3 tpp180 -150.46 72.51 9.09 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.25 25.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 123.297 2.665 . . . . 0.0 113.522 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 18.3 p30 -149.78 39.21 0.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.829 -1.17 . . . . 0.0 109.093 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.74 -153.57 0.49 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.58 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 29.0 mt-30 -64.79 -89.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.657 -0.652 . . . . 0.0 111.776 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.552 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -93.97 22.54 5.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.0 110.191 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 92.7 m -72.8 -24.88 60.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.306 -1.496 . . . . 0.0 109.951 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.9 m-20 -119.37 -13.93 9.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.136 -0.977 . . . . 0.0 111.291 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 mt -51.74 -19.9 1.87 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.62 -1.3 . . . . 0.0 108.79 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' NZ ' ' OG1' ' A' ' 63' ' ' THR . 12.1 pttm -88.55 -8.4 54.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 108.563 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -85.69 -21.78 28.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.4 -174.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 109.362 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' GLY . 45.9 mtmt -150.23 155.23 39.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -51.4 89.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 148.19 -15.94 1.32 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.6 m -62.59 114.22 3.44 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.0 ptm -68.9 -179.59 1.52 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.48 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.06 153.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.0 109.593 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -132.74 103.28 6.03 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.36 111.7 23.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -90.65 150.81 21.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.6 t -150.01 151.3 12.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.45 -4.89 0.42 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.547 ' H ' ' C ' ' A' ' 88' ' ' VAL . 55.0 m-20 -102.41 -45.96 4.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.311 -1.111 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -171.55 -156.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.985 -1.072 . . . . 0.0 109.106 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.4 m -132.88 120.3 21.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.345 -0.847 . . . . 0.0 109.941 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.512 ' CG ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -92.13 171.9 8.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.472 -0.768 . . . . 0.0 109.031 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.493 ' HZ1' ' CB ' ' A' ' 94' ' ' LYS . 8.5 mtmp? -144.84 152.32 40.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 11.4 m-85 -139.34 178.57 7.1 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -142.28 105.82 4.66 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.147 -0.971 . . . . 0.0 109.773 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 55.0 mtt -49.33 125.1 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.6 t -150.78 19.45 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 143' ' ' VAL . 3.4 p -174.69 122.87 0.26 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 pt -143.86 147.98 19.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.286 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.57 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.0 OUTLIER -98.68 -77.25 0.52 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.0 109.169 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.7 p30 42.81 33.7 0.51 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.579 0.704 . . . . 0.0 109.375 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.2 t -150.01 -76.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -117.45 82.26 15.07 Favored Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 107' ' ' ASP . 97.8 Cg_exo -43.49 -39.26 9.36 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.309 2.006 . . . . 0.0 112.658 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.7 p -68.48 46.17 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.32 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 105' ' ' PRO . 47.7 t0 -85.03 -83.02 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.253 -0.904 . . . . 0.0 109.729 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 m -112.84 34.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.406 -0.809 . . . . 0.0 109.654 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.16 120.2 0.07 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.45 -28.41 42.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.271 -1.135 . . . . 0.0 108.853 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.7 mt -138.16 80.82 1.82 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 20.1 t70 -119.47 -154.9 0.59 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.557 ' C ' HE21 ' A' ' 114' ' ' GLN . 27.2 tt0 -50.43 175.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.981 -1.074 . . . . 0.0 108.268 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.58 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.2 OUTLIER -88.44 68.29 8.78 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 117' ' ' LYS . 8.2 mmtm 1.77 110.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.718 0 CA-C-O 121.192 0.52 . . . . 0.0 111.584 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -51.71 80.34 0.01 OUTLIER Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 115' ' ' LYS . 30.2 ttmt -149.81 -133.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.298 -1.119 . . . . 0.0 108.897 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' GLN . 11.2 m-20 -119.45 169.63 9.86 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.492 ' CB ' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -37.84 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.907 0.86 . . . . 0.0 109.323 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -95.47 147.15 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.411 0.624 . . . . 0.0 110.123 -178.213 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -102.74 155.16 18.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.516 -0.74 . . . . 0.0 109.407 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -139.64 87.85 2.2 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.04 145.31 44.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 0.0 110.75 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.481 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 50.0 mt -139.69 148.31 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.468 -0.77 . . . . 0.0 109.085 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.59 170.16 9.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -149.81 95.56 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -155.39 141.94 18.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 109.485 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.6 55.66 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 0.0 109.073 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -64.13 123.18 18.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 109.833 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -84.4 122.83 29.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.0 109.302 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -87.53 4.74 42.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -80.17 -55.85 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.9 p -95.7 -12.05 26.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 45.55 10.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.7 t -146.96 153.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.259 -1.142 . . . . 0.0 109.61 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.538 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 66.0 m95 -61.73 110.69 1.59 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.184 -0.948 . . . . 0.0 108.591 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 136' ' ' TRP . 2.8 tm-20 -42.37 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.487 -0.758 . . . . 0.0 109.859 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 144.13 27.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 108.248 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.483 ' HG2' HH11 ' A' ' 139' ' ' ARG . 0.5 OUTLIER -161.05 94.33 1.01 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.0 110.548 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -75.1 163.84 27.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.457 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 4.2 mt -144.28 155.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.058 -1.026 . . . . 0.0 110.791 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 38.5 m-85 -140.74 165.01 28.66 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 99' ' ' SER . 57.6 t -147.65 148.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.839 -1.163 . . . . 0.0 110.385 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.73 179.24 6.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 t -143.46 142.71 31.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.09 -1.006 . . . . 0.0 109.979 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -56.82 152.32 12.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.608 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.4 m -92.72 168.36 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.827 . . . . 0.0 109.297 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.128 -0.983 . . . . 0.0 109.315 179.906 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -171.39 134.88 0.9 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.131 -0.981 . . . . 0.0 109.636 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.34 60.36 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.137 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -149.48 64.76 7.41 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.325 -0.86 . . . . 0.0 109.213 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.25 -151.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.808 2.338 . . . . 0.0 111.949 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -67.25 105.15 1.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.007 -1.058 . . . . 0.0 110.589 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mt -150.67 95.09 3.52 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 114.36 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.388 2.058 . . . . 0.0 112.916 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -60.03 -11.09 5.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.24 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 12' ' ' SER . 34.8 m-20 -77.02 100.53 5.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -59.38 0.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.9 m -122.85 39.49 3.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -142.71 143.58 32.34 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.8 t -58.23 155.28 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.37 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.7 6.62 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 162.79 -172.8 38.92 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -146.72 125.52 12.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -1.071 . . . . 0.0 109.706 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -95.08 144.25 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -146.98 129.13 15.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.879 -1.138 . . . . 0.0 110.569 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mt -144.76 126.98 8.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.3 Cg_endo -76.9 -42.15 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.673 1.582 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -52.75 -12.96 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.05 10.74 3.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 40.95 39.86 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.475 0.655 . . . . 0.0 110.121 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 25' ' ' ILE . 7.0 mt -94.7 146.23 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.944 0.878 . . . . 0.0 110.024 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' CB ' ' HZ2' ' A' ' 26' ' ' LYS . 7.6 ttpm? -166.02 83.16 0.3 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -139.96 159.53 64.15 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.388 -0.82 . . . . 0.0 110.645 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.47 161.5 22.35 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.946 2.431 . . . . 0.0 112.579 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.5 113.21 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.32 171.29 12.53 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.756 -1.215 . . . . 0.0 109.181 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -95.32 136.99 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.546 2.164 . . . . 0.0 112.018 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.72 173.53 22.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 35' ' ' THR . 57.0 Cg_endo -71.88 115.43 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.731 2.287 . . . . 0.0 110.785 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.49 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.59 -0.694 . . . . 0.0 110.741 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -109.0 152.52 42.49 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.527 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 32.7 Cg_endo -63.52 -43.22 18.15 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.072 1.848 . . . . 0.0 112.153 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.07 -27.41 69.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.027 -1.045 . . . . 0.0 109.527 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -84.14 -63.72 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.207 -0.933 . . . . 0.0 109.54 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.6 mt -47.5 -13.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.472 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.7 m120 -59.02 -28.13 66.12 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' C ' ' OH ' ' A' ' 30' ' ' TYR . 26.6 mtt-85 -79.84 -17.72 52.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.17 -101.61 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.59 -1.29 . . . . 0.0 111.057 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.416 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 4.8 t -135.5 155.14 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -1.073 . . . . 0.0 110.217 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 t -151.22 152.04 32.71 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.55 171.32 0.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.546 -1.346 . . . . 0.0 109.346 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -80.52 -10.38 59.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -149.71 154.68 38.93 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.778 0.799 . . . . 0.0 109.96 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.8 pt-20 -64.48 -43.09 95.25 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 31.6 m120 -84.68 10.3 11.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.597 -1.314 . . . . 0.0 111.037 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 58' ' ' SER . 4.5 mm-40 -64.75 96.74 0.19 Allowed 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 110.354 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.497 ' HG ' ' H ' ' A' ' 53' ' ' ASP . 38.6 p -93.69 175.27 6.8 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.469 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -79.92 -10.64 59.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.497 ' H ' ' HG ' ' A' ' 51' ' ' SER . 63.6 m-20 -102.19 -4.12 26.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.694 . . . . 0.0 109.975 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 56' ' ' ASN . 10.3 t70 -58.72 125.56 23.99 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.848 -1.158 . . . . 0.0 109.337 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.555 HE22 ' N ' ' A' ' 119' ' ' LYS . 34.8 tp60 -39.28 -24.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.73 -0.606 . . . . 0.0 109.956 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 54' ' ' ASP . 52.4 t-20 -151.96 113.87 4.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -96.11 156.04 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.513 ' N ' ' OE2' ' A' ' 50' ' ' GLU . 34.0 t -143.21 123.41 13.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 73.4 mt -110.9 153.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.547 -0.721 . . . . 0.0 110.567 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -133.9 132.56 40.43 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.28 157.28 25.5 Favored Glycine 0 N--CA 1.503 3.13 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.995 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -70.61 176.38 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.73 -0.865 . . . . 0.0 109.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -159.34 93.83 1.15 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.13 105.51 17.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.166 -0.959 . . . . 0.0 108.915 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.74 -29.09 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 8.2 t70 -84.55 11.22 9.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.399 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' ASN . 24.5 ttm180 -151.62 79.75 6.46 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.277 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.25 24.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 123.702 2.935 . . . . 0.0 114.357 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' ARG . 40.6 m-80 -151.09 62.77 0.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 108.597 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.52 ' CD2' ' OE1' ' A' ' 71' ' ' GLN . 15.3 t80 -146.73 102.93 3.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.165 -0.959 . . . . 0.0 110.272 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 15.2 mp0 55.28 -113.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 111.796 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.4 m-85 -92.42 7.73 41.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.085 -1.01 . . . . 0.0 110.421 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.8 m -47.16 -33.65 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.74 -1.225 . . . . 0.0 109.698 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ALA . 8.1 m120 -100.28 -28.95 12.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -0.773 . . . . 0.0 110.472 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 77' ' ' ALA . 6.9 tp -54.11 -31.94 53.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.616 -1.303 . . . . 0.0 108.792 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -65.99 -3.28 5.02 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 75' ' ' LEU . . . -102.33 -28.5 12.21 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -44.75 168.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 110.017 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.78 160.76 39.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.372 -0.83 . . . . 0.0 108.94 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -49.99 137.08 17.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.03 -1.044 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 -23.94 32.28 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 m -62.68 115.9 4.71 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.211 -1.17 . . . . 0.0 108.057 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.83 176.7 4.73 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.971 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.9 t -142.81 109.27 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.405 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -93.67 102.84 15.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -96.99 112.17 24.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -93.89 154.32 17.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.036 -1.04 . . . . 0.0 110.74 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.6 m -151.15 160.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.36 46.38 0.26 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 22.7 p30 -160.33 -36.78 0.05 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 109.783 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.0 tt0 -174.24 -157.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 108.925 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 t -141.54 129.76 22.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.048 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -92.12 162.37 14.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.813 . . . . 0.0 109.212 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -144.36 93.98 2.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.086 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -93.23 179.34 5.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.076 -1.015 . . . . 0.0 108.8 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 98' ' ' THR . 36.1 ttpt -144.96 114.82 7.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.3 mtt -48.96 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 109.113 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.6 m -126.03 29.65 5.83 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.7 . . . . 0.0 109.538 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.3 86.98 0.08 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.15 -0.969 . . . . 0.0 108.499 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.4 mm -83.04 147.43 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -145.34 -15.81 0.5 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.008 -1.057 . . . . 0.0 109.883 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 103' ' ' VAL . 29.2 p-10 -43.5 -51.41 6.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.493 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 79.6 t -82.52 130.0 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm 46.9 68.87 3.07 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.858 . . . . 0.0 109.439 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.7 -101.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.449 2.099 . . . . 0.0 112.034 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.7 p 46.19 50.58 11.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.193 -0.942 . . . . 0.0 109.79 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 109' ' ' GLY . 3.2 m-20 -94.43 -163.33 1.04 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.213 -0.929 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.2 m -78.29 37.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.139 -0.976 . . . . 0.0 109.44 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 88.99 136.75 5.88 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.6 -43.98 83.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.266 -1.138 . . . . 0.0 108.617 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.5 mt -100.37 62.25 1.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.665 . . . . 0.0 109.279 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 12.3 t70 -172.29 21.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.479 -0.763 . . . . 0.0 109.175 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -109.04 -3.63 17.27 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 116' ' ' GLY . 4.9 pp0? -98.7 8.45 44.92 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -47.22 -18.33 0.09 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.285 0.564 . . . . 0.0 109.533 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . -171.28 26.2 0.1 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.76 -151.13 0.32 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.286 -1.126 . . . . 0.0 108.961 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.535 ' C ' HE22 ' A' ' 55' ' ' GLN . 16.7 t70 -115.75 163.18 16.21 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.555 ' N ' HE22 ' A' ' 55' ' ' GLN . 46.4 mttp -43.35 129.81 4.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -148.42 167.43 25.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.0 -1.062 . . . . 0.0 110.117 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.7 tp -118.8 122.2 41.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.651 -0.656 . . . . 0.0 110.35 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -100.63 94.13 5.94 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 mp -73.78 147.4 43.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.923 . . . . 0.0 110.244 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.507 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 82.0 mt -138.13 148.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.578 ' HG1' ' H ' ' A' ' 140' ' ' LYS . 18.1 p -102.18 165.23 11.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 108.898 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.9 m -147.51 87.44 1.65 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.976 -1.077 . . . . 0.0 109.273 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 7.1 p30 -130.21 146.34 51.82 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.22 -0.925 . . . . 0.0 110.089 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 54.8 72.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.657 -0.652 . . . . 0.0 109.493 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -67.56 119.96 13.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.181 -0.949 . . . . 0.0 109.683 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -88.88 123.11 32.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.779 -1.201 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.3 pm0 -93.13 -13.01 29.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.847 . . . . 0.0 109.019 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -62.93 -49.72 73.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 46.7 p -97.35 -13.34 21.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 108.775 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 38.19 27.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.15 162.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.444 ' O ' ' C ' ' A' ' 137' ' ' GLU . 78.9 m95 -64.73 113.21 3.62 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.6 tp10 -36.99 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.947 -0.471 . . . . 0.0 110.418 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -111.12 137.72 48.44 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.49 113.85 5.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 109.753 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.578 ' H ' ' HG1' ' A' ' 125' ' ' THR . 44.5 mttm -75.45 166.84 22.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.107 -0.996 . . . . 0.0 108.517 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 102' ' ' ASP . 10.4 pt -149.6 134.51 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.937 -1.102 . . . . 0.0 110.331 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -130.06 169.85 14.76 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 t -145.85 143.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.818 -1.176 . . . . 0.0 110.667 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -132.8 126.24 31.89 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.4 t -94.49 145.65 24.65 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -58.41 147.12 32.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.2 m -90.03 147.3 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.544 -179.943 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -64.63 152.23 42.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.38 179.31 8.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.325 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' PRO . 20.5 pttm -50.18 127.55 22.18 Favored Pre-proline 0 N--CA 1.486 1.358 0 O-C-N 121.214 -0.929 . . . . 0.0 109.305 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LYS . 90.7 Cg_exo -42.07 176.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.382 2.055 . . . . 0.0 113.121 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -71.46 92.98 1.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.473 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.3 mt -86.3 119.3 71.48 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 108.755 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -42.57 156.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.475 1.45 . . . . 0.0 112.179 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -103.38 -23.71 13.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 12' ' ' SER . 21.5 t0 -76.96 108.13 9.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.668 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -58.28 -3.61 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.267 -0.895 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 10' ' ' ASP . 42.3 m -115.27 43.43 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.487 -0.758 . . . . 0.0 109.349 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -147.6 145.86 29.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.5 t -59.72 149.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.857 0.837 . . . . 0.0 110.742 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.39 12.46 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 160.17 177.07 32.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.25 122.5 9.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.27 . . . . 0.0 109.055 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.7 tt -97.57 151.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.48 132.25 15.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 20' ' ' ILE . 50.3 mt -142.29 125.71 9.57 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.451 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.2 Cg_endo -76.1 -43.07 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.692 1.595 . . . . 0.0 111.511 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -51.05 -14.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.89 . . . . 0.0 108.867 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.451 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.4 12.52 3.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.661 -0.649 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 4.6 p-10 43.02 51.86 5.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.42 -0.8 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.6 mm -95.69 147.25 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.045 0.926 . . . . 0.0 111.04 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -168.75 80.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 10.0 mt-10 -139.3 158.57 68.73 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.299 -0.876 . . . . 0.0 110.944 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.25 160.44 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.986 2.457 . . . . 0.0 112.91 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 t -132.46 101.7 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.65 171.72 11.19 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.918 -1.114 . . . . 0.0 109.76 -178.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -86.59 116.02 1.34 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.142 2.561 . . . . 0.0 112.945 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.23 160.99 22.78 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.736 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 90.3 Cg_endo -76.59 126.77 9.17 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.702 2.268 . . . . 0.0 111.053 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -41.58 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.753 -0.592 . . . . 0.0 110.77 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.7 p -127.17 149.61 70.02 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.525 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 19.7 Cg_endo -58.21 -43.04 50.65 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.925 1.75 . . . . 0.0 112.185 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.22 -20.87 65.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.106 -0.996 . . . . 0.0 109.788 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -89.26 -68.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.16 -0.962 . . . . 0.0 109.378 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.2 mt -47.34 -11.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.979 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 38' ' ' GLN . 4.0 m120 -56.84 -28.88 62.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 19.9 mmt180 -81.12 -18.31 46.9 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 147.83 -124.51 1.92 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 2.3 t -97.6 160.66 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.288 -1.125 . . . . 0.0 109.825 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 p -165.22 153.62 11.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 108.778 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -53.54 167.19 0.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.954 -1.091 . . . . 0.0 108.802 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -100.4 11.14 40.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.394 -0.816 . . . . 0.0 109.055 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -156.16 134.3 11.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.988 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.61 -25.63 68.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -87.07 17.29 4.29 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.926 -1.109 . . . . 0.0 110.03 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 51' ' ' SER . 1.7 pp20? -62.43 165.63 5.94 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.732 0.777 . . . . 0.0 110.347 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.533 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 2.1 p -150.77 174.12 13.42 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.12 2.74 33.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.9 -1.125 . . . . 0.0 108.368 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -154.86 25.02 0.44 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.473 -0.767 . . . . 0.0 110.126 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' N ' ' HG ' ' A' ' 51' ' ' SER . 24.2 t70 -56.7 124.04 17.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.742 -1.224 . . . . 0.0 108.571 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' CD ' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -43.77 -22.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 41.9 t-20 -140.18 97.1 3.16 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -94.41 154.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.291 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 p -142.64 120.8 12.19 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 79.5 mt -114.59 164.88 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.846 0.831 . . . . 0.0 110.753 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -141.12 139.87 34.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.03 145.08 13.45 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.587 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.694 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 39.0 m-70 -73.16 -172.19 1.05 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.99 . . . . 0.0 109.42 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.23 88.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.848 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -89.1 121.82 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 0.0 108.734 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.4 mt -61.65 -32.34 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.449 -0.782 . . . . 0.0 110.67 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.69 17.45 2.27 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.716 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.6 ' C ' ' H ' ' A' ' 69' ' ' ASN . 53.5 mtp180 -150.11 73.26 9.34 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.56 -0.712 . . . . 0.0 109.393 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.57 12.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.285 2.657 . . . . 0.0 113.62 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.6 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.6 p30 -147.15 57.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.916 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -141.87 112.66 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.364 -0.835 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.694 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 7.5 mt-30 51.85 -127.78 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.469 -0.77 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -93.97 42.5 1.1 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.834 -1.166 . . . . 0.0 110.404 -178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.9 m -68.79 -16.48 63.81 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.445 -1.409 . . . . 0.0 109.091 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 77' ' ' ALA . 14.8 m-20 -125.82 -25.54 3.62 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.582 -0.699 . . . . 0.0 109.99 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.92 -25.29 19.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 0.0 108.591 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -74.35 -6.06 45.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -94.16 -28.61 15.57 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.377 0.608 . . . . 0.0 109.409 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.86 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.486 -0.759 . . . . 0.0 109.801 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' C ' ' SD ' ' A' ' 97' ' ' MET . 14.6 ptpt -155.37 179.36 9.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.95 . . . . 0.0 109.369 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.603 ' HZ2' ' N ' ' A' ' 100' ' ' ILE . 58.1 mmtt -47.4 138.32 7.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.17 -16.05 59.64 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -62.54 97.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.168 -1.195 . . . . 0.0 108.494 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 70.3 mmm -62.93 168.28 4.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.773 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 t -142.32 114.87 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.519 -0.738 . . . . 0.0 109.482 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.25 107.29 19.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.114 -0.991 . . . . 0.0 109.614 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -94.64 112.33 24.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -94.18 135.0 36.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.088 -1.007 . . . . 0.0 110.969 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 m -157.06 132.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 55.96 -148.33 28.25 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -94.61 50.67 1.35 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.195 -1.179 . . . . 0.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -171.24 140.26 1.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.036 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -120.8 133.14 55.33 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.543 -0.723 . . . . 0.0 110.303 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.525 ' CG ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.8 178.23 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.253 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 15.1 ptpt -145.66 152.3 39.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.147 -0.971 . . . . 0.0 109.861 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.49 ' O ' ' SD ' ' A' ' 83' ' ' MET . 26.6 m-85 -141.23 178.79 7.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.259 -0.9 . . . . 0.0 108.759 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -143.35 110.34 5.64 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.18 -0.95 . . . . 0.0 109.938 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 79' ' ' LYS . 37.3 ttm -48.19 127.05 12.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.495 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . 11.1 m -161.78 25.68 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.1 . . . . 0.0 110.269 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.419 ' N ' ' NZ ' ' A' ' 80' ' ' LYS . 2.2 m -163.27 87.43 0.55 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.672 -1.267 . . . . 0.0 108.636 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.603 ' N ' ' HZ2' ' A' ' 80' ' ' LYS . 1.3 mp -82.49 140.03 16.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.671 HH11 ' NZ ' ' A' ' 115' ' ' LYS . 44.3 mtm180 -137.85 12.92 2.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.476 -0.765 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 141' ' ' ILE . 2.6 p30 -65.49 47.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.441 -0.787 . . . . 0.0 109.611 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.474 ' O ' ' CG1' ' A' ' 103' ' ' VAL . 52.9 t -148.91 9.19 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.251 -0.906 . . . . 0.0 108.793 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.8 mttm 58.3 58.14 6.43 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.805 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 106' ' ' THR . 84.2 Cg_endo -78.76 -4.5 14.08 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.661 2.24 . . . . 0.0 112.185 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' PRO . 2.4 t 33.89 59.33 0.56 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.336 0.589 . . . . 0.0 110.596 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -58.5 -72.1 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 m -152.02 20.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.9 122.65 1.89 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 m -68.64 -28.89 41.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.273 -1.134 . . . . 0.0 108.658 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.6 mt -138.59 73.87 1.45 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.603 -0.686 . . . . 0.0 109.6 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.541 ' CG ' HE22 ' A' ' 114' ' ' GLN . 25.7 t0 -103.27 -146.45 0.37 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.363 -0.835 . . . . 0.0 108.865 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.481 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 14.0 pt-20 -143.3 25.83 1.68 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.132 -0.98 . . . . 0.0 109.399 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.546 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -144.2 28.37 1.37 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.671 ' NZ ' HH11 ' A' ' 101' ' ' ARG . 1.0 OUTLIER -57.59 152.76 14.41 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.783 0.801 . . . . 0.0 110.304 -179.112 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 117' ' ' LYS . . . 46.54 -103.36 0.06 OUTLIER Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 116' ' ' GLY . 81.7 mttt -158.08 -44.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.641 -0.917 . . . . 0.0 110.305 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 119' ' ' LYS . 3.1 m-20 -118.39 170.92 8.51 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.7 -0.625 . . . . 0.0 109.909 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 118' ' ' ASP . 1.6 mptm? -30.89 129.85 0.12 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.256 0.551 . . . . 0.0 110.043 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -147.3 168.37 21.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.059 -1.025 . . . . 0.0 109.962 -178.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 60.7 mt -124.31 111.81 16.25 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.742 -0.598 . . . . 0.0 109.911 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.3 m -91.68 88.07 6.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.041 -1.037 . . . . 0.0 108.243 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.16 154.51 31.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 18.4 mt -140.01 148.89 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 56.2 p -99.03 163.64 12.5 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.6 m -147.34 149.54 33.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 109.579 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.88 130.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 27.8 t0 60.34 71.24 0.58 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.011 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 130' ' ' ASN . 40.7 t80 -65.1 132.43 49.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.655 -1.278 . . . . 0.0 110.026 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.436 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 51.7 t30 -79.64 119.64 22.86 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.982 -1.074 . . . . 0.0 109.351 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -91.97 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.227 -0.92 . . . . 0.0 109.544 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -78.87 -64.66 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 p -94.84 -7.65 39.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 53.78 4.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.98 151.4 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.199 -1.177 . . . . 0.0 109.551 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.39 116.41 5.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 128' ' ' ASP . 7.0 mm-40 -37.76 -85.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.149 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -111.76 156.03 22.59 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -170.16 -160.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 109.963 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.481 ' N ' ' OG1' ' A' ' 125' ' ' THR . 59.7 mttp -152.05 160.46 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 102' ' ' ASP . 17.5 mt -141.69 127.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.131 -0.981 . . . . 0.0 110.201 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -147.58 149.02 31.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.91 . . . . 0.0 108.715 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.4 t -125.47 136.22 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.463 -0.773 . . . . 0.0 111.142 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.73 174.85 5.71 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -140.26 135.95 32.83 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.87 131.12 49.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -90.22 146.85 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.2 pttp . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.379 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 mmt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -148.86 161.59 41.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.187 -0.946 . . . . 0.0 109.279 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.55 162.24 7.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.662 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' CD ' ' ND2' ' A' ' 90' ' ' ASN . 63.6 mttm -152.15 143.52 15.92 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.273 -0.892 . . . . 0.0 108.987 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.4 99.3 0.85 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.434 2.09 . . . . 0.0 113.059 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -151.04 72.73 1.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.928 -1.107 . . . . 0.0 109.355 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mt -151.07 93.71 3.61 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 -163.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.244 1.963 . . . . 0.0 112.168 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -126.41 -23.17 3.85 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 12' ' ' SER . 16.9 t0 -77.41 114.15 15.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.239 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -58.33 -2.55 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.85 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.2 p -112.39 41.78 1.94 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 109.618 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -146.24 137.25 24.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -1.0 . . . . 0.0 109.78 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.34 159.76 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 121.682 0.753 . . . . 0.0 110.762 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.65 1.4 1.91 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.67 -170.39 38.99 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -147.27 125.76 12.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.126 -1.22 . . . . 0.0 110.518 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 tp -95.51 140.13 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -145.15 145.49 31.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.827 -1.17 . . . . 0.0 110.822 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 mt -147.8 129.35 7.31 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.07 -53.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.86 1.707 . . . . 0.0 112.296 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.96 -27.89 6.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.742 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.37 5.91 20.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.43 -0.793 . . . . 0.0 109.163 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.4 p30 42.95 35.75 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.738 -0.601 . . . . 0.0 110.395 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt -90.5 146.39 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -0.834 . . . . 0.0 109.113 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -166.59 84.47 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.77 158.12 74.72 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.69 161.61 16.53 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 123.114 2.542 . . . . 0.0 113.083 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 t -125.01 123.35 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 2.5 m-85 -84.65 152.54 60.23 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.86 100.61 0.97 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.559 2.173 . . . . 0.0 111.844 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.46 179.12 47.56 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 35' ' ' THR . 71.5 Cg_endo -77.78 120.74 5.22 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.736 2.291 . . . . 0.0 111.097 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -40.33 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.34 0.59 . . . . 0.0 110.767 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -107.39 153.46 41.22 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.75 -41.88 7.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.232 1.954 . . . . 0.0 112.435 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -63.71 -19.79 65.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.005 . . . . 0.0 110.08 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -94.96 -63.61 1.15 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.101 -0.999 . . . . 0.0 109.117 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.08 -24.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.401 -0.812 . . . . 0.0 109.857 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' GLN . 21.4 m-20 -59.88 -24.77 64.53 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.5 mtt180 -89.11 -9.08 52.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.64 -136.03 4.99 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 6.1 t -101.42 157.25 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.485 -1.009 . . . . 0.0 109.586 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -151.74 147.94 27.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.277 -0.889 . . . . 0.0 108.85 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -55.13 168.89 0.28 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.864 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' OG ' ' A' ' 58' ' ' SER . . . -92.31 0.42 57.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -161.38 142.96 11.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.444 -0.785 . . . . 0.0 108.947 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.57 -37.44 78.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.492 -0.755 . . . . 0.0 111.222 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -89.72 -0.25 57.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.877 -1.139 . . . . 0.0 111.005 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 11.3 tp10 -63.24 89.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.853 -1.155 . . . . 0.0 109.749 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -89.4 177.0 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.347 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.84 -8.1 56.7 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 108.901 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.51 -19.39 29.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.462 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 40.7 t0 -59.43 111.44 1.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -44.88 -17.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 6.2 m120 -132.31 100.49 5.02 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -94.46 120.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 108.78 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.5 t -108.16 115.15 29.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.5 -0.75 . . . . 0.0 109.165 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.55 166.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.2 132.54 34.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.79 148.47 19.99 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.434 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.2 m-70 -72.31 168.06 19.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.28 88.57 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.0 109.352 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.644 ' N ' ' HG1' ' A' ' 73' ' ' THR . 15.7 m-85 -88.19 102.5 14.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 109.233 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.09 -29.93 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.32 -0.862 . . . . 0.0 110.094 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.29 12.4 6.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ASN . 23.5 ttm-85 -151.33 77.39 7.42 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.528 -0.732 . . . . 0.0 109.51 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.64 32.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 123.31 2.673 . . . . 0.0 113.319 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' ARG . 19.7 m-80 -149.41 61.11 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 0.0 108.376 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -130.94 -153.47 0.56 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 109.78 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -69.61 -83.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 111.715 -178.482 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 62' ' ' HIS . 28.5 t80 -93.56 -11.64 31.39 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.212 -0.93 . . . . 0.0 110.298 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.644 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 89.5 m -37.45 -40.71 0.39 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.671 . . . . 0.0 111.124 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.8 m120 -94.48 -21.61 18.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.131 -0.981 . . . . 0.0 111.605 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mt -53.42 -26.08 18.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.392 -1.443 . . . . 0.0 108.263 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 73' ' ' THR . 9.5 ptpt -75.53 -18.97 59.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -82.09 -14.41 55.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.15 -165.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -163.96 164.7 23.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.169 -0.957 . . . . 0.0 109.422 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -52.39 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 155.66 -26.83 0.59 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 p -63.07 117.83 7.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.352 -1.087 . . . . 0.0 108.252 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.0 mtp -70.91 179.26 2.77 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.008 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.8 t -145.17 111.65 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -93.89 106.33 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.272 -0.892 . . . . 0.0 110.072 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -94.7 112.5 24.24 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -89.44 151.92 21.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 111.111 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 90' ' ' ASN . 5.9 t -145.71 45.64 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.36 -80.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -53.08 -30.93 38.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.403 -1.057 . . . . 0.0 111.1 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -170.93 167.49 7.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.725 -1.234 . . . . 0.0 109.665 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 t -131.2 134.22 46.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.501 -0.749 . . . . 0.0 110.183 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.58 175.25 6.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.625 -0.672 . . . . 0.0 109.276 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -144.57 144.94 31.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.108 -0.995 . . . . 0.0 109.566 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 17.2 m-85 -131.56 177.19 7.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.439 -0.788 . . . . 0.0 108.926 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -133.71 104.32 6.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 109.601 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.9 mmt -48.59 120.03 3.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.35 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -161.82 28.81 0.12 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.289 -0.882 . . . . 0.0 109.42 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 7.7 m -165.58 133.33 2.99 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.8 mt -140.19 130.75 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.279 -0.888 . . . . 0.0 108.674 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 103' ' ' VAL . 19.0 mmm-85 -110.6 13.95 22.48 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.58 -0.7 . . . . 0.0 109.94 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 141' ' ' ILE . 73.6 m-20 -42.3 -20.01 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.407 -0.808 . . . . 0.0 109.578 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 101' ' ' ARG . 53.0 t -68.55 159.66 5.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -48.14 152.62 1.42 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 108.838 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -34.92 94.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.474 2.116 . . . . 0.0 112.403 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.534 ' OG1' ' NE ' ' A' ' 101' ' ' ARG . 6.4 p -71.85 -27.89 63.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.443 -0.785 . . . . 0.0 109.655 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 109' ' ' GLY . 27.2 t70 -139.96 140.38 36.32 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 m -67.99 43.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.045 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -146.64 54.46 0.54 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 m -66.49 -19.54 25.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.039 -1.271 . . . . 0.0 108.094 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 mt -139.49 59.82 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.533 ' OD2' ' NE2' ' A' ' 114' ' ' GLN . 9.8 p-10 -91.44 -135.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 109.217 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 112' ' ' ASP . 10.6 pt-20 -163.9 16.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 110.058 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.533 ' NE2' ' OD2' ' A' ' 112' ' ' ASP . 1.9 pm0 -153.4 18.48 0.55 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 110.45 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HZ2' ' NH1' ' A' ' 101' ' ' ARG . 7.8 mtpm? -78.44 166.41 22.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.991 -1.068 . . . . 0.0 110.226 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.22 -112.4 3.87 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -158.04 -54.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.645 -0.915 . . . . 0.0 109.942 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.484 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 70.7 m-20 -118.91 169.88 9.5 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 118' ' ' ASP . 34.2 ttmt -39.66 137.24 0.89 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.485 -0.759 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.75 155.6 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.274 -0.891 . . . . 0.0 109.202 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.4 mt -103.88 115.91 31.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.441 -0.787 . . . . 0.0 110.185 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.8 m -93.95 87.04 5.23 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.953 -1.092 . . . . 0.0 108.547 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.25 154.78 38.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.9 mt -140.02 140.98 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.467 -0.771 . . . . 0.0 108.973 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.3 p -94.24 162.13 13.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 109.493 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.479 ' SG ' ' CD1' ' A' ' 136' ' ' TRP . 51.3 m -146.9 137.11 23.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -173.3 134.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.123 -0.986 . . . . 0.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 55.09 69.63 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 108.916 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -62.28 122.11 14.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.04 -1.038 . . . . 0.0 109.844 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -84.99 122.42 29.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.1 -1.0 . . . . 0.0 109.355 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -86.03 5.89 31.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.294 -0.879 . . . . 0.0 109.749 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -79.93 -57.84 3.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 p -96.47 -4.27 41.89 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.232 -0.918 . . . . 0.0 109.354 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.53 46.86 53.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.66 155.42 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -1.116 . . . . 0.0 109.509 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CD1' ' SG ' ' A' ' 126' ' ' CYS . 65.1 m95 -63.13 112.15 2.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.198 -0.939 . . . . 0.0 108.651 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 136' ' ' TRP . 72.3 tt0 -39.03 -82.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.277 0.561 . . . . 0.0 110.037 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -77.45 120.67 22.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -134.98 137.13 42.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.339 -0.851 . . . . 0.0 109.827 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -140.5 134.33 30.51 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 15.3 mm -99.39 127.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.758 0.79 . . . . 0.0 111.22 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.528 ' CE1' ' OD2' ' A' ' 102' ' ' ASP . 27.5 m-85 -129.99 154.52 47.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 p -161.88 151.3 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.223 -1.548 . . . . 0.0 111.853 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.39 175.92 7.84 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -138.16 142.38 40.08 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 10.1 tp10 -60.78 137.17 58.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.773 . . . . 0.0 109.192 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 4.6 m -91.59 176.5 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.397 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.316 179.993 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mmm . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.268 0.556 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -86.89 173.85 9.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 109.55 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.54 71.46 0.76 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.331 -0.855 . . . . 0.0 109.185 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -133.18 65.32 72.94 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 109.728 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.22 -156.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.544 2.163 . . . . 0.0 112.049 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.29 104.14 3.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.054 -1.029 . . . . 0.0 110.275 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 mt -150.29 95.15 3.6 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.51 166.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.626 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -113.41 -13.25 12.88 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 105.02 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.157 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -56.44 -11.08 1.1 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.838 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m -102.48 30.72 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.317 -0.864 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 143.51 33.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.325 -0.859 . . . . 0.0 109.205 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.9 t -60.06 150.95 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.91 12.04 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.72 168.44 29.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.54 119.66 6.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.03 -1.277 . . . . 0.0 109.51 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.9 tt -99.05 141.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -146.2 136.27 23.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.18 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.3 mt -144.1 125.69 8.11 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 23' ' ' ALA . 74.4 Cg_endo -75.15 -41.26 0.66 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.633 1.555 . . . . 0.0 111.494 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.25 -15.42 0.37 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -0.878 . . . . 0.0 109.203 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . . . -137.81 15.46 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.808 . . . . 0.0 109.835 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 4.1 p-10 44.57 50.17 8.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.092 -1.005 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.6 mm -92.25 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.82 0.819 . . . . 0.0 109.983 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -169.65 82.74 0.12 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -142.69 150.3 53.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 0.0 110.68 -177.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.78 165.05 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.848 2.365 . . . . 0.0 113.04 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.8 t -126.91 122.32 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.626 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 7.6 m-85 -82.59 150.36 62.84 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.007 -1.058 . . . . 0.0 110.247 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.87 100.04 1.36 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 111.681 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.26 178.78 45.37 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.616 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 72.9 Cg_endo -76.49 118.81 5.0 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.755 2.304 . . . . 0.0 111.029 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.49 88.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.453 0.644 . . . . 0.0 110.572 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.4 p -113.67 152.43 45.47 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -40.21 10.91 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.124 1.883 . . . . 0.0 111.945 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -62.24 -20.06 63.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.098 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.626 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 7.3 tp60 -96.04 -63.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -45.05 -15.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 0.0 110.275 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.6 m-20 -62.55 -25.14 67.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.429 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 25.2 mtt-85 -88.13 -12.0 45.32 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.09 -135.93 4.78 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.408 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.18 160.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -1.021 . . . . 0.0 109.619 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -151.42 152.68 33.4 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 50.4 m-85 -60.32 167.95 2.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.197 . . . . 0.0 109.745 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.16 -8.35 59.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.448 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -152.85 150.95 29.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -62.77 -35.82 81.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.563 -0.71 . . . . 0.0 111.102 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.65 16.42 6.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.99 -1.069 . . . . 0.0 110.905 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.535 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 14.5 tm-20 -63.23 98.44 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 109.84 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.523 ' C ' ' H ' ' A' ' 53' ' ' ASP . 1.4 p -95.38 141.74 28.59 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.417 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -61.16 -3.73 0.93 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.756 -1.215 . . . . 0.0 107.881 179.422 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 51' ' ' SER . 23.1 m-20 -91.56 -17.7 25.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.594 -0.691 . . . . 0.0 109.861 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 38.6 p-10 -60.64 116.99 4.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.861 -1.149 . . . . 0.0 109.576 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.693 HE22 ' HZ2' ' A' ' 115' ' ' LYS . 7.5 pt20 -45.63 -15.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 38.2 t30 -132.6 108.58 9.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 109.673 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.0 mt -98.61 117.52 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.504 ' H ' ' HG ' ' A' ' 58' ' ' SER . 1.9 p -108.44 114.76 28.85 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 124' ' ' ILE . 61.2 mt -105.47 167.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.438 -0.789 . . . . 0.0 109.907 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.403 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -135.07 126.65 28.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.85 152.89 23.86 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.68 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.728 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 33.2 m-70 -72.85 -170.46 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.636 -0.92 . . . . 0.0 109.275 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.17 72.0 0.1 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 5.8 m-85 -87.6 114.11 23.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.91 -18.42 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -85.18 13.92 5.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.184 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.596 ' C ' ' H ' ' A' ' 69' ' ' ASN . 59.1 mtm-85 -151.41 74.35 8.13 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.29 14.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.673 2.915 . . . . 0.0 114.023 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.596 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -150.59 62.28 0.94 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.854 -1.154 . . . . 0.0 108.334 179.289 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.444 ' CE2' ' OE1' ' A' ' 71' ' ' GLN . 41.8 t80 -149.72 99.77 2.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.728 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 5.1 mt-30 61.09 -125.49 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.513 -0.742 . . . . 0.0 111.734 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 72' ' ' PHE . 86.2 t80 -92.48 38.88 1.02 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.186 -0.946 . . . . 0.0 110.37 -178.088 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.422 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 37.1 m -81.58 -65.21 1.04 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.995 -1.066 . . . . 0.0 109.034 179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 76' ' ' LYS . 9.9 t-20 -81.18 -24.72 37.32 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.611 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.85 -3.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.913 -1.117 . . . . 0.0 108.617 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' H ' ' C ' ' A' ' 74' ' ' ASN . 46.1 mtpt -87.03 -21.47 26.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -80.78 -37.15 30.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -45.43 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' SD ' ' A' ' 97' ' ' MET . 48.3 mtmt -144.24 172.86 12.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -49.08 153.5 0.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -17.58 31.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 97.86 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.45 -1.029 . . . . 0.0 108.423 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.1 mtp -55.76 171.63 0.21 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.512 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -143.51 113.96 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.444 -0.785 . . . . 0.0 109.492 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.92 102.89 14.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 109.438 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -97.54 112.0 24.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.235 -0.916 . . . . 0.0 108.571 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -100.25 144.28 29.46 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -169.77 140.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.4 -110.68 3.54 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -137.69 45.89 2.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.475 -1.015 . . . . 0.0 109.282 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 92' ' ' THR . 3.9 tm-20 -163.66 138.83 6.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.089 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.445 ' N ' ' CD ' ' A' ' 91' ' ' GLU . 21.6 m -115.13 125.15 53.13 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.775 . . . . 0.0 109.801 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 172.43 7.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.396 -0.815 . . . . 0.0 108.863 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 17.0 pttm -141.34 150.2 42.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.278 -0.889 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 15.8 m-85 -138.96 179.39 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -134.89 107.88 7.6 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.528 -0.733 . . . . 0.0 109.885 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.446 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 31.8 ttm -49.61 128.84 18.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 108.849 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.418 ' O ' ' CG2' ' A' ' 98' ' ' THR . 73.0 m -159.23 3.56 0.09 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.752 -1.217 . . . . 0.0 110.679 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' VAL . 13.4 t -149.14 122.24 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.708 -1.245 . . . . 0.0 107.886 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.49 ' CG2' ' OD2' ' A' ' 102' ' ' ASP . 78.3 mt -140.21 156.1 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -178.085 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 102' ' ' ASP . 66.7 mtm180 -124.5 -96.11 0.46 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.49 ' OD2' ' CG2' ' A' ' 100' ' ' ILE . 2.8 p30 39.53 35.86 0.2 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.554 -0.716 . . . . 0.0 110.686 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.3 t -138.52 -83.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.231 -0.918 . . . . 0.0 108.777 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' N ' ' CD ' ' A' ' 105' ' ' PRO . 18.0 mmmt -139.99 52.77 3.85 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.285 -0.884 . . . . 0.0 109.321 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 104' ' ' LYS . 73.9 Cg_endo -72.94 -167.77 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.359 2.039 . . . . 0.0 111.488 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' VAL . 22.4 p -103.1 -13.6 16.75 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 109' ' ' GLY . 4.6 t70 66.19 -42.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' THR . 18.1 m -76.84 25.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.093 -1.004 . . . . 0.0 109.179 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -135.14 6.94 4.38 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.14 -35.17 70.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.189 -1.183 . . . . 0.0 108.506 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.15 61.27 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.548 -0.72 . . . . 0.0 109.452 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.402 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 24.2 t70 -171.25 4.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.009 -1.057 . . . . 0.0 111.024 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -179.91 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.767 -1.208 . . . . 0.0 109.453 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.566 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -103.0 9.5 38.61 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.288 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.693 ' HZ2' HE22 ' A' ' 55' ' ' GLN . 0.3 OUTLIER -59.07 -19.0 40.24 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.97 -103.44 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -149.94 -40.08 0.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.322 -1.105 . . . . 0.0 109.508 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -118.59 167.45 11.61 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.494 -0.753 . . . . 0.0 110.353 -178.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 52' ' ' LEU . 46.7 tttp -47.04 157.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.566 HE22 ' C ' ' A' ' 115' ' ' LYS . 5.7 pt20 -157.98 161.86 38.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.008 -1.058 . . . . 0.0 109.847 -178.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 50.7 mt -114.95 103.39 10.87 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.603 -0.686 . . . . 0.0 110.0 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.9 m -99.34 149.2 23.39 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 tt -141.58 157.86 44.57 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.054 -1.029 . . . . 0.0 109.757 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.458 ' N ' ' O ' ' A' ' 59' ' ' ILE . 44.9 mt -128.77 150.05 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.8 p -89.83 163.59 14.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.579 -1.325 . . . . 0.0 108.725 179.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -146.4 81.94 1.58 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.418 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 14.9 p-10 -137.48 133.97 35.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.407 -0.808 . . . . 0.0 109.127 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 69.06 62.01 0.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -62.62 126.23 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.273 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -85.89 118.56 25.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 1.36 45.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.68 -52.91 7.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.0 p -94.89 -8.28 37.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.34 41.45 52.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.04 162.56 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.24 -1.153 . . . . 0.0 109.599 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 68.2 m95 -66.29 114.87 5.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.303 -0.873 . . . . 0.0 108.674 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' TRP . 24.6 tt0 -38.96 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.264 0.555 . . . . 0.0 110.13 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -83.2 148.25 27.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -148.25 73.89 1.27 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.95 -1.094 . . . . 0.0 110.482 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -76.75 159.01 30.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.919 -1.113 . . . . 0.0 108.225 178.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.74 153.43 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.982 -1.074 . . . . 0.0 111.277 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -135.45 171.37 14.55 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 99' ' ' SER . 1.7 p -162.93 117.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.214 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -96.99 177.95 5.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -147.51 127.93 14.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.762 -1.211 . . . . 0.0 110.131 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -63.89 117.45 6.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.15 -154.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.194 -0.941 . . . . 0.0 109.087 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.799 179.934 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 18.5 mp0 -72.03 142.3 49.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -0.99 . . . . 0.0 109.264 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.87 86.64 4.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.635 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -151.9 59.91 3.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.06 -173.66 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.684 2.256 . . . . 0.0 111.919 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.87 81.43 3.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.268 -0.895 . . . . 0.0 109.7 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mt -84.23 122.5 75.58 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.54 167.26 27.54 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.257 1.305 . . . . 0.0 112.032 -179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -102.09 -12.78 17.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 12' ' ' SER . 87.1 m-20 -77.16 102.4 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.681 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -58.22 -3.79 0.29 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 10' ' ' ASP . 15.1 t -115.59 44.63 1.84 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.589 -0.694 . . . . 0.0 109.331 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -141.11 133.28 27.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.341 -0.849 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.65 107.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.616 -0.678 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.73 19.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.44 -173.55 35.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.41 126.64 9.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.008 -1.289 . . . . 0.0 109.74 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -99.22 144.6 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -150.33 131.67 14.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.874 -1.141 . . . . 0.0 110.622 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 mt -144.25 125.88 8.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.09 -41.77 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.654 1.569 . . . . 0.0 111.458 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OG ' ' A' ' 82' ' ' SER . 47.5 t0 -50.98 -16.23 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.051 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.7 15.98 3.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.431 -0.793 . . . . 0.0 109.427 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.0 p30 41.78 48.96 3.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 mm -91.64 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.63 0.729 . . . . 0.0 109.635 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -169.13 84.98 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -145.48 157.19 52.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.063 -1.023 . . . . 0.0 110.33 -177.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.32 165.24 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.85 2.367 . . . . 0.0 112.425 179.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.37 112.92 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -85.98 158.31 56.08 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 109.449 -179.289 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.09 133.87 9.04 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.463 2.109 . . . . 0.0 112.398 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.6 176.89 24.0 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.217 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.589 ' O ' ' N ' ' A' ' 35' ' ' THR . 83.1 Cg_endo -79.14 118.01 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.758 2.305 . . . . 0.0 111.119 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.44 87.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.199 0.523 . . . . 0.0 110.61 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -108.3 152.89 42.15 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.19 -42.18 37.44 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.244 1.963 . . . . 0.0 112.092 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.89 -25.86 68.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.081 -1.012 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.8 -70.11 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.492 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.1 mt -42.06 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.565 -0.709 . . . . 0.0 110.113 -179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.11 -23.52 66.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -87.11 -11.71 49.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.81 -106.44 0.29 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 11.3 t -136.02 154.73 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.483 -1.01 . . . . 0.0 109.298 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 t -149.4 156.1 41.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -57.69 173.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.734 -1.228 . . . . 0.0 109.513 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -88.58 -3.24 58.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -155.04 148.61 25.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.524 -0.735 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.62 -29.89 70.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 111.733 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -88.49 -3.79 58.75 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.707 -1.245 . . . . 0.0 111.449 -177.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.27 114.59 3.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.729 -1.232 . . . . 0.0 109.673 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -91.53 -164.69 1.21 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 2.2 mp -102.72 17.9 22.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -144.42 4.27 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' ASN . 68.5 t0 -59.53 118.89 6.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.879 -1.138 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -13.55 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.998 -1.064 . . . . 0.0 109.899 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' ASP . 4.8 t-20 -131.42 93.81 3.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.425 -0.797 . . . . 0.0 109.08 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.42 145.61 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' ALA . 1.8 p -142.89 109.36 5.36 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.8 mt -103.81 159.19 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.664 0.745 . . . . 0.0 110.657 -178.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.36 124.31 38.31 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.85 146.04 17.68 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -178.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' PHE . 20.6 m-70 -73.16 174.87 7.35 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.41 -1.053 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.71 93.56 1.58 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.389 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.416 ' N ' ' HG1' ' A' ' 73' ' ' THR . 7.1 m-85 -89.06 113.49 24.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.962 . . . . 0.0 109.074 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 mt -60.47 -34.13 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.94 17.69 2.77 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.931 . . . . 0.0 109.291 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.576 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -150.66 73.7 8.82 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 63.9 Cg_exo -52.37 23.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 123.904 3.069 . . . . 0.0 114.219 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' ARG . 27.3 m-80 -153.55 63.53 0.74 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.603 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 12.8 t80 -148.29 100.46 3.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.102 -0.999 . . . . 0.0 110.953 -178.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 13.1 mp0 54.39 -109.04 0.46 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.671 -0.643 . . . . 0.0 112.57 177.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 62' ' ' HIS . 41.6 t80 -91.59 8.9 34.44 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.331 -0.855 . . . . 0.0 111.177 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.416 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 50.9 m -56.42 -45.35 80.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.465 -1.397 . . . . 0.0 110.921 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 77' ' ' ALA . 5.7 m120 -94.31 -22.09 18.58 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.04 -1.038 . . . . 0.0 111.498 -177.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -50.37 -36.82 34.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 108.777 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -60.72 -18.26 53.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -86.12 -23.78 26.5 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.331 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.52 167.61 5.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.412 -0.805 . . . . 0.0 110.0 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.557 ' H ' ' HG ' ' A' ' 82' ' ' SER . 56.4 mttm -149.66 175.67 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.86 158.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.86 -29.24 3.81 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.557 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 61.3 m -62.17 103.74 0.41 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.293 -1.122 . . . . 0.0 108.237 179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.4 mtp -63.36 176.11 0.87 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.777 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.4 t -144.15 114.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.482 -0.761 . . . . 0.0 109.17 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -93.64 107.29 19.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.22 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -94.99 113.9 25.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -85.69 151.04 24.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 110.644 -178.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.6 t -153.94 116.71 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.16 -102.86 0.05 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.02 34.98 4.87 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.545 -0.973 . . . . 0.0 109.499 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.84 119.89 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 108.797 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.6 t -111.2 132.87 53.98 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.52 -0.737 . . . . 0.0 110.253 -179.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -96.9 179.71 4.86 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.544 -0.723 . . . . 0.0 109.528 179.594 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -144.93 142.47 29.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 22.7 m-85 -128.82 178.92 6.02 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -135.32 110.36 8.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.275 -0.891 . . . . 0.0 109.755 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.7 mmt -52.13 118.43 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -151.05 31.21 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 109.717 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 t -164.89 86.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.028 -1.045 . . . . 0.0 109.338 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.27 135.72 24.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.477 ' NH1' ' CD ' ' A' ' 113' ' ' GLU . 33.0 mtp180 -134.0 -10.45 2.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.334 -0.854 . . . . 0.0 109.581 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.519 ' OD2' ' CZ ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER -43.83 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 179.606 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.517 ' C ' ' O ' ' A' ' 102' ' ' ASP . 9.7 p 22.37 61.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-O 121.49 0.662 . . . . 0.0 111.573 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 103' ' ' VAL . 31.2 mtmt 61.95 137.81 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.369 -0.832 . . . . 0.0 109.045 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -37.16 112.49 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.154 1.903 . . . . 0.0 112.832 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 107' ' ' ASP . 17.5 p -80.82 -59.96 2.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 108.909 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 109' ' ' GLY . 54.9 m-20 -146.12 147.25 31.36 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.95 42.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.189 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -111.97 52.06 0.66 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.7 m -65.34 -24.25 34.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.054 -1.262 . . . . 0.0 107.792 179.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.15 66.54 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.669 ' N ' HE21 ' A' ' 114' ' ' GLN . 24.0 t70 -175.15 26.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.477 ' CD ' ' NH1' ' A' ' 101' ' ' ARG . 18.0 pt-20 -163.19 29.19 0.09 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.669 HE21 ' N ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -139.54 14.06 2.55 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.612 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 116' ' ' GLY . 86.9 mttt -97.69 28.88 3.59 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 115' ' ' LYS . . . -48.69 -95.77 0.01 OUTLIER Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -154.76 -27.6 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -1.181 . . . . 0.0 110.882 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -101.08 143.68 30.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.072 -1.017 . . . . 0.0 110.07 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -47.66 139.27 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 7.8 pt20 -151.61 158.61 43.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.007 -1.058 . . . . 0.0 110.099 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.22 157.42 20.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.461 0.648 . . . . 0.0 110.214 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.2 m -139.22 88.34 2.26 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.89 147.08 52.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.523 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.8 mt -139.42 141.01 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -94.18 159.42 15.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.94 -1.1 . . . . 0.0 109.181 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -147.84 100.52 3.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -152.41 144.53 23.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.0 t0 60.53 58.7 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.07 119.41 8.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 11.1 p30 -86.96 124.04 32.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.066 -1.021 . . . . 0.0 109.988 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.9 14.22 10.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -71.5 -31.47 67.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -0.859 . . . . 0.0 109.163 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.2 p -140.64 3.2 1.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.36 53.1 6.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.4 t -146.95 159.42 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.087 -1.243 . . . . 0.0 109.912 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.551 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 70.6 m95 -72.77 116.1 12.86 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.239 -0.913 . . . . 0.0 108.626 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' TRP . 30.2 tt0 -40.29 -83.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.737 -0.602 . . . . 0.0 109.991 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.85 165.1 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 108.474 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.532 ' NE ' ' O ' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -167.08 76.61 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.904 -1.122 . . . . 0.0 110.12 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -88.97 156.88 18.61 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.8 pt -145.98 146.77 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.925 -1.11 . . . . 0.0 111.629 -178.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.519 ' CZ ' ' OD2' ' A' ' 102' ' ' ASP . 27.5 m-85 -128.98 165.98 20.07 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 78.3 t -149.14 143.61 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.653 -1.279 . . . . 0.0 110.339 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.75 163.94 30.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.2 t -140.91 141.14 34.58 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.07 -1.019 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.42 113.69 3.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t -93.85 177.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 108.821 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 73.8 mttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.437 179.922 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.6 mtm . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.344 0.593 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -74.0 112.89 10.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.267 -0.895 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.3 -175.22 1.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -0.959 . . . . 0.0 109.199 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.525 ' HZ2' HD22 ' A' ' 49' ' ' ASN . 94.1 mttt -45.24 107.62 0.67 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.369 -0.832 . . . . 0.0 109.757 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 4' ' ' LYS . 74.9 Cg_exo -49.81 -166.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.043 1.829 . . . . 0.0 112.682 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -80.81 105.43 12.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.067 -1.021 . . . . 0.0 110.06 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 mm -85.0 114.76 57.77 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -42.75 121.34 2.14 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.708 1.606 . . . . 0.0 112.31 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -66.13 -32.59 74.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 12' ' ' SER . 9.7 m-20 -76.87 111.4 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -60.87 -0.95 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.0 179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.6 t -111.21 42.75 1.59 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -142.92 133.38 24.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 t -58.75 120.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.44 -0.787 . . . . 0.0 111.263 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.12 -9.63 27.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.22 140.35 3.15 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.44 125.22 38.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -1.213 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 tp -95.29 143.04 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -148.07 138.81 23.07 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.712 -1.242 . . . . 0.0 110.936 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.0 mt -149.84 128.32 5.99 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.12 -44.06 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.825 1.683 . . . . 0.0 112.241 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -50.2 -28.3 7.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -113.4 7.07 17.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p30 43.54 30.25 0.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 109.888 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.12 145.2 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.102 0.953 . . . . 0.0 109.795 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -163.02 87.97 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -138.1 159.95 66.22 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.592 -0.693 . . . . 0.0 110.952 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.52 159.19 35.97 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.982 2.455 . . . . 0.0 113.229 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -135.64 98.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.52 170.74 14.68 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.119 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.46 164.21 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.072 1.848 . . . . 0.0 112.048 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.67 171.92 13.05 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.7 Cg_endo -78.56 120.37 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.758 2.305 . . . . 0.0 111.187 179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -41.6 87.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.235 0.54 . . . . 0.0 110.643 -179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.7 p -108.57 123.56 36.93 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.26 -43.57 7.74 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.804 1.669 . . . . 0.0 112.257 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.73 -16.49 61.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.081 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.563 HE21 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -97.07 -69.51 0.75 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.417 -0.802 . . . . 0.0 109.702 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.563 ' N ' HE21 ' A' ' 38' ' ' GLN . 22.5 mt -45.01 -18.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 109.796 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 38' ' ' GLN . 16.5 m-20 -62.15 -24.87 67.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -83.2 -13.7 54.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.69 -124.23 1.35 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.64 159.34 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.575 -0.956 . . . . 0.0 109.963 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.496 ' CB ' HE22 ' A' ' 38' ' ' GLN . 6.9 p -161.66 164.93 28.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 108.937 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.87 162.32 5.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.604 -1.31 . . . . 0.0 109.205 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -83.21 -9.09 59.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.387 -0.82 . . . . 0.0 109.366 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.53 144.31 29.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.147 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.98 -25.99 68.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.525 HD22 ' HZ2' ' A' ' 4' ' ' LYS . 65.3 t30 -87.8 3.9 46.44 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.917 -1.114 . . . . 0.0 110.677 -178.299 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.447 ' C ' ' HG ' ' A' ' 51' ' ' SER . 6.0 tp10 -64.93 157.59 27.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.339 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 50' ' ' GLU . 17.3 m -148.0 -179.84 7.2 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.559 ' H ' ' CD1' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -91.11 17.19 8.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 13.0 p-10 -141.16 -0.73 1.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.492 -0.755 . . . . 0.0 110.178 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' ASN . 48.6 t0 -57.89 114.58 2.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.733 -1.229 . . . . 0.0 108.998 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 113' ' ' GLU . 5.4 pt20 -43.07 -20.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.439 -0.788 . . . . 0.0 109.479 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.3 p-10 -134.96 104.09 5.83 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.43 156.06 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 46' ' ' ALA . 50.7 p -141.66 102.08 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 109.133 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.458 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 94.8 mt -97.98 162.03 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -145.08 134.18 22.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.44 158.77 27.61 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.754 -1.213 . . . . 0.0 110.209 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 72' ' ' PHE . 10.7 m-70 -71.49 -179.84 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.952 . . . . 0.0 109.913 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.79 80.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' N ' ' HG1' ' A' ' 73' ' ' THR . 7.8 m-85 -87.94 107.53 18.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 109.118 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.3 mt -58.46 -29.35 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 110.141 -179.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.36 12.63 5.18 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.791 . . . . 0.0 109.429 -178.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 69' ' ' ASN . 96.6 mtt180 -150.76 64.55 6.48 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -40.14 -19.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.701 2.268 . . . . 0.0 112.534 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' ARG . 28.6 p30 -98.29 28.72 3.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.605 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.9 t80 -89.68 -153.69 0.29 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.851 -1.156 . . . . 0.0 109.754 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -72.88 -96.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.619 -0.676 . . . . 0.0 111.322 -178.731 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.4 t80 -91.63 37.11 0.95 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.765 . . . . 0.0 110.327 -177.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.612 ' HG1' ' N ' ' A' ' 64' ' ' PHE . 53.0 m -77.37 -49.04 15.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.859 -1.151 . . . . 0.0 109.706 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 77' ' ' ALA . 19.1 m-20 -93.79 -19.99 20.51 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.644 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.93 -29.18 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.804 -1.185 . . . . 0.0 108.869 -179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -80.6 -6.71 58.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 108.287 179.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -83.68 -21.0 32.54 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -55.71 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -0.756 . . . . 0.0 109.396 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -155.13 152.95 30.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 108.708 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -50.14 108.08 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 109.678 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.44 -16.37 3.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.5 m -66.5 -172.73 0.17 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -1.157 . . . . 0.0 108.355 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.9 mmm -129.34 176.79 7.67 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.12 108.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 109.242 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -95.49 105.81 17.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 110.389 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -94.98 111.74 23.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -107.15 143.87 34.71 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.28 -0.887 . . . . 0.0 110.997 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -168.13 129.57 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.541 -0.725 . . . . 0.0 109.531 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 -105.53 1.6 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.31 22.16 2.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.321 -1.105 . . . . 0.0 109.218 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.27 138.73 35.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -119.91 138.94 53.13 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.677 0.751 . . . . 0.0 110.721 -179.031 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.42 170.68 9.76 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -146.57 128.52 15.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.126 -0.983 . . . . 0.0 110.385 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -128.41 172.74 10.83 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 98' ' ' THR . 16.5 ttpt -141.85 117.24 10.19 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.17 -0.956 . . . . 0.0 108.941 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 51.3 mtt -50.61 89.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.517 -0.74 . . . . 0.0 109.478 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -118.89 25.71 10.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 98' ' ' THR . 6.1 m -174.41 138.14 0.53 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 100' ' ' ILE . 58.6 mt -140.77 129.62 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.535 ' O ' ' N ' ' A' ' 103' ' ' VAL . 82.5 mtm180 -104.9 0.8 28.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.53 -0.731 . . . . 0.0 109.671 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -66.17 55.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.362 -0.836 . . . . 0.0 109.023 179.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 101' ' ' ARG . 72.8 t -154.87 -75.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.438 -0.789 . . . . 0.0 108.896 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -117.92 60.96 3.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 106' ' ' THR . 13.4 Cg_endo -55.29 88.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.903 1.736 . . . . 0.0 111.84 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 105' ' ' PRO . 3.8 m -166.59 40.24 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.463 -0.773 . . . . 0.0 108.987 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -74.46 -146.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 109.635 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.29 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.845 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 138.78 132.93 3.01 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 t -67.92 -36.45 75.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.316 -1.108 . . . . 0.0 108.341 179.327 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.4 mt -138.25 73.56 1.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.484 ' CG ' HE21 ' A' ' 114' ' ' GLN . 0.5 OUTLIER -93.45 136.47 33.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.174 -0.954 . . . . 0.0 108.949 -179.659 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.668 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 2.1 pm0 -93.95 18.37 10.65 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.668 ' NE2' ' H ' ' A' ' 113' ' ' GLU . 1.6 pm0 -146.76 31.39 0.96 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' GLN . 25.3 mmtp -38.97 -61.32 0.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.771 -0.581 . . . . 0.0 110.288 -179.395 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.44 -4.53 4.08 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -95.64 -145.27 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.156 -1.202 . . . . 0.0 109.554 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.556 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.7 m-20 -119.25 165.75 13.85 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.556 ' C ' ' O ' ' A' ' 118' ' ' ASP . 4.4 mmmt -21.23 131.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 CA-C-N 118.662 0.664 . . . . 0.0 110.34 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -135.69 179.95 6.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.909 -176.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.91 107.41 4.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.075 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 m -94.27 129.96 40.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.47 149.71 29.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.873 . . . . 0.0 109.209 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.4 mt -142.36 140.5 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 109.125 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -93.57 167.36 11.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.929 -1.107 . . . . 0.0 108.6 178.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.8 m -146.27 128.69 15.92 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.026 -1.047 . . . . 0.0 109.794 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -174.69 131.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.081 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 62.78 67.18 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.522 -0.736 . . . . 0.0 109.117 -179.824 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.09 128.41 35.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.943 -1.098 . . . . 0.0 109.51 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 10.4 t-20 -85.18 114.34 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 109.457 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.95 -3.09 58.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.849 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 51.2 mtmt -81.65 -46.56 14.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.6 p -96.13 -17.2 21.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 109.298 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.3 36.72 23.24 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.99 158.5 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -1.159 . . . . 0.0 109.528 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLU . 64.0 m95 -61.1 112.09 1.96 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.161 -0.962 . . . . 0.0 108.553 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.2 tp10 -39.01 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.163 0.506 . . . . 0.0 110.37 -179.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.39 150.8 19.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 0.0 109.087 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -172.75 156.94 3.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.984 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -130.11 162.95 27.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.03 130.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.466 -0.771 . . . . 0.0 111.273 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 -123.22 165.29 17.16 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.29 147.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.732 -1.23 . . . . 0.0 110.507 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.06 141.1 31.19 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 147' ' ' VAL . 12.0 t -98.68 146.52 25.78 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.244 -0.91 . . . . 0.0 109.918 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.46 34.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.607 ' H ' ' C ' ' A' ' 145' ' ' THR . 2.2 t -148.0 -138.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.037 -1.039 . . . . 0.0 109.016 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.51 ' CA ' ' HZ2' ' A' ' 96' ' ' LYS . 66.8 mttm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.296 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.4 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' C ' ' H ' ' A' ' 4' ' ' LYS . 17.5 mm100 -74.55 127.95 34.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.656 -179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.05 44.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.098 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 2' ' ' GLN . 58.3 tttm -152.12 59.4 3.04 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 109.213 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.19 -168.66 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.679 2.252 . . . . 0.0 111.868 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -88.02 78.71 8.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.241 -0.912 . . . . 0.0 109.996 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt -87.36 113.35 53.56 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.322 -0.861 . . . . 0.0 108.962 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.52 129.68 11.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.53 1.487 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -79.0 -18.92 52.8 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.054 -1.029 . . . . 0.0 108.971 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 12' ' ' SER . 28.1 t0 -78.15 101.43 7.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -58.29 -2.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.0 109.806 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 10' ' ' ASP . 12.6 t -108.95 40.52 1.8 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.458 -0.776 . . . . 0.0 109.578 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -146.46 139.91 25.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.16 119.41 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.858 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.71 -17.12 21.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.71 -169.18 34.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.45 121.69 8.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.312 -1.11 . . . . 0.0 109.041 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.53 143.02 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.39 134.51 22.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.006 -1.059 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.4 mt -145.04 126.55 7.77 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 23' ' ' ALA . 72.1 Cg_endo -76.68 -43.24 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.559 1.506 . . . . 0.0 111.375 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 15.7 t0 -53.58 -12.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.354 -0.841 . . . . 0.0 109.124 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -133.45 11.02 4.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.0 109.336 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 p30 41.89 34.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.633 -0.667 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -91.29 144.86 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.543 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -165.76 83.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -140.37 160.27 60.27 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 111.128 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.53 164.91 25.69 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 123.026 2.484 . . . . 0.0 113.0 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.59 107.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -72.56 155.59 90.94 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.821 -1.174 . . . . 0.0 109.515 -179.499 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.5 118.93 1.93 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.139 1.893 . . . . 0.0 111.668 178.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.3 -174.76 41.84 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.22 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 35' ' ' THR . 97.9 Cg_endo -80.7 117.63 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.77 2.313 . . . . 0.0 111.331 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -47.89 85.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.311 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.1 p -104.64 153.96 38.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 37.6 Cg_endo -65.57 -45.18 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.95 1.766 . . . . 0.0 111.616 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.43 -27.65 69.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.312 -0.868 . . . . 0.0 110.271 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.7 OUTLIER -82.73 -65.34 1.02 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.308 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' N ' ' NE2' ' A' ' 38' ' ' GLN . 17.5 mt -44.74 -17.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.9 m120 -58.23 -28.95 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.1 mtt180 -83.51 -15.35 49.73 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 160.25 -137.62 5.12 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.4 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.98 160.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.504 -0.998 . . . . 0.0 110.269 -178.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 t -155.75 156.66 35.22 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -56.29 171.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.591 -1.318 . . . . 0.0 109.38 -179.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -84.33 -9.06 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.597 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -151.77 145.57 25.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.569 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.99 -26.74 68.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.707 . . . . 0.0 110.972 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.638 HD21 ' N ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -86.57 1.08 52.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.856 -1.152 . . . . 0.0 109.886 -179.061 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.638 ' N ' HD21 ' A' ' 49' ' ' ASN . 9.4 tp10 -64.16 150.26 46.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.647 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 53' ' ' ASP . 51.8 p -147.48 159.77 43.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.401 ' HB2' HH12 ' A' ' 93' ' ' ARG . 0.4 OUTLIER -71.54 4.31 3.19 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' SER . 25.9 m-20 -112.57 -7.49 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t0 -60.32 114.02 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.003 -1.061 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.717 HE22 HE21 ' A' ' 120' ' ' GLN . 0.4 OUTLIER -47.72 -17.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 109.036 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.3 t-20 -133.04 104.74 6.68 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -95.05 150.66 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.1 p -144.41 115.21 7.77 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 78.5 mt -110.53 164.47 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.828 0.823 . . . . 0.0 110.629 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.422 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -141.92 139.15 32.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.66 153.36 25.12 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.895 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.724 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 20.7 m-70 -72.54 177.02 4.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.714 -0.874 . . . . 0.0 109.48 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.82 82.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.968 . . . . 0.0 109.416 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.461 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 10.3 m-85 -89.59 118.79 29.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.26 -0.9 . . . . 0.0 109.348 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mm -60.76 -23.05 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -0.817 . . . . 0.0 110.161 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -86.59 14.2 7.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.607 ' C ' ' H ' ' A' ' 69' ' ' ASN . 39.3 mtm-85 -150.76 74.36 8.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.569 -0.707 . . . . 0.0 109.243 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.13 13.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 123.403 2.735 . . . . 0.0 113.617 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.607 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -147.64 60.95 1.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 108.465 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -146.24 102.1 3.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.1 -1.0 . . . . 0.0 110.838 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.724 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 7.3 mt-30 58.46 -115.13 0.8 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.724 -0.61 . . . . 0.0 112.038 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.3 m-85 -95.17 19.36 10.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.097 -1.002 . . . . 0.0 110.938 -177.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -59.94 -20.11 55.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.422 -1.424 . . . . 0.0 109.492 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' ALA . 7.0 m-20 -121.92 -18.41 7.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 109.834 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 77' ' ' ALA . 2.4 tm? -53.51 -39.24 64.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.894 -1.129 . . . . 0.0 108.287 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -65.27 -3.19 3.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 75' ' ' LEU . . . -96.89 -29.37 13.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.01 -177.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.44 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.422 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -160.27 179.09 8.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.375 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.548 ' CB ' ' HZ1' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -49.58 149.9 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 109.104 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.81 -13.45 24.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 39.3 m -61.96 100.26 0.15 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.412 -1.052 . . . . 0.0 108.349 179.448 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mmm -67.35 170.07 7.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.669 -179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 t -145.16 110.95 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 109.194 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.19 108.45 19.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.826 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -94.71 111.9 23.65 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -100.74 146.24 27.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 t -132.93 167.64 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.654 -0.653 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' C ' ' ND2' ' A' ' 90' ' ' ASN . . . -45.23 -32.88 3.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.4 ' ND2' ' C ' ' A' ' 89' ' ' GLY . 7.2 m-80 -153.97 47.62 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.913 -1.345 . . . . 0.0 110.274 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -171.95 121.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.064 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.6 t -125.1 125.93 44.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.401 HH12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.37 175.51 9.22 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.545 -0.722 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -145.38 132.74 20.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.176 -0.953 . . . . 0.0 110.24 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.463 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 13.1 m-85 -102.93 -177.15 3.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.489 -0.757 . . . . 0.0 108.967 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -141.56 110.74 6.3 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.37 -0.831 . . . . 0.0 109.349 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.6 tpp -48.37 114.47 0.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -146.47 26.25 1.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 108.703 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 m -170.24 124.11 0.72 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 84.3 mt -138.34 146.71 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 0.0 109.841 -179.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.531 ' C ' ' H ' ' A' ' 103' ' ' VAL . 9.9 mpt_? -121.82 -29.21 4.35 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 50.11 10.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.781 . . . . 0.0 109.006 -179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 101' ' ' ARG . 70.0 t -155.4 113.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 30.8 tttm -55.11 -60.43 8.17 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.968 -1.083 . . . . 0.0 109.533 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 34.1 Cg_endo -61.55 78.1 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 122.15 1.9 . . . . 0.0 111.873 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.78 -73.41 0.6 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 109' ' ' GLY . 7.1 m-20 -84.22 -176.89 6.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 108.718 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.4 m -74.38 29.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.015 -1.053 . . . . 0.0 109.012 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 133.48 109.01 1.09 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.23 -23.84 32.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.189 -1.183 . . . . 0.0 108.373 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 mt -138.13 81.33 1.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 32.0 t0 -163.68 -20.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.081 -1.012 . . . . 0.0 110.97 -179.488 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -174.7 57.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 109.125 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 109' ' ' GLY . 2.4 mp0 -148.84 19.21 1.01 Allowed 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -85.32 9.27 15.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.835 -178.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.39 17.5 58.3 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -96.05 -138.79 0.25 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.123 -1.222 . . . . 0.0 109.338 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.0 t0 -116.2 145.94 42.71 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 118' ' ' ASP . 20.5 tptt -17.11 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 122.361 1.077 . . . . 0.0 111.153 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.717 HE21 HE22 ' A' ' 55' ' ' GLN . 13.2 mt-30 -93.76 173.61 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.106 -177.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.95 98.31 2.43 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.3 m -92.09 91.73 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.4 147.34 48.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.001 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.518 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 47.0 mt -136.97 149.32 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.325 -0.86 . . . . 0.0 109.782 -179.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.23 158.81 15.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.0 137.87 23.82 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.927 -1.108 . . . . 0.0 109.603 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.3 t0 178.39 138.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 6.4 t0 65.1 60.09 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -64.59 121.78 15.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.161 -0.962 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 12.1 p30 -85.55 126.72 34.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.934 -1.104 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.06 6.11 41.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 109.471 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -76.68 -58.81 3.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.33 -0.856 . . . . 0.0 109.118 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 48.8 p -97.87 -4.37 36.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.365 -0.834 . . . . 0.0 109.245 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.04 46.99 33.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.7 t -146.91 167.27 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -1.1 . . . . 0.0 109.459 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 137' ' ' GLU . 70.4 m95 -72.32 113.63 9.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.194 -0.941 . . . . 0.0 108.944 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' TRP . 36.9 tt0 -36.25 -63.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.114 0.483 . . . . 0.0 110.733 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.2 149.85 44.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 109.163 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -173.96 139.63 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.746 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.53 -179.58 6.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.862 . . . . 0.0 109.21 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 141' ' ' ILE . 7.0 tt -151.31 144.7 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 8.9 m-85 -137.54 166.57 23.57 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 88.1 t -146.74 148.57 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.977 -1.077 . . . . 0.0 110.084 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.92 179.95 6.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.442 -0.786 . . . . 0.0 109.011 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.2 t -153.63 146.64 24.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.048 -1.032 . . . . 0.0 110.087 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.52 139.36 57.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 109.444 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.7 m -89.02 159.44 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 mttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.54 -179.988 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ttt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.61 154.39 4.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.43 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.33 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.483 ' H ' ' CD ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -45.37 107.81 0.7 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 109.454 179.933 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' LYS . 82.2 Cg_exo -47.57 -176.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.916 1.744 . . . . 0.0 112.301 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 15.8 mp0 -78.26 98.98 6.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.211 -0.931 . . . . 0.0 110.073 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 mt -84.68 114.64 56.57 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -42.14 132.73 4.6 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.76 1.64 . . . . 0.0 112.442 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -83.85 -17.44 40.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 12' ' ' SER . 54.8 m-20 -77.01 106.63 8.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.58 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.58 -5.82 0.41 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 10' ' ' ASP . 67.4 p -110.83 42.14 1.67 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -146.6 134.17 20.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 38.3 t -61.64 133.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 111.097 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.97 -7.68 24.84 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . 171.65 -168.73 41.85 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 44.3 m-85 -146.88 126.81 13.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.937 -1.331 . . . . 0.0 109.679 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.93 141.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -145.27 137.01 25.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.92 -1.112 . . . . 0.0 110.431 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.8 mt -146.67 128.77 7.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 23' ' ' ALA . 73.9 Cg_endo -75.39 -42.87 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.614 1.543 . . . . 0.0 111.403 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -54.13 -11.62 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.858 . . . . 0.0 108.959 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -131.5 6.49 4.44 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 42.19 31.72 0.27 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.648 -0.658 . . . . 0.0 109.935 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.99 147.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.061 0.934 . . . . 0.0 109.977 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -164.32 84.49 0.43 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -134.73 159.25 72.87 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.54 -0.725 . . . . 0.0 110.728 -176.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.88 159.51 15.98 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.974 2.45 . . . . 0.0 112.88 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.27 111.34 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 7.6 m-85 -74.41 148.76 86.14 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.855 -1.153 . . . . 0.0 109.765 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.72 112.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.254 1.969 . . . . 0.0 111.96 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.07 -176.12 43.27 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.472 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.7 Cg_endo -79.74 110.57 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 123.045 2.496 . . . . 0.0 111.501 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.63 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.418 0.628 . . . . 0.0 111.443 -178.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -104.18 173.25 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.992 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.22 -28.44 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.693 1.595 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.86 -35.57 80.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.48 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.618 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -81.6 -67.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 110.41 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 38' ' ' GLN . 33.5 mt -42.75 -25.14 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.059 -1.026 . . . . 0.0 110.232 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.03 -24.81 67.29 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -96.14 -17.72 20.65 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 177.57 -133.15 2.14 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.894 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.482 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.1 t -125.82 159.44 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.534 -0.98 . . . . 0.0 109.572 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.618 ' CB ' HE22 ' A' ' 38' ' ' GLN . 4.2 p -155.97 163.0 40.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.231 -0.918 . . . . 0.0 108.833 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 39.9 m-85 -59.43 169.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 109.19 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.66 -14.36 54.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -144.62 146.38 32.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.28 -0.887 . . . . 0.0 110.067 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -23.82 67.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.678 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -87.53 2.49 50.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 2.8 tm-20 -63.56 156.37 26.71 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.498 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.514 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 5.0 m -145.73 178.13 8.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.674 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -87.33 14.79 7.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 108.324 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -140.44 0.86 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.678 . . . . 0.0 109.904 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 14.3 t0 -56.77 118.7 5.16 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.823 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.682 HE22 ' N ' ' A' ' 119' ' ' LYS . 41.5 tp60 -37.52 -24.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.029 0.442 . . . . 0.0 110.322 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 54' ' ' ASP . 18.9 t-20 -133.68 117.27 16.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.354 -0.841 . . . . 0.0 108.944 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 mm -92.72 142.85 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 108.597 179.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.5 p -140.67 109.69 6.12 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 60' ' ' ALA . 90.6 mt -111.15 161.2 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.646 0.736 . . . . 0.0 110.486 -178.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 59' ' ' ILE . . . -137.8 130.41 29.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.96 154.91 25.66 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 72' ' ' PHE . 15.9 m-70 -72.61 170.45 14.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.588 -0.948 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.94 82.42 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 108.97 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.62 114.99 23.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 0.0 108.799 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.7 mt -56.68 -29.91 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 109.948 -179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.82 16.24 2.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.602 -178.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -144.49 69.43 15.41 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.536 -0.728 . . . . 0.0 109.251 179.691 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.42 17.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.068 2.512 . . . . 0.0 113.543 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.59 ' H ' ' C ' ' A' ' 67' ' ' ARG . 37.0 m-80 -148.95 62.77 1.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.926 -1.108 . . . . 0.0 108.558 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -133.3 -154.04 0.58 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 109.77 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 79.4 mt-30 -57.77 -98.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.539 -0.726 . . . . 0.0 111.19 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.7 m-85 -96.0 27.36 3.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.226 -0.921 . . . . 0.0 110.549 -178.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.2 m -65.76 -12.4 53.66 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.58 -1.325 . . . . 0.0 109.581 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' ALA . 11.4 m-20 -128.05 -20.58 3.78 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.269 -0.894 . . . . 0.0 110.47 -179.274 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.65 -33.57 55.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 108.278 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -71.44 -9.56 58.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -87.76 -24.49 23.78 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.377 0.608 . . . . 0.0 109.468 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 171.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.659 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -144.77 167.14 23.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 109.221 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -49.42 138.6 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.42 -20.96 47.01 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -62.43 100.52 0.18 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.368 -1.078 . . . . 0.0 108.119 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.28 173.17 0.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 t -143.13 113.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 109.069 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -95.15 102.6 14.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -95.71 112.08 23.88 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -96.59 152.12 18.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.236 -0.915 . . . . 0.0 111.251 -178.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG2' HH12 ' A' ' 93' ' ' ARG . 76.6 t -156.15 93.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.49 -105.83 1.09 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -118.3 38.84 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.472 -1.016 . . . . 0.0 109.577 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -146.05 108.5 4.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.915 . . . . 0.0 108.828 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.4 ' O ' ' CG2' ' A' ' 92' ' ' THR . 12.8 t -110.39 119.54 39.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.505 -0.747 . . . . 0.0 110.387 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.523 HH12 ' CG2' ' A' ' 88' ' ' VAL . 2.2 mpt_? -95.22 172.54 8.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 109.308 179.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -144.41 146.9 32.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.858 -179.661 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 95' ' ' TYR . 12.8 m-85 -137.52 177.92 7.5 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -140.63 107.69 5.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 109.721 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 81' ' ' GLY . 64.7 mtp -51.86 120.68 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -153.09 28.66 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.264 -0.897 . . . . 0.0 108.904 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.2 t -166.46 121.58 1.16 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 61.3 mt -132.21 166.27 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.444 -0.785 . . . . 0.0 110.192 -178.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.687 HH21 ' H ' ' A' ' 107' ' ' ASP . 36.5 ttm180 -141.26 -76.38 0.3 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p30 41.94 21.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.548 -0.72 . . . . 0.0 109.758 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' ARG . 1.7 p -152.37 -155.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.363 -0.835 . . . . 0.0 108.751 -179.418 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.43 ' H ' HG22 ' A' ' 103' ' ' VAL . 57.2 mttm -49.12 151.25 2.46 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.889 -1.132 . . . . 0.0 109.065 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.24 118.4 5.61 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.161 1.908 . . . . 0.0 112.169 -179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 p -80.34 -58.7 3.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.257 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.687 ' H ' HH21 ' A' ' 101' ' ' ARG . 10.8 t70 -142.62 153.96 43.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.248 -0.907 . . . . 0.0 108.853 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.3 m -69.78 37.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.926 . . . . 0.0 109.547 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -91.35 20.94 37.64 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.581 ' CG1' HH12 ' A' ' 101' ' ' ARG . 34.0 m -67.13 -41.2 86.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.211 -1.17 . . . . 0.0 108.679 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.0 mt -135.71 56.59 1.82 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' ' ND2' ' A' ' 56' ' ' ASN . 1.2 p30 -84.39 83.9 7.83 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -103.11 10.05 38.12 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -132.43 -2.57 3.44 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.852 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -165.69 -132.64 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.511 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.18 -107.63 2.38 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.804 -1.719 . . . . 0.0 108.804 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -144.05 -102.67 0.12 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.491 -1.005 . . . . 0.0 109.191 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 119' ' ' LYS . 8.0 m-20 -119.24 171.13 8.51 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.682 ' N ' HE22 ' A' ' 55' ' ' GLN . 85.6 mttt -34.89 131.31 0.38 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.69 -0.631 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.441 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -145.79 162.24 38.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.052 -1.03 . . . . 0.0 110.263 -178.443 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 12.4 mt -109.18 120.47 42.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.706 -0.621 . . . . 0.0 110.497 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m -98.35 87.37 3.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.95 140.84 49.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.413 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -138.16 131.42 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -95.8 164.92 12.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.086 -1.009 . . . . 0.0 108.695 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 97.7 m -145.77 149.06 33.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.118 -0.989 . . . . 0.0 109.873 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 0.7 OUTLIER 176.79 132.09 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.306 -0.871 . . . . 0.0 109.35 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 0.8 OUTLIER 58.7 75.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.98 126.21 26.92 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.47 117.69 24.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.039 -1.038 . . . . 0.0 109.363 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -85.63 1.9 47.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.353 -0.842 . . . . 0.0 109.686 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -80.79 -55.88 4.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.6 p -94.66 -10.72 30.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.2 41.59 21.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.77 157.34 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 109.508 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.428 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.1 m95 -61.36 113.2 2.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.167 -0.958 . . . . 0.0 108.596 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' TRP . 35.2 tt0 -35.93 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.378 0.608 . . . . 0.0 110.759 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.591 ' CB ' ' HZ1' ' A' ' 138' ' ' LYS . 7.8 ttpm? -100.33 150.95 22.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 108.95 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -173.55 144.66 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.948 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -106.37 173.2 6.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.1 mt -145.69 130.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.09 -1.007 . . . . 0.0 109.868 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -128.32 168.43 15.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.4 t -149.57 147.71 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.778 -1.201 . . . . 0.0 110.978 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.12 175.48 9.58 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -146.75 139.15 24.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.929 -1.107 . . . . 0.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 15.8 tm-20 -60.75 112.51 2.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 10.9 m -92.93 166.05 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.845 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.4 pttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.416 179.957 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 7' ' ' ILE . 9.5 mt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.6 122.46 6.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.647 1.564 . . . . 0.0 112.324 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -59.48 -7.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 12' ' ' SER . 2.6 m-20 -77.31 94.95 4.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.275 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -57.21 -5.68 0.31 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.261 -0.9 . . . . 0.0 109.793 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 10' ' ' ASP . 18.3 t -110.55 40.5 1.97 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.36 135.73 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.77 120.04 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.95 -19.98 19.1 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.28 -168.12 32.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.61 126.73 9.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.01 146.08 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' OE2' ' N ' ' A' ' 20' ' ' ILE . 8.8 tp10 -146.13 127.5 14.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.041 -1.037 . . . . 0.0 109.703 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.489 ' N ' ' OE2' ' A' ' 19' ' ' GLU . 44.7 mt -144.28 127.6 8.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.94 -46.19 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.726 1.617 . . . . 0.0 111.644 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.97 -25.33 3.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.79 9.03 10.62 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.485 -0.759 . . . . 0.0 109.397 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 42.27 38.75 1.24 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.424 0.63 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.42 HG23 ' OE1' ' A' ' 27' ' ' GLU . 4.4 mt -92.72 146.44 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.88 0.848 . . . . 0.0 109.536 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -164.64 80.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' OE1' HG23 ' A' ' 25' ' ' ILE . 3.2 mp0 -132.09 156.16 80.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.398 -0.814 . . . . 0.0 111.278 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -82.31 164.98 16.84 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.953 2.436 . . . . 0.0 112.332 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.0 127.03 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.385 -0.822 . . . . 0.0 109.066 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 4.9 m-85 -89.77 150.41 43.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.919 -1.113 . . . . 0.0 109.594 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.81 104.98 1.48 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.139 1.893 . . . . 0.0 111.605 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.08 -176.41 47.64 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.309 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' THR . 73.4 Cg_endo -79.16 117.94 3.92 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.323 . . . . 0.0 111.101 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.22 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.392 0.615 . . . . 0.0 110.455 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.587 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.8 p -105.69 153.47 39.92 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.03 -43.15 2.58 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.037 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.82 -21.41 66.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.9 OUTLIER -93.34 -62.39 1.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.0 mt -46.26 -18.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.389 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.5 m-20 -63.25 -25.28 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 89.2 mtt180 -83.27 -17.95 40.82 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 164.94 -130.92 2.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.295 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.34 165.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.574 -0.956 . . . . 0.0 109.213 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.452 ' CB ' HE22 ' A' ' 38' ' ' GLN . 3.3 t -162.09 159.1 25.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.157 -0.964 . . . . 0.0 109.065 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.94 164.85 2.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.84 -1.163 . . . . 0.0 109.396 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.79 -21.84 54.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.375 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -138.19 147.42 43.79 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.315 -0.866 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 -24.14 67.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.555 -0.716 . . . . 0.0 111.185 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -86.28 3.39 43.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.867 -1.146 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.87 161.88 20.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.048 -1.033 . . . . 0.0 109.3 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.1 m -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.759 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.5 mp -84.44 17.23 2.71 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -145.52 2.27 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.46 -0.775 . . . . 0.0 110.359 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASN . 50.7 t0 -57.29 126.49 27.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.64 -1.287 . . . . 0.0 109.292 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -42.31 -20.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.512 -0.743 . . . . 0.0 109.777 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -143.07 104.15 4.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 108.834 179.083 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.03 119.93 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.104 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.4 p -108.11 122.89 47.81 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 60' ' ' ALA . 68.9 mt -112.5 161.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.943 0.878 . . . . 0.0 110.952 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.552 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.62 125.49 25.71 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.86 153.31 21.04 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.622 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' PHE . 19.2 m-70 -74.97 167.8 21.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.737 -0.86 . . . . 0.0 109.972 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.06 87.36 1.27 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 108.913 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -87.26 117.1 25.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 65' ' ' ILE . 17.9 mt -59.85 -29.13 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.786 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.32 19.4 2.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.444 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -150.05 70.01 9.2 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.748 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.496 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.2 Cg_exo -54.38 18.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 123.236 2.624 . . . . 0.0 113.564 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 17.2 m-80 -148.94 62.31 1.05 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.07 -153.9 0.6 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.459 -0.776 . . . . 0.0 110.068 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -62.46 -89.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 111.685 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.65 ' CE1' HG22 ' A' ' 125' ' ' THR . 4.9 t80 -95.08 14.1 23.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.537 -0.727 . . . . 0.0 110.692 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 95.8 m -65.17 -49.45 69.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.4 -1.438 . . . . 0.0 110.829 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 5.0 m120 -83.1 -19.1 37.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.435 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.806 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.8 tm? -53.84 -27.94 32.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.851 -1.155 . . . . 0.0 109.059 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 20.6 mtmm -66.73 -27.83 67.94 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -71.33 -26.06 62.67 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.08 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.3 170.22 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.549 -0.719 . . . . 0.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -150.06 168.0 25.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.264 -0.897 . . . . 0.0 109.069 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 6.5 ttmm -51.32 150.98 3.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.546 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.66 -15.12 32.45 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.452 ' O ' ' SD ' ' A' ' 97' ' ' MET . 25.9 p -63.58 108.08 1.3 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.359 -1.083 . . . . 0.0 108.679 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.464 ' CE ' ' OH ' ' A' ' 85' ' ' TYR . 21.0 ptm -80.65 166.46 21.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.049 -1.032 . . . . 0.0 109.452 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.15 175.8 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.316 -0.865 . . . . 0.0 110.108 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' OH ' ' CE ' ' A' ' 83' ' ' MET . 73.8 m-85 -142.54 111.39 6.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.3 115.99 28.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -85.93 141.12 29.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.6 m -146.64 127.69 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.534 -0.729 . . . . 0.0 109.163 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.57 -115.83 2.06 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -116.16 53.92 0.85 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.606 -0.937 . . . . 0.0 109.399 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -166.84 153.4 8.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.048 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 92' ' ' THR . 9.0 t -131.09 124.9 31.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.4 6.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 7.5 ptpp? -142.92 154.8 44.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.146 -0.971 . . . . 0.0 110.042 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 4.1 m-85 -138.25 177.77 7.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -140.23 110.45 6.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.26 135.21 17.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.05 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 p -153.11 18.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 109.991 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -170.14 87.45 0.13 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.624 -1.297 . . . . 0.0 109.259 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.296 -1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.247 -179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.3 m-20 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 118' ' ' ASP . 37.5 mtmt -38.52 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -154.7 157.37 37.98 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.183 -0.948 . . . . 0.0 110.053 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.7 tp -121.82 106.73 11.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.1 m -91.16 128.03 36.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.933 -1.104 . . . . 0.0 108.785 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.3 mp -103.43 145.27 30.24 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.22 -0.925 . . . . 0.0 110.161 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.6 mt -142.58 139.97 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.374 -0.829 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.65 HG22 ' CE1' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -96.07 166.11 11.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.013 -1.054 . . . . 0.0 108.787 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.473 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -149.86 102.49 3.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.04 -1.037 . . . . 0.0 109.754 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 p-10 -156.03 148.03 23.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 0.0 109.305 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.48 56.85 2.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 108.802 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -62.05 119.0 8.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.464 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 135' ' ' VAL . 2.6 p-10 -83.92 130.63 34.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.013 -1.054 . . . . 0.0 109.694 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.75 5.52 43.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 109.061 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -71.63 -61.43 1.78 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.464 -0.773 . . . . 0.0 108.936 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -100.49 -1.42 35.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 109.342 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.85 49.72 33.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 5.1 t -146.99 168.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -1.065 . . . . 0.0 109.417 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 91.6 m95 -73.82 113.64 11.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -40.28 -77.54 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -84.36 150.49 25.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.015 . . . . 0.0 108.584 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -151.03 79.48 1.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.862 -1.149 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 125' ' ' THR . 10.8 mtpt -75.2 148.72 39.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.455 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 11.9 pt -135.87 149.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 122.12 0.962 . . . . 0.0 110.902 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -144.09 143.86 31.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 99' ' ' SER . 4.7 p -136.89 149.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.897 -1.127 . . . . 0.0 110.938 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -130.89 -178.03 4.63 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.7 t -148.05 148.54 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.002 -1.061 . . . . 0.0 109.651 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -51.11 144.03 9.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.86 . . . . 0.0 109.223 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.346 -0.846 . . . . 0.0 109.164 -179.497 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.3 mm . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 98.9 Cg_exo -42.33 150.58 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.627 1.551 . . . . 0.0 112.004 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.08 -11.52 18.8 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.13 103.0 6.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 0.0 109.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -56.5 -13.0 1.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -98.48 30.81 3.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.4 -0.812 . . . . 0.0 109.203 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.5 140.53 23.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.624 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 58.5 t -60.65 163.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.72 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.568 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -138.51 -3.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 177.34 -175.19 47.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.624 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 69.6 m-85 -149.81 121.46 8.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.084 -1.245 . . . . 0.0 110.087 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.8 tt -98.66 143.93 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -146.84 136.03 22.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.03 -1.044 . . . . 0.0 110.675 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.492 ' CD1' HD21 ' A' ' 75' ' ' LEU . 51.4 mt -144.88 125.02 7.26 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.5 Cg_endo -76.3 -42.55 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.691 1.594 . . . . 0.0 111.434 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -50.66 -17.24 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.048 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.488 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -133.82 14.31 3.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.513 -0.742 . . . . 0.0 109.209 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.4 p-10 43.75 50.25 6.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.488 HG12 ' HB3' ' A' ' 23' ' ' ALA . 43.3 mm -92.7 142.79 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.645 0.736 . . . . 0.0 109.888 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -168.97 81.35 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.0 158.49 61.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.738 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' A' ' 14' ' ' VAL . 40.8 Cg_endo -86.07 169.74 8.68 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.184 2.589 . . . . 0.0 113.105 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.56 137.14 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 24.6 m-85 -92.41 149.84 39.0 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.907 -1.121 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 50.3 Cg_endo -81.46 79.37 3.25 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.806 2.338 . . . . 0.0 111.802 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.76 177.5 39.58 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.865 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 91.2 Cg_endo -79.86 121.66 4.62 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.824 2.349 . . . . 0.0 111.182 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -40.85 87.75 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.906 -0.496 . . . . 0.0 110.918 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -111.54 167.28 9.32 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.52 -45.36 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.739 1.626 . . . . 0.0 111.833 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -62.28 -17.03 57.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.856 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.482 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -96.98 -69.36 0.76 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 0.0 108.642 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' A' ' 34' ' ' ALA . 42.2 mt -41.35 -24.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.799 -0.563 . . . . 0.0 110.51 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 38' ' ' GLN . 31.3 m-20 -63.61 -25.13 68.09 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.436 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.4 mtp180 -84.49 -14.58 48.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' C ' HE21 ' A' ' 71' ' ' GLN . . . 156.51 -143.92 10.22 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.882 -1.151 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.636 HG23 ' NE2' ' A' ' 71' ' ' GLN . 3.9 t -88.61 152.88 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 t -148.81 141.02 24.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 108.967 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -56.45 162.35 2.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 108.944 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.31 -9.98 59.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.173 -0.954 . . . . 0.0 108.812 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -145.27 149.55 35.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.5 pt-20 -63.39 -41.84 98.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 111.152 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 8.2 p30 -89.65 17.81 6.11 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 111.222 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.87 95.77 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.866 -1.146 . . . . 0.0 109.839 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -89.75 173.31 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -82.44 0.13 43.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.089 -1.007 . . . . 0.0 108.647 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.91 -10.68 19.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.564 -0.71 . . . . 0.0 109.897 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.5 t70 -59.59 113.44 2.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.772 -1.205 . . . . 0.0 108.863 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -46.72 -14.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.133 -0.979 . . . . 0.0 109.56 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' ASP . 3.8 m120 -133.49 97.21 3.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -94.23 115.86 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.233 -0.917 . . . . 0.0 108.917 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.8 t -108.63 116.69 32.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.697 -0.627 . . . . 0.0 109.351 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 60' ' ' ALA . 92.1 mt -109.37 164.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.601 0.715 . . . . 0.0 109.579 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.561 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -138.32 135.25 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.07 148.78 20.7 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.081 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -74.53 -169.29 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.639 -0.918 . . . . 0.0 110.07 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.84 99.99 0.47 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.27 122.45 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.162 -0.962 . . . . 0.0 108.918 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 65' ' ' ILE . 16.2 mt -64.65 -43.06 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.783 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.26 18.91 2.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.187 -0.945 . . . . 0.0 109.888 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -151.04 75.58 8.16 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 72.9 Cg_exo -51.78 24.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.92 3.08 . . . . 0.0 114.642 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.4 m120 -151.7 62.92 0.86 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 108.55 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 73' ' ' THR . 36.8 t80 -141.7 90.24 2.26 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.235 -0.916 . . . . 0.0 110.498 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.636 ' NE2' HG23 ' A' ' 43' ' ' VAL . 1.5 mm100 65.03 -119.23 0.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.764 -0.585 . . . . 0.0 111.556 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.628 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 29.5 t80 -87.44 33.35 0.69 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.318 1.056 . . . . 0.0 109.142 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 70' ' ' TYR . 21.6 m -69.13 -57.21 5.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.15 -1.594 . . . . 0.0 110.607 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 2.1 m-20 -90.43 -13.56 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.181 -0.949 . . . . 0.0 111.775 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 20' ' ' ILE . 2.4 mt -52.38 -29.63 24.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 108.281 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -74.02 -1.77 21.36 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -99.37 -33.2 10.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.618 . . . . 0.0 109.337 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.25 163.23 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -129.03 162.73 26.97 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -49.06 132.41 19.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 109.282 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.94 -24.3 15.03 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -64.36 114.23 4.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.206 -1.173 . . . . 0.0 108.065 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -73.35 -174.11 1.55 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.839 -1.163 . . . . 0.0 109.454 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.584 ' N ' ' SD ' ' A' ' 83' ' ' MET . 21.4 t -146.46 110.75 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.515 ' CD2' ' SD ' ' A' ' 83' ' ' MET . 53.0 m-85 -87.45 102.44 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -97.56 117.54 32.07 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -107.75 139.77 41.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.414 -0.804 . . . . 0.0 110.112 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 89' ' ' GLY . 7.1 p -168.96 157.41 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.724 . . . . 0.0 109.484 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 88' ' ' VAL . . . 57.85 -96.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -154.27 29.8 0.44 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -140.17 -175.25 4.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.355 -0.841 . . . . 0.0 109.201 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 m -149.83 111.57 4.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.536 ' NH2' ' CD1' ' A' ' 52' ' ' LEU . 7.6 mpt_? -89.07 163.53 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -141.43 122.9 15.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.384 -0.823 . . . . 0.0 109.63 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 17.1 m-85 -109.15 175.1 5.58 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.429 -0.794 . . . . 0.0 109.128 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.89 111.06 8.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.28 -0.887 . . . . 0.0 109.886 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.9 mtt -50.67 123.23 8.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.123 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 p -149.44 20.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 109.431 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.1 t -171.37 123.69 0.57 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.691 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.3 mt . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 -179.081 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 49.1 t0 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.468 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 83.0 mttt -60.83 145.08 51.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -143.83 160.58 40.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.057 -1.027 . . . . 0.0 108.953 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.1 tp -114.87 107.98 16.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.675 . . . . 0.0 110.962 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 122' ' ' THR . 6.7 t -97.54 107.72 20.29 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.0 156.38 21.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.003 . . . . 0.0 110.278 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.7 mt -140.37 143.78 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.513 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -91.78 155.89 17.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.934 -1.104 . . . . 0.0 108.512 179.288 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.416 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 2.0 m -149.29 85.03 1.44 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.944 -1.097 . . . . 0.0 109.886 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 20.3 p-10 -142.8 143.88 32.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.141 -0.975 . . . . 0.0 109.235 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.34 61.09 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.451 -0.78 . . . . 0.0 109.072 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -63.7 119.98 10.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -85.67 123.48 31.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 109.602 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.7 pm0 -94.82 14.7 20.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.343 -0.848 . . . . 0.0 109.77 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -69.31 -35.5 76.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.0 108.57 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.0 p -140.99 1.92 1.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 109.037 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.63 3.03 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.3 t -146.99 133.72 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.225 -1.162 . . . . 0.0 109.642 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 53.3 m95 -53.11 113.65 1.19 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.07 -1.019 . . . . 0.0 108.493 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -36.96 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.291 0.567 . . . . 0.0 110.326 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 137' ' ' GLU . 19.2 ptmt -96.87 139.35 33.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -151.78 96.49 2.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.891 -1.131 . . . . 0.0 110.569 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.658 ' O ' HD13 ' A' ' 141' ' ' ILE . 40.4 mtpt -86.58 158.49 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.156 -0.965 . . . . 0.0 108.473 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 140' ' ' LYS . 7.9 mm -129.25 140.29 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 25.8 m-85 -129.49 170.63 13.47 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.1 t -154.06 140.85 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.692 -1.255 . . . . 0.0 110.86 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.24 139.3 40.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.8 t -109.85 137.61 47.39 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.399 -0.813 . . . . 0.0 110.389 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.03 133.55 55.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 109.547 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 147' ' ' VAL . 8.2 m . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 109.327 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 10' ' ' ASP . 93.1 Cg_endo -83.6 134.18 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.191 1.927 . . . . 0.0 112.432 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -60.21 0.76 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 12' ' ' SER . 13.2 t70 -76.49 91.18 3.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -64.76 38.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 10' ' ' ASP . 43.3 t -146.9 25.26 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 108.885 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -141.67 141.88 33.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.64 118.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.66 -0.65 . . . . 0.0 110.885 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.96 -16.81 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.97 -177.48 38.74 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 121.31 8.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -1.223 . . . . 0.0 109.586 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -99.9 142.04 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' CD ' ' NZ ' ' A' ' 87' ' ' LYS . 23.7 mt-10 -146.79 135.24 21.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.968 -1.083 . . . . 0.0 110.737 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.494 HD12 HD23 ' A' ' 75' ' ' LEU . 32.5 mt -144.84 127.06 8.12 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.07 -42.75 0.37 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.636 1.557 . . . . 0.0 111.599 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -52.16 -14.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.403 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.495 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -135.63 15.14 3.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.42 -0.8 . . . . 0.0 109.136 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 42.41 49.52 4.62 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.718 0.77 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 23' ' ' ALA . 50.0 mm -91.76 141.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 25' ' ' ILE . 42.3 mttp -165.9 81.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -143.91 156.58 58.79 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 0.0 110.817 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -84.79 165.36 11.84 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.041 2.494 . . . . 0.0 112.531 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.22 119.43 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.412 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 7.9 m-85 -79.37 149.43 72.23 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.817 -1.177 . . . . 0.0 110.207 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.58 88.5 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.479 2.119 . . . . 0.0 111.86 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.31 -179.44 41.23 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.575 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 35' ' ' THR . 85.2 Cg_endo -78.09 119.17 4.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.861 2.374 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.63 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.383 0.611 . . . . 0.0 110.397 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -112.55 153.47 44.94 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.63 -43.43 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.09 1.86 . . . . 0.0 111.664 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.09 -22.98 67.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' ASN . 4.0 tp-100 -89.94 -66.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.235 -0.916 . . . . 0.0 109.54 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.2 mt -46.39 -15.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.918 . . . . 0.0 109.947 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' GLN . 40.0 m-20 -63.25 -25.19 68.21 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.88 -11.24 45.18 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 158.15 -136.6 4.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 60' ' ' ALA . 2.9 t -108.42 159.03 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.992 . . . . 0.0 109.862 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 p -153.58 156.73 38.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -57.99 175.67 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.797 -1.189 . . . . 0.0 109.946 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -85.95 -12.18 51.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -147.24 151.12 36.15 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.472 0.653 . . . . 0.0 109.935 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.39 -38.73 92.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.6 -0.687 . . . . 0.0 111.34 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -87.38 12.31 12.38 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.897 -1.127 . . . . 0.0 110.643 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.31 84.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' ASP . 48.2 m -92.56 147.46 22.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.03 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.967 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.41 -8.77 0.37 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -77.12 -30.82 55.37 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.508 -0.745 . . . . 0.0 109.615 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 15.8 m-20 -62.16 104.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.055 -1.028 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.31 -16.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 54' ' ' ASP . 27.6 t-20 -117.97 97.86 6.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.646 -0.659 . . . . 0.0 109.223 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.425 ' O ' ' OG1' ' A' ' 122' ' ' THR . 92.2 mt -98.49 150.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.376 -0.827 . . . . 0.0 109.325 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -140.46 114.45 9.02 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -101.69 161.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.326 -0.859 . . . . 0.0 110.362 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.542 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -140.27 131.17 26.02 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.23 154.24 24.89 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.537 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -71.1 175.52 5.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.68 -0.894 . . . . 0.0 109.063 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.86 89.75 0.66 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.65 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.05 116.99 28.49 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.2 mm -59.59 -29.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.799 . . . . 0.0 110.097 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -87.54 19.51 3.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -149.71 70.56 9.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.536 -0.727 . . . . 0.0 109.191 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.88 14.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 123.442 2.761 . . . . 0.0 113.853 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 67' ' ' ARG . 56.5 m-80 -147.9 60.95 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.216 . . . . 0.0 108.839 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -146.8 103.63 3.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 110.48 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.4 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 59.3 mt-30 55.81 -115.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 111.907 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.68 30.65 2.87 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 111.13 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.1 m -63.92 -49.16 73.71 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.128 -1.608 . . . . 0.0 109.611 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.602 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.9 m-20 -93.95 -18.23 22.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.012 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.69 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.6 tm? -51.05 -39.07 55.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -68.91 -4.71 17.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -91.5 -27.99 17.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 162.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 109.742 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 166.36 24.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.348 -0.845 . . . . 0.0 108.807 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -50.18 137.31 18.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.54 13.19 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -64.19 119.7 10.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.407 -1.055 . . . . 0.0 108.269 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.7 mtp -82.96 137.12 34.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.0 -1.063 . . . . 0.0 110.102 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.02 114.12 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.607 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -93.26 102.46 14.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.151 -0.968 . . . . 0.0 109.544 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -97.13 114.63 26.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 0.0 108.755 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' NZ ' ' CD ' ' A' ' 19' ' ' GLU . 23.0 mtmm -106.12 142.08 36.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.94 123.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.79 -145.23 5.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 90' ' ' ASN . 28.0 t-20 -85.26 52.1 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.198 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 m -152.98 148.68 27.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.601 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 177.15 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -144.31 164.1 31.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.028 -1.045 . . . . 0.0 110.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 94' ' ' LYS . 23.7 m-85 -148.96 108.31 3.95 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.39 117.91 16.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.132 -0.98 . . . . 0.0 109.27 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -51.75 129.62 26.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.309 -0.869 . . . . 0.0 108.988 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -158.16 24.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.227 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.0 t -171.28 132.7 0.81 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.4 mt . . . . . 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -178.545 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 4.2 m-20 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -47.37 141.29 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 108.824 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -152.84 164.58 37.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 110.572 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.1 tp -127.23 116.59 20.81 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.067 0.46 . . . . 0.0 109.854 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.498 ' H ' ' HG1' ' A' ' 122' ' ' THR . 0.1 OUTLIER -96.05 92.37 6.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.07 143.17 54.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 110.136 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mt -140.92 135.62 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.462 -0.774 . . . . 0.0 109.324 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.6 p -96.63 167.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.058 -1.027 . . . . 0.0 108.521 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 70.8 m -147.03 139.5 24.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.022 -1.049 . . . . 0.0 110.124 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 1.7 p30 179.59 136.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 61.5 64.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.0 109.201 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -62.98 126.5 27.53 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 109.142 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -85.96 118.36 25.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.038 . . . . 0.0 109.509 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.74 -0.56 54.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.425 -0.797 . . . . 0.0 109.918 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.77 -50.24 9.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.008 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.7 p -95.13 -10.69 29.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.236 -0.915 . . . . 0.0 109.233 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.76 39.94 54.08 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.89 158.89 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.333 -1.098 . . . . 0.0 109.636 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.427 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.8 m95 -62.78 111.76 2.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -35.79 -77.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.064 0.459 . . . . 0.0 110.627 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.446 -0.784 . . . . 0.0 109.227 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -169.79 131.62 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.709 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.51 166.83 13.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.14 -0.975 . . . . 0.0 108.845 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 22.6 mt -141.51 144.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 13.1 m-85 -140.1 168.93 18.66 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -150.05 141.8 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.626 -1.296 . . . . 0.0 110.745 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.19 171.27 14.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 147' ' ' VAL . 14.4 t -146.87 147.53 30.91 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.84 -1.163 . . . . 0.0 110.93 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.17 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.7 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.181 -0.949 . . . . 0.0 108.99 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' PRO . 6.9 mm . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' ILE . 76.8 Cg_exo -47.27 -174.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.527 1.485 . . . . 0.0 112.509 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -120.66 -26.7 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' SER . 30.8 t70 -76.08 101.68 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -57.45 -2.67 0.13 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.6 p -115.59 43.98 1.97 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.499 -0.75 . . . . 0.0 109.345 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 136.83 30.24 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 t -61.19 108.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.52 -0.738 . . . . 0.0 111.402 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.7 -5.03 49.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.43 -170.24 40.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.08 126.33 10.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -1.183 . . . . 0.0 109.073 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 tp -97.41 140.77 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -146.58 132.54 19.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.167 . . . . 0.0 110.748 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.612 ' CD1' HD21 ' A' ' 75' ' ' LEU . 35.6 mt -144.8 120.58 6.02 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.94 -37.99 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.629 1.553 . . . . 0.0 111.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.32 -19.9 1.48 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.408 -0.807 . . . . 0.0 109.293 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 24' ' ' ASP . . . -130.54 5.32 4.72 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.5 -0.75 . . . . 0.0 109.465 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER 56.16 29.61 15.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.831 -0.543 . . . . 0.0 111.372 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CD1' ' ND2' ' A' ' 74' ' ' ASN . 1.5 mp -85.33 142.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.658 -1.276 . . . . 0.0 108.404 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -165.64 86.3 0.37 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 16.6 mt-10 -142.13 160.62 54.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.75 158.18 24.68 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.514 2.143 . . . . 0.0 112.17 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.06 108.39 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.75 166.94 27.01 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.948 -1.095 . . . . 0.0 109.11 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -86.1 130.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.486 2.124 . . . . 0.0 112.177 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.02 168.94 30.88 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.012 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.9 Cg_endo -77.78 121.02 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 111.286 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -39.78 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.33 0.586 . . . . 0.0 110.281 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 p -126.43 152.82 74.68 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.12 -43.0 12.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.187 1.924 . . . . 0.0 111.995 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -61.46 -21.98 64.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.576 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.4 OUTLIER -95.29 -69.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.158 -0.964 . . . . 0.0 109.253 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 17.5 mt -45.58 -16.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -62.18 -24.84 67.43 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.6 -15.64 54.06 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.188 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.61 -109.69 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.924 -1.131 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 60' ' ' ALA . 5.0 t -125.52 153.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.505 -0.997 . . . . 0.0 109.758 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -153.79 153.74 32.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -56.78 165.57 1.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.594 -1.317 . . . . 0.0 109.474 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.05 -5.12 53.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -150.9 146.42 26.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.519 -0.738 . . . . 0.0 109.591 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.49 -38.39 87.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 111.075 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -89.47 15.48 9.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.99 -1.069 . . . . 0.0 111.143 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.0 99.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.847 -1.158 . . . . 0.0 109.61 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.1 p -91.22 144.28 25.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 108.856 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.039 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.99 -7.1 0.95 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' SER . 20.5 t0 -96.01 -13.47 23.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.691 -0.631 . . . . 0.0 109.626 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' ASN . 46.4 t0 -58.97 105.08 0.28 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.02 -1.05 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -44.49 -17.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.506 -0.747 . . . . 0.0 109.36 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 54' ' ' ASP . 5.0 t-20 -122.3 92.75 3.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.1 mt -93.55 145.8 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 108.453 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 t -142.3 109.17 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 108.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.5 mt -95.27 162.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.181 -0.949 . . . . 0.0 110.162 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -134.02 131.78 39.3 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.03 145.47 15.44 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.844 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 18.1 m-70 -72.85 -169.95 0.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.685 -0.891 . . . . 0.0 109.304 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.48 94.15 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -89.44 113.09 24.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.923 . . . . 0.0 108.887 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mt -61.07 -31.67 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 110.12 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -84.27 15.47 3.56 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 109.302 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -151.49 74.23 8.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.38 24.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 123.861 3.041 . . . . 0.0 114.379 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.4 m120 -151.26 63.44 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.0 108.551 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 36.2 t80 -150.77 99.85 2.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.071 -1.018 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.542 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.8 mt-30 59.66 -122.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.706 . . . . 0.0 111.454 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 12.2 t80 -92.75 36.66 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.402 1.096 . . . . 0.0 109.574 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.7 m -67.05 -56.65 9.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 119.908 -1.745 . . . . 0.0 110.299 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.2 p30 -110.82 7.14 21.84 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.232 -0.917 . . . . 0.0 111.409 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.612 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.8 mt -57.8 -15.03 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.62 -12.35 59.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -81.54 -30.41 33.15 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.8 -179.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLY . 23.5 mmtp -139.76 153.48 47.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 9.7 ttmm -51.39 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.83 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.7 -15.35 0.36 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -62.86 121.25 13.02 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.335 -1.097 . . . . 0.0 108.119 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtp -70.94 -175.06 1.04 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.336 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -146.51 109.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.39 101.88 14.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE2' ' CG2' ' A' ' 88' ' ' VAL . 16.7 t80 -98.74 112.45 24.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 87' ' ' LYS . 7.0 mtmp? -92.12 146.55 23.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.064 -1.023 . . . . 0.0 110.809 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 90' ' ' ASN . 68.3 t -139.55 155.25 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.77 41.2 0.25 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 88' ' ' VAL . 43.1 t30 -160.4 -34.29 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.229 -1.159 . . . . 0.0 110.028 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.441 ' OE1' ' NH1' ' A' ' 93' ' ' ARG . 29.8 tt0 -172.4 165.9 5.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 92' ' ' THR . 11.0 t -107.14 123.04 47.67 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.441 ' NH1' ' OE1' ' A' ' 91' ' ' GLU . 5.3 mmt180 -92.94 160.16 15.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 108.737 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -144.87 121.18 10.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -114.59 176.76 4.91 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.607 -0.683 . . . . 0.0 109.223 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -136.56 107.21 6.55 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 0.0 109.395 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.445 ' HB3' ' H ' ' A' ' 81' ' ' GLY . 28.5 tpp -49.49 119.29 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.052 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -145.37 19.72 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.096 -1.002 . . . . 0.0 109.744 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.7 m -169.54 118.84 0.65 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 108.784 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.554 -0.716 . . . . 0.0 109.669 -179.217 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 121.549 0.69 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -44.86 140.77 2.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -152.21 173.4 15.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.997 -1.064 . . . . 0.0 110.08 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.7 tp -122.87 155.86 35.81 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.45 0.643 . . . . 0.0 110.122 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.0 m -141.98 88.96 2.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.77 149.44 49.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.378 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 96.8 mt -140.04 141.99 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.5 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -90.49 156.56 18.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.919 -1.113 . . . . 0.0 108.831 179.231 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.533 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 23.0 m -148.75 89.82 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.142 -0.973 . . . . 0.0 109.449 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -148.54 146.04 28.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.235 -0.916 . . . . 0.0 109.118 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 1.2 m-20 61.29 63.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 108.835 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -63.24 122.11 15.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -85.17 121.69 28.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.85 13.77 19.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.853 . . . . 0.0 109.638 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -81.19 -26.16 36.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 p -141.98 5.59 1.73 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.355 -0.84 . . . . 0.0 109.168 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.23 53.04 23.88 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.481 ' CG1' ' NH2' ' A' ' 139' ' ' ARG . 3.3 t -147.29 139.83 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.218 -1.166 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 56.9 m95 -56.09 115.39 2.4 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.38 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 12.6 tp10 -39.51 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.724 -0.61 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -81.28 146.92 30.16 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.481 ' NH2' ' CG1' ' A' ' 135' ' ' VAL . 26.8 ttm180 -158.76 75.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.872 -1.143 . . . . 0.0 110.482 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -75.27 163.59 27.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.287 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.47 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 6.9 mm -134.09 156.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.836 0.826 . . . . 0.0 110.426 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 21.3 m-85 -141.75 159.73 41.64 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.2 147.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.711 -1.243 . . . . 0.0 111.342 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.17 158.77 43.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.21 143.02 50.27 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.15 -0.968 . . . . 0.0 109.92 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 9.1 tm-20 -60.48 135.75 57.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.438 -0.789 . . . . 0.0 108.88 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.425 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.5 2.036 0 O-C-N 121.356 -0.84 . . . . 0.0 108.875 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.62 172.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.275 1.983 . . . . 0.0 112.345 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.57 2.08 12.33 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.57 -0.707 . . . . 0.0 109.514 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 12' ' ' SER . 63.2 t0 -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.98 3.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ASP . 27.2 p -129.24 39.81 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.259 -0.9 . . . . 0.0 109.82 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -150.42 150.36 31.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.149 -0.969 . . . . 0.0 109.143 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 15' ' ' ALA . 89.0 t -61.04 157.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.603 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -144.29 -30.09 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.82 -178.18 28.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -148.06 120.01 8.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -1.137 . . . . 0.0 108.963 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.602 HD11 ' CG1' ' A' ' 84' ' ' VAL . 9.8 tp -94.37 143.67 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -147.43 132.55 18.3 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.155 . . . . 0.0 110.914 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.2 mt -145.72 123.71 6.35 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.7 -39.42 0.52 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.752 1.635 . . . . 0.0 111.895 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.48 -23.32 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 25' ' ' ILE . . . -127.35 4.38 6.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 109.42 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.3 p30 52.38 37.38 22.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.832 -0.542 . . . . 0.0 111.359 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.552 HD11 ' OD1' ' A' ' 74' ' ' ASN . 1.5 mp -86.29 146.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.76 -1.212 . . . . 0.0 108.095 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -166.55 82.56 0.26 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -139.27 156.91 71.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 111.646 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.0 164.51 7.28 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.82 2.346 . . . . 0.0 113.308 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.86 129.72 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 2.0 m-85 -87.57 152.36 51.81 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 120.877 -1.139 . . . . 0.0 110.179 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.4 97.94 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.577 2.185 . . . . 0.0 111.43 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.77 -178.27 48.68 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.323 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.0 Cg_endo -80.61 117.78 3.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.867 2.378 . . . . 0.0 111.018 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.05 88.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.395 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.0 p -107.7 153.63 41.36 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.62 -41.35 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.191 1.928 . . . . 0.0 112.392 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.43 -22.22 66.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 109.678 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.4 tm0? -96.17 -53.74 3.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.9 mt -45.1 -23.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' GLN . 14.6 m-20 -64.03 -25.67 68.22 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.419 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 88.5 mtt180 -84.35 -16.0 44.45 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.0 -139.61 6.81 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.682 -1.246 . . . . 0.0 110.782 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.4 t -99.85 159.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.46 -1.023 . . . . 0.0 109.792 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -155.56 152.97 29.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.516 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 54.1 m-85 -58.68 160.21 5.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.522 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -75.39 -6.16 48.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.997 . . . . 0.0 109.413 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -154.37 149.56 26.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -62.99 -35.86 81.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 111.612 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.509 ' ND2' ' OE2' ' A' ' 48' ' ' GLU . 13.9 p30 -87.88 15.5 7.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.858 -1.151 . . . . 0.0 110.979 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 12.0 tm-20 -64.86 145.06 56.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.991 -1.068 . . . . 0.0 109.062 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.465 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 8.4 p -148.44 153.46 38.54 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -67.04 -4.64 10.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 51' ' ' SER . 39.2 m-20 -95.06 -17.42 21.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.9 t70 -59.15 115.56 3.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.944 -1.097 . . . . 0.0 108.846 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 9.3 tt0 -46.04 -19.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 109.607 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' ASP . 61.7 t-20 -131.88 113.48 13.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.692 . . . . 0.0 109.435 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.64 145.19 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 108.627 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.7 p -141.55 104.43 4.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.2 mt -103.13 158.83 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.543 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -126.86 129.06 47.5 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.8 149.05 20.55 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.924 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 31.3 m-70 -74.28 -163.54 0.2 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.61 -0.936 . . . . 0.0 110.046 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 63' ' ' THR . 10.0 t -164.34 80.56 0.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.332 -0.855 . . . . 0.0 108.794 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -87.51 108.0 18.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.798 -1.189 . . . . 0.0 109.11 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.99 -29.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -82.38 12.31 4.6 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.805 0.812 . . . . 0.0 109.401 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -146.01 75.39 12.95 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.52 8.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.617 2.878 . . . . 0.0 113.988 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -142.93 59.36 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 0.0 108.085 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -143.46 102.91 4.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.381 -0.824 . . . . 0.0 110.177 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 51.62 -132.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.423 -0.798 . . . . 0.0 110.752 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.679 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 1.1 t80 -87.65 63.39 7.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.881 1.324 . . . . 0.0 108.779 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 m -89.66 -32.69 16.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.657 -1.277 . . . . 0.0 108.377 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.556 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 3.6 p-10 -140.03 10.06 2.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -10.53 0.72 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.499 ' N ' ' C ' ' A' ' 74' ' ' ASN . 1.8 ptmm? -85.33 -23.48 28.05 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -67.33 -29.09 68.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.36 -157.15 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.7 ptmt -171.23 162.42 6.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -52.59 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.256 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 152.56 -25.09 0.85 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -63.41 113.66 3.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.1 mtp -63.24 -177.5 0.19 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.68 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' CG1' HD11 ' A' ' 18' ' ' ILE . 31.6 t -144.87 106.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.421 -0.8 . . . . 0.0 109.171 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.99 102.43 14.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.931 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -96.12 115.99 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -102.91 144.04 31.72 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.304 -0.873 . . . . 0.0 109.983 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 15' ' ' ALA . 2.2 p -169.24 140.29 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.399 -0.813 . . . . 0.0 109.105 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.5 -97.71 0.15 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.88 18.9 0.89 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -1.14 . . . . 0.0 109.299 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -132.73 139.82 47.78 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 92' ' ' THR . 12.7 t -112.53 132.35 55.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.439 -0.788 . . . . 0.0 110.287 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HG3' HH11 ' A' ' 93' ' ' ARG . 7.4 mmm-85 -92.93 167.56 11.74 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -148.46 92.76 2.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.9 -1.125 . . . . 0.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -87.7 -178.16 6.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 108.185 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -138.39 105.33 5.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.252 -0.905 . . . . 0.0 109.769 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.416 ' HB3' ' H ' ' A' ' 81' ' ' GLY . 35.7 ttm -50.06 115.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -157.59 24.76 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.1 m -164.69 119.53 1.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.428 -0.795 . . . . 0.0 109.63 -178.829 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' GLN . 34.7 m-20 . . . . . 0 N--CA 1.503 2.202 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' ASP . 42.4 mmtt -41.27 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.3 pm0 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -114.18 102.66 10.35 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -96.46 134.8 39.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.097 -1.002 . . . . 0.0 109.332 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.97 148.06 43.38 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.504 -0.748 . . . . 0.0 109.132 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.1 mt -133.77 143.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.43 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 p -91.13 153.23 20.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 109.335 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.515 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 10.6 m -149.31 92.18 1.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.327 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.416 ' OD2' ' OD1' ' A' ' 128' ' ' ASP . 6.5 p-10 -149.0 146.85 27.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.353 -0.842 . . . . 0.0 108.898 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.416 ' OD1' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-20 59.33 63.66 1.52 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.01 124.89 22.25 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.682 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 6.3 t-20 -85.11 115.1 22.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.947 . . . . 0.0 109.312 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -83.87 1.21 44.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 65.0 mmtt -79.86 -53.91 6.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.274 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.0 p -95.55 -9.8 31.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.52 42.94 31.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.22 152.26 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -1.118 . . . . 0.0 109.62 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.4 m95 -58.72 114.93 2.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.1 tt0 -38.3 -72.92 0.05 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 110.567 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -91.01 148.17 22.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.098 -1.001 . . . . 0.0 109.305 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -154.13 93.42 1.62 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.035 -1.041 . . . . 0.0 110.906 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.402 ' CB ' ' HZ3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -94.7 164.59 12.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.0 mt -139.38 149.88 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.251 -0.906 . . . . 0.0 110.505 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.2 m-85 -137.27 164.5 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 99' ' ' SER . 72.5 t -152.66 118.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.655 -1.278 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -101.81 -176.48 3.14 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.0 t -153.9 131.37 11.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.873 -1.142 . . . . 0.0 110.022 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.54 109.85 1.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 147' ' ' VAL . 98.9 t . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.87 0.843 . . . . 0.0 109.667 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 8' ' ' PRO . 5.7 mm . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 7' ' ' ILE . 74.2 Cg_exo -49.54 -140.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 121.96 1.773 . . . . 0.0 113.63 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -160.2 -30.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.882 -1.136 . . . . 0.0 109.783 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 12' ' ' SER . 26.3 t0 -74.96 112.6 11.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.496 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -57.8 -4.78 0.32 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 109.752 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.7 p -111.88 39.73 2.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.549 -0.719 . . . . 0.0 109.585 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.4 143.63 29.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.044 -1.035 . . . . 0.0 109.662 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.83 149.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.817 0.817 . . . . 0.0 110.846 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.87 10.45 1.78 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.66 176.05 38.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -147.96 117.27 6.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.305 -1.114 . . . . 0.0 109.437 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -97.76 141.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -146.34 138.89 25.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.996 -1.065 . . . . 0.0 110.45 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 75' ' ' LEU . 52.4 mt -144.46 125.8 7.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.72 -41.14 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.477 1.451 . . . . 0.0 111.333 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -51.79 -16.6 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.835 . . . . 0.0 109.315 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.523 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.29 14.88 3.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.81 . . . . 0.0 109.476 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.4 p-10 43.79 50.09 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.43 -0.794 . . . . 0.0 109.891 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 23' ' ' ALA . 49.6 mm -88.8 144.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.582 0.706 . . . . 0.0 109.664 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -168.9 81.25 0.14 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -140.83 152.5 65.77 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.239 -0.913 . . . . 0.0 110.33 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.14 166.92 10.95 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.827 2.351 . . . . 0.0 112.633 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.7 120.44 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -90.99 165.7 21.06 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.004 -1.06 . . . . 0.0 109.432 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.12 120.66 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.71 2.273 . . . . 0.0 112.569 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.28 168.46 20.57 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.566 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 69.3 Cg_endo -73.84 123.95 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.831 2.354 . . . . 0.0 111.195 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -42.95 87.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.781 -0.574 . . . . 0.0 110.654 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.0 p -112.21 151.65 43.83 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.22 -40.03 9.28 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.15 1.9 . . . . 0.0 111.636 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.61 -23.05 66.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.351 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 40' ' ' ASN . 5.4 tm0? -96.16 -58.92 1.95 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.301 -0.874 . . . . 0.0 108.791 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -47.13 -12.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.831 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.5 m-20 -60.93 -26.74 67.71 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.427 HH11 ' HB2' ' A' ' 40' ' ' ASN . 12.3 mpt_? -82.31 -16.84 47.88 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.24 -128.77 2.6 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.769 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 4.5 t -95.93 158.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.467 -1.019 . . . . 0.0 110.245 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -154.96 147.32 23.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.0 109.132 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -52.85 170.21 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.866 -1.146 . . . . 0.0 109.061 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -100.5 9.15 42.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.467 -0.771 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -167.91 132.24 1.75 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.003 . . . . 0.0 109.889 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 10.2 pt-20 -55.07 -19.41 7.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.71 -0.619 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -84.86 25.86 0.89 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.909 -1.119 . . . . 0.0 108.568 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.3 145.56 53.44 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.2 p -154.36 144.94 22.3 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 6.4 mt -71.95 10.1 0.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.5 OUTLIER -127.76 -1.14 6.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.89 -0.506 . . . . 0.0 110.312 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 56' ' ' ASN . 4.8 t70 -54.78 118.43 4.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.452 -1.405 . . . . 0.0 108.719 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.496 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -45.52 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 54' ' ' ASP . 6.7 p-10 -144.88 110.82 5.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -93.31 116.82 35.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 109.134 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 27.8 m -107.76 111.53 23.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -115.06 162.78 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.6 121.63 37.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.36 140.37 13.38 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.43 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.6 m-70 -73.1 170.33 15.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -1.034 . . . . 0.0 110.027 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.27 78.18 1.37 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.41 -0.806 . . . . 0.0 109.04 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.418 ' N ' ' OG1' ' A' ' 73' ' ' THR . 50.2 m-85 -86.53 110.19 19.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 109.291 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 65' ' ' ILE . 15.1 mt -57.73 -27.21 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.485 -0.759 . . . . 0.0 110.055 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.9 14.45 3.27 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 69' ' ' ASN . 80.9 mtt180 -148.21 72.37 11.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.45 25.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 123.33 2.687 . . . . 0.0 113.443 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 67' ' ' ARG . 11.3 p30 -148.82 25.76 0.93 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 0.0 108.509 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.41 -152.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.691 0.758 . . . . 0.0 109.991 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -71.31 -81.89 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.781 -0.575 . . . . 0.0 111.411 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 34.4 t80 -94.36 -6.81 43.41 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.023 -1.048 . . . . 0.0 110.116 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.458 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 96.1 m -43.32 -39.52 3.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.96 . . . . 0.0 110.813 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.0 m120 -94.17 -27.17 16.35 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.841 -1.162 . . . . 0.0 111.44 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' A' ' 20' ' ' ILE . 10.5 mt -51.74 -11.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.694 -1.254 . . . . 0.0 109.36 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 74' ' ' ASN . 3.3 ptmt -84.05 -2.71 57.2 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -103.76 -36.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.68 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.104 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' O ' ' SD ' ' A' ' 97' ' ' MET . 50.0 mttm -148.09 174.57 11.8 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -48.13 139.69 8.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 109.709 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.32 -15.19 62.65 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 97' ' ' MET . 53.2 p -64.22 98.18 0.22 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.262 -1.14 . . . . 0.0 108.486 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.461 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 11.3 ptm -67.63 178.08 1.79 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.32 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.2 t -144.24 117.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' OH ' ' SD ' ' A' ' 83' ' ' MET . 97.9 m-85 -93.82 102.71 14.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 88' ' ' VAL . 37.1 t80 -95.87 110.83 22.95 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 88' ' ' VAL . 36.3 ttpt -99.69 146.52 26.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 86' ' ' PHE . 20.2 m -156.89 142.03 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.719 -0.613 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.35 -96.64 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.522 ' ND2' ' OE2' ' A' ' 91' ' ' GLU . 4.4 p-10 -140.17 19.2 2.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -1.141 . . . . 0.0 109.296 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.522 ' OE2' ' ND2' ' A' ' 90' ' ' ASN . 4.2 mp0 -120.03 167.11 12.52 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -152.64 118.92 5.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 110.16 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.515 HH11 ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.85 169.86 10.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -143.8 117.29 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.876 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.28 176.19 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -138.89 106.44 5.58 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.442 -0.786 . . . . 0.0 109.867 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 36.7 ttm -48.26 124.93 8.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.085 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -153.83 0.21 0.22 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.033 -1.042 . . . . 0.0 109.81 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 143' ' ' VAL . 72.2 m -163.85 112.59 1.21 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.229 -0.919 . . . . 0.0 110.228 -177.472 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.7 t70 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 118' ' ' ASP . 66.2 mttm -36.79 132.58 0.64 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -148.32 -178.14 6.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.455 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.8 tp -134.99 111.31 9.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -96.04 87.54 4.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.27 -0.893 . . . . 0.0 108.716 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.72 121.04 23.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.12 -0.988 . . . . 0.0 109.145 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.2 mt -105.12 140.76 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.773 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -94.76 161.61 14.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.125 -0.985 . . . . 0.0 108.863 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.445 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 21.8 m -148.03 139.51 23.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -175.1 132.95 0.31 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.065 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.1 t0 61.83 66.01 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.812 . . . . 0.0 109.132 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -61.76 123.56 18.31 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.021 -1.049 . . . . 0.0 109.739 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -87.34 125.49 34.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.157 -0.965 . . . . 0.0 109.672 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.71 7.68 38.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.368 -0.833 . . . . 0.0 109.698 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -79.38 -58.65 3.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -0.924 . . . . 0.0 109.077 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.2 p -96.74 -3.9 41.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 109.3 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.82 35.98 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.15 157.37 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -1.073 . . . . 0.0 109.733 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.5 m95 -63.79 114.31 3.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 136' ' ' TRP . 31.0 tt0 -36.79 -81.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.244 0.545 . . . . 0.0 110.451 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.53 170.16 4.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.13 -0.981 . . . . 0.0 108.519 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.529 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -161.86 112.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 0.0 109.983 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.15 155.83 49.09 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 pt -150.78 160.52 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 111.187 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -138.11 157.37 46.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 99' ' ' SER . 96.5 t -144.24 111.68 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -99.3 175.08 6.0 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.1 t -138.88 133.89 32.54 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.035 -1.041 . . . . 0.0 109.706 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.22 127.68 33.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.441 -0.787 . . . . 0.0 109.706 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 147' ' ' VAL . 5.0 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.282 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.23 167.39 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.078 1.852 . . . . 0.0 112.5 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.81 -12.95 12.66 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 12' ' ' SER . 52.6 t0 -76.87 107.5 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -57.9 -5.39 0.41 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.404 -0.81 . . . . 0.0 109.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 10' ' ' ASP . 16.5 m -103.68 29.24 5.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.445 -0.784 . . . . 0.0 109.808 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -147.16 140.29 25.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.154 -0.966 . . . . 0.0 109.418 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG12 ' N ' ' A' ' 15' ' ' ALA . 94.8 t -59.91 166.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.71 0.767 . . . . 0.0 110.656 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.634 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -140.3 -34.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -160.49 -165.68 17.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 31.3 m-85 -149.41 126.24 11.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.983 -1.304 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -96.31 142.75 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -145.63 146.08 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.955 -1.091 . . . . 0.0 110.304 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.88 131.42 7.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.48 -51.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.883 1.722 . . . . 0.0 111.752 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -50.55 -29.18 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.412 -0.805 . . . . 0.0 109.321 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.38 3.27 19.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.52 -0.738 . . . . 0.0 109.062 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 42.84 41.13 2.4 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.577 0.703 . . . . 0.0 109.894 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.82 150.07 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.777 0.799 . . . . 0.0 110.016 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -167.25 83.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -135.8 158.51 73.93 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.351 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.84 161.98 16.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.008 2.472 . . . . 0.0 113.154 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.47 130.82 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 12.6 m-85 -85.77 148.84 49.65 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.845 -1.159 . . . . 0.0 109.993 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.37 82.73 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.647 2.231 . . . . 0.0 111.398 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.64 -173.96 35.48 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.187 -1.482 . . . . 0.0 110.897 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.8 Cg_endo -82.38 121.4 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.961 2.44 . . . . 0.0 111.406 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.53 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.851 -0.53 . . . . 0.0 110.576 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.1 p -110.47 151.33 42.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.51 -41.71 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.227 1.951 . . . . 0.0 112.04 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.64 -21.38 66.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' ASN . 1.6 tt0 -96.73 -60.68 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' GLY . 24.0 mt -45.16 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.69 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' GLN . 38.7 m-20 -64.35 -26.47 68.49 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 41' ' ' ARG . 23.4 mtt-85 -79.93 -19.55 47.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 162.48 -144.12 9.36 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.75 163.62 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.297 -1.119 . . . . 0.0 108.874 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.459 ' CB ' ' NE2' ' A' ' 38' ' ' GLN . 4.4 t -158.41 155.28 28.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 109.202 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -60.02 164.84 3.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.075 -1.016 . . . . 0.0 109.419 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -77.81 -19.16 55.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.176 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.77 150.5 41.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.397 -0.814 . . . . 0.0 110.248 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.44 -36.52 84.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.589 -0.694 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.17 9.27 15.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.891 -1.131 . . . . 0.0 110.989 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -65.02 138.53 58.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 0.0 109.391 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -147.23 169.42 19.41 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 108.986 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -10.19 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.92 -29.35 32.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.483 -0.761 . . . . 0.0 109.213 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.6 m-20 -64.4 100.7 0.37 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.73 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 2.8 pm0 -48.33 -15.92 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.982 -1.074 . . . . 0.0 109.012 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' ASP . 19.6 t30 -110.45 100.04 8.94 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.55 148.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.212 -0.93 . . . . 0.0 109.548 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -145.82 107.88 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 60' ' ' ALA . 79.1 mt -110.79 165.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.588 -0.695 . . . . 0.0 110.134 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.586 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -149.55 138.75 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.461 -0.775 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.55 157.73 27.49 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.29 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -73.11 -177.15 2.36 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.302 -1.116 . . . . 0.0 109.818 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.9 81.46 0.43 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -87.85 122.2 31.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.318 -0.863 . . . . 0.0 109.533 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 mm -58.9 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -0.894 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.72 20.53 2.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 69' ' ' ASN . 90.8 mtt180 -150.37 67.87 8.34 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.541 -0.725 . . . . 0.0 109.572 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.3 5.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 123.537 2.825 . . . . 0.0 114.124 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 67' ' ' ARG . 15.6 p-10 -146.13 61.24 1.24 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.89 -1.131 . . . . 0.0 108.638 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -152.86 121.0 6.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 110.509 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.728 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER 54.4 -124.71 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.681 -0.637 . . . . 0.0 110.864 178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 75' ' ' LEU . 3.3 m-85 -97.82 12.51 33.68 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.72 -1.237 . . . . 0.0 110.15 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.0 m -46.41 -19.93 0.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.911 -1.118 . . . . 0.0 110.311 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 72' ' ' PHE . 5.5 m-20 -121.77 -21.74 6.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.442 -0.786 . . . . 0.0 109.971 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 72' ' ' PHE . 5.9 tt -55.96 -25.22 42.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.57 -13.64 60.06 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -85.52 -16.43 39.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.96 174.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.827 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 81' ' ' GLY . 53.5 mtmt -150.49 159.21 44.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.901 . . . . 0.0 109.114 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -52.84 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.2 -22.71 0.51 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -66.43 121.12 14.59 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.459 -1.024 . . . . 0.0 108.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.6 mtm -77.58 -177.82 4.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.962 -1.086 . . . . 0.0 109.801 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' TYR . 61.4 t -145.65 159.51 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.808 . . . . 0.0 109.444 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' HG12 ' A' ' 84' ' ' VAL . 59.7 m-85 -144.17 102.46 3.87 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 109.371 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -95.0 113.5 25.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 108.658 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -102.08 139.1 38.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 15' ' ' ALA . 2.4 p -162.23 144.22 3.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 49.98 -151.65 4.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -92.94 59.33 3.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.197 -1.178 . . . . 0.0 109.297 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -168.36 163.37 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.335 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -144.86 151.78 39.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 159.38 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.47 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 37.5 pttt -143.1 164.82 29.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 3.1 m-85 -141.31 -174.62 4.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -141.95 115.03 8.75 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.16 -0.962 . . . . 0.0 108.964 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.458 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.2 mmt -49.36 110.09 0.33 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.598 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 p -139.46 20.69 2.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.436 -0.79 . . . . 0.0 109.14 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 143' ' ' VAL . 31.1 t -168.63 122.91 0.88 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.209 -0.932 . . . . 0.0 109.296 -178.99 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 120' ' ' GLN . 28.8 m-20 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.53 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 4.3 mptp? -26.04 87.77 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 122.315 1.055 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 118' ' ' ASP . 5.9 pt20 -89.04 161.16 16.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.05 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.405 HD21 HD21 ' A' ' 123' ' ' LEU . 59.7 tp -133.35 109.01 9.06 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -94.24 92.18 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.949 . . . . 0.0 109.909 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.405 HD21 HD21 ' A' ' 121' ' ' LEU . 30.3 mt -74.98 148.02 40.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.131 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.1 mt -138.74 143.27 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.213 -0.929 . . . . 0.0 109.628 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -105.49 155.67 18.95 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.341 -0.85 . . . . 0.0 108.726 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 127' ' ' ASP . 66.7 m -145.81 155.92 43.23 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.93 -1.106 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 0.5 OUTLIER 170.49 140.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.89 . . . . 0.0 109.56 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.4 OUTLIER 56.89 63.16 2.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.688 -0.633 . . . . 0.0 109.334 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.71 120.57 10.91 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.872 -1.142 . . . . 0.0 108.525 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -85.14 111.41 19.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 109.896 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.4 4.83 9.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.357 -0.839 . . . . 0.0 109.751 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.34 -53.83 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.0 p -96.48 -8.19 32.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.866 . . . . 0.0 109.195 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.62 41.37 43.71 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.71 155.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.224 -1.162 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.442 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.0 m95 -61.85 112.6 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.4 tt0 -38.08 -78.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.702 -0.624 . . . . 0.0 110.016 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 10.4 mtpp -89.92 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -152.54 108.24 3.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.909 -1.119 . . . . 0.0 110.524 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' A' ' 140' ' ' LYS . 3.8 mtmp? -109.84 133.81 52.75 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.5 mm -104.81 129.53 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -117.4 160.09 21.72 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.5 t -145.72 149.75 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.715 -1.24 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.75 179.3 7.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -161.37 156.38 23.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.575 -1.328 . . . . 0.0 111.309 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.25 135.05 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.312 0.577 . . . . 0.0 110.059 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 122.01 0.909 . . . . 0.0 109.426 179.522 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.34 152.43 3.79 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.022 . . . . 0.0 112.667 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -93.08 -17.08 24.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 108.885 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 12' ' ' SER . 36.2 t0 -77.58 106.03 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.453 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.9 OUTLIER -58.01 -5.45 0.44 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 10' ' ' ASP . 13.6 t -103.19 39.25 1.6 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.364 -0.835 . . . . 0.0 109.751 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -147.76 132.91 18.33 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.301 -0.874 . . . . 0.0 109.71 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 38.8 t -61.31 132.21 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.56 -16.3 20.12 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -176.7 -162.76 27.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.51 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 87.0 m-85 -148.89 128.78 13.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.251 -1.146 . . . . 0.0 109.687 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.72 144.67 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -144.27 147.45 33.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.874 -1.141 . . . . 0.0 110.75 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mt -149.68 131.88 7.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -50.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.936 1.757 . . . . 0.0 112.0 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.19 -20.98 1.75 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.829 . . . . 0.0 109.406 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB1' ' OD1' ' A' ' 74' ' ' ASN . . . -118.46 3.31 11.84 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ALA . 1.5 p30 40.91 38.86 0.72 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.542 0.687 . . . . 0.0 109.848 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.467 HG23 ' OE2' ' A' ' 27' ' ' GLU . 3.3 mt -98.08 155.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.86 0.838 . . . . 0.0 110.47 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -162.49 69.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' OE2' HG23 ' A' ' 25' ' ' ILE . 11.2 mt-10 -100.56 150.2 36.77 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.582 -0.699 . . . . 0.0 112.495 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -87.98 159.96 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.844 2.363 . . . . 0.0 111.608 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.71 130.55 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.117 -0.989 . . . . 0.0 109.646 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -94.42 155.92 39.2 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.881 -1.137 . . . . 0.0 108.888 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -81.59 95.12 0.92 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.311 2.007 . . . . 0.0 111.786 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.88 -177.66 39.86 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.336 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 89.0 Cg_endo -81.64 116.99 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.915 2.41 . . . . 0.0 111.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.46 87.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.331 0.586 . . . . 0.0 110.335 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -112.85 153.35 45.19 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.44 -45.04 19.63 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.07 1.847 . . . . 0.0 111.433 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.54 -19.04 64.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.417 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.7 tp-100 -93.02 -69.35 0.75 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 18.7 mt -45.37 -17.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 109.754 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 38' ' ' GLN . 13.7 m-20 -61.81 -24.92 67.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.6 mtt180 -85.56 -12.97 50.3 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.76 -110.64 0.45 Allowed Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.737 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.9 t -131.64 156.79 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.383 -1.069 . . . . 0.0 109.395 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 t -153.04 154.33 34.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 108.749 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.31 171.69 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.926 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -78.46 -26.28 46.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 109.517 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -135.15 150.24 50.13 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -0.781 . . . . 0.0 109.635 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.52 -32.77 72.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.626 -0.671 . . . . 0.0 111.456 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -85.93 11.32 11.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.885 -1.135 . . . . 0.0 110.81 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 58' ' ' SER . 1.4 tt0 -63.96 147.1 52.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.421 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 2.7 p -147.99 151.76 36.32 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -65.94 -5.52 9.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 51' ' ' SER . 13.7 t70 -91.58 -22.51 20.28 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 52.7 m-20 -60.11 100.67 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.199 -0.938 . . . . 0.0 108.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 9.0 tt0 -42.98 -20.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.519 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 22.1 t-20 -116.89 97.64 6.07 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.8 146.8 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' ALA . 10.6 m -144.66 109.61 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mt -108.82 167.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.374 -0.828 . . . . 0.0 109.948 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -142.96 135.17 27.26 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.38 157.9 27.1 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.835 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.422 ' H ' ' HG2' ' A' ' 71' ' ' GLN . 25.9 m-70 -73.67 -173.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.608 -0.937 . . . . 0.0 110.562 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -174.9 77.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.7 119.05 28.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.133 . . . . 0.0 108.977 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 65' ' ' ILE . 14.6 mt -61.09 -26.62 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.453 -0.779 . . . . 0.0 110.365 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.15 14.78 2.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.628 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 69' ' ' ASN . 83.0 mtt180 -150.77 76.66 8.06 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.641 . . . . 0.0 109.407 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.6 12.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 123.657 2.905 . . . . 0.0 114.021 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -146.5 52.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.892 -1.13 . . . . 0.0 108.125 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 15.7 t80 -136.93 100.72 4.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.411 -0.805 . . . . 0.0 109.96 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 12.1 mp0 54.86 -125.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.625 -0.672 . . . . 0.0 110.722 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.871 ' CE2' HD13 ' A' ' 75' ' ' LEU . 4.9 m-85 -90.23 34.08 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.685 -1.259 . . . . 0.0 110.092 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.4 m -57.55 -26.65 61.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.357 -1.464 . . . . 0.0 109.477 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.4 p30 -140.55 4.15 1.94 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 72' ' ' PHE . 9.2 tt -55.2 -21.63 14.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.853 -1.154 . . . . 0.0 107.929 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' NZ ' ' O ' ' A' ' 72' ' ' PHE . 14.2 mtmm -82.77 -18.54 40.29 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -62.29 -22.84 66.34 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -54.62 -169.9 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 81' ' ' GLY . 4.5 ptpt -154.58 157.52 38.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -0.961 . . . . 0.0 109.223 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.479 ' NZ ' ' CB ' ' A' ' 80' ' ' LYS . 5.3 ttpm? -52.2 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 109.543 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 153.42 -14.75 0.64 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -64.42 119.12 9.78 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.545 -0.974 . . . . 0.0 108.774 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.3 mmm -73.51 179.89 3.83 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.393 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 85' ' ' TYR . 22.0 t -146.26 161.74 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.967 . . . . 0.0 109.231 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 84' ' ' VAL . 77.9 m-85 -147.67 103.13 3.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.345 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -94.58 111.99 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -95.55 144.83 25.69 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.1 96.83 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.52 -0.738 . . . . 0.0 109.134 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 48.62 -131.35 21.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -82.22 52.54 2.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.154 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.25 143.44 10.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.14 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.4 m -152.87 146.95 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.987 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 177.99 7.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.475 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 23.9 pttm -144.28 161.09 39.82 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.091 -1.006 . . . . 0.0 110.351 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 10.9 m-85 -141.35 -179.79 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -147.13 130.54 16.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.935 -1.103 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.443 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 12.9 mtt -48.51 150.86 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.394 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 97' ' ' MET . 14.9 m -166.28 1.34 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.161 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 t -168.5 124.08 0.96 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.25 -0.906 . . . . 0.0 109.141 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.68 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 119' ' ' LYS . 97.6 m-20 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' ASP . 57.5 mttp -44.69 126.78 5.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.837 . . . . 0.0 109.334 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.589 ' N ' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -149.37 168.24 23.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.983 -179.331 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 143' ' ' VAL . 26.8 mt -116.71 154.0 31.37 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.552 0.691 . . . . 0.0 110.321 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.0 m -140.48 86.41 2.06 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.45 159.68 19.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 111.175 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.9 mt -140.14 126.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 p -90.31 118.7 30.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.767 -1.208 . . . . 0.0 109.025 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 23.1 m -99.1 154.2 18.31 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.619 -0.676 . . . . 0.0 110.129 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.1 t70 179.87 132.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 109.073 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.2 t0 59.76 72.27 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 109.331 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -65.27 122.27 16.73 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 10.0 p30 -85.7 129.47 34.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.893 -1.129 . . . . 0.0 109.476 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -91.25 4.84 51.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 108.962 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -71.96 -62.44 1.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.807 . . . . 0.0 109.088 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 p -98.49 -3.16 37.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.472 -0.767 . . . . 0.0 109.314 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.67 47.78 19.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.54 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 2.9 t -146.79 169.57 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -1.076 . . . . 0.0 109.329 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 73.4 m95 -73.2 114.19 11.11 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.177 -0.952 . . . . 0.0 108.943 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.6 tp10 -35.55 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.081 0.467 . . . . 0.0 110.727 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.13 150.42 40.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.608 -0.682 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.1 OUTLIER -166.96 164.91 16.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -130.41 133.19 46.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.499 -0.75 . . . . 0.0 109.1 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.4 mm -94.54 146.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.46 140.93 25.41 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 5.9 t -133.07 147.15 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.271 -0.893 . . . . 0.0 110.752 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.41 144.65 33.19 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.7 t -118.3 148.89 42.0 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 147' ' ' VAL . 7.7 tp10 -61.93 137.24 58.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.62 -0.675 . . . . 0.0 109.407 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.52 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 4.3 m . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.95 . . . . 0.0 109.358 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.21 118.94 1.86 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.595 1.53 . . . . 0.0 112.065 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -73.68 -18.61 60.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.945 . . . . 0.0 109.371 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -77.94 106.38 9.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.354 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -57.04 -10.6 1.19 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -94.26 27.2 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 109.771 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -141.52 131.64 24.77 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.317 -0.865 . . . . 0.0 109.481 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 44.7 t -61.84 142.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.472 -0.768 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.55 -23.78 14.97 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.496 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -174.2 -163.25 27.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 34.7 m-85 -149.88 130.84 14.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 0.0 109.539 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tt -95.62 144.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -146.04 142.09 28.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.037 -1.039 . . . . 0.0 110.343 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 75' ' ' LEU . 12.5 mt -150.13 132.23 7.87 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.09 -49.28 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.883 1.722 . . . . 0.0 111.882 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -51.75 -30.02 21.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.601 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -106.67 3.29 26.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.371 -0.83 . . . . 0.0 108.895 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.1 p30 43.61 30.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.28 147.66 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.898 0.856 . . . . 0.0 109.79 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -165.35 84.51 0.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.84 159.36 72.88 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.327 -0.858 . . . . 0.0 111.052 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.21 163.59 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.273 2.649 . . . . 0.0 113.32 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.79 132.54 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 42.2 m-85 -87.44 146.18 39.12 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.818 -1.176 . . . . 0.0 109.872 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.52 88.83 1.23 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.909 1.739 . . . . 0.0 111.365 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.19 -170.97 34.41 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.522 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 95.6 Cg_endo -81.11 117.97 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.883 2.389 . . . . 0.0 111.513 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -46.03 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.301 0.572 . . . . 0.0 110.724 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.7 OUTLIER -110.6 155.76 41.62 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.93 -44.15 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.223 1.949 . . . . 0.0 112.036 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -62.93 -26.2 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -84.12 -62.62 1.52 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.159 -0.963 . . . . 0.0 109.039 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -49.28 -11.99 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 38' ' ' GLN . 74.9 m-20 -61.93 -27.75 69.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.2 mtp180 -91.4 -10.88 39.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' C ' HE22 ' A' ' 71' ' ' GLN . . . 164.12 -139.45 5.86 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.259 -1.448 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 t -110.67 164.59 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.438 -1.037 . . . . 0.0 109.329 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -158.86 157.14 30.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.182 -0.949 . . . . 0.0 108.623 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.536 ' CE2' ' OE1' ' A' ' 50' ' ' GLU . 46.9 m-85 -58.04 175.92 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.863 -1.148 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -89.0 -3.35 58.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.457 -0.777 . . . . 0.0 109.126 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -153.97 145.82 23.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.287 -0.883 . . . . 0.0 109.966 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -62.49 -31.17 71.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -86.86 6.94 29.33 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.953 -1.092 . . . . 0.0 110.893 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 11.9 tm-20 -61.79 152.19 32.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' ASP . 76.5 p -146.32 163.38 35.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.017 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -74.54 10.64 1.25 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.9 OUTLIER -124.0 -6.25 7.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.838 -0.539 . . . . 0.0 109.751 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.7 t70 -59.73 113.9 2.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.859 -1.15 . . . . 0.0 109.308 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -45.4 -18.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.277 -0.889 . . . . 0.0 109.631 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' OE1' ' A' ' 55' ' ' GLN . 4.0 m120 -133.27 98.66 4.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.498 -0.751 . . . . 0.0 109.051 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 122' ' ' THR . 96.1 mt -96.68 113.31 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.698 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.5 m -108.6 120.23 41.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 60' ' ' ALA . 87.1 mt -107.21 164.45 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.473 -0.767 . . . . 0.0 110.226 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.571 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.99 124.61 23.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.65 152.4 22.07 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 119.932 -1.128 . . . . 0.0 110.748 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' PHE . 34.0 m-70 -72.72 -179.93 3.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.758 -0.848 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 88.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.02 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -87.51 123.68 32.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 109.06 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 65' ' ' ILE . 6.6 mt -63.76 -33.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.563 -0.71 . . . . 0.0 110.589 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -82.97 8.17 13.43 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 110.122 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 69' ' ' ASN . 21.7 mmt180 -140.72 75.28 25.92 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 87.7 Cg_exo -48.64 5.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.621 2.881 . . . . 0.0 113.844 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' ARG . 6.8 p30 -143.64 59.42 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.95 -1.094 . . . . 0.0 108.165 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.66 95.97 3.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.582 -0.699 . . . . 0.0 110.355 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.504 HE22 ' C ' ' A' ' 42' ' ' GLY . 1.1 mm100 61.0 -114.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.851 -0.53 . . . . 0.0 111.815 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.649 ' CE2' HG22 ' A' ' 125' ' ' THR . 2.3 t80 -91.93 26.85 2.29 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.138 -0.976 . . . . 0.0 110.803 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -69.22 -38.74 78.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.87 -1.144 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 15.6 m-20 -108.49 -17.0 14.09 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.226 -0.921 . . . . 0.0 111.072 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -53.16 -25.33 13.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.729 -1.232 . . . . 0.0 108.36 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -81.88 -14.35 56.34 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -78.4 -16.57 57.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.03 -162.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -174.32 174.97 2.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -48.85 149.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 -11.27 7.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 57.8 m -62.21 94.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.117 -1.225 . . . . 0.0 108.64 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptm -66.32 162.19 20.75 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.195 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.82 174.3 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.865 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -144.71 108.83 4.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -0.899 . . . . 0.0 110.001 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -95.09 113.37 25.06 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -96.49 144.37 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 110.301 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 18.3 t -143.02 86.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.36 -133.37 42.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.86 37.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -1.223 . . . . 0.0 109.587 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 88' ' ' VAL . 21.1 mp0 -138.81 151.98 47.5 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.268 -0.895 . . . . 0.0 108.916 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.6 m -152.97 143.82 22.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.005 . . . . 0.0 110.099 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.421 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -144.33 170.61 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.413 -0.805 . . . . 0.0 108.98 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 24.8 pttm -142.87 162.0 36.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 5.9 m-85 -139.35 -175.67 4.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -136.79 110.58 8.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.0 tpp -50.89 104.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.431 -0.793 . . . . 0.0 109.05 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -143.84 35.32 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 143' ' ' VAL . 16.5 t -173.67 131.91 0.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.2 mt . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 109.008 -179.3 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 121.371 0.605 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 119' ' ' LYS . 12.2 mptt -46.29 162.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -157.18 145.0 19.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.154 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.2 tp -103.57 107.56 18.46 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 57' ' ' ILE . 10.5 m -92.54 146.76 23.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.62 152.24 50.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.284 -0.885 . . . . 0.0 110.489 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 mt -141.3 134.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.649 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.1 p -92.21 160.61 15.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.932 -1.105 . . . . 0.0 108.423 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 56.6 m -144.97 140.1 27.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.06 -1.025 . . . . 0.0 109.943 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 p30 175.65 139.39 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.43 58.76 1.65 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.26 -0.9 . . . . 0.0 108.887 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.99 126.62 27.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 109.444 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -85.9 116.99 24.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.131 -0.981 . . . . 0.0 109.695 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -84.18 1.38 44.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -81.22 -52.18 7.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.328 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.6 p -95.65 -15.06 22.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.27 42.31 15.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -147.14 153.24 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.345 -1.091 . . . . 0.0 109.509 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 69.2 m95 -59.25 112.55 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 23.1 tt0 -35.24 -84.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -107.06 157.45 17.82 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.394 -0.816 . . . . 0.0 109.473 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -174.84 161.02 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -127.67 153.31 46.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 35.0 mm -115.91 139.12 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.583 0.706 . . . . 0.0 110.61 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -136.57 159.12 42.76 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 99' ' ' SER . 59.4 t -148.08 149.29 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.776 -1.202 . . . . 0.0 110.896 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.67 134.24 30.11 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.3 t -95.68 143.43 26.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 3.3 tm-20 -60.22 145.76 46.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 1.8 t . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 0.0 109.337 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 7' ' ' ILE . 11.9 mt . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.85 136.37 7.16 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.844 1.696 . . . . 0.0 112.196 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -87.44 -28.72 21.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.04 113.28 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -58.2 -11.78 2.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.328 -0.857 . . . . 0.0 109.626 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -79.95 21.04 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -147.51 136.16 21.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.057 -1.027 . . . . 0.0 109.659 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 15' ' ' ALA . 61.3 t -60.36 161.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.699 0.761 . . . . 0.0 110.223 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.553 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -136.13 -9.58 2.01 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -172.05 -179.16 42.8 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.6 120.11 7.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.3 . . . . 0.0 109.172 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 tt -97.04 140.33 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -146.23 138.89 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.105 -0.997 . . . . 0.0 110.081 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 8.3 mt -146.4 127.13 7.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.6 -44.22 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.742 1.628 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.24 -17.67 0.75 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.293 -0.88 . . . . 0.0 109.819 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -134.36 17.55 3.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.168 -0.958 . . . . 0.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.71 48.4 4.81 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.682 0.753 . . . . 0.0 109.912 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 23' ' ' ALA . 48.3 mm -88.89 141.42 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.655 0.741 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.31 82.69 0.17 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 19.2 mm-40 -143.13 156.78 61.39 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.139 -0.976 . . . . 0.0 110.561 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -83.49 165.72 14.12 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.888 2.392 . . . . 0.0 112.301 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.1 109.23 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -65.84 139.51 96.88 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.705 -1.247 . . . . 0.0 109.1 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.53 109.23 2.59 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.824 1.682 . . . . 0.0 111.904 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.54 -174.47 39.76 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.135 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.586 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 74.3 Cg_endo -76.75 113.93 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.576 2.184 . . . . 0.0 110.969 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -44.58 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.438 0.637 . . . . 0.0 111.151 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.575 ' OG1' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -100.24 169.35 8.08 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.56 -27.53 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.632 1.555 . . . . 0.0 112.42 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.48 -33.66 75.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.586 ' NE2' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -89.85 -51.7 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 109.231 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 39' ' ' LEU . 18.8 mt -46.88 -30.45 2.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.473 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -65.01 -27.32 68.74 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 38' ' ' GLN . 89.0 mtt180 -84.5 -19.61 32.98 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.67 -140.77 6.35 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.754 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.0 t -107.32 164.69 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.708 -0.878 . . . . 0.0 108.799 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -163.24 157.53 20.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.959 -1.088 . . . . 0.0 109.194 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 37.3 m-85 -59.67 161.86 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.354 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.56 5.28 36.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.39 142.03 9.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.717 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 -23.64 67.54 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.645 -0.659 . . . . 0.0 111.529 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -87.1 4.84 40.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.878 -1.139 . . . . 0.0 110.728 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -62.68 157.15 21.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 109.429 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.532 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -143.99 179.51 7.15 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.986 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -83.75 4.24 29.75 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -146.07 16.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.512 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.2 t70 -58.26 115.24 2.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.681 -1.262 . . . . 0.0 108.779 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -43.51 -19.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 54' ' ' ASP . 21.6 t-20 -135.17 97.24 3.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -94.85 151.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 109.347 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.7 m -143.64 116.84 8.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.7 mt -112.59 162.57 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.738 0.78 . . . . 0.0 110.601 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -132.78 131.76 41.48 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.24 148.3 19.98 Favored Glycine 0 N--CA 1.505 3.286 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.323 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -76.3 -169.89 1.31 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.646 -0.914 . . . . 0.0 110.422 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 63' ' ' THR . 14.7 t -158.82 83.44 0.81 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.75 0.786 . . . . 0.0 108.971 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.56 108.51 19.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.712 -1.243 . . . . 0.0 109.462 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 mm -60.06 -28.4 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 110.44 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -86.97 16.52 4.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 69' ' ' ASN . 33.2 ttm180 -150.56 72.99 9.02 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.81 14.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 123.909 3.073 . . . . 0.0 114.325 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.568 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.2 p-10 -148.47 62.63 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.802 -1.186 . . . . 0.0 108.572 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.469 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 44.7 t80 -151.47 98.79 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 20.4 mt-30 60.99 -127.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 111.179 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.71 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -92.01 59.08 3.51 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.682 1.23 . . . . 0.0 109.574 -178.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 m -91.17 -24.77 19.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.202 -1.561 . . . . 0.0 108.632 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -136.77 -0.97 2.28 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 -178.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -10.22 0.28 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.403 -1.435 . . . . 0.0 108.042 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.48 -37.59 50.95 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -27.6 69.13 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.06 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -175.11 171.51 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 109.919 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -51.14 101.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.5 -29.85 2.46 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.444 ' OG ' ' CG2' ' A' ' 20' ' ' ILE . 14.1 t -62.81 108.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.2 mtp -62.83 174.99 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.642 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.09 108.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.97 104.91 17.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 109.942 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -94.53 111.94 23.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -102.01 144.64 30.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 110.459 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 15' ' ' ALA . 4.7 p -170.24 128.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.557 -0.714 . . . . 0.0 109.268 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.19 -120.42 19.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.19 35.05 4.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.956 . . . . 0.0 109.117 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.3 133.61 16.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 108.944 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.8 t -119.01 133.91 55.53 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.674 0.749 . . . . 0.0 110.172 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -94.89 172.07 8.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -147.53 96.51 2.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.915 -1.116 . . . . 0.0 110.226 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 24.7 m-85 -87.57 -173.72 4.47 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.015 -1.053 . . . . 0.0 108.594 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER -150.25 111.55 4.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.138 -0.976 . . . . 0.0 109.886 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtp -48.67 117.27 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.326 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -158.54 21.11 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.053 -1.029 . . . . 0.0 109.555 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 11.2 p -167.83 86.04 0.22 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.635 -1.291 . . . . 0.0 109.299 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 119' ' ' LYS . 33.2 t0 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 16.8 ttmm -34.54 132.79 0.28 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.91 175.03 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.6 tp -128.82 102.97 6.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -93.03 87.24 5.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.185 -0.947 . . . . 0.0 109.151 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.82 152.3 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.909 -1.119 . . . . 0.0 109.256 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -129.03 151.56 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.669 -0.645 . . . . 0.0 109.29 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.422 HG22 ' CD2' ' A' ' 72' ' ' PHE . 52.0 p -96.37 153.3 17.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.154 -0.967 . . . . 0.0 108.568 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.77 97.88 2.97 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.968 -1.083 . . . . 0.0 109.799 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 127' ' ' ASP . 2.0 p30 -147.25 136.18 22.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 108.75 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 127' ' ' ASP . 1.5 m-20 70.84 64.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 109.576 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.99 125.75 25.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 0.0 109.865 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -86.87 125.74 34.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.135 -0.978 . . . . 0.0 109.399 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.72 4.5 47.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 109.811 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.67 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.408 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.8 p -95.21 -3.14 48.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.37 45.4 54.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 165.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -1.146 . . . . 0.0 109.24 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLU . 81.4 m95 -68.86 114.38 7.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.189 -0.945 . . . . 0.0 108.696 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.3 tp10 -35.42 -86.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.24 0.543 . . . . 0.0 110.325 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -103.76 148.86 25.58 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -157.19 138.9 14.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.792 -1.192 . . . . 0.0 110.618 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -99.76 166.35 11.14 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.3 132.84 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.435 -0.79 . . . . 0.0 110.157 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -141.34 147.25 37.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.529 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 19.2 t -135.94 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.077 -1.015 . . . . 0.0 111.296 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.15 -178.54 3.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.0 t -144.85 141.01 28.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.91 -1.119 . . . . 0.0 109.377 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -57.67 147.27 28.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.81 . . . . 0.0 109.555 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mm . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.08 168.56 0.36 Allowed 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.466 2.111 . . . . 0.0 112.446 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 -14.99 16.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.401 -0.812 . . . . 0.0 109.176 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 12' ' ' SER . 0.8 OUTLIER -76.71 107.45 9.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -60.52 -3.44 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.0 109.293 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 10' ' ' ASP . 80.9 p -116.69 44.23 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -150.46 128.13 11.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.32 -0.862 . . . . 0.0 109.262 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 16' ' ' GLY . 39.2 t -55.33 158.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 111.278 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.501 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -140.7 2.39 1.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.633 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 173.68 -175.44 46.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 67.3 m-85 -150.34 126.74 10.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.109 -1.23 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.443 ' CD1' HD11 ' A' ' 123' ' ' LEU . 13.3 tt -95.66 147.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -149.84 134.88 17.94 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.807 -1.183 . . . . 0.0 110.95 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 84' ' ' VAL . 32.4 mt -145.49 124.79 6.81 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.2 -41.19 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.65 1.567 . . . . 0.0 111.724 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.92 -17.95 1.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.6 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 24' ' ' ASP . . . -130.01 13.49 5.73 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.523 -0.736 . . . . 0.0 109.553 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.8 p30 42.23 36.4 0.72 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 mt -90.58 140.97 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -165.92 86.89 0.36 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.62 159.15 70.2 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.474 -0.767 . . . . 0.0 110.441 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HB2' HG22 ' A' ' 14' ' ' VAL . 41.4 Cg_endo -85.58 164.0 10.79 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.061 2.507 . . . . 0.0 112.952 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.18 113.5 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.29 168.34 13.75 Favored Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.776 -1.202 . . . . 0.0 109.801 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.91 124.49 4.47 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.894 2.396 . . . . 0.0 111.831 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.99 170.55 30.11 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.29 -1.434 . . . . 0.0 110.45 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 35' ' ' THR . 98.5 Cg_endo -78.43 117.29 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.79 2.327 . . . . 0.0 111.256 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.79 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.534 -0.729 . . . . 0.0 109.996 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -122.96 155.41 63.94 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 19.5 Cg_endo -58.25 -48.1 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.902 1.735 . . . . 0.0 111.191 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -63.01 -19.53 64.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.89 . . . . 0.0 109.205 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 40' ' ' ASN . 5.2 tp-100 -89.63 -69.51 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.006 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.1 mt -52.57 -3.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 38' ' ' GLN . 16.5 m-20 -59.54 -28.62 67.26 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.906 -1.121 . . . . 0.0 108.744 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' CD ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -87.79 -18.94 28.23 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.38 -127.52 1.73 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.267 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.53 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.8 t -101.66 157.11 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.538 -0.978 . . . . 0.0 109.97 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.3 m -155.58 151.82 28.02 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -56.53 170.2 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.751 -1.218 . . . . 0.0 109.829 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.43 -3.39 52.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.822 . . . . 0.0 109.06 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -153.57 150.49 28.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.0 109.874 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 13.1 pt-20 -62.73 -40.73 98.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.544 -0.722 . . . . 0.0 111.422 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 63.9 t30 -88.44 18.64 4.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 7.7 tp10 -62.92 139.44 58.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.718 -1.238 . . . . 0.0 109.696 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 53' ' ' ASP . 16.1 m -146.51 152.51 39.1 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -60.39 -5.66 1.24 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 51' ' ' SER . 5.1 m-20 -75.85 -33.08 60.01 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.677 -0.639 . . . . 0.0 109.679 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 56' ' ' ASN . 51.3 m-20 -59.84 111.22 1.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.295 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.589 ' CD ' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -48.41 -14.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 108.819 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.6 t30 -125.69 108.02 11.13 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.39 117.65 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.009 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -108.6 108.96 20.04 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.66 161.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.475 -0.766 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.54 ' HB1' ' SG ' ' A' ' 126' ' ' CYS . . . -132.61 137.29 46.99 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.21 147.86 19.26 Favored Glycine 0 N--CA 1.5 2.965 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.998 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.551 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 18.7 m-70 -75.79 -165.52 0.46 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.885 -0.774 . . . . 0.0 110.278 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.95 88.86 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -88.15 108.97 19.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.055 -1.028 . . . . 0.0 109.084 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 mt -57.48 -27.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.465 -0.772 . . . . 0.0 109.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.6 12.1 5.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.007 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 69' ' ' ASN . 87.1 mtt180 -150.94 74.79 8.42 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 80.9 Cg_exo -48.62 7.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 123.629 2.886 . . . . 0.0 113.927 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 67' ' ' ARG . 44.8 p30 -142.21 58.81 1.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.678 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 61.7 t80 -141.49 100.21 3.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.427 -0.796 . . . . 0.0 110.387 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.678 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 24.0 mt-30 60.75 -124.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.512 -0.742 . . . . 0.0 111.245 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.673 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -91.95 34.72 0.99 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 122.772 1.272 . . . . 0.0 109.297 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.9 m -73.6 -26.66 60.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.421 -2.049 . . . . 0.0 108.855 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 22.0 m-20 -133.55 -4.42 2.94 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.266 -0.897 . . . . 0.0 110.775 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.9 -23.42 7.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.733 -1.229 . . . . 0.0 108.775 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -2.09 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.949 -1.094 . . . . 0.0 108.388 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.56 -33.55 15.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.76 179.56 0.12 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.171 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -148.84 170.77 17.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.16 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -49.14 149.14 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 109.034 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.3 -23.13 23.15 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.9 t -62.45 103.08 0.37 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 58.2 mmm -62.01 171.25 1.79 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.162 -0.962 . . . . 0.0 110.149 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 20' ' ' ILE . 30.1 t -141.38 110.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.44 102.44 15.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -95.42 113.7 25.39 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -85.78 143.22 28.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.565 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 t -148.2 84.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.42 -128.04 27.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -95.28 37.36 1.18 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.174 -1.192 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 92' ' ' THR . 1.2 tm-20 -163.17 114.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.076 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 91' ' ' GLU . 9.8 t -107.35 147.1 30.75 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.426 -0.797 . . . . 0.0 110.082 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 93' ' ' ARG . 9.2 mmm-85 -93.7 172.9 7.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.498 -0.751 . . . . 0.0 109.369 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -146.36 92.94 2.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.105 -0.997 . . . . 0.0 109.999 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.431 ' O ' ' SD ' ' A' ' 83' ' ' MET . 22.7 m-85 -87.38 -176.39 5.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.904 -1.122 . . . . 0.0 108.726 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -147.33 107.93 4.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.239 -0.913 . . . . 0.0 109.428 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 23.9 mtt -48.29 117.83 2.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.451 ' OG1' HG22 ' A' ' 145' ' ' THR . 10.1 p -142.92 8.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.259 -0.901 . . . . 0.0 109.143 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 143' ' ' VAL . 30.9 t -164.87 107.98 0.87 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 108.646 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.522 -0.736 . . . . 0.0 109.544 -178.807 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 120' ' ' GLN . 14.3 t70 . . . . . 0 N--CA 1.501 2.102 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 18.7 mmmt -26.93 84.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.484 0.659 . . . . 0.0 110.842 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.8 pm0 -99.36 170.03 8.93 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.585 0.707 . . . . 0.0 110.664 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.97 102.5 8.04 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -94.93 87.55 5.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.131 -0.981 . . . . 0.0 109.355 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.443 HD11 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -81.5 132.53 35.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.89 -1.131 . . . . 0.0 109.367 -179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 125' ' ' THR . 52.7 mt -113.96 159.86 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.501 0.667 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 ' CG ' ' A' ' 72' ' ' PHE . 80.8 p -97.2 167.24 11.16 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.62 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.551 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 1.7 m -149.96 84.59 1.4 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.153 -0.967 . . . . 0.0 109.348 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 128' ' ' ASP . 15.0 t70 -148.22 129.0 14.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.976 -1.078 . . . . 0.0 108.953 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 4.5 t0 78.92 60.72 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.85 127.71 33.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.817 -1.177 . . . . 0.0 110.067 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -85.79 123.71 31.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.07 -1.019 . . . . 0.0 109.501 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -98.39 8.4 44.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.263 -0.898 . . . . 0.0 109.78 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -86.89 -20.22 27.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.7 p -140.29 0.69 1.72 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.5 49.04 53.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.72 137.79 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -1.156 . . . . 0.0 109.305 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 51.5 m95 -52.6 112.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.934 -1.104 . . . . 0.0 108.43 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 136' ' ' TRP . 8.2 tp10 -37.6 -81.14 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.904 -0.498 . . . . 0.0 110.174 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -103.67 139.15 39.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.524 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -147.25 114.21 6.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.896 -1.128 . . . . 0.0 110.415 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -95.53 166.69 11.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.2 pt -147.95 162.42 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.89 -1.131 . . . . 0.0 110.919 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.8 m-85 -137.41 150.49 47.69 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 99' ' ' SER . 21.7 t -132.62 111.73 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.179 -0.951 . . . . 0.0 111.161 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.75 177.59 4.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.451 HG22 ' OG1' ' A' ' 98' ' ' THR . 14.7 t -144.66 139.35 27.96 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.978 -1.076 . . . . 0.0 109.726 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.08 144.81 44.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 147' ' ' VAL . 9.8 m . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.603 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.6 155.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.807 1.672 . . . . 0.0 112.525 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -102.65 -19.01 14.97 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.0 109.455 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.9 m-20 -77.22 110.31 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -58.0 -3.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.428 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.8 t -111.99 41.63 1.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.487 -0.758 . . . . 0.0 109.473 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -149.11 133.79 17.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 16' ' ' GLY . 61.5 t -58.86 161.0 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 110.95 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -139.97 -0.8 1.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 172.73 -173.71 45.54 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 44.2 m-85 -150.09 128.68 12.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.294 -1.121 . . . . 0.0 109.923 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -95.0 146.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.753 ' C ' HD12 ' A' ' 20' ' ' ILE . 37.9 tt0 -149.79 119.6 7.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.819 -1.175 . . . . 0.0 111.171 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 19' ' ' GLU . 1.9 mp -131.52 127.12 21.46 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 23' ' ' ALA . 71.9 Cg_endo -76.37 -42.71 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.53 1.486 . . . . 0.0 111.483 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 40.8 t0 -52.25 -10.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.423 -0.798 . . . . 0.0 109.473 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -140.59 15.45 2.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ALA . 2.3 p-10 41.68 49.6 3.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.078 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 20' ' ' ILE . 40.2 mm -91.27 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.674 0.749 . . . . 0.0 109.71 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -170.27 80.94 0.1 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -142.03 157.52 63.77 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 110.536 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.03 162.0 15.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.099 2.533 . . . . 0.0 113.068 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.92 109.23 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.67 168.77 22.92 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 120.753 -1.217 . . . . 0.0 109.505 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -88.21 117.12 1.01 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 122.726 2.284 . . . . 0.0 112.032 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.6 175.92 40.91 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.108 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 80.6 Cg_endo -78.35 115.52 3.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.808 2.339 . . . . 0.0 111.271 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -45.95 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.611 -0.681 . . . . 0.0 110.084 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.5 p -120.15 152.99 55.29 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.39 -41.29 79.57 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.985 1.79 . . . . 0.0 111.745 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.13 -22.84 67.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 109.62 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -90.89 -70.31 0.69 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.489 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 39' ' ' LEU . 16.1 mt -43.87 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 109.916 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 38' ' ' GLN . 19.6 m-20 -60.99 -24.17 65.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -90.95 -10.73 41.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.46 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.1 -115.72 0.68 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.6 t -126.16 154.95 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -150.68 155.13 38.72 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 41.7 m-85 -56.28 173.88 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.65 -1.281 . . . . 0.0 109.391 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.01 -13.39 58.9 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -146.31 153.19 40.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.269 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -63.71 -41.24 98.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.525 -0.734 . . . . 0.0 111.394 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -86.92 12.61 10.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.037 -1.039 . . . . 0.0 111.012 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.57 90.78 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.96 -1.087 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 53' ' ' ASP . 17.4 m -89.37 151.64 21.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 108.671 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.4 0.67 1.4 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 51' ' ' SER . 45.3 m-20 -95.88 -14.37 23.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.651 -0.656 . . . . 0.0 109.339 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.9 t0 -58.35 119.28 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.039 -1.038 . . . . 0.0 109.571 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.99 -14.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.72 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' ASP . 40.5 t30 -145.56 109.95 4.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 0.0 108.97 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.6 mp -95.29 154.9 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 108.98 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' HD11 ' A' ' 124' ' ' ILE . 16.6 t -143.67 123.28 13.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 90.2 mt -110.59 162.23 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.453 -0.779 . . . . 0.0 110.597 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.97 131.12 26.44 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.29 156.34 26.07 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 119.88 -1.153 . . . . 0.0 110.527 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -72.08 177.02 4.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.539 -0.977 . . . . 0.0 109.47 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.5 87.16 0.75 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.297 -0.877 . . . . 0.0 109.65 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.13 102.69 15.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.292 -0.88 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 mt -53.02 -23.69 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.218 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.03 13.96 3.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.115 -0.99 . . . . 0.0 109.451 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' ASN . 19.5 ttm-85 -152.66 74.95 7.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 109.282 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.43 20.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 123.911 3.074 . . . . 0.0 114.495 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.9 p-10 -151.22 62.8 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.893 -1.129 . . . . 0.0 108.609 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -151.32 123.53 8.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.097 -1.002 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 61.1 mt-30 40.9 -115.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.812 -0.555 . . . . 0.0 111.357 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -98.03 9.22 43.34 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -49.34 -22.25 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.544 -1.347 . . . . 0.0 109.556 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.0 t-20 -119.57 -22.35 6.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.863 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.676 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.7 tm? -53.26 -35.7 60.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.068 -1.02 . . . . 0.0 108.57 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -72.31 -4.37 29.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.308 -0.87 . . . . 0.0 108.689 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -89.81 -28.37 19.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.6 -172.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.767 . . . . 0.0 109.678 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -162.07 -177.64 5.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.882 . . . . 0.0 109.071 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 82' ' ' SER . 26.9 mtmm -49.78 155.89 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.005 -1.06 . . . . 0.0 109.288 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.75 -18.86 4.48 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 80' ' ' LYS . 73.7 m -63.89 98.93 0.22 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.327 -1.102 . . . . 0.0 108.437 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.7 mtm -62.24 -179.32 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.616 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 20' ' ' ILE . 74.2 t -149.2 108.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.412 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.15 102.38 15.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.128 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' HG11 ' A' ' 88' ' ' VAL . 43.4 t80 -95.66 111.99 23.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -95.89 134.22 39.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.159 -0.963 . . . . 0.0 111.384 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' A' ' 86' ' ' PHE . 2.0 m -153.33 134.7 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.29 -138.95 26.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -101.62 43.98 1.04 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.31 -1.112 . . . . 0.0 109.665 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -162.24 136.44 6.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.315 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -117.28 140.53 49.44 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.521 -0.737 . . . . 0.0 110.081 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -93.26 168.29 11.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.572 -0.705 . . . . 0.0 109.301 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 15.5 pttp -145.8 118.89 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.995 . . . . 0.0 109.935 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.51 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 27.5 m-85 -116.44 168.48 10.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -130.22 108.98 10.44 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.239 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.5 tpp -50.89 135.09 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.514 -0.741 . . . . 0.0 109.237 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -166.28 19.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.8 t -164.88 92.34 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 100' ' ' ILE . 2.5 mp . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.887 . . . . 0.0 109.498 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.5 m-20 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 13.3 mptt -43.38 130.31 4.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.243 -0.911 . . . . 0.0 109.448 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.71 172.67 12.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.7 tp -118.51 156.34 29.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.661 -0.649 . . . . 0.0 110.019 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 m -134.77 88.38 2.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.51 145.54 52.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 110.883 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.46 HD11 ' OG ' ' A' ' 58' ' ' SER . 51.5 mt -138.55 138.26 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.542 -0.724 . . . . 0.0 109.158 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -102.2 156.85 17.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 85.5 m -144.76 138.06 26.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.944 -1.098 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 4.3 t0 178.96 146.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 108.891 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 8.3 t70 60.59 54.3 3.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -61.68 121.25 12.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.116 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -86.25 121.88 29.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.757 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.5 pm0 -87.08 6.72 31.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.45 -50.83 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.4 p -97.67 -14.39 20.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 108.952 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.02 17.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.12 163.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -1.141 . . . . 0.0 109.717 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' O ' ' C ' ' A' ' 137' ' ' GLU . 73.4 m95 -68.24 114.71 6.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -37.18 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.218 0.532 . . . . 0.0 110.181 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -93.94 153.18 18.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -156.51 94.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.852 -1.155 . . . . 0.0 110.71 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -86.79 159.39 19.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 9.8 pt -145.82 159.57 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.842 -1.162 . . . . 0.0 110.685 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.4 m-85 -139.95 168.42 19.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.19 142.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.802 -1.186 . . . . 0.0 110.423 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.16 147.85 40.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 147' ' ' VAL . 13.0 t -108.63 140.36 42.12 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.51 ' OE1' ' CD2' ' A' ' 95' ' ' TYR . 3.2 tp10 -65.72 45.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.4 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.118 -0.988 . . . . 0.0 109.223 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -41.08 143.3 0.7 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.304 2.003 . . . . 0.0 113.356 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -87.19 -16.24 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.148 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' SER . 12.9 m-20 -77.7 105.62 8.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 109.451 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 1.9 mptp? -58.56 -2.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.443 -0.786 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' ASP . 39.7 m -113.94 43.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HZ3' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -143.15 134.41 25.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.942 . . . . 0.0 109.04 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.6 115.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.818 . . . . 0.0 110.932 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -95.76 -4.53 43.82 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.53 -168.85 41.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.54 124.77 10.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.178 -1.189 . . . . 0.0 109.071 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.7 tt -98.91 147.38 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.18 145.95 30.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.01 -1.056 . . . . 0.0 109.828 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -147.86 131.82 8.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -52.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.981 1.787 . . . . 0.0 111.833 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -50.88 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 109.301 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.55 3.08 17.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.521 -0.737 . . . . 0.0 109.073 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 43.39 37.1 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.573 -0.705 . . . . 0.0 109.646 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -92.91 152.19 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 122.214 1.006 . . . . 0.0 110.665 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -166.07 82.64 0.3 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -132.4 158.69 74.97 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.47 -0.769 . . . . 0.0 110.694 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.67 162.01 21.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.006 2.47 . . . . 0.0 112.654 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -138.16 104.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -76.65 166.13 47.23 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.785 -1.197 . . . . 0.0 109.377 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 15' ' ' ALA . 43.7 Cg_endo -89.77 120.04 0.89 Allowed 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.488 2.126 . . . . 0.0 111.818 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.09 -178.4 43.53 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 35' ' ' THR . 88.3 Cg_endo -81.22 116.63 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.919 2.413 . . . . 0.0 111.712 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -46.61 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.765 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -119.62 153.9 54.43 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 22.4 Cg_endo -60.35 -45.12 23.93 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.127 1.884 . . . . 0.0 111.803 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -63.28 -27.8 69.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 109.698 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 40' ' ' ASN . 1.6 tm0? -86.51 -68.33 0.75 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -46.82 -14.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.738 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.6 m-20 -63.89 -24.96 67.94 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -80.14 -20.92 43.8 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.085 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' OE1' ' A' ' 71' ' ' GLN . . . 159.29 -119.29 0.88 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.9 t -118.55 157.8 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.605 -0.938 . . . . 0.0 110.102 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 158.9 37.86 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -56.18 173.37 0.16 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.716 -1.24 . . . . 0.0 109.355 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.1 -14.48 55.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.895 . . . . 0.0 109.139 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -146.78 145.62 29.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 110.063 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -24.41 67.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.52 -0.737 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -88.75 3.24 51.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.0 150.3 45.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 109.758 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 45.9 m -149.04 159.6 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -69.64 -4.22 18.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -99.52 -15.34 18.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.683 . . . . 0.0 109.932 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 51' ' ' SER . 31.2 m-20 -60.14 107.61 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.716 -1.24 . . . . 0.0 109.203 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -45.75 -18.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.379 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.4 t-20 -127.81 98.31 5.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 58' ' ' SER . 96.6 mt -94.51 154.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 109.277 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 46' ' ' ALA . 58.6 m -145.38 117.59 8.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.2 mt -112.62 158.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 110.22 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.52 136.61 34.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.95 156.38 25.93 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -71.77 178.41 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.484 -1.009 . . . . 0.0 109.535 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.462 ' CG2' ' OD1' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -163.52 86.51 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.42 -0.8 . . . . 0.0 109.28 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -88.41 119.34 28.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.7 -30.9 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.074 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -82.9 15.94 2.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 109.566 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 69' ' ' ASN . 54.7 ttt180 -150.32 70.97 9.17 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.19 18.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.843 3.028 . . . . 0.0 114.36 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.2 63.41 0.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.783 -1.198 . . . . 0.0 108.651 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -151.09 110.77 4.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 64.2 mt-30 54.81 -115.5 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.712 -0.618 . . . . 0.0 111.918 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.592 ' CE2' HD13 ' A' ' 75' ' ' LEU . 3.1 m-85 -96.21 10.98 36.07 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.186 -0.946 . . . . 0.0 110.559 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.4 m -49.08 -18.01 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.0 m-20 -122.05 -23.58 5.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.398 -0.814 . . . . 0.0 110.032 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.592 HD13 ' CE2' ' A' ' 72' ' ' PHE . 6.9 tt -54.2 -29.0 44.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.768 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -75.4 -7.2 53.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -88.41 -24.0 23.17 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.73 -178.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.584 -0.697 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.23 162.86 40.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -52.98 133.03 38.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.57 -5.06 66.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 83' ' ' MET . 25.8 t -63.33 -161.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.055 -1.262 . . . . 0.0 108.174 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.521 ' N ' ' OG ' ' A' ' 82' ' ' SER . 50.1 mmm -142.61 162.27 35.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 109.739 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 t -146.15 155.45 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.236 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.83 107.9 5.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.287 -0.883 . . . . 0.0 109.207 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -95.02 112.28 24.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -97.99 138.98 34.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.7 m -144.06 150.19 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.32 -14.83 0.06 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 88' ' ' VAL . 48.2 t30 -84.02 -58.48 2.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.035 -1.274 . . . . 0.0 109.999 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.474 ' H ' HG23 ' A' ' 88' ' ' VAL . 20.1 tt0 -172.08 171.68 4.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 108.904 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -97.61 149.7 21.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.202 -0.936 . . . . 0.0 110.037 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.65 169.5 17.52 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.524 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.78 156.49 44.99 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.05 -1.031 . . . . 0.0 110.911 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.527 ' CE2' ' OE1' ' A' ' 146' ' ' GLU . 6.5 m-85 -136.5 -178.07 5.01 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -145.68 116.45 7.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.164 -0.96 . . . . 0.0 109.054 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 40.2 mtt -51.03 111.98 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.438 -0.788 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -140.04 28.98 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.369 -0.832 . . . . 0.0 108.916 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 p -178.95 141.91 0.19 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -178.632 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.436 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 4.4 mptp? -46.83 137.54 7.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 108.54 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -150.05 152.04 34.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 110.528 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.28 117.32 30.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.949 -0.47 . . . . 0.0 110.22 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 m -92.41 88.17 6.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.0 mt -68.28 138.33 55.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.697 . . . . 0.0 109.986 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.2 mt -137.87 148.31 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.391 -0.818 . . . . 0.0 109.604 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -102.94 169.01 8.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.427 -0.796 . . . . 0.0 108.907 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 34.5 m -148.49 138.93 22.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.993 -1.067 . . . . 0.0 109.619 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.462 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 0.3 OUTLIER 175.3 140.23 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 109.078 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 t0 59.86 66.36 1.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 108.986 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -65.52 127.53 32.23 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 109.668 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -84.77 124.94 32.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.027 -1.045 . . . . 0.0 109.759 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.3 6.25 48.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.461 -0.774 . . . . 0.0 109.228 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -88.36 -19.73 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.808 . . . . 0.0 109.681 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.7 p -137.29 -2.36 2.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.382 -0.824 . . . . 0.0 109.323 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.42 44.29 59.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.78 154.34 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.63 112.99 3.07 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.3 tp10 -37.96 -82.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.93 -0.481 . . . . 0.0 110.691 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -105.24 140.34 38.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.491 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -170.45 138.84 1.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.9 160.58 21.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.89 159.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.833 -1.167 . . . . 0.0 110.92 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 4.8 m-85 -132.66 177.45 7.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.4 t -150.66 133.61 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.852 -1.155 . . . . 0.0 110.586 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.57 15.03 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 147' ' ' VAL . 12.6 t -139.93 147.33 40.39 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.0 -1.063 . . . . 0.0 110.853 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.527 ' OE1' ' CE2' ' A' ' 95' ' ' TYR . 18.2 tp10 -65.51 48.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.778 -0.576 . . . . 0.0 109.459 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 145' ' ' THR . 2.0 t . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.084 -1.01 . . . . 0.0 108.961 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -41.39 130.58 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.818 1.679 . . . . 0.0 112.51 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -78.03 -29.27 49.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.503 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' SER . 40.3 m-20 -77.28 112.65 14.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -58.66 -2.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.524 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.2 m -105.68 38.84 1.89 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.345 -0.847 . . . . 0.0 109.543 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -142.51 126.37 17.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.302 -0.874 . . . . 0.0 109.261 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.497 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 24.9 t -59.62 132.34 24.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.914 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.07 -10.61 21.34 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 176.16 -161.13 29.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.497 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 66.0 m-85 -148.9 131.58 15.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.768 -1.43 . . . . 0.0 110.179 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -98.16 142.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -145.38 133.26 21.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.996 -1.065 . . . . 0.0 110.166 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 23' ' ' ALA . 53.5 mt -142.63 125.94 9.37 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.98 -44.35 0.21 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.707 1.604 . . . . 0.0 111.956 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -53.17 -20.48 3.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.087 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -121.6 8.33 10.09 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.4 p30 43.15 31.71 0.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.593 -0.692 . . . . 0.0 110.01 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 mt -91.08 143.2 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -164.2 85.89 0.46 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.4 159.6 68.76 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 110.624 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.06 162.01 26.28 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.048 2.499 . . . . 0.0 113.036 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 43' ' ' VAL . 3.1 t -139.63 115.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.442 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.73 170.37 13.19 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 120.794 -1.191 . . . . 0.0 108.733 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -89.16 130.91 2.1 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.451 2.101 . . . . 0.0 112.194 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' PHE . . . 164.74 175.08 35.17 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.612 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 35' ' ' THR . 61.9 Cg_endo -85.95 128.01 3.17 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.909 2.406 . . . . 0.0 111.589 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.618 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -38.84 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.662 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -118.79 154.13 52.71 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.76 -41.37 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.267 1.978 . . . . 0.0 111.89 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -63.08 -21.28 66.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 109.588 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -94.64 -70.08 0.72 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.296 -0.877 . . . . 0.0 109.269 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 16.7 mt -44.29 -26.29 0.31 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -61.11 -24.17 66.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 26.9 mtt-85 -89.13 -11.76 42.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.32 -122.33 1.14 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.222 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 60' ' ' ALA . 18.2 t -122.3 151.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.61 -0.936 . . . . 0.0 109.094 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -151.23 151.01 31.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 32' ' ' GLY . 27.7 m-85 -55.4 155.78 4.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.544 -1.348 . . . . 0.0 108.41 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -83.43 4.88 25.74 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.265 -0.897 . . . . 0.0 109.04 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -149.99 130.83 14.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.403 -0.811 . . . . 0.0 110.109 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.76 -22.83 65.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.775 . . . . 0.0 110.486 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -88.0 -2.8 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.035 -1.041 . . . . 0.0 110.075 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -60.45 163.55 5.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 109.081 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -145.43 -167.97 2.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 108.893 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.4 mp -95.05 11.64 31.35 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.215 -0.928 . . . . 0.0 109.079 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.92 12.38 0.44 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 19.6 t0 -57.03 120.38 7.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.756 -1.215 . . . . 0.0 108.751 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -45.86 -15.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.289 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 4.8 m120 -136.12 99.32 4.1 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.0 mm -93.26 153.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.03 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 t -142.02 103.29 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -100.4 158.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.854 0.835 . . . . 0.0 110.336 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.588 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -138.12 134.7 34.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.87 27.43 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.684 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' PHE . 14.3 m-70 -76.49 178.4 6.65 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.585 -0.95 . . . . 0.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.48 90.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 108.74 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' N ' ' OG1' ' A' ' 73' ' ' THR . 5.3 m-85 -87.48 110.54 20.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.199 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 mm -58.32 -30.68 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 110.155 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -87.96 19.38 3.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.13 -0.981 . . . . 0.0 109.465 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -149.88 74.5 9.33 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.433 -0.792 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.1 Cg_exo -56.06 26.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 123.48 2.787 . . . . 0.0 113.524 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -150.57 29.21 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.835 -1.166 . . . . 0.0 109.073 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.8 t80 -89.28 -153.2 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -0.956 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.4 mp0 -71.29 -84.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.711 0.767 . . . . 0.0 110.808 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -94.78 19.45 10.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.677 -0.639 . . . . 0.0 109.968 -178.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.491 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 55.5 m -69.74 -38.19 76.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.326 -1.484 . . . . 0.0 109.93 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 77' ' ' ALA . 16.0 m-20 -103.92 -10.28 18.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.182 -0.948 . . . . 0.0 111.46 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 72' ' ' PHE . 2.6 mt -53.16 -29.27 30.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.406 -1.433 . . . . 0.0 108.365 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 10.6 pttp -80.36 -10.44 59.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -79.51 -23.37 42.98 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.85 -175.34 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLY . 34.3 mttm -150.53 154.98 38.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.029 -1.045 . . . . 0.0 109.686 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -51.06 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 109.734 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 97' ' ' MET . . . 150.84 -20.93 1.0 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -66.03 -165.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.104 -1.233 . . . . 0.0 108.185 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.3 mmm -137.88 171.65 14.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.14 108.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.0 109.145 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -93.37 109.37 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' O ' ' OG1' ' A' ' 92' ' ' THR . 39.9 t80 -94.76 116.89 29.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -85.24 139.11 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 111.115 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.3 m -147.78 124.98 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.53 -132.79 35.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.477 ' N ' ' OE2' ' A' ' 91' ' ' GLU . 49.8 t30 -97.95 35.98 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -1.198 . . . . 0.0 109.832 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.477 ' OE2' ' N ' ' A' ' 90' ' ' ASN . 1.2 pm0 -159.64 170.0 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -0.979 . . . . 0.0 108.955 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 86' ' ' PHE . 6.3 t -141.26 150.22 42.33 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.714 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -92.29 175.53 6.81 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -146.87 133.48 19.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 1.7 m-85 -138.85 126.84 22.42 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.544 ' NZ ' HG21 ' A' ' 147' ' ' VAL . 4.1 ttpm? -93.95 120.39 34.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 109.399 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.423 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 85.2 mtp -48.13 120.64 3.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.522 ' OG1' HG22 ' A' ' 145' ' ' THR . 8.7 p -149.83 31.62 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.37 -0.831 . . . . 0.0 109.304 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 m -171.54 86.95 0.09 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.834 -179.192 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.471 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 2.2 m-20 . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 118' ' ' ASP . 58.2 mttm -44.7 147.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -150.6 150.74 31.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.677 -1.265 . . . . 0.0 110.791 -178.036 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.38 111.9 24.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.88 -0.513 . . . . 0.0 109.753 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 m -98.04 120.79 39.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.201 -0.937 . . . . 0.0 108.696 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mp -104.43 147.11 27.92 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.471 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 77.3 mt -137.89 147.41 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.226 -0.921 . . . . 0.0 110.076 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.452 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.1 p -97.74 155.6 16.94 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.9 m -148.63 97.17 2.7 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.954 -1.091 . . . . 0.0 109.658 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 138' ' ' LYS . 4.9 p-10 -149.39 149.17 30.42 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 61.39 61.23 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.745 . . . . 0.0 109.282 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -64.38 118.87 9.34 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -86.72 118.04 25.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.051 -1.03 . . . . 0.0 109.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 5.1 pm0 -84.86 10.72 10.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -81.99 -54.53 5.24 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.8 p -96.29 -8.13 33.55 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.87 41.47 33.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -147.21 163.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.276 -1.132 . . . . 0.0 109.837 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.443 ' O ' ' C ' ' A' ' 137' ' ' GLU . 71.1 m95 -67.09 116.44 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' TRP . 16.4 tp10 -37.96 -86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.778 -0.576 . . . . 0.0 109.893 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.525 ' NZ ' ' OD2' ' A' ' 127' ' ' ASP . 1.9 pttp -89.0 152.06 21.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.463 ' NH2' HD13 ' A' ' 124' ' ' ILE . 54.8 ttt180 -157.45 89.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -79.28 167.99 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.493 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -148.58 151.38 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.756 -1.215 . . . . 0.0 110.023 -179.552 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 1.3 m-85 -143.09 162.52 35.31 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.1 t -148.68 152.72 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.764 -1.21 . . . . 0.0 110.929 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.41 160.96 38.19 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.522 HG22 ' OG1' ' A' ' 98' ' ' THR . 8.3 t -127.91 135.43 49.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.97 105.61 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.52 -0.738 . . . . 0.0 109.677 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.544 HG21 ' NZ ' ' A' ' 96' ' ' LYS . 1.3 t . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 108.889 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mt . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.37 162.82 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.474 2.116 . . . . 0.0 112.753 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -103.32 -12.41 17.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.511 -0.743 . . . . 0.0 109.363 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.533 ' CG ' ' HZ1' ' A' ' 13' ' ' LYS . 2.6 m-20 -77.55 109.06 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 11.9 mptt -59.62 -0.32 0.17 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.892 . . . . 0.0 109.604 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 10' ' ' ASP . 41.6 m -114.28 36.81 3.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.466 -0.771 . . . . 0.0 110.282 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HZ1' ' CG ' ' A' ' 10' ' ' ASP . 2.1 ttmp? -144.18 143.83 31.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.027 -1.046 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.19 145.12 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 110.098 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.46 11.79 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.87 173.54 34.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.75 119.98 7.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -1.175 . . . . 0.0 109.147 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -97.03 141.5 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -145.09 136.71 25.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 0.0 110.101 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.8 mt -144.37 127.05 8.47 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.9 Cg_endo -75.71 -43.23 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.524 1.483 . . . . 0.0 111.312 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.36 -15.24 0.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.464 -0.772 . . . . 0.0 109.128 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.1 13.6 3.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.46 52.4 4.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.454 -0.779 . . . . 0.0 109.944 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' ' 23' ' ' ALA . 49.8 mm -92.46 146.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.864 0.84 . . . . 0.0 110.214 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -169.83 80.28 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -142.9 158.79 58.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.54 162.27 14.64 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.511 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.52 112.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 5.7 m-85 -73.11 146.48 87.21 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -79.93 97.36 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.571 2.181 . . . . 0.0 111.884 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.19 -174.13 46.49 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.671 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 93.7 Cg_endo -80.55 120.97 4.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.839 2.359 . . . . 0.0 111.431 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -45.5 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.696 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.1 p -103.67 152.11 38.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.95 -44.31 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.958 1.772 . . . . 0.0 111.803 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.42 -24.68 67.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.701 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 40' ' ' ASN . 14.3 tt0 -88.59 -59.81 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.651 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -47.29 -15.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' GLN . 87.6 m-20 -58.63 -29.89 66.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 85.7 mtt180 -80.38 -19.7 45.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.9 -141.7 7.55 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.459 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.1 t -98.36 161.47 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.401 -1.058 . . . . 0.0 109.388 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -158.84 156.97 30.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.072 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -56.06 171.84 0.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -95.46 -2.43 48.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.97 140.41 18.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.024 -1.048 . . . . 0.0 110.62 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -62.56 -22.84 66.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.69 20.85 2.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 0.0 109.486 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.22 145.63 53.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.233 1.016 . . . . 0.0 111.116 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 53' ' ' ASP . 3.3 m -155.33 136.32 13.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' CB ' HH22 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -60.87 -4.91 1.11 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' SER . 92.8 m-20 -93.73 -17.8 22.79 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.745 -0.597 . . . . 0.0 109.677 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 56' ' ' ASN . 42.0 t0 -58.94 109.84 0.91 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.777 -1.202 . . . . 0.0 109.286 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -47.56 -12.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 109.638 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' ASP . 50.0 t-20 -140.28 104.97 4.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.198 -0.939 . . . . 0.0 109.074 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 58' ' ' SER . 4.0 mp -95.07 159.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.494 ' N ' HG22 ' A' ' 57' ' ' ILE . 2.9 p -145.43 123.15 11.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.3 mt -120.23 160.15 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.679 0.752 . . . . 0.0 110.396 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.49 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -134.28 134.28 41.72 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.76 22.37 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -71.66 176.48 4.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.983 . . . . 0.0 109.272 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.16 90.5 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.55 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -89.42 111.42 22.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.908 . . . . 0.0 109.258 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 mm -60.47 -29.19 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.855 . . . . 0.0 110.627 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.44 15.97 4.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.912 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 69' ' ' ASN . 51.5 ttt180 -152.18 77.56 6.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.6 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 30.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 123.128 2.552 . . . . 0.0 112.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 67' ' ' ARG . 17.4 m-80 -150.95 63.46 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.085 -1.009 . . . . 0.0 108.622 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.612 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 3.0 t80 -137.83 -153.76 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.612 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 2.4 mp0 -58.43 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CD2' HD22 ' A' ' 75' ' ' LEU . 3.8 m-30 -94.61 16.61 15.11 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.8 m -49.14 -24.87 1.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.722 -1.236 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.466 ' C ' ' HB1' ' A' ' 23' ' ' ALA . 2.8 m-20 -115.31 -29.04 6.69 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.763 . . . . 0.0 110.006 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 72' ' ' PHE . 6.7 tt -50.81 -20.89 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -76.44 -18.1 58.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.04 31.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.526 0.679 . . . . 0.0 109.338 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.67 123.86 7.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.802 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -102.67 177.57 4.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -0.831 . . . . 0.0 109.143 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -51.06 152.49 2.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.77 -19.72 19.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.5 m -62.97 95.66 0.08 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.339 -1.095 . . . . 0.0 108.579 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.74 165.75 9.95 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.49 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -143.89 121.5 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.948 . . . . 0.0 109.099 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 12.5 m-85 -95.09 110.57 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 88' ' ' VAL . 28.6 t80 -96.15 112.16 23.98 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -96.13 149.85 21.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.295 -0.878 . . . . 0.0 111.034 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' CZ ' ' A' ' 86' ' ' PHE . 74.1 t -155.42 103.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.93 -127.43 31.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -90.29 53.04 2.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -1.146 . . . . 0.0 109.692 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -155.1 146.23 22.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.2 m -151.31 109.94 3.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.523 HH22 ' CB ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -100.83 169.51 8.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.559 -0.713 . . . . 0.0 110.003 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 147.96 41.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 109.586 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 121' ' ' LEU . 3.3 m-85 -134.1 175.36 9.55 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' THR . 59.5 tttp -131.66 106.7 8.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.0 ttm -49.01 98.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 108.876 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -133.65 24.17 4.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.851 . . . . 0.0 109.835 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.8 t -167.06 121.85 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.8 mt . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.415 -0.803 . . . . 0.0 110.203 -178.222 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 120' ' ' GLN . 2.3 m-20 . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' ASP . 19.1 ttpp -47.32 96.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.876 -1.14 . . . . 0.0 108.788 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.1 pm0 -95.89 174.54 6.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.844 0.83 . . . . 0.0 110.777 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 95' ' ' TYR . 94.8 mt -129.08 119.41 24.14 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -95.26 93.51 7.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 0.0 108.949 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.684 HD22 ' N ' ' A' ' 123' ' ' LEU . 3.1 mm? -76.45 148.34 37.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 16.9 mt -142.32 140.68 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -97.18 164.84 12.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.232 -0.917 . . . . 0.0 108.691 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.431 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 22.6 m -148.97 140.76 23.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.009 -1.057 . . . . 0.0 109.934 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 177.81 142.93 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 2.6 m-20 55.99 63.41 2.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.743 . . . . 0.0 109.101 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.34 125.4 24.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.104 -0.998 . . . . 0.0 109.393 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -86.7 124.03 32.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.084 -1.01 . . . . 0.0 109.562 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.17 4.22 46.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -78.44 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.164 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.0 p -95.6 -3.21 46.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.335 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.84 46.33 53.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 t -146.78 157.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -1.158 . . . . 0.0 109.374 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.9 m95 -63.86 111.63 2.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.165 -0.96 . . . . 0.0 108.596 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' TRP . 74.6 tt0 -32.49 -72.39 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.872 0.368 . . . . 0.0 111.309 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -134.03 146.52 50.45 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.269 -0.895 . . . . 0.0 109.853 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.755 ' HE ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -167.38 -162.86 0.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.121 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -145.88 162.18 38.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.006 -1.058 . . . . 0.0 108.992 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.5 mt -133.78 138.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.42 -0.8 . . . . 0.0 109.843 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.7 m-85 -128.79 165.76 20.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 99' ' ' SER . 12.8 t -146.38 114.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.946 -1.096 . . . . 0.0 110.423 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.23 169.38 9.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 145' ' ' THR . 14.1 t -132.02 127.76 36.9 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.486 -0.759 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 3.2 tm-20 -59.0 131.92 52.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.13 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.239 -0.913 . . . . 0.0 109.075 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.497 1.881 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.8 179.54 6.19 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.786 1.657 . . . . 0.0 112.313 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -103.77 20.8 17.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.469 -0.77 . . . . 0.0 109.578 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.7 m-20 -77.98 101.94 7.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.983 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 3.5 mptp? -62.29 7.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.383 -0.823 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 10' ' ' ASP . 75.6 p -141.37 41.85 1.76 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -147.66 142.0 26.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.023 -1.048 . . . . 0.0 109.827 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 58.3 t -61.35 122.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.595 -0.691 . . . . 0.0 110.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.81 -25.3 15.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -172.95 -161.64 23.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.542 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 13.0 m-85 -147.26 126.97 13.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.132 -1.217 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -96.04 138.44 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 178.081 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' H ' HD13 ' A' ' 18' ' ' ILE . 22.4 mt-10 -145.23 141.29 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.652 -1.28 . . . . 0.0 111.836 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.0 mt -148.26 127.26 6.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.431 ' C ' ' N ' ' A' ' 23' ' ' ALA . 73.8 Cg_endo -75.8 -43.65 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.567 1.511 . . . . 0.0 111.379 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.51 -11.33 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -0.857 . . . . 0.0 109.364 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.36 11.4 3.82 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.405 -0.809 . . . . 0.0 109.687 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ALA . 3.7 p30 42.26 36.31 0.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.457 -0.777 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.18 140.71 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 109.155 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -166.03 86.47 0.35 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -139.79 157.93 68.8 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.5 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -80.96 162.01 20.82 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.115 2.544 . . . . 0.0 113.108 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.76 134.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 5.3 m-85 -94.48 151.1 39.06 Favored Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 120.869 -1.144 . . . . 0.0 110.56 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.17 82.45 2.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.74 2.293 . . . . 0.0 111.442 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 178.84 39.75 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.128 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 35' ' ' THR . 87.3 Cg_endo -78.75 109.53 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.247 2.631 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.09 89.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 111.694 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' PRO . 10.3 p -121.41 152.26 57.56 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -40.13 65.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.36 1.374 . . . . 0.0 111.969 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -66.37 -34.66 78.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.751 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.575 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -88.64 -26.33 21.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.49 -1.381 . . . . 0.0 110.769 -178.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.94 -10.88 59.95 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.014 -1.054 . . . . 0.0 108.871 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -56.88 -29.3 62.82 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -79.04 -20.06 49.85 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.238 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.33 -135.23 4.75 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.9 t -84.79 169.18 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.567 -0.961 . . . . 0.0 110.235 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.575 ' CB ' HE22 ' A' ' 38' ' ' GLN . 1.6 t -167.78 152.97 6.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.0 109.096 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.63 155.4 26.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.817 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -72.49 -2.97 21.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -151.86 147.63 26.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 110.184 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.73 -39.11 93.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.727 -0.608 . . . . 0.0 111.54 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -88.01 20.75 2.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.119 . . . . 0.0 111.327 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.09 137.06 58.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.833 -1.167 . . . . 0.0 109.49 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 m -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 109.425 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 52' ' ' LEU . 7.5 mp -61.15 -13.92 21.15 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.094 -1.004 . . . . 0.0 108.525 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.55 -27.41 51.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.546 -0.721 . . . . 0.0 109.623 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 56' ' ' ASN . 3.4 m-20 -61.78 112.43 2.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.155 -0.965 . . . . 0.0 109.862 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -65.9 6.63 0.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.083 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 54' ' ' ASP . 46.6 t-20 -147.04 95.14 2.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.5 115.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.505 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -108.71 113.69 26.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.95 155.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.56 115.32 23.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.11 145.22 16.07 Favored Glycine 0 N--CA 1.503 3.153 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' A' ' 72' ' ' PHE . 9.2 m-70 -72.88 175.95 6.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.502 -0.999 . . . . 0.0 109.761 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.48 79.73 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -88.01 129.6 35.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 109.885 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mt -64.33 -34.79 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.531 -0.73 . . . . 0.0 109.935 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.04 20.28 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 109.45 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -149.98 68.2 8.75 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.099 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 66.7 Cg_exo -52.27 15.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.187 0 C-N-CA 123.481 2.787 . . . . 0.0 113.915 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.2 p30 -151.29 63.75 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.894 -1.129 . . . . 0.0 108.217 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 33.5 t80 -148.02 99.42 3.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.7 mt-30 61.01 -110.89 0.45 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 125' ' ' THR . 35.6 t80 -91.14 0.16 57.59 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.111 -0.993 . . . . 0.0 111.55 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.9 m -49.17 -43.65 42.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.535 -1.353 . . . . 0.0 110.626 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ALA . 3.8 m120 -94.93 -21.51 18.59 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.027 -1.045 . . . . 0.0 112.028 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.4 tm? -51.07 -32.28 21.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.562 -1.336 . . . . 0.0 108.279 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 1.11 2.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -105.96 -27.36 11.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.2 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.845 . . . . 0.0 109.543 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 175.23 5.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 110.02 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -49.37 135.68 17.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.1 -17.79 55.87 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 m -62.14 107.98 0.98 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.011 -1.288 . . . . 0.0 107.748 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mtp -70.23 176.27 4.02 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.287 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.69 154.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.22 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -145.65 104.88 3.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.06 111.8 23.56 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -99.21 148.23 24.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 0.0 110.453 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.1 p -167.09 107.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.86 -146.37 48.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -83.54 43.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 109.62 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.42 150.1 37.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.197 -0.94 . . . . 0.0 109.246 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.9 m -150.53 118.85 6.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -0.895 . . . . 0.0 109.704 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -92.7 164.16 13.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.414 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -145.61 118.89 8.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 109.587 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 16.7 m-85 -112.36 -171.49 1.86 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -143.61 101.67 3.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.16 -0.963 . . . . 0.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.6 mtp -48.94 116.58 1.71 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.326 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -161.54 29.9 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.089 . . . . 0.0 110.561 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 t -163.5 86.31 0.51 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.958 -1.089 . . . . 0.0 108.151 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 100' ' ' ILE . 2.1 mp . . . . . 0 C--N 1.301 -1.507 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 13.1 t70 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 60.6 mttm -38.05 135.5 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.73 161.8 39.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.892 -1.13 . . . . 0.0 111.104 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.51 103.8 13.39 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.2 m -91.48 152.95 20.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.84 146.8 36.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.7 mt -136.76 142.02 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.523 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.3 p -91.84 169.67 10.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.866 -1.146 . . . . 0.0 108.815 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 m -147.8 106.41 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.08 -1.012 . . . . 0.0 109.803 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 128' ' ' ASP . 10.5 t70 -157.35 144.9 18.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.012 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 127' ' ' ASP . 70.6 m-20 53.69 64.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.476 -0.765 . . . . 0.0 109.135 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -65.27 124.11 21.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 110.056 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -86.76 127.52 34.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.937 -1.102 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.8 pm0 -94.6 12.19 28.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.454 -0.779 . . . . 0.0 109.649 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -85.61 -57.97 2.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 109.073 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.0 p -95.72 -9.95 30.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.834 . . . . 0.0 109.136 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.83 46.86 9.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -147.05 153.55 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -1.094 . . . . 0.0 109.551 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.426 ' O ' ' C ' ' A' ' 137' ' ' GLU . 72.5 m95 -61.44 112.29 2.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 136' ' ' TRP . 42.5 tt0 -38.68 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.247 0.546 . . . . 0.0 110.326 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -91.38 135.96 33.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.106 -0.996 . . . . 0.0 108.61 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -157.04 122.26 4.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.946 -1.096 . . . . 0.0 110.334 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -100.79 164.48 11.83 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 141' ' ' ILE . 29.3 pt -148.35 151.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.832 -1.168 . . . . 0.0 110.481 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.28 172.2 14.23 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.65 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 43.0 t -147.32 129.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.856 -1.153 . . . . 0.0 110.961 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.19 -176.28 3.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.0 t -148.26 136.71 21.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.745 -1.222 . . . . 0.0 109.426 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.24 150.18 18.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.405 -0.809 . . . . 0.0 109.537 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.343 -0.848 . . . . 0.0 109.131 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -40.85 137.49 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.56 1.506 . . . . 0.0 112.248 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -82.46 -20.15 37.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.244 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' SER . 67.2 m-20 -77.87 108.89 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -62.68 -1.09 0.74 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' ASP . 22.6 p -120.49 47.33 1.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.667 -0.645 . . . . 0.0 109.517 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -144.8 136.04 25.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.3 -0.875 . . . . 0.0 109.274 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.47 114.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.767 . . . . 0.0 110.995 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.96 -17.33 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.26 -173.0 35.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.99 125.0 9.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.101 -1.235 . . . . 0.0 109.211 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -97.29 146.88 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -150.6 131.76 14.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.045 . . . . 0.0 110.476 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 HD21 ' A' ' 75' ' ' LEU . 26.6 mt -144.29 126.47 8.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.45 -41.54 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.648 1.565 . . . . 0.0 111.572 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -51.38 -16.19 0.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.0 109.469 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -136.13 15.32 3.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.2 p-10 44.23 48.51 7.81 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.404 -0.81 . . . . 0.0 109.875 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 23' ' ' ALA . 46.5 mm -90.31 138.64 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.208 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.08 84.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -144.67 151.99 51.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.039 -1.038 . . . . 0.0 110.5 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.05 161.71 18.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.575 2.183 . . . . 0.0 112.155 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.46 102.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.69 171.49 12.17 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.761 -1.212 . . . . 0.0 109.109 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -86.39 137.11 4.94 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.592 2.194 . . . . 0.0 112.301 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.66 171.62 20.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' ' N ' ' A' ' 35' ' ' THR . 92.2 Cg_endo -78.01 117.88 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.587 2.192 . . . . 0.0 110.767 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.04 88.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.698 -0.626 . . . . 0.0 110.338 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -114.6 153.89 46.71 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.05 -41.9 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.944 1.763 . . . . 0.0 112.112 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.04 -23.46 67.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.906 -1.121 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -90.82 -66.82 0.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.013 . . . . 0.0 109.17 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -45.27 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -64.2 -24.45 67.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mtt-85 -87.34 -10.63 51.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.67 -129.47 2.59 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.5 t -112.67 156.63 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.613 -0.933 . . . . 0.0 109.907 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -150.68 154.84 38.18 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -58.56 169.96 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.593 -1.317 . . . . 0.0 110.068 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.64 -0.92 49.4 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -154.95 150.67 27.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.59 0.71 . . . . 0.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -63.9 -40.28 96.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 111.631 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.63 12.76 11.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.874 -1.141 . . . . 0.0 111.595 -177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -62.67 101.9 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.786 -1.196 . . . . 0.0 109.519 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 53' ' ' ASP . 8.6 p -93.61 141.85 28.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.154 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -54.85 -9.91 0.41 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' SER . 7.8 t70 -95.16 -9.91 32.08 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.678 -0.639 . . . . 0.0 109.817 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.7 t0 -56.35 113.26 1.51 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.832 -1.167 . . . . 0.0 109.001 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 54' ' ' ASP . 1.1 tt0 -41.58 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.693 -0.629 . . . . 0.0 110.186 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 15.4 p-10 -137.34 115.21 11.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.27 -0.894 . . . . 0.0 108.772 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -97.72 152.26 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 46' ' ' ALA . 9.3 m -140.66 105.42 4.93 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.6 mt -100.28 161.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.773 0.797 . . . . 0.0 110.725 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.535 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.05 129.84 26.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.94 160.14 25.24 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.54 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' PHE . 19.3 m-70 -77.25 179.11 6.58 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.585 -0.95 . . . . 0.0 109.791 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.426 ' OG1' ' NZ ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -153.49 91.75 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 108.734 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' N ' ' OG1' ' A' ' 73' ' ' THR . 7.3 m-85 -86.51 104.55 16.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.132 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.83 -32.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.24 17.05 2.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 0.0 109.059 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.527 ' C ' ' H ' ' A' ' 69' ' ' ASN . 6.3 tpp180 -150.46 72.51 9.09 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.25 25.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 123.297 2.665 . . . . 0.0 113.522 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 67' ' ' ARG . 18.3 p30 -149.78 39.21 0.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.829 -1.17 . . . . 0.0 109.093 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.465 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 5.9 t80 -105.74 -153.57 0.49 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.465 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 57.3 mt-30 -64.79 -89.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.657 -0.652 . . . . 0.0 111.776 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -93.97 22.54 5.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.0 110.191 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 92.7 m -72.8 -24.88 60.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.306 -1.496 . . . . 0.0 109.951 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -119.37 -13.93 9.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.136 -0.977 . . . . 0.0 111.291 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.436 HD21 HD12 ' A' ' 20' ' ' ILE . 7.1 mt -51.74 -19.9 1.87 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.62 -1.3 . . . . 0.0 108.79 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' NZ ' ' OG1' ' A' ' 63' ' ' THR . 12.1 pttm -88.55 -8.4 54.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 108.563 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -85.69 -21.78 28.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.4 -174.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 109.362 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' GLY . 45.9 mtmt -150.23 155.23 39.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 11.0 ttmm -51.4 89.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 148.19 -15.94 1.32 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.6 m -62.59 114.22 3.44 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.0 ptm -68.9 -179.59 1.52 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.48 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.06 153.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.0 109.593 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -132.74 103.28 6.03 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.36 111.7 23.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -90.65 150.81 21.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.6 t -150.01 151.3 12.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.45 -4.89 0.42 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 88' ' ' VAL . 22.5 m120 -102.41 -45.96 4.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.311 -1.111 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -171.55 -156.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.985 -1.072 . . . . 0.0 109.106 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.4 m -132.88 120.3 21.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.345 -0.847 . . . . 0.0 109.941 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.528 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -92.13 171.9 8.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.472 -0.768 . . . . 0.0 109.031 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 8.5 mtmp? -144.84 152.32 40.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 11.4 m-85 -139.34 178.57 7.1 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -142.28 105.82 4.66 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.147 -0.971 . . . . 0.0 109.773 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 55.0 mtt -49.33 125.1 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.6 t -150.78 19.45 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 143' ' ' VAL . 3.4 p -174.69 122.87 0.26 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 C--N 1.298 -1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.286 -177.538 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' GLN . 11.2 m-20 . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HZ2' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -37.84 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.907 0.86 . . . . 0.0 109.323 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -95.47 147.15 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.411 0.624 . . . . 0.0 110.123 -178.213 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -102.74 155.16 18.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.516 -0.74 . . . . 0.0 109.407 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -139.64 87.85 2.2 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 141' ' ' ILE . 9.6 mt -74.04 145.31 44.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 0.0 110.75 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.481 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 50.0 mt -139.69 148.31 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.468 -0.77 . . . . 0.0 109.085 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.464 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -96.59 170.16 9.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -149.81 95.56 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -155.39 141.94 18.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 109.485 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.6 55.66 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 0.0 109.073 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -64.13 123.18 18.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 109.833 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -84.4 122.83 29.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.0 109.302 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -87.53 4.74 42.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -80.17 -55.85 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.9 p -95.7 -12.05 26.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 45.55 10.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.7 t -146.96 153.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.259 -1.142 . . . . 0.0 109.61 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.538 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 66.0 m95 -61.73 110.69 1.59 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.184 -0.948 . . . . 0.0 108.591 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 136' ' ' TRP . 2.8 tm-20 -42.37 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.487 -0.758 . . . . 0.0 109.859 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 144.13 27.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 108.248 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.5 OUTLIER -161.05 94.33 1.01 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.0 110.548 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -75.1 163.84 27.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.457 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 4.2 mt -144.28 155.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.058 -1.026 . . . . 0.0 110.791 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 38.5 m-85 -140.74 165.01 28.66 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 99' ' ' SER . 57.6 t -147.65 148.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.839 -1.163 . . . . 0.0 110.385 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.73 179.24 6.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 t -143.46 142.71 31.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.09 -1.006 . . . . 0.0 109.979 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -56.82 152.32 12.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.608 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.827 . . . . 0.0 109.297 179.763 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 114.36 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.388 2.058 . . . . 0.0 112.916 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -60.03 -11.09 5.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.24 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 12' ' ' SER . 34.8 m-20 -77.02 100.53 5.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -59.38 0.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.9 m -122.85 39.49 3.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -142.71 143.58 32.34 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 16' ' ' GLY . 62.8 t -58.23 155.28 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.37 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -141.7 6.62 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 162.79 -172.8 38.92 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 81.1 m-85 -146.72 125.52 12.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -1.071 . . . . 0.0 109.706 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.586 HD11 ' CG1' ' A' ' 84' ' ' VAL . 9.0 tp -95.08 144.25 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -146.98 129.13 15.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.879 -1.138 . . . . 0.0 110.569 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mt -144.76 126.98 8.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.3 Cg_endo -76.9 -42.15 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.673 1.582 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -52.75 -12.96 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.05 10.74 3.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 40.95 39.86 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.475 0.655 . . . . 0.0 110.121 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.415 HD11 ' H ' ' A' ' 75' ' ' LEU . 7.0 mt -94.7 146.23 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.944 0.878 . . . . 0.0 110.024 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -166.02 83.16 0.3 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -139.96 159.53 64.15 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.388 -0.82 . . . . 0.0 110.645 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.47 161.5 22.35 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.946 2.431 . . . . 0.0 112.579 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.5 113.21 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.32 171.29 12.53 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.756 -1.215 . . . . 0.0 109.181 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -95.32 136.99 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.546 2.164 . . . . 0.0 112.018 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.72 173.53 22.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 35' ' ' THR . 57.0 Cg_endo -71.88 115.43 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.731 2.287 . . . . 0.0 110.785 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.49 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.59 -0.694 . . . . 0.0 110.741 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -109.0 152.52 42.49 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.52 -43.22 18.15 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.072 1.848 . . . . 0.0 112.153 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.07 -27.41 69.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.027 -1.045 . . . . 0.0 109.527 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 40' ' ' ASN . 2.4 tm0? -84.14 -63.72 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.207 -0.933 . . . . 0.0 109.54 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.6 mt -47.5 -13.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.472 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 38' ' ' GLN . 78.4 m-20 -59.02 -28.13 66.12 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.423 ' C ' ' OH ' ' A' ' 30' ' ' TYR . 26.6 mtt-85 -79.84 -17.72 52.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.17 -101.61 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.59 -1.29 . . . . 0.0 111.057 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 60' ' ' ALA . 4.8 t -135.5 155.14 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -1.073 . . . . 0.0 110.217 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 t -151.22 152.04 32.71 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.55 171.32 0.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.546 -1.346 . . . . 0.0 109.346 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -80.52 -10.38 59.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -149.71 154.68 38.93 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.778 0.799 . . . . 0.0 109.96 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.8 pt-20 -64.48 -43.09 95.25 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 31.6 m120 -84.68 10.3 11.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.597 -1.314 . . . . 0.0 111.037 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 58' ' ' SER . 4.5 mm-40 -64.75 96.74 0.19 Allowed 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 110.354 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 p -93.69 175.27 6.8 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -79.92 -10.64 59.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -102.19 -4.12 26.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.694 . . . . 0.0 109.975 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 56' ' ' ASN . 10.3 t70 -58.72 125.56 23.99 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.848 -1.158 . . . . 0.0 109.337 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.468 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 6.0 tp-100 -39.28 -24.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.73 -0.606 . . . . 0.0 109.956 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 54' ' ' ASP . 52.4 t-20 -151.96 113.87 4.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 58' ' ' SER . 4.1 mp -96.11 156.04 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.513 ' N ' ' OE2' ' A' ' 50' ' ' GLU . 34.0 t -143.21 123.41 13.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 60' ' ' ALA . 73.4 mt -110.9 153.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.547 -0.721 . . . . 0.0 110.567 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -133.9 132.56 40.43 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.28 157.28 25.5 Favored Glycine 0 N--CA 1.503 3.13 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.995 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -70.61 176.38 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.73 -0.865 . . . . 0.0 109.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -159.34 93.83 1.15 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.13 105.51 17.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.166 -0.959 . . . . 0.0 108.915 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 65' ' ' ILE . 18.9 mt -59.74 -29.09 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 8.2 t70 -84.55 11.22 9.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.399 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' ASN . 24.5 ttm180 -151.62 79.75 6.46 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.277 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.25 24.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 123.702 2.935 . . . . 0.0 114.357 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' ARG . 40.6 m-80 -151.09 62.77 0.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 108.597 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.52 ' CD2' ' OE1' ' A' ' 71' ' ' GLN . 15.3 t80 -146.73 102.93 3.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.165 -0.959 . . . . 0.0 110.272 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 15.2 mp0 55.28 -113.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 111.796 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.4 m-85 -92.42 7.73 41.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.085 -1.01 . . . . 0.0 110.421 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.8 m -47.16 -33.65 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.74 -1.225 . . . . 0.0 109.698 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 8.1 m120 -100.28 -28.95 12.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -0.773 . . . . 0.0 110.472 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' ALA . 6.9 tp -54.11 -31.94 53.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.616 -1.303 . . . . 0.0 108.792 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -65.99 -3.28 5.02 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -102.33 -28.5 12.21 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -44.75 168.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 110.017 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.78 160.76 39.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.372 -0.83 . . . . 0.0 108.94 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -49.99 137.08 17.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.03 -1.044 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 -23.94 32.28 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 m -62.68 115.9 4.71 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.211 -1.17 . . . . 0.0 108.057 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.83 176.7 4.73 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.971 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.586 ' CG1' HD11 ' A' ' 18' ' ' ILE . 13.9 t -142.81 109.27 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.405 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -93.67 102.84 15.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -96.99 112.17 24.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -93.89 154.32 17.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.036 -1.04 . . . . 0.0 110.74 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.6 m -151.15 160.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.36 46.38 0.26 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 22.7 p30 -160.33 -36.78 0.05 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 109.783 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.0 tt0 -174.24 -157.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 108.925 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 92' ' ' THR . 7.0 t -141.54 129.76 22.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -92.12 162.37 14.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.813 . . . . 0.0 109.212 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -144.36 93.98 2.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.086 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -93.23 179.34 5.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.076 -1.015 . . . . 0.0 108.8 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 98' ' ' THR . 36.1 ttpt -144.96 114.82 7.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.3 mtt -48.96 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 109.113 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.6 m -126.03 29.65 5.83 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.7 . . . . 0.0 109.538 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.3 86.98 0.08 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.15 -0.969 . . . . 0.0 108.499 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.4 mm . . . . . 0 C--N 1.298 -1.66 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.57 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.529 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 16.7 t70 . . . . . 0 N--CA 1.501 2.076 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' ASP . 46.4 mttp -43.35 129.81 4.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.538 ' N ' ' OE1' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -148.42 167.43 25.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.0 -1.062 . . . . 0.0 110.117 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.7 tp -118.8 122.2 41.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.651 -0.656 . . . . 0.0 110.35 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -100.63 94.13 5.94 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 123' ' ' LEU . 5.4 mp -73.78 147.4 43.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.923 . . . . 0.0 110.244 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.507 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 82.0 mt -138.13 148.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 18.1 p -102.18 165.23 11.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 108.898 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.9 m -147.51 87.44 1.65 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.976 -1.077 . . . . 0.0 109.273 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 7.1 p30 -130.21 146.34 51.82 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.22 -0.925 . . . . 0.0 110.089 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 54.8 72.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.657 -0.652 . . . . 0.0 109.493 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -67.56 119.96 13.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.181 -0.949 . . . . 0.0 109.683 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -88.88 123.11 32.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.779 -1.201 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.3 pm0 -93.13 -13.01 29.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.847 . . . . 0.0 109.019 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -62.93 -49.72 73.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 46.7 p -97.35 -13.34 21.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 108.775 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 38.19 27.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.15 162.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.444 ' O ' ' C ' ' A' ' 137' ' ' GLU . 78.9 m95 -64.73 113.21 3.62 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.6 tp10 -36.99 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.947 -0.471 . . . . 0.0 110.418 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -111.12 137.72 48.44 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.49 113.85 5.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 109.753 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.48 ' N ' ' OG1' ' A' ' 125' ' ' THR . 44.5 mttm -75.45 166.84 22.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.107 -0.996 . . . . 0.0 108.517 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 pt -149.6 134.51 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.937 -1.102 . . . . 0.0 110.331 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -130.06 169.85 14.76 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 t -145.85 143.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.818 -1.176 . . . . 0.0 110.667 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -132.8 126.24 31.89 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.4 t -94.49 145.65 24.65 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -58.41 147.12 32.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 147' ' ' VAL . 5.2 m . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.3 mt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -42.57 156.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.475 1.45 . . . . 0.0 112.179 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -103.38 -23.71 13.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 21.5 t0 -76.96 108.13 9.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.668 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -58.28 -3.61 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.267 -0.895 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 42.3 m -115.27 43.43 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.487 -0.758 . . . . 0.0 109.349 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -147.6 145.86 29.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 16' ' ' GLY . 86.5 t -59.72 149.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.857 0.837 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.39 12.46 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 160.17 177.07 32.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.25 122.5 9.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.27 . . . . 0.0 109.055 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.7 tt -97.57 151.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.48 132.25 15.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mt -142.29 125.71 9.57 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.451 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.2 Cg_endo -76.1 -43.07 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.692 1.595 . . . . 0.0 111.511 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -51.05 -14.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.89 . . . . 0.0 108.867 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.451 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.4 12.52 3.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.661 -0.649 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 p-10 43.02 51.86 5.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.42 -0.8 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.6 mm -95.69 147.25 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.045 0.926 . . . . 0.0 111.04 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -168.75 80.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 10.0 mt-10 -139.3 158.57 68.73 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.299 -0.876 . . . . 0.0 110.944 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.25 160.44 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.986 2.457 . . . . 0.0 112.91 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 t -132.46 101.7 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.65 171.72 11.19 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.918 -1.114 . . . . 0.0 109.76 -178.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -86.59 116.02 1.34 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.142 2.561 . . . . 0.0 112.945 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.23 160.99 22.78 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.736 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 90.3 Cg_endo -76.59 126.77 9.17 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.702 2.268 . . . . 0.0 111.053 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -41.58 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.753 -0.592 . . . . 0.0 110.77 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.7 p -127.17 149.61 70.02 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.21 -43.04 50.65 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.925 1.75 . . . . 0.0 112.185 -178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.22 -20.87 65.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.106 -0.996 . . . . 0.0 109.788 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.6 OUTLIER -89.26 -68.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.16 -0.962 . . . . 0.0 109.378 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.2 mt -47.34 -11.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.979 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 38' ' ' GLN . 73.4 m-20 -56.84 -28.88 62.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 19.9 mmt180 -81.12 -18.31 46.9 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.83 -124.51 1.92 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 2.3 t -97.6 160.66 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.288 -1.125 . . . . 0.0 109.825 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 p -165.22 153.62 11.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 108.778 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -53.54 167.19 0.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.954 -1.091 . . . . 0.0 108.802 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -100.4 11.14 40.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.394 -0.816 . . . . 0.0 109.055 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -156.16 134.3 11.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.988 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.61 -25.63 68.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -87.07 17.29 4.29 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.926 -1.109 . . . . 0.0 110.03 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 51' ' ' SER . 1.7 pp20? -62.43 165.63 5.94 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.732 0.777 . . . . 0.0 110.347 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.533 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 2.1 p -150.77 174.12 13.42 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.12 2.74 33.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.9 -1.125 . . . . 0.0 108.368 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -154.86 25.02 0.44 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.473 -0.767 . . . . 0.0 110.126 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OG ' ' A' ' 51' ' ' SER . 24.2 t70 -56.7 124.04 17.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.742 -1.224 . . . . 0.0 108.571 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.483 ' CD ' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -43.77 -22.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 41.9 t-20 -140.18 97.1 3.16 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 58' ' ' SER . 96.9 mt -94.41 154.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.291 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 57' ' ' ILE . 23.1 p -142.64 120.8 12.19 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 60' ' ' ALA . 79.5 mt -114.59 164.88 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.846 0.831 . . . . 0.0 110.753 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.588 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -141.12 139.87 34.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.03 145.08 13.45 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.587 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -73.16 -172.19 1.05 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.99 . . . . 0.0 109.42 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.23 88.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.848 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -89.1 121.82 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 0.0 108.734 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 65' ' ' ILE . 7.4 mt -61.65 -32.34 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.449 -0.782 . . . . 0.0 110.67 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.69 17.45 2.27 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.716 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.563 ' C ' ' H ' ' A' ' 69' ' ' ASN . 53.5 mtp180 -150.11 73.26 9.34 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.56 -0.712 . . . . 0.0 109.393 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.57 12.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.285 2.657 . . . . 0.0 113.62 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.563 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.6 p30 -147.15 57.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.916 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -141.87 112.66 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.364 -0.835 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.533 ' N ' ' OE2' ' A' ' 27' ' ' GLU . 36.8 mt-30 51.85 -127.78 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.469 -0.77 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.419 ' CE2' HD13 ' A' ' 75' ' ' LEU . 5.8 m-30 -93.97 42.5 1.1 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.834 -1.166 . . . . 0.0 110.404 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.9 m -68.79 -16.48 63.81 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.445 -1.409 . . . . 0.0 109.091 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 14.8 m-20 -125.82 -25.54 3.62 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.582 -0.699 . . . . 0.0 109.99 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -53.92 -25.29 19.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 0.0 108.591 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -74.35 -6.06 45.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -94.16 -28.61 15.57 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.377 0.608 . . . . 0.0 109.409 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.86 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.486 -0.759 . . . . 0.0 109.801 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' C ' ' SD ' ' A' ' 97' ' ' MET . 14.6 ptpt -155.37 179.36 9.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.95 . . . . 0.0 109.369 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.606 ' HZ1' ' H ' ' A' ' 100' ' ' ILE . 58.1 mmtt -47.4 138.32 7.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.17 -16.05 59.64 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -62.54 97.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.168 -1.195 . . . . 0.0 108.494 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 70.3 mmm -62.93 168.28 4.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.773 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 t -142.32 114.87 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.519 -0.738 . . . . 0.0 109.482 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.25 107.29 19.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.114 -0.991 . . . . 0.0 109.614 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 88' ' ' VAL . 41.0 t80 -94.64 112.33 24.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 88' ' ' VAL . 35.6 ttpt -94.18 135.0 36.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.088 -1.007 . . . . 0.0 110.969 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 86' ' ' PHE . 4.2 m -157.06 132.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 55.96 -148.33 28.25 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -94.61 50.67 1.35 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.195 -1.179 . . . . 0.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -171.24 140.26 1.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.036 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 92' ' ' THR . 15.2 t -120.8 133.14 55.33 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.543 -0.723 . . . . 0.0 110.303 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.537 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.8 178.23 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.253 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 15.1 ptpt -145.66 152.3 39.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.147 -0.971 . . . . 0.0 109.861 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.497 ' CD1' HD11 ' A' ' 121' ' ' LEU . 26.6 m-85 -141.23 178.79 7.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.259 -0.9 . . . . 0.0 108.759 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -143.35 110.34 5.64 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.18 -0.95 . . . . 0.0 109.938 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 79' ' ' LYS . 37.3 ttm -48.19 127.05 12.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 98' ' ' THR . 11.1 m -161.78 25.68 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.1 . . . . 0.0 110.269 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.476 ' N ' ' HZ3' ' A' ' 80' ' ' LYS . 2.2 m -163.27 87.43 0.55 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.672 -1.267 . . . . 0.0 108.636 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.606 ' H ' ' HZ1' ' A' ' 80' ' ' LYS . 1.3 mp . . . . . 0 C--N 1.303 -1.456 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 119' ' ' LYS . 3.1 m-20 . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.555 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 1.6 mptm? -30.89 129.85 0.12 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.256 0.551 . . . . 0.0 110.043 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -147.3 168.37 21.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.059 -1.025 . . . . 0.0 109.962 -178.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 95' ' ' TYR . 60.7 mt -124.31 111.81 16.25 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.742 -0.598 . . . . 0.0 109.911 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.3 m -91.68 88.07 6.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.041 -1.037 . . . . 0.0 108.243 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 123' ' ' LEU . 6.9 mp -78.16 154.51 31.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 18.4 mt -140.01 148.89 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 56.2 p -99.03 163.64 12.5 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.6 m -147.34 149.54 33.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 109.579 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.88 130.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 27.8 t0 60.34 71.24 0.58 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.011 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 130' ' ' ASN . 40.7 t80 -65.1 132.43 49.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.655 -1.278 . . . . 0.0 110.026 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.436 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 51.7 t30 -79.64 119.64 22.86 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.982 -1.074 . . . . 0.0 109.351 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -91.97 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.227 -0.92 . . . . 0.0 109.544 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -78.87 -64.66 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 p -94.84 -7.65 39.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 53.78 4.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.98 151.4 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.199 -1.177 . . . . 0.0 109.551 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.39 116.41 5.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 128' ' ' ASP . 7.0 mm-40 -37.76 -85.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.149 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -111.76 156.03 22.59 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -170.16 -160.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 109.963 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.481 ' N ' ' OG1' ' A' ' 125' ' ' THR . 59.7 mttp -152.05 160.46 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.5 mt -141.69 127.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.131 -0.981 . . . . 0.0 110.201 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -147.58 149.02 31.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.91 . . . . 0.0 108.715 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.4 t -125.47 136.22 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.463 -0.773 . . . . 0.0 111.142 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.73 174.85 5.71 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -140.26 135.95 32.83 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.87 131.12 49.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.888 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 -163.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.244 1.963 . . . . 0.0 112.168 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -126.41 -23.17 3.85 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' SER . 16.9 t0 -77.41 114.15 15.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.239 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 35.1 mmtm -58.33 -2.55 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.85 . . . . 0.0 109.634 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.2 p -112.39 41.78 1.94 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 109.618 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -146.24 137.25 24.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -1.0 . . . . 0.0 109.78 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 16' ' ' GLY . 60.1 t -61.34 159.76 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 121.682 0.753 . . . . 0.0 110.762 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -139.65 1.4 1.91 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.579 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 163.67 -170.39 38.99 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 62.5 m-85 -147.27 125.76 12.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.126 -1.22 . . . . 0.0 110.518 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 tp -95.51 140.13 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -145.15 145.49 31.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.827 -1.17 . . . . 0.0 110.822 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.484 ' CD1' HD21 ' A' ' 75' ' ' LEU . 12.6 mt -147.8 129.35 7.31 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.07 -53.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.86 1.707 . . . . 0.0 112.296 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.96 -27.89 6.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.742 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.37 5.91 20.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.43 -0.793 . . . . 0.0 109.163 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.4 p30 42.95 35.75 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.738 -0.601 . . . . 0.0 110.395 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt -90.5 146.39 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -0.834 . . . . 0.0 109.113 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -166.59 84.47 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.77 158.12 74.72 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.69 161.61 16.53 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 123.114 2.542 . . . . 0.0 113.083 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 t -125.01 123.35 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 2.5 m-85 -84.65 152.54 60.23 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.86 100.61 0.97 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.559 2.173 . . . . 0.0 111.844 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.46 179.12 47.56 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 35' ' ' THR . 71.5 Cg_endo -77.78 120.74 5.22 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.736 2.291 . . . . 0.0 111.097 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -40.33 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.34 0.59 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -107.39 153.46 41.22 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.75 -41.88 7.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.232 1.954 . . . . 0.0 112.435 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -63.71 -19.79 65.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.005 . . . . 0.0 110.08 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.484 ' OE1' ' CD2' ' A' ' 30' ' ' TYR . 0.8 OUTLIER -94.96 -63.61 1.15 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.101 -0.999 . . . . 0.0 109.117 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.08 -24.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.401 -0.812 . . . . 0.0 109.857 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' GLN . 21.4 m-20 -59.88 -24.77 64.53 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.5 mtt180 -89.11 -9.08 52.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.64 -136.03 4.99 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 6.1 t -101.42 157.25 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.485 -1.009 . . . . 0.0 109.586 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -151.74 147.94 27.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.277 -0.889 . . . . 0.0 108.85 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -55.13 168.89 0.28 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.864 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' OG ' ' A' ' 58' ' ' SER . . . -92.31 0.42 57.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -161.38 142.96 11.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.444 -0.785 . . . . 0.0 108.947 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.57 -37.44 78.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.492 -0.755 . . . . 0.0 111.222 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -89.72 -0.25 57.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.877 -1.139 . . . . 0.0 111.005 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 11.3 tp10 -63.24 89.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.853 -1.155 . . . . 0.0 109.749 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -89.4 177.0 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.347 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.84 -8.1 56.7 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 108.901 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.51 -19.39 29.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.462 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 40.7 t0 -59.43 111.44 1.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -44.88 -17.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 6.2 m120 -132.31 100.49 5.02 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -94.46 120.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 108.78 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.5 t -108.16 115.15 29.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.5 -0.75 . . . . 0.0 109.165 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 60' ' ' ALA . 61.8 mt -108.55 166.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.56 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -137.2 132.54 34.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.79 148.47 19.99 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.434 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.2 m-70 -72.31 168.06 19.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.28 88.57 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.0 109.352 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.516 ' N ' ' OG1' ' A' ' 73' ' ' THR . 15.7 m-85 -88.19 102.5 14.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 109.233 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.09 -29.93 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.32 -0.862 . . . . 0.0 110.094 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.29 12.4 6.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ASN . 23.5 ttm-85 -151.33 77.39 7.42 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.528 -0.732 . . . . 0.0 109.51 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.64 32.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 123.31 2.673 . . . . 0.0 113.319 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' ARG . 19.7 m-80 -149.41 61.11 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 0.0 108.376 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -130.94 -153.47 0.56 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 109.78 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -69.61 -83.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 111.715 -178.482 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 28.5 t80 -93.56 -11.64 31.39 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.212 -0.93 . . . . 0.0 110.298 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 89.5 m -37.45 -40.71 0.39 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.671 . . . . 0.0 111.124 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.8 m120 -94.48 -21.61 18.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.131 -0.981 . . . . 0.0 111.605 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.5 mt -53.42 -26.08 18.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.392 -1.443 . . . . 0.0 108.263 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 73' ' ' THR . 9.5 ptpt -75.53 -18.97 59.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -82.09 -14.41 55.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.15 -165.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -163.96 164.7 23.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.169 -0.957 . . . . 0.0 109.422 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -52.39 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 155.66 -26.83 0.59 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 p -63.07 117.83 7.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.352 -1.087 . . . . 0.0 108.252 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.0 mtp -70.91 179.26 2.77 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.008 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.8 t -145.17 111.65 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -93.89 106.33 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.272 -0.892 . . . . 0.0 110.072 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -94.7 112.5 24.24 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -89.44 151.92 21.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 111.111 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 90' ' ' ASN . 5.9 t -145.71 45.64 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.36 -80.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 88' ' ' VAL . 10.6 p30 -53.08 -30.93 38.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.403 -1.057 . . . . 0.0 111.1 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -170.93 167.49 7.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.725 -1.234 . . . . 0.0 109.665 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 t -131.2 134.22 46.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.501 -0.749 . . . . 0.0 110.183 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.535 HH11 ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.58 175.25 6.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.625 -0.672 . . . . 0.0 109.276 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -144.57 144.94 31.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.108 -0.995 . . . . 0.0 109.566 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 17.2 m-85 -131.56 177.19 7.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.439 -0.788 . . . . 0.0 108.926 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -133.71 104.32 6.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 109.601 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.446 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.9 mmt -48.59 120.03 3.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.35 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -161.82 28.81 0.12 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.289 -0.882 . . . . 0.0 109.42 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 7.7 m -165.58 133.33 2.99 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.279 -0.888 . . . . 0.0 108.674 -178.841 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.484 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 70.7 m-20 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 118' ' ' ASP . 34.2 ttmt -39.66 137.24 0.89 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.485 -0.759 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.75 155.6 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.274 -0.891 . . . . 0.0 109.202 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' A' ' 95' ' ' TYR . 46.4 mt -103.88 115.91 31.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.441 -0.787 . . . . 0.0 110.185 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.8 m -93.95 87.04 5.23 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.953 -1.092 . . . . 0.0 108.547 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 123' ' ' LEU . 7.5 mp -74.25 154.78 38.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.9 mt -140.02 140.98 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.467 -0.771 . . . . 0.0 108.973 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 ' CZ ' ' A' ' 72' ' ' PHE . 1.3 p -94.24 162.13 13.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 109.493 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.433 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 51.3 m -146.9 137.11 23.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -173.3 134.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.123 -0.986 . . . . 0.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 55.09 69.63 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 108.916 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -62.28 122.11 14.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.04 -1.038 . . . . 0.0 109.844 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -84.99 122.42 29.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.1 -1.0 . . . . 0.0 109.355 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -86.03 5.89 31.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.294 -0.879 . . . . 0.0 109.749 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -79.93 -57.84 3.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 p -96.47 -4.27 41.89 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.232 -0.918 . . . . 0.0 109.354 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.53 46.86 53.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.66 155.42 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -1.116 . . . . 0.0 109.509 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.433 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.1 m95 -63.13 112.15 2.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.198 -0.939 . . . . 0.0 108.651 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 136' ' ' TRP . 72.3 tt0 -39.03 -82.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.277 0.561 . . . . 0.0 110.037 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -77.45 120.67 22.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -134.98 137.13 42.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.339 -0.851 . . . . 0.0 109.827 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -140.5 134.33 30.51 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.3 mm -99.39 127.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.758 0.79 . . . . 0.0 111.22 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -129.99 154.52 47.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 p -161.88 151.3 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.223 -1.548 . . . . 0.0 111.853 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.39 175.92 7.84 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -138.16 142.38 40.08 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 10.1 tp10 -60.78 137.17 58.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.773 . . . . 0.0 109.192 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 4.6 m . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.397 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 7' ' ' ILE . 15.2 mt . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.51 166.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.626 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -113.41 -13.25 12.88 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 105.02 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.157 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -56.44 -11.08 1.1 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.838 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m -102.48 30.72 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.317 -0.864 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 143.51 33.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.325 -0.859 . . . . 0.0 109.205 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.9 t -60.06 150.95 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -144.91 12.04 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.72 168.44 29.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.54 119.66 6.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.03 -1.277 . . . . 0.0 109.51 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.9 tt -99.05 141.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -146.2 136.27 23.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.18 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.3 mt -144.1 125.69 8.11 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 23' ' ' ALA . 74.4 Cg_endo -75.15 -41.26 0.66 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.633 1.555 . . . . 0.0 111.494 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.25 -15.42 0.37 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -0.878 . . . . 0.0 109.203 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.81 15.46 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.808 . . . . 0.0 109.835 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.1 p-10 44.57 50.17 8.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.092 -1.005 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 23' ' ' ALA . 48.6 mm -92.25 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.82 0.819 . . . . 0.0 109.983 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -169.65 82.74 0.12 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 4.9 mm-40 -142.69 150.3 53.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 0.0 110.68 -177.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.78 165.05 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.848 2.365 . . . . 0.0 113.04 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.8 t -126.91 122.32 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.475 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 7.6 m-85 -82.59 150.36 62.84 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.007 -1.058 . . . . 0.0 110.247 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.87 100.04 1.36 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 111.681 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.26 178.78 45.37 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.616 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 72.9 Cg_endo -76.49 118.81 5.0 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.755 2.304 . . . . 0.0 111.029 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.49 88.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.453 0.644 . . . . 0.0 110.572 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.4 p -113.67 152.43 45.47 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -40.21 10.91 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.124 1.883 . . . . 0.0 111.945 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -62.24 -20.06 63.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.098 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.6 tp-100 -96.04 -63.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -45.05 -15.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 0.0 110.275 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.6 m-20 -62.55 -25.14 67.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 41' ' ' ARG . 25.2 mtt-85 -88.13 -12.0 45.32 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.09 -135.93 4.78 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.408 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.1 t -101.18 160.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -1.021 . . . . 0.0 109.619 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -151.42 152.68 33.4 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 50.4 m-85 -60.32 167.95 2.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.197 . . . . 0.0 109.745 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.16 -8.35 59.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.448 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -152.85 150.95 29.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -62.77 -35.82 81.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.563 -0.71 . . . . 0.0 111.102 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -88.65 16.42 6.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.99 -1.069 . . . . 0.0 110.905 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.535 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 14.5 tm-20 -63.23 98.44 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 109.84 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASP . 1.4 p -95.38 141.74 28.59 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -61.16 -3.73 0.93 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.756 -1.215 . . . . 0.0 107.881 179.422 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 51' ' ' SER . 23.1 m-20 -91.56 -17.7 25.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.594 -0.691 . . . . 0.0 109.861 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 38.6 p-10 -60.64 116.99 4.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.861 -1.149 . . . . 0.0 109.576 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -45.63 -15.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 38.2 t30 -132.6 108.58 9.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 109.673 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.0 mt -98.61 117.52 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -108.44 114.76 28.85 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 60' ' ' ALA . 61.2 mt -105.47 167.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.438 -0.789 . . . . 0.0 109.907 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.587 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.07 126.65 28.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.85 152.89 23.86 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.68 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -72.85 -170.46 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.636 -0.92 . . . . 0.0 109.275 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.17 72.0 0.1 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 5.8 m-85 -87.6 114.11 23.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.91 -18.42 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -85.18 13.92 5.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.184 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.564 ' NH2' ' CG ' ' A' ' 64' ' ' PHE . 59.1 mtm-85 -151.41 74.35 8.13 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.29 14.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.673 2.915 . . . . 0.0 114.023 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 10.1 p30 -150.59 62.28 0.94 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.854 -1.154 . . . . 0.0 108.334 179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.551 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 41.8 t80 -149.72 99.77 2.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 25.2 mt-30 61.09 -125.49 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.513 -0.742 . . . . 0.0 111.734 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 86.2 t80 -92.48 38.88 1.02 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.186 -0.946 . . . . 0.0 110.37 -178.088 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -81.58 -65.21 1.04 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.995 -1.066 . . . . 0.0 109.034 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.518 ' C ' ' H ' ' A' ' 76' ' ' LYS . 9.9 t-20 -81.18 -24.72 37.32 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.611 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.85 -3.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.913 -1.117 . . . . 0.0 108.617 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 74' ' ' ASN . 46.1 mtpt -87.03 -21.47 26.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -80.78 -37.15 30.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -45.43 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' SD ' ' A' ' 97' ' ' MET . 48.3 mtmt -144.24 172.86 12.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -49.08 153.5 0.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -17.58 31.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 97.86 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.45 -1.029 . . . . 0.0 108.423 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.1 mtp -55.76 171.63 0.21 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.512 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -143.51 113.96 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.444 -0.785 . . . . 0.0 109.492 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.92 102.89 14.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 109.438 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -97.54 112.0 24.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.235 -0.916 . . . . 0.0 108.571 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -100.25 144.28 29.46 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 15' ' ' ALA . 8.8 p -169.77 140.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.4 -110.68 3.54 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -137.69 45.89 2.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.475 -1.015 . . . . 0.0 109.282 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 92' ' ' THR . 3.9 tm-20 -163.66 138.83 6.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.089 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.445 ' N ' ' CD ' ' A' ' 91' ' ' GLU . 21.6 m -115.13 125.15 53.13 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.775 . . . . 0.0 109.801 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 172.43 7.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.396 -0.815 . . . . 0.0 108.863 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 17.0 pttm -141.34 150.2 42.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.278 -0.889 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.554 ' CD1' HD11 ' A' ' 121' ' ' LEU . 15.8 m-85 -138.96 179.39 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -134.89 107.88 7.6 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.528 -0.733 . . . . 0.0 109.885 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.47 ' SD ' HD11 ' A' ' 100' ' ' ILE . 31.8 ttm -49.61 128.84 18.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 108.849 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 98' ' ' THR . 73.0 m -159.23 3.56 0.09 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.752 -1.217 . . . . 0.0 110.679 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' VAL . 13.4 t -149.14 122.24 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.708 -1.245 . . . . 0.0 107.886 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.47 HD11 ' SD ' ' A' ' 97' ' ' MET . 78.3 mt . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -178.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 . . . . . 0 N--CA 1.501 2.123 0 CA-C-O 121.511 0.672 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -47.04 157.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -157.98 161.86 38.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.008 -1.058 . . . . 0.0 109.847 -178.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.554 HD11 ' CD1' ' A' ' 95' ' ' TYR . 50.7 mt -114.95 103.39 10.87 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.603 -0.686 . . . . 0.0 110.0 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.9 m -99.34 149.2 23.39 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.4 tt -141.58 157.86 44.57 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.054 -1.029 . . . . 0.0 109.757 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.469 ' N ' HD23 ' A' ' 123' ' ' LEU . 44.9 mt -128.77 150.05 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.447 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.8 p -89.83 163.59 14.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.579 -1.325 . . . . 0.0 108.725 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -146.4 81.94 1.58 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.418 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 14.9 p-10 -137.48 133.97 35.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.407 -0.808 . . . . 0.0 109.127 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 69.06 62.01 0.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -62.62 126.23 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.273 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -85.89 118.56 25.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 1.36 45.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.68 -52.91 7.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.0 p -94.89 -8.28 37.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.34 41.45 52.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.04 162.56 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.24 -1.153 . . . . 0.0 109.599 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 68.2 m95 -66.29 114.87 5.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.303 -0.873 . . . . 0.0 108.674 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' TRP . 24.6 tt0 -38.96 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.264 0.555 . . . . 0.0 110.13 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -83.2 148.25 27.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -148.25 73.89 1.27 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.95 -1.094 . . . . 0.0 110.482 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -76.75 159.01 30.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.919 -1.113 . . . . 0.0 108.225 178.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.74 153.43 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.982 -1.074 . . . . 0.0 111.277 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -135.45 171.37 14.55 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.844 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 99' ' ' SER . 1.7 p -162.93 117.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.214 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -96.99 177.95 5.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 145' ' ' THR . 15.0 t -147.51 127.93 14.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.762 -1.211 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -63.89 117.45 6.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.968 0 O-C-N 121.194 -0.941 . . . . 0.0 109.087 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mt . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.54 167.26 27.54 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.257 1.305 . . . . 0.0 112.032 -179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -102.09 -12.78 17.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' SER . 87.1 m-20 -77.16 102.4 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.681 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -58.22 -3.79 0.29 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' ASP . 15.1 t -115.59 44.63 1.84 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.589 -0.694 . . . . 0.0 109.331 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -141.11 133.28 27.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.341 -0.849 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.65 107.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.616 -0.678 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.73 19.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.44 -173.55 35.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.41 126.64 9.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.008 -1.289 . . . . 0.0 109.74 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -99.22 144.6 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -150.33 131.67 14.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.874 -1.141 . . . . 0.0 110.622 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 mt -144.25 125.88 8.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.09 -41.77 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.654 1.569 . . . . 0.0 111.458 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OG ' ' A' ' 82' ' ' SER . 47.5 t0 -50.98 -16.23 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.051 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.7 15.98 3.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.431 -0.793 . . . . 0.0 109.427 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.0 p30 41.78 48.96 3.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 mm -91.64 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.63 0.729 . . . . 0.0 109.635 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -169.13 84.98 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -145.48 157.19 52.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.063 -1.023 . . . . 0.0 110.33 -177.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.32 165.24 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.85 2.367 . . . . 0.0 112.425 179.022 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.37 112.92 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -85.98 158.31 56.08 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 109.449 -179.289 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.09 133.87 9.04 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.463 2.109 . . . . 0.0 112.398 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.6 176.89 24.0 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.217 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.589 ' O ' ' N ' ' A' ' 35' ' ' THR . 83.1 Cg_endo -79.14 118.01 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.758 2.305 . . . . 0.0 111.119 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -42.44 87.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.199 0.523 . . . . 0.0 110.61 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -108.3 152.89 42.15 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.19 -42.18 37.44 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.244 1.963 . . . . 0.0 112.092 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.89 -25.86 68.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.081 -1.012 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.8 -70.11 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.492 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 39' ' ' LEU . 36.1 mt -42.06 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.565 -0.709 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.11 -23.52 66.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -87.11 -11.71 49.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.81 -106.44 0.29 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 11.3 t -136.02 154.73 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.483 -1.01 . . . . 0.0 109.298 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 t -149.4 156.1 41.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -57.69 173.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.734 -1.228 . . . . 0.0 109.513 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -88.58 -3.24 58.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -155.04 148.61 25.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.524 -0.735 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.62 -29.89 70.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 111.733 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -88.49 -3.79 58.75 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.707 -1.245 . . . . 0.0 111.449 -177.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.27 114.59 3.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.729 -1.232 . . . . 0.0 109.673 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -91.53 -164.69 1.21 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 2.2 mp -102.72 17.9 22.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -144.42 4.27 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' ASN . 68.5 t0 -59.53 118.89 6.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.879 -1.138 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -13.55 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.998 -1.064 . . . . 0.0 109.899 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' ASP . 4.8 t-20 -131.42 93.81 3.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.425 -0.797 . . . . 0.0 109.08 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.42 145.61 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' ALA . 1.8 p -142.89 109.36 5.36 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 60' ' ' ALA . 83.8 mt -103.81 159.19 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.664 0.745 . . . . 0.0 110.657 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -127.36 124.31 38.31 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.85 146.04 17.68 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -178.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' PHE . 20.6 m-70 -73.16 174.87 7.35 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.41 -1.053 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.71 93.56 1.58 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.389 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.06 113.49 24.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.962 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 mt -60.47 -34.13 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.94 17.69 2.77 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.931 . . . . 0.0 109.291 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -150.66 73.7 8.82 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 63.9 Cg_exo -52.37 23.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 123.904 3.069 . . . . 0.0 114.219 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 67' ' ' ARG . 27.3 m-80 -153.55 63.53 0.74 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.603 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 12.8 t80 -148.29 100.46 3.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.102 -0.999 . . . . 0.0 110.953 -178.406 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 13.1 mp0 54.39 -109.04 0.46 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.671 -0.643 . . . . 0.0 112.57 177.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.568 ' CE2' HG22 ' A' ' 125' ' ' THR . 41.6 t80 -91.59 8.9 34.44 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.331 -0.855 . . . . 0.0 111.177 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 m -56.42 -45.35 80.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.465 -1.397 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 5.7 m120 -94.31 -22.09 18.58 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.04 -1.038 . . . . 0.0 111.498 -177.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.5 tm? -50.37 -36.82 34.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 108.777 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -60.72 -18.26 53.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -86.12 -23.78 26.5 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.331 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.52 167.61 5.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.412 -0.805 . . . . 0.0 110.0 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -149.66 175.67 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.86 158.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.86 -29.24 3.81 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.423 ' OG ' ' OD2' ' A' ' 22' ' ' ASP . 61.3 m -62.17 103.74 0.41 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.293 -1.122 . . . . 0.0 108.237 179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.4 mtp -63.36 176.11 0.87 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.777 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.4 t -144.15 114.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.482 -0.761 . . . . 0.0 109.17 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -93.64 107.29 19.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.22 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -94.99 113.9 25.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -85.69 151.04 24.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 110.644 -178.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG21 ' NH1' ' A' ' 93' ' ' ARG . 65.6 t -153.94 116.71 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.16 -102.86 0.05 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.02 34.98 4.87 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.545 -0.973 . . . . 0.0 109.499 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.84 119.89 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 108.797 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 92' ' ' THR . 12.6 t -111.2 132.87 53.98 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.52 -0.737 . . . . 0.0 110.253 -179.323 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -96.9 179.71 4.86 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.544 -0.723 . . . . 0.0 109.528 179.594 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -144.93 142.47 29.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 22.7 m-85 -128.82 178.92 6.02 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -135.32 110.36 8.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.275 -0.891 . . . . 0.0 109.755 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.7 mmt -52.13 118.43 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -151.05 31.21 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 109.717 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 t -164.89 86.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.028 -1.045 . . . . 0.0 109.338 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.7 mp . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 p30 . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 121.329 0.585 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -47.66 139.27 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -151.61 158.61 43.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.007 -1.058 . . . . 0.0 110.099 -178.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.22 157.42 20.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.461 0.648 . . . . 0.0 110.214 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.2 m -139.22 88.34 2.26 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.89 147.08 52.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.523 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.8 mt -139.42 141.01 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.568 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.1 p -94.18 159.42 15.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.94 -1.1 . . . . 0.0 109.181 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -147.84 100.52 3.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -152.41 144.53 23.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.0 t0 60.53 58.7 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.07 119.41 8.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 130' ' ' ASN . 1.7 p-10 -86.96 124.04 32.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.066 -1.021 . . . . 0.0 109.988 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.9 14.22 10.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -71.5 -31.47 67.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -0.859 . . . . 0.0 109.163 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.2 p -140.64 3.2 1.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.36 53.1 6.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.95 159.42 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.087 -1.243 . . . . 0.0 109.912 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.551 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 70.6 m95 -72.77 116.1 12.86 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.239 -0.913 . . . . 0.0 108.626 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' TRP . 30.2 tt0 -40.29 -83.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.737 -0.602 . . . . 0.0 109.991 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.85 165.1 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 108.474 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.532 ' NE ' ' O ' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -167.08 76.61 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.904 -1.122 . . . . 0.0 110.12 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -88.97 156.88 18.61 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.8 pt -145.98 146.77 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.925 -1.11 . . . . 0.0 111.629 -178.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -128.98 165.98 20.07 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 78.3 t -149.14 143.61 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.653 -1.279 . . . . 0.0 110.339 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.75 163.94 30.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.2 t -140.91 141.14 34.58 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.07 -1.019 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.42 113.69 3.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 108.821 179.569 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 mm . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -42.75 121.34 2.14 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.708 1.606 . . . . 0.0 112.31 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 9' ' ' LYS . 19.5 mtmm -66.13 -32.59 74.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 12' ' ' SER . 9.7 m-20 -76.87 111.4 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.463 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 1.8 mppt? -60.87 -0.95 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.0 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.6 t -111.21 42.75 1.59 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -142.92 133.38 24.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 5.4 t -58.75 120.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.44 -0.787 . . . . 0.0 111.263 -178.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.12 -9.63 27.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.22 140.35 3.15 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 90.2 m-85 -94.44 125.22 38.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -1.213 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 tp -95.29 143.04 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -148.07 138.81 23.07 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.712 -1.242 . . . . 0.0 110.936 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.857 HD12 HD21 ' A' ' 75' ' ' LEU . 14.0 mt -149.84 128.32 5.99 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.179 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.12 -44.06 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.825 1.683 . . . . 0.0 112.241 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -50.2 -28.3 7.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -113.4 7.07 17.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p30 43.54 30.25 0.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 109.888 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.12 145.2 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.102 0.953 . . . . 0.0 109.795 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -163.02 87.97 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -138.1 159.95 66.22 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.592 -0.693 . . . . 0.0 110.952 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.444 ' CB ' HG13 ' A' ' 14' ' ' VAL . 92.5 Cg_endo -76.52 159.19 35.97 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.982 2.455 . . . . 0.0 113.229 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -135.64 98.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.52 170.74 14.68 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.119 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.46 164.21 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.072 1.848 . . . . 0.0 112.048 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.67 171.92 13.05 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.7 Cg_endo -78.56 120.37 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.758 2.305 . . . . 0.0 111.187 179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -41.6 87.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.235 0.54 . . . . 0.0 110.643 -179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.7 p -108.57 123.56 36.93 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.26 -43.57 7.74 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.804 1.669 . . . . 0.0 112.257 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.73 -16.49 61.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.081 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.694 HE22 ' CB ' ' A' ' 44' ' ' SER . 2.3 tt0 -97.07 -69.51 0.75 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.417 -0.802 . . . . 0.0 109.702 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.5 mt -45.01 -18.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 109.796 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 38' ' ' GLN . 16.5 m-20 -62.15 -24.87 67.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -83.2 -13.7 54.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.69 -124.23 1.35 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.64 159.34 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.575 -0.956 . . . . 0.0 109.963 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.694 ' CB ' HE22 ' A' ' 38' ' ' GLN . 6.9 p -161.66 164.93 28.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 108.937 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.87 162.32 5.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.604 -1.31 . . . . 0.0 109.205 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -83.21 -9.09 59.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.387 -0.82 . . . . 0.0 109.366 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.53 144.31 29.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.147 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.98 -25.99 68.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -87.8 3.9 46.44 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.917 -1.114 . . . . 0.0 110.677 -178.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' OE1' ' OG ' ' A' ' 58' ' ' SER . 6.0 tp10 -64.93 157.59 27.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.339 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -148.0 -179.84 7.2 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.949 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -91.11 17.19 8.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 13.0 p-10 -141.16 -0.73 1.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.492 -0.755 . . . . 0.0 110.178 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' ASN . 48.6 t0 -57.89 114.58 2.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.733 -1.229 . . . . 0.0 108.998 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -43.07 -20.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.439 -0.788 . . . . 0.0 109.479 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.3 p-10 -134.96 104.09 5.83 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.43 156.06 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' ALA . 50.7 p -141.66 102.08 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 109.133 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.545 HG22 ' N ' ' A' ' 60' ' ' ALA . 94.8 mt -97.98 162.03 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.545 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -145.08 134.18 22.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.44 158.77 27.61 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.754 -1.213 . . . . 0.0 110.209 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 72' ' ' PHE . 10.7 m-70 -71.49 -179.84 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.952 . . . . 0.0 109.913 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.79 80.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -87.94 107.53 18.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 109.118 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 65' ' ' ILE . 8.3 mt -58.46 -29.35 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 110.141 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.36 12.63 5.18 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.791 . . . . 0.0 109.429 -178.147 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 69' ' ' ASN . 96.6 mtt180 -150.76 64.55 6.48 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -40.14 -19.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.701 2.268 . . . . 0.0 112.534 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' ARG . 28.6 p30 -98.29 28.72 3.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.605 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.9 t80 -89.68 -153.69 0.29 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.851 -1.156 . . . . 0.0 109.754 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -72.88 -96.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.619 -0.676 . . . . 0.0 111.322 -178.731 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.4 t80 -91.63 37.11 0.95 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.765 . . . . 0.0 110.327 -177.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -77.37 -49.04 15.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.859 -1.151 . . . . 0.0 109.706 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ALA . 19.1 m-20 -93.79 -19.99 20.51 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.644 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD21 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -52.93 -29.18 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.804 -1.185 . . . . 0.0 108.869 -179.481 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 140' ' ' LYS . 34.9 pttt -80.6 -6.71 58.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 108.287 179.008 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -83.68 -21.0 32.54 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -55.71 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -0.756 . . . . 0.0 109.396 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -155.13 152.95 30.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 108.708 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -50.14 108.08 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 109.678 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 97' ' ' MET . . . 137.44 -16.37 3.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.5 m -66.5 -172.73 0.17 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -1.157 . . . . 0.0 108.355 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.9 mmm -129.34 176.79 7.67 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.122 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.12 108.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 109.242 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -95.49 105.81 17.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 110.389 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -94.98 111.74 23.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.295 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -107.15 143.87 34.71 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.28 -0.887 . . . . 0.0 110.997 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.3 p -168.13 129.57 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.541 -0.725 . . . . 0.0 109.531 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 -105.53 1.6 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -140.31 22.16 2.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.321 -1.105 . . . . 0.0 109.218 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.27 138.73 35.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -119.91 138.94 53.13 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.677 0.751 . . . . 0.0 110.721 -179.031 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.42 170.68 9.76 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -146.57 128.52 15.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.126 -0.983 . . . . 0.0 110.385 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -128.41 172.74 10.83 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 98' ' ' THR . 16.5 ttpt -141.85 117.24 10.19 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.17 -0.956 . . . . 0.0 108.941 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.436 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 51.3 mtt -50.61 89.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.517 -0.74 . . . . 0.0 109.478 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -118.89 25.71 10.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.1 m -174.41 138.14 0.53 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.02 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.556 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.7 m-20 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.556 ' C ' ' O ' ' A' ' 118' ' ' ASP . 4.4 mmmt -21.23 131.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 CA-C-N 118.662 0.664 . . . . 0.0 110.34 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -135.69 179.95 6.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.909 -176.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.91 107.41 4.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.075 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 m -94.27 129.96 40.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.47 149.71 29.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.873 . . . . 0.0 109.209 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 124' ' ' ILE . 12.4 mt -142.36 140.5 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 109.125 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -93.57 167.36 11.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.929 -1.107 . . . . 0.0 108.6 178.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.8 m -146.27 128.69 15.92 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.026 -1.047 . . . . 0.0 109.794 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -174.69 131.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.081 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 62.78 67.18 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.522 -0.736 . . . . 0.0 109.117 -179.824 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.09 128.41 35.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.943 -1.098 . . . . 0.0 109.51 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 10.4 t-20 -85.18 114.34 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 109.457 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.95 -3.09 58.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.849 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 51.2 mtmt -81.65 -46.56 14.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.6 p -96.13 -17.2 21.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 109.298 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.3 36.72 23.24 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.99 158.5 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -1.159 . . . . 0.0 109.528 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLU . 64.0 m95 -61.1 112.09 1.96 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.161 -0.962 . . . . 0.0 108.553 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.2 tp10 -39.01 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.163 0.506 . . . . 0.0 110.37 -179.038 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.39 150.8 19.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 0.0 109.087 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -172.75 156.94 3.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.984 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 55.1 mtmt -130.11 162.95 27.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.03 130.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.466 -0.771 . . . . 0.0 111.273 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 -123.22 165.29 17.16 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.29 147.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.732 -1.23 . . . . 0.0 110.507 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.06 141.1 31.19 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 147' ' ' VAL . 12.0 t -98.68 146.52 25.78 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.244 -0.91 . . . . 0.0 109.918 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.46 34.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 145' ' ' THR . 2.2 t . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.037 -1.039 . . . . 0.0 109.016 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.52 129.68 11.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.53 1.487 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -79.0 -18.92 52.8 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.054 -1.029 . . . . 0.0 108.971 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 28.1 t0 -78.15 101.43 7.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -58.29 -2.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.0 109.806 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 12.6 t -108.95 40.52 1.8 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.458 -0.776 . . . . 0.0 109.578 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -146.46 139.91 25.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.16 119.41 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.858 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.71 -17.12 21.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.129 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.71 -169.18 34.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.45 121.69 8.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.312 -1.11 . . . . 0.0 109.041 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.53 143.02 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.39 134.51 22.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.006 -1.059 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.4 mt -145.04 126.55 7.77 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.1 Cg_endo -76.68 -43.24 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.559 1.506 . . . . 0.0 111.375 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 15.7 t0 -53.58 -12.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.354 -0.841 . . . . 0.0 109.124 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -133.45 11.02 4.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.0 109.336 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 p30 41.89 34.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.633 -0.667 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -91.29 144.86 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.543 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -165.76 83.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -140.37 160.27 60.27 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 111.128 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.53 164.91 25.69 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 123.026 2.484 . . . . 0.0 113.0 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.59 107.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.668 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -72.56 155.59 90.94 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.821 -1.174 . . . . 0.0 109.515 -179.499 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.5 118.93 1.93 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.139 1.893 . . . . 0.0 111.668 178.381 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.3 -174.76 41.84 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.22 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 35' ' ' THR . 97.9 Cg_endo -80.7 117.63 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.77 2.313 . . . . 0.0 111.331 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -47.89 85.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.311 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.1 p -104.64 153.96 38.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.57 -45.18 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.95 1.766 . . . . 0.0 111.616 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.43 -27.65 69.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.312 -0.868 . . . . 0.0 110.271 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.668 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 9.2 tm0? -82.73 -65.34 1.02 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.308 -179.646 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.5 mt -44.74 -17.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 38' ' ' GLN . 80.4 m-20 -58.23 -28.95 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.1 mtt180 -83.51 -15.35 49.73 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 160.25 -137.62 5.12 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.4 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.2 t -105.98 160.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.504 -0.998 . . . . 0.0 110.269 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 t -155.75 156.66 35.22 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 32.1 m-85 -56.29 171.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.591 -1.318 . . . . 0.0 109.38 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -84.33 -9.06 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.597 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -151.77 145.57 25.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.99 -26.74 68.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.707 . . . . 0.0 110.972 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -86.57 1.08 52.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.856 -1.152 . . . . 0.0 109.886 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.16 150.26 46.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.647 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 53' ' ' ASP . 51.8 p -147.48 159.77 43.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -71.54 4.31 3.19 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 51' ' ' SER . 25.9 m-20 -112.57 -7.49 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t0 -60.32 114.02 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.003 -1.061 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -47.72 -17.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 109.036 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.3 t-20 -133.04 104.74 6.68 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -95.05 150.66 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.1 p -144.41 115.21 7.77 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 60' ' ' ALA . 78.5 mt -110.53 164.47 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.828 0.823 . . . . 0.0 110.629 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.577 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -141.92 139.15 32.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.66 153.36 25.12 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.895 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -72.54 177.02 4.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.714 -0.874 . . . . 0.0 109.48 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.82 82.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.968 . . . . 0.0 109.416 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.461 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 10.3 m-85 -89.59 118.79 29.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.26 -0.9 . . . . 0.0 109.348 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mm -60.76 -23.05 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -0.817 . . . . 0.0 110.161 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -86.59 14.2 7.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 69' ' ' ASN . 39.3 mtm-85 -150.76 74.36 8.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.569 -0.707 . . . . 0.0 109.243 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.13 13.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 123.403 2.735 . . . . 0.0 113.617 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -147.64 60.95 1.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 108.465 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -146.24 102.1 3.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.1 -1.0 . . . . 0.0 110.838 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 58.46 -115.13 0.8 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.724 -0.61 . . . . 0.0 112.038 178.047 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.3 m-85 -95.17 19.36 10.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.097 -1.002 . . . . 0.0 110.938 -177.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -59.94 -20.11 55.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.422 -1.424 . . . . 0.0 109.492 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.641 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 7.0 m-20 -121.92 -18.41 7.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 109.834 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.699 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.4 tm? -53.51 -39.24 64.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.894 -1.129 . . . . 0.0 108.287 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -65.27 -3.19 3.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -96.89 -29.37 13.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.01 -177.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.44 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -160.27 179.09 8.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.375 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -49.58 149.9 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 109.104 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.81 -13.45 24.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 39.3 m -61.96 100.26 0.15 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.412 -1.052 . . . . 0.0 108.349 179.448 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mmm -67.35 170.07 7.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.669 -179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 t -145.16 110.95 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 109.194 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.19 108.45 19.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.826 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -94.71 111.9 23.65 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -100.74 146.24 27.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 89' ' ' GLY . 14.9 t -132.93 167.64 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.654 -0.653 . . . . 0.0 109.264 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 88' ' ' VAL . . . -45.23 -32.88 3.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -153.97 47.62 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.913 -1.345 . . . . 0.0 110.274 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -171.95 121.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.064 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 92' ' ' THR . 12.6 t -125.1 125.93 44.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.437 HH12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.37 175.51 9.22 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.545 -0.722 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -145.38 132.74 20.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.176 -0.953 . . . . 0.0 110.24 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 13.1 m-85 -102.93 -177.15 3.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.489 -0.757 . . . . 0.0 108.967 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -141.56 110.74 6.3 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.37 -0.831 . . . . 0.0 109.349 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.6 tpp -48.37 114.47 0.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -146.47 26.25 1.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 108.703 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 m -170.24 124.11 0.72 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 0.0 109.841 -179.038 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.0 t0 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 118' ' ' ASP . 20.5 tptt -17.11 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 122.361 1.077 . . . . 0.0 111.153 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -93.76 173.61 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.106 -177.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.95 98.31 2.43 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.3 m -92.09 91.73 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.4 147.34 48.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.001 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.518 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 47.0 mt -136.97 149.32 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.325 -0.86 . . . . 0.0 109.782 -179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.23 158.81 15.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.0 137.87 23.82 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.927 -1.108 . . . . 0.0 109.603 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.3 t0 178.39 138.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 6.4 t0 65.1 60.09 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -64.59 121.78 15.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.161 -0.962 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 12.1 p30 -85.55 126.72 34.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.934 -1.104 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.06 6.11 41.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 109.471 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -76.68 -58.81 3.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.33 -0.856 . . . . 0.0 109.118 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 48.8 p -97.87 -4.37 36.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.365 -0.834 . . . . 0.0 109.245 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.04 46.99 33.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.7 t -146.91 167.27 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -1.1 . . . . 0.0 109.459 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 137' ' ' GLU . 70.4 m95 -72.32 113.63 9.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.194 -0.941 . . . . 0.0 108.944 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' TRP . 36.9 tt0 -36.25 -63.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.114 0.483 . . . . 0.0 110.733 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -139.2 149.85 44.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 109.163 179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -173.96 139.63 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.746 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.53 -179.58 6.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.862 . . . . 0.0 109.21 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.0 tt -151.31 144.7 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 8.9 m-85 -137.54 166.57 23.57 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 88.1 t -146.74 148.57 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.977 -1.077 . . . . 0.0 110.084 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.92 179.95 6.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.442 -0.786 . . . . 0.0 109.011 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.2 t -153.63 146.64 24.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.048 -1.032 . . . . 0.0 110.087 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.52 139.36 57.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 109.444 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.528 -179.992 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 mt . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -42.14 132.73 4.6 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.76 1.64 . . . . 0.0 112.442 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -83.85 -17.44 40.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 12' ' ' SER . 54.8 m-20 -77.01 106.63 8.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.58 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.58 -5.82 0.41 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 10' ' ' ASP . 67.4 p -110.83 42.14 1.67 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -146.6 134.17 20.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 16' ' ' GLY . 38.3 t -61.64 133.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 111.097 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.97 -7.68 24.84 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.599 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 171.65 -168.73 41.85 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.564 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 44.3 m-85 -146.88 126.81 13.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.937 -1.331 . . . . 0.0 109.679 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.93 141.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -145.27 137.01 25.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.92 -1.112 . . . . 0.0 110.431 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.731 HD12 HD21 ' A' ' 75' ' ' LEU . 9.8 mt -146.67 128.77 7.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 73.9 Cg_endo -75.39 -42.87 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.614 1.543 . . . . 0.0 111.403 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -54.13 -11.62 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.858 . . . . 0.0 108.959 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -131.5 6.49 4.44 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 42.19 31.72 0.27 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.648 -0.658 . . . . 0.0 109.935 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.99 147.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.061 0.934 . . . . 0.0 109.977 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -164.32 84.49 0.43 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -134.73 159.25 72.87 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.54 -0.725 . . . . 0.0 110.728 -176.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.88 159.51 15.98 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.974 2.45 . . . . 0.0 112.88 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.27 111.34 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 7.6 m-85 -74.41 148.76 86.14 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.855 -1.153 . . . . 0.0 109.765 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.72 112.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.254 1.969 . . . . 0.0 111.96 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.07 -176.12 43.27 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.472 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 84.7 Cg_endo -79.74 110.57 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 123.045 2.496 . . . . 0.0 111.501 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -42.63 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.418 0.628 . . . . 0.0 111.443 -178.752 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.574 ' H ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -104.18 173.25 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.992 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.22 -28.44 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.693 1.595 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.86 -35.57 80.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.48 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.6 ' NE2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -81.6 -67.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 110.41 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 38' ' ' GLN . 33.5 mt -42.75 -25.14 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.059 -1.026 . . . . 0.0 110.232 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.03 -24.81 67.29 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -96.14 -17.72 20.65 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 177.57 -133.15 2.14 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.894 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.482 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.1 t -125.82 159.44 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.534 -0.98 . . . . 0.0 109.572 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 p -155.97 163.0 40.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.231 -0.918 . . . . 0.0 108.833 179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 39.9 m-85 -59.43 169.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 109.19 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.66 -14.36 54.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -144.62 146.38 32.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.28 -0.887 . . . . 0.0 110.067 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -23.82 67.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.678 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -87.53 2.49 50.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 2.8 tm-20 -63.56 156.37 26.71 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.498 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.509 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 5.0 m -145.73 178.13 8.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.984 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -87.33 14.79 7.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 108.324 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -140.44 0.86 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.678 . . . . 0.0 109.904 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 14.3 t0 -56.77 118.7 5.16 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.823 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 54' ' ' ASP . 5.5 tp-100 -37.52 -24.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.029 0.442 . . . . 0.0 110.322 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 54' ' ' ASP . 18.9 t-20 -133.68 117.27 16.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.354 -0.841 . . . . 0.0 108.944 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.44 HD13 ' OE2' ' A' ' 50' ' ' GLU . 37.3 mm -92.72 142.85 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 108.597 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.5 p -140.67 109.69 6.12 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 60' ' ' ALA . 90.6 mt -111.15 161.2 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.646 0.736 . . . . 0.0 110.486 -178.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -137.8 130.41 29.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.96 154.91 25.66 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 72' ' ' PHE . 15.9 m-70 -72.61 170.45 14.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.588 -0.948 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.94 82.42 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 108.97 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.62 114.99 23.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 0.0 108.799 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 65' ' ' ILE . 6.7 mt -56.68 -29.91 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 109.948 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.82 16.24 2.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.602 -178.284 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.557 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -144.49 69.43 15.41 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.536 -0.728 . . . . 0.0 109.251 179.691 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.42 17.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.068 2.512 . . . . 0.0 113.543 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.557 ' H ' ' C ' ' A' ' 67' ' ' ARG . 37.0 m-80 -148.95 62.77 1.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.926 -1.108 . . . . 0.0 108.558 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -133.3 -154.04 0.58 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 109.77 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 79.4 mt-30 -57.77 -98.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.539 -0.726 . . . . 0.0 111.19 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.7 m-85 -96.0 27.36 3.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.226 -0.921 . . . . 0.0 110.549 -178.21 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 73' ' ' THR . 98.2 m -65.76 -12.4 53.66 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.58 -1.325 . . . . 0.0 109.581 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.4 m-20 -128.05 -20.58 3.78 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.269 -0.894 . . . . 0.0 110.47 -179.274 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.731 HD21 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -53.65 -33.57 55.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 108.278 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -71.44 -9.56 58.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -87.76 -24.49 23.78 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.377 0.608 . . . . 0.0 109.468 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 171.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.659 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -144.77 167.14 23.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 109.221 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -49.42 138.6 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.42 -20.96 47.01 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -62.43 100.52 0.18 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.368 -1.078 . . . . 0.0 108.119 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.28 173.17 0.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -178.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 t -143.13 113.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 109.069 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -95.15 102.6 14.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -95.71 112.08 23.88 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 88' ' ' VAL . 33.5 mtmt -96.59 152.12 18.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.236 -0.915 . . . . 0.0 111.251 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.574 HG21 HH12 ' A' ' 93' ' ' ARG . 76.6 t -156.15 93.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.49 -105.83 1.09 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -118.3 38.84 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.472 -1.016 . . . . 0.0 109.577 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -146.05 108.5 4.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.915 . . . . 0.0 108.828 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 92' ' ' THR . 12.8 t -110.39 119.54 39.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.505 -0.747 . . . . 0.0 110.387 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.574 HH12 HG21 ' A' ' 88' ' ' VAL . 2.2 mpt_? -95.22 172.54 8.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 109.308 179.48 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -144.41 146.9 32.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.858 -179.661 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 12.8 m-85 -137.52 177.92 7.5 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -140.63 107.69 5.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 109.721 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 81' ' ' GLY . 64.7 mtp -51.86 120.68 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -153.09 28.66 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.264 -0.897 . . . . 0.0 108.904 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.2 t -166.46 121.58 1.16 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 61.3 mt . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.444 -0.785 . . . . 0.0 110.192 -178.207 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 119' ' ' LYS . 8.0 m-20 . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 118' ' ' ASP . 85.6 mttt -34.89 131.31 0.38 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.69 -0.631 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.79 162.24 38.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.052 -1.03 . . . . 0.0 110.263 -178.443 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.456 HD11 ' CD1' ' A' ' 95' ' ' TYR . 12.4 mt -109.18 120.47 42.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.706 -0.621 . . . . 0.0 110.497 -178.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m -98.35 87.37 3.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.95 140.84 49.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.413 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -138.16 131.42 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -95.8 164.92 12.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.086 -1.009 . . . . 0.0 108.695 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 97.7 m -145.77 149.06 33.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.118 -0.989 . . . . 0.0 109.873 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 0.7 OUTLIER 176.79 132.09 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.306 -0.871 . . . . 0.0 109.35 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.8 OUTLIER 58.7 75.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.98 126.21 26.92 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.47 117.69 24.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.039 -1.038 . . . . 0.0 109.363 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -85.63 1.9 47.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.353 -0.842 . . . . 0.0 109.686 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -80.79 -55.88 4.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.6 p -94.66 -10.72 30.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.2 41.59 21.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.77 157.34 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 109.508 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.428 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.1 m95 -61.36 113.2 2.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.167 -0.958 . . . . 0.0 108.596 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' TRP . 35.2 tt0 -35.93 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.378 0.608 . . . . 0.0 110.759 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -100.33 150.95 22.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 108.95 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -173.55 144.66 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.948 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -106.37 173.2 6.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.1 mt -145.69 130.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.09 -1.007 . . . . 0.0 109.868 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -128.32 168.43 15.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.4 t -149.57 147.71 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.778 -1.201 . . . . 0.0 110.978 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.12 175.48 9.58 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -146.75 139.15 24.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.929 -1.107 . . . . 0.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 15.8 tm-20 -60.75 112.51 2.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 10.9 m . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.845 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -65.79 143.15 57.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.571 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.527 ' O ' ' NE2' ' A' ' 2' ' ' GLN . . . -71.13 166.33 21.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 0.0 109.394 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -152.14 58.16 2.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.234 -0.916 . . . . 0.0 109.809 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.44 -160.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.395 2.063 . . . . 0.0 111.502 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -94.7 72.54 3.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.989 -1.069 . . . . 0.0 109.995 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 7' ' ' ILE . 9.5 mt -89.22 113.43 56.31 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.6 122.46 6.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.647 1.564 . . . . 0.0 112.324 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -59.48 -7.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 12' ' ' SER . 2.6 m-20 -77.31 94.95 4.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.275 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -57.21 -5.68 0.31 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.261 -0.9 . . . . 0.0 109.793 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 10' ' ' ASP . 18.3 t -110.55 40.5 1.97 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.36 135.73 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.77 120.04 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.95 -19.98 19.1 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.28 -168.12 32.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.61 126.73 9.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.01 146.08 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' OE2' ' N ' ' A' ' 20' ' ' ILE . 8.8 tp10 -146.13 127.5 14.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.041 -1.037 . . . . 0.0 109.703 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' N ' ' OE2' ' A' ' 19' ' ' GLU . 44.7 mt -144.28 127.6 8.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.94 -46.19 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.726 1.617 . . . . 0.0 111.644 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.97 -25.33 3.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.79 9.03 10.62 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.485 -0.759 . . . . 0.0 109.397 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 42.27 38.75 1.24 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.424 0.63 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.42 HG23 ' OE1' ' A' ' 27' ' ' GLU . 4.4 mt -92.72 146.44 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.88 0.848 . . . . 0.0 109.536 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -164.64 80.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' OE1' HG23 ' A' ' 25' ' ' ILE . 3.2 mp0 -132.09 156.16 80.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.398 -0.814 . . . . 0.0 111.278 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -82.31 164.98 16.84 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.953 2.436 . . . . 0.0 112.332 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.0 127.03 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.385 -0.822 . . . . 0.0 109.066 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 4.9 m-85 -89.77 150.41 43.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.919 -1.113 . . . . 0.0 109.594 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.81 104.98 1.48 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.139 1.893 . . . . 0.0 111.605 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.08 -176.41 47.64 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.309 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' THR . 73.4 Cg_endo -79.16 117.94 3.92 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.323 . . . . 0.0 111.101 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.22 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.392 0.615 . . . . 0.0 110.455 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.587 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.8 p -105.69 153.47 39.92 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.03 -43.15 2.58 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.037 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.82 -21.41 66.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.9 OUTLIER -93.34 -62.39 1.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.0 mt -46.26 -18.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.389 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.5 m-20 -63.25 -25.28 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 89.2 mtt180 -83.27 -17.95 40.82 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 164.94 -130.92 2.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.295 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.34 165.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.574 -0.956 . . . . 0.0 109.213 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.452 ' CB ' HE22 ' A' ' 38' ' ' GLN . 3.3 t -162.09 159.1 25.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.157 -0.964 . . . . 0.0 109.065 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.94 164.85 2.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.84 -1.163 . . . . 0.0 109.396 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.79 -21.84 54.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.375 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -138.19 147.42 43.79 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.315 -0.866 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 -24.14 67.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.555 -0.716 . . . . 0.0 111.185 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -86.28 3.39 43.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.867 -1.146 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.87 161.88 20.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.048 -1.033 . . . . 0.0 109.3 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.1 m -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.759 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.5 mp -84.44 17.23 2.71 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -145.52 2.27 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.46 -0.775 . . . . 0.0 110.359 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASN . 50.7 t0 -57.29 126.49 27.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.64 -1.287 . . . . 0.0 109.292 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -42.31 -20.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.512 -0.743 . . . . 0.0 109.777 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 54' ' ' ASP . 14.7 t-20 -143.07 104.15 4.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 108.834 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.03 119.93 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.104 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.4 p -108.11 122.89 47.81 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 60' ' ' ALA . 68.9 mt -112.5 161.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.943 0.878 . . . . 0.0 110.952 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.552 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.62 125.49 25.71 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.86 153.31 21.04 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.622 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' PHE . 19.2 m-70 -74.97 167.8 21.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.737 -0.86 . . . . 0.0 109.972 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.06 87.36 1.27 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 108.913 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -87.26 117.1 25.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 65' ' ' ILE . 17.9 mt -59.85 -29.13 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.786 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.32 19.4 2.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.444 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -150.05 70.01 9.2 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.748 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.496 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.2 Cg_exo -54.38 18.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 123.236 2.624 . . . . 0.0 113.564 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 17.2 m-80 -148.94 62.31 1.05 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.07 -153.9 0.6 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.459 -0.776 . . . . 0.0 110.068 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -62.46 -89.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 111.685 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.65 ' CE1' HG22 ' A' ' 125' ' ' THR . 4.9 t80 -95.08 14.1 23.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.537 -0.727 . . . . 0.0 110.692 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 95.8 m -65.17 -49.45 69.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.4 -1.438 . . . . 0.0 110.829 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 5.0 m120 -83.1 -19.1 37.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.435 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.806 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.8 tm? -53.84 -27.94 32.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.851 -1.155 . . . . 0.0 109.059 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 20.6 mtmm -66.73 -27.83 67.94 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -71.33 -26.06 62.67 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.08 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.3 170.22 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.549 -0.719 . . . . 0.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -150.06 168.0 25.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.264 -0.897 . . . . 0.0 109.069 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 6.5 ttmm -51.32 150.98 3.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.546 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.66 -15.12 32.45 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.452 ' O ' ' SD ' ' A' ' 97' ' ' MET . 25.9 p -63.58 108.08 1.3 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.359 -1.083 . . . . 0.0 108.679 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.464 ' CE ' ' OH ' ' A' ' 85' ' ' TYR . 21.0 ptm -80.65 166.46 21.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.049 -1.032 . . . . 0.0 109.452 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.15 175.8 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.316 -0.865 . . . . 0.0 110.108 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' OH ' ' CE ' ' A' ' 83' ' ' MET . 73.8 m-85 -142.54 111.39 6.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.3 115.99 28.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -85.93 141.12 29.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.6 m -146.64 127.69 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.534 -0.729 . . . . 0.0 109.163 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.57 -115.83 2.06 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -116.16 53.92 0.85 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.606 -0.937 . . . . 0.0 109.399 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -166.84 153.4 8.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.048 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 92' ' ' THR . 9.0 t -131.09 124.9 31.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.4 6.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 7.5 ptpp? -142.92 154.8 44.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.146 -0.971 . . . . 0.0 110.042 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 4.1 m-85 -138.25 177.77 7.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -140.23 110.45 6.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.26 135.21 17.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.05 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 p -153.11 18.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 109.991 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.519 ' OG ' ' NE ' ' A' ' 101' ' ' ARG . 0.6 OUTLIER -170.14 87.45 0.13 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.624 -1.297 . . . . 0.0 109.259 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.418 ' CG2' ' OD2' ' A' ' 102' ' ' ASP . 43.4 mm -81.33 136.51 22.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.247 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.0 OUTLIER -124.52 -8.85 7.43 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.393 -0.817 . . . . 0.0 109.353 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 103' ' ' VAL . 6.4 p30 -43.64 -16.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.239 -0.913 . . . . 0.0 110.236 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 101' ' ' ARG . 20.5 t -59.5 -112.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -70.65 135.39 85.97 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.31 -34.25 13.07 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.204 1.269 . . . . 0.0 112.292 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' A' ' 106' ' ' THR . 17.8 p -84.85 91.31 7.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 109.614 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -135.39 160.34 38.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.411 -0.805 . . . . 0.0 108.933 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.75 46.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.759 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 107' ' ' ASP . . . -161.7 38.6 0.39 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 t -65.98 -29.09 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.1 mt -139.99 -33.39 0.58 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.523 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 45.7 t0 47.62 41.94 14.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.185 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -114.29 -7.57 12.94 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 114' ' ' GLN . 24.7 mp0 -103.03 -9.21 19.96 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -64.68 -155.68 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.91 42.54 0.54 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -95.99 -121.61 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.252 -1.146 . . . . 0.0 109.434 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.3 m-20 -118.82 169.74 9.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.32 -0.863 . . . . 0.0 108.773 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 118' ' ' ASP . 37.5 mtmt -38.52 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.423 ' OE1' ' OD1' ' A' ' 112' ' ' ASP . 7.0 pt20 -154.7 157.37 37.98 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.183 -0.948 . . . . 0.0 110.053 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.7 tp -121.82 106.73 11.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.1 m -91.16 128.03 36.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.933 -1.104 . . . . 0.0 108.785 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.3 mp -103.43 145.27 30.24 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.22 -0.925 . . . . 0.0 110.161 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.6 mt -142.58 139.97 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.374 -0.829 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.65 HG22 ' CE1' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -96.07 166.11 11.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.013 -1.054 . . . . 0.0 108.787 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.473 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -149.86 102.49 3.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.04 -1.037 . . . . 0.0 109.754 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 p-10 -156.03 148.03 23.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 0.0 109.305 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.48 56.85 2.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 108.802 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -62.05 119.0 8.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.464 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 135' ' ' VAL . 2.6 p-10 -83.92 130.63 34.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.013 -1.054 . . . . 0.0 109.694 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.75 5.52 43.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 109.061 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -71.63 -61.43 1.78 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.464 -0.773 . . . . 0.0 108.936 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -100.49 -1.42 35.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 109.342 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.85 49.72 33.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 5.1 t -146.99 168.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -1.065 . . . . 0.0 109.417 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 91.6 m95 -73.82 113.64 11.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -40.28 -77.54 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -84.36 150.49 25.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.015 . . . . 0.0 108.584 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -151.03 79.48 1.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.862 -1.149 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 125' ' ' THR . 10.8 mtpt -75.2 148.72 39.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.463 ' H ' ' HA ' ' A' ' 102' ' ' ASP . 11.9 pt -135.87 149.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 122.12 0.962 . . . . 0.0 110.902 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -144.09 143.86 31.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 99' ' ' SER . 4.7 p -136.89 149.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.897 -1.127 . . . . 0.0 110.938 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -130.89 -178.03 4.63 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.7 t -148.05 148.54 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.002 -1.061 . . . . 0.0 109.651 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -51.11 144.03 9.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.86 . . . . 0.0 109.223 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.1 t -91.97 -153.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.346 -0.846 . . . . 0.0 109.164 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.485 ' H ' HG12 ' A' ' 147' ' ' VAL . 84.3 mttt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.45 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.476 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -154.56 146.67 23.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.259 -0.901 . . . . 0.0 109.515 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.85 158.36 18.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.249 -0.907 . . . . 0.0 109.702 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.56 ' O ' ' O ' ' A' ' 5' ' ' PRO . 1.6 pttm -71.07 153.43 94.56 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 109.015 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' O ' ' O ' ' A' ' 4' ' ' LYS . 66.1 Cg_exo -42.52 -125.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 123.047 2.498 . . . . 0.0 113.726 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -147.76 116.06 6.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.707 -1.246 . . . . 0.0 110.264 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.3 mm -85.27 114.0 53.69 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 98.9 Cg_exo -42.33 150.58 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.627 1.551 . . . . 0.0 112.004 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.08 -11.52 18.8 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.13 103.0 6.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 0.0 109.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -56.5 -13.0 1.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -98.48 30.81 3.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.4 -0.812 . . . . 0.0 109.203 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.5 140.53 23.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.624 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 58.5 t -60.65 163.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.72 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -138.51 -3.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 177.34 -175.19 47.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.624 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 69.6 m-85 -149.81 121.46 8.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.084 -1.245 . . . . 0.0 110.087 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.8 tt -98.66 143.93 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -146.84 136.03 22.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.03 -1.044 . . . . 0.0 110.675 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.492 ' CD1' HD21 ' A' ' 75' ' ' LEU . 51.4 mt -144.88 125.02 7.26 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.5 Cg_endo -76.3 -42.55 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.691 1.594 . . . . 0.0 111.434 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -50.66 -17.24 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.048 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.488 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -133.82 14.31 3.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.513 -0.742 . . . . 0.0 109.209 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.4 p-10 43.75 50.25 6.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.488 HG12 ' HB3' ' A' ' 23' ' ' ALA . 43.3 mm -92.7 142.79 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.645 0.736 . . . . 0.0 109.888 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -168.97 81.35 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.0 158.49 61.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.738 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' A' ' 14' ' ' VAL . 40.8 Cg_endo -86.07 169.74 8.68 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.184 2.589 . . . . 0.0 113.105 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.56 137.14 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 24.6 m-85 -92.41 149.84 39.0 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.907 -1.121 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 50.3 Cg_endo -81.46 79.37 3.25 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.806 2.338 . . . . 0.0 111.802 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.76 177.5 39.58 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.865 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 91.2 Cg_endo -79.86 121.66 4.62 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.824 2.349 . . . . 0.0 111.182 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -40.85 87.75 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.906 -0.496 . . . . 0.0 110.918 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -111.54 167.28 9.32 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.52 -45.36 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.739 1.626 . . . . 0.0 111.833 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -62.28 -17.03 57.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.856 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.482 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -96.98 -69.36 0.76 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 0.0 108.642 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' A' ' 34' ' ' ALA . 42.2 mt -41.35 -24.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.799 -0.563 . . . . 0.0 110.51 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 38' ' ' GLN . 31.3 m-20 -63.61 -25.13 68.09 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.436 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.4 mtp180 -84.49 -14.58 48.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' C ' HE21 ' A' ' 71' ' ' GLN . . . 156.51 -143.92 10.22 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.882 -1.151 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.636 HG23 ' NE2' ' A' ' 71' ' ' GLN . 3.9 t -88.61 152.88 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 t -148.81 141.02 24.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 108.967 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -56.45 162.35 2.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 108.944 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.31 -9.98 59.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.173 -0.954 . . . . 0.0 108.812 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -145.27 149.55 35.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.5 pt-20 -63.39 -41.84 98.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 111.152 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 8.2 p30 -89.65 17.81 6.11 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 111.222 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.87 95.77 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.866 -1.146 . . . . 0.0 109.839 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -89.75 173.31 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -82.44 0.13 43.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.089 -1.007 . . . . 0.0 108.647 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.91 -10.68 19.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.564 -0.71 . . . . 0.0 109.897 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.5 t70 -59.59 113.44 2.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.772 -1.205 . . . . 0.0 108.863 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -46.72 -14.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.133 -0.979 . . . . 0.0 109.56 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 114' ' ' GLN . 3.8 m120 -133.49 97.21 3.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -94.23 115.86 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.233 -0.917 . . . . 0.0 108.917 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.8 t -108.63 116.69 32.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.697 -0.627 . . . . 0.0 109.351 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 60' ' ' ALA . 92.1 mt -109.37 164.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.601 0.715 . . . . 0.0 109.579 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.561 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -138.32 135.25 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.07 148.78 20.7 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.081 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -74.53 -169.29 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.639 -0.918 . . . . 0.0 110.07 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.84 99.99 0.47 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.27 122.45 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.162 -0.962 . . . . 0.0 108.918 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 65' ' ' ILE . 16.2 mt -64.65 -43.06 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.783 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.26 18.91 2.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.187 -0.945 . . . . 0.0 109.888 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -151.04 75.58 8.16 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 72.9 Cg_exo -51.78 24.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.92 3.08 . . . . 0.0 114.642 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.4 m120 -151.7 62.92 0.86 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 108.55 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 73' ' ' THR . 36.8 t80 -141.7 90.24 2.26 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.235 -0.916 . . . . 0.0 110.498 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.636 ' NE2' HG23 ' A' ' 43' ' ' VAL . 1.5 mm100 65.03 -119.23 0.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.764 -0.585 . . . . 0.0 111.556 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.628 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 29.5 t80 -87.44 33.35 0.69 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.318 1.056 . . . . 0.0 109.142 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 70' ' ' TYR . 21.6 m -69.13 -57.21 5.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.15 -1.594 . . . . 0.0 110.607 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 2.1 m-20 -90.43 -13.56 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.181 -0.949 . . . . 0.0 111.775 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 20' ' ' ILE . 2.4 mt -52.38 -29.63 24.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 108.281 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -74.02 -1.77 21.36 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -99.37 -33.2 10.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.618 . . . . 0.0 109.337 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.25 163.23 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -129.03 162.73 26.97 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -49.06 132.41 19.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 109.282 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.94 -24.3 15.03 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -64.36 114.23 4.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.206 -1.173 . . . . 0.0 108.065 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -73.35 -174.11 1.55 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.839 -1.163 . . . . 0.0 109.454 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.584 ' N ' ' SD ' ' A' ' 83' ' ' MET . 21.4 t -146.46 110.75 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.515 ' CD2' ' SD ' ' A' ' 83' ' ' MET . 53.0 m-85 -87.45 102.44 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -97.56 117.54 32.07 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -107.75 139.77 41.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.414 -0.804 . . . . 0.0 110.112 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 89' ' ' GLY . 7.1 p -168.96 157.41 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.724 . . . . 0.0 109.484 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 88' ' ' VAL . . . 57.85 -96.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -154.27 29.8 0.44 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -140.17 -175.25 4.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.355 -0.841 . . . . 0.0 109.201 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 m -149.83 111.57 4.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.536 ' NH2' ' CD1' ' A' ' 52' ' ' LEU . 7.6 mpt_? -89.07 163.53 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -141.43 122.9 15.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.384 -0.823 . . . . 0.0 109.63 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 17.1 m-85 -109.15 175.1 5.58 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.429 -0.794 . . . . 0.0 109.128 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.89 111.06 8.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.28 -0.887 . . . . 0.0 109.886 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.9 mtt -50.67 123.23 8.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.123 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 p -149.44 20.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 109.431 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.1 t -171.37 123.69 0.57 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.691 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.3 mt -138.82 128.78 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 101' ' ' ARG . 3.6 mtt-85 -86.54 -70.8 0.58 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.189 -0.944 . . . . 0.0 108.945 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 51.16 10.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.113 -0.992 . . . . 0.0 109.179 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.774 HG12 ' N ' ' A' ' 104' ' ' LYS . 10.6 t -91.05 -93.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.774 ' N ' HG12 ' A' ' 103' ' ' VAL . 52.0 mtpt -100.0 140.96 21.91 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.06 28.89 0.29 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.207 1.271 . . . . 0.0 111.879 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -178.56 75.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.397 -0.814 . . . . 0.0 109.544 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 106' ' ' THR . 49.5 t0 -61.77 -115.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -0.969 . . . . 0.0 108.81 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.436 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 6.4 m -104.14 22.34 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.33 -0.856 . . . . 0.0 109.126 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.48 103.85 0.84 Allowed Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.64 -15.25 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.214 -1.168 . . . . 0.0 108.337 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.4 mt -135.38 54.88 1.9 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -171.74 20.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.469 -0.77 . . . . 0.0 109.097 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 113' ' ' GLU . 10.2 tt0 -156.64 0.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 109.553 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.582 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 3.6 mp0 -94.37 15.73 16.9 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.431 ' N ' HD21 ' A' ' 56' ' ' ASN . 14.9 pttp -96.16 44.55 1.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -92.44 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -145.91 -26.49 0.44 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 49.1 t0 -118.86 168.16 11.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.144 -0.973 . . . . 0.0 108.617 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.468 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 83.0 mttt -60.83 145.08 51.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -143.83 160.58 40.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.057 -1.027 . . . . 0.0 108.953 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.1 tp -114.87 107.98 16.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.675 . . . . 0.0 110.962 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 122' ' ' THR . 6.7 t -97.54 107.72 20.29 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.0 156.38 21.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.003 . . . . 0.0 110.278 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.7 mt -140.37 143.78 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.513 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -91.78 155.89 17.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.934 -1.104 . . . . 0.0 108.512 179.288 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.416 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 2.0 m -149.29 85.03 1.44 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.944 -1.097 . . . . 0.0 109.886 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 20.3 p-10 -142.8 143.88 32.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.141 -0.975 . . . . 0.0 109.235 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.34 61.09 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.451 -0.78 . . . . 0.0 109.072 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -63.7 119.98 10.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -85.67 123.48 31.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 109.602 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.7 pm0 -94.82 14.7 20.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.343 -0.848 . . . . 0.0 109.77 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -69.31 -35.5 76.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.0 108.57 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.0 p -140.99 1.92 1.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 109.037 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.63 3.03 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.3 t -146.99 133.72 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.225 -1.162 . . . . 0.0 109.642 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 53.3 m95 -53.11 113.65 1.19 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.07 -1.019 . . . . 0.0 108.493 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -36.96 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.291 0.567 . . . . 0.0 110.326 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 137' ' ' GLU . 19.2 ptmt -96.87 139.35 33.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -151.78 96.49 2.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.891 -1.131 . . . . 0.0 110.569 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.658 ' O ' HD13 ' A' ' 141' ' ' ILE . 40.4 mtpt -86.58 158.49 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.156 -0.965 . . . . 0.0 108.473 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 140' ' ' LYS . 7.9 mm -129.25 140.29 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 25.8 m-85 -129.49 170.63 13.47 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.1 t -154.06 140.85 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.692 -1.255 . . . . 0.0 110.86 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.24 139.3 40.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.8 t -109.85 137.61 47.39 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.399 -0.813 . . . . 0.0 110.389 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.03 133.55 55.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 109.547 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 147' ' ' VAL . 8.2 m -91.63 148.17 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 109.327 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.7 pttp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.438 -179.998 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.309 0.575 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -74.43 91.25 2.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.913 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.19 60.08 2.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.409 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 5' ' ' PRO . 43.7 mttp -146.81 77.26 11.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.323 -0.861 . . . . 0.0 109.431 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' CD ' ' OD1' ' A' ' 53' ' ' ASP . 52.9 Cg_exo -54.58 -140.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.972 2.448 . . . . 0.0 112.495 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -67.37 91.84 0.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.765 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mt -149.46 95.57 3.75 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 10' ' ' ASP . 93.1 Cg_endo -83.6 134.18 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.191 1.927 . . . . 0.0 112.432 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -60.21 0.76 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 12' ' ' SER . 13.2 t70 -76.49 91.18 3.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -64.76 38.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 10' ' ' ASP . 43.3 t -146.9 25.26 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 108.885 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -141.67 141.88 33.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.64 118.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.66 -0.65 . . . . 0.0 110.885 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.96 -16.81 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.97 -177.48 38.74 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 121.31 8.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -1.223 . . . . 0.0 109.586 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -99.9 142.04 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' CD ' ' NZ ' ' A' ' 87' ' ' LYS . 23.7 mt-10 -146.79 135.24 21.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.968 -1.083 . . . . 0.0 110.737 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.494 HD12 HD23 ' A' ' 75' ' ' LEU . 32.5 mt -144.84 127.06 8.12 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.07 -42.75 0.37 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.636 1.557 . . . . 0.0 111.599 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -52.16 -14.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.403 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.495 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -135.63 15.14 3.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.42 -0.8 . . . . 0.0 109.136 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 42.41 49.52 4.62 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.718 0.77 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 23' ' ' ALA . 50.0 mm -91.76 141.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 25' ' ' ILE . 42.3 mttp -165.9 81.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -143.91 156.58 58.79 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 0.0 110.817 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -84.79 165.36 11.84 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.041 2.494 . . . . 0.0 112.531 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.22 119.43 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.412 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 7.9 m-85 -79.37 149.43 72.23 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.817 -1.177 . . . . 0.0 110.207 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.58 88.5 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.479 2.119 . . . . 0.0 111.86 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.31 -179.44 41.23 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.575 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 35' ' ' THR . 85.2 Cg_endo -78.09 119.17 4.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.861 2.374 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.63 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.383 0.611 . . . . 0.0 110.397 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -112.55 153.47 44.94 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.63 -43.43 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.09 1.86 . . . . 0.0 111.664 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.09 -22.98 67.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' ASN . 4.0 tp-100 -89.94 -66.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.235 -0.916 . . . . 0.0 109.54 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.2 mt -46.39 -15.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.918 . . . . 0.0 109.947 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' GLN . 40.0 m-20 -63.25 -25.19 68.21 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.88 -11.24 45.18 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 158.15 -136.6 4.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 60' ' ' ALA . 2.9 t -108.42 159.03 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.992 . . . . 0.0 109.862 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 p -153.58 156.73 38.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -57.99 175.67 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.797 -1.189 . . . . 0.0 109.946 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -85.95 -12.18 51.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -147.24 151.12 36.15 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.472 0.653 . . . . 0.0 109.935 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.39 -38.73 92.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.6 -0.687 . . . . 0.0 111.34 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -87.38 12.31 12.38 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.897 -1.127 . . . . 0.0 110.643 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.31 84.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' ASP . 48.2 m -92.56 147.46 22.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.03 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.967 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.41 -8.77 0.37 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -77.12 -30.82 55.37 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.508 -0.745 . . . . 0.0 109.615 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 15.8 m-20 -62.16 104.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.055 -1.028 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.31 -16.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 54' ' ' ASP . 10.0 t30 -117.97 97.86 6.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.646 -0.659 . . . . 0.0 109.223 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.425 ' O ' ' OG1' ' A' ' 122' ' ' THR . 92.2 mt -98.49 150.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.376 -0.827 . . . . 0.0 109.325 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -140.46 114.45 9.02 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -101.69 161.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.326 -0.859 . . . . 0.0 110.362 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.542 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -140.27 131.17 26.02 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.23 154.24 24.89 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.537 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -71.1 175.52 5.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.68 -0.894 . . . . 0.0 109.063 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.86 89.75 0.66 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.65 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.05 116.99 28.49 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.2 mm -59.59 -29.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.799 . . . . 0.0 110.097 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -87.54 19.51 3.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -149.71 70.56 9.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.536 -0.727 . . . . 0.0 109.191 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.88 14.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 123.442 2.761 . . . . 0.0 113.853 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 67' ' ' ARG . 56.5 m-80 -147.9 60.95 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.216 . . . . 0.0 108.839 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -146.8 103.63 3.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 110.48 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.4 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 59.3 mt-30 55.81 -115.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 111.907 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.68 30.65 2.87 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 111.13 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.1 m -63.92 -49.16 73.71 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.128 -1.608 . . . . 0.0 109.611 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.602 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.9 m-20 -93.95 -18.23 22.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.012 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.69 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.6 tm? -51.05 -39.07 55.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -68.91 -4.71 17.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -91.5 -27.99 17.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 162.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 109.742 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 166.36 24.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.348 -0.845 . . . . 0.0 108.807 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -50.18 137.31 18.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.54 13.19 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -64.19 119.7 10.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.407 -1.055 . . . . 0.0 108.269 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.7 mtp -82.96 137.12 34.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.0 -1.063 . . . . 0.0 110.102 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.02 114.12 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.607 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -93.26 102.46 14.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.151 -0.968 . . . . 0.0 109.544 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -97.13 114.63 26.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 0.0 108.755 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' NZ ' ' CD ' ' A' ' 19' ' ' GLU . 23.0 mtmm -106.12 142.08 36.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.94 123.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.79 -145.23 5.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 90' ' ' ASN . 28.0 t-20 -85.26 52.1 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.198 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 m -152.98 148.68 27.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.601 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 177.15 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -144.31 164.1 31.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.028 -1.045 . . . . 0.0 110.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 94' ' ' LYS . 23.7 m-85 -148.96 108.31 3.95 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.39 117.91 16.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.132 -0.98 . . . . 0.0 109.27 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -51.75 129.62 26.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.309 -0.869 . . . . 0.0 108.988 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -158.16 24.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.227 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.0 t -171.28 132.7 0.81 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 101' ' ' ARG . 64.4 mt -142.1 166.74 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.624 ' CG ' HH11 ' A' ' 101' ' ' ARG . 2.9 mtt-85 -140.35 -26.74 0.76 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' HA ' ' H ' ' A' ' 141' ' ' ILE . 25.5 t0 42.68 20.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.678 . . . . 0.0 109.186 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -167.95 141.57 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' PRO . 38.8 tttm -65.66 -62.25 4.71 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.897 -1.127 . . . . 0.0 110.606 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 107' ' ' ASP . 28.0 Cg_exo -23.81 -109.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 123.788 2.992 . . . . 0.0 114.462 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 107' ' ' ASP . 31.0 p 50.34 -89.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.753 -1.217 . . . . 0.0 109.705 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' OG1' ' A' ' 106' ' ' THR . 50.8 m-20 -96.73 169.35 9.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 108' ' ' VAL . 15.6 m -72.79 33.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.076 -1.015 . . . . 0.0 108.962 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 154.67 122.16 0.81 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.09 -35.95 73.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.186 -1.185 . . . . 0.0 108.597 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.08 67.83 0.67 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -173.45 25.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.987 . . . . 0.0 110.187 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -155.02 22.87 0.44 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.866 -1.146 . . . . 0.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.466 ' NE2' ' OE1' ' A' ' 120' ' ' GLN . 9.4 pt20 -146.34 13.79 1.25 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.433 -0.792 . . . . 0.0 109.121 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -80.35 31.81 0.28 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.679 -0.638 . . . . 0.0 109.551 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -150.51 8.36 0.74 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -96.65 -125.1 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -1.22 . . . . 0.0 108.982 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 4.2 m-20 -116.45 168.37 10.21 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -47.37 141.29 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 108.824 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.466 ' OE1' ' NE2' ' A' ' 114' ' ' GLN . 6.8 pt20 -152.84 164.58 37.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 110.572 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.1 tp -127.23 116.59 20.81 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.067 0.46 . . . . 0.0 109.854 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.498 ' H ' ' HG1' ' A' ' 122' ' ' THR . 0.1 OUTLIER -96.05 92.37 6.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.07 143.17 54.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 110.136 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mt -140.92 135.62 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.462 -0.774 . . . . 0.0 109.324 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.6 p -96.63 167.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.058 -1.027 . . . . 0.0 108.521 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 70.8 m -147.03 139.5 24.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.022 -1.049 . . . . 0.0 110.124 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 1.7 p30 179.59 136.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 61.5 64.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.0 109.201 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -62.98 126.5 27.53 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 109.142 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -85.96 118.36 25.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.038 . . . . 0.0 109.509 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.74 -0.56 54.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.425 -0.797 . . . . 0.0 109.918 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.77 -50.24 9.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.008 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.7 p -95.13 -10.69 29.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.236 -0.915 . . . . 0.0 109.233 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.76 39.94 54.08 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.89 158.89 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.333 -1.098 . . . . 0.0 109.636 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.427 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.8 m95 -62.78 111.76 2.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -35.79 -77.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.064 0.459 . . . . 0.0 110.627 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.446 -0.784 . . . . 0.0 109.227 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -169.79 131.62 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.709 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.51 166.83 13.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.14 -0.975 . . . . 0.0 108.845 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 22.6 mt -141.51 144.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 13.1 m-85 -140.1 168.93 18.66 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -150.05 141.8 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.626 -1.296 . . . . 0.0 110.745 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.19 171.27 14.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 147' ' ' VAL . 14.4 t -146.87 147.53 30.91 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.84 -1.163 . . . . 0.0 110.93 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.17 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.7 t -148.1 175.17 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.181 -0.949 . . . . 0.0 108.99 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.473 ' H ' HG12 ' A' ' 147' ' ' VAL . 41.4 pttt . . . . . 0 N--CA 1.499 2.007 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.377 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -164.41 143.91 7.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 109.242 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.76 143.67 1.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' PRO . 45.8 mttt -82.17 154.91 69.82 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' LYS . 99.8 Cg_exo -42.11 172.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.081 1.854 . . . . 0.0 112.062 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -92.32 113.04 25.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.907 -1.12 . . . . 0.0 111.252 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' PRO . 6.9 mm -87.82 118.52 69.82 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' ILE . 76.8 Cg_exo -47.27 -174.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.527 1.485 . . . . 0.0 112.509 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -120.66 -26.7 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' SER . 30.8 t70 -76.08 101.68 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -57.45 -2.67 0.13 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.6 p -115.59 43.98 1.97 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.499 -0.75 . . . . 0.0 109.345 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 136.83 30.24 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 t -61.19 108.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.52 -0.738 . . . . 0.0 111.402 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.7 -5.03 49.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.43 -170.24 40.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.08 126.33 10.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -1.183 . . . . 0.0 109.073 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 tp -97.41 140.77 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -146.58 132.54 19.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.167 . . . . 0.0 110.748 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.612 ' CD1' HD21 ' A' ' 75' ' ' LEU . 35.6 mt -144.8 120.58 6.02 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.94 -37.99 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.629 1.553 . . . . 0.0 111.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.32 -19.9 1.48 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.408 -0.807 . . . . 0.0 109.293 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 24' ' ' ASP . . . -130.54 5.32 4.72 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.5 -0.75 . . . . 0.0 109.465 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER 56.16 29.61 15.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.831 -0.543 . . . . 0.0 111.372 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CD1' ' ND2' ' A' ' 74' ' ' ASN . 1.5 mp -85.33 142.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.658 -1.276 . . . . 0.0 108.404 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -165.64 86.3 0.37 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 16.6 mt-10 -142.13 160.62 54.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.75 158.18 24.68 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.514 2.143 . . . . 0.0 112.17 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.06 108.39 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.75 166.94 27.01 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.948 -1.095 . . . . 0.0 109.11 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -86.1 130.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.486 2.124 . . . . 0.0 112.177 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.02 168.94 30.88 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.012 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.9 Cg_endo -77.78 121.02 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 111.286 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -39.78 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.33 0.586 . . . . 0.0 110.281 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 p -126.43 152.82 74.68 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.12 -43.0 12.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.187 1.924 . . . . 0.0 111.995 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -61.46 -21.98 64.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.576 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.4 OUTLIER -95.29 -69.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.158 -0.964 . . . . 0.0 109.253 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 17.5 mt -45.58 -16.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -62.18 -24.84 67.43 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.6 -15.64 54.06 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.188 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.61 -109.69 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.924 -1.131 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 60' ' ' ALA . 5.0 t -125.52 153.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.505 -0.997 . . . . 0.0 109.758 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -153.79 153.74 32.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -56.78 165.57 1.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.594 -1.317 . . . . 0.0 109.474 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.05 -5.12 53.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -150.9 146.42 26.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.519 -0.738 . . . . 0.0 109.591 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.49 -38.39 87.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 111.075 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -89.47 15.48 9.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.99 -1.069 . . . . 0.0 111.143 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.0 99.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.847 -1.158 . . . . 0.0 109.61 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.1 p -91.22 144.28 25.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 108.856 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.039 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.99 -7.1 0.95 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' SER . 20.5 t0 -96.01 -13.47 23.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.691 -0.631 . . . . 0.0 109.626 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' ASN . 46.4 t0 -58.97 105.08 0.28 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.02 -1.05 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' NE2' ' A' ' 55' ' ' GLN . 6.0 tm0? -44.49 -17.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.506 -0.747 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 54' ' ' ASP . 5.0 t-20 -122.3 92.75 3.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.1 mt -93.55 145.8 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 108.453 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 t -142.3 109.17 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 108.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.5 mt -95.27 162.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.181 -0.949 . . . . 0.0 110.162 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -134.02 131.78 39.3 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.03 145.47 15.44 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.844 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 18.1 m-70 -72.85 -169.95 0.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.685 -0.891 . . . . 0.0 109.304 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.48 94.15 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -89.44 113.09 24.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.923 . . . . 0.0 108.887 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mt -61.07 -31.67 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 110.12 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -84.27 15.47 3.56 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 109.302 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -151.49 74.23 8.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.38 24.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 123.861 3.041 . . . . 0.0 114.379 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.4 m120 -151.26 63.44 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.0 108.551 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 36.2 t80 -150.77 99.85 2.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.071 -1.018 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.542 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.8 mt-30 59.66 -122.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.706 . . . . 0.0 111.454 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 12.2 t80 -92.75 36.66 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.402 1.096 . . . . 0.0 109.574 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.7 m -67.05 -56.65 9.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 119.908 -1.745 . . . . 0.0 110.299 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.2 p30 -110.82 7.14 21.84 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.232 -0.917 . . . . 0.0 111.409 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.612 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.8 mt -57.8 -15.03 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.62 -12.35 59.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -81.54 -30.41 33.15 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.8 -179.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLY . 23.5 mmtp -139.76 153.48 47.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 9.7 ttmm -51.39 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.83 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.7 -15.35 0.36 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -62.86 121.25 13.02 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.335 -1.097 . . . . 0.0 108.119 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtp -70.94 -175.06 1.04 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.336 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -146.51 109.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.39 101.88 14.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE2' ' CG2' ' A' ' 88' ' ' VAL . 16.7 t80 -98.74 112.45 24.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 87' ' ' LYS . 7.0 mtmp? -92.12 146.55 23.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.064 -1.023 . . . . 0.0 110.809 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 90' ' ' ASN . 68.3 t -139.55 155.25 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.77 41.2 0.25 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 88' ' ' VAL . 43.1 t30 -160.4 -34.29 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.229 -1.159 . . . . 0.0 110.028 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.441 ' OE1' ' NH1' ' A' ' 93' ' ' ARG . 29.8 tt0 -172.4 165.9 5.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 92' ' ' THR . 11.0 t -107.14 123.04 47.67 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.441 ' NH1' ' OE1' ' A' ' 91' ' ' GLU . 5.3 mmt180 -92.94 160.16 15.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 108.737 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -144.87 121.18 10.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -114.59 176.76 4.91 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.607 -0.683 . . . . 0.0 109.223 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -136.56 107.21 6.55 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 0.0 109.395 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.445 ' HB3' ' H ' ' A' ' 81' ' ' GLY . 28.5 tpp -49.49 119.29 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.052 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -145.37 19.72 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.096 -1.002 . . . . 0.0 109.744 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.401 ' HB3' HH12 ' A' ' 101' ' ' ARG . 45.7 m -169.54 118.84 0.65 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 108.784 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.3 mt -134.34 151.92 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.554 -0.716 . . . . 0.0 109.669 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.519 ' NH2' ' OE1' ' A' ' 113' ' ' GLU . 10.9 mpt_? -112.66 -65.43 1.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 101' ' ' ARG . 18.5 t70 37.68 54.57 1.5 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.339 0.59 . . . . 0.0 110.001 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 103' ' ' VAL . 6.2 p -159.58 40.15 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.253 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 74.11 155.16 0.15 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.482 -0.761 . . . . 0.0 109.211 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -35.25 101.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.801 2.334 . . . . 0.0 112.484 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.6 p -88.18 -42.82 12.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.5 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 109' ' ' GLY . 30.3 t70 -98.83 160.79 14.02 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.69 32.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.086 -1.009 . . . . 0.0 108.88 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 157.12 134.4 1.76 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.168 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.9 m -69.75 -34.38 60.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.414 -1.051 . . . . 0.0 108.911 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 112' ' ' ASP . 19.8 mt -101.13 67.61 1.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.489 -0.757 . . . . 0.0 109.413 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.693 ' N ' HE21 ' A' ' 114' ' ' GLN . 1.8 m-20 -178.22 28.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.519 ' OE1' ' NH2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -160.88 25.14 0.14 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.693 HE21 ' N ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -137.96 16.94 2.84 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 116' ' ' GLY . 6.8 mtpm? -97.87 35.77 1.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 115' ' ' LYS . . . -48.35 -96.16 0.01 OUTLIER Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -154.79 -32.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -1.203 . . . . 0.0 110.647 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -104.99 149.96 25.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.207 -0.933 . . . . 0.0 110.442 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -44.86 140.77 2.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.433 ' CD ' ' O ' ' A' ' 114' ' ' GLN . 7.2 pt20 -152.21 173.4 15.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.997 -1.064 . . . . 0.0 110.08 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.7 tp -122.87 155.86 35.81 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.45 0.643 . . . . 0.0 110.122 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.0 m -141.98 88.96 2.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.77 149.44 49.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.378 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 96.8 mt -140.04 141.99 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.5 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -90.49 156.56 18.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.919 -1.113 . . . . 0.0 108.831 179.231 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.533 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 23.0 m -148.75 89.82 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.142 -0.973 . . . . 0.0 109.449 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -148.54 146.04 28.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.235 -0.916 . . . . 0.0 109.118 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 1.2 m-20 61.29 63.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 108.835 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -63.24 122.11 15.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -85.17 121.69 28.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.85 13.77 19.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.853 . . . . 0.0 109.638 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -81.19 -26.16 36.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 p -141.98 5.59 1.73 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.355 -0.84 . . . . 0.0 109.168 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.23 53.04 23.88 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.481 ' CG1' ' NH2' ' A' ' 139' ' ' ARG . 3.3 t -147.29 139.83 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.218 -1.166 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 56.9 m95 -56.09 115.39 2.4 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.38 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 12.6 tp10 -39.51 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.724 -0.61 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -81.28 146.92 30.16 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.481 ' NH2' ' CG1' ' A' ' 135' ' ' VAL . 26.8 ttm180 -158.76 75.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.872 -1.143 . . . . 0.0 110.482 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -75.27 163.59 27.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.287 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.47 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 6.9 mm -134.09 156.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.836 0.826 . . . . 0.0 110.426 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 21.3 m-85 -141.75 159.73 41.64 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.2 147.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.711 -1.243 . . . . 0.0 111.342 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.17 158.77 43.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.21 143.02 50.27 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.15 -0.968 . . . . 0.0 109.92 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 9.1 tm-20 -60.48 135.75 57.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.438 -0.789 . . . . 0.0 108.88 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.4 t -136.89 175.84 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.356 -0.84 . . . . 0.0 108.875 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' H ' HG12 ' A' ' 147' ' ' VAL . 58.9 pttt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.085 -1.009 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.376 0.608 . . . . 0.0 109.393 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -69.9 111.32 5.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.624 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.18 154.97 41.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.17 -0.956 . . . . 0.0 109.363 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.3 pttp -56.15 143.82 62.32 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.14 -0.975 . . . . 0.0 109.159 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 4' ' ' LYS . 74.6 Cg_exo -49.25 -156.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.225 1.95 . . . . 0.0 113.21 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -67.5 101.66 1.02 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.016 . . . . 0.0 109.909 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.483 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . 11.8 mt -149.75 94.92 3.77 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 0.0 108.964 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.62 172.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.275 1.983 . . . . 0.0 112.345 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.57 2.08 12.33 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.57 -0.707 . . . . 0.0 109.514 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 12' ' ' SER . 63.2 t0 -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.98 3.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ASP . 27.2 p -129.24 39.81 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.259 -0.9 . . . . 0.0 109.82 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -150.42 150.36 31.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.149 -0.969 . . . . 0.0 109.143 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 15' ' ' ALA . 89.0 t -61.04 157.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.603 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -144.29 -30.09 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.82 -178.18 28.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -148.06 120.01 8.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -1.137 . . . . 0.0 108.963 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.602 HD11 ' CG1' ' A' ' 84' ' ' VAL . 9.8 tp -94.37 143.67 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -147.43 132.55 18.3 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.155 . . . . 0.0 110.914 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.2 mt -145.72 123.71 6.35 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.7 -39.42 0.52 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.752 1.635 . . . . 0.0 111.895 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.48 -23.32 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 25' ' ' ILE . . . -127.35 4.38 6.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 109.42 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.3 p30 52.38 37.38 22.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.832 -0.542 . . . . 0.0 111.359 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.552 HD11 ' OD1' ' A' ' 74' ' ' ASN . 1.5 mp -86.29 146.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.76 -1.212 . . . . 0.0 108.095 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -166.55 82.56 0.26 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -139.27 156.91 71.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 111.646 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.0 164.51 7.28 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.82 2.346 . . . . 0.0 113.308 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.86 129.72 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 2.0 m-85 -87.57 152.36 51.81 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 120.877 -1.139 . . . . 0.0 110.179 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.4 97.94 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.577 2.185 . . . . 0.0 111.43 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.77 -178.27 48.68 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.323 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.0 Cg_endo -80.61 117.78 3.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.867 2.378 . . . . 0.0 111.018 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.05 88.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.395 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.0 p -107.7 153.63 41.36 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.62 -41.35 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.191 1.928 . . . . 0.0 112.392 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.43 -22.22 66.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 109.678 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.4 tm0? -96.17 -53.74 3.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.9 mt -45.1 -23.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' GLN . 14.6 m-20 -64.03 -25.67 68.22 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.419 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 88.5 mtt180 -84.35 -16.0 44.45 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.0 -139.61 6.81 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.682 -1.246 . . . . 0.0 110.782 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.4 t -99.85 159.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.46 -1.023 . . . . 0.0 109.792 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -155.56 152.97 29.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.516 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 54.1 m-85 -58.68 160.21 5.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.522 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -75.39 -6.16 48.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.997 . . . . 0.0 109.413 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -154.37 149.56 26.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -62.99 -35.86 81.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 111.612 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.509 ' ND2' ' OE2' ' A' ' 48' ' ' GLU . 13.9 p30 -87.88 15.5 7.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.858 -1.151 . . . . 0.0 110.979 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 12.0 tm-20 -64.86 145.06 56.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.991 -1.068 . . . . 0.0 109.062 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.465 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 8.4 p -148.44 153.46 38.54 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -67.04 -4.64 10.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 51' ' ' SER . 39.2 m-20 -95.06 -17.42 21.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.9 t70 -59.15 115.56 3.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.944 -1.097 . . . . 0.0 108.846 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 9.3 tt0 -46.04 -19.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 109.607 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -131.88 113.48 13.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.692 . . . . 0.0 109.435 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' N ' HD21 ' A' ' 56' ' ' ASN . 85.9 mt -96.64 145.19 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 108.627 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.7 p -141.55 104.43 4.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.2 mt -103.13 158.83 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.543 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -126.86 129.06 47.5 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.8 149.05 20.55 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.924 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 31.3 m-70 -74.28 -163.54 0.2 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.61 -0.936 . . . . 0.0 110.046 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 63' ' ' THR . 10.0 t -164.34 80.56 0.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.332 -0.855 . . . . 0.0 108.794 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -87.51 108.0 18.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.798 -1.189 . . . . 0.0 109.11 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.99 -29.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -82.38 12.31 4.6 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.805 0.812 . . . . 0.0 109.401 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -146.01 75.39 12.95 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.52 8.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.617 2.878 . . . . 0.0 113.988 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -142.93 59.36 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 0.0 108.085 179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -143.46 102.91 4.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.381 -0.824 . . . . 0.0 110.177 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 51.62 -132.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.423 -0.798 . . . . 0.0 110.752 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.679 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 1.1 t80 -87.65 63.39 7.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.881 1.324 . . . . 0.0 108.779 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 m -89.66 -32.69 16.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.657 -1.277 . . . . 0.0 108.377 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.556 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 3.6 p-10 -140.03 10.06 2.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -10.53 0.72 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.499 ' N ' ' C ' ' A' ' 74' ' ' ASN . 1.8 ptmm? -85.33 -23.48 28.05 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -67.33 -29.09 68.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.36 -157.15 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.7 ptmt -171.23 162.42 6.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -52.59 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.256 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 152.56 -25.09 0.85 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -63.41 113.66 3.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.1 mtp -63.24 -177.5 0.19 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.68 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' CG1' HD11 ' A' ' 18' ' ' ILE . 31.6 t -144.87 106.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.421 -0.8 . . . . 0.0 109.171 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.99 102.43 14.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.931 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -96.12 115.99 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -102.91 144.04 31.72 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.304 -0.873 . . . . 0.0 109.983 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 15' ' ' ALA . 2.2 p -169.24 140.29 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.399 -0.813 . . . . 0.0 109.105 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.5 -97.71 0.15 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.88 18.9 0.89 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -1.14 . . . . 0.0 109.299 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -132.73 139.82 47.78 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 92' ' ' THR . 12.7 t -112.53 132.35 55.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.439 -0.788 . . . . 0.0 110.287 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HG3' HH11 ' A' ' 93' ' ' ARG . 7.4 mmm-85 -92.93 167.56 11.74 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -148.46 92.76 2.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.9 -1.125 . . . . 0.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -87.7 -178.16 6.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 108.185 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -138.39 105.33 5.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.252 -0.905 . . . . 0.0 109.769 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.416 ' HB3' ' H ' ' A' ' 81' ' ' GLY . 35.7 ttm -50.06 115.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -157.59 24.76 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.1 m -164.69 119.53 1.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 101' ' ' ARG . 71.4 mt -130.49 166.97 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.428 -0.795 . . . . 0.0 109.63 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 101' ' ' ARG . 4.1 mtt-85 -142.02 -71.85 0.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -0.828 . . . . 0.0 109.04 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 101' ' ' ARG . 2.7 p30 40.81 27.45 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.525 0.678 . . . . 0.0 109.645 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 103' ' ' VAL . 9.7 p -145.07 118.26 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 103' ' ' VAL . 11.4 mptt 52.24 97.09 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.117 -0.99 . . . . 0.0 108.628 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.61 74.6 4.25 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.582 1.521 . . . . 0.0 112.249 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 106' ' ' THR . 0.7 OUTLIER -178.22 41.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -82.16 -54.67 5.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -0.969 . . . . 0.0 109.768 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -145.0 33.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 109.498 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.85 102.04 1.5 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.37 -18.35 23.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.395 -1.061 . . . . 0.0 108.475 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.66 49.12 2.08 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.91 115.39 27.18 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 1.6 pm0 -87.79 20.49 3.01 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -149.7 24.33 0.87 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.454 ' NZ ' ' OD1' ' A' ' 56' ' ' ASN . 55.6 mttp -38.58 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.286 0.565 . . . . 0.0 110.191 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . 89.92 3.74 73.16 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -96.28 -138.91 0.26 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.193 -1.18 . . . . 0.0 109.652 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' GLN . 34.7 m-20 -118.81 169.21 10.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.154 -0.966 . . . . 0.0 109.226 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' ASP . 42.4 mmtt -41.27 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.3 pm0 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -114.18 102.66 10.35 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -96.46 134.8 39.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.097 -1.002 . . . . 0.0 109.332 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.97 148.06 43.38 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.504 -0.748 . . . . 0.0 109.132 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.1 mt -133.77 143.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.43 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 p -91.13 153.23 20.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 109.335 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.515 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 10.6 m -149.31 92.18 1.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.327 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.416 ' OD2' ' OD1' ' A' ' 128' ' ' ASP . 6.5 p-10 -149.0 146.85 27.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.353 -0.842 . . . . 0.0 108.898 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.416 ' OD1' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-20 59.33 63.66 1.52 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.01 124.89 22.25 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.682 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 6.3 t-20 -85.11 115.1 22.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.947 . . . . 0.0 109.312 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -83.87 1.21 44.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 65.0 mmtt -79.86 -53.91 6.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.274 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.0 p -95.55 -9.8 31.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.52 42.94 31.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.22 152.26 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -1.118 . . . . 0.0 109.62 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.4 m95 -58.72 114.93 2.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.1 tt0 -38.3 -72.92 0.05 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 110.567 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -91.01 148.17 22.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.098 -1.001 . . . . 0.0 109.305 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -154.13 93.42 1.62 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.035 -1.041 . . . . 0.0 110.906 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.402 ' CB ' ' HZ3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -94.7 164.59 12.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.0 mt -139.38 149.88 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.251 -0.906 . . . . 0.0 110.505 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.2 m-85 -137.27 164.5 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 99' ' ' SER . 72.5 t -152.66 118.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.655 -1.278 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -101.81 -176.48 3.14 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.0 t -153.9 131.37 11.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.873 -1.142 . . . . 0.0 110.022 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.54 109.85 1.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 147' ' ' VAL . 98.9 t -95.59 -14.65 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.87 0.843 . . . . 0.0 109.667 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.9 mttp . . . . . 0 C--N 1.29 -1.994 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.28 -179.488 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.307 0.575 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 18.9 mp0 -64.91 150.66 47.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.46 110.8 15.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.636 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.532 ' O ' ' O ' ' A' ' 5' ' ' PRO . 23.3 pttm -55.15 150.72 19.87 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 108.972 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' O ' ' O ' ' A' ' 4' ' ' LYS . 25.7 Cg_exo -36.44 -116.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 123.196 2.597 . . . . 0.0 113.858 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -148.19 109.72 4.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.631 -1.293 . . . . 0.0 110.77 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 8' ' ' PRO . 5.7 mm -85.43 124.02 72.16 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 7' ' ' ILE . 74.2 Cg_exo -49.54 -140.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 121.96 1.773 . . . . 0.0 113.63 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -160.2 -30.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.882 -1.136 . . . . 0.0 109.783 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 12' ' ' SER . 26.3 t0 -74.96 112.6 11.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.496 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -57.8 -4.78 0.32 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 109.752 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.7 p -111.88 39.73 2.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.549 -0.719 . . . . 0.0 109.585 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.4 143.63 29.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.044 -1.035 . . . . 0.0 109.662 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.83 149.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.817 0.817 . . . . 0.0 110.846 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.87 10.45 1.78 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.66 176.05 38.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -147.96 117.27 6.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.305 -1.114 . . . . 0.0 109.437 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -97.76 141.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -146.34 138.89 25.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.996 -1.065 . . . . 0.0 110.45 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 75' ' ' LEU . 52.4 mt -144.46 125.8 7.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.72 -41.14 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.477 1.451 . . . . 0.0 111.333 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -51.79 -16.6 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.835 . . . . 0.0 109.315 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.523 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.29 14.88 3.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.81 . . . . 0.0 109.476 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.4 p-10 43.79 50.09 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.43 -0.794 . . . . 0.0 109.891 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 23' ' ' ALA . 49.6 mm -88.8 144.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.582 0.706 . . . . 0.0 109.664 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -168.9 81.25 0.14 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -140.83 152.5 65.77 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.239 -0.913 . . . . 0.0 110.33 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.14 166.92 10.95 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.827 2.351 . . . . 0.0 112.633 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.7 120.44 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -90.99 165.7 21.06 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.004 -1.06 . . . . 0.0 109.432 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.12 120.66 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.71 2.273 . . . . 0.0 112.569 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.28 168.46 20.57 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.566 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 69.3 Cg_endo -73.84 123.95 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.831 2.354 . . . . 0.0 111.195 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -42.95 87.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.781 -0.574 . . . . 0.0 110.654 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.0 p -112.21 151.65 43.83 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.22 -40.03 9.28 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.15 1.9 . . . . 0.0 111.636 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.61 -23.05 66.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.351 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 40' ' ' ASN . 5.4 tm0? -96.16 -58.92 1.95 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.301 -0.874 . . . . 0.0 108.791 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -47.13 -12.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.831 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.5 m-20 -60.93 -26.74 67.71 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.427 HH11 ' HB2' ' A' ' 40' ' ' ASN . 12.3 mpt_? -82.31 -16.84 47.88 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.24 -128.77 2.6 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.769 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 4.5 t -95.93 158.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.467 -1.019 . . . . 0.0 110.245 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -154.96 147.32 23.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.0 109.132 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -52.85 170.21 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.866 -1.146 . . . . 0.0 109.061 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -100.5 9.15 42.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.467 -0.771 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -167.91 132.24 1.75 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.003 . . . . 0.0 109.889 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 10.2 pt-20 -55.07 -19.41 7.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.71 -0.619 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -84.86 25.86 0.89 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.909 -1.119 . . . . 0.0 108.568 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.3 145.56 53.44 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.2 p -154.36 144.94 22.3 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 6.4 mt -71.95 10.1 0.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.5 OUTLIER -127.76 -1.14 6.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.89 -0.506 . . . . 0.0 110.312 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 56' ' ' ASN . 4.8 t70 -54.78 118.43 4.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.452 -1.405 . . . . 0.0 108.719 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.496 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -45.52 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 54' ' ' ASP . 6.7 p-10 -144.88 110.82 5.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -93.31 116.82 35.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 109.134 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 27.8 m -107.76 111.53 23.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -115.06 162.78 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.6 121.63 37.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.36 140.37 13.38 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.43 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.6 m-70 -73.1 170.33 15.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -1.034 . . . . 0.0 110.027 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.27 78.18 1.37 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.41 -0.806 . . . . 0.0 109.04 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.418 ' N ' ' OG1' ' A' ' 73' ' ' THR . 50.2 m-85 -86.53 110.19 19.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 109.291 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 65' ' ' ILE . 15.1 mt -57.73 -27.21 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.485 -0.759 . . . . 0.0 110.055 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.9 14.45 3.27 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 69' ' ' ASN . 80.9 mtt180 -148.21 72.37 11.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.45 25.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 123.33 2.687 . . . . 0.0 113.443 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 67' ' ' ARG . 11.3 p30 -148.82 25.76 0.93 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 0.0 108.509 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.41 -152.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.691 0.758 . . . . 0.0 109.991 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -71.31 -81.89 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.781 -0.575 . . . . 0.0 111.411 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 34.4 t80 -94.36 -6.81 43.41 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.023 -1.048 . . . . 0.0 110.116 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.458 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 96.1 m -43.32 -39.52 3.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.96 . . . . 0.0 110.813 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.0 m120 -94.17 -27.17 16.35 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.841 -1.162 . . . . 0.0 111.44 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' A' ' 20' ' ' ILE . 10.5 mt -51.74 -11.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.694 -1.254 . . . . 0.0 109.36 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 74' ' ' ASN . 3.3 ptmt -84.05 -2.71 57.2 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -103.76 -36.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.68 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.104 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' O ' ' SD ' ' A' ' 97' ' ' MET . 50.0 mttm -148.09 174.57 11.8 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -48.13 139.69 8.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 109.709 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.32 -15.19 62.65 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 97' ' ' MET . 53.2 p -64.22 98.18 0.22 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.262 -1.14 . . . . 0.0 108.486 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.461 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 11.3 ptm -67.63 178.08 1.79 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.32 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.2 t -144.24 117.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' OH ' ' SD ' ' A' ' 83' ' ' MET . 97.9 m-85 -93.82 102.71 14.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 88' ' ' VAL . 37.1 t80 -95.87 110.83 22.95 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 88' ' ' VAL . 36.3 ttpt -99.69 146.52 26.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 86' ' ' PHE . 20.2 m -156.89 142.03 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.719 -0.613 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.35 -96.64 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.522 ' ND2' ' OE2' ' A' ' 91' ' ' GLU . 4.4 p-10 -140.17 19.2 2.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -1.141 . . . . 0.0 109.296 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.522 ' OE2' ' ND2' ' A' ' 90' ' ' ASN . 4.2 mp0 -120.03 167.11 12.52 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -152.64 118.92 5.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 110.16 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.515 HH11 ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.85 169.86 10.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -143.8 117.29 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.876 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.28 176.19 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -138.89 106.44 5.58 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.442 -0.786 . . . . 0.0 109.867 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 36.7 ttm -48.26 124.93 8.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.085 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -153.83 0.21 0.22 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.033 -1.042 . . . . 0.0 109.81 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 143' ' ' VAL . 72.2 m -163.85 112.59 1.21 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.0 pt -139.68 -166.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.229 -0.919 . . . . 0.0 110.228 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 101' ' ' ARG . 3.5 mtt-85 -146.6 -74.77 0.21 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.217 -0.927 . . . . 0.0 109.183 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 101' ' ' ARG . 1.7 p30 40.38 24.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.712 0.767 . . . . 0.0 109.323 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.697 ' O ' HG13 ' A' ' 103' ' ' VAL . 9.4 p -154.21 98.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 121.799 0.809 . . . . 0.0 109.069 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.65 62.97 10.69 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.765 -1.21 . . . . 0.0 109.254 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -39.53 131.29 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.967 2.445 . . . . 0.0 112.81 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 30.1 p -75.23 -21.21 58.78 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.492 -0.755 . . . . 0.0 109.351 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 106' ' ' THR . 5.3 t70 83.25 -2.28 1.21 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.84 -0.537 . . . . 0.0 109.921 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.511 HG22 ' OG1' ' A' ' 106' ' ' THR . 3.3 m -79.9 16.4 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.006 -1.059 . . . . 0.0 109.158 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -161.5 44.43 0.39 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.11 -30.28 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 120.973 -1.31 . . . . 0.0 107.743 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.6 mt -137.35 -33.89 0.73 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.476 ' OD1' ' NE2' ' A' ' 120' ' ' GLN . 12.3 t70 50.29 55.57 9.26 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.409 -0.807 . . . . 0.0 109.562 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -108.89 8.11 26.36 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.0 1.81 0.77 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.352 0.596 . . . . 0.0 109.657 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 117' ' ' LYS . 54.6 mmtt -75.39 132.68 41.07 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 109.046 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.01 85.14 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 115' ' ' LYS . 58.2 mttp -145.69 -166.67 2.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.185 -1.185 . . . . 0.0 109.38 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.7 t70 -118.22 170.45 8.87 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 118' ' ' ASP . 66.2 mttm -36.79 132.58 0.64 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.476 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 5.0 pt20 -148.32 -178.14 6.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.455 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.8 tp -134.99 111.31 9.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -96.04 87.54 4.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.27 -0.893 . . . . 0.0 108.716 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.72 121.04 23.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.12 -0.988 . . . . 0.0 109.145 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.2 mt -105.12 140.76 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.773 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -94.76 161.61 14.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.125 -0.985 . . . . 0.0 108.863 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.445 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 21.8 m -148.03 139.51 23.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -175.1 132.95 0.31 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.065 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.1 t0 61.83 66.01 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.812 . . . . 0.0 109.132 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -61.76 123.56 18.31 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.021 -1.049 . . . . 0.0 109.739 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -87.34 125.49 34.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.157 -0.965 . . . . 0.0 109.672 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.71 7.68 38.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.368 -0.833 . . . . 0.0 109.698 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -79.38 -58.65 3.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -0.924 . . . . 0.0 109.077 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.2 p -96.74 -3.9 41.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 109.3 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.82 35.98 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.15 157.37 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -1.073 . . . . 0.0 109.733 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.5 m95 -63.79 114.31 3.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 136' ' ' TRP . 31.0 tt0 -36.79 -81.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.244 0.545 . . . . 0.0 110.451 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.53 170.16 4.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.13 -0.981 . . . . 0.0 108.519 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.529 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -161.86 112.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 0.0 109.983 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.15 155.83 49.09 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 pt -150.78 160.52 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 111.187 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -138.11 157.37 46.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 99' ' ' SER . 96.5 t -144.24 111.68 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -99.3 175.08 6.0 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.1 t -138.88 133.89 32.54 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.035 -1.041 . . . . 0.0 109.706 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.22 127.68 33.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.441 -0.787 . . . . 0.0 109.706 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 147' ' ' VAL . 5.0 m -92.14 -169.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.282 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.408 179.881 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 tpp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -78.97 90.69 4.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.386 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.57 117.34 29.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.177 -0.952 . . . . 0.0 109.544 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -46.06 111.81 1.56 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.435 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.36 -141.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.018 1.812 . . . . 0.0 111.973 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -66.05 91.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.806 -1.184 . . . . 0.0 110.556 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt -145.62 94.5 5.11 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.23 167.39 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.078 1.852 . . . . 0.0 112.5 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.81 -12.95 12.66 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 12' ' ' SER . 52.6 t0 -76.87 107.5 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -57.9 -5.39 0.41 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.404 -0.81 . . . . 0.0 109.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 10' ' ' ASP . 16.5 m -103.68 29.24 5.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.445 -0.784 . . . . 0.0 109.808 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -147.16 140.29 25.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.154 -0.966 . . . . 0.0 109.418 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG12 ' N ' ' A' ' 15' ' ' ALA . 94.8 t -59.91 166.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.71 0.767 . . . . 0.0 110.656 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.634 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -140.3 -34.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -160.49 -165.68 17.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 31.3 m-85 -149.41 126.24 11.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.983 -1.304 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -96.31 142.75 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -145.63 146.08 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.955 -1.091 . . . . 0.0 110.304 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.88 131.42 7.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.48 -51.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.883 1.722 . . . . 0.0 111.752 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -50.55 -29.18 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.412 -0.805 . . . . 0.0 109.321 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.38 3.27 19.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.52 -0.738 . . . . 0.0 109.062 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 42.84 41.13 2.4 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.577 0.703 . . . . 0.0 109.894 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.82 150.07 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.777 0.799 . . . . 0.0 110.016 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -167.25 83.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -135.8 158.51 73.93 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.351 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.84 161.98 16.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.008 2.472 . . . . 0.0 113.154 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.47 130.82 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 12.6 m-85 -85.77 148.84 49.65 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.845 -1.159 . . . . 0.0 109.993 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.37 82.73 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.647 2.231 . . . . 0.0 111.398 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.64 -173.96 35.48 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.187 -1.482 . . . . 0.0 110.897 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.8 Cg_endo -82.38 121.4 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.961 2.44 . . . . 0.0 111.406 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.53 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.851 -0.53 . . . . 0.0 110.576 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.1 p -110.47 151.33 42.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.51 -41.71 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.227 1.951 . . . . 0.0 112.04 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.64 -21.38 66.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' ASN . 1.6 tt0 -96.73 -60.68 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' GLY . 24.0 mt -45.16 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.69 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' GLN . 38.7 m-20 -64.35 -26.47 68.49 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 41' ' ' ARG . 23.4 mtt-85 -79.93 -19.55 47.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 162.48 -144.12 9.36 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 t -94.75 163.62 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.297 -1.119 . . . . 0.0 108.874 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.459 ' CB ' ' NE2' ' A' ' 38' ' ' GLN . 4.4 t -158.41 155.28 28.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 109.202 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -60.02 164.84 3.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.075 -1.016 . . . . 0.0 109.419 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -77.81 -19.16 55.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.176 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.77 150.5 41.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.397 -0.814 . . . . 0.0 110.248 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.44 -36.52 84.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.589 -0.694 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.17 9.27 15.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.891 -1.131 . . . . 0.0 110.989 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -65.02 138.53 58.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 0.0 109.391 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -147.23 169.42 19.41 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 108.986 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -10.19 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.92 -29.35 32.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.483 -0.761 . . . . 0.0 109.213 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.6 m-20 -64.4 100.7 0.37 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.73 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.622 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -48.33 -15.92 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.982 -1.074 . . . . 0.0 109.012 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' ASP . 19.6 t30 -110.45 100.04 8.94 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.55 148.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.212 -0.93 . . . . 0.0 109.548 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -145.82 107.88 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 60' ' ' ALA . 79.1 mt -110.79 165.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.588 -0.695 . . . . 0.0 110.134 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.586 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -149.55 138.75 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.461 -0.775 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.55 157.73 27.49 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.29 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -73.11 -177.15 2.36 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.302 -1.116 . . . . 0.0 109.818 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.9 81.46 0.43 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -87.85 122.2 31.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.318 -0.863 . . . . 0.0 109.533 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 mm -58.9 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -0.894 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.72 20.53 2.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 69' ' ' ASN . 90.8 mtt180 -150.37 67.87 8.34 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.541 -0.725 . . . . 0.0 109.572 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.3 5.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 123.537 2.825 . . . . 0.0 114.124 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 67' ' ' ARG . 15.6 p-10 -146.13 61.24 1.24 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.89 -1.131 . . . . 0.0 108.638 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -152.86 121.0 6.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 110.509 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.728 ' N ' ' NE2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER 54.4 -124.71 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.681 -0.637 . . . . 0.0 110.864 178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 75' ' ' LEU . 3.3 m-85 -97.82 12.51 33.68 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.72 -1.237 . . . . 0.0 110.15 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.0 m -46.41 -19.93 0.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.911 -1.118 . . . . 0.0 110.311 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 72' ' ' PHE . 5.5 m-20 -121.77 -21.74 6.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.442 -0.786 . . . . 0.0 109.971 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 72' ' ' PHE . 5.9 tt -55.96 -25.22 42.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.57 -13.64 60.06 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -85.52 -16.43 39.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.96 174.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.827 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 81' ' ' GLY . 53.5 mtmt -150.49 159.21 44.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.901 . . . . 0.0 109.114 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -52.84 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.2 -22.71 0.51 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -66.43 121.12 14.59 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.459 -1.024 . . . . 0.0 108.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.6 mtm -77.58 -177.82 4.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.962 -1.086 . . . . 0.0 109.801 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' TYR . 61.4 t -145.65 159.51 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.808 . . . . 0.0 109.444 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' HG12 ' A' ' 84' ' ' VAL . 59.7 m-85 -144.17 102.46 3.87 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 109.371 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -95.0 113.5 25.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 108.658 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -102.08 139.1 38.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 15' ' ' ALA . 2.4 p -162.23 144.22 3.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 49.98 -151.65 4.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -92.94 59.33 3.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.197 -1.178 . . . . 0.0 109.297 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -168.36 163.37 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.335 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -144.86 151.78 39.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 159.38 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.47 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 37.5 pttt -143.1 164.82 29.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 3.1 m-85 -141.31 -174.62 4.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -141.95 115.03 8.75 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.16 -0.962 . . . . 0.0 108.964 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.458 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.2 mmt -49.36 110.09 0.33 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.598 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 p -139.46 20.69 2.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.436 -0.79 . . . . 0.0 109.14 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 143' ' ' VAL . 31.1 t -168.63 122.91 0.88 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.9 mt -136.02 124.94 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.209 -0.932 . . . . 0.0 109.296 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.503 ' C ' ' N ' ' A' ' 103' ' ' VAL . 22.5 mmm180 -79.42 -71.81 0.43 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 51.08 13.85 0.18 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.022 -1.049 . . . . 0.0 108.184 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.503 ' N ' ' C ' ' A' ' 101' ' ' ARG . 20.2 t -74.59 150.33 7.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 106' ' ' THR . 46.4 tttp -63.52 -64.99 2.34 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.733 -1.23 . . . . 0.0 109.622 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' ASP . 37.9 Cg_endo -63.4 40.02 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.816 1.678 . . . . 0.0 111.057 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 106' ' ' THR . 6.6 t -48.36 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.192 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER 171.82 -2.33 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 0.0 110.14 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.467 ' CG2' ' NH2' ' A' ' 101' ' ' ARG . 32.2 m -71.0 16.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.696 -1.252 . . . . 0.0 109.574 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 138.91 22.26 0.4 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.4 m -69.14 -34.94 65.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.979 -1.306 . . . . 0.0 108.604 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.1 mt -139.16 74.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -134.94 -109.27 0.22 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.468 -0.77 . . . . 0.0 109.058 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -81.55 -175.47 5.54 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.187 -0.945 . . . . 0.0 108.775 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.463 ' NE2' ' CB ' ' A' ' 56' ' ' ASN . 2.9 mm100 -91.01 63.38 5.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.215 -0.928 . . . . 0.0 108.841 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -44.7 -53.22 7.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.354 -0.841 . . . . 0.0 109.242 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.578 ' O ' ' NE2' ' A' ' 120' ' ' GLN . . . -60.86 113.43 5.59 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -80.24 -6.59 58.1 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.839 -1.389 . . . . 0.0 108.401 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 120' ' ' GLN . 28.8 m-20 -119.14 136.99 53.9 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.53 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 4.3 mptp? -26.04 87.77 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 122.315 1.055 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 116' ' ' GLY . 5.9 pt20 -89.04 161.16 16.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.05 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.405 HD21 HD21 ' A' ' 123' ' ' LEU . 59.7 tp -133.35 109.01 9.06 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -94.24 92.18 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.949 . . . . 0.0 109.909 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.405 HD21 HD21 ' A' ' 121' ' ' LEU . 30.3 mt -74.98 148.02 40.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.131 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.1 mt -138.74 143.27 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.213 -0.929 . . . . 0.0 109.628 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -105.49 155.67 18.95 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.341 -0.85 . . . . 0.0 108.726 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 127' ' ' ASP . 66.7 m -145.81 155.92 43.23 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.93 -1.106 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 0.5 OUTLIER 170.49 140.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.89 . . . . 0.0 109.56 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.4 OUTLIER 56.89 63.16 2.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.688 -0.633 . . . . 0.0 109.334 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.71 120.57 10.91 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.872 -1.142 . . . . 0.0 108.525 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -85.14 111.41 19.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 109.896 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.4 4.83 9.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.357 -0.839 . . . . 0.0 109.751 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.34 -53.83 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.0 p -96.48 -8.19 32.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.866 . . . . 0.0 109.195 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.62 41.37 43.71 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.71 155.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.224 -1.162 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.442 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.0 m95 -61.85 112.6 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.4 tt0 -38.08 -78.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.702 -0.624 . . . . 0.0 110.016 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 10.4 mtpp -89.92 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -152.54 108.24 3.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.909 -1.119 . . . . 0.0 110.524 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' A' ' 140' ' ' LYS . 3.8 mtmp? -109.84 133.81 52.75 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.5 mm -104.81 129.53 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -117.4 160.09 21.72 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.5 t -145.72 149.75 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.715 -1.24 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.75 179.3 7.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -161.37 156.38 23.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.575 -1.328 . . . . 0.0 111.309 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 148' ' ' LYS . 41.9 tt0 -60.25 135.05 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.312 0.577 . . . . 0.0 110.059 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.5 t -91.01 -18.33 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 122.01 0.909 . . . . 0.0 109.426 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.425 ' H ' ' HG2' ' A' ' 146' ' ' GLU . 52.1 mmtt . . . . . 0 C--N 1.288 -2.078 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.539 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.328 0.585 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -50.14 143.86 7.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -0.958 . . . . 0.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.37 -170.19 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.0 109.263 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -54.65 142.44 52.75 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.915 . . . . 0.0 109.08 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.39 -110.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.299 1.999 . . . . 0.0 111.843 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -101.05 116.26 32.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.34 -0.85 . . . . 0.0 109.721 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 mt -149.41 95.06 3.83 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.34 152.43 3.79 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.022 . . . . 0.0 112.667 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -93.08 -17.08 24.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 108.885 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 12' ' ' SER . 36.2 t0 -77.58 106.03 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.453 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.9 OUTLIER -58.01 -5.45 0.44 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 10' ' ' ASP . 13.6 t -103.19 39.25 1.6 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.364 -0.835 . . . . 0.0 109.751 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -147.76 132.91 18.33 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.301 -0.874 . . . . 0.0 109.71 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 38.8 t -61.31 132.21 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.56 -16.3 20.12 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -176.7 -162.76 27.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 87.0 m-85 -148.89 128.78 13.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.251 -1.146 . . . . 0.0 109.687 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.72 144.67 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -144.27 147.45 33.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.874 -1.141 . . . . 0.0 110.75 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mt -149.68 131.88 7.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -50.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.936 1.757 . . . . 0.0 112.0 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.19 -20.98 1.75 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.829 . . . . 0.0 109.406 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB1' ' OD1' ' A' ' 74' ' ' ASN . . . -118.46 3.31 11.84 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ALA . 1.5 p30 40.91 38.86 0.72 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.542 0.687 . . . . 0.0 109.848 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG23 ' OE2' ' A' ' 27' ' ' GLU . 3.3 mt -98.08 155.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.86 0.838 . . . . 0.0 110.47 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -162.49 69.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' OE2' HG23 ' A' ' 25' ' ' ILE . 11.2 mt-10 -100.56 150.2 36.77 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.582 -0.699 . . . . 0.0 112.495 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -87.98 159.96 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.844 2.363 . . . . 0.0 111.608 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.71 130.55 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.117 -0.989 . . . . 0.0 109.646 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -94.42 155.92 39.2 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.881 -1.137 . . . . 0.0 108.888 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -81.59 95.12 0.92 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.311 2.007 . . . . 0.0 111.786 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.88 -177.66 39.86 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.336 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 89.0 Cg_endo -81.64 116.99 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.915 2.41 . . . . 0.0 111.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.46 87.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.331 0.586 . . . . 0.0 110.335 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -112.85 153.35 45.19 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.44 -45.04 19.63 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.07 1.847 . . . . 0.0 111.433 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.54 -19.04 64.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.417 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.7 tp-100 -93.02 -69.35 0.75 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 18.7 mt -45.37 -17.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 109.754 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 38' ' ' GLN . 13.7 m-20 -61.81 -24.92 67.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.6 mtt180 -85.56 -12.97 50.3 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.76 -110.64 0.45 Allowed Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.737 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.9 t -131.64 156.79 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.383 -1.069 . . . . 0.0 109.395 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 t -153.04 154.33 34.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 108.749 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.31 171.69 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.926 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -78.46 -26.28 46.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 109.517 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -135.15 150.24 50.13 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -0.781 . . . . 0.0 109.635 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.52 -32.77 72.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.626 -0.671 . . . . 0.0 111.456 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -85.93 11.32 11.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.885 -1.135 . . . . 0.0 110.81 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 58' ' ' SER . 1.4 tt0 -63.96 147.1 52.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.421 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 2.7 p -147.99 151.76 36.32 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -65.94 -5.52 9.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 51' ' ' SER . 13.7 t70 -91.58 -22.51 20.28 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 52.7 m-20 -60.11 100.67 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.199 -0.938 . . . . 0.0 108.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 10.5 tt0 -42.98 -20.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.519 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 35.6 t30 -116.89 97.64 6.07 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.8 146.8 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' ALA . 10.6 m -144.66 109.61 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mt -108.82 167.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.374 -0.828 . . . . 0.0 109.948 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -142.96 135.17 27.26 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.38 157.9 27.1 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.835 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.422 ' H ' ' HG2' ' A' ' 71' ' ' GLN . 25.9 m-70 -73.67 -173.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.608 -0.937 . . . . 0.0 110.562 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -174.9 77.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.7 119.05 28.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.133 . . . . 0.0 108.977 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 65' ' ' ILE . 14.6 mt -61.09 -26.62 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.453 -0.779 . . . . 0.0 110.365 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.15 14.78 2.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.628 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 69' ' ' ASN . 83.0 mtt180 -150.77 76.66 8.06 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.641 . . . . 0.0 109.407 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.6 12.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 123.657 2.905 . . . . 0.0 114.021 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -146.5 52.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.892 -1.13 . . . . 0.0 108.125 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 15.7 t80 -136.93 100.72 4.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.411 -0.805 . . . . 0.0 109.96 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 12.1 mp0 54.86 -125.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.625 -0.672 . . . . 0.0 110.722 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.871 ' CE2' HD13 ' A' ' 75' ' ' LEU . 4.9 m-85 -90.23 34.08 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.685 -1.259 . . . . 0.0 110.092 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.4 m -57.55 -26.65 61.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.357 -1.464 . . . . 0.0 109.477 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.4 p30 -140.55 4.15 1.94 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 72' ' ' PHE . 9.2 tt -55.2 -21.63 14.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.853 -1.154 . . . . 0.0 107.929 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' NZ ' ' O ' ' A' ' 72' ' ' PHE . 14.2 mtmm -82.77 -18.54 40.29 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -62.29 -22.84 66.34 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -54.62 -169.9 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 81' ' ' GLY . 4.5 ptpt -154.58 157.52 38.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -0.961 . . . . 0.0 109.223 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.479 ' NZ ' ' CB ' ' A' ' 80' ' ' LYS . 5.3 ttpm? -52.2 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 109.543 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 153.42 -14.75 0.64 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -64.42 119.12 9.78 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.545 -0.974 . . . . 0.0 108.774 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.3 mmm -73.51 179.89 3.83 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.393 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 85' ' ' TYR . 22.0 t -146.26 161.74 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.967 . . . . 0.0 109.231 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 84' ' ' VAL . 77.9 m-85 -147.67 103.13 3.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.345 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -94.58 111.99 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -95.55 144.83 25.69 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.1 96.83 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.52 -0.738 . . . . 0.0 109.134 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 48.62 -131.35 21.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -82.22 52.54 2.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.154 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.25 143.44 10.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.14 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.4 m -152.87 146.95 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.987 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 177.99 7.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.475 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 23.9 pttm -144.28 161.09 39.82 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.091 -1.006 . . . . 0.0 110.351 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 10.9 m-85 -141.35 -179.79 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -147.13 130.54 16.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.935 -1.103 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.443 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 12.9 mtt -48.51 150.86 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.394 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 97' ' ' MET . 14.9 m -166.28 1.34 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.161 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 t -168.5 124.08 0.96 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.25 -0.906 . . . . 0.0 109.141 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mt -137.09 132.0 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 103' ' ' VAL . 82.5 mtt180 -100.62 -66.54 0.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.474 -0.766 . . . . 0.0 109.398 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 102' ' ' ASP . 63.9 t0 46.9 17.06 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.221 -0.924 . . . . 0.0 109.214 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 101' ' ' ARG . 53.6 t -134.43 -10.12 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.457 ' NZ ' HH12 ' A' ' 139' ' ' ARG . 6.0 ttmm 55.72 56.53 10.12 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.454 -0.779 . . . . 0.0 109.856 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.0 -54.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.861 2.374 . . . . 0.0 111.425 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -84.56 -35.68 22.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 109.063 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 0.3 OUTLIER 65.54 -58.44 0.3 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.781 -0.574 . . . . 0.0 109.491 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 106' ' ' THR . 31.2 m -95.88 33.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.152 -0.967 . . . . 0.0 109.801 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.43 15.12 6.8 Favored Glycine 0 N--CA 1.502 3.078 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.465 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 60.9 t -71.76 -34.67 52.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 120.933 -1.334 . . . . 0.0 108.511 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.407 HD12 ' HB ' ' A' ' 110' ' ' VAL . 1.6 mp -137.07 72.72 1.42 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -172.65 22.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -163.42 29.19 0.09 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 109.055 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 110' ' ' VAL . 35.0 mt-30 -134.4 8.93 3.69 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.43 -65.91 0.72 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.18 64.69 4.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -143.95 -154.51 0.53 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.315 -1.109 . . . . 0.0 108.522 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 119' ' ' LYS . 97.6 m-20 -106.18 160.29 15.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.276 -0.89 . . . . 0.0 108.859 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' ASP . 57.5 mttp -44.69 126.78 5.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.837 . . . . 0.0 109.334 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.589 ' N ' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -149.37 168.24 23.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.983 -179.331 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 143' ' ' VAL . 26.8 mt -116.71 154.0 31.37 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.552 0.691 . . . . 0.0 110.321 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.0 m -140.48 86.41 2.06 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.45 159.68 19.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 111.175 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.9 mt -140.14 126.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 p -90.31 118.7 30.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.767 -1.208 . . . . 0.0 109.025 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 23.1 m -99.1 154.2 18.31 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.619 -0.676 . . . . 0.0 110.129 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.1 t70 179.87 132.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 109.073 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.2 t0 59.76 72.27 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 109.331 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -65.27 122.27 16.73 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 10.0 p30 -85.7 129.47 34.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.893 -1.129 . . . . 0.0 109.476 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -91.25 4.84 51.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 108.962 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -71.96 -62.44 1.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.807 . . . . 0.0 109.088 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 p -98.49 -3.16 37.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.472 -0.767 . . . . 0.0 109.314 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.67 47.78 19.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.54 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 2.9 t -146.79 169.57 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -1.076 . . . . 0.0 109.329 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 73.4 m95 -73.2 114.19 11.11 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.177 -0.952 . . . . 0.0 108.943 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.6 tp10 -35.55 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.081 0.467 . . . . 0.0 110.727 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.13 150.42 40.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.608 -0.682 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.1 OUTLIER -166.96 164.91 16.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -130.41 133.19 46.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.499 -0.75 . . . . 0.0 109.1 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.4 mm -94.54 146.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.46 140.93 25.41 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 5.9 t -133.07 147.15 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.271 -0.893 . . . . 0.0 110.752 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.41 144.65 33.19 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.7 t -118.3 148.89 42.0 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 147' ' ' VAL . 7.7 tp10 -61.93 137.24 58.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.62 -0.675 . . . . 0.0 109.407 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.52 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 4.3 m -93.11 -175.46 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.95 . . . . 0.0 109.358 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.427 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 mtm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -159.82 117.98 2.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.393 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.01 75.48 10.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 109.683 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.8 pttt -67.73 155.86 90.46 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 108.956 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 4' ' ' LYS . 71.0 Cg_exo -50.79 -160.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.053 1.835 . . . . 0.0 112.35 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -99.35 101.95 13.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.087 -1.008 . . . . 0.0 110.067 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 mt -88.38 113.39 55.1 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 109.255 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.21 118.94 1.86 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.595 1.53 . . . . 0.0 112.065 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -73.68 -18.61 60.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.945 . . . . 0.0 109.371 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -77.94 106.38 9.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.354 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -57.04 -10.6 1.19 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -94.26 27.2 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 109.771 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -141.52 131.64 24.77 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.317 -0.865 . . . . 0.0 109.481 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 44.7 t -61.84 142.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.472 -0.768 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.55 -23.78 14.97 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.496 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -174.2 -163.25 27.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 34.7 m-85 -149.88 130.84 14.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 0.0 109.539 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tt -95.62 144.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -146.04 142.09 28.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.037 -1.039 . . . . 0.0 110.343 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 75' ' ' LEU . 12.5 mt -150.13 132.23 7.87 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.09 -49.28 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.883 1.722 . . . . 0.0 111.882 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -51.75 -30.02 21.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.601 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -106.67 3.29 26.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.371 -0.83 . . . . 0.0 108.895 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.1 p30 43.61 30.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.28 147.66 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.898 0.856 . . . . 0.0 109.79 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -165.35 84.51 0.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.84 159.36 72.88 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.327 -0.858 . . . . 0.0 111.052 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.21 163.59 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.273 2.649 . . . . 0.0 113.32 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.79 132.54 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 42.2 m-85 -87.44 146.18 39.12 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.818 -1.176 . . . . 0.0 109.872 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.52 88.83 1.23 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.909 1.739 . . . . 0.0 111.365 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.19 -170.97 34.41 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.522 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 95.6 Cg_endo -81.11 117.97 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.883 2.389 . . . . 0.0 111.513 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -46.03 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.301 0.572 . . . . 0.0 110.724 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.7 OUTLIER -110.6 155.76 41.62 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.93 -44.15 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.223 1.949 . . . . 0.0 112.036 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -62.93 -26.2 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -84.12 -62.62 1.52 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.159 -0.963 . . . . 0.0 109.039 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -49.28 -11.99 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 38' ' ' GLN . 74.9 m-20 -61.93 -27.75 69.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.2 mtp180 -91.4 -10.88 39.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' C ' HE22 ' A' ' 71' ' ' GLN . . . 164.12 -139.45 5.86 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.259 -1.448 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 t -110.67 164.59 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.438 -1.037 . . . . 0.0 109.329 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -158.86 157.14 30.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.182 -0.949 . . . . 0.0 108.623 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.536 ' CE2' ' OE1' ' A' ' 50' ' ' GLU . 46.9 m-85 -58.04 175.92 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.863 -1.148 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -89.0 -3.35 58.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.457 -0.777 . . . . 0.0 109.126 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -153.97 145.82 23.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.287 -0.883 . . . . 0.0 109.966 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -62.49 -31.17 71.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -86.86 6.94 29.33 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.953 -1.092 . . . . 0.0 110.893 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 11.9 tm-20 -61.79 152.19 32.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' ASP . 76.5 p -146.32 163.38 35.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.017 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -74.54 10.64 1.25 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.9 OUTLIER -124.0 -6.25 7.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.838 -0.539 . . . . 0.0 109.751 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.7 t70 -59.73 113.9 2.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.859 -1.15 . . . . 0.0 109.308 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -45.4 -18.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.277 -0.889 . . . . 0.0 109.631 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' OE1' ' A' ' 55' ' ' GLN . 4.0 m120 -133.27 98.66 4.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.498 -0.751 . . . . 0.0 109.051 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 122' ' ' THR . 96.1 mt -96.68 113.31 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.698 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.5 m -108.6 120.23 41.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 60' ' ' ALA . 87.1 mt -107.21 164.45 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.473 -0.767 . . . . 0.0 110.226 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.571 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.99 124.61 23.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.65 152.4 22.07 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 119.932 -1.128 . . . . 0.0 110.748 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' PHE . 34.0 m-70 -72.72 -179.93 3.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.758 -0.848 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 88.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.02 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -87.51 123.68 32.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 109.06 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 65' ' ' ILE . 6.6 mt -63.76 -33.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.563 -0.71 . . . . 0.0 110.589 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -82.97 8.17 13.43 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 110.122 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 69' ' ' ASN . 21.7 mmt180 -140.72 75.28 25.92 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 87.7 Cg_exo -48.64 5.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.621 2.881 . . . . 0.0 113.844 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' ARG . 6.8 p30 -143.64 59.42 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.95 -1.094 . . . . 0.0 108.165 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.66 95.97 3.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.582 -0.699 . . . . 0.0 110.355 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.504 HE22 ' C ' ' A' ' 42' ' ' GLY . 1.1 mm100 61.0 -114.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.851 -0.53 . . . . 0.0 111.815 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.649 ' CE2' HG22 ' A' ' 125' ' ' THR . 2.3 t80 -91.93 26.85 2.29 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.138 -0.976 . . . . 0.0 110.803 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -69.22 -38.74 78.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.87 -1.144 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 15.6 m-20 -108.49 -17.0 14.09 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.226 -0.921 . . . . 0.0 111.072 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -53.16 -25.33 13.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.729 -1.232 . . . . 0.0 108.36 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -81.88 -14.35 56.34 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -78.4 -16.57 57.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.03 -162.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -174.32 174.97 2.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -48.85 149.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 -11.27 7.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 57.8 m -62.21 94.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.117 -1.225 . . . . 0.0 108.64 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptm -66.32 162.19 20.75 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.195 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.82 174.3 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.865 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -144.71 108.83 4.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -0.899 . . . . 0.0 110.001 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -95.09 113.37 25.06 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -96.49 144.37 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 110.301 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 18.3 t -143.02 86.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.36 -133.37 42.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.86 37.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -1.223 . . . . 0.0 109.587 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 88' ' ' VAL . 21.1 mp0 -138.81 151.98 47.5 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.268 -0.895 . . . . 0.0 108.916 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.6 m -152.97 143.82 22.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.005 . . . . 0.0 110.099 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.421 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -144.33 170.61 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.413 -0.805 . . . . 0.0 108.98 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 24.8 pttm -142.87 162.0 36.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 5.9 m-85 -139.35 -175.67 4.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -136.79 110.58 8.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.0 tpp -50.89 104.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.431 -0.793 . . . . 0.0 109.05 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -143.84 35.32 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 143' ' ' VAL . 16.5 t -173.67 131.91 0.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.2 mt -138.64 144.57 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 109.008 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.0 OUTLIER -119.83 1.04 10.98 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -67.88 45.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 108.757 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 101' ' ' ARG . 7.4 p -157.07 -21.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -166.48 62.2 0.7 Allowed Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.558 ' C ' ' H ' ' A' ' 107' ' ' ASP . 89.5 Cg_endo -76.4 -49.21 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.949 2.433 . . . . 0.0 113.053 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.552 HG23 ' C ' ' A' ' 105' ' ' PRO . 1.3 p 69.15 -27.58 0.15 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 105' ' ' PRO . 1.4 m-20 67.6 -43.27 0.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.157 -0.965 . . . . 0.0 109.505 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 106' ' ' THR . 26.9 m -76.33 26.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.193 -0.942 . . . . 0.0 109.26 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -153.18 -21.69 0.05 OUTLIER Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.407 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.5 t -67.51 -22.81 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.919 -1.342 . . . . 0.0 108.887 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.8 mt -138.67 79.95 1.76 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.624 -0.672 . . . . 0.0 109.243 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -162.65 -34.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.732 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -179.81 30.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 116' ' ' GLY . 8.9 tt0 -91.55 23.77 3.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 117' ' ' LYS . 19.8 pttp -50.69 -9.68 0.05 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . 49.87 -97.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' LYS . 32.5 pttt -146.59 -45.03 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -1.112 . . . . 0.0 109.564 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -118.73 167.68 11.45 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.487 -0.758 . . . . 0.0 109.525 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 119' ' ' LYS . 12.2 mptt -46.29 162.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.18 145.0 19.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.154 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.2 tp -103.57 107.56 18.46 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 57' ' ' ILE . 10.5 m -92.54 146.76 23.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.62 152.24 50.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.284 -0.885 . . . . 0.0 110.489 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 mt -141.3 134.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.649 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.1 p -92.21 160.61 15.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.932 -1.105 . . . . 0.0 108.423 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 56.6 m -144.97 140.1 27.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.06 -1.025 . . . . 0.0 109.943 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 p30 175.65 139.39 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.43 58.76 1.65 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.26 -0.9 . . . . 0.0 108.887 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.99 126.62 27.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 109.444 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -85.9 116.99 24.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.131 -0.981 . . . . 0.0 109.695 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -84.18 1.38 44.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -81.22 -52.18 7.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.328 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.6 p -95.65 -15.06 22.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.27 42.31 15.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -147.14 153.24 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.345 -1.091 . . . . 0.0 109.509 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 69.2 m95 -59.25 112.55 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 23.1 tt0 -35.24 -84.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -107.06 157.45 17.82 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.394 -0.816 . . . . 0.0 109.473 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -174.84 161.02 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -127.67 153.31 46.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 35.0 mm -115.91 139.12 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.583 0.706 . . . . 0.0 110.61 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -136.57 159.12 42.76 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 99' ' ' SER . 59.4 t -148.08 149.29 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.776 -1.202 . . . . 0.0 110.896 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.67 134.24 30.11 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.3 t -95.68 143.43 26.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 3.3 tm-20 -60.22 145.76 46.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 1.8 t -91.47 -142.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 0.0 109.337 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.475 ' H ' HG12 ' A' ' 147' ' ' VAL . 41.5 mtmt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.464 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.6 mpp? . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.348 0.594 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -159.74 91.07 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.841 . . . . 0.0 109.033 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.83 32.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.812 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.533 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 47.8 pttt -135.62 48.02 2.51 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.413 -0.805 . . . . 0.0 109.967 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 42.4 Cg_endo -66.0 -160.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.637 2.224 . . . . 0.0 111.802 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -79.58 119.62 22.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.617 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 7' ' ' ILE . 11.9 mt -150.58 101.68 3.09 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.307 -0.871 . . . . 0.0 108.813 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.85 136.37 7.16 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.844 1.696 . . . . 0.0 112.196 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -87.44 -28.72 21.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.04 113.28 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -58.2 -11.78 2.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.328 -0.857 . . . . 0.0 109.626 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -79.95 21.04 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -147.51 136.16 21.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.057 -1.027 . . . . 0.0 109.659 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 15' ' ' ALA . 61.3 t -60.36 161.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.699 0.761 . . . . 0.0 110.223 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.553 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -136.13 -9.58 2.01 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -172.05 -179.16 42.8 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.6 120.11 7.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.3 . . . . 0.0 109.172 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 tt -97.04 140.33 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -146.23 138.89 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.105 -0.997 . . . . 0.0 110.081 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 8.3 mt -146.4 127.13 7.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.6 -44.22 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.742 1.628 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.24 -17.67 0.75 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.293 -0.88 . . . . 0.0 109.819 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -134.36 17.55 3.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.168 -0.958 . . . . 0.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.71 48.4 4.81 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.682 0.753 . . . . 0.0 109.912 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 23' ' ' ALA . 48.3 mm -88.89 141.42 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.655 0.741 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.31 82.69 0.17 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 19.2 mm-40 -143.13 156.78 61.39 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.139 -0.976 . . . . 0.0 110.561 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -83.49 165.72 14.12 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.888 2.392 . . . . 0.0 112.301 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.1 109.23 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -65.84 139.51 96.88 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.705 -1.247 . . . . 0.0 109.1 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.53 109.23 2.59 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.824 1.682 . . . . 0.0 111.904 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.54 -174.47 39.76 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.135 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.586 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 74.3 Cg_endo -76.75 113.93 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.576 2.184 . . . . 0.0 110.969 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -44.58 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.438 0.637 . . . . 0.0 111.151 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.575 ' OG1' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -100.24 169.35 8.08 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.56 -27.53 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.632 1.555 . . . . 0.0 112.42 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.48 -33.66 75.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.586 ' NE2' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -89.85 -51.7 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 109.231 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 39' ' ' LEU . 18.8 mt -46.88 -30.45 2.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.473 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -65.01 -27.32 68.74 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 38' ' ' GLN . 89.0 mtt180 -84.5 -19.61 32.98 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.67 -140.77 6.35 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.754 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.0 t -107.32 164.69 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.708 -0.878 . . . . 0.0 108.799 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.5 t -163.24 157.53 20.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.959 -1.088 . . . . 0.0 109.194 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 37.3 m-85 -59.67 161.86 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.354 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.56 5.28 36.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.39 142.03 9.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.717 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 -23.64 67.54 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.645 -0.659 . . . . 0.0 111.529 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -87.1 4.84 40.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.878 -1.139 . . . . 0.0 110.728 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -62.68 157.15 21.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 109.429 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.532 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -143.99 179.51 7.15 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.986 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -83.75 4.24 29.75 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -146.07 16.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.512 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.2 t70 -58.26 115.24 2.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.681 -1.262 . . . . 0.0 108.779 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -43.51 -19.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 112' ' ' ASP . 21.6 t-20 -135.17 97.24 3.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -94.85 151.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 109.347 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.7 m -143.64 116.84 8.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.7 mt -112.59 162.57 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.738 0.78 . . . . 0.0 110.601 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -132.78 131.76 41.48 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.24 148.3 19.98 Favored Glycine 0 N--CA 1.505 3.286 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.323 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -76.3 -169.89 1.31 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.646 -0.914 . . . . 0.0 110.422 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 63' ' ' THR . 14.7 t -158.82 83.44 0.81 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.75 0.786 . . . . 0.0 108.971 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.56 108.51 19.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.712 -1.243 . . . . 0.0 109.462 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 mm -60.06 -28.4 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 110.44 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -86.97 16.52 4.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 69' ' ' ASN . 33.2 ttm180 -150.56 72.99 9.02 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.81 14.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 123.909 3.073 . . . . 0.0 114.325 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.568 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.2 p-10 -148.47 62.63 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.802 -1.186 . . . . 0.0 108.572 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.469 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 44.7 t80 -151.47 98.79 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 20.4 mt-30 60.99 -127.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 111.179 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.71 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -92.01 59.08 3.51 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.682 1.23 . . . . 0.0 109.574 -178.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 m -91.17 -24.77 19.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.202 -1.561 . . . . 0.0 108.632 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -136.77 -0.97 2.28 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 -178.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -10.22 0.28 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.403 -1.435 . . . . 0.0 108.042 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.48 -37.59 50.95 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -27.6 69.13 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.06 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -175.11 171.51 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 109.919 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -51.14 101.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.5 -29.85 2.46 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.444 ' OG ' ' CG2' ' A' ' 20' ' ' ILE . 14.1 t -62.81 108.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.2 mtp -62.83 174.99 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.642 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.09 108.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.97 104.91 17.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 109.942 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -94.53 111.94 23.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -102.01 144.64 30.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 110.459 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 15' ' ' ALA . 4.7 p -170.24 128.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.557 -0.714 . . . . 0.0 109.268 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.19 -120.42 19.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.19 35.05 4.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.956 . . . . 0.0 109.117 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.3 133.61 16.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 108.944 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.8 t -119.01 133.91 55.53 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.674 0.749 . . . . 0.0 110.172 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -94.89 172.07 8.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -147.53 96.51 2.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.915 -1.116 . . . . 0.0 110.226 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 24.7 m-85 -87.57 -173.72 4.47 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.015 -1.053 . . . . 0.0 108.594 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER -150.25 111.55 4.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.138 -0.976 . . . . 0.0 109.886 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtp -48.67 117.27 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.326 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -158.54 21.11 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.053 -1.029 . . . . 0.0 109.555 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 11.2 p -167.83 86.04 0.22 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.635 -1.291 . . . . 0.0 109.299 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.9 mp -79.28 166.29 2.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 102' ' ' ASP . 3.4 mmp_? -142.98 -5.45 0.88 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.798 -1.189 . . . . 0.0 109.89 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.566 ' CG ' ' H ' ' A' ' 103' ' ' VAL . 41.5 t0 -58.67 -151.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 108.896 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.566 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 60.6 t 54.18 -85.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 0.0 109.414 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 102' ' ' ASP . 17.5 tptm -126.8 89.26 52.55 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.65 -103.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.895 1.73 . . . . 0.0 112.028 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.6 p 44.51 52.97 7.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -0.918 . . . . 0.0 110.0 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -78.73 -118.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.113 -0.992 . . . . 0.0 108.735 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.61 26.51 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 147.04 106.6 0.46 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.23 -33.66 64.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.279 -1.13 . . . . 0.0 108.082 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.1 mt -137.82 76.67 1.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.528 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -131.02 179.5 5.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.505 -0.747 . . . . 0.0 109.367 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 14.4 mp0 -60.65 -123.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 109.498 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -86.45 86.74 7.34 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.531 ' HB3' ' HZ3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -43.3 -17.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 110.377 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . 141.12 32.8 0.13 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' CG ' ' H ' ' A' ' 118' ' ' ASP . 10.0 tptm -143.72 -145.04 0.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.254 -1.145 . . . . 0.0 110.495 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 119' ' ' LYS . 33.2 t0 -118.98 171.6 8.13 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 16.8 ttmm -34.54 132.79 0.28 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.91 175.03 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.6 tp -128.82 102.97 6.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -93.03 87.24 5.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.185 -0.947 . . . . 0.0 109.151 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.82 152.3 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.909 -1.119 . . . . 0.0 109.256 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -129.03 151.56 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.669 -0.645 . . . . 0.0 109.29 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.422 HG22 ' CD2' ' A' ' 72' ' ' PHE . 52.0 p -96.37 153.3 17.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.154 -0.967 . . . . 0.0 108.568 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.77 97.88 2.97 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.968 -1.083 . . . . 0.0 109.799 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 127' ' ' ASP . 2.0 p30 -147.25 136.18 22.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 108.75 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 127' ' ' ASP . 1.5 m-20 70.84 64.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 109.576 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.99 125.75 25.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 0.0 109.865 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -86.87 125.74 34.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.135 -0.978 . . . . 0.0 109.399 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.72 4.5 47.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 109.811 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.67 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.408 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.8 p -95.21 -3.14 48.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.37 45.4 54.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 165.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -1.146 . . . . 0.0 109.24 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLU . 81.4 m95 -68.86 114.38 7.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.189 -0.945 . . . . 0.0 108.696 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.3 tp10 -35.42 -86.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.24 0.543 . . . . 0.0 110.325 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -103.76 148.86 25.58 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -157.19 138.9 14.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.792 -1.192 . . . . 0.0 110.618 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -99.76 166.35 11.14 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 102' ' ' ASP . 2.3 mt -138.3 132.84 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.435 -0.79 . . . . 0.0 110.157 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -141.34 147.25 37.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.529 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 19.2 t -135.94 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.077 -1.015 . . . . 0.0 111.296 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.15 -178.54 3.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.0 t -144.85 141.01 28.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.91 -1.119 . . . . 0.0 109.377 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -57.67 147.27 28.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.81 . . . . 0.0 109.555 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 148' ' ' LYS . 17.8 m -91.43 170.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 147' ' ' VAL . 37.6 pttt . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.47 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.41 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 3.8 mp0 -71.29 106.36 3.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.967 . . . . 0.0 109.292 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.08 120.08 24.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.384 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 40.7 pttt -141.67 41.39 0.4 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.362 -0.836 . . . . 0.0 110.39 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 29.8 Cg_endo -62.44 -157.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.325 2.017 . . . . 0.0 111.72 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -79.99 94.57 5.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.98 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mm -141.89 94.15 7.3 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.08 168.56 0.36 Allowed 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.466 2.111 . . . . 0.0 112.446 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 -14.99 16.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.401 -0.812 . . . . 0.0 109.176 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 12' ' ' SER . 0.8 OUTLIER -76.71 107.45 9.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -60.52 -3.44 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.0 109.293 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 10' ' ' ASP . 80.9 p -116.69 44.23 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -150.46 128.13 11.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.32 -0.862 . . . . 0.0 109.262 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 16' ' ' GLY . 39.2 t -55.33 158.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 111.278 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -140.7 2.39 1.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.633 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 173.68 -175.44 46.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 67.3 m-85 -150.34 126.74 10.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.109 -1.23 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.443 ' CD1' HD11 ' A' ' 123' ' ' LEU . 13.3 tt -95.66 147.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -149.84 134.88 17.94 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.807 -1.183 . . . . 0.0 110.95 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 84' ' ' VAL . 32.4 mt -145.49 124.79 6.81 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.2 -41.19 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.65 1.567 . . . . 0.0 111.724 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.92 -17.95 1.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.6 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 24' ' ' ASP . . . -130.01 13.49 5.73 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.523 -0.736 . . . . 0.0 109.553 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.8 p30 42.23 36.4 0.72 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 mt -90.58 140.97 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -165.92 86.89 0.36 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.62 159.15 70.2 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.474 -0.767 . . . . 0.0 110.441 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HB2' HG22 ' A' ' 14' ' ' VAL . 41.4 Cg_endo -85.58 164.0 10.79 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.061 2.507 . . . . 0.0 112.952 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.18 113.5 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.29 168.34 13.75 Favored Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.776 -1.202 . . . . 0.0 109.801 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.91 124.49 4.47 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.894 2.396 . . . . 0.0 111.831 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.99 170.55 30.11 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.29 -1.434 . . . . 0.0 110.45 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 35' ' ' THR . 98.5 Cg_endo -78.43 117.29 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.79 2.327 . . . . 0.0 111.256 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.79 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.534 -0.729 . . . . 0.0 109.996 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -122.96 155.41 63.94 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 19.5 Cg_endo -58.25 -48.1 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.902 1.735 . . . . 0.0 111.191 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -63.01 -19.53 64.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.89 . . . . 0.0 109.205 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 40' ' ' ASN . 5.2 tp-100 -89.63 -69.51 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.006 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.1 mt -52.57 -3.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 38' ' ' GLN . 16.5 m-20 -59.54 -28.62 67.26 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.906 -1.121 . . . . 0.0 108.744 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' CD ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -87.79 -18.94 28.23 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.38 -127.52 1.73 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.267 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.53 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.8 t -101.66 157.11 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.538 -0.978 . . . . 0.0 109.97 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.3 m -155.58 151.82 28.02 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -56.53 170.2 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.751 -1.218 . . . . 0.0 109.829 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.43 -3.39 52.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.822 . . . . 0.0 109.06 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -153.57 150.49 28.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.0 109.874 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 13.1 pt-20 -62.73 -40.73 98.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.544 -0.722 . . . . 0.0 111.422 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 63.9 t30 -88.44 18.64 4.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 7.7 tp10 -62.92 139.44 58.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.718 -1.238 . . . . 0.0 109.696 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 53' ' ' ASP . 16.1 m -146.51 152.51 39.1 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -60.39 -5.66 1.24 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 51' ' ' SER . 5.1 m-20 -75.85 -33.08 60.01 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.677 -0.639 . . . . 0.0 109.679 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 56' ' ' ASN . 51.3 m-20 -59.84 111.22 1.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.295 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.589 ' CD ' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -48.41 -14.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 108.819 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.6 t30 -125.69 108.02 11.13 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.39 117.65 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.009 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -108.6 108.96 20.04 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.66 161.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.475 -0.766 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.54 ' HB1' ' SG ' ' A' ' 126' ' ' CYS . . . -132.61 137.29 46.99 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.21 147.86 19.26 Favored Glycine 0 N--CA 1.5 2.965 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.998 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.551 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 18.7 m-70 -75.79 -165.52 0.46 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.885 -0.774 . . . . 0.0 110.278 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.95 88.86 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -88.15 108.97 19.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.055 -1.028 . . . . 0.0 109.084 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 mt -57.48 -27.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.465 -0.772 . . . . 0.0 109.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.6 12.1 5.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.007 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 69' ' ' ASN . 87.1 mtt180 -150.94 74.79 8.42 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 80.9 Cg_exo -48.62 7.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 123.629 2.886 . . . . 0.0 113.927 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 67' ' ' ARG . 44.8 p30 -142.21 58.81 1.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.678 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 61.7 t80 -141.49 100.21 3.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.427 -0.796 . . . . 0.0 110.387 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.678 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 24.0 mt-30 60.75 -124.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.512 -0.742 . . . . 0.0 111.245 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.673 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -91.95 34.72 0.99 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 122.772 1.272 . . . . 0.0 109.297 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.9 m -73.6 -26.66 60.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.421 -2.049 . . . . 0.0 108.855 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 22.0 m-20 -133.55 -4.42 2.94 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.266 -0.897 . . . . 0.0 110.775 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.9 -23.42 7.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.733 -1.229 . . . . 0.0 108.775 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -2.09 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.949 -1.094 . . . . 0.0 108.388 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.56 -33.55 15.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.76 179.56 0.12 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.171 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -148.84 170.77 17.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.16 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -49.14 149.14 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 109.034 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.3 -23.13 23.15 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.9 t -62.45 103.08 0.37 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 58.2 mmm -62.01 171.25 1.79 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.162 -0.962 . . . . 0.0 110.149 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 20' ' ' ILE . 30.1 t -141.38 110.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.44 102.44 15.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -95.42 113.7 25.39 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -85.78 143.22 28.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.565 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 t -148.2 84.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.42 -128.04 27.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -95.28 37.36 1.18 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.174 -1.192 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 92' ' ' THR . 1.2 tm-20 -163.17 114.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.076 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 91' ' ' GLU . 9.8 t -107.35 147.1 30.75 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.426 -0.797 . . . . 0.0 110.082 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 93' ' ' ARG . 9.2 mmm-85 -93.7 172.9 7.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.498 -0.751 . . . . 0.0 109.369 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -146.36 92.94 2.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.105 -0.997 . . . . 0.0 109.999 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.431 ' O ' ' SD ' ' A' ' 83' ' ' MET . 22.7 m-85 -87.38 -176.39 5.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.904 -1.122 . . . . 0.0 108.726 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -147.33 107.93 4.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.239 -0.913 . . . . 0.0 109.428 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 23.9 mtt -48.29 117.83 2.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.451 ' OG1' HG22 ' A' ' 145' ' ' THR . 10.1 p -142.92 8.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.259 -0.901 . . . . 0.0 109.143 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 143' ' ' VAL . 30.9 t -164.87 107.98 0.87 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 108.646 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 101' ' ' ARG . 55.5 mt -119.51 166.47 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.522 -0.736 . . . . 0.0 109.544 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.556 ' N ' HG22 ' A' ' 100' ' ' ILE . 4.2 mmt-85 -131.11 -84.77 0.51 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 102' ' ' ASP . 8.6 t70 44.53 18.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.467 -0.77 . . . . 0.0 109.217 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 103' ' ' VAL . 4.4 p -151.59 114.34 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.409 -0.807 . . . . 0.0 109.257 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt 45.09 60.55 13.02 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -37.25 102.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.935 2.423 . . . . 0.0 112.509 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 0.7 OUTLIER -57.25 -44.1 83.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 0.0 109.841 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 106' ' ' THR . 4.4 t0 85.42 27.87 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 m -60.11 -6.67 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 157.58 85.37 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 110' ' ' VAL . 2.7 m -68.54 -35.2 69.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.242 -1.152 . . . . 0.0 108.48 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.4 mt -139.29 42.45 2.05 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -92.7 125.28 37.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.104 -0.997 . . . . 0.0 109.647 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 1.1 pm0 -90.67 16.98 8.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.3 OUTLIER -148.47 26.25 0.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -48.71 -9.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.604 -0.685 . . . . 0.0 110.117 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . 92.43 39.04 5.44 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -137.36 -164.25 1.56 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.494 -1.004 . . . . 0.0 109.415 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 120' ' ' GLN . 14.3 t70 -117.55 169.07 9.83 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 18.7 mmmt -26.93 84.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.484 0.659 . . . . 0.0 110.842 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.8 pm0 -99.36 170.03 8.93 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.585 0.707 . . . . 0.0 110.664 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.97 102.5 8.04 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -94.93 87.55 5.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.131 -0.981 . . . . 0.0 109.355 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.443 HD11 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -81.5 132.53 35.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.89 -1.131 . . . . 0.0 109.367 -179.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 125' ' ' THR . 52.7 mt -113.96 159.86 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.501 0.667 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 ' CG ' ' A' ' 72' ' ' PHE . 80.8 p -97.2 167.24 11.16 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.62 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.551 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 1.7 m -149.96 84.59 1.4 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.153 -0.967 . . . . 0.0 109.348 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 128' ' ' ASP . 15.0 t70 -148.22 129.0 14.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.976 -1.078 . . . . 0.0 108.953 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 4.5 t0 78.92 60.72 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.85 127.71 33.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.817 -1.177 . . . . 0.0 110.067 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -85.79 123.71 31.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.07 -1.019 . . . . 0.0 109.501 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -98.39 8.4 44.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.263 -0.898 . . . . 0.0 109.78 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -86.89 -20.22 27.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.7 p -140.29 0.69 1.72 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.5 49.04 53.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.72 137.79 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -1.156 . . . . 0.0 109.305 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 51.5 m95 -52.6 112.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.934 -1.104 . . . . 0.0 108.43 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 136' ' ' TRP . 8.2 tp10 -37.6 -81.14 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.904 -0.498 . . . . 0.0 110.174 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -103.67 139.15 39.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.524 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -147.25 114.21 6.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.896 -1.128 . . . . 0.0 110.415 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -95.53 166.69 11.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.2 pt -147.95 162.42 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.89 -1.131 . . . . 0.0 110.919 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.8 m-85 -137.41 150.49 47.69 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 99' ' ' SER . 21.7 t -132.62 111.73 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.179 -0.951 . . . . 0.0 111.161 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.75 177.59 4.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.451 HG22 ' OG1' ' A' ' 98' ' ' THR . 14.7 t -144.66 139.35 27.96 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.978 -1.076 . . . . 0.0 109.726 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.08 144.81 44.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 147' ' ' VAL . 9.8 m -90.46 166.23 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.603 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.455 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mmm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -162.02 167.54 24.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.664 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.65 77.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 109.427 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -45.55 108.8 0.83 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 109.793 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.15 -148.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.192 1.928 . . . . 0.0 111.918 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -66.92 118.73 10.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.896 -1.128 . . . . 0.0 110.839 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.6 mt -152.3 98.38 2.91 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.6 155.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.807 1.672 . . . . 0.0 112.525 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -102.65 -19.01 14.97 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.0 109.455 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.9 m-20 -77.22 110.31 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -58.0 -3.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.428 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.8 t -111.99 41.63 1.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.487 -0.758 . . . . 0.0 109.473 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -149.11 133.79 17.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 16' ' ' GLY . 61.5 t -58.86 161.0 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 110.95 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -139.97 -0.8 1.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 172.73 -173.71 45.54 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 44.2 m-85 -150.09 128.68 12.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.294 -1.121 . . . . 0.0 109.923 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -95.0 146.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.753 ' C ' HD12 ' A' ' 20' ' ' ILE . 37.9 tt0 -149.79 119.6 7.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.819 -1.175 . . . . 0.0 111.171 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 19' ' ' GLU . 1.9 mp -131.52 127.12 21.46 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 23' ' ' ALA . 71.9 Cg_endo -76.37 -42.71 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.53 1.486 . . . . 0.0 111.483 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 40.8 t0 -52.25 -10.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.423 -0.798 . . . . 0.0 109.473 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -140.59 15.45 2.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ALA . 2.3 p-10 41.68 49.6 3.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.078 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 20' ' ' ILE . 40.2 mm -91.27 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.674 0.749 . . . . 0.0 109.71 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -170.27 80.94 0.1 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -142.03 157.52 63.77 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 110.536 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.03 162.0 15.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.099 2.533 . . . . 0.0 113.068 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.92 109.23 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.67 168.77 22.92 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 120.753 -1.217 . . . . 0.0 109.505 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -88.21 117.12 1.01 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 122.726 2.284 . . . . 0.0 112.032 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.6 175.92 40.91 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.108 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 80.6 Cg_endo -78.35 115.52 3.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.808 2.339 . . . . 0.0 111.271 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -45.95 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.611 -0.681 . . . . 0.0 110.084 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.5 p -120.15 152.99 55.29 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.39 -41.29 79.57 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.985 1.79 . . . . 0.0 111.745 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.13 -22.84 67.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 109.62 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -90.89 -70.31 0.69 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.489 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 39' ' ' LEU . 16.1 mt -43.87 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 109.916 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 38' ' ' GLN . 19.6 m-20 -60.99 -24.17 65.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -90.95 -10.73 41.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.46 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.1 -115.72 0.68 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.6 t -126.16 154.95 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -150.68 155.13 38.72 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 41.7 m-85 -56.28 173.88 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.65 -1.281 . . . . 0.0 109.391 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.01 -13.39 58.9 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -146.31 153.19 40.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.269 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -63.71 -41.24 98.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.525 -0.734 . . . . 0.0 111.394 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -86.92 12.61 10.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.037 -1.039 . . . . 0.0 111.012 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.57 90.78 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.96 -1.087 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 53' ' ' ASP . 17.4 m -89.37 151.64 21.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 108.671 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.4 0.67 1.4 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 51' ' ' SER . 45.3 m-20 -95.88 -14.37 23.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.651 -0.656 . . . . 0.0 109.339 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.9 t0 -58.35 119.28 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.039 -1.038 . . . . 0.0 109.571 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -45.99 -14.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.72 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.638 HD21 ' HG2' ' A' ' 120' ' ' GLN . 13.0 t-20 -145.56 109.95 4.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 0.0 108.97 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.6 mp -95.29 154.9 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 108.98 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' HD11 ' A' ' 124' ' ' ILE . 16.6 t -143.67 123.28 13.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 90.2 mt -110.59 162.23 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.453 -0.779 . . . . 0.0 110.597 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.97 131.12 26.44 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.29 156.34 26.07 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 119.88 -1.153 . . . . 0.0 110.527 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -72.08 177.02 4.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.539 -0.977 . . . . 0.0 109.47 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.5 87.16 0.75 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.297 -0.877 . . . . 0.0 109.65 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.13 102.69 15.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.292 -0.88 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 mt -53.02 -23.69 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.218 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.03 13.96 3.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.115 -0.99 . . . . 0.0 109.451 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' ASN . 19.5 ttm-85 -152.66 74.95 7.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 109.282 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.43 20.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 123.911 3.074 . . . . 0.0 114.495 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.9 p-10 -151.22 62.8 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.893 -1.129 . . . . 0.0 108.609 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -151.32 123.53 8.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.097 -1.002 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 61.1 mt-30 40.9 -115.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.812 -0.555 . . . . 0.0 111.357 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -98.03 9.22 43.34 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -49.34 -22.25 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.544 -1.347 . . . . 0.0 109.556 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.0 t-20 -119.57 -22.35 6.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.863 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.676 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.7 tm? -53.26 -35.7 60.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.068 -1.02 . . . . 0.0 108.57 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -72.31 -4.37 29.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.308 -0.87 . . . . 0.0 108.689 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -89.81 -28.37 19.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.6 -172.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.767 . . . . 0.0 109.678 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -162.07 -177.64 5.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.882 . . . . 0.0 109.071 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 82' ' ' SER . 26.9 mtmm -49.78 155.89 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.005 -1.06 . . . . 0.0 109.288 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.75 -18.86 4.48 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 80' ' ' LYS . 73.7 m -63.89 98.93 0.22 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.327 -1.102 . . . . 0.0 108.437 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.7 mtm -62.24 -179.32 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.616 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 20' ' ' ILE . 74.2 t -149.2 108.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.412 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.15 102.38 15.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.128 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' HG11 ' A' ' 88' ' ' VAL . 43.4 t80 -95.66 111.99 23.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -95.89 134.22 39.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.159 -0.963 . . . . 0.0 111.384 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' A' ' 86' ' ' PHE . 2.0 m -153.33 134.7 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.29 -138.95 26.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -101.62 43.98 1.04 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.31 -1.112 . . . . 0.0 109.665 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -162.24 136.44 6.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.315 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -117.28 140.53 49.44 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.521 -0.737 . . . . 0.0 110.081 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -93.26 168.29 11.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.572 -0.705 . . . . 0.0 109.301 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 15.5 pttp -145.8 118.89 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.995 . . . . 0.0 109.935 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.51 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 27.5 m-85 -116.44 168.48 10.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -130.22 108.98 10.44 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.239 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.5 tpp -50.89 135.09 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.514 -0.741 . . . . 0.0 109.237 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -166.28 19.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.8 t -164.88 92.34 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 100' ' ' ILE . 2.5 mp -97.7 162.31 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.887 . . . . 0.0 109.498 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 103' ' ' VAL . 74.8 mtt180 -136.33 -86.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.476 ' H ' HG13 ' A' ' 141' ' ' ILE . 3.3 p30 44.22 16.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.377 -0.827 . . . . 0.0 109.931 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.636 HG12 ' N ' ' A' ' 104' ' ' LYS . 3.8 t -94.39 -81.99 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.749 ' H ' ' CD ' ' A' ' 105' ' ' PRO . 9.1 ttpt -129.6 -42.76 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.441 -0.787 . . . . 0.0 109.958 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.749 ' CD ' ' H ' ' A' ' 104' ' ' LYS . 20.6 Cg_exo -65.62 66.8 0.37 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.218 1.945 . . . . 0.0 111.299 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 108' ' ' VAL . 22.2 p -89.17 89.64 8.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.101 -1.0 . . . . 0.0 110.714 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER 63.07 -1.26 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.412 -0.805 . . . . 0.0 110.294 178.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 106' ' ' THR . 3.5 m -67.72 2.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.87 -1.144 . . . . 0.0 108.145 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 176.87 10.58 0.02 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.881 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.531 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 23.7 t -69.83 -37.51 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.636 -1.508 . . . . 0.0 108.334 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.6 mt -98.85 58.48 1.16 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -176.04 23.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.499 -0.751 . . . . 0.0 109.52 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -156.69 14.41 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 109.143 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 110' ' ' VAL . 7.5 mt-30 -101.49 6.05 42.18 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -75.78 30.06 0.11 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.703 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . -149.69 -14.78 0.09 OUTLIER Glycine 0 N--CA 1.498 2.815 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.655 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -93.27 -147.39 0.24 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.876 -1.367 . . . . 0.0 109.429 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.5 m-20 -116.2 168.87 9.73 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 13.3 mptt -43.38 130.31 4.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.243 -0.911 . . . . 0.0 109.448 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.638 ' HG2' HD21 ' A' ' 56' ' ' ASN . 0.0 OUTLIER -145.71 172.67 12.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -178.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.7 tp -118.51 156.34 29.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.661 -0.649 . . . . 0.0 110.019 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 m -134.77 88.38 2.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.51 145.54 52.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 110.883 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.46 HD11 ' OG ' ' A' ' 58' ' ' SER . 51.5 mt -138.55 138.26 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.542 -0.724 . . . . 0.0 109.158 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -102.2 156.85 17.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 85.5 m -144.76 138.06 26.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.944 -1.098 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 4.3 t0 178.96 146.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 108.891 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 8.3 t70 60.59 54.3 3.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -61.68 121.25 12.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.116 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -86.25 121.88 29.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.757 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.5 pm0 -87.08 6.72 31.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.45 -50.83 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.4 p -97.67 -14.39 20.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 108.952 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.02 17.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.12 163.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -1.141 . . . . 0.0 109.717 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.445 ' O ' ' C ' ' A' ' 137' ' ' GLU . 73.4 m95 -68.24 114.71 6.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -37.18 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.218 0.532 . . . . 0.0 110.181 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -93.94 153.18 18.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -156.51 94.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.852 -1.155 . . . . 0.0 110.71 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -86.79 159.39 19.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.476 HG13 ' H ' ' A' ' 102' ' ' ASP . 9.8 pt -145.82 159.57 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.842 -1.162 . . . . 0.0 110.685 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.4 m-85 -139.95 168.42 19.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.19 142.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.802 -1.186 . . . . 0.0 110.423 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.16 147.85 40.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 147' ' ' VAL . 13.0 t -108.63 140.36 42.12 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.51 ' OE1' ' CD2' ' A' ' 95' ' ' TYR . 3.2 tp10 -65.72 45.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.4 t -146.7 177.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.118 -0.988 . . . . 0.0 109.223 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.46 ' H ' HG12 ' A' ' 147' ' ' VAL . 29.3 mmtp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.329 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -66.75 155.48 38.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.902 . . . . 0.0 109.556 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.5 129.89 6.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.482 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -45.84 148.7 1.31 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.91 -152.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.43 2.087 . . . . 0.0 111.684 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -68.76 129.17 39.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.023 -1.048 . . . . 0.0 110.258 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.1 mt -150.63 96.56 3.37 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -41.08 143.3 0.7 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.304 2.003 . . . . 0.0 113.356 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -87.19 -16.24 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.148 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' SER . 12.9 m-20 -77.7 105.62 8.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 109.451 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 1.9 mptp? -58.56 -2.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.443 -0.786 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' ASP . 39.7 m -113.94 43.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HZ3' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -143.15 134.41 25.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.942 . . . . 0.0 109.04 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.6 115.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.818 . . . . 0.0 110.932 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -95.76 -4.53 43.82 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.53 -168.85 41.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.54 124.77 10.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.178 -1.189 . . . . 0.0 109.071 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.7 tt -98.91 147.38 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.18 145.95 30.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.01 -1.056 . . . . 0.0 109.828 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -147.86 131.82 8.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -52.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.981 1.787 . . . . 0.0 111.833 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -50.88 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 109.301 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.55 3.08 17.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.521 -0.737 . . . . 0.0 109.073 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 43.39 37.1 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.573 -0.705 . . . . 0.0 109.646 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -92.91 152.19 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 122.214 1.006 . . . . 0.0 110.665 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -166.07 82.64 0.3 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -132.4 158.69 74.97 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.47 -0.769 . . . . 0.0 110.694 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.67 162.01 21.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.006 2.47 . . . . 0.0 112.654 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -138.16 104.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -76.65 166.13 47.23 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.785 -1.197 . . . . 0.0 109.377 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 15' ' ' ALA . 43.7 Cg_endo -89.77 120.04 0.89 Allowed 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.488 2.126 . . . . 0.0 111.818 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.09 -178.4 43.53 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 35' ' ' THR . 88.3 Cg_endo -81.22 116.63 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.919 2.413 . . . . 0.0 111.712 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -46.61 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.765 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -119.62 153.9 54.43 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 22.4 Cg_endo -60.35 -45.12 23.93 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.127 1.884 . . . . 0.0 111.803 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -63.28 -27.8 69.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 109.698 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 40' ' ' ASN . 1.6 tm0? -86.51 -68.33 0.75 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -46.82 -14.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.738 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.6 m-20 -63.89 -24.96 67.94 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -80.14 -20.92 43.8 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.085 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' OE1' ' A' ' 71' ' ' GLN . . . 159.29 -119.29 0.88 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.9 t -118.55 157.8 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.605 -0.938 . . . . 0.0 110.102 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 158.9 37.86 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -56.18 173.37 0.16 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.716 -1.24 . . . . 0.0 109.355 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.1 -14.48 55.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.895 . . . . 0.0 109.139 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -146.78 145.62 29.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 110.063 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -24.41 67.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.52 -0.737 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -88.75 3.24 51.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.0 150.3 45.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 109.758 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 45.9 m -149.04 159.6 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -69.64 -4.22 18.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -99.52 -15.34 18.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.683 . . . . 0.0 109.932 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 51' ' ' SER . 31.2 m-20 -60.14 107.61 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.716 -1.24 . . . . 0.0 109.203 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -45.75 -18.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.379 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.4 t-20 -127.81 98.31 5.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 58' ' ' SER . 96.6 mt -94.51 154.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 109.277 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 46' ' ' ALA . 58.6 m -145.38 117.59 8.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.2 mt -112.62 158.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 110.22 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.52 136.61 34.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.95 156.38 25.93 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -71.77 178.41 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.484 -1.009 . . . . 0.0 109.535 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.462 ' CG2' ' OD1' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -163.52 86.51 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.42 -0.8 . . . . 0.0 109.28 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -88.41 119.34 28.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.7 -30.9 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.074 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -82.9 15.94 2.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 109.566 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 69' ' ' ASN . 54.7 ttt180 -150.32 70.97 9.17 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.19 18.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.843 3.028 . . . . 0.0 114.36 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.2 63.41 0.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.783 -1.198 . . . . 0.0 108.651 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -151.09 110.77 4.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 64.2 mt-30 54.81 -115.5 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.712 -0.618 . . . . 0.0 111.918 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.592 ' CE2' HD13 ' A' ' 75' ' ' LEU . 3.1 m-85 -96.21 10.98 36.07 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.186 -0.946 . . . . 0.0 110.559 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.4 m -49.08 -18.01 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.0 m-20 -122.05 -23.58 5.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.398 -0.814 . . . . 0.0 110.032 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.592 HD13 ' CE2' ' A' ' 72' ' ' PHE . 6.9 tt -54.2 -29.0 44.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.768 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -75.4 -7.2 53.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -88.41 -24.0 23.17 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.73 -178.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.584 -0.697 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.23 162.86 40.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -52.98 133.03 38.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.57 -5.06 66.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 83' ' ' MET . 25.8 t -63.33 -161.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.055 -1.262 . . . . 0.0 108.174 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.521 ' N ' ' OG ' ' A' ' 82' ' ' SER . 50.1 mmm -142.61 162.27 35.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 109.739 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 t -146.15 155.45 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.236 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.83 107.9 5.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.287 -0.883 . . . . 0.0 109.207 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -95.02 112.28 24.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -97.99 138.98 34.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.7 m -144.06 150.19 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.32 -14.83 0.06 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 88' ' ' VAL . 48.2 t30 -84.02 -58.48 2.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.035 -1.274 . . . . 0.0 109.999 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' H ' HG23 ' A' ' 88' ' ' VAL . 20.1 tt0 -172.08 171.68 4.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 108.904 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -97.61 149.7 21.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.202 -0.936 . . . . 0.0 110.037 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.65 169.5 17.52 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.78 156.49 44.99 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.05 -1.031 . . . . 0.0 110.911 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.527 ' CE2' ' OE1' ' A' ' 146' ' ' GLU . 6.5 m-85 -136.5 -178.07 5.01 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -145.68 116.45 7.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.164 -0.96 . . . . 0.0 109.054 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 40.2 mtt -51.03 111.98 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.438 -0.788 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -140.04 28.98 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.369 -0.832 . . . . 0.0 108.916 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 p -178.95 141.91 0.19 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 50.3 mt -140.76 164.2 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 104' ' ' LYS . 22.5 mmt180 -140.82 -9.08 1.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.426 -0.796 . . . . 0.0 109.157 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 103' ' ' VAL . 23.4 p30 -45.82 -22.47 0.19 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.228 -0.92 . . . . 0.0 109.713 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.521 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 8.9 p -83.51 -23.9 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.0 109.321 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 101' ' ' ARG . 19.1 pttm -149.36 61.97 5.62 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' A' ' 107' ' ' ASP . 58.6 Cg_endo -72.16 -69.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.392 2.061 . . . . 0.0 112.629 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 105' ' ' PRO . 1.5 p 65.83 -35.95 0.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.277 -0.889 . . . . 0.0 109.548 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.552 ' H ' ' C ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER 71.03 -37.11 0.38 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.486 ' H ' ' C ' ' A' ' 106' ' ' THR . 15.3 m -75.81 25.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 109.214 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -159.6 -20.63 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.485 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 t -67.26 -38.64 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.902 -1.352 . . . . 0.0 108.823 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.9 mt -100.21 63.37 1.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.494 -0.754 . . . . 0.0 109.338 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -172.44 22.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.298 -0.876 . . . . 0.0 109.953 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -175.85 29.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.181 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -140.26 17.1 2.42 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -104.82 13.46 31.21 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -128.86 45.15 1.16 Allowed Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -142.92 -131.9 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.316 -1.108 . . . . 0.0 108.795 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -106.77 164.13 12.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.244 -0.91 . . . . 0.0 108.593 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.436 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 4.4 mptp? -46.83 137.54 7.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 108.54 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -150.05 152.04 34.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 110.528 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.28 117.32 30.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.949 -0.47 . . . . 0.0 110.22 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 m -92.41 88.17 6.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.0 mt -68.28 138.33 55.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.697 . . . . 0.0 109.986 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.2 mt -137.87 148.31 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.391 -0.818 . . . . 0.0 109.604 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -102.94 169.01 8.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.427 -0.796 . . . . 0.0 108.907 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 34.5 m -148.49 138.93 22.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.993 -1.067 . . . . 0.0 109.619 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.462 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 0.3 OUTLIER 175.3 140.23 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 109.078 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 t0 59.86 66.36 1.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 108.986 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -65.52 127.53 32.23 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 109.668 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -84.77 124.94 32.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.027 -1.045 . . . . 0.0 109.759 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.3 6.25 48.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.461 -0.774 . . . . 0.0 109.228 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -88.36 -19.73 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.808 . . . . 0.0 109.681 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.7 p -137.29 -2.36 2.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.382 -0.824 . . . . 0.0 109.323 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.42 44.29 59.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.78 154.34 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.63 112.99 3.07 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.3 tp10 -37.96 -82.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.93 -0.481 . . . . 0.0 110.691 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -105.24 140.34 38.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.491 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -170.45 138.84 1.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.9 160.58 21.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.89 159.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.833 -1.167 . . . . 0.0 110.92 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 4.8 m-85 -132.66 177.45 7.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.4 t -150.66 133.61 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.852 -1.155 . . . . 0.0 110.586 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.57 15.03 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 147' ' ' VAL . 12.6 t -139.93 147.33 40.39 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.0 -1.063 . . . . 0.0 110.853 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.527 ' OE1' ' CE2' ' A' ' 95' ' ' TYR . 18.2 tp10 -65.51 48.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.778 -0.576 . . . . 0.0 109.459 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 145' ' ' THR . 2.0 t -146.64 177.05 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.084 -1.01 . . . . 0.0 108.961 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.532 ' H ' HG12 ' A' ' 147' ' ' VAL . 15.0 pttp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.319 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -82.36 142.52 31.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.842 . . . . 0.0 109.533 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.7 127.33 32.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 0.0 109.348 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' PRO . 38.4 mmtt -80.91 151.71 70.92 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 109.118 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 4' ' ' LYS . 66.8 Cg_exo -36.9 161.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.359 2.039 . . . . 0.0 112.464 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.507 ' CD ' ' H ' ' A' ' 6' ' ' GLN . 1.2 mp0 -70.73 119.38 14.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.617 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mt -83.59 115.18 58.21 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -41.39 130.58 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.818 1.679 . . . . 0.0 112.51 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -78.03 -29.27 49.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.503 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' SER . 40.3 m-20 -77.28 112.65 14.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -58.66 -2.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.524 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.2 m -105.68 38.84 1.89 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.345 -0.847 . . . . 0.0 109.543 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -142.51 126.37 17.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.302 -0.874 . . . . 0.0 109.261 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.497 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 24.9 t -59.62 132.34 24.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.914 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.07 -10.61 21.34 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 176.16 -161.13 29.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 66.0 m-85 -148.9 131.58 15.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.768 -1.43 . . . . 0.0 110.179 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -98.16 142.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -145.38 133.26 21.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.996 -1.065 . . . . 0.0 110.166 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 23' ' ' ALA . 53.5 mt -142.63 125.94 9.37 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.98 -44.35 0.21 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.707 1.604 . . . . 0.0 111.956 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -53.17 -20.48 3.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.087 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -121.6 8.33 10.09 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.4 p30 43.15 31.71 0.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.593 -0.692 . . . . 0.0 110.01 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 mt -91.08 143.2 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -164.2 85.89 0.46 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.4 159.6 68.76 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 110.624 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.06 162.01 26.28 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.048 2.499 . . . . 0.0 113.036 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 43' ' ' VAL . 3.1 t -139.63 115.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.442 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.73 170.37 13.19 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 120.794 -1.191 . . . . 0.0 108.733 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -89.16 130.91 2.1 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.451 2.101 . . . . 0.0 112.194 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' PHE . . . 164.74 175.08 35.17 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.612 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 35' ' ' THR . 61.9 Cg_endo -85.95 128.01 3.17 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.909 2.406 . . . . 0.0 111.589 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.618 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -38.84 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.662 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -118.79 154.13 52.71 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.76 -41.37 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.267 1.978 . . . . 0.0 111.89 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -63.08 -21.28 66.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 109.588 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -94.64 -70.08 0.72 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.296 -0.877 . . . . 0.0 109.269 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 16.7 mt -44.29 -26.29 0.31 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -61.11 -24.17 66.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 26.9 mtt-85 -89.13 -11.76 42.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.32 -122.33 1.14 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.222 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 60' ' ' ALA . 18.2 t -122.3 151.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.61 -0.936 . . . . 0.0 109.094 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -151.23 151.01 31.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 32' ' ' GLY . 27.7 m-85 -55.4 155.78 4.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.544 -1.348 . . . . 0.0 108.41 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -83.43 4.88 25.74 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.265 -0.897 . . . . 0.0 109.04 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -149.99 130.83 14.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.403 -0.811 . . . . 0.0 110.109 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.76 -22.83 65.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.775 . . . . 0.0 110.486 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -88.0 -2.8 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.035 -1.041 . . . . 0.0 110.075 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -60.45 163.55 5.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 109.081 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -145.43 -167.97 2.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 108.893 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.4 mp -95.05 11.64 31.35 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.215 -0.928 . . . . 0.0 109.079 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.92 12.38 0.44 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 19.6 t0 -57.03 120.38 7.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.756 -1.215 . . . . 0.0 108.751 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -45.86 -15.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.289 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 4.8 m120 -136.12 99.32 4.1 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.0 mm -93.26 153.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.03 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 t -142.02 103.29 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -100.4 158.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.854 0.835 . . . . 0.0 110.336 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.588 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -138.12 134.7 34.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.87 27.43 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.684 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' PHE . 14.3 m-70 -76.49 178.4 6.65 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.585 -0.95 . . . . 0.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.48 90.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 108.74 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' N ' ' OG1' ' A' ' 73' ' ' THR . 5.3 m-85 -87.48 110.54 20.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.199 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 mm -58.32 -30.68 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 110.155 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -87.96 19.38 3.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.13 -0.981 . . . . 0.0 109.465 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -149.88 74.5 9.33 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.433 -0.792 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.1 Cg_exo -56.06 26.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 123.48 2.787 . . . . 0.0 113.524 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -150.57 29.21 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.835 -1.166 . . . . 0.0 109.073 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.8 t80 -89.28 -153.2 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -0.956 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.4 mp0 -71.29 -84.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.711 0.767 . . . . 0.0 110.808 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -94.78 19.45 10.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.677 -0.639 . . . . 0.0 109.968 -178.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.491 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 55.5 m -69.74 -38.19 76.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.326 -1.484 . . . . 0.0 109.93 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 77' ' ' ALA . 16.0 m-20 -103.92 -10.28 18.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.182 -0.948 . . . . 0.0 111.46 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 72' ' ' PHE . 2.6 mt -53.16 -29.27 30.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.406 -1.433 . . . . 0.0 108.365 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 10.6 pttp -80.36 -10.44 59.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -79.51 -23.37 42.98 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.85 -175.34 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLY . 34.3 mttm -150.53 154.98 38.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.029 -1.045 . . . . 0.0 109.686 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -51.06 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 109.734 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 97' ' ' MET . . . 150.84 -20.93 1.0 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -66.03 -165.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.104 -1.233 . . . . 0.0 108.185 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.3 mmm -137.88 171.65 14.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.14 108.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.0 109.145 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -93.37 109.37 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' O ' ' OG1' ' A' ' 92' ' ' THR . 39.9 t80 -94.76 116.89 29.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -85.24 139.11 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 111.115 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.3 m -147.78 124.98 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.53 -132.79 35.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.477 ' N ' ' OE2' ' A' ' 91' ' ' GLU . 49.8 t30 -97.95 35.98 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -1.198 . . . . 0.0 109.832 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.477 ' OE2' ' N ' ' A' ' 90' ' ' ASN . 1.2 pm0 -159.64 170.0 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -0.979 . . . . 0.0 108.955 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 86' ' ' PHE . 6.3 t -141.26 150.22 42.33 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.714 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -92.29 175.53 6.81 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -146.87 133.48 19.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 1.7 m-85 -138.85 126.84 22.42 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.544 ' NZ ' HG21 ' A' ' 147' ' ' VAL . 4.1 ttpm? -93.95 120.39 34.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 109.399 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.423 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 85.2 mtp -48.13 120.64 3.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.522 ' OG1' HG22 ' A' ' 145' ' ' THR . 8.7 p -149.83 31.62 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.37 -0.831 . . . . 0.0 109.304 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 m -171.54 86.95 0.09 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.8 mm -89.13 125.93 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.834 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.503 ' C ' ' H ' ' A' ' 103' ' ' VAL . 23.2 mmt180 -96.67 -116.02 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.463 ' H ' HG13 ' A' ' 141' ' ' ILE . 37.9 t0 58.18 3.6 0.26 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.213 -0.93 . . . . 0.0 109.227 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.941 HG12 ' H ' ' A' ' 104' ' ' LYS . 85.7 t -114.3 -167.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.941 ' H ' HG12 ' A' ' 103' ' ' VAL . 1.6 mmmp? -39.36 -55.87 3.01 Favored Pre-proline 0 N--CA 1.499 2.025 0 O-C-N 120.805 -1.185 . . . . 0.0 110.896 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -43.28 88.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.009 1.806 . . . . 0.0 111.741 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 10.1 p -126.85 94.29 4.0 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.394 -0.816 . . . . 0.0 109.712 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 106' ' ' THR . 3.6 t70 83.38 13.3 0.39 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 108' ' ' VAL . 8.2 m -69.18 3.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 135.34 16.62 0.92 Allowed Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 m -66.91 -24.58 32.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.032 -1.275 . . . . 0.0 108.428 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.8 mt -100.91 33.04 2.94 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 114' ' ' GLN . 30.1 t0 -83.58 121.93 27.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.195 -0.941 . . . . 0.0 109.076 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -61.1 -5.26 1.38 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.031 0.92 . . . . 0.0 108.652 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.683 HE22 ' HA2' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -155.26 74.36 0.9 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' GLN . 1.5 mmmm -41.98 -63.14 0.78 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.178 -0.951 . . . . 0.0 109.71 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.683 ' HA2' HE22 ' A' ' 114' ' ' GLN . . . 148.99 -19.61 1.23 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.532 ' NZ ' ' OE1' ' A' ' 120' ' ' GLN . 11.0 pttp -97.9 -106.42 0.18 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.165 -1.197 . . . . 0.0 110.823 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.471 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 2.2 m-20 -121.16 171.18 8.88 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.288 -0.882 . . . . 0.0 109.57 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 118' ' ' ASP . 58.2 mttm -44.7 147.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.532 ' OE1' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -150.6 150.74 31.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.677 -1.265 . . . . 0.0 110.791 -178.036 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.38 111.9 24.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.88 -0.513 . . . . 0.0 109.753 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 m -98.04 120.79 39.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.201 -0.937 . . . . 0.0 108.696 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mp -104.43 147.11 27.92 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.471 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 77.3 mt -137.89 147.41 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.226 -0.921 . . . . 0.0 110.076 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.452 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.1 p -97.74 155.6 16.94 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.9 m -148.63 97.17 2.7 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.954 -1.091 . . . . 0.0 109.658 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 138' ' ' LYS . 4.9 p-10 -149.39 149.17 30.42 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 61.39 61.23 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.745 . . . . 0.0 109.282 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -64.38 118.87 9.34 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -86.72 118.04 25.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.051 -1.03 . . . . 0.0 109.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 5.1 pm0 -84.86 10.72 10.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -81.99 -54.53 5.24 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.8 p -96.29 -8.13 33.55 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.87 41.47 33.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -147.21 163.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.276 -1.132 . . . . 0.0 109.837 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.443 ' O ' ' C ' ' A' ' 137' ' ' GLU . 71.1 m95 -67.09 116.44 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' TRP . 16.4 tp10 -37.96 -86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.778 -0.576 . . . . 0.0 109.893 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' NZ ' ' OD2' ' A' ' 127' ' ' ASP . 1.9 pttp -89.0 152.06 21.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.463 ' NH2' HD13 ' A' ' 124' ' ' ILE . 54.8 ttt180 -157.45 89.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -79.28 167.99 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.493 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -148.58 151.38 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.756 -1.215 . . . . 0.0 110.023 -179.552 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 1.3 m-85 -143.09 162.52 35.31 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.1 t -148.68 152.72 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.764 -1.21 . . . . 0.0 110.929 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.41 160.96 38.19 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.522 HG22 ' OG1' ' A' ' 98' ' ' THR . 8.3 t -127.91 135.43 49.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.97 105.61 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.52 -0.738 . . . . 0.0 109.677 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.544 HG21 ' NZ ' ' A' ' 96' ' ' LYS . 1.3 t -93.02 176.97 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 108.889 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.419 ' H ' HG12 ' A' ' 147' ' ' VAL . 59.9 mttm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.429 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mmt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.464 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 16.9 mp0 -57.07 114.07 1.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.9 137.43 35.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.49 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 57.3 mttp -152.12 52.93 0.99 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 109.656 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 60.0 Cg_endo -70.51 -155.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.582 2.188 . . . . 0.0 111.869 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -75.36 96.99 3.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.095 -1.003 . . . . 0.0 110.271 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mt -149.5 94.21 3.94 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.37 162.82 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.474 2.116 . . . . 0.0 112.753 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -103.32 -12.41 17.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.511 -0.743 . . . . 0.0 109.363 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.533 ' CG ' ' HZ1' ' A' ' 13' ' ' LYS . 2.6 m-20 -77.55 109.06 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 11.9 mptt -59.62 -0.32 0.17 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.892 . . . . 0.0 109.604 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 10' ' ' ASP . 41.6 m -114.28 36.81 3.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.466 -0.771 . . . . 0.0 110.282 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HZ1' ' CG ' ' A' ' 10' ' ' ASP . 2.1 ttmp? -144.18 143.83 31.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.027 -1.046 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.19 145.12 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 110.098 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.46 11.79 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.87 173.54 34.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.75 119.98 7.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -1.175 . . . . 0.0 109.147 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -97.03 141.5 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -145.09 136.71 25.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 0.0 110.101 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.8 mt -144.37 127.05 8.47 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.9 Cg_endo -75.71 -43.23 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.524 1.483 . . . . 0.0 111.312 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.36 -15.24 0.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.464 -0.772 . . . . 0.0 109.128 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.1 13.6 3.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.46 52.4 4.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.454 -0.779 . . . . 0.0 109.944 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' ' 23' ' ' ALA . 49.8 mm -92.46 146.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.864 0.84 . . . . 0.0 110.214 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -169.83 80.28 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -142.9 158.79 58.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.54 162.27 14.64 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.511 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.52 112.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 5.7 m-85 -73.11 146.48 87.21 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -79.93 97.36 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.571 2.181 . . . . 0.0 111.884 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.19 -174.13 46.49 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.671 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 93.7 Cg_endo -80.55 120.97 4.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.839 2.359 . . . . 0.0 111.431 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -45.5 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.696 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.1 p -103.67 152.11 38.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -68.95 -44.31 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.958 1.772 . . . . 0.0 111.803 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.42 -24.68 67.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.701 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 40' ' ' ASN . 14.3 tt0 -88.59 -59.81 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.651 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -47.29 -15.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 38' ' ' GLN . 87.6 m-20 -58.63 -29.89 66.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 85.7 mtt180 -80.38 -19.7 45.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.9 -141.7 7.55 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.459 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.1 t -98.36 161.47 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.401 -1.058 . . . . 0.0 109.388 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.7 p -158.84 156.97 30.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.072 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -56.06 171.84 0.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -95.46 -2.43 48.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.97 140.41 18.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.024 -1.048 . . . . 0.0 110.62 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -62.56 -22.84 66.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.69 20.85 2.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 0.0 109.486 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.22 145.63 53.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.233 1.016 . . . . 0.0 111.116 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 53' ' ' ASP . 3.3 m -155.33 136.32 13.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' CB ' HH22 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -60.87 -4.91 1.11 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' SER . 92.8 m-20 -93.73 -17.8 22.79 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.745 -0.597 . . . . 0.0 109.677 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 56' ' ' ASN . 42.0 t0 -58.94 109.84 0.91 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.777 -1.202 . . . . 0.0 109.286 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -47.56 -12.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 109.638 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' ASP . 50.0 t-20 -140.28 104.97 4.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.198 -0.939 . . . . 0.0 109.074 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 58' ' ' SER . 4.0 mp -95.07 159.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.494 ' N ' HG22 ' A' ' 57' ' ' ILE . 2.9 p -145.43 123.15 11.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.3 mt -120.23 160.15 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.679 0.752 . . . . 0.0 110.396 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.49 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -134.28 134.28 41.72 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.76 22.37 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -71.66 176.48 4.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.983 . . . . 0.0 109.272 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.16 90.5 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.55 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -89.42 111.42 22.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.908 . . . . 0.0 109.258 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 mm -60.47 -29.19 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.855 . . . . 0.0 110.627 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.44 15.97 4.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.912 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 69' ' ' ASN . 51.5 ttt180 -152.18 77.56 6.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.6 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 30.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 123.128 2.552 . . . . 0.0 112.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 67' ' ' ARG . 17.4 m-80 -150.95 63.46 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.085 -1.009 . . . . 0.0 108.622 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.612 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 3.0 t80 -137.83 -153.76 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.612 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 2.4 mp0 -58.43 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CD2' HD22 ' A' ' 75' ' ' LEU . 3.8 m-30 -94.61 16.61 15.11 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.8 m -49.14 -24.87 1.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.722 -1.236 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.466 ' C ' ' HB1' ' A' ' 23' ' ' ALA . 2.8 m-20 -115.31 -29.04 6.69 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.763 . . . . 0.0 110.006 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 72' ' ' PHE . 6.7 tt -50.81 -20.89 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -76.44 -18.1 58.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.04 31.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.526 0.679 . . . . 0.0 109.338 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.67 123.86 7.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.802 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -102.67 177.57 4.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -0.831 . . . . 0.0 109.143 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -51.06 152.49 2.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.77 -19.72 19.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.5 m -62.97 95.66 0.08 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.339 -1.095 . . . . 0.0 108.579 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.74 165.75 9.95 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.49 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -143.89 121.5 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.948 . . . . 0.0 109.099 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 12.5 m-85 -95.09 110.57 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 88' ' ' VAL . 28.6 t80 -96.15 112.16 23.98 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -96.13 149.85 21.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.295 -0.878 . . . . 0.0 111.034 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' CZ ' ' A' ' 86' ' ' PHE . 74.1 t -155.42 103.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.93 -127.43 31.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -90.29 53.04 2.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -1.146 . . . . 0.0 109.692 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -155.1 146.23 22.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.2 m -151.31 109.94 3.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.523 HH22 ' CB ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -100.83 169.51 8.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.559 -0.713 . . . . 0.0 110.003 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 147.96 41.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 109.586 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 121' ' ' LEU . 3.3 m-85 -134.1 175.36 9.55 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' THR . 59.5 tttp -131.66 106.7 8.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.0 ttm -49.01 98.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 108.876 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -133.65 24.17 4.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.851 . . . . 0.0 109.835 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.8 t -167.06 121.85 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.566 HG22 ' N ' ' A' ' 101' ' ' ARG . 65.8 mt -131.48 167.4 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.415 -0.803 . . . . 0.0 110.203 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.571 ' NH1' ' N ' ' A' ' 103' ' ' VAL . 4.9 ttt-85 -137.45 -91.11 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 141' ' ' ILE . 1.9 p30 44.1 19.56 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.953 0.882 . . . . 0.0 108.935 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.571 ' N ' ' NH1' ' A' ' 101' ' ' ARG . 1.7 p -171.32 129.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.538 ' O ' ' O ' ' A' ' 103' ' ' VAL . 16.8 ttmm 59.5 134.52 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 107' ' ' ASP . 30.3 Cg_endo -62.99 8.3 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.727 0.938 . . . . 0.0 112.321 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 104' ' ' LYS . 3.8 p 43.56 -90.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 0.0 109.849 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' PRO . 16.5 m-20 -118.33 144.82 45.58 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.1 41.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 108.964 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -150.33 55.45 0.47 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 110' ' ' VAL . 5.0 m -66.03 -27.3 40.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.011 -1.288 . . . . 0.0 108.089 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.0 mt -137.8 64.81 1.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.565 ' CG ' HE22 ' A' ' 114' ' ' GLN . 9.8 t0 -96.12 -141.49 0.27 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.034 -1.041 . . . . 0.0 108.692 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.87 19.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.038 -1.039 . . . . 0.0 109.654 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.565 HE22 ' CG ' ' A' ' 112' ' ' ASP . 1.6 pm0 -152.08 19.97 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.379 -0.826 . . . . 0.0 109.841 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 117' ' ' LYS . 18.6 mmtp -43.05 127.77 4.27 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.378 -0.826 . . . . 0.0 109.61 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.47 58.75 0.18 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 115' ' ' LYS . 25.5 mtpp -143.15 -143.74 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.235 -1.156 . . . . 0.0 108.886 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 120' ' ' GLN . 2.3 m-20 -118.42 168.95 10.17 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.184 -0.948 . . . . 0.0 108.714 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' ASP . 19.1 ttpp -47.32 96.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.876 -1.14 . . . . 0.0 108.788 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.1 pm0 -95.89 174.54 6.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.844 0.83 . . . . 0.0 110.777 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 95' ' ' TYR . 94.8 mt -129.08 119.41 24.14 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -95.26 93.51 7.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 0.0 108.949 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.684 HD22 ' N ' ' A' ' 123' ' ' LEU . 3.1 mm? -76.45 148.34 37.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 16.9 mt -142.32 140.68 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -97.18 164.84 12.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.232 -0.917 . . . . 0.0 108.691 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.431 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 22.6 m -148.97 140.76 23.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.009 -1.057 . . . . 0.0 109.934 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 177.81 142.93 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 2.6 m-20 55.99 63.41 2.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.743 . . . . 0.0 109.101 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.34 125.4 24.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.104 -0.998 . . . . 0.0 109.393 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -86.7 124.03 32.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.084 -1.01 . . . . 0.0 109.562 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.17 4.22 46.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -78.44 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.164 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.0 p -95.6 -3.21 46.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.335 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.84 46.33 53.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 t -146.78 157.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -1.158 . . . . 0.0 109.374 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.9 m95 -63.86 111.63 2.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.165 -0.96 . . . . 0.0 108.596 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' TRP . 74.6 tt0 -32.49 -72.39 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.872 0.368 . . . . 0.0 111.309 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -134.03 146.52 50.45 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.269 -0.895 . . . . 0.0 109.853 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.755 ' HE ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -167.38 -162.86 0.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.121 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -145.88 162.18 38.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.006 -1.058 . . . . 0.0 108.992 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 3.5 mt -133.78 138.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.42 -0.8 . . . . 0.0 109.843 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.7 m-85 -128.79 165.76 20.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 99' ' ' SER . 12.8 t -146.38 114.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.946 -1.096 . . . . 0.0 110.423 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.23 169.38 9.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 145' ' ' THR . 14.1 t -132.02 127.76 36.9 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.486 -0.759 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 3.2 tm-20 -59.0 131.92 52.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.13 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t -93.68 176.32 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.239 -0.913 . . . . 0.0 109.075 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.425 ' H ' HG12 ' A' ' 147' ' ' VAL . 66.3 mttm . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.543 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.577 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.2 mpp? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -72.15 158.84 35.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.34 42.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -152.04 60.06 3.39 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.263 -0.898 . . . . 0.0 109.023 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.14 -155.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.533 2.155 . . . . 0.0 111.355 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -83.44 71.93 10.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.92 -1.112 . . . . 0.0 109.803 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.6 mt -148.52 108.98 3.59 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.8 179.54 6.19 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.786 1.657 . . . . 0.0 112.313 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -103.77 20.8 17.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.469 -0.77 . . . . 0.0 109.578 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.7 m-20 -77.98 101.94 7.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.983 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 3.5 mptp? -62.29 7.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.383 -0.823 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 10' ' ' ASP . 75.6 p -141.37 41.85 1.76 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -147.66 142.0 26.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.023 -1.048 . . . . 0.0 109.827 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 58.3 t -61.35 122.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.595 -0.691 . . . . 0.0 110.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.81 -25.3 15.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -172.95 -161.64 23.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.542 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 13.0 m-85 -147.26 126.97 13.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.132 -1.217 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -96.04 138.44 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 178.081 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' H ' HD13 ' A' ' 18' ' ' ILE . 22.4 mt-10 -145.23 141.29 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.652 -1.28 . . . . 0.0 111.836 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.0 mt -148.26 127.26 6.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.431 ' C ' ' N ' ' A' ' 23' ' ' ALA . 73.8 Cg_endo -75.8 -43.65 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.567 1.511 . . . . 0.0 111.379 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.51 -11.33 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -0.857 . . . . 0.0 109.364 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.36 11.4 3.82 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.405 -0.809 . . . . 0.0 109.687 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ALA . 3.7 p30 42.26 36.31 0.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.457 -0.777 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.18 140.71 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 109.155 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -166.03 86.47 0.35 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -139.79 157.93 68.8 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.5 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -80.96 162.01 20.82 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.115 2.544 . . . . 0.0 113.108 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.76 134.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 5.3 m-85 -94.48 151.1 39.06 Favored Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 120.869 -1.144 . . . . 0.0 110.56 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.17 82.45 2.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.74 2.293 . . . . 0.0 111.442 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 178.84 39.75 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.128 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 35' ' ' THR . 87.3 Cg_endo -78.75 109.53 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.247 2.631 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.09 89.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 111.694 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' PRO . 10.3 p -121.41 152.26 57.56 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -40.13 65.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.36 1.374 . . . . 0.0 111.969 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -66.37 -34.66 78.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.751 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.575 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -88.64 -26.33 21.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.49 -1.381 . . . . 0.0 110.769 -178.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.94 -10.88 59.95 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.014 -1.054 . . . . 0.0 108.871 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -56.88 -29.3 62.82 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -79.04 -20.06 49.85 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.238 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.33 -135.23 4.75 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.9 t -84.79 169.18 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.567 -0.961 . . . . 0.0 110.235 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.575 ' CB ' HE22 ' A' ' 38' ' ' GLN . 1.6 t -167.78 152.97 6.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.0 109.096 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.63 155.4 26.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.817 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -72.49 -2.97 21.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -151.86 147.63 26.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 110.184 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.73 -39.11 93.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.727 -0.608 . . . . 0.0 111.54 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -88.01 20.75 2.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.119 . . . . 0.0 111.327 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.09 137.06 58.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.833 -1.167 . . . . 0.0 109.49 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 m -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 109.425 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 52' ' ' LEU . 7.5 mp -61.15 -13.92 21.15 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.094 -1.004 . . . . 0.0 108.525 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.55 -27.41 51.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.546 -0.721 . . . . 0.0 109.623 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 56' ' ' ASN . 3.4 m-20 -61.78 112.43 2.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.155 -0.965 . . . . 0.0 109.862 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -65.9 6.63 0.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.083 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 54' ' ' ASP . 46.6 t-20 -147.04 95.14 2.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.5 115.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.505 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -108.71 113.69 26.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.95 155.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.56 115.32 23.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.11 145.22 16.07 Favored Glycine 0 N--CA 1.503 3.153 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' A' ' 72' ' ' PHE . 9.2 m-70 -72.88 175.95 6.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.502 -0.999 . . . . 0.0 109.761 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.48 79.73 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -88.01 129.6 35.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 109.885 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mt -64.33 -34.79 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.531 -0.73 . . . . 0.0 109.935 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.04 20.28 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 109.45 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -149.98 68.2 8.75 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.099 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 66.7 Cg_exo -52.27 15.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.187 0 C-N-CA 123.481 2.787 . . . . 0.0 113.915 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.2 p30 -151.29 63.75 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.894 -1.129 . . . . 0.0 108.217 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 33.5 t80 -148.02 99.42 3.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.7 mt-30 61.01 -110.89 0.45 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 125' ' ' THR . 35.6 t80 -91.14 0.16 57.59 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.111 -0.993 . . . . 0.0 111.55 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.9 m -49.17 -43.65 42.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.535 -1.353 . . . . 0.0 110.626 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ALA . 3.8 m120 -94.93 -21.51 18.59 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.027 -1.045 . . . . 0.0 112.028 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.4 tm? -51.07 -32.28 21.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.562 -1.336 . . . . 0.0 108.279 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 1.11 2.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -105.96 -27.36 11.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.2 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.845 . . . . 0.0 109.543 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 175.23 5.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 110.02 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -49.37 135.68 17.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.1 -17.79 55.87 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 m -62.14 107.98 0.98 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.011 -1.288 . . . . 0.0 107.748 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mtp -70.23 176.27 4.02 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.287 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.69 154.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.22 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -145.65 104.88 3.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.06 111.8 23.56 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -99.21 148.23 24.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 0.0 110.453 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.1 p -167.09 107.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.86 -146.37 48.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -83.54 43.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 109.62 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.42 150.1 37.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.197 -0.94 . . . . 0.0 109.246 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.9 m -150.53 118.85 6.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -0.895 . . . . 0.0 109.704 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -92.7 164.16 13.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.414 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -145.61 118.89 8.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 109.587 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 16.7 m-85 -112.36 -171.49 1.86 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -143.61 101.67 3.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.16 -0.963 . . . . 0.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.6 mtp -48.94 116.58 1.71 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.326 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -161.54 29.9 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.089 . . . . 0.0 110.561 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 t -163.5 86.31 0.51 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.958 -1.089 . . . . 0.0 108.151 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 100' ' ' ILE . 2.1 mp -82.64 158.3 3.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.538 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.1 OUTLIER -142.12 -15.72 0.77 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 141' ' ' ILE . 3.0 p30 -47.69 -30.19 3.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 109.372 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 11.9 p -82.2 -32.87 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.427 -0.796 . . . . 0.0 109.452 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -130.32 72.33 81.94 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 106' ' ' THR . 94.6 Cg_endo -79.41 -158.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.605 2.203 . . . . 0.0 112.147 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 105' ' ' PRO . 6.1 t 36.34 47.56 0.5 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.375 0.607 . . . . 0.0 110.624 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.56 -133.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.406 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.38 27.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.327 -0.858 . . . . 0.0 109.706 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 159.06 89.26 0.07 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.41 -31.2 51.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 mt -139.65 54.08 1.69 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.51 ' OD2' ' NE2' ' A' ' 114' ' ' GLN . 1.4 m-20 -78.52 115.92 18.55 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 5.3 pt-20 -83.51 16.87 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.51 ' NE2' ' OD2' ' A' ' 112' ' ' ASP . 2.1 pp0? -150.0 28.69 0.75 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 117' ' ' LYS . 84.9 mttt -40.89 140.65 0.7 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.686 -0.634 . . . . 0.0 109.845 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.25 8.25 0.7 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 115' ' ' LYS . 63.9 mmtt -96.64 -145.91 0.29 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.147 -1.208 . . . . 0.0 109.685 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 13.1 t70 -118.86 169.71 9.63 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 60.6 mttm -38.05 135.5 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.73 161.8 39.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.892 -1.13 . . . . 0.0 111.104 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.51 103.8 13.39 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.2 m -91.48 152.95 20.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.84 146.8 36.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.7 mt -136.76 142.02 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.523 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.3 p -91.84 169.67 10.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.866 -1.146 . . . . 0.0 108.815 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 m -147.8 106.41 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.08 -1.012 . . . . 0.0 109.803 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 128' ' ' ASP . 10.5 t70 -157.35 144.9 18.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.012 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 127' ' ' ASP . 70.6 m-20 53.69 64.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.476 -0.765 . . . . 0.0 109.135 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -65.27 124.11 21.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 110.056 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -86.76 127.52 34.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.937 -1.102 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.8 pm0 -94.6 12.19 28.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.454 -0.779 . . . . 0.0 109.649 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -85.61 -57.97 2.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 109.073 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.0 p -95.72 -9.95 30.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.834 . . . . 0.0 109.136 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.83 46.86 9.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -147.05 153.55 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -1.094 . . . . 0.0 109.551 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.426 ' O ' ' C ' ' A' ' 137' ' ' GLU . 72.5 m95 -61.44 112.29 2.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 136' ' ' TRP . 42.5 tt0 -38.68 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.247 0.546 . . . . 0.0 110.326 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -91.38 135.96 33.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.106 -0.996 . . . . 0.0 108.61 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -157.04 122.26 4.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.946 -1.096 . . . . 0.0 110.334 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -100.79 164.48 11.83 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 102' ' ' ASP . 29.3 pt -148.35 151.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.832 -1.168 . . . . 0.0 110.481 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.28 172.2 14.23 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.65 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 43.0 t -147.32 129.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.856 -1.153 . . . . 0.0 110.961 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.19 -176.28 3.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.0 t -148.26 136.71 21.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.745 -1.222 . . . . 0.0 109.426 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.24 150.18 18.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.405 -0.809 . . . . 0.0 109.537 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.7 t -90.48 -144.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.343 -0.848 . . . . 0.0 109.131 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.502 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.534 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 ttm . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.302 0.572 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -75.46 141.35 43.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.45 -168.51 1.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.855 . . . . 0.0 109.371 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.0 mptt -82.09 156.38 69.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.006 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' LYS . 90.0 Cg_exo -40.87 174.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.615 2.21 . . . . 0.0 112.835 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -67.24 152.06 46.4 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.118 -0.989 . . . . 0.0 109.386 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 mt -83.75 127.57 67.05 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 108.989 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -40.85 137.49 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.56 1.506 . . . . 0.0 112.248 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -82.46 -20.15 37.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.244 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' SER . 67.2 m-20 -77.87 108.89 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -62.68 -1.09 0.74 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' ASP . 22.6 p -120.49 47.33 1.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.667 -0.645 . . . . 0.0 109.517 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -144.8 136.04 25.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.3 -0.875 . . . . 0.0 109.274 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.47 114.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.767 . . . . 0.0 110.995 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.96 -17.33 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.26 -173.0 35.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.99 125.0 9.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.101 -1.235 . . . . 0.0 109.211 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -97.29 146.88 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -150.6 131.76 14.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.045 . . . . 0.0 110.476 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 HD21 ' A' ' 75' ' ' LEU . 26.6 mt -144.29 126.47 8.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.45 -41.54 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.648 1.565 . . . . 0.0 111.572 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -51.38 -16.19 0.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.0 109.469 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -136.13 15.32 3.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.2 p-10 44.23 48.51 7.81 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.404 -0.81 . . . . 0.0 109.875 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 23' ' ' ALA . 46.5 mm -90.31 138.64 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.208 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.08 84.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -144.67 151.99 51.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.039 -1.038 . . . . 0.0 110.5 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.05 161.71 18.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.575 2.183 . . . . 0.0 112.155 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.46 102.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.69 171.49 12.17 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.761 -1.212 . . . . 0.0 109.109 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -86.39 137.11 4.94 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.592 2.194 . . . . 0.0 112.301 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.66 171.62 20.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' ' N ' ' A' ' 35' ' ' THR . 92.2 Cg_endo -78.01 117.88 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.587 2.192 . . . . 0.0 110.767 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.04 88.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.698 -0.626 . . . . 0.0 110.338 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -114.6 153.89 46.71 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.05 -41.9 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.944 1.763 . . . . 0.0 112.112 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.04 -23.46 67.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.906 -1.121 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -90.82 -66.82 0.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.013 . . . . 0.0 109.17 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -45.27 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -64.2 -24.45 67.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mtt-85 -87.34 -10.63 51.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.67 -129.47 2.59 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.5 t -112.67 156.63 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.613 -0.933 . . . . 0.0 109.907 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -150.68 154.84 38.18 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -58.56 169.96 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.593 -1.317 . . . . 0.0 110.068 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.64 -0.92 49.4 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -154.95 150.67 27.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.59 0.71 . . . . 0.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -63.9 -40.28 96.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 111.631 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.63 12.76 11.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.874 -1.141 . . . . 0.0 111.595 -177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -62.67 101.9 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.786 -1.196 . . . . 0.0 109.519 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 53' ' ' ASP . 8.6 p -93.61 141.85 28.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.154 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -54.85 -9.91 0.41 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' SER . 7.8 t70 -95.16 -9.91 32.08 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.678 -0.639 . . . . 0.0 109.817 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.7 t0 -56.35 113.26 1.51 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.832 -1.167 . . . . 0.0 109.001 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 54' ' ' ASP . 8.8 tt0 -41.58 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.693 -0.629 . . . . 0.0 110.186 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.575 ' OD1' ' NE2' ' A' ' 114' ' ' GLN . 15.4 p-10 -137.34 115.21 11.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.27 -0.894 . . . . 0.0 108.772 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -97.72 152.26 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 46' ' ' ALA . 9.3 m -140.66 105.42 4.93 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.6 mt -100.28 161.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.773 0.797 . . . . 0.0 110.725 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.535 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.05 129.84 26.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.94 160.14 25.24 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.54 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' PHE . 19.3 m-70 -77.25 179.11 6.58 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.585 -0.95 . . . . 0.0 109.791 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.426 ' OG1' ' NZ ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -153.49 91.75 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 108.734 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' N ' ' OG1' ' A' ' 73' ' ' THR . 7.3 m-85 -86.51 104.55 16.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.132 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.83 -32.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.24 17.05 2.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 0.0 109.059 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.527 ' C ' ' H ' ' A' ' 69' ' ' ASN . 6.3 tpp180 -150.46 72.51 9.09 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.25 25.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 123.297 2.665 . . . . 0.0 113.522 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 67' ' ' ARG . 18.3 p30 -149.78 39.21 0.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.829 -1.17 . . . . 0.0 109.093 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.465 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 5.9 t80 -105.74 -153.57 0.49 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.465 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 57.3 mt-30 -64.79 -89.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.657 -0.652 . . . . 0.0 111.776 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -93.97 22.54 5.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.0 110.191 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 92.7 m -72.8 -24.88 60.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.306 -1.496 . . . . 0.0 109.951 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -119.37 -13.93 9.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.136 -0.977 . . . . 0.0 111.291 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.436 HD21 HD12 ' A' ' 20' ' ' ILE . 7.1 mt -51.74 -19.9 1.87 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.62 -1.3 . . . . 0.0 108.79 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' NZ ' ' OG1' ' A' ' 63' ' ' THR . 12.1 pttm -88.55 -8.4 54.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 108.563 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -85.69 -21.78 28.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.4 -174.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 109.362 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' GLY . 45.9 mtmt -150.23 155.23 39.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 11.0 ttmm -51.4 89.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 148.19 -15.94 1.32 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.6 m -62.59 114.22 3.44 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.0 ptm -68.9 -179.59 1.52 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.48 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.06 153.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.0 109.593 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -132.74 103.28 6.03 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.36 111.7 23.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -90.65 150.81 21.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.6 t -150.01 151.3 12.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.45 -4.89 0.42 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 88' ' ' VAL . 55.0 m-20 -102.41 -45.96 4.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.311 -1.111 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -171.55 -156.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.985 -1.072 . . . . 0.0 109.106 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.4 m -132.88 120.3 21.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.345 -0.847 . . . . 0.0 109.941 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.528 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -92.13 171.9 8.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.472 -0.768 . . . . 0.0 109.031 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 8.5 mtmp? -144.84 152.32 40.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 11.4 m-85 -139.34 178.57 7.1 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -142.28 105.82 4.66 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.147 -0.971 . . . . 0.0 109.773 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 55.0 mtt -49.33 125.1 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.6 t -150.78 19.45 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 143' ' ' VAL . 3.4 p -174.69 122.87 0.26 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 pt -143.86 147.98 19.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.286 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.0 OUTLIER -98.68 -77.25 0.52 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.0 109.169 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 102' ' ' ASP . 2.7 p30 42.81 33.7 0.51 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.579 0.704 . . . . 0.0 109.375 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 104' ' ' LYS . 24.2 t -150.01 -76.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' N ' HG12 ' A' ' 103' ' ' VAL . 53.0 tttp -117.45 82.26 15.07 Favored Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 107' ' ' ASP . 97.8 Cg_exo -43.49 -39.26 9.36 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.309 2.006 . . . . 0.0 112.658 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.7 p -68.48 46.17 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.32 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 105' ' ' PRO . 47.7 t0 -85.03 -83.02 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.253 -0.904 . . . . 0.0 109.729 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 m -112.84 34.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.406 -0.809 . . . . 0.0 109.654 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.16 120.2 0.07 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.45 -28.41 42.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.271 -1.135 . . . . 0.0 108.853 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.7 mt -138.16 80.82 1.82 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 20.1 t70 -119.47 -154.9 0.59 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.488 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 27.2 tt0 -50.43 175.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.981 -1.074 . . . . 0.0 108.268 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.575 ' NE2' ' OD1' ' A' ' 56' ' ' ASN . 3.5 mm100 -88.44 68.29 8.78 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 117' ' ' LYS . 8.2 mmtm 1.77 110.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.718 0 CA-C-O 121.192 0.52 . . . . 0.0 111.584 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -51.71 80.34 0.01 OUTLIER Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 115' ' ' LYS . 30.2 ttmt -149.81 -133.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.298 -1.119 . . . . 0.0 108.897 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' GLN . 11.2 m-20 -119.45 169.63 9.86 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HZ2' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -37.84 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.907 0.86 . . . . 0.0 109.323 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -95.47 147.15 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.411 0.624 . . . . 0.0 110.123 -178.213 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -102.74 155.16 18.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.516 -0.74 . . . . 0.0 109.407 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -139.64 87.85 2.2 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 141' ' ' ILE . 9.6 mt -74.04 145.31 44.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 0.0 110.75 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.481 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 50.0 mt -139.69 148.31 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.468 -0.77 . . . . 0.0 109.085 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.464 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -96.59 170.16 9.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -149.81 95.56 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -155.39 141.94 18.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 109.485 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.6 55.66 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 0.0 109.073 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -64.13 123.18 18.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 109.833 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -84.4 122.83 29.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.0 109.302 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -87.53 4.74 42.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -80.17 -55.85 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.9 p -95.7 -12.05 26.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 45.55 10.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.7 t -146.96 153.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.259 -1.142 . . . . 0.0 109.61 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.538 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 66.0 m95 -61.73 110.69 1.59 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.184 -0.948 . . . . 0.0 108.591 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 136' ' ' TRP . 2.8 tm-20 -42.37 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.487 -0.758 . . . . 0.0 109.859 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 144.13 27.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 108.248 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.5 OUTLIER -161.05 94.33 1.01 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.0 110.548 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -75.1 163.84 27.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.457 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 4.2 mt -144.28 155.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.058 -1.026 . . . . 0.0 110.791 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 38.5 m-85 -140.74 165.01 28.66 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 99' ' ' SER . 57.6 t -147.65 148.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.839 -1.163 . . . . 0.0 110.385 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.73 179.24 6.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 t -143.46 142.71 31.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.09 -1.006 . . . . 0.0 109.979 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -56.82 152.32 12.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.608 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.4 m -92.72 168.36 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.827 . . . . 0.0 109.297 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.128 -0.983 . . . . 0.0 109.315 179.906 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.553 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -171.39 134.88 0.9 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.131 -0.981 . . . . 0.0 109.636 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.34 60.36 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.137 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -149.48 64.76 7.41 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.325 -0.86 . . . . 0.0 109.213 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.25 -151.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.808 2.338 . . . . 0.0 111.949 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -67.25 105.15 1.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.007 -1.058 . . . . 0.0 110.589 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mt -150.67 95.09 3.52 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 114.36 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.388 2.058 . . . . 0.0 112.916 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -60.03 -11.09 5.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.24 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 12' ' ' SER . 34.8 m-20 -77.02 100.53 5.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -59.38 0.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.9 m -122.85 39.49 3.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -142.71 143.58 32.34 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 16' ' ' GLY . 62.8 t -58.23 155.28 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.37 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -141.7 6.62 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 162.79 -172.8 38.92 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 81.1 m-85 -146.72 125.52 12.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -1.071 . . . . 0.0 109.706 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.586 HD11 ' CG1' ' A' ' 84' ' ' VAL . 9.0 tp -95.08 144.25 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -146.98 129.13 15.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.879 -1.138 . . . . 0.0 110.569 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mt -144.76 126.98 8.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.3 Cg_endo -76.9 -42.15 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.673 1.582 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -52.75 -12.96 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.05 10.74 3.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 40.95 39.86 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.475 0.655 . . . . 0.0 110.121 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.415 HD11 ' H ' ' A' ' 75' ' ' LEU . 7.0 mt -94.7 146.23 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.944 0.878 . . . . 0.0 110.024 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -166.02 83.16 0.3 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -139.96 159.53 64.15 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.388 -0.82 . . . . 0.0 110.645 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.47 161.5 22.35 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.946 2.431 . . . . 0.0 112.579 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.5 113.21 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.32 171.29 12.53 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.756 -1.215 . . . . 0.0 109.181 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -95.32 136.99 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.546 2.164 . . . . 0.0 112.018 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.72 173.53 22.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 35' ' ' THR . 57.0 Cg_endo -71.88 115.43 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.731 2.287 . . . . 0.0 110.785 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.49 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.59 -0.694 . . . . 0.0 110.741 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -109.0 152.52 42.49 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.52 -43.22 18.15 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.072 1.848 . . . . 0.0 112.153 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.07 -27.41 69.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.027 -1.045 . . . . 0.0 109.527 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 40' ' ' ASN . 2.4 tm0? -84.14 -63.72 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.207 -0.933 . . . . 0.0 109.54 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.6 mt -47.5 -13.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.472 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 38' ' ' GLN . 78.4 m-20 -59.02 -28.13 66.12 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' C ' ' OH ' ' A' ' 30' ' ' TYR . 26.6 mtt-85 -79.84 -17.72 52.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.17 -101.61 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.59 -1.29 . . . . 0.0 111.057 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 60' ' ' ALA . 4.8 t -135.5 155.14 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -1.073 . . . . 0.0 110.217 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 t -151.22 152.04 32.71 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.55 171.32 0.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.546 -1.346 . . . . 0.0 109.346 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -80.52 -10.38 59.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -149.71 154.68 38.93 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.778 0.799 . . . . 0.0 109.96 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.8 pt-20 -64.48 -43.09 95.25 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 31.6 m120 -84.68 10.3 11.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.597 -1.314 . . . . 0.0 111.037 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 58' ' ' SER . 4.5 mm-40 -64.75 96.74 0.19 Allowed 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 110.354 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 p -93.69 175.27 6.8 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -79.92 -10.64 59.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -102.19 -4.12 26.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.694 . . . . 0.0 109.975 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 56' ' ' ASN . 10.3 t70 -58.72 125.56 23.99 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.848 -1.158 . . . . 0.0 109.337 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 6.0 tp-100 -39.28 -24.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.73 -0.606 . . . . 0.0 109.956 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 54' ' ' ASP . 52.4 t-20 -151.96 113.87 4.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 58' ' ' SER . 4.1 mp -96.11 156.04 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.513 ' N ' ' OE2' ' A' ' 50' ' ' GLU . 34.0 t -143.21 123.41 13.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 60' ' ' ALA . 73.4 mt -110.9 153.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.547 -0.721 . . . . 0.0 110.567 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -133.9 132.56 40.43 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.28 157.28 25.5 Favored Glycine 0 N--CA 1.503 3.13 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.995 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -70.61 176.38 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.73 -0.865 . . . . 0.0 109.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -159.34 93.83 1.15 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.13 105.51 17.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.166 -0.959 . . . . 0.0 108.915 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 65' ' ' ILE . 18.9 mt -59.74 -29.09 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 8.2 t70 -84.55 11.22 9.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.399 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' ASN . 24.5 ttm180 -151.62 79.75 6.46 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.277 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.25 24.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 123.702 2.935 . . . . 0.0 114.357 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' ARG . 40.6 m-80 -151.09 62.77 0.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 108.597 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.52 ' CD2' ' OE1' ' A' ' 71' ' ' GLN . 15.3 t80 -146.73 102.93 3.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.165 -0.959 . . . . 0.0 110.272 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 15.2 mp0 55.28 -113.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 111.796 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.4 m-85 -92.42 7.73 41.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.085 -1.01 . . . . 0.0 110.421 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.8 m -47.16 -33.65 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.74 -1.225 . . . . 0.0 109.698 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 8.1 m120 -100.28 -28.95 12.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -0.773 . . . . 0.0 110.472 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' ALA . 6.9 tp -54.11 -31.94 53.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.616 -1.303 . . . . 0.0 108.792 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -65.99 -3.28 5.02 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -102.33 -28.5 12.21 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -44.75 168.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 110.017 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.78 160.76 39.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.372 -0.83 . . . . 0.0 108.94 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -49.99 137.08 17.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.03 -1.044 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 -23.94 32.28 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 m -62.68 115.9 4.71 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.211 -1.17 . . . . 0.0 108.057 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.83 176.7 4.73 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.971 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.586 ' CG1' HD11 ' A' ' 18' ' ' ILE . 13.9 t -142.81 109.27 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.405 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -93.67 102.84 15.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -96.99 112.17 24.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -93.89 154.32 17.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.036 -1.04 . . . . 0.0 110.74 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.6 m -151.15 160.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.36 46.38 0.26 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 22.7 p30 -160.33 -36.78 0.05 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 109.783 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.0 tt0 -174.24 -157.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 108.925 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 92' ' ' THR . 7.0 t -141.54 129.76 22.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -92.12 162.37 14.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.813 . . . . 0.0 109.212 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -144.36 93.98 2.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.086 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -93.23 179.34 5.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.076 -1.015 . . . . 0.0 108.8 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 98' ' ' THR . 36.1 ttpt -144.96 114.82 7.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.3 mtt -48.96 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 109.113 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.6 m -126.03 29.65 5.83 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.7 . . . . 0.0 109.538 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.3 86.98 0.08 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.15 -0.969 . . . . 0.0 108.499 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.4 mm -83.04 147.43 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -145.34 -15.81 0.5 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.008 -1.057 . . . . 0.0 109.883 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 103' ' ' VAL . 29.2 p-10 -43.5 -51.41 6.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.493 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 79.6 t -82.52 130.0 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm 46.9 68.87 3.07 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.858 . . . . 0.0 109.439 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.7 -101.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.449 2.099 . . . . 0.0 112.034 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.7 p 46.19 50.58 11.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.193 -0.942 . . . . 0.0 109.79 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.43 -163.33 1.04 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.213 -0.929 . . . . 0.0 109.332 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.2 m -78.29 37.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.139 -0.976 . . . . 0.0 109.44 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.99 136.75 5.88 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.6 -43.98 83.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.266 -1.138 . . . . 0.0 108.617 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.5 mt -100.37 62.25 1.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.665 . . . . 0.0 109.279 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.3 t70 -172.29 21.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.479 -0.763 . . . . 0.0 109.175 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -109.04 -3.63 17.27 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 116' ' ' GLY . 4.9 pp0? -98.7 8.45 44.92 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -47.22 -18.33 0.09 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.285 0.564 . . . . 0.0 109.533 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . -171.28 26.2 0.1 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.76 -151.13 0.32 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.286 -1.126 . . . . 0.0 108.961 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.529 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 16.7 t70 -115.75 163.18 16.21 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 118' ' ' ASP . 46.4 mttp -43.35 129.81 4.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.538 ' N ' ' OE1' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -148.42 167.43 25.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.0 -1.062 . . . . 0.0 110.117 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.7 tp -118.8 122.2 41.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.651 -0.656 . . . . 0.0 110.35 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -100.63 94.13 5.94 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 123' ' ' LEU . 5.4 mp -73.78 147.4 43.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.923 . . . . 0.0 110.244 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.507 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 82.0 mt -138.13 148.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 18.1 p -102.18 165.23 11.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 108.898 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.9 m -147.51 87.44 1.65 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.976 -1.077 . . . . 0.0 109.273 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 7.1 p30 -130.21 146.34 51.82 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.22 -0.925 . . . . 0.0 110.089 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 54.8 72.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.657 -0.652 . . . . 0.0 109.493 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -67.56 119.96 13.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.181 -0.949 . . . . 0.0 109.683 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -88.88 123.11 32.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.779 -1.201 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.3 pm0 -93.13 -13.01 29.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.847 . . . . 0.0 109.019 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -62.93 -49.72 73.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 46.7 p -97.35 -13.34 21.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 108.775 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 38.19 27.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.15 162.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.444 ' O ' ' C ' ' A' ' 137' ' ' GLU . 78.9 m95 -64.73 113.21 3.62 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.6 tp10 -36.99 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.947 -0.471 . . . . 0.0 110.418 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -111.12 137.72 48.44 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.49 113.85 5.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 109.753 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.48 ' N ' ' OG1' ' A' ' 125' ' ' THR . 44.5 mttm -75.45 166.84 22.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.107 -0.996 . . . . 0.0 108.517 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 102' ' ' ASP . 10.4 pt -149.6 134.51 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.937 -1.102 . . . . 0.0 110.331 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -130.06 169.85 14.76 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 t -145.85 143.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.818 -1.176 . . . . 0.0 110.667 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -132.8 126.24 31.89 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.4 t -94.49 145.65 24.65 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -58.41 147.12 32.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 147' ' ' VAL . 5.2 m -90.03 147.3 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.544 -179.943 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.579 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -64.63 152.23 42.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.38 179.31 8.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.325 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' PRO . 20.5 pttm -50.18 127.55 22.18 Favored Pre-proline 0 N--CA 1.486 1.358 0 O-C-N 121.214 -0.929 . . . . 0.0 109.305 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LYS . 90.7 Cg_exo -42.07 176.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.382 2.055 . . . . 0.0 113.121 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -71.46 92.98 1.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.473 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.3 mt -86.3 119.3 71.48 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 108.755 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -42.57 156.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.475 1.45 . . . . 0.0 112.179 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -103.38 -23.71 13.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 21.5 t0 -76.96 108.13 9.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.668 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -58.28 -3.61 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.267 -0.895 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 42.3 m -115.27 43.43 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.487 -0.758 . . . . 0.0 109.349 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -147.6 145.86 29.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 16' ' ' GLY . 86.5 t -59.72 149.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.857 0.837 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.39 12.46 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 160.17 177.07 32.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.25 122.5 9.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.27 . . . . 0.0 109.055 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.7 tt -97.57 151.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.48 132.25 15.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mt -142.29 125.71 9.57 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.451 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.2 Cg_endo -76.1 -43.07 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.692 1.595 . . . . 0.0 111.511 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -51.05 -14.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.89 . . . . 0.0 108.867 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.451 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.4 12.52 3.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.661 -0.649 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 p-10 43.02 51.86 5.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.42 -0.8 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.6 mm -95.69 147.25 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.045 0.926 . . . . 0.0 111.04 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -168.75 80.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 10.0 mt-10 -139.3 158.57 68.73 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.299 -0.876 . . . . 0.0 110.944 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.25 160.44 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.986 2.457 . . . . 0.0 112.91 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 t -132.46 101.7 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.65 171.72 11.19 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.918 -1.114 . . . . 0.0 109.76 -178.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -86.59 116.02 1.34 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.142 2.561 . . . . 0.0 112.945 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.23 160.99 22.78 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.736 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 90.3 Cg_endo -76.59 126.77 9.17 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.702 2.268 . . . . 0.0 111.053 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -41.58 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.753 -0.592 . . . . 0.0 110.77 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.7 p -127.17 149.61 70.02 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.21 -43.04 50.65 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.925 1.75 . . . . 0.0 112.185 -178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.22 -20.87 65.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.106 -0.996 . . . . 0.0 109.788 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.6 OUTLIER -89.26 -68.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.16 -0.962 . . . . 0.0 109.378 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.2 mt -47.34 -11.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.979 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 38' ' ' GLN . 73.4 m-20 -56.84 -28.88 62.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 19.9 mmt180 -81.12 -18.31 46.9 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.83 -124.51 1.92 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 2.3 t -97.6 160.66 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.288 -1.125 . . . . 0.0 109.825 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 p -165.22 153.62 11.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 108.778 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -53.54 167.19 0.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.954 -1.091 . . . . 0.0 108.802 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -100.4 11.14 40.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.394 -0.816 . . . . 0.0 109.055 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -156.16 134.3 11.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.988 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.61 -25.63 68.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -87.07 17.29 4.29 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.926 -1.109 . . . . 0.0 110.03 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 51' ' ' SER . 1.7 pp20? -62.43 165.63 5.94 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.732 0.777 . . . . 0.0 110.347 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.533 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 2.1 p -150.77 174.12 13.42 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.12 2.74 33.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.9 -1.125 . . . . 0.0 108.368 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -154.86 25.02 0.44 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.473 -0.767 . . . . 0.0 110.126 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OG ' ' A' ' 51' ' ' SER . 24.2 t70 -56.7 124.04 17.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.742 -1.224 . . . . 0.0 108.571 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' CD ' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -43.77 -22.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 41.9 t-20 -140.18 97.1 3.16 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 58' ' ' SER . 96.9 mt -94.41 154.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.291 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 57' ' ' ILE . 23.1 p -142.64 120.8 12.19 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 60' ' ' ALA . 79.5 mt -114.59 164.88 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.846 0.831 . . . . 0.0 110.753 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.588 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -141.12 139.87 34.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.03 145.08 13.45 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.587 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -73.16 -172.19 1.05 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.99 . . . . 0.0 109.42 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.23 88.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.848 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -89.1 121.82 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 0.0 108.734 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 65' ' ' ILE . 7.4 mt -61.65 -32.34 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.449 -0.782 . . . . 0.0 110.67 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.69 17.45 2.27 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.716 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.563 ' C ' ' H ' ' A' ' 69' ' ' ASN . 53.5 mtp180 -150.11 73.26 9.34 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.56 -0.712 . . . . 0.0 109.393 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.57 12.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.285 2.657 . . . . 0.0 113.62 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.563 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.6 p30 -147.15 57.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.916 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -141.87 112.66 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.364 -0.835 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.533 ' N ' ' OE2' ' A' ' 27' ' ' GLU . 36.8 mt-30 51.85 -127.78 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.469 -0.77 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.419 ' CE2' HD13 ' A' ' 75' ' ' LEU . 5.8 m-30 -93.97 42.5 1.1 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.834 -1.166 . . . . 0.0 110.404 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.9 m -68.79 -16.48 63.81 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.445 -1.409 . . . . 0.0 109.091 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 14.8 m-20 -125.82 -25.54 3.62 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.582 -0.699 . . . . 0.0 109.99 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -53.92 -25.29 19.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 0.0 108.591 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -74.35 -6.06 45.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -94.16 -28.61 15.57 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.377 0.608 . . . . 0.0 109.409 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.86 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.486 -0.759 . . . . 0.0 109.801 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' C ' ' SD ' ' A' ' 97' ' ' MET . 14.6 ptpt -155.37 179.36 9.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.95 . . . . 0.0 109.369 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.606 ' HZ1' ' H ' ' A' ' 100' ' ' ILE . 58.1 mmtt -47.4 138.32 7.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.17 -16.05 59.64 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -62.54 97.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.168 -1.195 . . . . 0.0 108.494 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 70.3 mmm -62.93 168.28 4.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.773 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 t -142.32 114.87 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.519 -0.738 . . . . 0.0 109.482 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.25 107.29 19.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.114 -0.991 . . . . 0.0 109.614 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 88' ' ' VAL . 41.0 t80 -94.64 112.33 24.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 88' ' ' VAL . 35.6 ttpt -94.18 135.0 36.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.088 -1.007 . . . . 0.0 110.969 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 86' ' ' PHE . 4.2 m -157.06 132.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 55.96 -148.33 28.25 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -94.61 50.67 1.35 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.195 -1.179 . . . . 0.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -171.24 140.26 1.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.036 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 92' ' ' THR . 15.2 t -120.8 133.14 55.33 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.543 -0.723 . . . . 0.0 110.303 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.537 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.8 178.23 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.253 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 15.1 ptpt -145.66 152.3 39.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.147 -0.971 . . . . 0.0 109.861 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.497 ' CD1' HD11 ' A' ' 121' ' ' LEU . 26.6 m-85 -141.23 178.79 7.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.259 -0.9 . . . . 0.0 108.759 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -143.35 110.34 5.64 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.18 -0.95 . . . . 0.0 109.938 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 79' ' ' LYS . 37.3 ttm -48.19 127.05 12.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 98' ' ' THR . 11.1 m -161.78 25.68 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.1 . . . . 0.0 110.269 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.476 ' N ' ' HZ3' ' A' ' 80' ' ' LYS . 2.2 m -163.27 87.43 0.55 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.672 -1.267 . . . . 0.0 108.636 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.606 ' H ' ' HZ1' ' A' ' 80' ' ' LYS . 1.3 mp -82.49 140.03 16.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.681 HH11 ' NZ ' ' A' ' 115' ' ' LYS . 44.3 mtm180 -137.85 12.92 2.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.476 -0.765 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 141' ' ' ILE . 2.6 p30 -65.49 47.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.441 -0.787 . . . . 0.0 109.611 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.657 ' O ' HG12 ' A' ' 103' ' ' VAL . 52.9 t -148.91 9.19 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.251 -0.906 . . . . 0.0 108.793 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.8 mttm 58.3 58.14 6.43 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.805 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 106' ' ' THR . 84.2 Cg_endo -78.76 -4.5 14.08 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.661 2.24 . . . . 0.0 112.185 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' PRO . 2.4 t 33.89 59.33 0.56 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.336 0.589 . . . . 0.0 110.596 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -58.5 -72.1 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 m -152.02 20.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.9 122.65 1.89 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 110' ' ' VAL . 4.3 m -68.64 -28.89 41.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.273 -1.134 . . . . 0.0 108.658 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.6 mt -138.59 73.87 1.45 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.603 -0.686 . . . . 0.0 109.6 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 113' ' ' GLU . 25.7 t0 -103.27 -146.45 0.37 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.363 -0.835 . . . . 0.0 108.865 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.422 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 14.0 pt-20 -143.3 25.83 1.68 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.132 -0.98 . . . . 0.0 109.399 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -144.2 28.37 1.37 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.681 ' NZ ' HH11 ' A' ' 101' ' ' ARG . 1.0 OUTLIER -57.59 152.76 14.41 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.783 0.801 . . . . 0.0 110.304 -179.112 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 117' ' ' LYS . . . 46.54 -103.36 0.06 OUTLIER Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 116' ' ' GLY . 81.7 mttt -158.08 -44.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.641 -0.917 . . . . 0.0 110.305 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 119' ' ' LYS . 3.1 m-20 -118.39 170.92 8.51 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.7 -0.625 . . . . 0.0 109.909 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.555 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 1.6 mptm? -30.89 129.85 0.12 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.256 0.551 . . . . 0.0 110.043 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -147.3 168.37 21.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.059 -1.025 . . . . 0.0 109.962 -178.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 95' ' ' TYR . 60.7 mt -124.31 111.81 16.25 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.742 -0.598 . . . . 0.0 109.911 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.3 m -91.68 88.07 6.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.041 -1.037 . . . . 0.0 108.243 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 123' ' ' LEU . 6.9 mp -78.16 154.51 31.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 18.4 mt -140.01 148.89 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 56.2 p -99.03 163.64 12.5 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.6 m -147.34 149.54 33.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 109.579 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.88 130.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 27.8 t0 60.34 71.24 0.58 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.011 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 130' ' ' ASN . 40.7 t80 -65.1 132.43 49.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.655 -1.278 . . . . 0.0 110.026 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.436 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 51.7 t30 -79.64 119.64 22.86 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.982 -1.074 . . . . 0.0 109.351 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -91.97 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.227 -0.92 . . . . 0.0 109.544 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -78.87 -64.66 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 p -94.84 -7.65 39.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 53.78 4.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.98 151.4 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.199 -1.177 . . . . 0.0 109.551 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.39 116.41 5.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 128' ' ' ASP . 7.0 mm-40 -37.76 -85.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.149 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -111.76 156.03 22.59 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -170.16 -160.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 109.963 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.481 ' N ' ' OG1' ' A' ' 125' ' ' THR . 59.7 mttp -152.05 160.46 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 102' ' ' ASP . 17.5 mt -141.69 127.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.131 -0.981 . . . . 0.0 110.201 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -147.58 149.02 31.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.91 . . . . 0.0 108.715 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.4 t -125.47 136.22 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.463 -0.773 . . . . 0.0 111.142 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.73 174.85 5.71 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -140.26 135.95 32.83 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.87 131.12 49.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -90.22 146.85 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.2 pttp . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.379 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 mmt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -148.86 161.59 41.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.187 -0.946 . . . . 0.0 109.279 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.55 162.24 7.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.662 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.42 ' H ' HD11 ' A' ' 52' ' ' LEU . 63.6 mttm -152.15 143.52 15.92 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.273 -0.892 . . . . 0.0 108.987 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.4 99.3 0.85 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.434 2.09 . . . . 0.0 113.059 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -151.04 72.73 1.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.928 -1.107 . . . . 0.0 109.355 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mt -151.07 93.71 3.61 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 -163.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.244 1.963 . . . . 0.0 112.168 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -126.41 -23.17 3.85 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' SER . 16.9 t0 -77.41 114.15 15.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.239 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 35.1 mmtm -58.33 -2.55 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.85 . . . . 0.0 109.634 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.2 p -112.39 41.78 1.94 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 109.618 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -146.24 137.25 24.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -1.0 . . . . 0.0 109.78 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 16' ' ' GLY . 60.1 t -61.34 159.76 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 121.682 0.753 . . . . 0.0 110.762 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -139.65 1.4 1.91 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.579 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 163.67 -170.39 38.99 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 62.5 m-85 -147.27 125.76 12.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.126 -1.22 . . . . 0.0 110.518 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 tp -95.51 140.13 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -145.15 145.49 31.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.827 -1.17 . . . . 0.0 110.822 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.484 ' CD1' HD21 ' A' ' 75' ' ' LEU . 12.6 mt -147.8 129.35 7.31 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.07 -53.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.86 1.707 . . . . 0.0 112.296 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.96 -27.89 6.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.742 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.37 5.91 20.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.43 -0.793 . . . . 0.0 109.163 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.4 p30 42.95 35.75 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.738 -0.601 . . . . 0.0 110.395 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt -90.5 146.39 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -0.834 . . . . 0.0 109.113 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -166.59 84.47 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.77 158.12 74.72 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.69 161.61 16.53 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 123.114 2.542 . . . . 0.0 113.083 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 t -125.01 123.35 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 2.5 m-85 -84.65 152.54 60.23 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.86 100.61 0.97 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.559 2.173 . . . . 0.0 111.844 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.46 179.12 47.56 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 35' ' ' THR . 71.5 Cg_endo -77.78 120.74 5.22 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.736 2.291 . . . . 0.0 111.097 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -40.33 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.34 0.59 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -107.39 153.46 41.22 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.75 -41.88 7.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.232 1.954 . . . . 0.0 112.435 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -63.71 -19.79 65.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.005 . . . . 0.0 110.08 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.484 ' OE1' ' CD2' ' A' ' 30' ' ' TYR . 0.8 OUTLIER -94.96 -63.61 1.15 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.101 -0.999 . . . . 0.0 109.117 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.08 -24.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.401 -0.812 . . . . 0.0 109.857 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' GLN . 21.4 m-20 -59.88 -24.77 64.53 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.5 mtt180 -89.11 -9.08 52.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.64 -136.03 4.99 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 6.1 t -101.42 157.25 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.485 -1.009 . . . . 0.0 109.586 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -151.74 147.94 27.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.277 -0.889 . . . . 0.0 108.85 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -55.13 168.89 0.28 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.864 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' OG ' ' A' ' 58' ' ' SER . . . -92.31 0.42 57.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -161.38 142.96 11.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.444 -0.785 . . . . 0.0 108.947 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.57 -37.44 78.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.492 -0.755 . . . . 0.0 111.222 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -89.72 -0.25 57.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.877 -1.139 . . . . 0.0 111.005 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 11.3 tp10 -63.24 89.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.853 -1.155 . . . . 0.0 109.749 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -89.4 177.0 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.347 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.42 HD11 ' H ' ' A' ' 4' ' ' LYS . 2.6 pp -76.84 -8.1 56.7 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 108.901 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.51 -19.39 29.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.462 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 40.7 t0 -59.43 111.44 1.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -44.88 -17.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 6.2 m120 -132.31 100.49 5.02 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -94.46 120.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 108.78 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.5 t -108.16 115.15 29.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.5 -0.75 . . . . 0.0 109.165 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 60' ' ' ALA . 61.8 mt -108.55 166.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.56 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -137.2 132.54 34.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.79 148.47 19.99 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.434 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.2 m-70 -72.31 168.06 19.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.28 88.57 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.0 109.352 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.516 ' N ' ' OG1' ' A' ' 73' ' ' THR . 15.7 m-85 -88.19 102.5 14.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 109.233 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.09 -29.93 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.32 -0.862 . . . . 0.0 110.094 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.29 12.4 6.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ASN . 23.5 ttm-85 -151.33 77.39 7.42 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.528 -0.732 . . . . 0.0 109.51 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.64 32.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 123.31 2.673 . . . . 0.0 113.319 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' ARG . 19.7 m-80 -149.41 61.11 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 0.0 108.376 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -130.94 -153.47 0.56 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 109.78 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -69.61 -83.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 111.715 -178.482 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 28.5 t80 -93.56 -11.64 31.39 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.212 -0.93 . . . . 0.0 110.298 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 89.5 m -37.45 -40.71 0.39 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.671 . . . . 0.0 111.124 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.8 m120 -94.48 -21.61 18.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.131 -0.981 . . . . 0.0 111.605 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.5 mt -53.42 -26.08 18.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.392 -1.443 . . . . 0.0 108.263 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 73' ' ' THR . 9.5 ptpt -75.53 -18.97 59.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -82.09 -14.41 55.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.15 -165.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -163.96 164.7 23.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.169 -0.957 . . . . 0.0 109.422 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -52.39 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 155.66 -26.83 0.59 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 p -63.07 117.83 7.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.352 -1.087 . . . . 0.0 108.252 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.0 mtp -70.91 179.26 2.77 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.008 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.8 t -145.17 111.65 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -93.89 106.33 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.272 -0.892 . . . . 0.0 110.072 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -94.7 112.5 24.24 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -89.44 151.92 21.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 111.111 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 90' ' ' ASN . 5.9 t -145.71 45.64 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.36 -80.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 88' ' ' VAL . 10.6 p30 -53.08 -30.93 38.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.403 -1.057 . . . . 0.0 111.1 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -170.93 167.49 7.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.725 -1.234 . . . . 0.0 109.665 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 t -131.2 134.22 46.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.501 -0.749 . . . . 0.0 110.183 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.535 HH11 ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.58 175.25 6.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.625 -0.672 . . . . 0.0 109.276 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -144.57 144.94 31.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.108 -0.995 . . . . 0.0 109.566 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 17.2 m-85 -131.56 177.19 7.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.439 -0.788 . . . . 0.0 108.926 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -133.71 104.32 6.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 109.601 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.446 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.9 mmt -48.59 120.03 3.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.35 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -161.82 28.81 0.12 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.289 -0.882 . . . . 0.0 109.42 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 7.7 m -165.58 133.33 2.99 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.8 mt -140.19 130.75 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.279 -0.888 . . . . 0.0 108.674 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 103' ' ' VAL . 19.0 mmm-85 -110.6 13.95 22.48 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.58 -0.7 . . . . 0.0 109.94 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.533 ' HA ' ' H ' ' A' ' 141' ' ' ILE . 73.6 m-20 -42.3 -20.01 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.407 -0.808 . . . . 0.0 109.578 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 101' ' ' ARG . 53.0 t -68.55 159.66 5.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' N ' HG12 ' A' ' 103' ' ' VAL . 85.6 mttt -48.14 152.62 1.42 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 108.838 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -34.92 94.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.474 2.116 . . . . 0.0 112.403 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.534 ' OG1' ' NE ' ' A' ' 101' ' ' ARG . 6.4 p -71.85 -27.89 63.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.443 -0.785 . . . . 0.0 109.655 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 109' ' ' GLY . 27.2 t70 -139.96 140.38 36.32 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 m -67.99 43.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.045 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 107' ' ' ASP . . . -146.64 54.46 0.54 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.449 ' H ' HG22 ' A' ' 110' ' ' VAL . 3.9 m -66.49 -19.54 25.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.039 -1.271 . . . . 0.0 108.094 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 mt -139.49 59.82 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.533 ' OD2' ' NE2' ' A' ' 114' ' ' GLN . 9.8 p-10 -91.44 -135.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 109.217 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 112' ' ' ASP . 10.6 pt-20 -163.9 16.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 110.058 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.533 ' NE2' ' OD2' ' A' ' 112' ' ' ASP . 1.9 pm0 -153.4 18.48 0.55 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 110.45 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HB3' ' HZ3' ' A' ' 115' ' ' LYS . 7.8 mtpm? -78.44 166.41 22.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.991 -1.068 . . . . 0.0 110.226 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.22 -112.4 3.87 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -158.04 -54.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.645 -0.915 . . . . 0.0 109.942 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.484 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 70.7 m-20 -118.91 169.88 9.5 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 118' ' ' ASP . 34.2 ttmt -39.66 137.24 0.89 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.485 -0.759 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.75 155.6 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.274 -0.891 . . . . 0.0 109.202 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' A' ' 95' ' ' TYR . 46.4 mt -103.88 115.91 31.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.441 -0.787 . . . . 0.0 110.185 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.8 m -93.95 87.04 5.23 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.953 -1.092 . . . . 0.0 108.547 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 123' ' ' LEU . 7.5 mp -74.25 154.78 38.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.9 mt -140.02 140.98 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.467 -0.771 . . . . 0.0 108.973 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 ' CZ ' ' A' ' 72' ' ' PHE . 1.3 p -94.24 162.13 13.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 109.493 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.433 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 51.3 m -146.9 137.11 23.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -173.3 134.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.123 -0.986 . . . . 0.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 55.09 69.63 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 108.916 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -62.28 122.11 14.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.04 -1.038 . . . . 0.0 109.844 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -84.99 122.42 29.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.1 -1.0 . . . . 0.0 109.355 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -86.03 5.89 31.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.294 -0.879 . . . . 0.0 109.749 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -79.93 -57.84 3.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 p -96.47 -4.27 41.89 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.232 -0.918 . . . . 0.0 109.354 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.53 46.86 53.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.66 155.42 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -1.116 . . . . 0.0 109.509 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.433 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.1 m95 -63.13 112.15 2.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.198 -0.939 . . . . 0.0 108.651 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 136' ' ' TRP . 72.3 tt0 -39.03 -82.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.277 0.561 . . . . 0.0 110.037 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -77.45 120.67 22.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -134.98 137.13 42.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.339 -0.851 . . . . 0.0 109.827 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -140.5 134.33 30.51 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.533 ' H ' ' HA ' ' A' ' 102' ' ' ASP . 15.3 mm -99.39 127.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.758 0.79 . . . . 0.0 111.22 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.528 ' CE1' ' OD2' ' A' ' 102' ' ' ASP . 27.5 m-85 -129.99 154.52 47.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 p -161.88 151.3 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.223 -1.548 . . . . 0.0 111.853 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.39 175.92 7.84 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -138.16 142.38 40.08 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 10.1 tp10 -60.78 137.17 58.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.773 . . . . 0.0 109.192 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 4.6 m -91.59 176.5 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.397 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.316 179.993 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mmm . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.268 0.556 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -86.89 173.85 9.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 109.55 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.54 71.46 0.76 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.331 -0.855 . . . . 0.0 109.185 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -133.18 65.32 72.94 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 109.728 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.22 -156.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.544 2.163 . . . . 0.0 112.049 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.29 104.14 3.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.054 -1.029 . . . . 0.0 110.275 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 7' ' ' ILE . 15.2 mt -150.29 95.15 3.6 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.51 166.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.626 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -113.41 -13.25 12.88 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 105.02 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.157 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -56.44 -11.08 1.1 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.838 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m -102.48 30.72 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.317 -0.864 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 143.51 33.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.325 -0.859 . . . . 0.0 109.205 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.9 t -60.06 150.95 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -144.91 12.04 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.72 168.44 29.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.54 119.66 6.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.03 -1.277 . . . . 0.0 109.51 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.9 tt -99.05 141.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -146.2 136.27 23.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.18 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.3 mt -144.1 125.69 8.11 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 23' ' ' ALA . 74.4 Cg_endo -75.15 -41.26 0.66 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.633 1.555 . . . . 0.0 111.494 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.25 -15.42 0.37 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -0.878 . . . . 0.0 109.203 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.81 15.46 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.808 . . . . 0.0 109.835 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.1 p-10 44.57 50.17 8.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.092 -1.005 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 23' ' ' ALA . 48.6 mm -92.25 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.82 0.819 . . . . 0.0 109.983 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -169.65 82.74 0.12 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 4.9 mm-40 -142.69 150.3 53.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 0.0 110.68 -177.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.78 165.05 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.848 2.365 . . . . 0.0 113.04 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.8 t -126.91 122.32 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.475 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 7.6 m-85 -82.59 150.36 62.84 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.007 -1.058 . . . . 0.0 110.247 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.87 100.04 1.36 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 111.681 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.26 178.78 45.37 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.616 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 72.9 Cg_endo -76.49 118.81 5.0 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.755 2.304 . . . . 0.0 111.029 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.49 88.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.453 0.644 . . . . 0.0 110.572 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.4 p -113.67 152.43 45.47 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -40.21 10.91 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.124 1.883 . . . . 0.0 111.945 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -62.24 -20.06 63.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.098 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.6 tp-100 -96.04 -63.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -45.05 -15.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 0.0 110.275 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.6 m-20 -62.55 -25.14 67.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 41' ' ' ARG . 25.2 mtt-85 -88.13 -12.0 45.32 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.09 -135.93 4.78 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.408 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.1 t -101.18 160.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -1.021 . . . . 0.0 109.619 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -151.42 152.68 33.4 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 50.4 m-85 -60.32 167.95 2.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.197 . . . . 0.0 109.745 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.16 -8.35 59.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.448 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -152.85 150.95 29.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -62.77 -35.82 81.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.563 -0.71 . . . . 0.0 111.102 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -88.65 16.42 6.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.99 -1.069 . . . . 0.0 110.905 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.535 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 14.5 tm-20 -63.23 98.44 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 109.84 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASP . 1.4 p -95.38 141.74 28.59 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -61.16 -3.73 0.93 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.756 -1.215 . . . . 0.0 107.881 179.422 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 51' ' ' SER . 23.1 m-20 -91.56 -17.7 25.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.594 -0.691 . . . . 0.0 109.861 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 38.6 p-10 -60.64 116.99 4.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.861 -1.149 . . . . 0.0 109.576 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -45.63 -15.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 38.2 t30 -132.6 108.58 9.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 109.673 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.0 mt -98.61 117.52 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -108.44 114.76 28.85 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 60' ' ' ALA . 61.2 mt -105.47 167.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.438 -0.789 . . . . 0.0 109.907 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.587 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.07 126.65 28.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.85 152.89 23.86 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.68 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -72.85 -170.46 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.636 -0.92 . . . . 0.0 109.275 179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.17 72.0 0.1 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 5.8 m-85 -87.6 114.11 23.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.91 -18.42 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -85.18 13.92 5.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.184 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.564 ' NH2' ' CG ' ' A' ' 64' ' ' PHE . 59.1 mtm-85 -151.41 74.35 8.13 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.29 14.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.673 2.915 . . . . 0.0 114.023 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 10.1 p30 -150.59 62.28 0.94 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.854 -1.154 . . . . 0.0 108.334 179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.551 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 41.8 t80 -149.72 99.77 2.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.551 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 25.2 mt-30 61.09 -125.49 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.513 -0.742 . . . . 0.0 111.734 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 86.2 t80 -92.48 38.88 1.02 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.186 -0.946 . . . . 0.0 110.37 -178.088 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -81.58 -65.21 1.04 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.995 -1.066 . . . . 0.0 109.034 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.518 ' C ' ' H ' ' A' ' 76' ' ' LYS . 9.9 t-20 -81.18 -24.72 37.32 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.611 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.85 -3.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.913 -1.117 . . . . 0.0 108.617 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 74' ' ' ASN . 46.1 mtpt -87.03 -21.47 26.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -80.78 -37.15 30.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -45.43 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' SD ' ' A' ' 97' ' ' MET . 48.3 mtmt -144.24 172.86 12.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -49.08 153.5 0.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -17.58 31.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 97.86 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.45 -1.029 . . . . 0.0 108.423 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.1 mtp -55.76 171.63 0.21 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.512 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -143.51 113.96 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.444 -0.785 . . . . 0.0 109.492 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.92 102.89 14.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 109.438 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -97.54 112.0 24.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.235 -0.916 . . . . 0.0 108.571 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -100.25 144.28 29.46 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 15' ' ' ALA . 8.8 p -169.77 140.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.4 -110.68 3.54 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -137.69 45.89 2.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.475 -1.015 . . . . 0.0 109.282 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 92' ' ' THR . 3.9 tm-20 -163.66 138.83 6.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.089 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.445 ' N ' ' CD ' ' A' ' 91' ' ' GLU . 21.6 m -115.13 125.15 53.13 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.775 . . . . 0.0 109.801 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 172.43 7.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.396 -0.815 . . . . 0.0 108.863 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 17.0 pttm -141.34 150.2 42.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.278 -0.889 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.554 ' CD1' HD11 ' A' ' 121' ' ' LEU . 15.8 m-85 -138.96 179.39 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -134.89 107.88 7.6 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.528 -0.733 . . . . 0.0 109.885 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.47 ' SD ' HD11 ' A' ' 100' ' ' ILE . 31.8 ttm -49.61 128.84 18.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 108.849 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 98' ' ' THR . 73.0 m -159.23 3.56 0.09 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.752 -1.217 . . . . 0.0 110.679 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' VAL . 13.4 t -149.14 122.24 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.708 -1.245 . . . . 0.0 107.886 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.49 ' CG2' ' OD2' ' A' ' 102' ' ' ASP . 78.3 mt -140.21 156.1 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -178.085 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 102' ' ' ASP . 66.7 mtm180 -124.5 -96.11 0.46 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.49 ' OD2' ' CG2' ' A' ' 100' ' ' ILE . 2.8 p30 39.53 35.86 0.2 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.554 -0.716 . . . . 0.0 110.686 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 104' ' ' LYS . 35.3 t -138.52 -83.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.231 -0.918 . . . . 0.0 108.777 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.512 ' N ' HG12 ' A' ' 103' ' ' VAL . 18.0 mmmt -139.99 52.77 3.85 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.285 -0.884 . . . . 0.0 109.321 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 104' ' ' LYS . 73.9 Cg_endo -72.94 -167.77 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.359 2.039 . . . . 0.0 111.488 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' VAL . 22.4 p -103.1 -13.6 16.75 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 109' ' ' GLY . 4.6 t70 66.19 -42.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' THR . 18.1 m -76.84 25.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.093 -1.004 . . . . 0.0 109.179 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -135.14 6.94 4.38 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.14 -35.17 70.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.189 -1.183 . . . . 0.0 108.506 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.15 61.27 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.548 -0.72 . . . . 0.0 109.452 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -171.25 4.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.009 -1.057 . . . . 0.0 111.024 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -179.91 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.767 -1.208 . . . . 0.0 109.453 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.634 ' CD ' ' H ' ' A' ' 114' ' ' GLN . 1.1 pm0 -103.0 9.5 38.61 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.07 -19.0 40.24 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.97 -103.44 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -149.94 -40.08 0.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.322 -1.105 . . . . 0.0 109.508 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -118.59 167.45 11.61 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.494 -0.753 . . . . 0.0 110.353 -178.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -47.04 157.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 5.2 pt20 -157.98 161.86 38.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.008 -1.058 . . . . 0.0 109.847 -178.028 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.554 HD11 ' CD1' ' A' ' 95' ' ' TYR . 50.7 mt -114.95 103.39 10.87 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.603 -0.686 . . . . 0.0 110.0 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.9 m -99.34 149.2 23.39 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.4 tt -141.58 157.86 44.57 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.054 -1.029 . . . . 0.0 109.757 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.469 ' N ' HD23 ' A' ' 123' ' ' LEU . 44.9 mt -128.77 150.05 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.447 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.8 p -89.83 163.59 14.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.579 -1.325 . . . . 0.0 108.725 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -146.4 81.94 1.58 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.418 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 14.9 p-10 -137.48 133.97 35.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.407 -0.808 . . . . 0.0 109.127 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 69.06 62.01 0.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -62.62 126.23 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.273 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -85.89 118.56 25.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 1.36 45.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.68 -52.91 7.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.0 p -94.89 -8.28 37.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.34 41.45 52.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.04 162.56 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.24 -1.153 . . . . 0.0 109.599 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 68.2 m95 -66.29 114.87 5.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.303 -0.873 . . . . 0.0 108.674 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' TRP . 24.6 tt0 -38.96 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.264 0.555 . . . . 0.0 110.13 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -83.2 148.25 27.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -148.25 73.89 1.27 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.95 -1.094 . . . . 0.0 110.482 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -76.75 159.01 30.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.919 -1.113 . . . . 0.0 108.225 178.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.74 153.43 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.982 -1.074 . . . . 0.0 111.277 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -135.45 171.37 14.55 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.844 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 99' ' ' SER . 1.7 p -162.93 117.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.214 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -96.99 177.95 5.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 145' ' ' THR . 15.0 t -147.51 127.93 14.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.762 -1.211 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -63.89 117.45 6.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.0 OUTLIER -93.15 -154.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.194 -0.941 . . . . 0.0 109.087 -179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.488 ' H ' HG12 ' A' ' 147' ' ' VAL . 53.3 mtpt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.799 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 18.5 mp0 -72.03 142.3 49.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -0.99 . . . . 0.0 109.264 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.87 86.64 4.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.635 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 2' ' ' GLN . 28.1 mtmm -151.9 59.91 3.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.06 -173.66 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.684 2.256 . . . . 0.0 111.919 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.87 81.43 3.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.268 -0.895 . . . . 0.0 109.7 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mt -84.23 122.5 75.58 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.54 167.26 27.54 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.257 1.305 . . . . 0.0 112.032 -179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -102.09 -12.78 17.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' SER . 87.1 m-20 -77.16 102.4 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.681 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -58.22 -3.79 0.29 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' ASP . 15.1 t -115.59 44.63 1.84 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.589 -0.694 . . . . 0.0 109.331 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -141.11 133.28 27.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.341 -0.849 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.65 107.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.616 -0.678 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.73 19.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.44 -173.55 35.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.41 126.64 9.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.008 -1.289 . . . . 0.0 109.74 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -99.22 144.6 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -150.33 131.67 14.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.874 -1.141 . . . . 0.0 110.622 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 mt -144.25 125.88 8.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.09 -41.77 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.654 1.569 . . . . 0.0 111.458 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OG ' ' A' ' 82' ' ' SER . 47.5 t0 -50.98 -16.23 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.051 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.7 15.98 3.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.431 -0.793 . . . . 0.0 109.427 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.0 p30 41.78 48.96 3.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 mm -91.64 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.63 0.729 . . . . 0.0 109.635 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -169.13 84.98 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -145.48 157.19 52.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.063 -1.023 . . . . 0.0 110.33 -177.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.32 165.24 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.85 2.367 . . . . 0.0 112.425 179.022 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.37 112.92 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -85.98 158.31 56.08 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 109.449 -179.289 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.09 133.87 9.04 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.463 2.109 . . . . 0.0 112.398 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.6 176.89 24.0 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.217 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.589 ' O ' ' N ' ' A' ' 35' ' ' THR . 83.1 Cg_endo -79.14 118.01 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.758 2.305 . . . . 0.0 111.119 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -42.44 87.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.199 0.523 . . . . 0.0 110.61 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -108.3 152.89 42.15 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.19 -42.18 37.44 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.244 1.963 . . . . 0.0 112.092 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.89 -25.86 68.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.081 -1.012 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.8 -70.11 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.492 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 39' ' ' LEU . 36.1 mt -42.06 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.565 -0.709 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.11 -23.52 66.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -87.11 -11.71 49.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.81 -106.44 0.29 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 11.3 t -136.02 154.73 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.483 -1.01 . . . . 0.0 109.298 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 t -149.4 156.1 41.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -57.69 173.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.734 -1.228 . . . . 0.0 109.513 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -88.58 -3.24 58.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -155.04 148.61 25.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.524 -0.735 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.62 -29.89 70.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 111.733 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -88.49 -3.79 58.75 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.707 -1.245 . . . . 0.0 111.449 -177.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.27 114.59 3.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.729 -1.232 . . . . 0.0 109.673 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -91.53 -164.69 1.21 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 2.2 mp -102.72 17.9 22.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -144.42 4.27 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' ASN . 68.5 t0 -59.53 118.89 6.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.879 -1.138 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.453 HE22 ' CB ' ' A' ' 56' ' ' ASN . 4.0 pp0? -47.27 -13.55 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.998 -1.064 . . . . 0.0 109.899 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' ASP . 4.8 t-20 -131.42 93.81 3.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.425 -0.797 . . . . 0.0 109.08 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.42 145.61 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' ALA . 1.8 p -142.89 109.36 5.36 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 60' ' ' ALA . 83.8 mt -103.81 159.19 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.664 0.745 . . . . 0.0 110.657 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -127.36 124.31 38.31 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.85 146.04 17.68 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -178.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' PHE . 20.6 m-70 -73.16 174.87 7.35 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.41 -1.053 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.71 93.56 1.58 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.389 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.06 113.49 24.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.962 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 mt -60.47 -34.13 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.94 17.69 2.77 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.931 . . . . 0.0 109.291 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -150.66 73.7 8.82 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 63.9 Cg_exo -52.37 23.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 123.904 3.069 . . . . 0.0 114.219 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 67' ' ' ARG . 27.3 m-80 -153.55 63.53 0.74 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.603 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 12.8 t80 -148.29 100.46 3.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.102 -0.999 . . . . 0.0 110.953 -178.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 13.1 mp0 54.39 -109.04 0.46 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.671 -0.643 . . . . 0.0 112.57 177.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.568 ' CE2' HG22 ' A' ' 125' ' ' THR . 41.6 t80 -91.59 8.9 34.44 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.331 -0.855 . . . . 0.0 111.177 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 m -56.42 -45.35 80.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.465 -1.397 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 5.7 m120 -94.31 -22.09 18.58 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.04 -1.038 . . . . 0.0 111.498 -177.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.5 tm? -50.37 -36.82 34.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 108.777 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -60.72 -18.26 53.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -86.12 -23.78 26.5 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.331 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.52 167.61 5.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.412 -0.805 . . . . 0.0 110.0 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -149.66 175.67 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.86 158.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.86 -29.24 3.81 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.423 ' OG ' ' OD2' ' A' ' 22' ' ' ASP . 61.3 m -62.17 103.74 0.41 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.293 -1.122 . . . . 0.0 108.237 179.371 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.4 mtp -63.36 176.11 0.87 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.777 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.4 t -144.15 114.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.482 -0.761 . . . . 0.0 109.17 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -93.64 107.29 19.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.22 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -94.99 113.9 25.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -85.69 151.04 24.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 110.644 -178.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG21 ' NH1' ' A' ' 93' ' ' ARG . 65.6 t -153.94 116.71 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.16 -102.86 0.05 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.02 34.98 4.87 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.545 -0.973 . . . . 0.0 109.499 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.84 119.89 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 108.797 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 92' ' ' THR . 12.6 t -111.2 132.87 53.98 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.52 -0.737 . . . . 0.0 110.253 -179.323 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -96.9 179.71 4.86 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.544 -0.723 . . . . 0.0 109.528 179.594 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -144.93 142.47 29.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 22.7 m-85 -128.82 178.92 6.02 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -135.32 110.36 8.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.275 -0.891 . . . . 0.0 109.755 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.7 mmt -52.13 118.43 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -151.05 31.21 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 109.717 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 t -164.89 86.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.028 -1.045 . . . . 0.0 109.338 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.7 mp -84.27 135.72 24.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.477 ' NH1' ' CD ' ' A' ' 113' ' ' GLU . 33.0 mtp180 -134.0 -10.45 2.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.334 -0.854 . . . . 0.0 109.581 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.519 ' OD2' ' CZ ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER -43.83 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 179.606 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.69 ' O ' HG13 ' A' ' 103' ' ' VAL . 9.7 p 22.37 61.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-O 121.49 0.662 . . . . 0.0 111.573 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 103' ' ' VAL . 31.2 mtmt 61.95 137.81 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.369 -0.832 . . . . 0.0 109.045 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -37.16 112.49 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.154 1.903 . . . . 0.0 112.832 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 107' ' ' ASP . 17.5 p -80.82 -59.96 2.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 108.909 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 109' ' ' GLY . 54.9 m-20 -146.12 147.25 31.36 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.95 42.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.189 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 107' ' ' ASP . . . -111.97 52.06 0.66 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.7 m -65.34 -24.25 34.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.054 -1.262 . . . . 0.0 107.792 179.201 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.15 66.54 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.697 ' N ' HE21 ' A' ' 114' ' ' GLN . 24.0 t70 -175.15 26.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.477 ' CD ' ' NH1' ' A' ' 101' ' ' ARG . 18.0 pt-20 -163.19 29.19 0.09 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.697 HE21 ' N ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -139.54 14.06 2.55 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.612 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 116' ' ' GLY . 86.9 mttt -97.69 28.88 3.59 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 115' ' ' LYS . . . -48.69 -95.77 0.01 OUTLIER Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -154.76 -27.6 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -1.181 . . . . 0.0 110.882 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -101.08 143.68 30.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.072 -1.017 . . . . 0.0 110.07 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -47.66 139.27 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.409 ' CD ' ' O ' ' A' ' 114' ' ' GLN . 6.9 pt20 -151.61 158.61 43.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.007 -1.058 . . . . 0.0 110.099 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.22 157.42 20.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.461 0.648 . . . . 0.0 110.214 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.2 m -139.22 88.34 2.26 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.89 147.08 52.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.523 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.8 mt -139.42 141.01 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.568 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.1 p -94.18 159.42 15.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.94 -1.1 . . . . 0.0 109.181 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -147.84 100.52 3.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -152.41 144.53 23.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.0 t0 60.53 58.7 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.07 119.41 8.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 130' ' ' ASN . 1.7 p-10 -86.96 124.04 32.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.066 -1.021 . . . . 0.0 109.988 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.9 14.22 10.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -71.5 -31.47 67.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -0.859 . . . . 0.0 109.163 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.2 p -140.64 3.2 1.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.36 53.1 6.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.95 159.42 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.087 -1.243 . . . . 0.0 109.912 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.551 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 70.6 m95 -72.77 116.1 12.86 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.239 -0.913 . . . . 0.0 108.626 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' TRP . 30.2 tt0 -40.29 -83.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.737 -0.602 . . . . 0.0 109.991 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.85 165.1 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 108.474 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.532 ' NE ' ' O ' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -167.08 76.61 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.904 -1.122 . . . . 0.0 110.12 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -88.97 156.88 18.61 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.413 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 21.8 pt -145.98 146.77 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.925 -1.11 . . . . 0.0 111.629 -178.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.519 ' CZ ' ' OD2' ' A' ' 102' ' ' ASP . 27.5 m-85 -128.98 165.98 20.07 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 78.3 t -149.14 143.61 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.653 -1.279 . . . . 0.0 110.339 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.75 163.94 30.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.2 t -140.91 141.14 34.58 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.07 -1.019 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.42 113.69 3.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.7 t -93.85 177.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 108.821 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.482 ' H ' HG12 ' A' ' 147' ' ' VAL . 73.8 mttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.437 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.6 mtm . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.344 0.593 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -74.0 112.89 10.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.267 -0.895 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.3 -175.22 1.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -0.959 . . . . 0.0 109.199 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.502 ' NZ ' ' OD1' ' A' ' 49' ' ' ASN . 94.1 mttt -45.24 107.62 0.67 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.369 -0.832 . . . . 0.0 109.757 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 4' ' ' LYS . 74.9 Cg_exo -49.81 -166.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.043 1.829 . . . . 0.0 112.682 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -80.81 105.43 12.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.067 -1.021 . . . . 0.0 110.06 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 mm -85.0 114.76 57.77 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -42.75 121.34 2.14 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.708 1.606 . . . . 0.0 112.31 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 9' ' ' LYS . 19.5 mtmm -66.13 -32.59 74.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 12' ' ' SER . 9.7 m-20 -76.87 111.4 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.463 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 1.8 mppt? -60.87 -0.95 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.0 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.6 t -111.21 42.75 1.59 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -142.92 133.38 24.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 5.4 t -58.75 120.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.44 -0.787 . . . . 0.0 111.263 -178.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.12 -9.63 27.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.22 140.35 3.15 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 90.2 m-85 -94.44 125.22 38.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -1.213 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 tp -95.29 143.04 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -148.07 138.81 23.07 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.712 -1.242 . . . . 0.0 110.936 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.857 HD12 HD21 ' A' ' 75' ' ' LEU . 14.0 mt -149.84 128.32 5.99 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.179 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.12 -44.06 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.825 1.683 . . . . 0.0 112.241 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -50.2 -28.3 7.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -113.4 7.07 17.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p30 43.54 30.25 0.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 109.888 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.12 145.2 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.102 0.953 . . . . 0.0 109.795 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -163.02 87.97 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -138.1 159.95 66.22 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.592 -0.693 . . . . 0.0 110.952 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.444 ' CB ' HG13 ' A' ' 14' ' ' VAL . 92.5 Cg_endo -76.52 159.19 35.97 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.982 2.455 . . . . 0.0 113.229 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -135.64 98.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.52 170.74 14.68 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.119 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.46 164.21 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.072 1.848 . . . . 0.0 112.048 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.67 171.92 13.05 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.7 Cg_endo -78.56 120.37 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.758 2.305 . . . . 0.0 111.187 179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -41.6 87.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.235 0.54 . . . . 0.0 110.643 -179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.7 p -108.57 123.56 36.93 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.26 -43.57 7.74 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.804 1.669 . . . . 0.0 112.257 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.73 -16.49 61.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.081 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.694 HE22 ' CB ' ' A' ' 44' ' ' SER . 2.3 tt0 -97.07 -69.51 0.75 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.417 -0.802 . . . . 0.0 109.702 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 34' ' ' ALA . 22.5 mt -45.01 -18.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 109.796 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 38' ' ' GLN . 16.5 m-20 -62.15 -24.87 67.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -83.2 -13.7 54.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.69 -124.23 1.35 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.64 159.34 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.575 -0.956 . . . . 0.0 109.963 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.694 ' CB ' HE22 ' A' ' 38' ' ' GLN . 6.9 p -161.66 164.93 28.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 108.937 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.87 162.32 5.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.604 -1.31 . . . . 0.0 109.205 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -83.21 -9.09 59.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.387 -0.82 . . . . 0.0 109.366 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.53 144.31 29.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.147 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.98 -25.99 68.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.502 ' OD1' ' NZ ' ' A' ' 4' ' ' LYS . 65.3 t30 -87.8 3.9 46.44 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.917 -1.114 . . . . 0.0 110.677 -178.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' OE1' ' OG ' ' A' ' 58' ' ' SER . 6.0 tp10 -64.93 157.59 27.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.339 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -148.0 -179.84 7.2 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.949 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -91.11 17.19 8.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 13.0 p-10 -141.16 -0.73 1.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.492 -0.755 . . . . 0.0 110.178 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' ASN . 48.6 t0 -57.89 114.58 2.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.733 -1.229 . . . . 0.0 108.998 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -43.07 -20.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.439 -0.788 . . . . 0.0 109.479 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.3 p-10 -134.96 104.09 5.83 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.43 156.06 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' ALA . 50.7 p -141.66 102.08 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 109.133 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.545 HG22 ' N ' ' A' ' 60' ' ' ALA . 94.8 mt -97.98 162.03 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.545 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -145.08 134.18 22.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.44 158.77 27.61 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.754 -1.213 . . . . 0.0 110.209 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 72' ' ' PHE . 10.7 m-70 -71.49 -179.84 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.952 . . . . 0.0 109.913 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.79 80.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -87.94 107.53 18.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 109.118 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 65' ' ' ILE . 8.3 mt -58.46 -29.35 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 110.141 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.36 12.63 5.18 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.791 . . . . 0.0 109.429 -178.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 69' ' ' ASN . 96.6 mtt180 -150.76 64.55 6.48 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -40.14 -19.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.701 2.268 . . . . 0.0 112.534 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' ARG . 28.6 p30 -98.29 28.72 3.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.605 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.9 t80 -89.68 -153.69 0.29 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.851 -1.156 . . . . 0.0 109.754 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -72.88 -96.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.619 -0.676 . . . . 0.0 111.322 -178.731 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.4 t80 -91.63 37.11 0.95 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.765 . . . . 0.0 110.327 -177.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -77.37 -49.04 15.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.859 -1.151 . . . . 0.0 109.706 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ALA . 19.1 m-20 -93.79 -19.99 20.51 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.644 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD21 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -52.93 -29.18 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.804 -1.185 . . . . 0.0 108.869 -179.481 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 140' ' ' LYS . 34.9 pttt -80.6 -6.71 58.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 108.287 179.008 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -83.68 -21.0 32.54 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -55.71 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -0.756 . . . . 0.0 109.396 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -155.13 152.95 30.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 108.708 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -50.14 108.08 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 109.678 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 97' ' ' MET . . . 137.44 -16.37 3.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.5 m -66.5 -172.73 0.17 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -1.157 . . . . 0.0 108.355 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.9 mmm -129.34 176.79 7.67 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.12 108.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 109.242 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -95.49 105.81 17.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 110.389 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -94.98 111.74 23.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -107.15 143.87 34.71 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.28 -0.887 . . . . 0.0 110.997 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.3 p -168.13 129.57 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.541 -0.725 . . . . 0.0 109.531 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 -105.53 1.6 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -140.31 22.16 2.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.321 -1.105 . . . . 0.0 109.218 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.27 138.73 35.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -119.91 138.94 53.13 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.677 0.751 . . . . 0.0 110.721 -179.031 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.42 170.68 9.76 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -146.57 128.52 15.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.126 -0.983 . . . . 0.0 110.385 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -128.41 172.74 10.83 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 98' ' ' THR . 16.5 ttpt -141.85 117.24 10.19 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.17 -0.956 . . . . 0.0 108.941 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.436 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 51.3 mtt -50.61 89.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.517 -0.74 . . . . 0.0 109.478 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -118.89 25.71 10.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.1 m -174.41 138.14 0.53 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.6 mt -140.77 129.62 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 103' ' ' VAL . 82.5 mtm180 -104.9 0.8 28.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.53 -0.731 . . . . 0.0 109.671 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 141' ' ' ILE . 15.2 t0 -66.17 55.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.362 -0.836 . . . . 0.0 109.023 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 101' ' ' ARG . 72.8 t -154.87 -75.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.438 -0.789 . . . . 0.0 108.896 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -117.92 60.96 3.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' O ' ' OG1' ' A' ' 106' ' ' THR . 13.4 Cg_endo -55.29 88.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.903 1.736 . . . . 0.0 111.84 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 105' ' ' PRO . 3.8 m -166.59 40.24 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.463 -0.773 . . . . 0.0 108.987 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -74.46 -146.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 109.635 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.29 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.845 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 138.78 132.93 3.01 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 t -67.92 -36.45 75.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.316 -1.108 . . . . 0.0 108.341 179.327 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.4 mt -138.25 73.56 1.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.443 ' H ' ' HE3' ' A' ' 115' ' ' LYS . 0.5 OUTLIER -93.45 136.47 33.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.174 -0.954 . . . . 0.0 108.949 -179.659 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 2.1 pm0 -93.95 18.37 10.65 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 0.3 OUTLIER -146.76 31.39 0.96 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.314 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HE3' ' H ' ' A' ' 112' ' ' ASP . 25.3 mmtp -38.97 -61.32 0.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.771 -0.581 . . . . 0.0 110.288 -179.395 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.44 -4.53 4.08 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -95.64 -145.27 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.156 -1.202 . . . . 0.0 109.554 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.556 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.7 m-20 -119.25 165.75 13.85 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.556 ' C ' ' O ' ' A' ' 118' ' ' ASP . 4.4 mmmt -21.23 131.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 CA-C-N 118.662 0.664 . . . . 0.0 110.34 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -135.69 179.95 6.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.909 -176.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.91 107.41 4.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.075 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 m -94.27 129.96 40.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.47 149.71 29.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.873 . . . . 0.0 109.209 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 124' ' ' ILE . 12.4 mt -142.36 140.5 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 109.125 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -93.57 167.36 11.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.929 -1.107 . . . . 0.0 108.6 178.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.8 m -146.27 128.69 15.92 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.026 -1.047 . . . . 0.0 109.794 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -174.69 131.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.081 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 62.78 67.18 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.522 -0.736 . . . . 0.0 109.117 -179.824 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.09 128.41 35.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.943 -1.098 . . . . 0.0 109.51 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 10.4 t-20 -85.18 114.34 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 109.457 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.95 -3.09 58.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.849 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 51.2 mtmt -81.65 -46.56 14.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.6 p -96.13 -17.2 21.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 109.298 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.3 36.72 23.24 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.99 158.5 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -1.159 . . . . 0.0 109.528 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLU . 64.0 m95 -61.1 112.09 1.96 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.161 -0.962 . . . . 0.0 108.553 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.2 tp10 -39.01 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.163 0.506 . . . . 0.0 110.37 -179.038 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.39 150.8 19.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 0.0 109.087 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -172.75 156.94 3.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.984 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 55.1 mtmt -130.11 162.95 27.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' ' 102' ' ' ASP . 5.4 mt -135.03 130.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.466 -0.771 . . . . 0.0 111.273 -178.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 -123.22 165.29 17.16 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.29 147.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.732 -1.23 . . . . 0.0 110.507 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.06 141.1 31.19 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 147' ' ' VAL . 12.0 t -98.68 146.52 25.78 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.244 -0.91 . . . . 0.0 109.918 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.46 34.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 145' ' ' THR . 2.2 t -148.0 -138.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.037 -1.039 . . . . 0.0 109.016 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.522 ' H ' HG12 ' A' ' 147' ' ' VAL . 66.8 mttm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.296 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.4 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -74.55 127.95 34.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.656 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.05 44.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.098 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -152.12 59.4 3.04 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 109.213 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.19 -168.66 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.679 2.252 . . . . 0.0 111.868 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -88.02 78.71 8.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.241 -0.912 . . . . 0.0 109.996 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt -87.36 113.35 53.56 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.322 -0.861 . . . . 0.0 108.962 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.52 129.68 11.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.53 1.487 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -79.0 -18.92 52.8 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.054 -1.029 . . . . 0.0 108.971 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 28.1 t0 -78.15 101.43 7.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -58.29 -2.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.0 109.806 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 12.6 t -108.95 40.52 1.8 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.458 -0.776 . . . . 0.0 109.578 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -146.46 139.91 25.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.16 119.41 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.858 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.71 -17.12 21.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.129 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.71 -169.18 34.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.45 121.69 8.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.312 -1.11 . . . . 0.0 109.041 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.53 143.02 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.39 134.51 22.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.006 -1.059 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.4 mt -145.04 126.55 7.77 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.1 Cg_endo -76.68 -43.24 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.559 1.506 . . . . 0.0 111.375 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 15.7 t0 -53.58 -12.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.354 -0.841 . . . . 0.0 109.124 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -133.45 11.02 4.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.0 109.336 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 p30 41.89 34.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.633 -0.667 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -91.29 144.86 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.543 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -165.76 83.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -140.37 160.27 60.27 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 111.128 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.53 164.91 25.69 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 123.026 2.484 . . . . 0.0 113.0 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.59 107.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.668 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -72.56 155.59 90.94 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.821 -1.174 . . . . 0.0 109.515 -179.499 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.5 118.93 1.93 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.139 1.893 . . . . 0.0 111.668 178.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.3 -174.76 41.84 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.22 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 35' ' ' THR . 97.9 Cg_endo -80.7 117.63 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.77 2.313 . . . . 0.0 111.331 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -47.89 85.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.311 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.1 p -104.64 153.96 38.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.57 -45.18 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.95 1.766 . . . . 0.0 111.616 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.43 -27.65 69.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.312 -0.868 . . . . 0.0 110.271 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.668 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 9.2 tm0? -82.73 -65.34 1.02 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.308 -179.646 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.5 mt -44.74 -17.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 38' ' ' GLN . 80.4 m-20 -58.23 -28.95 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.1 mtt180 -83.51 -15.35 49.73 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 160.25 -137.62 5.12 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.4 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.2 t -105.98 160.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.504 -0.998 . . . . 0.0 110.269 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 t -155.75 156.66 35.22 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 32.1 m-85 -56.29 171.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.591 -1.318 . . . . 0.0 109.38 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -84.33 -9.06 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.597 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -151.77 145.57 25.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.569 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.99 -26.74 68.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.707 . . . . 0.0 110.972 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -86.57 1.08 52.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.856 -1.152 . . . . 0.0 109.886 -179.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.16 150.26 46.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.647 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 53' ' ' ASP . 51.8 p -147.48 159.77 43.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -71.54 4.31 3.19 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 51' ' ' SER . 25.9 m-20 -112.57 -7.49 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t0 -60.32 114.02 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.003 -1.061 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.448 ' OE1' ' O ' ' A' ' 55' ' ' GLN . 0.4 OUTLIER -47.72 -17.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 109.036 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.3 t-20 -133.04 104.74 6.68 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -95.05 150.66 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.1 p -144.41 115.21 7.77 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 60' ' ' ALA . 78.5 mt -110.53 164.47 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.828 0.823 . . . . 0.0 110.629 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.577 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -141.92 139.15 32.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.66 153.36 25.12 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.895 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -72.54 177.02 4.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.714 -0.874 . . . . 0.0 109.48 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.82 82.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.968 . . . . 0.0 109.416 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.461 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 10.3 m-85 -89.59 118.79 29.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.26 -0.9 . . . . 0.0 109.348 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mm -60.76 -23.05 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -0.817 . . . . 0.0 110.161 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -86.59 14.2 7.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 69' ' ' ASN . 39.3 mtm-85 -150.76 74.36 8.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.569 -0.707 . . . . 0.0 109.243 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.13 13.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 123.403 2.735 . . . . 0.0 113.617 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -147.64 60.95 1.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 108.465 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -146.24 102.1 3.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.1 -1.0 . . . . 0.0 110.838 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 58.46 -115.13 0.8 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.724 -0.61 . . . . 0.0 112.038 178.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.3 m-85 -95.17 19.36 10.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.097 -1.002 . . . . 0.0 110.938 -177.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -59.94 -20.11 55.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.422 -1.424 . . . . 0.0 109.492 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.641 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 7.0 m-20 -121.92 -18.41 7.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 109.834 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.699 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.4 tm? -53.51 -39.24 64.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.894 -1.129 . . . . 0.0 108.287 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -65.27 -3.19 3.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -96.89 -29.37 13.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.01 -177.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.44 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -160.27 179.09 8.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.375 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -49.58 149.9 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 109.104 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.81 -13.45 24.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 39.3 m -61.96 100.26 0.15 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.412 -1.052 . . . . 0.0 108.349 179.448 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mmm -67.35 170.07 7.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.669 -179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 t -145.16 110.95 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 109.194 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.19 108.45 19.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.826 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -94.71 111.9 23.65 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -100.74 146.24 27.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 89' ' ' GLY . 14.9 t -132.93 167.64 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.654 -0.653 . . . . 0.0 109.264 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 88' ' ' VAL . . . -45.23 -32.88 3.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -153.97 47.62 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.913 -1.345 . . . . 0.0 110.274 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -171.95 121.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.064 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 92' ' ' THR . 12.6 t -125.1 125.93 44.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.437 HH12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.37 175.51 9.22 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.545 -0.722 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -145.38 132.74 20.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.176 -0.953 . . . . 0.0 110.24 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 13.1 m-85 -102.93 -177.15 3.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.489 -0.757 . . . . 0.0 108.967 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -141.56 110.74 6.3 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.37 -0.831 . . . . 0.0 109.349 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.6 tpp -48.37 114.47 0.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -146.47 26.25 1.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 108.703 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 m -170.24 124.11 0.72 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 84.3 mt -138.34 146.71 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 0.0 109.841 -179.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 103' ' ' VAL . 9.9 mpt_? -121.82 -29.21 4.35 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 50.11 10.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.781 . . . . 0.0 109.006 -179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 101' ' ' ARG . 70.0 t -155.4 113.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.287 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 30.8 tttm -55.11 -60.43 8.17 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.968 -1.083 . . . . 0.0 109.533 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 34.1 Cg_endo -61.55 78.1 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 122.15 1.9 . . . . 0.0 111.873 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.78 -73.41 0.6 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 109' ' ' GLY . 7.1 m-20 -84.22 -176.89 6.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 108.718 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.4 m -74.38 29.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.015 -1.053 . . . . 0.0 109.012 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 133.48 109.01 1.09 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.23 -23.84 32.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.189 -1.183 . . . . 0.0 108.373 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 mt -138.13 81.33 1.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 32.0 t0 -163.68 -20.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.081 -1.012 . . . . 0.0 110.97 -179.488 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -174.7 57.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 109.125 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -148.84 19.21 1.01 Allowed 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -85.32 9.27 15.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.835 -178.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.39 17.5 58.3 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -96.05 -138.79 0.25 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.123 -1.222 . . . . 0.0 109.338 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.0 t0 -116.2 145.94 42.71 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 118' ' ' ASP . 20.5 tptt -17.11 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 122.361 1.077 . . . . 0.0 111.153 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -93.76 173.61 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.106 -177.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.95 98.31 2.43 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.3 m -92.09 91.73 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.4 147.34 48.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.001 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.518 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 47.0 mt -136.97 149.32 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.325 -0.86 . . . . 0.0 109.782 -179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.23 158.81 15.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.0 137.87 23.82 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.927 -1.108 . . . . 0.0 109.603 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.3 t0 178.39 138.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 6.4 t0 65.1 60.09 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -64.59 121.78 15.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.161 -0.962 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 12.1 p30 -85.55 126.72 34.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.934 -1.104 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.06 6.11 41.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 109.471 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -76.68 -58.81 3.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.33 -0.856 . . . . 0.0 109.118 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 48.8 p -97.87 -4.37 36.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.365 -0.834 . . . . 0.0 109.245 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.04 46.99 33.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.7 t -146.91 167.27 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -1.1 . . . . 0.0 109.459 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 137' ' ' GLU . 70.4 m95 -72.32 113.63 9.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.194 -0.941 . . . . 0.0 108.944 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' TRP . 36.9 tt0 -36.25 -63.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.114 0.483 . . . . 0.0 110.733 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -139.2 149.85 44.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 109.163 179.844 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -173.96 139.63 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.746 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.53 -179.58 6.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.862 . . . . 0.0 109.21 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.0 tt -151.31 144.7 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 8.9 m-85 -137.54 166.57 23.57 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 88.1 t -146.74 148.57 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.977 -1.077 . . . . 0.0 110.084 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.92 179.95 6.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.442 -0.786 . . . . 0.0 109.011 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.2 t -153.63 146.64 24.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.048 -1.032 . . . . 0.0 110.087 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.52 139.36 57.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 109.444 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.7 m -89.02 159.44 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 mttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.54 -179.988 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ttt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.61 154.39 4.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.43 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.33 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.557 ' CD ' ' H ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -45.37 107.81 0.7 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 109.454 179.933 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' LYS . 82.2 Cg_exo -47.57 -176.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.916 1.744 . . . . 0.0 112.301 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 15.8 mp0 -78.26 98.98 6.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.211 -0.931 . . . . 0.0 110.073 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 mt -84.68 114.64 56.57 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -42.14 132.73 4.6 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.76 1.64 . . . . 0.0 112.442 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -83.85 -17.44 40.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 12' ' ' SER . 54.8 m-20 -77.01 106.63 8.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.58 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.58 -5.82 0.41 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 10' ' ' ASP . 67.4 p -110.83 42.14 1.67 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -146.6 134.17 20.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 16' ' ' GLY . 38.3 t -61.64 133.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 111.097 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.97 -7.68 24.84 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.599 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 171.65 -168.73 41.85 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.564 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 44.3 m-85 -146.88 126.81 13.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.937 -1.331 . . . . 0.0 109.679 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.93 141.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -145.27 137.01 25.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.92 -1.112 . . . . 0.0 110.431 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.731 HD12 HD21 ' A' ' 75' ' ' LEU . 9.8 mt -146.67 128.77 7.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 73.9 Cg_endo -75.39 -42.87 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.614 1.543 . . . . 0.0 111.403 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -54.13 -11.62 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.858 . . . . 0.0 108.959 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -131.5 6.49 4.44 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 42.19 31.72 0.27 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.648 -0.658 . . . . 0.0 109.935 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.99 147.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.061 0.934 . . . . 0.0 109.977 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -164.32 84.49 0.43 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -134.73 159.25 72.87 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.54 -0.725 . . . . 0.0 110.728 -176.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.88 159.51 15.98 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.974 2.45 . . . . 0.0 112.88 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.27 111.34 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 7.6 m-85 -74.41 148.76 86.14 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.855 -1.153 . . . . 0.0 109.765 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.72 112.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.254 1.969 . . . . 0.0 111.96 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.07 -176.12 43.27 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.472 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 84.7 Cg_endo -79.74 110.57 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 123.045 2.496 . . . . 0.0 111.501 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -42.63 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.418 0.628 . . . . 0.0 111.443 -178.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.574 ' H ' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -104.18 173.25 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.992 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.22 -28.44 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.693 1.595 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.86 -35.57 80.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.48 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.6 ' NE2' ' O ' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -81.6 -67.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 110.41 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 38' ' ' GLN . 33.5 mt -42.75 -25.14 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.059 -1.026 . . . . 0.0 110.232 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.03 -24.81 67.29 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -96.14 -17.72 20.65 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 177.57 -133.15 2.14 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.894 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.482 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.1 t -125.82 159.44 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.534 -0.98 . . . . 0.0 109.572 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 p -155.97 163.0 40.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.231 -0.918 . . . . 0.0 108.833 179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 39.9 m-85 -59.43 169.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 109.19 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.66 -14.36 54.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -144.62 146.38 32.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.28 -0.887 . . . . 0.0 110.067 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -23.82 67.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.678 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -87.53 2.49 50.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 2.8 tm-20 -63.56 156.37 26.71 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.498 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.509 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 5.0 m -145.73 178.13 8.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.984 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -87.33 14.79 7.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 108.324 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -140.44 0.86 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.678 . . . . 0.0 109.904 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 14.3 t0 -56.77 118.7 5.16 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.823 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 54' ' ' ASP . 5.5 tp-100 -37.52 -24.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.029 0.442 . . . . 0.0 110.322 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 54' ' ' ASP . 0.1 OUTLIER -133.68 117.27 16.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.354 -0.841 . . . . 0.0 108.944 179.228 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.44 HD13 ' OE2' ' A' ' 50' ' ' GLU . 37.3 mm -92.72 142.85 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 108.597 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.5 p -140.67 109.69 6.12 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 60' ' ' ALA . 90.6 mt -111.15 161.2 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.646 0.736 . . . . 0.0 110.486 -178.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -137.8 130.41 29.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.96 154.91 25.66 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 72' ' ' PHE . 15.9 m-70 -72.61 170.45 14.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.588 -0.948 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.94 82.42 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 108.97 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.62 114.99 23.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 0.0 108.799 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 65' ' ' ILE . 6.7 mt -56.68 -29.91 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 109.948 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.82 16.24 2.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.602 -178.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.557 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -144.49 69.43 15.41 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.536 -0.728 . . . . 0.0 109.251 179.691 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.42 17.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.068 2.512 . . . . 0.0 113.543 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.557 ' H ' ' C ' ' A' ' 67' ' ' ARG . 37.0 m-80 -148.95 62.77 1.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.926 -1.108 . . . . 0.0 108.558 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -133.3 -154.04 0.58 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 109.77 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 79.4 mt-30 -57.77 -98.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.539 -0.726 . . . . 0.0 111.19 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.7 m-85 -96.0 27.36 3.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.226 -0.921 . . . . 0.0 110.549 -178.21 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 73' ' ' THR . 98.2 m -65.76 -12.4 53.66 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.58 -1.325 . . . . 0.0 109.581 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.4 m-20 -128.05 -20.58 3.78 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.269 -0.894 . . . . 0.0 110.47 -179.274 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.731 HD21 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -53.65 -33.57 55.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 108.278 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -71.44 -9.56 58.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -87.76 -24.49 23.78 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.377 0.608 . . . . 0.0 109.468 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 171.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.659 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -144.77 167.14 23.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 109.221 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -49.42 138.6 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.42 -20.96 47.01 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -62.43 100.52 0.18 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.368 -1.078 . . . . 0.0 108.119 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.28 173.17 0.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -178.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 t -143.13 113.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 109.069 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -95.15 102.6 14.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -95.71 112.08 23.88 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 88' ' ' VAL . 33.5 mtmt -96.59 152.12 18.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.236 -0.915 . . . . 0.0 111.251 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.574 HG21 HH12 ' A' ' 93' ' ' ARG . 76.6 t -156.15 93.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.49 -105.83 1.09 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -118.3 38.84 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.472 -1.016 . . . . 0.0 109.577 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -146.05 108.5 4.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.915 . . . . 0.0 108.828 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 92' ' ' THR . 12.8 t -110.39 119.54 39.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.505 -0.747 . . . . 0.0 110.387 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.574 HH12 HG21 ' A' ' 88' ' ' VAL . 2.2 mpt_? -95.22 172.54 8.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 109.308 179.48 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -144.41 146.9 32.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.858 -179.661 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 12.8 m-85 -137.52 177.92 7.5 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -140.63 107.69 5.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 109.721 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 81' ' ' GLY . 64.7 mtp -51.86 120.68 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -153.09 28.66 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.264 -0.897 . . . . 0.0 108.904 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.2 t -166.46 121.58 1.16 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 101' ' ' ARG . 61.3 mt -132.21 166.27 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.444 -0.785 . . . . 0.0 110.192 -178.207 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.716 ' NH2' ' H ' ' A' ' 107' ' ' ASP . 36.5 ttm180 -141.26 -76.38 0.3 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p30 41.94 21.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.548 -0.72 . . . . 0.0 109.758 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 104' ' ' LYS . 1.7 p -152.37 -155.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.363 -0.835 . . . . 0.0 108.751 -179.418 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.668 ' N ' HG13 ' A' ' 103' ' ' VAL . 57.2 mttm -49.12 151.25 2.46 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.889 -1.132 . . . . 0.0 109.065 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.24 118.4 5.61 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.161 1.908 . . . . 0.0 112.169 -179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 p -80.34 -58.7 3.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.257 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.716 ' H ' ' NH2' ' A' ' 101' ' ' ARG . 10.8 t70 -142.62 153.96 43.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.248 -0.907 . . . . 0.0 108.853 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 108' ' ' VAL . 15.3 m -69.78 37.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.926 . . . . 0.0 109.547 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -91.35 20.94 37.64 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.591 ' CG1' HH12 ' A' ' 101' ' ' ARG . 34.0 m -67.13 -41.2 86.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.211 -1.17 . . . . 0.0 108.679 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.524 ' N ' HG23 ' A' ' 110' ' ' VAL . 32.0 mt -135.71 56.59 1.82 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.441 ' OD1' ' NE2' ' A' ' 120' ' ' GLN . 1.2 p30 -84.39 83.9 7.83 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.461 ' CG ' ' NE2' ' A' ' 114' ' ' GLN . 14.2 pt-20 -103.11 10.05 38.12 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.461 ' NE2' ' CG ' ' A' ' 113' ' ' GLU . 11.2 mp0 -132.43 -2.57 3.44 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -165.69 -132.64 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.511 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.18 -107.63 2.38 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.804 -1.719 . . . . 0.0 108.804 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -144.05 -102.67 0.12 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.491 -1.005 . . . . 0.0 109.191 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 119' ' ' LYS . 8.0 m-20 -119.24 171.13 8.51 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 118' ' ' ASP . 85.6 mttt -34.89 131.31 0.38 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.69 -0.631 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.441 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -145.79 162.24 38.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.052 -1.03 . . . . 0.0 110.263 -178.443 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.456 HD11 ' CD1' ' A' ' 95' ' ' TYR . 12.4 mt -109.18 120.47 42.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.706 -0.621 . . . . 0.0 110.497 -178.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m -98.35 87.37 3.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.95 140.84 49.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.413 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -138.16 131.42 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -95.8 164.92 12.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.086 -1.009 . . . . 0.0 108.695 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 97.7 m -145.77 149.06 33.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.118 -0.989 . . . . 0.0 109.873 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 0.7 OUTLIER 176.79 132.09 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.306 -0.871 . . . . 0.0 109.35 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.8 OUTLIER 58.7 75.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.98 126.21 26.92 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.47 117.69 24.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.039 -1.038 . . . . 0.0 109.363 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -85.63 1.9 47.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.353 -0.842 . . . . 0.0 109.686 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -80.79 -55.88 4.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.6 p -94.66 -10.72 30.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.2 41.59 21.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.77 157.34 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 109.508 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.428 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.1 m95 -61.36 113.2 2.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.167 -0.958 . . . . 0.0 108.596 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' TRP . 35.2 tt0 -35.93 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.378 0.608 . . . . 0.0 110.759 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -100.33 150.95 22.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 108.95 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -173.55 144.66 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.948 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -106.37 173.2 6.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.1 mt -145.69 130.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.09 -1.007 . . . . 0.0 109.868 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -128.32 168.43 15.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.4 t -149.57 147.71 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.778 -1.201 . . . . 0.0 110.978 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.12 175.48 9.58 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -146.75 139.15 24.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.929 -1.107 . . . . 0.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 15.8 tm-20 -60.75 112.51 2.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 10.9 m -92.93 166.05 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.845 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.4 pttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.416 179.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 7' ' ' ILE . 9.5 mt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.6 122.46 6.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.647 1.564 . . . . 0.0 112.324 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -59.48 -7.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 12' ' ' SER . 2.6 m-20 -77.31 94.95 4.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.275 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -57.21 -5.68 0.31 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.261 -0.9 . . . . 0.0 109.793 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 10' ' ' ASP . 18.3 t -110.55 40.5 1.97 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.36 135.73 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.77 120.04 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.95 -19.98 19.1 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.28 -168.12 32.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.61 126.73 9.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.01 146.08 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.489 ' OE2' ' N ' ' A' ' 20' ' ' ILE . 8.8 tp10 -146.13 127.5 14.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.041 -1.037 . . . . 0.0 109.703 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.489 ' N ' ' OE2' ' A' ' 19' ' ' GLU . 44.7 mt -144.28 127.6 8.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.94 -46.19 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.726 1.617 . . . . 0.0 111.644 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.97 -25.33 3.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.79 9.03 10.62 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.485 -0.759 . . . . 0.0 109.397 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 42.27 38.75 1.24 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.424 0.63 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.42 HG23 ' OE1' ' A' ' 27' ' ' GLU . 4.4 mt -92.72 146.44 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.88 0.848 . . . . 0.0 109.536 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -164.64 80.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' OE1' HG23 ' A' ' 25' ' ' ILE . 3.2 mp0 -132.09 156.16 80.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.398 -0.814 . . . . 0.0 111.278 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -82.31 164.98 16.84 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.953 2.436 . . . . 0.0 112.332 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.0 127.03 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.385 -0.822 . . . . 0.0 109.066 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 4.9 m-85 -89.77 150.41 43.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.919 -1.113 . . . . 0.0 109.594 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.81 104.98 1.48 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.139 1.893 . . . . 0.0 111.605 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.08 -176.41 47.64 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.309 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' THR . 73.4 Cg_endo -79.16 117.94 3.92 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.323 . . . . 0.0 111.101 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.22 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.392 0.615 . . . . 0.0 110.455 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.587 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.8 p -105.69 153.47 39.92 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.03 -43.15 2.58 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.037 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.82 -21.41 66.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.9 OUTLIER -93.34 -62.39 1.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.0 mt -46.26 -18.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.389 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.5 m-20 -63.25 -25.28 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 89.2 mtt180 -83.27 -17.95 40.82 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 164.94 -130.92 2.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.295 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.34 165.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.574 -0.956 . . . . 0.0 109.213 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.452 ' CB ' HE22 ' A' ' 38' ' ' GLN . 3.3 t -162.09 159.1 25.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.157 -0.964 . . . . 0.0 109.065 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.94 164.85 2.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.84 -1.163 . . . . 0.0 109.396 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.79 -21.84 54.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.375 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -138.19 147.42 43.79 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.315 -0.866 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 -24.14 67.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.555 -0.716 . . . . 0.0 111.185 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -86.28 3.39 43.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.867 -1.146 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.87 161.88 20.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.048 -1.033 . . . . 0.0 109.3 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.1 m -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.759 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.5 mp -84.44 17.23 2.71 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -145.52 2.27 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.46 -0.775 . . . . 0.0 110.359 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASN . 50.7 t0 -57.29 126.49 27.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.64 -1.287 . . . . 0.0 109.292 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -42.31 -20.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.512 -0.743 . . . . 0.0 109.777 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 54' ' ' ASP . 14.7 t-20 -143.07 104.15 4.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 108.834 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.03 119.93 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.104 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.4 p -108.11 122.89 47.81 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 60' ' ' ALA . 68.9 mt -112.5 161.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.943 0.878 . . . . 0.0 110.952 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.552 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.62 125.49 25.71 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.86 153.31 21.04 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.622 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' PHE . 19.2 m-70 -74.97 167.8 21.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.737 -0.86 . . . . 0.0 109.972 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.06 87.36 1.27 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 108.913 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -87.26 117.1 25.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 65' ' ' ILE . 17.9 mt -59.85 -29.13 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.786 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.32 19.4 2.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.444 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -150.05 70.01 9.2 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.748 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.496 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.2 Cg_exo -54.38 18.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 123.236 2.624 . . . . 0.0 113.564 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 17.2 m-80 -148.94 62.31 1.05 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.07 -153.9 0.6 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.459 -0.776 . . . . 0.0 110.068 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -62.46 -89.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 111.685 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.65 ' CE1' HG22 ' A' ' 125' ' ' THR . 4.9 t80 -95.08 14.1 23.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.537 -0.727 . . . . 0.0 110.692 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 95.8 m -65.17 -49.45 69.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.4 -1.438 . . . . 0.0 110.829 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 5.0 m120 -83.1 -19.1 37.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.435 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.806 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.8 tm? -53.84 -27.94 32.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.851 -1.155 . . . . 0.0 109.059 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 20.6 mtmm -66.73 -27.83 67.94 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -71.33 -26.06 62.67 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.08 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.3 170.22 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.549 -0.719 . . . . 0.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -150.06 168.0 25.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.264 -0.897 . . . . 0.0 109.069 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 6.5 ttmm -51.32 150.98 3.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.546 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.66 -15.12 32.45 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.452 ' O ' ' SD ' ' A' ' 97' ' ' MET . 25.9 p -63.58 108.08 1.3 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.359 -1.083 . . . . 0.0 108.679 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.464 ' CE ' ' OH ' ' A' ' 85' ' ' TYR . 21.0 ptm -80.65 166.46 21.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.049 -1.032 . . . . 0.0 109.452 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.15 175.8 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.316 -0.865 . . . . 0.0 110.108 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' OH ' ' CE ' ' A' ' 83' ' ' MET . 73.8 m-85 -142.54 111.39 6.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.3 115.99 28.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -85.93 141.12 29.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.6 m -146.64 127.69 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.534 -0.729 . . . . 0.0 109.163 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.57 -115.83 2.06 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -116.16 53.92 0.85 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.606 -0.937 . . . . 0.0 109.399 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -166.84 153.4 8.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.048 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 92' ' ' THR . 9.0 t -131.09 124.9 31.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.4 6.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 7.5 ptpp? -142.92 154.8 44.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.146 -0.971 . . . . 0.0 110.042 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 4.1 m-85 -138.25 177.77 7.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -140.23 110.45 6.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.26 135.21 17.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.05 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 p -153.11 18.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 109.991 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 143' ' ' VAL . 0.6 OUTLIER -170.14 87.45 0.13 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.624 -1.297 . . . . 0.0 109.259 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 C--N 1.296 -1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.247 -179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.3 m-20 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 118' ' ' ASP . 37.5 mtmt -38.52 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -154.7 157.37 37.98 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.183 -0.948 . . . . 0.0 110.053 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.7 tp -121.82 106.73 11.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.1 m -91.16 128.03 36.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.933 -1.104 . . . . 0.0 108.785 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.3 mp -103.43 145.27 30.24 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.22 -0.925 . . . . 0.0 110.161 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.6 mt -142.58 139.97 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.374 -0.829 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.65 HG22 ' CE1' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -96.07 166.11 11.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.013 -1.054 . . . . 0.0 108.787 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.473 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -149.86 102.49 3.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.04 -1.037 . . . . 0.0 109.754 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 p-10 -156.03 148.03 23.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 0.0 109.305 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.48 56.85 2.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 108.802 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -62.05 119.0 8.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.464 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 135' ' ' VAL . 2.6 p-10 -83.92 130.63 34.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.013 -1.054 . . . . 0.0 109.694 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.75 5.52 43.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 109.061 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -71.63 -61.43 1.78 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.464 -0.773 . . . . 0.0 108.936 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -100.49 -1.42 35.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 109.342 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.85 49.72 33.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 5.1 t -146.99 168.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -1.065 . . . . 0.0 109.417 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 91.6 m95 -73.82 113.64 11.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -40.28 -77.54 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -84.36 150.49 25.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.015 . . . . 0.0 108.584 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -151.03 79.48 1.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.862 -1.149 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 125' ' ' THR . 10.8 mtpt -75.2 148.72 39.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.455 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 11.9 pt -135.87 149.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 122.12 0.962 . . . . 0.0 110.902 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -144.09 143.86 31.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 99' ' ' SER . 4.7 p -136.89 149.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.897 -1.127 . . . . 0.0 110.938 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -130.89 -178.03 4.63 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.7 t -148.05 148.54 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.002 -1.061 . . . . 0.0 109.651 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -51.11 144.03 9.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.86 . . . . 0.0 109.223 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.346 -0.846 . . . . 0.0 109.164 -179.497 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.3 mm . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 98.9 Cg_exo -42.33 150.58 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.627 1.551 . . . . 0.0 112.004 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.08 -11.52 18.8 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.13 103.0 6.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 0.0 109.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -56.5 -13.0 1.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -98.48 30.81 3.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.4 -0.812 . . . . 0.0 109.203 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.5 140.53 23.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.624 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 58.5 t -60.65 163.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.72 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.568 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -138.51 -3.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 177.34 -175.19 47.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.624 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 69.6 m-85 -149.81 121.46 8.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.084 -1.245 . . . . 0.0 110.087 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.8 tt -98.66 143.93 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -146.84 136.03 22.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.03 -1.044 . . . . 0.0 110.675 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.492 ' CD1' HD21 ' A' ' 75' ' ' LEU . 51.4 mt -144.88 125.02 7.26 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.5 Cg_endo -76.3 -42.55 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.691 1.594 . . . . 0.0 111.434 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -50.66 -17.24 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.048 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.488 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -133.82 14.31 3.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.513 -0.742 . . . . 0.0 109.209 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.4 p-10 43.75 50.25 6.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.488 HG12 ' HB3' ' A' ' 23' ' ' ALA . 43.3 mm -92.7 142.79 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.645 0.736 . . . . 0.0 109.888 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -168.97 81.35 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.0 158.49 61.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.738 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' A' ' 14' ' ' VAL . 40.8 Cg_endo -86.07 169.74 8.68 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.184 2.589 . . . . 0.0 113.105 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.56 137.14 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 24.6 m-85 -92.41 149.84 39.0 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.907 -1.121 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 50.3 Cg_endo -81.46 79.37 3.25 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.806 2.338 . . . . 0.0 111.802 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.76 177.5 39.58 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.865 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 91.2 Cg_endo -79.86 121.66 4.62 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.824 2.349 . . . . 0.0 111.182 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -40.85 87.75 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.906 -0.496 . . . . 0.0 110.918 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -111.54 167.28 9.32 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.52 -45.36 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.739 1.626 . . . . 0.0 111.833 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -62.28 -17.03 57.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.856 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.599 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -96.98 -69.36 0.76 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 0.0 108.642 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' A' ' 34' ' ' ALA . 42.2 mt -41.35 -24.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.799 -0.563 . . . . 0.0 110.51 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 38' ' ' GLN . 31.3 m-20 -63.61 -25.13 68.09 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.436 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.4 mtp180 -84.49 -14.58 48.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' C ' HE21 ' A' ' 71' ' ' GLN . . . 156.51 -143.92 10.22 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.882 -1.151 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.636 HG23 ' NE2' ' A' ' 71' ' ' GLN . 3.9 t -88.61 152.88 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 t -148.81 141.02 24.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 108.967 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -56.45 162.35 2.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 108.944 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.31 -9.98 59.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.173 -0.954 . . . . 0.0 108.812 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -145.27 149.55 35.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.5 pt-20 -63.39 -41.84 98.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 111.152 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 8.2 p30 -89.65 17.81 6.11 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 111.222 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.87 95.77 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.866 -1.146 . . . . 0.0 109.839 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -89.75 173.31 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -82.44 0.13 43.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.089 -1.007 . . . . 0.0 108.647 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.91 -10.68 19.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.564 -0.71 . . . . 0.0 109.897 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.5 t70 -59.59 113.44 2.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.772 -1.205 . . . . 0.0 108.863 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -46.72 -14.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.133 -0.979 . . . . 0.0 109.56 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' ASP . 3.8 m120 -133.49 97.21 3.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -94.23 115.86 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.233 -0.917 . . . . 0.0 108.917 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.8 t -108.63 116.69 32.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.697 -0.627 . . . . 0.0 109.351 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 60' ' ' ALA . 92.1 mt -109.37 164.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.601 0.715 . . . . 0.0 109.579 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.561 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -138.32 135.25 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.07 148.78 20.7 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.081 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -74.53 -169.29 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.639 -0.918 . . . . 0.0 110.07 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.84 99.99 0.47 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.27 122.45 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.162 -0.962 . . . . 0.0 108.918 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 65' ' ' ILE . 16.2 mt -64.65 -43.06 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.783 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.26 18.91 2.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.187 -0.945 . . . . 0.0 109.888 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -151.04 75.58 8.16 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 72.9 Cg_exo -51.78 24.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.92 3.08 . . . . 0.0 114.642 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.4 m120 -151.7 62.92 0.86 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 108.55 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 73' ' ' THR . 36.8 t80 -141.7 90.24 2.26 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.235 -0.916 . . . . 0.0 110.498 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.636 ' NE2' HG23 ' A' ' 43' ' ' VAL . 1.5 mm100 65.03 -119.23 0.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.764 -0.585 . . . . 0.0 111.556 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.628 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 29.5 t80 -87.44 33.35 0.69 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.318 1.056 . . . . 0.0 109.142 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 70' ' ' TYR . 21.6 m -69.13 -57.21 5.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.15 -1.594 . . . . 0.0 110.607 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 2.1 m-20 -90.43 -13.56 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.181 -0.949 . . . . 0.0 111.775 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 20' ' ' ILE . 2.4 mt -52.38 -29.63 24.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 108.281 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -74.02 -1.77 21.36 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -99.37 -33.2 10.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.618 . . . . 0.0 109.337 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.25 163.23 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -129.03 162.73 26.97 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -49.06 132.41 19.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 109.282 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.94 -24.3 15.03 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -64.36 114.23 4.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.206 -1.173 . . . . 0.0 108.065 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -73.35 -174.11 1.55 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.839 -1.163 . . . . 0.0 109.454 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.584 ' N ' ' SD ' ' A' ' 83' ' ' MET . 21.4 t -146.46 110.75 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.515 ' CD2' ' SD ' ' A' ' 83' ' ' MET . 53.0 m-85 -87.45 102.44 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -97.56 117.54 32.07 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -107.75 139.77 41.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.414 -0.804 . . . . 0.0 110.112 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 89' ' ' GLY . 7.1 p -168.96 157.41 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.724 . . . . 0.0 109.484 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 88' ' ' VAL . . . 57.85 -96.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -154.27 29.8 0.44 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -140.17 -175.25 4.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.355 -0.841 . . . . 0.0 109.201 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 m -149.83 111.57 4.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.536 ' NH2' ' CD1' ' A' ' 52' ' ' LEU . 7.6 mpt_? -89.07 163.53 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -141.43 122.9 15.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.384 -0.823 . . . . 0.0 109.63 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 17.1 m-85 -109.15 175.1 5.58 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.429 -0.794 . . . . 0.0 109.128 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.89 111.06 8.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.28 -0.887 . . . . 0.0 109.886 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.9 mtt -50.67 123.23 8.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.123 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 p -149.44 20.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 109.431 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.1 t -171.37 123.69 0.57 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.691 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.3 mt . . . . . 0 N--CA 1.495 1.822 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 -179.081 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 49.1 t0 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.468 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 83.0 mttt -60.83 145.08 51.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -143.83 160.58 40.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.057 -1.027 . . . . 0.0 108.953 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.1 tp -114.87 107.98 16.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.675 . . . . 0.0 110.962 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 122' ' ' THR . 6.7 t -97.54 107.72 20.29 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.0 156.38 21.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.003 . . . . 0.0 110.278 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.7 mt -140.37 143.78 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.513 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -91.78 155.89 17.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.934 -1.104 . . . . 0.0 108.512 179.288 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.416 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 2.0 m -149.29 85.03 1.44 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.944 -1.097 . . . . 0.0 109.886 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 20.3 p-10 -142.8 143.88 32.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.141 -0.975 . . . . 0.0 109.235 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.34 61.09 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.451 -0.78 . . . . 0.0 109.072 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -63.7 119.98 10.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -85.67 123.48 31.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 109.602 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.7 pm0 -94.82 14.7 20.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.343 -0.848 . . . . 0.0 109.77 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -69.31 -35.5 76.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.0 108.57 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.0 p -140.99 1.92 1.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 109.037 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.63 3.03 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.3 t -146.99 133.72 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.225 -1.162 . . . . 0.0 109.642 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 53.3 m95 -53.11 113.65 1.19 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.07 -1.019 . . . . 0.0 108.493 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -36.96 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.291 0.567 . . . . 0.0 110.326 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 137' ' ' GLU . 19.2 ptmt -96.87 139.35 33.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -151.78 96.49 2.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.891 -1.131 . . . . 0.0 110.569 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.658 ' O ' HD13 ' A' ' 141' ' ' ILE . 40.4 mtpt -86.58 158.49 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.156 -0.965 . . . . 0.0 108.473 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 140' ' ' LYS . 7.9 mm -129.25 140.29 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 25.8 m-85 -129.49 170.63 13.47 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.1 t -154.06 140.85 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.692 -1.255 . . . . 0.0 110.86 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.24 139.3 40.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.8 t -109.85 137.61 47.39 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.399 -0.813 . . . . 0.0 110.389 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.03 133.55 55.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 109.547 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 147' ' ' VAL . 8.2 m . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 109.327 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 10' ' ' ASP . 93.1 Cg_endo -83.6 134.18 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.191 1.927 . . . . 0.0 112.432 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -60.21 0.76 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 12' ' ' SER . 13.2 t70 -76.49 91.18 3.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -64.76 38.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 10' ' ' ASP . 43.3 t -146.9 25.26 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 108.885 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -141.67 141.88 33.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.64 118.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.66 -0.65 . . . . 0.0 110.885 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.96 -16.81 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.97 -177.48 38.74 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 121.31 8.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -1.223 . . . . 0.0 109.586 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -99.9 142.04 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' CD ' ' NZ ' ' A' ' 87' ' ' LYS . 23.7 mt-10 -146.79 135.24 21.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.968 -1.083 . . . . 0.0 110.737 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.494 HD12 HD23 ' A' ' 75' ' ' LEU . 32.5 mt -144.84 127.06 8.12 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.07 -42.75 0.37 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.636 1.557 . . . . 0.0 111.599 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -52.16 -14.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.403 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.495 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -135.63 15.14 3.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.42 -0.8 . . . . 0.0 109.136 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 42.41 49.52 4.62 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.718 0.77 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 23' ' ' ALA . 50.0 mm -91.76 141.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 25' ' ' ILE . 42.3 mttp -165.9 81.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -143.91 156.58 58.79 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 0.0 110.817 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -84.79 165.36 11.84 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.041 2.494 . . . . 0.0 112.531 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.22 119.43 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.565 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 7.9 m-85 -79.37 149.43 72.23 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.817 -1.177 . . . . 0.0 110.207 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.58 88.5 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.479 2.119 . . . . 0.0 111.86 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.31 -179.44 41.23 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.575 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 35' ' ' THR . 85.2 Cg_endo -78.09 119.17 4.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.861 2.374 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.63 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.383 0.611 . . . . 0.0 110.397 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -112.55 153.47 44.94 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.63 -43.43 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.09 1.86 . . . . 0.0 111.664 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.09 -22.98 67.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.565 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 7.1 tp60 -89.94 -66.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.235 -0.916 . . . . 0.0 109.54 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.2 mt -46.39 -15.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.918 . . . . 0.0 109.947 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' GLN . 40.0 m-20 -63.25 -25.19 68.21 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.88 -11.24 45.18 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 158.15 -136.6 4.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 60' ' ' ALA . 2.9 t -108.42 159.03 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.992 . . . . 0.0 109.862 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 p -153.58 156.73 38.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -57.99 175.67 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.797 -1.189 . . . . 0.0 109.946 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -85.95 -12.18 51.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -147.24 151.12 36.15 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.472 0.653 . . . . 0.0 109.935 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.39 -38.73 92.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.6 -0.687 . . . . 0.0 111.34 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -87.38 12.31 12.38 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.897 -1.127 . . . . 0.0 110.643 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.31 84.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' ASP . 48.2 m -92.56 147.46 22.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.03 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.967 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.41 -8.77 0.37 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -77.12 -30.82 55.37 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.508 -0.745 . . . . 0.0 109.615 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 15.8 m-20 -62.16 104.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.055 -1.028 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.31 -16.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 54' ' ' ASP . 27.6 t-20 -117.97 97.86 6.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.646 -0.659 . . . . 0.0 109.223 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.425 ' O ' ' OG1' ' A' ' 122' ' ' THR . 92.2 mt -98.49 150.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.376 -0.827 . . . . 0.0 109.325 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -140.46 114.45 9.02 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -101.69 161.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.326 -0.859 . . . . 0.0 110.362 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.542 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -140.27 131.17 26.02 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.23 154.24 24.89 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.537 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.713 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 19.9 m-70 -71.1 175.52 5.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.68 -0.894 . . . . 0.0 109.063 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.86 89.75 0.66 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.65 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.05 116.99 28.49 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.2 mm -59.59 -29.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.799 . . . . 0.0 110.097 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -87.54 19.51 3.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -149.71 70.56 9.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.536 -0.727 . . . . 0.0 109.191 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.88 14.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 123.442 2.761 . . . . 0.0 113.853 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 67' ' ' ARG . 56.5 m-80 -147.9 60.95 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.216 . . . . 0.0 108.839 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -146.8 103.63 3.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 110.48 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.713 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 15.0 mt-30 55.81 -115.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 111.907 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.68 30.65 2.87 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 111.13 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.1 m -63.92 -49.16 73.71 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.128 -1.608 . . . . 0.0 109.611 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.602 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.9 m-20 -93.95 -18.23 22.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.012 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.69 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.6 tm? -51.05 -39.07 55.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -68.91 -4.71 17.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -91.5 -27.99 17.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 162.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 109.742 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 166.36 24.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.348 -0.845 . . . . 0.0 108.807 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -50.18 137.31 18.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.54 13.19 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -64.19 119.7 10.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.407 -1.055 . . . . 0.0 108.269 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.7 mtp -82.96 137.12 34.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.0 -1.063 . . . . 0.0 110.102 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.02 114.12 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.607 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -93.26 102.46 14.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.151 -0.968 . . . . 0.0 109.544 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -97.13 114.63 26.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 0.0 108.755 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' NZ ' ' CD ' ' A' ' 19' ' ' GLU . 23.0 mtmm -106.12 142.08 36.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.94 123.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.79 -145.23 5.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 90' ' ' ASN . 28.0 t-20 -85.26 52.1 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.198 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 m -152.98 148.68 27.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.601 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 177.15 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -144.31 164.1 31.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.028 -1.045 . . . . 0.0 110.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 94' ' ' LYS . 23.7 m-85 -148.96 108.31 3.95 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.39 117.91 16.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.132 -0.98 . . . . 0.0 109.27 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -51.75 129.62 26.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.309 -0.869 . . . . 0.0 108.988 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -158.16 24.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.227 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.0 t -171.28 132.7 0.81 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.4 mt . . . . . 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -178.545 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 4.2 m-20 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -47.37 141.29 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 108.824 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -152.84 164.58 37.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 110.572 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.1 tp -127.23 116.59 20.81 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.067 0.46 . . . . 0.0 109.854 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.498 ' H ' ' HG1' ' A' ' 122' ' ' THR . 0.1 OUTLIER -96.05 92.37 6.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.07 143.17 54.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 110.136 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mt -140.92 135.62 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.462 -0.774 . . . . 0.0 109.324 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.6 p -96.63 167.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.058 -1.027 . . . . 0.0 108.521 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 70.8 m -147.03 139.5 24.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.022 -1.049 . . . . 0.0 110.124 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 1.7 p30 179.59 136.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 61.5 64.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.0 109.201 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -62.98 126.5 27.53 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 109.142 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -85.96 118.36 25.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.038 . . . . 0.0 109.509 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.74 -0.56 54.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.425 -0.797 . . . . 0.0 109.918 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.77 -50.24 9.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.008 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.7 p -95.13 -10.69 29.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.236 -0.915 . . . . 0.0 109.233 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.76 39.94 54.08 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.89 158.89 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.333 -1.098 . . . . 0.0 109.636 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.427 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.8 m95 -62.78 111.76 2.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -35.79 -77.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.064 0.459 . . . . 0.0 110.627 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.446 -0.784 . . . . 0.0 109.227 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -169.79 131.62 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.709 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.51 166.83 13.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.14 -0.975 . . . . 0.0 108.845 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 22.6 mt -141.51 144.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 13.1 m-85 -140.1 168.93 18.66 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -150.05 141.8 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.626 -1.296 . . . . 0.0 110.745 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.19 171.27 14.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 147' ' ' VAL . 14.4 t -146.87 147.53 30.91 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.84 -1.163 . . . . 0.0 110.93 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.17 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.7 t . . . . . 0 N--CA 1.497 1.895 0 O-C-N 121.181 -0.949 . . . . 0.0 108.99 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' PRO . 6.9 mm . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' ILE . 76.8 Cg_exo -47.27 -174.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.527 1.485 . . . . 0.0 112.509 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -120.66 -26.7 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' SER . 30.8 t70 -76.08 101.68 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -57.45 -2.67 0.13 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.6 p -115.59 43.98 1.97 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.499 -0.75 . . . . 0.0 109.345 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 136.83 30.24 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 t -61.19 108.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.52 -0.738 . . . . 0.0 111.402 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.7 -5.03 49.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.43 -170.24 40.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.08 126.33 10.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -1.183 . . . . 0.0 109.073 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 tp -97.41 140.77 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -146.58 132.54 19.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.167 . . . . 0.0 110.748 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.612 ' CD1' HD21 ' A' ' 75' ' ' LEU . 35.6 mt -144.8 120.58 6.02 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.94 -37.99 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.629 1.553 . . . . 0.0 111.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.32 -19.9 1.48 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.408 -0.807 . . . . 0.0 109.293 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 24' ' ' ASP . . . -130.54 5.32 4.72 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.5 -0.75 . . . . 0.0 109.465 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER 56.16 29.61 15.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.831 -0.543 . . . . 0.0 111.372 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CD1' ' ND2' ' A' ' 74' ' ' ASN . 1.5 mp -85.33 142.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.658 -1.276 . . . . 0.0 108.404 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -165.64 86.3 0.37 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 16.6 mt-10 -142.13 160.62 54.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.75 158.18 24.68 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.514 2.143 . . . . 0.0 112.17 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.06 108.39 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.75 166.94 27.01 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.948 -1.095 . . . . 0.0 109.11 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -86.1 130.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.486 2.124 . . . . 0.0 112.177 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.02 168.94 30.88 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.012 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.9 Cg_endo -77.78 121.02 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 111.286 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -39.78 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.33 0.586 . . . . 0.0 110.281 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 p -126.43 152.82 74.68 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.12 -43.0 12.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.187 1.924 . . . . 0.0 111.995 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -61.46 -21.98 64.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.576 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -95.29 -69.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.158 -0.964 . . . . 0.0 109.253 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 17.5 mt -45.58 -16.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -62.18 -24.84 67.43 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.6 -15.64 54.06 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.61 -109.69 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.924 -1.131 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 60' ' ' ALA . 5.0 t -125.52 153.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.505 -0.997 . . . . 0.0 109.758 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 2.7 m -153.79 153.74 32.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -56.78 165.57 1.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.594 -1.317 . . . . 0.0 109.474 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.05 -5.12 53.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -150.9 146.42 26.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.519 -0.738 . . . . 0.0 109.591 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.49 -38.39 87.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 111.075 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -89.47 15.48 9.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.99 -1.069 . . . . 0.0 111.143 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.0 99.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.847 -1.158 . . . . 0.0 109.61 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.1 p -91.22 144.28 25.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 108.856 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.039 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.99 -7.1 0.95 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' SER . 20.5 t0 -96.01 -13.47 23.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.691 -0.631 . . . . 0.0 109.626 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' ASN . 46.4 t0 -58.97 105.08 0.28 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.02 -1.05 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.782 HE21 HE21 ' A' ' 120' ' ' GLN . 6.0 tm0? -44.49 -17.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.506 -0.747 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 54' ' ' ASP . 5.0 t-20 -122.3 92.75 3.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.1 mt -93.55 145.8 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 108.453 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 t -142.3 109.17 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 108.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.5 mt -95.27 162.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.181 -0.949 . . . . 0.0 110.162 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -134.02 131.78 39.3 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.03 145.47 15.44 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.844 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 18.1 m-70 -72.85 -169.95 0.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.685 -0.891 . . . . 0.0 109.304 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.48 94.15 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -89.44 113.09 24.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.923 . . . . 0.0 108.887 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mt -61.07 -31.67 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 110.12 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -84.27 15.47 3.56 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 109.302 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -151.49 74.23 8.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.466 ' C ' ' ND2' ' A' ' 69' ' ' ASN . 76.8 Cg_exo -52.38 24.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 123.861 3.041 . . . . 0.0 114.379 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.9 m-80 -151.26 63.44 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.0 108.551 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 36.2 t80 -150.77 99.85 2.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.071 -1.018 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.542 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.8 mt-30 59.66 -122.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.706 . . . . 0.0 111.454 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 12.2 t80 -92.75 36.66 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.402 1.096 . . . . 0.0 109.574 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.7 m -67.05 -56.65 9.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 119.908 -1.745 . . . . 0.0 110.299 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.2 p30 -110.82 7.14 21.84 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.232 -0.917 . . . . 0.0 111.409 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.612 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.8 mt -57.8 -15.03 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.62 -12.35 59.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -81.54 -30.41 33.15 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.8 -179.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLY . 23.5 mmtp -139.76 153.48 47.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 9.7 ttmm -51.39 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.83 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.7 -15.35 0.36 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -62.86 121.25 13.02 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.335 -1.097 . . . . 0.0 108.119 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtp -70.94 -175.06 1.04 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.336 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -146.51 109.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.39 101.88 14.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE2' ' CG2' ' A' ' 88' ' ' VAL . 16.7 t80 -98.74 112.45 24.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 87' ' ' LYS . 7.0 mtmp? -92.12 146.55 23.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.064 -1.023 . . . . 0.0 110.809 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 90' ' ' ASN . 68.3 t -139.55 155.25 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.77 41.2 0.25 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 88' ' ' VAL . 43.1 t30 -160.4 -34.29 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.229 -1.159 . . . . 0.0 110.028 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.441 ' OE1' ' NH1' ' A' ' 93' ' ' ARG . 29.8 tt0 -172.4 165.9 5.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 92' ' ' THR . 11.0 t -107.14 123.04 47.67 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.441 ' NH1' ' OE1' ' A' ' 91' ' ' GLU . 5.3 mmt180 -92.94 160.16 15.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 108.737 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -144.87 121.18 10.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -114.59 176.76 4.91 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.607 -0.683 . . . . 0.0 109.223 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -136.56 107.21 6.55 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 0.0 109.395 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.445 ' HB3' ' H ' ' A' ' 81' ' ' GLY . 28.5 tpp -49.49 119.29 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.052 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -145.37 19.72 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.096 -1.002 . . . . 0.0 109.744 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.7 m -169.54 118.84 0.65 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 108.784 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.554 -0.716 . . . . 0.0 109.669 -179.217 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 47.3 t0 . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 121.549 0.69 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -44.86 140.77 2.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.782 HE21 HE21 ' A' ' 55' ' ' GLN . 9.0 pt20 -152.21 173.4 15.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.997 -1.064 . . . . 0.0 110.08 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.7 tp -122.87 155.86 35.81 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.45 0.643 . . . . 0.0 110.122 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.0 m -141.98 88.96 2.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.77 149.44 49.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.378 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 96.8 mt -140.04 141.99 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.5 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -90.49 156.56 18.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.919 -1.113 . . . . 0.0 108.831 179.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.533 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 23.0 m -148.75 89.82 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.142 -0.973 . . . . 0.0 109.449 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -148.54 146.04 28.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.235 -0.916 . . . . 0.0 109.118 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 1.2 m-20 61.29 63.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 108.835 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -63.24 122.11 15.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -85.17 121.69 28.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.85 13.77 19.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.853 . . . . 0.0 109.638 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -81.19 -26.16 36.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 p -141.98 5.59 1.73 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.355 -0.84 . . . . 0.0 109.168 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.23 53.04 23.88 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.481 ' CG1' ' NH2' ' A' ' 139' ' ' ARG . 3.3 t -147.29 139.83 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.218 -1.166 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 56.9 m95 -56.09 115.39 2.4 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.38 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 12.6 tp10 -39.51 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.724 -0.61 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -81.28 146.92 30.16 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.481 ' NH2' ' CG1' ' A' ' 135' ' ' VAL . 26.8 ttm180 -158.76 75.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.872 -1.143 . . . . 0.0 110.482 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -75.27 163.59 27.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.47 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 6.9 mm -134.09 156.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.836 0.826 . . . . 0.0 110.426 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 21.3 m-85 -141.75 159.73 41.64 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.2 147.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.711 -1.243 . . . . 0.0 111.342 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.17 158.77 43.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.21 143.02 50.27 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.15 -0.968 . . . . 0.0 109.92 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 9.1 tm-20 -60.48 135.75 57.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.438 -0.789 . . . . 0.0 108.88 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.425 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.5 2.036 0 O-C-N 121.356 -0.84 . . . . 0.0 108.875 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.62 172.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.275 1.983 . . . . 0.0 112.345 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.57 2.08 12.33 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.57 -0.707 . . . . 0.0 109.514 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 12' ' ' SER . 63.2 t0 -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.98 3.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ASP . 27.2 p -129.24 39.81 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.259 -0.9 . . . . 0.0 109.82 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -150.42 150.36 31.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.149 -0.969 . . . . 0.0 109.143 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 15' ' ' ALA . 89.0 t -61.04 157.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.603 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -144.29 -30.09 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.82 -178.18 28.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -148.06 120.01 8.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -1.137 . . . . 0.0 108.963 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.602 HD11 ' CG1' ' A' ' 84' ' ' VAL . 9.8 tp -94.37 143.67 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -147.43 132.55 18.3 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.155 . . . . 0.0 110.914 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.2 mt -145.72 123.71 6.35 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.7 -39.42 0.52 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.752 1.635 . . . . 0.0 111.895 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.48 -23.32 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 25' ' ' ILE . . . -127.35 4.38 6.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 109.42 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.3 p30 52.38 37.38 22.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.832 -0.542 . . . . 0.0 111.359 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.552 HD11 ' OD1' ' A' ' 74' ' ' ASN . 1.5 mp -86.29 146.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.76 -1.212 . . . . 0.0 108.095 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -166.55 82.56 0.26 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -139.27 156.91 71.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 111.646 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.0 164.51 7.28 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.82 2.346 . . . . 0.0 113.308 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.86 129.72 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 2.0 m-85 -87.57 152.36 51.81 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 120.877 -1.139 . . . . 0.0 110.179 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.4 97.94 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.577 2.185 . . . . 0.0 111.43 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.77 -178.27 48.68 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.323 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.0 Cg_endo -80.61 117.78 3.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.867 2.378 . . . . 0.0 111.018 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.05 88.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.395 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.0 p -107.7 153.63 41.36 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.62 -41.35 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.191 1.928 . . . . 0.0 112.392 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.43 -22.22 66.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 109.678 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.4 tm0? -96.17 -53.74 3.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.9 mt -45.1 -23.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' GLN . 14.6 m-20 -64.03 -25.67 68.22 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.419 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 88.5 mtt180 -84.35 -16.0 44.45 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.0 -139.61 6.81 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.682 -1.246 . . . . 0.0 110.782 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.4 t -99.85 159.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.46 -1.023 . . . . 0.0 109.792 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -155.56 152.97 29.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.516 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 54.1 m-85 -58.68 160.21 5.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.522 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -75.39 -6.16 48.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.997 . . . . 0.0 109.413 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -154.37 149.56 26.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -62.99 -35.86 81.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 111.612 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.509 ' ND2' ' OE2' ' A' ' 48' ' ' GLU . 13.9 p30 -87.88 15.5 7.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.858 -1.151 . . . . 0.0 110.979 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 12.0 tm-20 -64.86 145.06 56.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.991 -1.068 . . . . 0.0 109.062 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.465 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 8.4 p -148.44 153.46 38.54 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -67.04 -4.64 10.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 51' ' ' SER . 39.2 m-20 -95.06 -17.42 21.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.9 t70 -59.15 115.56 3.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.944 -1.097 . . . . 0.0 108.846 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 9.3 tt0 -46.04 -19.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 109.607 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' ASP . 61.7 t-20 -131.88 113.48 13.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.692 . . . . 0.0 109.435 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.64 145.19 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 108.627 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.7 p -141.55 104.43 4.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.2 mt -103.13 158.83 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.543 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -126.86 129.06 47.5 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.8 149.05 20.55 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.924 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 31.3 m-70 -74.28 -163.54 0.2 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.61 -0.936 . . . . 0.0 110.046 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 63' ' ' THR . 10.0 t -164.34 80.56 0.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.332 -0.855 . . . . 0.0 108.794 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -87.51 108.0 18.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.798 -1.189 . . . . 0.0 109.11 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.99 -29.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -82.38 12.31 4.6 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.805 0.812 . . . . 0.0 109.401 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -146.01 75.39 12.95 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.52 8.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.617 2.878 . . . . 0.0 113.988 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 67' ' ' ARG . 12.2 p30 -142.93 59.36 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 0.0 108.085 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -143.46 102.91 4.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.381 -0.824 . . . . 0.0 110.177 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 51.62 -132.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.423 -0.798 . . . . 0.0 110.752 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.679 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 1.1 t80 -87.65 63.39 7.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.881 1.324 . . . . 0.0 108.779 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 m -89.66 -32.69 16.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.657 -1.277 . . . . 0.0 108.377 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.556 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 3.6 p-10 -140.03 10.06 2.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -10.53 0.72 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.499 ' N ' ' C ' ' A' ' 74' ' ' ASN . 1.8 ptmm? -85.33 -23.48 28.05 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -67.33 -29.09 68.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.36 -157.15 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.7 ptmt -171.23 162.42 6.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -52.59 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.256 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 152.56 -25.09 0.85 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -63.41 113.66 3.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.1 mtp -63.24 -177.5 0.19 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.68 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' CG1' HD11 ' A' ' 18' ' ' ILE . 31.6 t -144.87 106.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.421 -0.8 . . . . 0.0 109.171 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.99 102.43 14.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.931 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -96.12 115.99 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -102.91 144.04 31.72 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.304 -0.873 . . . . 0.0 109.983 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 15' ' ' ALA . 2.2 p -169.24 140.29 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.399 -0.813 . . . . 0.0 109.105 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.5 -97.71 0.15 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.88 18.9 0.89 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -1.14 . . . . 0.0 109.299 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -132.73 139.82 47.78 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 92' ' ' THR . 12.7 t -112.53 132.35 55.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.439 -0.788 . . . . 0.0 110.287 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HG3' HH11 ' A' ' 93' ' ' ARG . 7.4 mmm-85 -92.93 167.56 11.74 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -148.46 92.76 2.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.9 -1.125 . . . . 0.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -87.7 -178.16 6.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 108.185 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -138.39 105.33 5.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.252 -0.905 . . . . 0.0 109.769 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.416 ' HB3' ' H ' ' A' ' 81' ' ' GLY . 35.7 ttm -50.06 115.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -157.59 24.76 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.1 m -164.69 119.53 1.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.428 -0.795 . . . . 0.0 109.63 -178.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' GLN . 34.7 m-20 . . . . . 0 N--CA 1.503 2.202 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' ASP . 42.4 mmtt -41.27 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.3 pm0 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -114.18 102.66 10.35 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -96.46 134.8 39.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.097 -1.002 . . . . 0.0 109.332 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.97 148.06 43.38 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.504 -0.748 . . . . 0.0 109.132 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.1 mt -133.77 143.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.43 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 p -91.13 153.23 20.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 109.335 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.515 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 10.6 m -149.31 92.18 1.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.327 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.416 ' OD2' ' OD1' ' A' ' 128' ' ' ASP . 6.5 p-10 -149.0 146.85 27.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.353 -0.842 . . . . 0.0 108.898 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.416 ' OD1' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-20 59.33 63.66 1.52 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.01 124.89 22.25 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.682 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 6.3 t-20 -85.11 115.1 22.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.947 . . . . 0.0 109.312 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -83.87 1.21 44.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 65.0 mmtt -79.86 -53.91 6.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.274 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.0 p -95.55 -9.8 31.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.52 42.94 31.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.22 152.26 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -1.118 . . . . 0.0 109.62 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.4 m95 -58.72 114.93 2.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.1 tt0 -38.3 -72.92 0.05 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 110.567 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -91.01 148.17 22.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.098 -1.001 . . . . 0.0 109.305 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -154.13 93.42 1.62 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.035 -1.041 . . . . 0.0 110.906 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.402 ' CB ' ' HZ3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -94.7 164.59 12.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.0 mt -139.38 149.88 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.251 -0.906 . . . . 0.0 110.505 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.2 m-85 -137.27 164.5 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 99' ' ' SER . 72.5 t -152.66 118.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.655 -1.278 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -101.81 -176.48 3.14 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.0 t -153.9 131.37 11.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.873 -1.142 . . . . 0.0 110.022 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.54 109.85 1.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 147' ' ' VAL . 98.9 t . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.87 0.843 . . . . 0.0 109.667 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 8' ' ' PRO . 5.7 mm . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 7' ' ' ILE . 74.2 Cg_exo -49.54 -140.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 121.96 1.773 . . . . 0.0 113.63 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -160.2 -30.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.882 -1.136 . . . . 0.0 109.783 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 12' ' ' SER . 26.3 t0 -74.96 112.6 11.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.496 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -57.8 -4.78 0.32 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 109.752 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.7 p -111.88 39.73 2.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.549 -0.719 . . . . 0.0 109.585 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.4 143.63 29.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.044 -1.035 . . . . 0.0 109.662 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.83 149.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.817 0.817 . . . . 0.0 110.846 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.87 10.45 1.78 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.66 176.05 38.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -147.96 117.27 6.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.305 -1.114 . . . . 0.0 109.437 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -97.76 141.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -146.34 138.89 25.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.996 -1.065 . . . . 0.0 110.45 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 75' ' ' LEU . 52.4 mt -144.46 125.8 7.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.72 -41.14 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.477 1.451 . . . . 0.0 111.333 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -51.79 -16.6 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.835 . . . . 0.0 109.315 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.523 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.29 14.88 3.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.81 . . . . 0.0 109.476 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.4 p-10 43.79 50.09 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.43 -0.794 . . . . 0.0 109.891 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 23' ' ' ALA . 49.6 mm -88.8 144.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.582 0.706 . . . . 0.0 109.664 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -168.9 81.25 0.14 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -140.83 152.5 65.77 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.239 -0.913 . . . . 0.0 110.33 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.14 166.92 10.95 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.827 2.351 . . . . 0.0 112.633 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.7 120.44 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -90.99 165.7 21.06 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.004 -1.06 . . . . 0.0 109.432 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.12 120.66 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.71 2.273 . . . . 0.0 112.569 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.28 168.46 20.57 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.566 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 69.3 Cg_endo -73.84 123.95 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.831 2.354 . . . . 0.0 111.195 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -42.95 87.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.781 -0.574 . . . . 0.0 110.654 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.0 p -112.21 151.65 43.83 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.22 -40.03 9.28 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.15 1.9 . . . . 0.0 111.636 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.61 -23.05 66.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.351 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -96.16 -58.92 1.95 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.301 -0.874 . . . . 0.0 108.791 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -47.13 -12.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.831 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.5 m-20 -60.93 -26.74 67.71 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.427 HH11 ' HB2' ' A' ' 40' ' ' ASN . 12.3 mpt_? -82.31 -16.84 47.88 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.24 -128.77 2.6 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.769 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.517 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 4.5 t -95.93 158.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.467 -1.019 . . . . 0.0 110.245 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -154.96 147.32 23.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.0 109.132 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -52.85 170.21 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.866 -1.146 . . . . 0.0 109.061 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -100.5 9.15 42.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.467 -0.771 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -167.91 132.24 1.75 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.003 . . . . 0.0 109.889 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 10.2 pt-20 -55.07 -19.41 7.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.71 -0.619 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.86 25.86 0.89 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.909 -1.119 . . . . 0.0 108.568 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.3 145.56 53.44 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.2 p -154.36 144.94 22.3 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 6.4 mt -71.95 10.1 0.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.5 OUTLIER -127.76 -1.14 6.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.89 -0.506 . . . . 0.0 110.312 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.551 ' CG ' HE22 ' A' ' 55' ' ' GLN . 4.8 t70 -54.78 118.43 4.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.452 -1.405 . . . . 0.0 108.719 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.786 HE21 ' H ' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -45.52 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.786 ' H ' HE21 ' A' ' 55' ' ' GLN . 6.7 p-10 -144.88 110.82 5.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -93.31 116.82 35.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 109.134 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 27.8 m -107.76 111.53 23.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -115.06 162.78 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.6 121.63 37.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.36 140.37 13.38 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.43 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.6 m-70 -73.1 170.33 15.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -1.034 . . . . 0.0 110.027 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.27 78.18 1.37 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.41 -0.806 . . . . 0.0 109.04 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.418 ' N ' ' OG1' ' A' ' 73' ' ' THR . 50.2 m-85 -86.53 110.19 19.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 109.291 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 65' ' ' ILE . 15.1 mt -57.73 -27.21 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.485 -0.759 . . . . 0.0 110.055 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.9 14.45 3.27 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 69' ' ' ASN . 80.9 mtt180 -148.21 72.37 11.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.45 25.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 123.33 2.687 . . . . 0.0 113.443 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 67' ' ' ARG . 11.3 p30 -148.82 25.76 0.93 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 0.0 108.509 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.41 -152.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.691 0.758 . . . . 0.0 109.991 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -71.31 -81.89 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.781 -0.575 . . . . 0.0 111.411 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 34.4 t80 -94.36 -6.81 43.41 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.023 -1.048 . . . . 0.0 110.116 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.458 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 96.1 m -43.32 -39.52 3.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.96 . . . . 0.0 110.813 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.0 m120 -94.17 -27.17 16.35 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.841 -1.162 . . . . 0.0 111.44 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' A' ' 20' ' ' ILE . 10.5 mt -51.74 -11.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.694 -1.254 . . . . 0.0 109.36 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 74' ' ' ASN . 3.3 ptmt -84.05 -2.71 57.2 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -103.76 -36.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.68 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.104 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' O ' ' SD ' ' A' ' 97' ' ' MET . 50.0 mttm -148.09 174.57 11.8 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -48.13 139.69 8.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 109.709 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.32 -15.19 62.65 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 97' ' ' MET . 53.2 p -64.22 98.18 0.22 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.262 -1.14 . . . . 0.0 108.486 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.461 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 11.3 ptm -67.63 178.08 1.79 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.32 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.2 t -144.24 117.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' OH ' ' SD ' ' A' ' 83' ' ' MET . 97.9 m-85 -93.82 102.71 14.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 88' ' ' VAL . 37.1 t80 -95.87 110.83 22.95 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 88' ' ' VAL . 36.3 ttpt -99.69 146.52 26.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 86' ' ' PHE . 20.2 m -156.89 142.03 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.719 -0.613 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.35 -96.64 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.522 ' ND2' ' OE2' ' A' ' 91' ' ' GLU . 4.4 p-10 -140.17 19.2 2.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -1.141 . . . . 0.0 109.296 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.522 ' OE2' ' ND2' ' A' ' 90' ' ' ASN . 4.2 mp0 -120.03 167.11 12.52 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -152.64 118.92 5.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 110.16 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.515 HH11 ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.85 169.86 10.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -143.8 117.29 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.876 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.28 176.19 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -138.89 106.44 5.58 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.442 -0.786 . . . . 0.0 109.867 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 36.7 ttm -48.26 124.93 8.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.085 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -153.83 0.21 0.22 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.033 -1.042 . . . . 0.0 109.81 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 143' ' ' VAL . 72.2 m -163.85 112.59 1.21 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.229 -0.919 . . . . 0.0 110.228 -177.472 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.7 t70 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 118' ' ' ASP . 66.2 mttm -36.79 132.58 0.64 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -148.32 -178.14 6.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.455 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.8 tp -134.99 111.31 9.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -96.04 87.54 4.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.27 -0.893 . . . . 0.0 108.716 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.72 121.04 23.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.12 -0.988 . . . . 0.0 109.145 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.2 mt -105.12 140.76 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.773 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -94.76 161.61 14.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.125 -0.985 . . . . 0.0 108.863 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.445 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 21.8 m -148.03 139.51 23.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -175.1 132.95 0.31 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.065 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.1 t0 61.83 66.01 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.812 . . . . 0.0 109.132 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -61.76 123.56 18.31 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.021 -1.049 . . . . 0.0 109.739 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -87.34 125.49 34.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.157 -0.965 . . . . 0.0 109.672 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.71 7.68 38.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.368 -0.833 . . . . 0.0 109.698 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -79.38 -58.65 3.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -0.924 . . . . 0.0 109.077 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.2 p -96.74 -3.9 41.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 109.3 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.82 35.98 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.15 157.37 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -1.073 . . . . 0.0 109.733 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.5 m95 -63.79 114.31 3.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 136' ' ' TRP . 31.0 tt0 -36.79 -81.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.244 0.545 . . . . 0.0 110.451 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.53 170.16 4.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.13 -0.981 . . . . 0.0 108.519 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.529 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -161.86 112.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 0.0 109.983 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.15 155.83 49.09 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 pt -150.78 160.52 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 111.187 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -138.11 157.37 46.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 99' ' ' SER . 96.5 t -144.24 111.68 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -99.3 175.08 6.0 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.1 t -138.88 133.89 32.54 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.035 -1.041 . . . . 0.0 109.706 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.22 127.68 33.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.441 -0.787 . . . . 0.0 109.706 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 147' ' ' VAL . 5.0 m . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.282 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.23 167.39 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.078 1.852 . . . . 0.0 112.5 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.81 -12.95 12.66 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 12' ' ' SER . 52.6 t0 -76.87 107.5 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -57.9 -5.39 0.41 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.404 -0.81 . . . . 0.0 109.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 10' ' ' ASP . 16.5 m -103.68 29.24 5.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.445 -0.784 . . . . 0.0 109.808 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -147.16 140.29 25.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.154 -0.966 . . . . 0.0 109.418 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.634 HG12 ' N ' ' A' ' 15' ' ' ALA . 94.8 t -59.91 166.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.71 0.767 . . . . 0.0 110.656 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.634 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -140.3 -34.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -160.49 -165.68 17.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 31.3 m-85 -149.41 126.24 11.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.983 -1.304 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -96.31 142.75 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -145.63 146.08 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.955 -1.091 . . . . 0.0 110.304 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.88 131.42 7.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.48 -51.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.883 1.722 . . . . 0.0 111.752 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -50.55 -29.18 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.412 -0.805 . . . . 0.0 109.321 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.38 3.27 19.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.52 -0.738 . . . . 0.0 109.062 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 42.84 41.13 2.4 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.577 0.703 . . . . 0.0 109.894 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.82 150.07 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.777 0.799 . . . . 0.0 110.016 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -167.25 83.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -135.8 158.51 73.93 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.351 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.84 161.98 16.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.008 2.472 . . . . 0.0 113.154 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.47 130.82 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 12.6 m-85 -85.77 148.84 49.65 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.845 -1.159 . . . . 0.0 109.993 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.37 82.73 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.647 2.231 . . . . 0.0 111.398 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.64 -173.96 35.48 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.187 -1.482 . . . . 0.0 110.897 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.8 Cg_endo -82.38 121.4 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.961 2.44 . . . . 0.0 111.406 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.53 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.851 -0.53 . . . . 0.0 110.576 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.1 p -110.47 151.33 42.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.51 -41.71 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.227 1.951 . . . . 0.0 112.04 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.64 -21.38 66.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' ASN . 1.6 tt0 -96.73 -60.68 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' GLY . 24.0 mt -45.16 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.69 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' GLN . 38.7 m-20 -64.35 -26.47 68.49 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 41' ' ' ARG . 23.4 mtt-85 -79.93 -19.55 47.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 162.48 -144.12 9.36 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.515 HG23 HE21 ' A' ' 71' ' ' GLN . 4.1 t -94.75 163.62 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.297 -1.119 . . . . 0.0 108.874 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.459 ' CB ' ' NE2' ' A' ' 38' ' ' GLN . 4.4 t -158.41 155.28 28.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 109.202 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -60.02 164.84 3.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.075 -1.016 . . . . 0.0 109.419 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -77.81 -19.16 55.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.176 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.77 150.5 41.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.397 -0.814 . . . . 0.0 110.248 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.44 -36.52 84.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.589 -0.694 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.17 9.27 15.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.891 -1.131 . . . . 0.0 110.989 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -65.02 138.53 58.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 0.0 109.391 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -147.23 169.42 19.41 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 108.986 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -10.19 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.92 -29.35 32.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.483 -0.761 . . . . 0.0 109.213 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.6 m-20 -64.4 100.7 0.37 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.73 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.495 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 2.8 pm0 -48.33 -15.92 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.982 -1.074 . . . . 0.0 109.012 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' ASP . 19.6 t30 -110.45 100.04 8.94 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.55 148.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.212 -0.93 . . . . 0.0 109.548 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -145.82 107.88 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 60' ' ' ALA . 79.1 mt -110.79 165.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.588 -0.695 . . . . 0.0 110.134 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.586 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -149.55 138.75 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.461 -0.775 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.55 157.73 27.49 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.29 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -73.11 -177.15 2.36 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.302 -1.116 . . . . 0.0 109.818 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.9 81.46 0.43 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -87.85 122.2 31.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.318 -0.863 . . . . 0.0 109.533 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 mm -58.9 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -0.894 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.72 20.53 2.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 69' ' ' ASN . 90.8 mtt180 -150.37 67.87 8.34 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.541 -0.725 . . . . 0.0 109.572 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.3 5.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 123.537 2.825 . . . . 0.0 114.124 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -146.13 61.24 1.24 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.89 -1.131 . . . . 0.0 108.638 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -152.86 121.0 6.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 110.509 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.578 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.4 -124.71 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.681 -0.637 . . . . 0.0 110.864 178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 75' ' ' LEU . 3.3 m-85 -97.82 12.51 33.68 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.72 -1.237 . . . . 0.0 110.15 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.0 m -46.41 -19.93 0.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.911 -1.118 . . . . 0.0 110.311 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 72' ' ' PHE . 5.5 m-20 -121.77 -21.74 6.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.442 -0.786 . . . . 0.0 109.971 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 72' ' ' PHE . 5.9 tt -55.96 -25.22 42.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.57 -13.64 60.06 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -85.52 -16.43 39.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.96 174.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.827 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 81' ' ' GLY . 53.5 mtmt -150.49 159.21 44.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.901 . . . . 0.0 109.114 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -52.84 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.2 -22.71 0.51 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -66.43 121.12 14.59 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.459 -1.024 . . . . 0.0 108.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.6 mtm -77.58 -177.82 4.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.962 -1.086 . . . . 0.0 109.801 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' TYR . 61.4 t -145.65 159.51 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.808 . . . . 0.0 109.444 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' HG12 ' A' ' 84' ' ' VAL . 59.7 m-85 -144.17 102.46 3.87 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 109.371 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -95.0 113.5 25.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 108.658 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -102.08 139.1 38.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 15' ' ' ALA . 2.4 p -162.23 144.22 3.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 49.98 -151.65 4.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -92.94 59.33 3.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.197 -1.178 . . . . 0.0 109.297 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -168.36 163.37 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.335 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -144.86 151.78 39.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 159.38 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.47 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 37.5 pttt -143.1 164.82 29.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 3.1 m-85 -141.31 -174.62 4.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -141.95 115.03 8.75 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.16 -0.962 . . . . 0.0 108.964 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.458 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.2 mmt -49.36 110.09 0.33 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.598 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 p -139.46 20.69 2.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.436 -0.79 . . . . 0.0 109.14 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 143' ' ' VAL . 31.1 t -168.63 122.91 0.88 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.9 mt . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.209 -0.932 . . . . 0.0 109.296 -178.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 120' ' ' GLN . 28.8 m-20 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.53 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 4.3 mptp? -26.04 87.77 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 122.315 1.055 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 118' ' ' ASP . 5.9 pt20 -89.04 161.16 16.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.05 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.405 HD21 HD21 ' A' ' 123' ' ' LEU . 59.7 tp -133.35 109.01 9.06 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -94.24 92.18 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.949 . . . . 0.0 109.909 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.405 HD21 HD21 ' A' ' 121' ' ' LEU . 30.3 mt -74.98 148.02 40.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.131 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.1 mt -138.74 143.27 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.213 -0.929 . . . . 0.0 109.628 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -105.49 155.67 18.95 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.341 -0.85 . . . . 0.0 108.726 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 127' ' ' ASP . 66.7 m -145.81 155.92 43.23 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.93 -1.106 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 0.5 OUTLIER 170.49 140.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.89 . . . . 0.0 109.56 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.4 OUTLIER 56.89 63.16 2.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.688 -0.633 . . . . 0.0 109.334 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.71 120.57 10.91 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.872 -1.142 . . . . 0.0 108.525 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -85.14 111.41 19.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 109.896 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.4 4.83 9.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.357 -0.839 . . . . 0.0 109.751 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.34 -53.83 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.0 p -96.48 -8.19 32.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.866 . . . . 0.0 109.195 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.62 41.37 43.71 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.71 155.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.224 -1.162 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.442 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.0 m95 -61.85 112.6 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.4 tt0 -38.08 -78.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.702 -0.624 . . . . 0.0 110.016 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 10.4 mtpp -89.92 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -152.54 108.24 3.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.909 -1.119 . . . . 0.0 110.524 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' A' ' 140' ' ' LYS . 3.8 mtmp? -109.84 133.81 52.75 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.5 mm -104.81 129.53 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -117.4 160.09 21.72 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.5 t -145.72 149.75 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.715 -1.24 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.75 179.3 7.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -161.37 156.38 23.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.575 -1.328 . . . . 0.0 111.309 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.25 135.05 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.312 0.577 . . . . 0.0 110.059 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 122.01 0.909 . . . . 0.0 109.426 179.522 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 mt . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.34 152.43 3.79 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.022 . . . . 0.0 112.667 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -93.08 -17.08 24.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 108.885 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 12' ' ' SER . 36.2 t0 -77.58 106.03 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.453 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.9 OUTLIER -58.01 -5.45 0.44 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 10' ' ' ASP . 13.6 t -103.19 39.25 1.6 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.364 -0.835 . . . . 0.0 109.751 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -147.76 132.91 18.33 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.301 -0.874 . . . . 0.0 109.71 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 38.8 t -61.31 132.21 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.56 -16.3 20.12 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -176.7 -162.76 27.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.51 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 87.0 m-85 -148.89 128.78 13.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.251 -1.146 . . . . 0.0 109.687 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.72 144.67 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -144.27 147.45 33.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.874 -1.141 . . . . 0.0 110.75 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mt -149.68 131.88 7.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -50.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.936 1.757 . . . . 0.0 112.0 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.19 -20.98 1.75 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.829 . . . . 0.0 109.406 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB1' ' OD1' ' A' ' 74' ' ' ASN . . . -118.46 3.31 11.84 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ALA . 1.5 p30 40.91 38.86 0.72 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.542 0.687 . . . . 0.0 109.848 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.467 HG23 ' OE2' ' A' ' 27' ' ' GLU . 3.3 mt -98.08 155.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.86 0.838 . . . . 0.0 110.47 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -162.49 69.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.467 ' OE2' HG23 ' A' ' 25' ' ' ILE . 11.2 mt-10 -100.56 150.2 36.77 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.582 -0.699 . . . . 0.0 112.495 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -87.98 159.96 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.844 2.363 . . . . 0.0 111.608 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.71 130.55 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.117 -0.989 . . . . 0.0 109.646 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -94.42 155.92 39.2 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.881 -1.137 . . . . 0.0 108.888 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -81.59 95.12 0.92 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.311 2.007 . . . . 0.0 111.786 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.88 -177.66 39.86 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.336 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 89.0 Cg_endo -81.64 116.99 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.915 2.41 . . . . 0.0 111.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.46 87.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.331 0.586 . . . . 0.0 110.335 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -112.85 153.35 45.19 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.44 -45.04 19.63 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.07 1.847 . . . . 0.0 111.433 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.54 -19.04 64.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.417 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' ASN . 6.7 tp60 -93.02 -69.35 0.75 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 18.7 mt -45.37 -17.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 109.754 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 38' ' ' GLN . 13.7 m-20 -61.81 -24.92 67.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.415 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.6 mtt180 -85.56 -12.97 50.3 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.76 -110.64 0.45 Allowed Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.737 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.9 t -131.64 156.79 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.383 -1.069 . . . . 0.0 109.395 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 t -153.04 154.33 34.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 108.749 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.31 171.69 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.926 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -78.46 -26.28 46.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 109.517 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -135.15 150.24 50.13 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -0.781 . . . . 0.0 109.635 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.52 -32.77 72.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.626 -0.671 . . . . 0.0 111.456 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -85.93 11.32 11.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.885 -1.135 . . . . 0.0 110.81 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 58' ' ' SER . 1.4 tt0 -63.96 147.1 52.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.421 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 2.7 p -147.99 151.76 36.32 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -65.94 -5.52 9.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 51' ' ' SER . 13.7 t70 -91.58 -22.51 20.28 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 52.7 m-20 -60.11 100.67 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.199 -0.938 . . . . 0.0 108.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.461 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 9.0 tt0 -42.98 -20.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.519 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 22.1 t-20 -116.89 97.64 6.07 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.8 146.8 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' ALA . 10.6 m -144.66 109.61 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mt -108.82 167.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.374 -0.828 . . . . 0.0 109.948 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -142.96 135.17 27.26 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.38 157.9 27.1 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.835 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.422 ' H ' ' HG2' ' A' ' 71' ' ' GLN . 25.9 m-70 -73.67 -173.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.608 -0.937 . . . . 0.0 110.562 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -174.9 77.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.7 119.05 28.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.133 . . . . 0.0 108.977 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 65' ' ' ILE . 14.6 mt -61.09 -26.62 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.453 -0.779 . . . . 0.0 110.365 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.15 14.78 2.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.628 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 69' ' ' ASN . 83.0 mtt180 -150.77 76.66 8.06 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.641 . . . . 0.0 109.407 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.6 12.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 123.657 2.905 . . . . 0.0 114.021 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -146.5 52.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.892 -1.13 . . . . 0.0 108.125 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 15.7 t80 -136.93 100.72 4.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.411 -0.805 . . . . 0.0 109.96 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 12.1 mp0 54.86 -125.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.625 -0.672 . . . . 0.0 110.722 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.871 ' CE2' HD13 ' A' ' 75' ' ' LEU . 4.9 m-85 -90.23 34.08 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.685 -1.259 . . . . 0.0 110.092 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.4 m -57.55 -26.65 61.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.357 -1.464 . . . . 0.0 109.477 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.4 p30 -140.55 4.15 1.94 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 72' ' ' PHE . 9.2 tt -55.2 -21.63 14.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.853 -1.154 . . . . 0.0 107.929 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' NZ ' ' O ' ' A' ' 72' ' ' PHE . 14.2 mtmm -82.77 -18.54 40.29 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -62.29 -22.84 66.34 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -54.62 -169.9 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 81' ' ' GLY . 4.5 ptpt -154.58 157.52 38.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -0.961 . . . . 0.0 109.223 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.479 ' NZ ' ' CB ' ' A' ' 80' ' ' LYS . 5.3 ttpm? -52.2 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 109.543 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 153.42 -14.75 0.64 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -64.42 119.12 9.78 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.545 -0.974 . . . . 0.0 108.774 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.3 mmm -73.51 179.89 3.83 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.393 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 85' ' ' TYR . 22.0 t -146.26 161.74 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.967 . . . . 0.0 109.231 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 84' ' ' VAL . 77.9 m-85 -147.67 103.13 3.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.345 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -94.58 111.99 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -95.55 144.83 25.69 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.1 96.83 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.52 -0.738 . . . . 0.0 109.134 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 48.62 -131.35 21.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -82.22 52.54 2.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.154 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.25 143.44 10.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.14 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.4 m -152.87 146.95 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.987 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 177.99 7.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.475 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 23.9 pttm -144.28 161.09 39.82 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.091 -1.006 . . . . 0.0 110.351 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 10.9 m-85 -141.35 -179.79 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -147.13 130.54 16.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.935 -1.103 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.443 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 12.9 mtt -48.51 150.86 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.394 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 97' ' ' MET . 14.9 m -166.28 1.34 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.161 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 t -168.5 124.08 0.96 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.25 -0.906 . . . . 0.0 109.141 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.68 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 119' ' ' LYS . 97.6 m-20 . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' ASP . 57.5 mttp -44.69 126.78 5.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.837 . . . . 0.0 109.334 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.589 ' N ' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -149.37 168.24 23.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.983 -179.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 143' ' ' VAL . 26.8 mt -116.71 154.0 31.37 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.552 0.691 . . . . 0.0 110.321 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.0 m -140.48 86.41 2.06 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.45 159.68 19.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 111.175 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.9 mt -140.14 126.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 p -90.31 118.7 30.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.767 -1.208 . . . . 0.0 109.025 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 23.1 m -99.1 154.2 18.31 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.619 -0.676 . . . . 0.0 110.129 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.1 t70 179.87 132.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 109.073 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.2 t0 59.76 72.27 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 109.331 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -65.27 122.27 16.73 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 10.0 p30 -85.7 129.47 34.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.893 -1.129 . . . . 0.0 109.476 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -91.25 4.84 51.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 108.962 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -71.96 -62.44 1.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.807 . . . . 0.0 109.088 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 p -98.49 -3.16 37.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.472 -0.767 . . . . 0.0 109.314 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.67 47.78 19.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.54 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 2.9 t -146.79 169.57 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -1.076 . . . . 0.0 109.329 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 73.4 m95 -73.2 114.19 11.11 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.177 -0.952 . . . . 0.0 108.943 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.6 tp10 -35.55 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.081 0.467 . . . . 0.0 110.727 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.13 150.42 40.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.608 -0.682 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.1 OUTLIER -166.96 164.91 16.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -130.41 133.19 46.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.499 -0.75 . . . . 0.0 109.1 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.4 mm -94.54 146.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.46 140.93 25.41 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 5.9 t -133.07 147.15 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.271 -0.893 . . . . 0.0 110.752 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.41 144.65 33.19 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.7 t -118.3 148.89 42.0 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 147' ' ' VAL . 7.7 tp10 -61.93 137.24 58.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.62 -0.675 . . . . 0.0 109.407 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.52 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 4.3 m . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.95 . . . . 0.0 109.358 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 mt . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.21 118.94 1.86 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.595 1.53 . . . . 0.0 112.065 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -73.68 -18.61 60.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.945 . . . . 0.0 109.371 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -77.94 106.38 9.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.354 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -57.04 -10.6 1.19 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -94.26 27.2 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 109.771 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -141.52 131.64 24.77 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.317 -0.865 . . . . 0.0 109.481 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 44.7 t -61.84 142.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.472 -0.768 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.55 -23.78 14.97 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.496 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -174.2 -163.25 27.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 34.7 m-85 -149.88 130.84 14.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 0.0 109.539 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tt -95.62 144.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -146.04 142.09 28.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.037 -1.039 . . . . 0.0 110.343 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 75' ' ' LEU . 12.5 mt -150.13 132.23 7.87 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.09 -49.28 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.883 1.722 . . . . 0.0 111.882 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -51.75 -30.02 21.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.601 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -106.67 3.29 26.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.371 -0.83 . . . . 0.0 108.895 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.1 p30 43.61 30.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.28 147.66 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.898 0.856 . . . . 0.0 109.79 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -165.35 84.51 0.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.84 159.36 72.88 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.327 -0.858 . . . . 0.0 111.052 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.21 163.59 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.273 2.649 . . . . 0.0 113.32 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.79 132.54 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 42.2 m-85 -87.44 146.18 39.12 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.818 -1.176 . . . . 0.0 109.872 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.52 88.83 1.23 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.909 1.739 . . . . 0.0 111.365 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.19 -170.97 34.41 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.522 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 95.6 Cg_endo -81.11 117.97 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.883 2.389 . . . . 0.0 111.513 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -46.03 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.301 0.572 . . . . 0.0 110.724 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.7 OUTLIER -110.6 155.76 41.62 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 56.8 Cg_endo -69.93 -44.15 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.223 1.949 . . . . 0.0 112.036 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -62.93 -26.2 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.618 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -84.12 -62.62 1.52 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.159 -0.963 . . . . 0.0 109.039 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -49.28 -11.99 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.3 m120 -61.93 -27.75 69.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.433 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.2 mtp180 -91.4 -10.88 39.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.504 ' C ' HE22 ' A' ' 71' ' ' GLN . . . 164.12 -139.45 5.86 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.259 -1.448 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 t -110.67 164.59 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.438 -1.037 . . . . 0.0 109.329 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -158.86 157.14 30.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.182 -0.949 . . . . 0.0 108.623 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.536 ' CE2' ' OE1' ' A' ' 50' ' ' GLU . 46.9 m-85 -58.04 175.92 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.863 -1.148 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -89.0 -3.35 58.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.457 -0.777 . . . . 0.0 109.126 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -153.97 145.82 23.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.287 -0.883 . . . . 0.0 109.966 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -62.49 -31.17 71.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -86.86 6.94 29.33 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.953 -1.092 . . . . 0.0 110.893 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 11.9 tm-20 -61.79 152.19 32.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' ASP . 76.5 p -146.32 163.38 35.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.017 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -74.54 10.64 1.25 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.9 OUTLIER -124.0 -6.25 7.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.838 -0.539 . . . . 0.0 109.751 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.7 t70 -59.73 113.9 2.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.859 -1.15 . . . . 0.0 109.308 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -45.4 -18.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.277 -0.889 . . . . 0.0 109.631 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' OE1' ' A' ' 55' ' ' GLN . 4.0 m120 -133.27 98.66 4.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.498 -0.751 . . . . 0.0 109.051 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 122' ' ' THR . 96.1 mt -96.68 113.31 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.698 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.5 m -108.6 120.23 41.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 60' ' ' ALA . 87.1 mt -107.21 164.45 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.473 -0.767 . . . . 0.0 110.226 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.571 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.99 124.61 23.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.65 152.4 22.07 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 119.932 -1.128 . . . . 0.0 110.748 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' PHE . 34.0 m-70 -72.72 -179.93 3.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.758 -0.848 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 88.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.02 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -87.51 123.68 32.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 109.06 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 65' ' ' ILE . 6.6 mt -63.76 -33.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.563 -0.71 . . . . 0.0 110.589 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -82.97 8.17 13.43 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 110.122 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 69' ' ' ASN . 21.7 mmt180 -140.72 75.28 25.92 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 87.7 Cg_exo -48.64 5.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.621 2.881 . . . . 0.0 113.844 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' ARG . 6.8 p30 -143.64 59.42 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.95 -1.094 . . . . 0.0 108.165 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.66 95.97 3.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.582 -0.699 . . . . 0.0 110.355 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.504 HE22 ' C ' ' A' ' 42' ' ' GLY . 1.1 mm100 61.0 -114.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.851 -0.53 . . . . 0.0 111.815 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.649 ' CE2' HG22 ' A' ' 125' ' ' THR . 2.3 t80 -91.93 26.85 2.29 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.138 -0.976 . . . . 0.0 110.803 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -69.22 -38.74 78.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.87 -1.144 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 15.6 m-20 -108.49 -17.0 14.09 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.226 -0.921 . . . . 0.0 111.072 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -53.16 -25.33 13.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.729 -1.232 . . . . 0.0 108.36 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -81.88 -14.35 56.34 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -78.4 -16.57 57.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.03 -162.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -174.32 174.97 2.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -48.85 149.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 -11.27 7.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 57.8 m -62.21 94.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.117 -1.225 . . . . 0.0 108.64 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptm -66.32 162.19 20.75 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.195 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.82 174.3 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.865 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -144.71 108.83 4.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -0.899 . . . . 0.0 110.001 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -95.09 113.37 25.06 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -96.49 144.37 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 110.301 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 18.3 t -143.02 86.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.36 -133.37 42.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.86 37.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -1.223 . . . . 0.0 109.587 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 88' ' ' VAL . 21.1 mp0 -138.81 151.98 47.5 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.268 -0.895 . . . . 0.0 108.916 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.6 m -152.97 143.82 22.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.005 . . . . 0.0 110.099 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.421 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -144.33 170.61 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.413 -0.805 . . . . 0.0 108.98 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 24.8 pttm -142.87 162.0 36.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 5.9 m-85 -139.35 -175.67 4.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -136.79 110.58 8.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.0 tpp -50.89 104.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.431 -0.793 . . . . 0.0 109.05 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -143.84 35.32 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 143' ' ' VAL . 16.5 t -173.67 131.91 0.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.2 mt . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 109.008 -179.3 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 121.371 0.605 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 119' ' ' LYS . 12.2 mptt -46.29 162.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -157.18 145.0 19.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.154 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.2 tp -103.57 107.56 18.46 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 57' ' ' ILE . 10.5 m -92.54 146.76 23.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.62 152.24 50.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.284 -0.885 . . . . 0.0 110.489 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 mt -141.3 134.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.649 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.1 p -92.21 160.61 15.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.932 -1.105 . . . . 0.0 108.423 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 56.6 m -144.97 140.1 27.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.06 -1.025 . . . . 0.0 109.943 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 p30 175.65 139.39 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.43 58.76 1.65 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.26 -0.9 . . . . 0.0 108.887 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.99 126.62 27.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 109.444 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -85.9 116.99 24.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.131 -0.981 . . . . 0.0 109.695 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -84.18 1.38 44.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -81.22 -52.18 7.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.328 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.6 p -95.65 -15.06 22.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.27 42.31 15.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -147.14 153.24 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.345 -1.091 . . . . 0.0 109.509 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 69.2 m95 -59.25 112.55 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 23.1 tt0 -35.24 -84.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -107.06 157.45 17.82 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.394 -0.816 . . . . 0.0 109.473 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -174.84 161.02 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -127.67 153.31 46.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 35.0 mm -115.91 139.12 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.583 0.706 . . . . 0.0 110.61 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -136.57 159.12 42.76 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 99' ' ' SER . 59.4 t -148.08 149.29 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.776 -1.202 . . . . 0.0 110.896 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.67 134.24 30.11 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.3 t -95.68 143.43 26.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 3.3 tm-20 -60.22 145.76 46.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 1.8 t . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 0.0 109.337 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 7' ' ' ILE . 11.9 mt . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.85 136.37 7.16 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.844 1.696 . . . . 0.0 112.196 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -87.44 -28.72 21.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.04 113.28 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -58.2 -11.78 2.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.328 -0.857 . . . . 0.0 109.626 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -79.95 21.04 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -147.51 136.16 21.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.057 -1.027 . . . . 0.0 109.659 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 15' ' ' ALA . 61.3 t -60.36 161.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.699 0.761 . . . . 0.0 110.223 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.553 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -136.13 -9.58 2.01 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -172.05 -179.16 42.8 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.6 120.11 7.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.3 . . . . 0.0 109.172 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 tt -97.04 140.33 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -146.23 138.89 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.105 -0.997 . . . . 0.0 110.081 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 8.3 mt -146.4 127.13 7.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.6 -44.22 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.742 1.628 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.24 -17.67 0.75 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.293 -0.88 . . . . 0.0 109.819 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -134.36 17.55 3.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.168 -0.958 . . . . 0.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.71 48.4 4.81 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.682 0.753 . . . . 0.0 109.912 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 23' ' ' ALA . 48.3 mm -88.89 141.42 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.655 0.741 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.31 82.69 0.17 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 19.2 mm-40 -143.13 156.78 61.39 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.139 -0.976 . . . . 0.0 110.561 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -83.49 165.72 14.12 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.888 2.392 . . . . 0.0 112.301 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.1 109.23 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -65.84 139.51 96.88 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.705 -1.247 . . . . 0.0 109.1 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.53 109.23 2.59 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.824 1.682 . . . . 0.0 111.904 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.54 -174.47 39.76 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.135 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' THR . 74.3 Cg_endo -76.75 113.93 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.576 2.184 . . . . 0.0 110.969 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -44.58 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.438 0.637 . . . . 0.0 111.151 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.24 169.35 8.08 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.56 -27.53 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.632 1.555 . . . . 0.0 112.42 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.48 -33.66 75.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.672 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.85 -51.7 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 109.231 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 39' ' ' LEU . 18.8 mt -46.88 -30.45 2.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.473 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -65.01 -27.32 68.74 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 38' ' ' GLN . 89.0 mtt180 -84.5 -19.61 32.98 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.67 -140.77 6.35 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.754 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.0 t -107.32 164.69 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.708 -0.878 . . . . 0.0 108.799 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.672 ' CB ' HE22 ' A' ' 38' ' ' GLN . 35.5 t -163.24 157.53 20.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.959 -1.088 . . . . 0.0 109.194 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 37.3 m-85 -59.67 161.86 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.354 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.56 5.28 36.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.39 142.03 9.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.717 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 -23.64 67.54 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.645 -0.659 . . . . 0.0 111.529 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -87.1 4.84 40.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.878 -1.139 . . . . 0.0 110.728 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -62.68 157.15 21.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 109.429 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.532 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -143.99 179.51 7.15 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.986 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -83.75 4.24 29.75 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -146.07 16.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.512 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.2 t70 -58.26 115.24 2.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.681 -1.262 . . . . 0.0 108.779 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -43.51 -19.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 54' ' ' ASP . 21.6 t-20 -135.17 97.24 3.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -94.85 151.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 109.347 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.7 m -143.64 116.84 8.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.7 mt -112.59 162.57 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.738 0.78 . . . . 0.0 110.601 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -132.78 131.76 41.48 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.24 148.3 19.98 Favored Glycine 0 N--CA 1.505 3.286 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.323 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.72 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 41.5 m-70 -76.3 -169.89 1.31 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.646 -0.914 . . . . 0.0 110.422 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 63' ' ' THR . 14.7 t -158.82 83.44 0.81 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.75 0.786 . . . . 0.0 108.971 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.56 108.51 19.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.712 -1.243 . . . . 0.0 109.462 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 mm -60.06 -28.4 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 110.44 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -86.97 16.52 4.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 69' ' ' ASN . 33.2 ttm180 -150.56 72.99 9.02 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.81 14.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 123.909 3.073 . . . . 0.0 114.325 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.568 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.8 p30 -148.47 62.63 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.802 -1.186 . . . . 0.0 108.572 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -151.47 98.79 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.72 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 4.1 mt-30 60.99 -127.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 111.179 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.71 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -92.01 59.08 3.51 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.682 1.23 . . . . 0.0 109.574 -178.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 m -91.17 -24.77 19.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.202 -1.561 . . . . 0.0 108.632 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -136.77 -0.97 2.28 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 -178.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -10.22 0.28 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.403 -1.435 . . . . 0.0 108.042 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.491 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.48 -37.59 50.95 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -27.6 69.13 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.06 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -175.11 171.51 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 109.919 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -51.14 101.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.5 -29.85 2.46 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.444 ' OG ' ' CG2' ' A' ' 20' ' ' ILE . 14.1 t -62.81 108.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.2 mtp -62.83 174.99 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.642 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.09 108.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.97 104.91 17.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 109.942 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -94.53 111.94 23.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -102.01 144.64 30.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 110.459 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 15' ' ' ALA . 4.7 p -170.24 128.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.557 -0.714 . . . . 0.0 109.268 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.19 -120.42 19.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.19 35.05 4.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.956 . . . . 0.0 109.117 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.3 133.61 16.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 108.944 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.8 t -119.01 133.91 55.53 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.674 0.749 . . . . 0.0 110.172 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -94.89 172.07 8.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -147.53 96.51 2.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.915 -1.116 . . . . 0.0 110.226 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 24.7 m-85 -87.57 -173.72 4.47 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.015 -1.053 . . . . 0.0 108.594 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER -150.25 111.55 4.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.138 -0.976 . . . . 0.0 109.886 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtp -48.67 117.27 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.326 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -158.54 21.11 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.053 -1.029 . . . . 0.0 109.555 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 11.2 p -167.83 86.04 0.22 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.635 -1.291 . . . . 0.0 109.299 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 119' ' ' LYS . 33.2 t0 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 16.8 ttmm -34.54 132.79 0.28 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.91 175.03 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.6 tp -128.82 102.97 6.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -93.03 87.24 5.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.185 -0.947 . . . . 0.0 109.151 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.82 152.3 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.909 -1.119 . . . . 0.0 109.256 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -129.03 151.56 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.669 -0.645 . . . . 0.0 109.29 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.422 HG22 ' CD2' ' A' ' 72' ' ' PHE . 52.0 p -96.37 153.3 17.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.154 -0.967 . . . . 0.0 108.568 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.77 97.88 2.97 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.968 -1.083 . . . . 0.0 109.799 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 127' ' ' ASP . 2.0 p30 -147.25 136.18 22.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 108.75 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 127' ' ' ASP . 1.5 m-20 70.84 64.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 109.576 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.99 125.75 25.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 0.0 109.865 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -86.87 125.74 34.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.135 -0.978 . . . . 0.0 109.399 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.72 4.5 47.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 109.811 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.67 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.408 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.8 p -95.21 -3.14 48.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.37 45.4 54.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 165.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -1.146 . . . . 0.0 109.24 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLU . 81.4 m95 -68.86 114.38 7.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.189 -0.945 . . . . 0.0 108.696 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.3 tp10 -35.42 -86.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.24 0.543 . . . . 0.0 110.325 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -103.76 148.86 25.58 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -157.19 138.9 14.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.792 -1.192 . . . . 0.0 110.618 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -99.76 166.35 11.14 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 mt -138.3 132.84 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.435 -0.79 . . . . 0.0 110.157 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -141.34 147.25 37.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.529 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 19.2 t -135.94 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.077 -1.015 . . . . 0.0 111.296 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.15 -178.54 3.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.0 t -144.85 141.01 28.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.91 -1.119 . . . . 0.0 109.377 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -57.67 147.27 28.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.81 . . . . 0.0 109.555 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.772 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mm . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.08 168.56 0.36 Allowed 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.466 2.111 . . . . 0.0 112.446 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 -14.99 16.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.401 -0.812 . . . . 0.0 109.176 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 12' ' ' SER . 0.8 OUTLIER -76.71 107.45 9.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -60.52 -3.44 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.0 109.293 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 10' ' ' ASP . 80.9 p -116.69 44.23 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -150.46 128.13 11.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.32 -0.862 . . . . 0.0 109.262 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 16' ' ' GLY . 39.2 t -55.33 158.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 111.278 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.501 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -140.7 2.39 1.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.633 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 173.68 -175.44 46.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 67.3 m-85 -150.34 126.74 10.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.109 -1.23 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.443 ' CD1' HD11 ' A' ' 123' ' ' LEU . 13.3 tt -95.66 147.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -149.84 134.88 17.94 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.807 -1.183 . . . . 0.0 110.95 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 84' ' ' VAL . 32.4 mt -145.49 124.79 6.81 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.2 -41.19 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.65 1.567 . . . . 0.0 111.724 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.92 -17.95 1.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.6 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 24' ' ' ASP . . . -130.01 13.49 5.73 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.523 -0.736 . . . . 0.0 109.553 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.8 p30 42.23 36.4 0.72 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 mt -90.58 140.97 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -165.92 86.89 0.36 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.62 159.15 70.2 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.474 -0.767 . . . . 0.0 110.441 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HB2' HG22 ' A' ' 14' ' ' VAL . 41.4 Cg_endo -85.58 164.0 10.79 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.061 2.507 . . . . 0.0 112.952 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.18 113.5 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.29 168.34 13.75 Favored Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.776 -1.202 . . . . 0.0 109.801 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.91 124.49 4.47 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.894 2.396 . . . . 0.0 111.831 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.99 170.55 30.11 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.29 -1.434 . . . . 0.0 110.45 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 35' ' ' THR . 98.5 Cg_endo -78.43 117.29 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.79 2.327 . . . . 0.0 111.256 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.79 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.534 -0.729 . . . . 0.0 109.996 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -122.96 155.41 63.94 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 19.5 Cg_endo -58.25 -48.1 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.902 1.735 . . . . 0.0 111.191 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -63.01 -19.53 64.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.89 . . . . 0.0 109.205 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 40' ' ' ASN . 19.5 tp60 -89.63 -69.51 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.006 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.1 mt -52.57 -3.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 38' ' ' GLN . 16.5 m-20 -59.54 -28.62 67.26 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.906 -1.121 . . . . 0.0 108.744 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' CD ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -87.79 -18.94 28.23 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.38 -127.52 1.73 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.267 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.53 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.8 t -101.66 157.11 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.538 -0.978 . . . . 0.0 109.97 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.3 m -155.58 151.82 28.02 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -56.53 170.2 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.751 -1.218 . . . . 0.0 109.829 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.43 -3.39 52.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.822 . . . . 0.0 109.06 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -153.57 150.49 28.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.0 109.874 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 13.1 pt-20 -62.73 -40.73 98.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.544 -0.722 . . . . 0.0 111.422 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 6.4 t-20 -88.44 18.64 4.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.427 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 7.7 tp10 -62.92 139.44 58.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.718 -1.238 . . . . 0.0 109.696 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 53' ' ' ASP . 16.1 m -146.51 152.51 39.1 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -60.39 -5.66 1.24 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 51' ' ' SER . 5.1 m-20 -75.85 -33.08 60.01 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.677 -0.639 . . . . 0.0 109.679 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 56' ' ' ASN . 51.3 m-20 -59.84 111.22 1.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.295 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.589 ' CD ' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -48.41 -14.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 108.819 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.6 t30 -125.69 108.02 11.13 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.39 117.65 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.009 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -108.6 108.96 20.04 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.66 161.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.475 -0.766 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.54 ' HB1' ' SG ' ' A' ' 126' ' ' CYS . . . -132.61 137.29 46.99 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.21 147.86 19.26 Favored Glycine 0 N--CA 1.5 2.965 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.998 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.742 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 18.7 m-70 -75.79 -165.52 0.46 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.885 -0.774 . . . . 0.0 110.278 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.95 88.86 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -88.15 108.97 19.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.055 -1.028 . . . . 0.0 109.084 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 mt -57.48 -27.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.465 -0.772 . . . . 0.0 109.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.6 12.1 5.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.007 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 69' ' ' ASN . 87.1 mtt180 -150.94 74.79 8.42 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 80.9 Cg_exo -48.62 7.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 123.629 2.886 . . . . 0.0 113.927 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 67' ' ' ARG . 44.8 p30 -142.21 58.81 1.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 71' ' ' GLN . 61.7 t80 -141.49 100.21 3.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.427 -0.796 . . . . 0.0 110.387 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.742 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 5.1 mt-30 60.75 -124.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.512 -0.742 . . . . 0.0 111.245 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.673 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -91.95 34.72 0.99 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 122.772 1.272 . . . . 0.0 109.297 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.9 m -73.6 -26.66 60.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.421 -2.049 . . . . 0.0 108.855 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 22.0 m-20 -133.55 -4.42 2.94 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.266 -0.897 . . . . 0.0 110.775 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.9 -23.42 7.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.733 -1.229 . . . . 0.0 108.775 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -2.09 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.949 -1.094 . . . . 0.0 108.388 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.56 -33.55 15.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.76 179.56 0.12 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.171 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -148.84 170.77 17.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.16 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -49.14 149.14 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 109.034 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.3 -23.13 23.15 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.9 t -62.45 103.08 0.37 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 58.2 mmm -62.01 171.25 1.79 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.162 -0.962 . . . . 0.0 110.149 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 20' ' ' ILE . 30.1 t -141.38 110.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.44 102.44 15.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -95.42 113.7 25.39 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -85.78 143.22 28.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.565 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 t -148.2 84.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.42 -128.04 27.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -95.28 37.36 1.18 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.174 -1.192 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 92' ' ' THR . 1.2 tm-20 -163.17 114.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.076 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 91' ' ' GLU . 9.8 t -107.35 147.1 30.75 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.426 -0.797 . . . . 0.0 110.082 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 93' ' ' ARG . 9.2 mmm-85 -93.7 172.9 7.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.498 -0.751 . . . . 0.0 109.369 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -146.36 92.94 2.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.105 -0.997 . . . . 0.0 109.999 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.431 ' O ' ' SD ' ' A' ' 83' ' ' MET . 22.7 m-85 -87.38 -176.39 5.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.904 -1.122 . . . . 0.0 108.726 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -147.33 107.93 4.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.239 -0.913 . . . . 0.0 109.428 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 23.9 mtt -48.29 117.83 2.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.451 ' OG1' HG22 ' A' ' 145' ' ' THR . 10.1 p -142.92 8.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.259 -0.901 . . . . 0.0 109.143 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 143' ' ' VAL . 30.9 t -164.87 107.98 0.87 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 108.646 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.522 -0.736 . . . . 0.0 109.544 -178.807 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 120' ' ' GLN . 14.3 t70 . . . . . 0 N--CA 1.501 2.102 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 18.7 mmmt -26.93 84.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.484 0.659 . . . . 0.0 110.842 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.8 pm0 -99.36 170.03 8.93 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.585 0.707 . . . . 0.0 110.664 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.97 102.5 8.04 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -94.93 87.55 5.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.131 -0.981 . . . . 0.0 109.355 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.443 HD11 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -81.5 132.53 35.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.89 -1.131 . . . . 0.0 109.367 -179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 125' ' ' THR . 52.7 mt -113.96 159.86 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.501 0.667 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 ' CG ' ' A' ' 72' ' ' PHE . 80.8 p -97.2 167.24 11.16 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.62 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.551 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 1.7 m -149.96 84.59 1.4 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.153 -0.967 . . . . 0.0 109.348 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 128' ' ' ASP . 15.0 t70 -148.22 129.0 14.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.976 -1.078 . . . . 0.0 108.953 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 4.5 t0 78.92 60.72 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.85 127.71 33.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.817 -1.177 . . . . 0.0 110.067 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -85.79 123.71 31.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.07 -1.019 . . . . 0.0 109.501 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' HD22 ' A' ' 130' ' ' ASN . 19.0 pt-20 -98.39 8.4 44.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.263 -0.898 . . . . 0.0 109.78 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.597 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 33.3 mtpt -86.89 -20.22 27.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.7 p -140.29 0.69 1.72 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.5 49.04 53.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.72 137.79 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -1.156 . . . . 0.0 109.305 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 51.5 m95 -52.6 112.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.934 -1.104 . . . . 0.0 108.43 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 136' ' ' TRP . 8.2 tp10 -37.6 -81.14 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.904 -0.498 . . . . 0.0 110.174 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -103.67 139.15 39.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.524 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -147.25 114.21 6.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.896 -1.128 . . . . 0.0 110.415 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -95.53 166.69 11.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.2 pt -147.95 162.42 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.89 -1.131 . . . . 0.0 110.919 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.8 m-85 -137.41 150.49 47.69 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 99' ' ' SER . 21.7 t -132.62 111.73 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.179 -0.951 . . . . 0.0 111.161 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.75 177.59 4.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.451 HG22 ' OG1' ' A' ' 98' ' ' THR . 14.7 t -144.66 139.35 27.96 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.978 -1.076 . . . . 0.0 109.726 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.08 144.81 44.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 147' ' ' VAL . 9.8 m . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.603 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.6 155.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.807 1.672 . . . . 0.0 112.525 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -102.65 -19.01 14.97 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.0 109.455 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.9 m-20 -77.22 110.31 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -58.0 -3.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.428 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.8 t -111.99 41.63 1.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.487 -0.758 . . . . 0.0 109.473 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -149.11 133.79 17.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 16' ' ' GLY . 61.5 t -58.86 161.0 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 110.95 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -139.97 -0.8 1.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 172.73 -173.71 45.54 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 44.2 m-85 -150.09 128.68 12.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.294 -1.121 . . . . 0.0 109.923 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -95.0 146.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.753 ' C ' HD12 ' A' ' 20' ' ' ILE . 37.9 tt0 -149.79 119.6 7.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.819 -1.175 . . . . 0.0 111.171 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 19' ' ' GLU . 1.9 mp -131.52 127.12 21.46 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 23' ' ' ALA . 71.9 Cg_endo -76.37 -42.71 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.53 1.486 . . . . 0.0 111.483 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 40.8 t0 -52.25 -10.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.423 -0.798 . . . . 0.0 109.473 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -140.59 15.45 2.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ALA . 2.3 p-10 41.68 49.6 3.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.078 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 20' ' ' ILE . 40.2 mm -91.27 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.674 0.749 . . . . 0.0 109.71 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -170.27 80.94 0.1 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -142.03 157.52 63.77 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 110.536 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.03 162.0 15.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.099 2.533 . . . . 0.0 113.068 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.92 109.23 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.67 168.77 22.92 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 120.753 -1.217 . . . . 0.0 109.505 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -88.21 117.12 1.01 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 122.726 2.284 . . . . 0.0 112.032 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.6 175.92 40.91 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.108 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 80.6 Cg_endo -78.35 115.52 3.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.808 2.339 . . . . 0.0 111.271 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -45.95 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.611 -0.681 . . . . 0.0 110.084 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.5 p -120.15 152.99 55.29 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.39 -41.29 79.57 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.985 1.79 . . . . 0.0 111.745 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.13 -22.84 67.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 109.62 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -90.89 -70.31 0.69 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.489 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 39' ' ' LEU . 16.1 mt -43.87 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 109.916 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 38' ' ' GLN . 19.6 m-20 -60.99 -24.17 65.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -90.95 -10.73 41.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.1 -115.72 0.68 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.6 t -126.16 154.95 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 5.1 m -150.68 155.13 38.72 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 41.7 m-85 -56.28 173.88 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.65 -1.281 . . . . 0.0 109.391 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.01 -13.39 58.9 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -146.31 153.19 40.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.269 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -63.71 -41.24 98.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.525 -0.734 . . . . 0.0 111.394 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -86.92 12.61 10.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.037 -1.039 . . . . 0.0 111.012 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.57 90.78 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.96 -1.087 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 53' ' ' ASP . 17.4 m -89.37 151.64 21.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 108.671 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.4 0.67 1.4 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 51' ' ' SER . 45.3 m-20 -95.88 -14.37 23.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.651 -0.656 . . . . 0.0 109.339 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.9 t0 -58.35 119.28 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.039 -1.038 . . . . 0.0 109.571 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -45.99 -14.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.72 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' ASP . 40.5 t30 -145.56 109.95 4.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 0.0 108.97 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.6 mp -95.29 154.9 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 108.98 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' HD11 ' A' ' 124' ' ' ILE . 16.6 t -143.67 123.28 13.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 90.2 mt -110.59 162.23 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.453 -0.779 . . . . 0.0 110.597 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.97 131.12 26.44 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.29 156.34 26.07 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 119.88 -1.153 . . . . 0.0 110.527 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -72.08 177.02 4.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.539 -0.977 . . . . 0.0 109.47 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.5 87.16 0.75 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.297 -0.877 . . . . 0.0 109.65 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.13 102.69 15.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.292 -0.88 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 mt -53.02 -23.69 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.218 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.03 13.96 3.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.115 -0.99 . . . . 0.0 109.451 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' ASN . 19.5 ttm-85 -152.66 74.95 7.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 109.282 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.43 20.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 123.911 3.074 . . . . 0.0 114.495 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.22 62.8 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.893 -1.129 . . . . 0.0 108.609 179.217 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -151.32 123.53 8.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.097 -1.002 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 61.1 mt-30 40.9 -115.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.812 -0.555 . . . . 0.0 111.357 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -98.03 9.22 43.34 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -49.34 -22.25 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.544 -1.347 . . . . 0.0 109.556 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.0 t-20 -119.57 -22.35 6.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.863 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.676 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.7 tm? -53.26 -35.7 60.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.068 -1.02 . . . . 0.0 108.57 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -72.31 -4.37 29.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.308 -0.87 . . . . 0.0 108.689 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -89.81 -28.37 19.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.6 -172.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.767 . . . . 0.0 109.678 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -162.07 -177.64 5.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.882 . . . . 0.0 109.071 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 82' ' ' SER . 26.9 mtmm -49.78 155.89 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.005 -1.06 . . . . 0.0 109.288 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.75 -18.86 4.48 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 80' ' ' LYS . 73.7 m -63.89 98.93 0.22 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.327 -1.102 . . . . 0.0 108.437 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.7 mtm -62.24 -179.32 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.616 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 20' ' ' ILE . 74.2 t -149.2 108.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.412 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.15 102.38 15.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.128 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' HG11 ' A' ' 88' ' ' VAL . 43.4 t80 -95.66 111.99 23.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -95.89 134.22 39.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.159 -0.963 . . . . 0.0 111.384 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' A' ' 86' ' ' PHE . 2.0 m -153.33 134.7 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.29 -138.95 26.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -101.62 43.98 1.04 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.31 -1.112 . . . . 0.0 109.665 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -162.24 136.44 6.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.315 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -117.28 140.53 49.44 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.521 -0.737 . . . . 0.0 110.081 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -93.26 168.29 11.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.572 -0.705 . . . . 0.0 109.301 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 15.5 pttp -145.8 118.89 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.995 . . . . 0.0 109.935 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.51 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 27.5 m-85 -116.44 168.48 10.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -130.22 108.98 10.44 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.239 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.5 tpp -50.89 135.09 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.514 -0.741 . . . . 0.0 109.237 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -166.28 19.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.8 t -164.88 92.34 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 100' ' ' ILE . 2.5 mp . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.887 . . . . 0.0 109.498 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.5 m-20 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 13.3 mptt -43.38 130.31 4.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.243 -0.911 . . . . 0.0 109.448 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.71 172.67 12.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.7 tp -118.51 156.34 29.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.661 -0.649 . . . . 0.0 110.019 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 m -134.77 88.38 2.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.51 145.54 52.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 110.883 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.46 HD11 ' OG ' ' A' ' 58' ' ' SER . 51.5 mt -138.55 138.26 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.542 -0.724 . . . . 0.0 109.158 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -102.2 156.85 17.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 85.5 m -144.76 138.06 26.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.944 -1.098 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 4.3 t0 178.96 146.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 108.891 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 8.3 t70 60.59 54.3 3.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -61.68 121.25 12.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.116 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -86.25 121.88 29.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.757 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.5 pm0 -87.08 6.72 31.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.45 -50.83 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.4 p -97.67 -14.39 20.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 108.952 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.02 17.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.12 163.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -1.141 . . . . 0.0 109.717 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.445 ' O ' ' C ' ' A' ' 137' ' ' GLU . 73.4 m95 -68.24 114.71 6.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -37.18 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.218 0.532 . . . . 0.0 110.181 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -93.94 153.18 18.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -156.51 94.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.852 -1.155 . . . . 0.0 110.71 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -86.79 159.39 19.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 9.8 pt -145.82 159.57 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.842 -1.162 . . . . 0.0 110.685 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.4 m-85 -139.95 168.42 19.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.19 142.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.802 -1.186 . . . . 0.0 110.423 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.16 147.85 40.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 147' ' ' VAL . 13.0 t -108.63 140.36 42.12 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.51 ' OE1' ' CD2' ' A' ' 95' ' ' TYR . 3.2 tp10 -65.72 45.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.4 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.118 -0.988 . . . . 0.0 109.223 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -41.08 143.3 0.7 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.304 2.003 . . . . 0.0 113.356 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -87.19 -16.24 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.148 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' SER . 12.9 m-20 -77.7 105.62 8.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 109.451 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 1.9 mptp? -58.56 -2.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.443 -0.786 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' ASP . 39.7 m -113.94 43.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HZ3' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -143.15 134.41 25.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.942 . . . . 0.0 109.04 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.6 115.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.818 . . . . 0.0 110.932 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -95.76 -4.53 43.82 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.53 -168.85 41.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.54 124.77 10.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.178 -1.189 . . . . 0.0 109.071 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.7 tt -98.91 147.38 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.18 145.95 30.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.01 -1.056 . . . . 0.0 109.828 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -147.86 131.82 8.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -52.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.981 1.787 . . . . 0.0 111.833 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -50.88 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 109.301 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.55 3.08 17.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.521 -0.737 . . . . 0.0 109.073 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 43.39 37.1 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.573 -0.705 . . . . 0.0 109.646 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -92.91 152.19 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 122.214 1.006 . . . . 0.0 110.665 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -166.07 82.64 0.3 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -132.4 158.69 74.97 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.47 -0.769 . . . . 0.0 110.694 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.67 162.01 21.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.006 2.47 . . . . 0.0 112.654 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -138.16 104.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -76.65 166.13 47.23 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.785 -1.197 . . . . 0.0 109.377 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 15' ' ' ALA . 43.7 Cg_endo -89.77 120.04 0.89 Allowed 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.488 2.126 . . . . 0.0 111.818 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.09 -178.4 43.53 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 35' ' ' THR . 88.3 Cg_endo -81.22 116.63 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.919 2.413 . . . . 0.0 111.712 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -46.61 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.765 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -119.62 153.9 54.43 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.416 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 22.4 Cg_endo -60.35 -45.12 23.93 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.127 1.884 . . . . 0.0 111.803 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -63.28 -27.8 69.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 109.698 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -86.51 -68.33 0.75 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -46.82 -14.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.738 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.6 m-20 -63.89 -24.96 67.94 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.435 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -80.14 -20.92 43.8 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.085 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' OE1' ' A' ' 71' ' ' GLN . . . 159.29 -119.29 0.88 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.9 t -118.55 157.8 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.605 -0.938 . . . . 0.0 110.102 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 158.9 37.86 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -56.18 173.37 0.16 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.716 -1.24 . . . . 0.0 109.355 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.1 -14.48 55.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.895 . . . . 0.0 109.139 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -146.78 145.62 29.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 110.063 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -24.41 67.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.52 -0.737 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -88.75 3.24 51.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.0 150.3 45.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 109.758 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 45.9 m -149.04 159.6 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -69.64 -4.22 18.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -99.52 -15.34 18.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.683 . . . . 0.0 109.932 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 51' ' ' SER . 31.2 m-20 -60.14 107.61 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.716 -1.24 . . . . 0.0 109.203 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -45.75 -18.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.379 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.4 t-20 -127.81 98.31 5.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 58' ' ' SER . 96.6 mt -94.51 154.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 109.277 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 46' ' ' ALA . 58.6 m -145.38 117.59 8.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.2 mt -112.62 158.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 110.22 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.52 136.61 34.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.95 156.38 25.93 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -71.77 178.41 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.484 -1.009 . . . . 0.0 109.535 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.462 ' CG2' ' OD1' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -163.52 86.51 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.42 -0.8 . . . . 0.0 109.28 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -88.41 119.34 28.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.7 -30.9 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.074 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -82.9 15.94 2.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 109.566 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 69' ' ' ASN . 54.7 ttt180 -150.32 70.97 9.17 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.19 18.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.843 3.028 . . . . 0.0 114.36 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.2 63.41 0.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.783 -1.198 . . . . 0.0 108.651 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -151.09 110.77 4.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 64.2 mt-30 54.81 -115.5 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.712 -0.618 . . . . 0.0 111.918 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.592 ' CE2' HD13 ' A' ' 75' ' ' LEU . 3.1 m-85 -96.21 10.98 36.07 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.186 -0.946 . . . . 0.0 110.559 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.4 m -49.08 -18.01 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.0 m-20 -122.05 -23.58 5.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.398 -0.814 . . . . 0.0 110.032 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.592 HD13 ' CE2' ' A' ' 72' ' ' PHE . 6.9 tt -54.2 -29.0 44.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.768 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -75.4 -7.2 53.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -88.41 -24.0 23.17 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.73 -178.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.584 -0.697 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.23 162.86 40.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -52.98 133.03 38.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.57 -5.06 66.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 83' ' ' MET . 25.8 t -63.33 -161.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.055 -1.262 . . . . 0.0 108.174 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.521 ' N ' ' OG ' ' A' ' 82' ' ' SER . 50.1 mmm -142.61 162.27 35.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 109.739 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 t -146.15 155.45 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.236 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.83 107.9 5.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.287 -0.883 . . . . 0.0 109.207 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -95.02 112.28 24.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -97.99 138.98 34.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.7 m -144.06 150.19 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.32 -14.83 0.06 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 88' ' ' VAL . 48.2 t30 -84.02 -58.48 2.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.035 -1.274 . . . . 0.0 109.999 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.474 ' H ' HG23 ' A' ' 88' ' ' VAL . 20.1 tt0 -172.08 171.68 4.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 108.904 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -97.61 149.7 21.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.202 -0.936 . . . . 0.0 110.037 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.65 169.5 17.52 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.524 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.78 156.49 44.99 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.05 -1.031 . . . . 0.0 110.911 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.527 ' CE2' ' OE1' ' A' ' 146' ' ' GLU . 6.5 m-85 -136.5 -178.07 5.01 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -145.68 116.45 7.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.164 -0.96 . . . . 0.0 109.054 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 40.2 mtt -51.03 111.98 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.438 -0.788 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -140.04 28.98 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.369 -0.832 . . . . 0.0 108.916 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 p -178.95 141.91 0.19 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -178.632 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.436 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 4.4 mptp? -46.83 137.54 7.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 108.54 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -150.05 152.04 34.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 110.528 -178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.28 117.32 30.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.949 -0.47 . . . . 0.0 110.22 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 m -92.41 88.17 6.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.0 mt -68.28 138.33 55.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.697 . . . . 0.0 109.986 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.2 mt -137.87 148.31 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.391 -0.818 . . . . 0.0 109.604 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -102.94 169.01 8.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.427 -0.796 . . . . 0.0 108.907 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 34.5 m -148.49 138.93 22.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.993 -1.067 . . . . 0.0 109.619 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.462 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 0.3 OUTLIER 175.3 140.23 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 109.078 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 t0 59.86 66.36 1.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 108.986 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -65.52 127.53 32.23 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 109.668 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -84.77 124.94 32.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.027 -1.045 . . . . 0.0 109.759 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.3 6.25 48.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.461 -0.774 . . . . 0.0 109.228 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -88.36 -19.73 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.808 . . . . 0.0 109.681 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.7 p -137.29 -2.36 2.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.382 -0.824 . . . . 0.0 109.323 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.42 44.29 59.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.78 154.34 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.63 112.99 3.07 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.3 tp10 -37.96 -82.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.93 -0.481 . . . . 0.0 110.691 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -105.24 140.34 38.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.491 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -170.45 138.84 1.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.9 160.58 21.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.89 159.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.833 -1.167 . . . . 0.0 110.92 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 4.8 m-85 -132.66 177.45 7.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.4 t -150.66 133.61 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.852 -1.155 . . . . 0.0 110.586 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.57 15.03 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 147' ' ' VAL . 12.6 t -139.93 147.33 40.39 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.0 -1.063 . . . . 0.0 110.853 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.527 ' OE1' ' CE2' ' A' ' 95' ' ' TYR . 18.2 tp10 -65.51 48.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.778 -0.576 . . . . 0.0 109.459 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 145' ' ' THR . 2.0 t . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.084 -1.01 . . . . 0.0 108.961 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -41.39 130.58 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.818 1.679 . . . . 0.0 112.51 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -78.03 -29.27 49.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.503 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' SER . 40.3 m-20 -77.28 112.65 14.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -58.66 -2.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.524 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.2 m -105.68 38.84 1.89 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.345 -0.847 . . . . 0.0 109.543 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -142.51 126.37 17.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.302 -0.874 . . . . 0.0 109.261 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.497 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 24.9 t -59.62 132.34 24.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.914 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.07 -10.61 21.34 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 176.16 -161.13 29.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.497 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 66.0 m-85 -148.9 131.58 15.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.768 -1.43 . . . . 0.0 110.179 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -98.16 142.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -145.38 133.26 21.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.996 -1.065 . . . . 0.0 110.166 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 23' ' ' ALA . 53.5 mt -142.63 125.94 9.37 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.98 -44.35 0.21 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.707 1.604 . . . . 0.0 111.956 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -53.17 -20.48 3.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.087 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -121.6 8.33 10.09 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.4 p30 43.15 31.71 0.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.593 -0.692 . . . . 0.0 110.01 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 mt -91.08 143.2 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -164.2 85.89 0.46 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.4 159.6 68.76 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 110.624 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.06 162.01 26.28 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.048 2.499 . . . . 0.0 113.036 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 43' ' ' VAL . 3.1 t -139.63 115.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.442 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.73 170.37 13.19 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 120.794 -1.191 . . . . 0.0 108.733 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -89.16 130.91 2.1 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.451 2.101 . . . . 0.0 112.194 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' PHE . . . 164.74 175.08 35.17 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.612 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 35' ' ' THR . 61.9 Cg_endo -85.95 128.01 3.17 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.909 2.406 . . . . 0.0 111.589 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.618 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -38.84 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.662 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -118.79 154.13 52.71 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.76 -41.37 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.267 1.978 . . . . 0.0 111.89 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -63.08 -21.28 66.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 109.588 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -94.64 -70.08 0.72 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.296 -0.877 . . . . 0.0 109.269 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 16.7 mt -44.29 -26.29 0.31 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -61.11 -24.17 66.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 26.9 mtt-85 -89.13 -11.76 42.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.32 -122.33 1.14 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.222 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 60' ' ' ALA . 18.2 t -122.3 151.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.61 -0.936 . . . . 0.0 109.094 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.481 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 m -151.23 151.01 31.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 32' ' ' GLY . 27.7 m-85 -55.4 155.78 4.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.544 -1.348 . . . . 0.0 108.41 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -83.43 4.88 25.74 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.265 -0.897 . . . . 0.0 109.04 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -149.99 130.83 14.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.403 -0.811 . . . . 0.0 110.109 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.76 -22.83 65.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.775 . . . . 0.0 110.486 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.0 -2.8 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.035 -1.041 . . . . 0.0 110.075 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -60.45 163.55 5.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 109.081 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -145.43 -167.97 2.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 108.893 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.4 mp -95.05 11.64 31.35 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.215 -0.928 . . . . 0.0 109.079 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.92 12.38 0.44 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.576 ' CG ' HE22 ' A' ' 55' ' ' GLN . 19.6 t0 -57.03 120.38 7.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.756 -1.215 . . . . 0.0 108.751 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.713 HE21 ' N ' ' A' ' 56' ' ' ASN . 1.1 pm0 -45.86 -15.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.713 ' N ' HE21 ' A' ' 55' ' ' GLN . 4.8 m120 -136.12 99.32 4.1 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.0 mm -93.26 153.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.03 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 t -142.02 103.29 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -100.4 158.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.854 0.835 . . . . 0.0 110.336 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.588 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -138.12 134.7 34.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.87 27.43 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.684 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' PHE . 14.3 m-70 -76.49 178.4 6.65 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.585 -0.95 . . . . 0.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.48 90.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 108.74 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' N ' ' OG1' ' A' ' 73' ' ' THR . 5.3 m-85 -87.48 110.54 20.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.199 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 mm -58.32 -30.68 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 110.155 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -87.96 19.38 3.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.13 -0.981 . . . . 0.0 109.465 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -149.88 74.5 9.33 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.433 -0.792 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.1 Cg_exo -56.06 26.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 123.48 2.787 . . . . 0.0 113.524 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -150.57 29.21 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.835 -1.166 . . . . 0.0 109.073 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.8 t80 -89.28 -153.2 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -0.956 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.4 mp0 -71.29 -84.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.711 0.767 . . . . 0.0 110.808 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -94.78 19.45 10.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.677 -0.639 . . . . 0.0 109.968 -178.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.491 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 55.5 m -69.74 -38.19 76.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.326 -1.484 . . . . 0.0 109.93 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 77' ' ' ALA . 16.0 m-20 -103.92 -10.28 18.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.182 -0.948 . . . . 0.0 111.46 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 72' ' ' PHE . 2.6 mt -53.16 -29.27 30.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.406 -1.433 . . . . 0.0 108.365 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 10.6 pttp -80.36 -10.44 59.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -79.51 -23.37 42.98 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.85 -175.34 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLY . 34.3 mttm -150.53 154.98 38.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.029 -1.045 . . . . 0.0 109.686 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -51.06 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 109.734 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 97' ' ' MET . . . 150.84 -20.93 1.0 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -66.03 -165.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.104 -1.233 . . . . 0.0 108.185 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.3 mmm -137.88 171.65 14.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.14 108.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.0 109.145 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -93.37 109.37 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' O ' ' OG1' ' A' ' 92' ' ' THR . 39.9 t80 -94.76 116.89 29.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -85.24 139.11 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 111.115 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.3 m -147.78 124.98 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.53 -132.79 35.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.477 ' N ' ' OE2' ' A' ' 91' ' ' GLU . 49.8 t30 -97.95 35.98 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -1.198 . . . . 0.0 109.832 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.477 ' OE2' ' N ' ' A' ' 90' ' ' ASN . 1.2 pm0 -159.64 170.0 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -0.979 . . . . 0.0 108.955 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 86' ' ' PHE . 6.3 t -141.26 150.22 42.33 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.714 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -92.29 175.53 6.81 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -146.87 133.48 19.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 1.7 m-85 -138.85 126.84 22.42 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.544 ' NZ ' HG21 ' A' ' 147' ' ' VAL . 4.1 ttpm? -93.95 120.39 34.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 109.399 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.423 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 85.2 mtp -48.13 120.64 3.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.522 ' OG1' HG22 ' A' ' 145' ' ' THR . 8.7 p -149.83 31.62 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.37 -0.831 . . . . 0.0 109.304 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 m -171.54 86.95 0.09 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.834 -179.192 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.471 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 2.2 m-20 . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 118' ' ' ASP . 58.2 mttm -44.7 147.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.471 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -150.6 150.74 31.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.677 -1.265 . . . . 0.0 110.791 -178.036 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.38 111.9 24.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.88 -0.513 . . . . 0.0 109.753 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 m -98.04 120.79 39.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.201 -0.937 . . . . 0.0 108.696 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mp -104.43 147.11 27.92 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.471 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 77.3 mt -137.89 147.41 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.226 -0.921 . . . . 0.0 110.076 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.452 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.1 p -97.74 155.6 16.94 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.9 m -148.63 97.17 2.7 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.954 -1.091 . . . . 0.0 109.658 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 138' ' ' LYS . 4.9 p-10 -149.39 149.17 30.42 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 61.39 61.23 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.745 . . . . 0.0 109.282 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -64.38 118.87 9.34 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -86.72 118.04 25.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.051 -1.03 . . . . 0.0 109.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 5.1 pm0 -84.86 10.72 10.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -81.99 -54.53 5.24 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.8 p -96.29 -8.13 33.55 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.87 41.47 33.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -147.21 163.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.276 -1.132 . . . . 0.0 109.837 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.443 ' O ' ' C ' ' A' ' 137' ' ' GLU . 71.1 m95 -67.09 116.44 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' TRP . 16.4 tp10 -37.96 -86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.778 -0.576 . . . . 0.0 109.893 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.525 ' NZ ' ' OD2' ' A' ' 127' ' ' ASP . 1.9 pttp -89.0 152.06 21.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.463 ' NH2' HD13 ' A' ' 124' ' ' ILE . 54.8 ttt180 -157.45 89.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -79.28 167.99 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.493 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -148.58 151.38 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.756 -1.215 . . . . 0.0 110.023 -179.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 1.3 m-85 -143.09 162.52 35.31 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.1 t -148.68 152.72 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.764 -1.21 . . . . 0.0 110.929 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.41 160.96 38.19 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.522 HG22 ' OG1' ' A' ' 98' ' ' THR . 8.3 t -127.91 135.43 49.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.97 105.61 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.52 -0.738 . . . . 0.0 109.677 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.544 HG21 ' NZ ' ' A' ' 96' ' ' LYS . 1.3 t . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 108.889 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mt . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.37 162.82 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.474 2.116 . . . . 0.0 112.753 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -103.32 -12.41 17.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.511 -0.743 . . . . 0.0 109.363 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.533 ' CG ' ' HZ1' ' A' ' 13' ' ' LYS . 2.6 m-20 -77.55 109.06 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 11.9 mptt -59.62 -0.32 0.17 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.892 . . . . 0.0 109.604 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 10' ' ' ASP . 41.6 m -114.28 36.81 3.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.466 -0.771 . . . . 0.0 110.282 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HZ1' ' CG ' ' A' ' 10' ' ' ASP . 2.1 ttmp? -144.18 143.83 31.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.027 -1.046 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.19 145.12 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 110.098 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.46 11.79 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.87 173.54 34.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.75 119.98 7.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -1.175 . . . . 0.0 109.147 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -97.03 141.5 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -145.09 136.71 25.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 0.0 110.101 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.8 mt -144.37 127.05 8.47 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.9 Cg_endo -75.71 -43.23 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.524 1.483 . . . . 0.0 111.312 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.36 -15.24 0.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.464 -0.772 . . . . 0.0 109.128 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.1 13.6 3.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.46 52.4 4.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.454 -0.779 . . . . 0.0 109.944 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' ' 23' ' ' ALA . 49.8 mm -92.46 146.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.864 0.84 . . . . 0.0 110.214 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -169.83 80.28 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -142.9 158.79 58.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.54 162.27 14.64 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.511 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.52 112.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 5.7 m-85 -73.11 146.48 87.21 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -79.93 97.36 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.571 2.181 . . . . 0.0 111.884 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.19 -174.13 46.49 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.671 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 93.7 Cg_endo -80.55 120.97 4.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.839 2.359 . . . . 0.0 111.431 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -45.5 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.696 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.1 p -103.67 152.11 38.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 53.5 Cg_endo -68.95 -44.31 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.958 1.772 . . . . 0.0 111.803 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.42 -24.68 67.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.701 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.506 HE22 ' CB ' ' A' ' 44' ' ' SER . 2.8 tt0 -88.59 -59.81 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.651 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -47.29 -15.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 5.9 m120 -58.63 -29.89 66.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 85.7 mtt180 -80.38 -19.7 45.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.9 -141.7 7.55 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.459 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.1 t -98.36 161.47 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.401 -1.058 . . . . 0.0 109.388 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.506 ' CB ' HE22 ' A' ' 38' ' ' GLN . 11.7 p -158.84 156.97 30.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.072 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -56.06 171.84 0.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -95.46 -2.43 48.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.97 140.41 18.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.024 -1.048 . . . . 0.0 110.62 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -62.56 -22.84 66.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.69 20.85 2.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 0.0 109.486 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.22 145.63 53.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.233 1.016 . . . . 0.0 111.116 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 53' ' ' ASP . 3.3 m -155.33 136.32 13.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' CB ' HH22 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -60.87 -4.91 1.11 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' SER . 92.8 m-20 -93.73 -17.8 22.79 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.745 -0.597 . . . . 0.0 109.677 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 56' ' ' ASN . 42.0 t0 -58.94 109.84 0.91 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.777 -1.202 . . . . 0.0 109.286 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -47.56 -12.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 109.638 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' ASP . 50.0 t-20 -140.28 104.97 4.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.198 -0.939 . . . . 0.0 109.074 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 58' ' ' SER . 4.0 mp -95.07 159.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.494 ' N ' HG22 ' A' ' 57' ' ' ILE . 2.9 p -145.43 123.15 11.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.3 mt -120.23 160.15 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.679 0.752 . . . . 0.0 110.396 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.49 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -134.28 134.28 41.72 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.76 22.37 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -71.66 176.48 4.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.983 . . . . 0.0 109.272 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.16 90.5 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.55 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -89.42 111.42 22.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.908 . . . . 0.0 109.258 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 mm -60.47 -29.19 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.855 . . . . 0.0 110.627 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.44 15.97 4.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.912 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 69' ' ' ASN . 51.5 ttt180 -152.18 77.56 6.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.6 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 30.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 123.128 2.552 . . . . 0.0 112.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 67' ' ' ARG . 17.4 m-80 -150.95 63.46 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.085 -1.009 . . . . 0.0 108.622 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.612 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 3.0 t80 -137.83 -153.76 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.612 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 2.4 mp0 -58.43 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CD2' HD22 ' A' ' 75' ' ' LEU . 3.8 m-30 -94.61 16.61 15.11 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.8 m -49.14 -24.87 1.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.722 -1.236 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.466 ' C ' ' HB1' ' A' ' 23' ' ' ALA . 2.8 m-20 -115.31 -29.04 6.69 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.763 . . . . 0.0 110.006 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 72' ' ' PHE . 6.7 tt -50.81 -20.89 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -76.44 -18.1 58.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.04 31.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.526 0.679 . . . . 0.0 109.338 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.67 123.86 7.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.802 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -102.67 177.57 4.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -0.831 . . . . 0.0 109.143 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -51.06 152.49 2.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.77 -19.72 19.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.5 m -62.97 95.66 0.08 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.339 -1.095 . . . . 0.0 108.579 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.74 165.75 9.95 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.49 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -143.89 121.5 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.948 . . . . 0.0 109.099 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 12.5 m-85 -95.09 110.57 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 88' ' ' VAL . 28.6 t80 -96.15 112.16 23.98 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -96.13 149.85 21.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.295 -0.878 . . . . 0.0 111.034 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' CZ ' ' A' ' 86' ' ' PHE . 74.1 t -155.42 103.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.93 -127.43 31.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -90.29 53.04 2.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -1.146 . . . . 0.0 109.692 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -155.1 146.23 22.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.2 m -151.31 109.94 3.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.523 HH22 ' CB ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -100.83 169.51 8.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.559 -0.713 . . . . 0.0 110.003 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 147.96 41.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 109.586 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 121' ' ' LEU . 3.3 m-85 -134.1 175.36 9.55 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' THR . 59.5 tttp -131.66 106.7 8.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.0 ttm -49.01 98.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 108.876 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -133.65 24.17 4.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.851 . . . . 0.0 109.835 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.8 t -167.06 121.85 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.8 mt . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.415 -0.803 . . . . 0.0 110.203 -178.222 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 120' ' ' GLN . 2.3 m-20 . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' ASP . 19.1 ttpp -47.32 96.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.876 -1.14 . . . . 0.0 108.788 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.1 pm0 -95.89 174.54 6.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.844 0.83 . . . . 0.0 110.777 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 95' ' ' TYR . 94.8 mt -129.08 119.41 24.14 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -95.26 93.51 7.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 0.0 108.949 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.684 HD22 ' N ' ' A' ' 123' ' ' LEU . 3.1 mm? -76.45 148.34 37.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 16.9 mt -142.32 140.68 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -97.18 164.84 12.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.232 -0.917 . . . . 0.0 108.691 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.431 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 22.6 m -148.97 140.76 23.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.009 -1.057 . . . . 0.0 109.934 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 177.81 142.93 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 2.6 m-20 55.99 63.41 2.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.743 . . . . 0.0 109.101 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.34 125.4 24.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.104 -0.998 . . . . 0.0 109.393 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -86.7 124.03 32.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.084 -1.01 . . . . 0.0 109.562 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.17 4.22 46.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -78.44 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.164 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.0 p -95.6 -3.21 46.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.335 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.84 46.33 53.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 t -146.78 157.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -1.158 . . . . 0.0 109.374 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.9 m95 -63.86 111.63 2.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.165 -0.96 . . . . 0.0 108.596 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' TRP . 74.6 tt0 -32.49 -72.39 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.872 0.368 . . . . 0.0 111.309 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -134.03 146.52 50.45 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.269 -0.895 . . . . 0.0 109.853 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.755 ' HE ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -167.38 -162.86 0.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.121 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -145.88 162.18 38.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.006 -1.058 . . . . 0.0 108.992 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.5 mt -133.78 138.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.42 -0.8 . . . . 0.0 109.843 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.7 m-85 -128.79 165.76 20.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 99' ' ' SER . 12.8 t -146.38 114.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.946 -1.096 . . . . 0.0 110.423 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.23 169.38 9.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 145' ' ' THR . 14.1 t -132.02 127.76 36.9 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.486 -0.759 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 3.2 tm-20 -59.0 131.92 52.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.13 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.239 -0.913 . . . . 0.0 109.075 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.497 1.881 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.8 179.54 6.19 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.786 1.657 . . . . 0.0 112.313 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -103.77 20.8 17.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.469 -0.77 . . . . 0.0 109.578 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.7 m-20 -77.98 101.94 7.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.983 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 3.5 mptp? -62.29 7.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.383 -0.823 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 10' ' ' ASP . 75.6 p -141.37 41.85 1.76 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -147.66 142.0 26.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.023 -1.048 . . . . 0.0 109.827 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 58.3 t -61.35 122.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.595 -0.691 . . . . 0.0 110.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.81 -25.3 15.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -172.95 -161.64 23.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.542 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 13.0 m-85 -147.26 126.97 13.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.132 -1.217 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -96.04 138.44 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 178.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' H ' HD13 ' A' ' 18' ' ' ILE . 22.4 mt-10 -145.23 141.29 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.652 -1.28 . . . . 0.0 111.836 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.0 mt -148.26 127.26 6.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.431 ' C ' ' N ' ' A' ' 23' ' ' ALA . 73.8 Cg_endo -75.8 -43.65 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.567 1.511 . . . . 0.0 111.379 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.51 -11.33 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -0.857 . . . . 0.0 109.364 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.36 11.4 3.82 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.405 -0.809 . . . . 0.0 109.687 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ALA . 3.7 p30 42.26 36.31 0.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.457 -0.777 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.18 140.71 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 109.155 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -166.03 86.47 0.35 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -139.79 157.93 68.8 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.5 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -80.96 162.01 20.82 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.115 2.544 . . . . 0.0 113.108 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.76 134.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 5.3 m-85 -94.48 151.1 39.06 Favored Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 120.869 -1.144 . . . . 0.0 110.56 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.17 82.45 2.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.74 2.293 . . . . 0.0 111.442 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 178.84 39.75 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.128 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 35' ' ' THR . 87.3 Cg_endo -78.75 109.53 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.247 2.631 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.09 89.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 111.694 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' PRO . 10.3 p -121.41 152.26 57.56 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -40.13 65.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.36 1.374 . . . . 0.0 111.969 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -66.37 -34.66 78.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.751 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.575 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -88.64 -26.33 21.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.49 -1.381 . . . . 0.0 110.769 -178.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.94 -10.88 59.95 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.014 -1.054 . . . . 0.0 108.871 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -56.88 -29.3 62.82 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -79.04 -20.06 49.85 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.33 -135.23 4.75 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.9 t -84.79 169.18 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.567 -0.961 . . . . 0.0 110.235 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.575 ' CB ' HE22 ' A' ' 38' ' ' GLN . 1.6 t -167.78 152.97 6.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.0 109.096 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.63 155.4 26.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.817 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -72.49 -2.97 21.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -151.86 147.63 26.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 110.184 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.73 -39.11 93.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.727 -0.608 . . . . 0.0 111.54 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -88.01 20.75 2.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.119 . . . . 0.0 111.327 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.09 137.06 58.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.833 -1.167 . . . . 0.0 109.49 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 m -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 109.425 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 52' ' ' LEU . 7.5 mp -61.15 -13.92 21.15 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.094 -1.004 . . . . 0.0 108.525 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.55 -27.41 51.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.546 -0.721 . . . . 0.0 109.623 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 56' ' ' ASN . 3.4 m-20 -61.78 112.43 2.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.155 -0.965 . . . . 0.0 109.862 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -65.9 6.63 0.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.083 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 54' ' ' ASP . 46.6 t-20 -147.04 95.14 2.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.5 115.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.505 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -108.71 113.69 26.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.95 155.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.56 115.32 23.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.11 145.22 16.07 Favored Glycine 0 N--CA 1.503 3.153 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' A' ' 72' ' ' PHE . 9.2 m-70 -72.88 175.95 6.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.502 -0.999 . . . . 0.0 109.761 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.48 79.73 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -88.01 129.6 35.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 109.885 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mt -64.33 -34.79 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.531 -0.73 . . . . 0.0 109.935 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.04 20.28 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 109.45 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -149.98 68.2 8.75 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.099 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 66.7 Cg_exo -52.27 15.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.187 0 C-N-CA 123.481 2.787 . . . . 0.0 113.915 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.2 p30 -151.29 63.75 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.894 -1.129 . . . . 0.0 108.217 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 33.5 t80 -148.02 99.42 3.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.7 mt-30 61.01 -110.89 0.45 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 125' ' ' THR . 35.6 t80 -91.14 0.16 57.59 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.111 -0.993 . . . . 0.0 111.55 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.9 m -49.17 -43.65 42.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.535 -1.353 . . . . 0.0 110.626 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ALA . 3.8 m120 -94.93 -21.51 18.59 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.027 -1.045 . . . . 0.0 112.028 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.4 tm? -51.07 -32.28 21.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.562 -1.336 . . . . 0.0 108.279 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 1.11 2.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -105.96 -27.36 11.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.2 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.845 . . . . 0.0 109.543 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 175.23 5.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 110.02 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -49.37 135.68 17.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.1 -17.79 55.87 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 m -62.14 107.98 0.98 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.011 -1.288 . . . . 0.0 107.748 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mtp -70.23 176.27 4.02 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.287 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.69 154.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.22 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -145.65 104.88 3.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.06 111.8 23.56 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -99.21 148.23 24.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 0.0 110.453 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.1 p -167.09 107.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.86 -146.37 48.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -83.54 43.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 109.62 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.42 150.1 37.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.197 -0.94 . . . . 0.0 109.246 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.9 m -150.53 118.85 6.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -0.895 . . . . 0.0 109.704 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -92.7 164.16 13.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.414 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -145.61 118.89 8.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 109.587 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 16.7 m-85 -112.36 -171.49 1.86 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -143.61 101.67 3.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.16 -0.963 . . . . 0.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.6 mtp -48.94 116.58 1.71 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.326 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -161.54 29.9 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.089 . . . . 0.0 110.561 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 t -163.5 86.31 0.51 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.958 -1.089 . . . . 0.0 108.151 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 100' ' ' ILE . 2.1 mp . . . . . 0 C--N 1.301 -1.507 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 13.1 t70 . . . . . 0 N--CA 1.5 2.042 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 60.6 mttm -38.05 135.5 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.73 161.8 39.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.892 -1.13 . . . . 0.0 111.104 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.51 103.8 13.39 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.2 m -91.48 152.95 20.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.84 146.8 36.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.7 mt -136.76 142.02 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.523 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.3 p -91.84 169.67 10.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.866 -1.146 . . . . 0.0 108.815 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 m -147.8 106.41 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.08 -1.012 . . . . 0.0 109.803 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 128' ' ' ASP . 10.5 t70 -157.35 144.9 18.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.012 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 127' ' ' ASP . 70.6 m-20 53.69 64.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.476 -0.765 . . . . 0.0 109.135 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -65.27 124.11 21.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 110.056 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -86.76 127.52 34.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.937 -1.102 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.8 pm0 -94.6 12.19 28.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.454 -0.779 . . . . 0.0 109.649 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -85.61 -57.97 2.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 109.073 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.0 p -95.72 -9.95 30.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.834 . . . . 0.0 109.136 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.83 46.86 9.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -147.05 153.55 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -1.094 . . . . 0.0 109.551 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.426 ' O ' ' C ' ' A' ' 137' ' ' GLU . 72.5 m95 -61.44 112.29 2.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 136' ' ' TRP . 42.5 tt0 -38.68 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.247 0.546 . . . . 0.0 110.326 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -91.38 135.96 33.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.106 -0.996 . . . . 0.0 108.61 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -157.04 122.26 4.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.946 -1.096 . . . . 0.0 110.334 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -100.79 164.48 11.83 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 141' ' ' ILE . 29.3 pt -148.35 151.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.832 -1.168 . . . . 0.0 110.481 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.28 172.2 14.23 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.65 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 43.0 t -147.32 129.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.856 -1.153 . . . . 0.0 110.961 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.19 -176.28 3.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.0 t -148.26 136.71 21.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.745 -1.222 . . . . 0.0 109.426 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.24 150.18 18.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.405 -0.809 . . . . 0.0 109.537 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.343 -0.848 . . . . 0.0 109.131 -179.932 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -40.85 137.49 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.56 1.506 . . . . 0.0 112.248 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -82.46 -20.15 37.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.244 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' SER . 67.2 m-20 -77.87 108.89 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -62.68 -1.09 0.74 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' ASP . 22.6 p -120.49 47.33 1.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.667 -0.645 . . . . 0.0 109.517 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -144.8 136.04 25.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.3 -0.875 . . . . 0.0 109.274 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.47 114.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.767 . . . . 0.0 110.995 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.96 -17.33 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.26 -173.0 35.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.99 125.0 9.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.101 -1.235 . . . . 0.0 109.211 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -97.29 146.88 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -150.6 131.76 14.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.045 . . . . 0.0 110.476 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 HD21 ' A' ' 75' ' ' LEU . 26.6 mt -144.29 126.47 8.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.45 -41.54 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.648 1.565 . . . . 0.0 111.572 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -51.38 -16.19 0.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.0 109.469 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -136.13 15.32 3.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.2 p-10 44.23 48.51 7.81 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.404 -0.81 . . . . 0.0 109.875 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 23' ' ' ALA . 46.5 mm -90.31 138.64 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.208 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.08 84.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -144.67 151.99 51.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.039 -1.038 . . . . 0.0 110.5 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.05 161.71 18.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.575 2.183 . . . . 0.0 112.155 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.46 102.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.69 171.49 12.17 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.761 -1.212 . . . . 0.0 109.109 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -86.39 137.11 4.94 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.592 2.194 . . . . 0.0 112.301 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.66 171.62 20.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' ' N ' ' A' ' 35' ' ' THR . 92.2 Cg_endo -78.01 117.88 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.587 2.192 . . . . 0.0 110.767 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.04 88.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.698 -0.626 . . . . 0.0 110.338 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -114.6 153.89 46.71 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.05 -41.9 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.944 1.763 . . . . 0.0 112.112 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.04 -23.46 67.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.906 -1.121 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -90.82 -66.82 0.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.013 . . . . 0.0 109.17 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -45.27 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -64.2 -24.45 67.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mtt-85 -87.34 -10.63 51.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 154.67 -129.47 2.59 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.5 t -112.67 156.63 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.613 -0.933 . . . . 0.0 109.907 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -150.68 154.84 38.18 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -58.56 169.96 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.593 -1.317 . . . . 0.0 110.068 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.64 -0.92 49.4 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -154.95 150.67 27.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.59 0.71 . . . . 0.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -63.9 -40.28 96.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 111.631 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.63 12.76 11.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.874 -1.141 . . . . 0.0 111.595 -177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -62.67 101.9 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.786 -1.196 . . . . 0.0 109.519 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 53' ' ' ASP . 8.6 p -93.61 141.85 28.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.154 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -54.85 -9.91 0.41 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' SER . 7.8 t70 -95.16 -9.91 32.08 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.678 -0.639 . . . . 0.0 109.817 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.7 t0 -56.35 113.26 1.51 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.832 -1.167 . . . . 0.0 109.001 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 54' ' ' ASP . 1.1 tt0 -41.58 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.693 -0.629 . . . . 0.0 110.186 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 15.4 p-10 -137.34 115.21 11.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.27 -0.894 . . . . 0.0 108.772 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -97.72 152.26 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 46' ' ' ALA . 9.3 m -140.66 105.42 4.93 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.6 mt -100.28 161.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.773 0.797 . . . . 0.0 110.725 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.535 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.05 129.84 26.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.94 160.14 25.24 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.54 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.604 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 19.3 m-70 -77.25 179.11 6.58 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.585 -0.95 . . . . 0.0 109.791 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.426 ' OG1' ' NZ ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -153.49 91.75 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 108.734 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' N ' ' OG1' ' A' ' 73' ' ' THR . 7.3 m-85 -86.51 104.55 16.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.132 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.83 -32.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.24 17.05 2.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 0.0 109.059 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.527 ' C ' ' H ' ' A' ' 69' ' ' ASN . 6.3 tpp180 -150.46 72.51 9.09 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.25 25.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 123.297 2.665 . . . . 0.0 113.522 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 67' ' ' ARG . 18.3 p30 -149.78 39.21 0.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.829 -1.17 . . . . 0.0 109.093 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.74 -153.57 0.49 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.604 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 29.0 mt-30 -64.79 -89.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.657 -0.652 . . . . 0.0 111.776 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -93.97 22.54 5.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.0 110.191 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 92.7 m -72.8 -24.88 60.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.306 -1.496 . . . . 0.0 109.951 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -119.37 -13.93 9.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.136 -0.977 . . . . 0.0 111.291 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.436 HD21 HD12 ' A' ' 20' ' ' ILE . 7.1 mt -51.74 -19.9 1.87 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.62 -1.3 . . . . 0.0 108.79 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' NZ ' ' OG1' ' A' ' 63' ' ' THR . 12.1 pttm -88.55 -8.4 54.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 108.563 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -85.69 -21.78 28.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.4 -174.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 109.362 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' GLY . 45.9 mtmt -150.23 155.23 39.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 11.0 ttmm -51.4 89.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 148.19 -15.94 1.32 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.6 m -62.59 114.22 3.44 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.0 ptm -68.9 -179.59 1.52 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.48 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.06 153.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.0 109.593 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -132.74 103.28 6.03 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.36 111.7 23.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -90.65 150.81 21.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.6 t -150.01 151.3 12.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.45 -4.89 0.42 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 88' ' ' VAL . 55.0 m-20 -102.41 -45.96 4.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.311 -1.111 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -171.55 -156.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.985 -1.072 . . . . 0.0 109.106 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.4 m -132.88 120.3 21.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.345 -0.847 . . . . 0.0 109.941 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.528 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -92.13 171.9 8.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.472 -0.768 . . . . 0.0 109.031 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 8.5 mtmp? -144.84 152.32 40.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 11.4 m-85 -139.34 178.57 7.1 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -142.28 105.82 4.66 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.147 -0.971 . . . . 0.0 109.773 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 55.0 mtt -49.33 125.1 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.6 t -150.78 19.45 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 143' ' ' VAL . 3.4 p -174.69 122.87 0.26 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 C--N 1.298 -1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.286 -177.538 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' GLN . 11.2 m-20 . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HZ2' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -37.84 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.907 0.86 . . . . 0.0 109.323 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -95.47 147.15 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.411 0.624 . . . . 0.0 110.123 -178.213 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -102.74 155.16 18.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.516 -0.74 . . . . 0.0 109.407 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -139.64 87.85 2.2 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 141' ' ' ILE . 9.6 mt -74.04 145.31 44.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 0.0 110.75 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.481 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 50.0 mt -139.69 148.31 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.468 -0.77 . . . . 0.0 109.085 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.464 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -96.59 170.16 9.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -149.81 95.56 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -155.39 141.94 18.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 109.485 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.6 55.66 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 0.0 109.073 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -64.13 123.18 18.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 109.833 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -84.4 122.83 29.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.0 109.302 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -87.53 4.74 42.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -80.17 -55.85 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.9 p -95.7 -12.05 26.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 45.55 10.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.7 t -146.96 153.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.259 -1.142 . . . . 0.0 109.61 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.538 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 66.0 m95 -61.73 110.69 1.59 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.184 -0.948 . . . . 0.0 108.591 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 136' ' ' TRP . 2.8 tm-20 -42.37 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.487 -0.758 . . . . 0.0 109.859 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 144.13 27.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 108.248 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.5 OUTLIER -161.05 94.33 1.01 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.0 110.548 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -75.1 163.84 27.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.457 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 4.2 mt -144.28 155.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.058 -1.026 . . . . 0.0 110.791 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 38.5 m-85 -140.74 165.01 28.66 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 99' ' ' SER . 57.6 t -147.65 148.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.839 -1.163 . . . . 0.0 110.385 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.73 179.24 6.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 t -143.46 142.71 31.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.09 -1.006 . . . . 0.0 109.979 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -56.82 152.32 12.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.608 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.827 . . . . 0.0 109.297 179.763 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.495 1.792 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 114.36 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.388 2.058 . . . . 0.0 112.916 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -60.03 -11.09 5.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.24 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 12' ' ' SER . 34.8 m-20 -77.02 100.53 5.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -59.38 0.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.9 m -122.85 39.49 3.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -142.71 143.58 32.34 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 16' ' ' GLY . 62.8 t -58.23 155.28 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.37 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -141.7 6.62 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 162.79 -172.8 38.92 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 81.1 m-85 -146.72 125.52 12.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -1.071 . . . . 0.0 109.706 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.586 HD11 ' CG1' ' A' ' 84' ' ' VAL . 9.0 tp -95.08 144.25 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -146.98 129.13 15.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.879 -1.138 . . . . 0.0 110.569 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mt -144.76 126.98 8.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.3 Cg_endo -76.9 -42.15 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.673 1.582 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -52.75 -12.96 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.05 10.74 3.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 40.95 39.86 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.475 0.655 . . . . 0.0 110.121 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.415 HD11 ' H ' ' A' ' 75' ' ' LEU . 7.0 mt -94.7 146.23 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.944 0.878 . . . . 0.0 110.024 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -166.02 83.16 0.3 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -139.96 159.53 64.15 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.388 -0.82 . . . . 0.0 110.645 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.47 161.5 22.35 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.946 2.431 . . . . 0.0 112.579 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.5 113.21 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.32 171.29 12.53 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.756 -1.215 . . . . 0.0 109.181 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -95.32 136.99 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.546 2.164 . . . . 0.0 112.018 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.72 173.53 22.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 35' ' ' THR . 57.0 Cg_endo -71.88 115.43 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.731 2.287 . . . . 0.0 110.785 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.49 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.59 -0.694 . . . . 0.0 110.741 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -109.0 152.52 42.49 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.527 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 32.7 Cg_endo -63.52 -43.22 18.15 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.072 1.848 . . . . 0.0 112.153 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.07 -27.41 69.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.027 -1.045 . . . . 0.0 109.527 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -84.14 -63.72 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.207 -0.933 . . . . 0.0 109.54 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.6 mt -47.5 -13.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.472 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.7 m120 -59.02 -28.13 66.12 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.423 ' C ' ' OH ' ' A' ' 30' ' ' TYR . 26.6 mtt-85 -79.84 -17.72 52.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.17 -101.61 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.59 -1.29 . . . . 0.0 111.057 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 60' ' ' ALA . 4.8 t -135.5 155.14 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -1.073 . . . . 0.0 110.217 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 t -151.22 152.04 32.71 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.55 171.32 0.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.546 -1.346 . . . . 0.0 109.346 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -80.52 -10.38 59.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -149.71 154.68 38.93 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.778 0.799 . . . . 0.0 109.96 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.8 pt-20 -64.48 -43.09 95.25 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 31.6 m120 -84.68 10.3 11.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.597 -1.314 . . . . 0.0 111.037 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 58' ' ' SER . 4.5 mm-40 -64.75 96.74 0.19 Allowed 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 110.354 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 p -93.69 175.27 6.8 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -79.92 -10.64 59.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -102.19 -4.12 26.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.694 . . . . 0.0 109.975 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 56' ' ' ASN . 10.3 t70 -58.72 125.56 23.99 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.848 -1.158 . . . . 0.0 109.337 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.595 HE22 ' N ' ' A' ' 119' ' ' LYS . 34.8 tp60 -39.28 -24.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.73 -0.606 . . . . 0.0 109.956 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 54' ' ' ASP . 52.4 t-20 -151.96 113.87 4.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 58' ' ' SER . 4.1 mp -96.11 156.04 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.513 ' N ' ' OE2' ' A' ' 50' ' ' GLU . 34.0 t -143.21 123.41 13.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 60' ' ' ALA . 73.4 mt -110.9 153.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.547 -0.721 . . . . 0.0 110.567 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -133.9 132.56 40.43 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.28 157.28 25.5 Favored Glycine 0 N--CA 1.503 3.13 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.995 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -70.61 176.38 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.73 -0.865 . . . . 0.0 109.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -159.34 93.83 1.15 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.13 105.51 17.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.166 -0.959 . . . . 0.0 108.915 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 65' ' ' ILE . 18.9 mt -59.74 -29.09 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 8.2 t70 -84.55 11.22 9.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.399 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' ASN . 24.5 ttm180 -151.62 79.75 6.46 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.277 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.25 24.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 123.702 2.935 . . . . 0.0 114.357 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' ARG . 40.6 m-80 -151.09 62.77 0.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 108.597 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.52 ' CD2' ' OE1' ' A' ' 71' ' ' GLN . 15.3 t80 -146.73 102.93 3.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.165 -0.959 . . . . 0.0 110.272 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 15.2 mp0 55.28 -113.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 111.796 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.4 m-85 -92.42 7.73 41.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.085 -1.01 . . . . 0.0 110.421 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.8 m -47.16 -33.65 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.74 -1.225 . . . . 0.0 109.698 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 8.1 m120 -100.28 -28.95 12.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -0.773 . . . . 0.0 110.472 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' ALA . 6.9 tp -54.11 -31.94 53.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.616 -1.303 . . . . 0.0 108.792 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -65.99 -3.28 5.02 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -102.33 -28.5 12.21 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -44.75 168.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 110.017 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.78 160.76 39.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.372 -0.83 . . . . 0.0 108.94 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -49.99 137.08 17.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.03 -1.044 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 -23.94 32.28 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 m -62.68 115.9 4.71 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.211 -1.17 . . . . 0.0 108.057 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.83 176.7 4.73 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.971 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.586 ' CG1' HD11 ' A' ' 18' ' ' ILE . 13.9 t -142.81 109.27 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.405 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -93.67 102.84 15.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -96.99 112.17 24.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -93.89 154.32 17.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.036 -1.04 . . . . 0.0 110.74 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.6 m -151.15 160.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.36 46.38 0.26 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 22.7 p30 -160.33 -36.78 0.05 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 109.783 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.0 tt0 -174.24 -157.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 108.925 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 92' ' ' THR . 7.0 t -141.54 129.76 22.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -92.12 162.37 14.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.813 . . . . 0.0 109.212 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -144.36 93.98 2.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.086 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -93.23 179.34 5.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.076 -1.015 . . . . 0.0 108.8 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 98' ' ' THR . 36.1 ttpt -144.96 114.82 7.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.3 mtt -48.96 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 109.113 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.6 m -126.03 29.65 5.83 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.7 . . . . 0.0 109.538 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.3 86.98 0.08 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.15 -0.969 . . . . 0.0 108.499 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.4 mm . . . . . 0 C--N 1.298 -1.66 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.57 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.569 ' C ' HE22 ' A' ' 55' ' ' GLN . 16.7 t70 . . . . . 0 N--CA 1.501 2.076 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.595 ' N ' HE22 ' A' ' 55' ' ' GLN . 46.4 mttp -43.35 129.81 4.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.589 HE22 HE21 ' A' ' 55' ' ' GLN . 0.1 OUTLIER -148.42 167.43 25.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.0 -1.062 . . . . 0.0 110.117 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.7 tp -118.8 122.2 41.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.651 -0.656 . . . . 0.0 110.35 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -100.63 94.13 5.94 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 123' ' ' LEU . 5.4 mp -73.78 147.4 43.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.923 . . . . 0.0 110.244 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.507 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 82.0 mt -138.13 148.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 18.1 p -102.18 165.23 11.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 108.898 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.9 m -147.51 87.44 1.65 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.976 -1.077 . . . . 0.0 109.273 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 7.1 p30 -130.21 146.34 51.82 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.22 -0.925 . . . . 0.0 110.089 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 54.8 72.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.657 -0.652 . . . . 0.0 109.493 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -67.56 119.96 13.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.181 -0.949 . . . . 0.0 109.683 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -88.88 123.11 32.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.779 -1.201 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.3 pm0 -93.13 -13.01 29.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.847 . . . . 0.0 109.019 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -62.93 -49.72 73.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 46.7 p -97.35 -13.34 21.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 108.775 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 38.19 27.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.15 162.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.444 ' O ' ' C ' ' A' ' 137' ' ' GLU . 78.9 m95 -64.73 113.21 3.62 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.6 tp10 -36.99 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.947 -0.471 . . . . 0.0 110.418 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -111.12 137.72 48.44 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.49 113.85 5.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 109.753 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.48 ' N ' ' OG1' ' A' ' 125' ' ' THR . 44.5 mttm -75.45 166.84 22.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.107 -0.996 . . . . 0.0 108.517 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 pt -149.6 134.51 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.937 -1.102 . . . . 0.0 110.331 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -130.06 169.85 14.76 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 t -145.85 143.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.818 -1.176 . . . . 0.0 110.667 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -132.8 126.24 31.89 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.4 t -94.49 145.65 24.65 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -58.41 147.12 32.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 147' ' ' VAL . 5.2 m . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.3 mt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -42.57 156.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.475 1.45 . . . . 0.0 112.179 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -103.38 -23.71 13.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 21.5 t0 -76.96 108.13 9.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.668 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -58.28 -3.61 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.267 -0.895 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 42.3 m -115.27 43.43 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.487 -0.758 . . . . 0.0 109.349 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -147.6 145.86 29.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 16' ' ' GLY . 86.5 t -59.72 149.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.857 0.837 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.39 12.46 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 160.17 177.07 32.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.25 122.5 9.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.27 . . . . 0.0 109.055 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.7 tt -97.57 151.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.48 132.25 15.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mt -142.29 125.71 9.57 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.451 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.2 Cg_endo -76.1 -43.07 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.692 1.595 . . . . 0.0 111.511 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -51.05 -14.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.89 . . . . 0.0 108.867 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.451 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.4 12.52 3.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.661 -0.649 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 p-10 43.02 51.86 5.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.42 -0.8 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.6 mm -95.69 147.25 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.045 0.926 . . . . 0.0 111.04 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -168.75 80.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 10.0 mt-10 -139.3 158.57 68.73 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.299 -0.876 . . . . 0.0 110.944 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.25 160.44 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.986 2.457 . . . . 0.0 112.91 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 t -132.46 101.7 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.65 171.72 11.19 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.918 -1.114 . . . . 0.0 109.76 -178.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -86.59 116.02 1.34 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.142 2.561 . . . . 0.0 112.945 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.23 160.99 22.78 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.736 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 90.3 Cg_endo -76.59 126.77 9.17 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.702 2.268 . . . . 0.0 111.053 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -41.58 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.753 -0.592 . . . . 0.0 110.77 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.7 p -127.17 149.61 70.02 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.525 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 19.7 Cg_endo -58.21 -43.04 50.65 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.925 1.75 . . . . 0.0 112.185 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.22 -20.87 65.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.106 -0.996 . . . . 0.0 109.788 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -89.26 -68.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.16 -0.962 . . . . 0.0 109.378 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.2 mt -47.34 -11.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.979 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 38' ' ' GLN . 4.0 m120 -56.84 -28.88 62.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 19.9 mmt180 -81.12 -18.31 46.9 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 147.83 -124.51 1.92 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 2.3 t -97.6 160.66 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.288 -1.125 . . . . 0.0 109.825 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 p -165.22 153.62 11.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 108.778 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -53.54 167.19 0.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.954 -1.091 . . . . 0.0 108.802 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -100.4 11.14 40.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.394 -0.816 . . . . 0.0 109.055 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -156.16 134.3 11.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.988 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.61 -25.63 68.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -87.07 17.29 4.29 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.926 -1.109 . . . . 0.0 110.03 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 51' ' ' SER . 1.7 pp20? -62.43 165.63 5.94 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.732 0.777 . . . . 0.0 110.347 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.533 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 2.1 p -150.77 174.12 13.42 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.12 2.74 33.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.9 -1.125 . . . . 0.0 108.368 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -154.86 25.02 0.44 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.473 -0.767 . . . . 0.0 110.126 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OG ' ' A' ' 51' ' ' SER . 24.2 t70 -56.7 124.04 17.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.742 -1.224 . . . . 0.0 108.571 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.483 ' CD ' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -43.77 -22.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 41.9 t-20 -140.18 97.1 3.16 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 58' ' ' SER . 96.9 mt -94.41 154.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.291 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 57' ' ' ILE . 23.1 p -142.64 120.8 12.19 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 60' ' ' ALA . 79.5 mt -114.59 164.88 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.846 0.831 . . . . 0.0 110.753 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.588 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -141.12 139.87 34.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.03 145.08 13.45 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.587 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.694 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 39.0 m-70 -73.16 -172.19 1.05 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.99 . . . . 0.0 109.42 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.23 88.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.848 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -89.1 121.82 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 0.0 108.734 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 65' ' ' ILE . 7.4 mt -61.65 -32.34 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.449 -0.782 . . . . 0.0 110.67 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.69 17.45 2.27 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.716 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.563 ' C ' ' H ' ' A' ' 69' ' ' ASN . 53.5 mtp180 -150.11 73.26 9.34 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.56 -0.712 . . . . 0.0 109.393 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.57 12.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.285 2.657 . . . . 0.0 113.62 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.563 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.6 p30 -147.15 57.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.916 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -141.87 112.66 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.364 -0.835 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.694 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 7.5 mt-30 51.85 -127.78 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.469 -0.77 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.419 ' CE2' HD13 ' A' ' 75' ' ' LEU . 5.8 m-30 -93.97 42.5 1.1 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.834 -1.166 . . . . 0.0 110.404 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.9 m -68.79 -16.48 63.81 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.445 -1.409 . . . . 0.0 109.091 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 14.8 m-20 -125.82 -25.54 3.62 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.582 -0.699 . . . . 0.0 109.99 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -53.92 -25.29 19.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 0.0 108.591 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -74.35 -6.06 45.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -94.16 -28.61 15.57 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.377 0.608 . . . . 0.0 109.409 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.86 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.486 -0.759 . . . . 0.0 109.801 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' C ' ' SD ' ' A' ' 97' ' ' MET . 14.6 ptpt -155.37 179.36 9.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.95 . . . . 0.0 109.369 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.606 ' HZ1' ' H ' ' A' ' 100' ' ' ILE . 58.1 mmtt -47.4 138.32 7.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.17 -16.05 59.64 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -62.54 97.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.168 -1.195 . . . . 0.0 108.494 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 70.3 mmm -62.93 168.28 4.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.773 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 t -142.32 114.87 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.519 -0.738 . . . . 0.0 109.482 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.25 107.29 19.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.114 -0.991 . . . . 0.0 109.614 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 88' ' ' VAL . 41.0 t80 -94.64 112.33 24.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 88' ' ' VAL . 35.6 ttpt -94.18 135.0 36.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.088 -1.007 . . . . 0.0 110.969 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 86' ' ' PHE . 4.2 m -157.06 132.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 55.96 -148.33 28.25 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -94.61 50.67 1.35 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.195 -1.179 . . . . 0.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -171.24 140.26 1.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.036 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 92' ' ' THR . 15.2 t -120.8 133.14 55.33 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.543 -0.723 . . . . 0.0 110.303 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.537 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.8 178.23 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.253 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 15.1 ptpt -145.66 152.3 39.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.147 -0.971 . . . . 0.0 109.861 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.497 ' CD1' HD11 ' A' ' 121' ' ' LEU . 26.6 m-85 -141.23 178.79 7.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.259 -0.9 . . . . 0.0 108.759 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -143.35 110.34 5.64 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.18 -0.95 . . . . 0.0 109.938 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 79' ' ' LYS . 37.3 ttm -48.19 127.05 12.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 98' ' ' THR . 11.1 m -161.78 25.68 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.1 . . . . 0.0 110.269 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.476 ' N ' ' HZ3' ' A' ' 80' ' ' LYS . 2.2 m -163.27 87.43 0.55 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.672 -1.267 . . . . 0.0 108.636 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.606 ' H ' ' HZ1' ' A' ' 80' ' ' LYS . 1.3 mp . . . . . 0 C--N 1.303 -1.456 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 119' ' ' LYS . 3.1 m-20 . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.555 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 1.6 mptm? -30.89 129.85 0.12 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.256 0.551 . . . . 0.0 110.043 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -147.3 168.37 21.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.059 -1.025 . . . . 0.0 109.962 -178.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 95' ' ' TYR . 60.7 mt -124.31 111.81 16.25 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.742 -0.598 . . . . 0.0 109.911 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.3 m -91.68 88.07 6.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.041 -1.037 . . . . 0.0 108.243 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 123' ' ' LEU . 6.9 mp -78.16 154.51 31.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 18.4 mt -140.01 148.89 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 56.2 p -99.03 163.64 12.5 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.6 m -147.34 149.54 33.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 109.579 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.88 130.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 27.8 t0 60.34 71.24 0.58 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.011 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 130' ' ' ASN . 40.7 t80 -65.1 132.43 49.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.655 -1.278 . . . . 0.0 110.026 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.436 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 51.7 t30 -79.64 119.64 22.86 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.982 -1.074 . . . . 0.0 109.351 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -91.97 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.227 -0.92 . . . . 0.0 109.544 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -78.87 -64.66 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 p -94.84 -7.65 39.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 53.78 4.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.98 151.4 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.199 -1.177 . . . . 0.0 109.551 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.39 116.41 5.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 128' ' ' ASP . 7.0 mm-40 -37.76 -85.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.149 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -111.76 156.03 22.59 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -170.16 -160.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 109.963 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.481 ' N ' ' OG1' ' A' ' 125' ' ' THR . 59.7 mttp -152.05 160.46 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.5 mt -141.69 127.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.131 -0.981 . . . . 0.0 110.201 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -147.58 149.02 31.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.91 . . . . 0.0 108.715 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.4 t -125.47 136.22 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.463 -0.773 . . . . 0.0 111.142 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.73 174.85 5.71 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -140.26 135.95 32.83 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.87 131.12 49.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.888 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 -163.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.244 1.963 . . . . 0.0 112.168 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -126.41 -23.17 3.85 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' SER . 16.9 t0 -77.41 114.15 15.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.239 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -58.33 -2.55 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.85 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.2 p -112.39 41.78 1.94 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 109.618 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -146.24 137.25 24.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -1.0 . . . . 0.0 109.78 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 16' ' ' GLY . 60.1 t -61.34 159.76 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 121.682 0.753 . . . . 0.0 110.762 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -139.65 1.4 1.91 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.579 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 163.67 -170.39 38.99 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 62.5 m-85 -147.27 125.76 12.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.126 -1.22 . . . . 0.0 110.518 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 tp -95.51 140.13 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -145.15 145.49 31.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.827 -1.17 . . . . 0.0 110.822 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.484 ' CD1' HD21 ' A' ' 75' ' ' LEU . 12.6 mt -147.8 129.35 7.31 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.07 -53.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.86 1.707 . . . . 0.0 112.296 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.96 -27.89 6.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.742 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.37 5.91 20.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.43 -0.793 . . . . 0.0 109.163 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.4 p30 42.95 35.75 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.738 -0.601 . . . . 0.0 110.395 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt -90.5 146.39 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -0.834 . . . . 0.0 109.113 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -166.59 84.47 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.77 158.12 74.72 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.69 161.61 16.53 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 123.114 2.542 . . . . 0.0 113.083 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 t -125.01 123.35 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 2.5 m-85 -84.65 152.54 60.23 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.86 100.61 0.97 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.559 2.173 . . . . 0.0 111.844 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.46 179.12 47.56 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 35' ' ' THR . 71.5 Cg_endo -77.78 120.74 5.22 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.736 2.291 . . . . 0.0 111.097 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -40.33 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.34 0.59 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -107.39 153.46 41.22 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.75 -41.88 7.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.232 1.954 . . . . 0.0 112.435 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -63.71 -19.79 65.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.005 . . . . 0.0 110.08 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -94.96 -63.61 1.15 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.101 -0.999 . . . . 0.0 109.117 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.08 -24.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.401 -0.812 . . . . 0.0 109.857 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' GLN . 21.4 m-20 -59.88 -24.77 64.53 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.5 mtt180 -89.11 -9.08 52.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.64 -136.03 4.99 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 6.1 t -101.42 157.25 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.485 -1.009 . . . . 0.0 109.586 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -151.74 147.94 27.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.277 -0.889 . . . . 0.0 108.85 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -55.13 168.89 0.28 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.864 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' OG ' ' A' ' 58' ' ' SER . . . -92.31 0.42 57.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -161.38 142.96 11.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.444 -0.785 . . . . 0.0 108.947 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.57 -37.44 78.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.492 -0.755 . . . . 0.0 111.222 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -89.72 -0.25 57.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.877 -1.139 . . . . 0.0 111.005 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 11.3 tp10 -63.24 89.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.853 -1.155 . . . . 0.0 109.749 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -89.4 177.0 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.347 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.84 -8.1 56.7 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 108.901 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.51 -19.39 29.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.462 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 40.7 t0 -59.43 111.44 1.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -44.88 -17.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 6.2 m120 -132.31 100.49 5.02 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -94.46 120.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 108.78 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.5 t -108.16 115.15 29.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.5 -0.75 . . . . 0.0 109.165 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 60' ' ' ALA . 61.8 mt -108.55 166.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.56 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -137.2 132.54 34.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.79 148.47 19.99 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.434 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.2 m-70 -72.31 168.06 19.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.28 88.57 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.0 109.352 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.516 ' N ' ' OG1' ' A' ' 73' ' ' THR . 15.7 m-85 -88.19 102.5 14.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 109.233 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.09 -29.93 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.32 -0.862 . . . . 0.0 110.094 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.29 12.4 6.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ASN . 23.5 ttm-85 -151.33 77.39 7.42 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.528 -0.732 . . . . 0.0 109.51 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.64 32.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 123.31 2.673 . . . . 0.0 113.319 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' ARG . 19.7 m-80 -149.41 61.11 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 0.0 108.376 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -130.94 -153.47 0.56 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 109.78 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -69.61 -83.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 111.715 -178.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 28.5 t80 -93.56 -11.64 31.39 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.212 -0.93 . . . . 0.0 110.298 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 89.5 m -37.45 -40.71 0.39 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.671 . . . . 0.0 111.124 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.8 m120 -94.48 -21.61 18.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.131 -0.981 . . . . 0.0 111.605 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.5 mt -53.42 -26.08 18.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.392 -1.443 . . . . 0.0 108.263 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 73' ' ' THR . 9.5 ptpt -75.53 -18.97 59.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -82.09 -14.41 55.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.15 -165.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -163.96 164.7 23.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.169 -0.957 . . . . 0.0 109.422 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -52.39 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 155.66 -26.83 0.59 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 p -63.07 117.83 7.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.352 -1.087 . . . . 0.0 108.252 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.0 mtp -70.91 179.26 2.77 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.008 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.8 t -145.17 111.65 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -93.89 106.33 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.272 -0.892 . . . . 0.0 110.072 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -94.7 112.5 24.24 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -89.44 151.92 21.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 111.111 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 90' ' ' ASN . 5.9 t -145.71 45.64 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.36 -80.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -53.08 -30.93 38.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.403 -1.057 . . . . 0.0 111.1 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -170.93 167.49 7.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.725 -1.234 . . . . 0.0 109.665 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 t -131.2 134.22 46.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.501 -0.749 . . . . 0.0 110.183 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.535 HH11 ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.58 175.25 6.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.625 -0.672 . . . . 0.0 109.276 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -144.57 144.94 31.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.108 -0.995 . . . . 0.0 109.566 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 17.2 m-85 -131.56 177.19 7.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.439 -0.788 . . . . 0.0 108.926 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -133.71 104.32 6.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 109.601 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.446 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.9 mmt -48.59 120.03 3.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.35 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -161.82 28.81 0.12 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.289 -0.882 . . . . 0.0 109.42 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 7.7 m -165.58 133.33 2.99 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.279 -0.888 . . . . 0.0 108.674 -178.841 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.484 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 70.7 m-20 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 118' ' ' ASP . 34.2 ttmt -39.66 137.24 0.89 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.485 -0.759 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.75 155.6 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.274 -0.891 . . . . 0.0 109.202 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' A' ' 95' ' ' TYR . 46.4 mt -103.88 115.91 31.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.441 -0.787 . . . . 0.0 110.185 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.8 m -93.95 87.04 5.23 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.953 -1.092 . . . . 0.0 108.547 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 123' ' ' LEU . 7.5 mp -74.25 154.78 38.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.9 mt -140.02 140.98 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.467 -0.771 . . . . 0.0 108.973 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 ' CZ ' ' A' ' 72' ' ' PHE . 1.3 p -94.24 162.13 13.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 109.493 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.433 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 51.3 m -146.9 137.11 23.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -173.3 134.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.123 -0.986 . . . . 0.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 55.09 69.63 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 108.916 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -62.28 122.11 14.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.04 -1.038 . . . . 0.0 109.844 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -84.99 122.42 29.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.1 -1.0 . . . . 0.0 109.355 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -86.03 5.89 31.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.294 -0.879 . . . . 0.0 109.749 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -79.93 -57.84 3.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 p -96.47 -4.27 41.89 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.232 -0.918 . . . . 0.0 109.354 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.53 46.86 53.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.66 155.42 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -1.116 . . . . 0.0 109.509 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.433 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.1 m95 -63.13 112.15 2.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.198 -0.939 . . . . 0.0 108.651 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 136' ' ' TRP . 72.3 tt0 -39.03 -82.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.277 0.561 . . . . 0.0 110.037 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -77.45 120.67 22.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -134.98 137.13 42.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.339 -0.851 . . . . 0.0 109.827 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -140.5 134.33 30.51 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.3 mm -99.39 127.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.758 0.79 . . . . 0.0 111.22 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -129.99 154.52 47.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 p -161.88 151.3 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.223 -1.548 . . . . 0.0 111.853 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.39 175.92 7.84 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -138.16 142.38 40.08 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 10.1 tp10 -60.78 137.17 58.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.773 . . . . 0.0 109.192 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 4.6 m . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.397 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 7' ' ' ILE . 15.2 mt . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.51 166.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.626 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -113.41 -13.25 12.88 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 105.02 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.157 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -56.44 -11.08 1.1 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.838 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m -102.48 30.72 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.317 -0.864 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 143.51 33.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.325 -0.859 . . . . 0.0 109.205 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.9 t -60.06 150.95 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -144.91 12.04 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.72 168.44 29.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.54 119.66 6.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.03 -1.277 . . . . 0.0 109.51 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.9 tt -99.05 141.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -146.2 136.27 23.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.18 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.3 mt -144.1 125.69 8.11 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 23' ' ' ALA . 74.4 Cg_endo -75.15 -41.26 0.66 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.633 1.555 . . . . 0.0 111.494 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.25 -15.42 0.37 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -0.878 . . . . 0.0 109.203 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.81 15.46 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.808 . . . . 0.0 109.835 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.1 p-10 44.57 50.17 8.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.092 -1.005 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 23' ' ' ALA . 48.6 mm -92.25 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.82 0.819 . . . . 0.0 109.983 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -169.65 82.74 0.12 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 4.9 mm-40 -142.69 150.3 53.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 0.0 110.68 -177.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.78 165.05 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.848 2.365 . . . . 0.0 113.04 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.8 t -126.91 122.32 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.626 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 7.6 m-85 -82.59 150.36 62.84 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.007 -1.058 . . . . 0.0 110.247 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.87 100.04 1.36 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 111.681 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.26 178.78 45.37 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.616 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 72.9 Cg_endo -76.49 118.81 5.0 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.755 2.304 . . . . 0.0 111.029 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.49 88.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.453 0.644 . . . . 0.0 110.572 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.4 p -113.67 152.43 45.47 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -40.21 10.91 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.124 1.883 . . . . 0.0 111.945 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -62.24 -20.06 63.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.098 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.626 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 7.3 tp60 -96.04 -63.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -45.05 -15.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 0.0 110.275 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.6 m-20 -62.55 -25.14 67.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 41' ' ' ARG . 25.2 mtt-85 -88.13 -12.0 45.32 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.09 -135.93 4.78 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.408 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.1 t -101.18 160.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -1.021 . . . . 0.0 109.619 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -151.42 152.68 33.4 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 50.4 m-85 -60.32 167.95 2.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.197 . . . . 0.0 109.745 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.16 -8.35 59.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.448 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -152.85 150.95 29.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -62.77 -35.82 81.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.563 -0.71 . . . . 0.0 111.102 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.65 16.42 6.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.99 -1.069 . . . . 0.0 110.905 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.535 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 14.5 tm-20 -63.23 98.44 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 109.84 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASP . 1.4 p -95.38 141.74 28.59 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -61.16 -3.73 0.93 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.756 -1.215 . . . . 0.0 107.881 179.422 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 51' ' ' SER . 23.1 m-20 -91.56 -17.7 25.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.594 -0.691 . . . . 0.0 109.861 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 38.6 p-10 -60.64 116.99 4.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.861 -1.149 . . . . 0.0 109.576 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -45.63 -15.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 38.2 t30 -132.6 108.58 9.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 109.673 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.0 mt -98.61 117.52 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -108.44 114.76 28.85 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 60' ' ' ALA . 61.2 mt -105.47 167.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.438 -0.789 . . . . 0.0 109.907 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.587 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.07 126.65 28.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.85 152.89 23.86 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.68 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.734 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 33.2 m-70 -72.85 -170.46 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.636 -0.92 . . . . 0.0 109.275 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.17 72.0 0.1 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 5.8 m-85 -87.6 114.11 23.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.91 -18.42 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -85.18 13.92 5.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.184 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.564 ' NH2' ' CG ' ' A' ' 64' ' ' PHE . 59.1 mtm-85 -151.41 74.35 8.13 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.29 14.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.673 2.915 . . . . 0.0 114.023 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -150.59 62.28 0.94 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.854 -1.154 . . . . 0.0 108.334 179.289 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.444 ' CE2' ' OE1' ' A' ' 71' ' ' GLN . 41.8 t80 -149.72 99.77 2.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.734 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 5.1 mt-30 61.09 -125.49 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.513 -0.742 . . . . 0.0 111.734 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 86.2 t80 -92.48 38.88 1.02 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.186 -0.946 . . . . 0.0 110.37 -178.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -81.58 -65.21 1.04 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.995 -1.066 . . . . 0.0 109.034 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.518 ' C ' ' H ' ' A' ' 76' ' ' LYS . 9.9 t-20 -81.18 -24.72 37.32 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.611 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.85 -3.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.913 -1.117 . . . . 0.0 108.617 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 74' ' ' ASN . 46.1 mtpt -87.03 -21.47 26.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -80.78 -37.15 30.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -45.43 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' SD ' ' A' ' 97' ' ' MET . 48.3 mtmt -144.24 172.86 12.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -49.08 153.5 0.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -17.58 31.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 97.86 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.45 -1.029 . . . . 0.0 108.423 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.1 mtp -55.76 171.63 0.21 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.512 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -143.51 113.96 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.444 -0.785 . . . . 0.0 109.492 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.92 102.89 14.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 109.438 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -97.54 112.0 24.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.235 -0.916 . . . . 0.0 108.571 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -100.25 144.28 29.46 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 15' ' ' ALA . 8.8 p -169.77 140.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.4 -110.68 3.54 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -137.69 45.89 2.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.475 -1.015 . . . . 0.0 109.282 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 92' ' ' THR . 3.9 tm-20 -163.66 138.83 6.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.089 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.445 ' N ' ' CD ' ' A' ' 91' ' ' GLU . 21.6 m -115.13 125.15 53.13 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.775 . . . . 0.0 109.801 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 172.43 7.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.396 -0.815 . . . . 0.0 108.863 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 17.0 pttm -141.34 150.2 42.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.278 -0.889 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.554 ' CD1' HD11 ' A' ' 121' ' ' LEU . 15.8 m-85 -138.96 179.39 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -134.89 107.88 7.6 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.528 -0.733 . . . . 0.0 109.885 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.47 ' SD ' HD11 ' A' ' 100' ' ' ILE . 31.8 ttm -49.61 128.84 18.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 108.849 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 98' ' ' THR . 73.0 m -159.23 3.56 0.09 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.752 -1.217 . . . . 0.0 110.679 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' VAL . 13.4 t -149.14 122.24 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.708 -1.245 . . . . 0.0 107.886 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.47 HD11 ' SD ' ' A' ' 97' ' ' MET . 78.3 mt . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -178.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 . . . . . 0 N--CA 1.501 2.123 0 CA-C-O 121.511 0.672 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -47.04 157.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -157.98 161.86 38.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.008 -1.058 . . . . 0.0 109.847 -178.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.554 HD11 ' CD1' ' A' ' 95' ' ' TYR . 50.7 mt -114.95 103.39 10.87 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.603 -0.686 . . . . 0.0 110.0 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.9 m -99.34 149.2 23.39 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.4 tt -141.58 157.86 44.57 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.054 -1.029 . . . . 0.0 109.757 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.469 ' N ' HD23 ' A' ' 123' ' ' LEU . 44.9 mt -128.77 150.05 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.447 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.8 p -89.83 163.59 14.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.579 -1.325 . . . . 0.0 108.725 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -146.4 81.94 1.58 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.418 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 14.9 p-10 -137.48 133.97 35.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.407 -0.808 . . . . 0.0 109.127 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 69.06 62.01 0.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -62.62 126.23 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.273 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -85.89 118.56 25.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 1.36 45.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.68 -52.91 7.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.0 p -94.89 -8.28 37.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.34 41.45 52.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.04 162.56 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.24 -1.153 . . . . 0.0 109.599 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 68.2 m95 -66.29 114.87 5.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.303 -0.873 . . . . 0.0 108.674 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' TRP . 24.6 tt0 -38.96 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.264 0.555 . . . . 0.0 110.13 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -83.2 148.25 27.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -148.25 73.89 1.27 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.95 -1.094 . . . . 0.0 110.482 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -76.75 159.01 30.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.919 -1.113 . . . . 0.0 108.225 178.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.74 153.43 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.982 -1.074 . . . . 0.0 111.277 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -135.45 171.37 14.55 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 99' ' ' SER . 1.7 p -162.93 117.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.214 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -96.99 177.95 5.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 145' ' ' THR . 15.0 t -147.51 127.93 14.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.762 -1.211 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -63.89 117.45 6.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.968 0 O-C-N 121.194 -0.941 . . . . 0.0 109.087 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mt . . . . . 0 N--CA 1.492 1.625 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.54 167.26 27.54 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.257 1.305 . . . . 0.0 112.032 -179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -102.09 -12.78 17.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' SER . 87.1 m-20 -77.16 102.4 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.681 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -58.22 -3.79 0.29 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' ASP . 15.1 t -115.59 44.63 1.84 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.589 -0.694 . . . . 0.0 109.331 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -141.11 133.28 27.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.341 -0.849 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.65 107.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.616 -0.678 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.73 19.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.44 -173.55 35.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.41 126.64 9.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.008 -1.289 . . . . 0.0 109.74 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -99.22 144.6 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -150.33 131.67 14.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.874 -1.141 . . . . 0.0 110.622 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 mt -144.25 125.88 8.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.09 -41.77 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.654 1.569 . . . . 0.0 111.458 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OG ' ' A' ' 82' ' ' SER . 47.5 t0 -50.98 -16.23 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.051 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.7 15.98 3.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.431 -0.793 . . . . 0.0 109.427 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.0 p30 41.78 48.96 3.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 mm -91.64 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.63 0.729 . . . . 0.0 109.635 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -169.13 84.98 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -145.48 157.19 52.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.063 -1.023 . . . . 0.0 110.33 -177.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.32 165.24 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.85 2.367 . . . . 0.0 112.425 179.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.37 112.92 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -85.98 158.31 56.08 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 109.449 -179.289 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.09 133.87 9.04 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.463 2.109 . . . . 0.0 112.398 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.6 176.89 24.0 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.217 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.589 ' O ' ' N ' ' A' ' 35' ' ' THR . 83.1 Cg_endo -79.14 118.01 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.758 2.305 . . . . 0.0 111.119 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -42.44 87.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.199 0.523 . . . . 0.0 110.61 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -108.3 152.89 42.15 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.19 -42.18 37.44 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.244 1.963 . . . . 0.0 112.092 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.89 -25.86 68.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.081 -1.012 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.8 -70.11 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.492 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 39' ' ' LEU . 36.1 mt -42.06 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.565 -0.709 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.11 -23.52 66.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -87.11 -11.71 49.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.81 -106.44 0.29 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 11.3 t -136.02 154.73 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.483 -1.01 . . . . 0.0 109.298 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 t -149.4 156.1 41.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -57.69 173.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.734 -1.228 . . . . 0.0 109.513 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -88.58 -3.24 58.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -155.04 148.61 25.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.524 -0.735 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.62 -29.89 70.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 111.733 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -88.49 -3.79 58.75 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.707 -1.245 . . . . 0.0 111.449 -177.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.27 114.59 3.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.729 -1.232 . . . . 0.0 109.673 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -91.53 -164.69 1.21 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.534 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 2.2 mp -102.72 17.9 22.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -144.42 4.27 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' ASN . 68.5 t0 -59.53 118.89 6.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.879 -1.138 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -13.55 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.998 -1.064 . . . . 0.0 109.899 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' ASP . 4.8 t-20 -131.42 93.81 3.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.425 -0.797 . . . . 0.0 109.08 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.42 145.61 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' ALA . 1.8 p -142.89 109.36 5.36 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 60' ' ' ALA . 83.8 mt -103.81 159.19 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.664 0.745 . . . . 0.0 110.657 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -127.36 124.31 38.31 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.85 146.04 17.68 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -178.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' PHE . 20.6 m-70 -73.16 174.87 7.35 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.41 -1.053 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.71 93.56 1.58 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.389 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.06 113.49 24.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.962 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 mt -60.47 -34.13 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.94 17.69 2.77 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.931 . . . . 0.0 109.291 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -150.66 73.7 8.82 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 63.9 Cg_exo -52.37 23.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 123.904 3.069 . . . . 0.0 114.219 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 67' ' ' ARG . 27.3 m-80 -153.55 63.53 0.74 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.603 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 12.8 t80 -148.29 100.46 3.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.102 -0.999 . . . . 0.0 110.953 -178.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 13.1 mp0 54.39 -109.04 0.46 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.671 -0.643 . . . . 0.0 112.57 177.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.568 ' CE2' HG22 ' A' ' 125' ' ' THR . 41.6 t80 -91.59 8.9 34.44 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.331 -0.855 . . . . 0.0 111.177 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 m -56.42 -45.35 80.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.465 -1.397 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 5.7 m120 -94.31 -22.09 18.58 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.04 -1.038 . . . . 0.0 111.498 -177.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.5 tm? -50.37 -36.82 34.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 108.777 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -60.72 -18.26 53.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -86.12 -23.78 26.5 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.331 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.52 167.61 5.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.412 -0.805 . . . . 0.0 110.0 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -149.66 175.67 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.86 158.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.86 -29.24 3.81 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.423 ' OG ' ' OD2' ' A' ' 22' ' ' ASP . 61.3 m -62.17 103.74 0.41 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.293 -1.122 . . . . 0.0 108.237 179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.4 mtp -63.36 176.11 0.87 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.777 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.4 t -144.15 114.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.482 -0.761 . . . . 0.0 109.17 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -93.64 107.29 19.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.22 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -94.99 113.9 25.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -85.69 151.04 24.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 110.644 -178.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG21 ' NH1' ' A' ' 93' ' ' ARG . 65.6 t -153.94 116.71 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.16 -102.86 0.05 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.02 34.98 4.87 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.545 -0.973 . . . . 0.0 109.499 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.84 119.89 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 108.797 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 92' ' ' THR . 12.6 t -111.2 132.87 53.98 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.52 -0.737 . . . . 0.0 110.253 -179.323 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -96.9 179.71 4.86 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.544 -0.723 . . . . 0.0 109.528 179.594 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -144.93 142.47 29.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 22.7 m-85 -128.82 178.92 6.02 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -135.32 110.36 8.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.275 -0.891 . . . . 0.0 109.755 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.7 mmt -52.13 118.43 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -151.05 31.21 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 109.717 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 t -164.89 86.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.028 -1.045 . . . . 0.0 109.338 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.7 mp . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 p30 . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 121.329 0.585 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -47.66 139.27 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -151.61 158.61 43.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.007 -1.058 . . . . 0.0 110.099 -178.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.22 157.42 20.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.461 0.648 . . . . 0.0 110.214 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.2 m -139.22 88.34 2.26 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.89 147.08 52.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.523 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.8 mt -139.42 141.01 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.568 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.1 p -94.18 159.42 15.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.94 -1.1 . . . . 0.0 109.181 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -147.84 100.52 3.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -152.41 144.53 23.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.0 t0 60.53 58.7 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.07 119.41 8.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 11.1 p30 -86.96 124.04 32.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.066 -1.021 . . . . 0.0 109.988 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.9 14.22 10.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -71.5 -31.47 67.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -0.859 . . . . 0.0 109.163 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.2 p -140.64 3.2 1.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.36 53.1 6.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.4 t -146.95 159.42 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.087 -1.243 . . . . 0.0 109.912 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.551 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 70.6 m95 -72.77 116.1 12.86 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.239 -0.913 . . . . 0.0 108.626 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' TRP . 30.2 tt0 -40.29 -83.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.737 -0.602 . . . . 0.0 109.991 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.85 165.1 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 108.474 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.532 ' NE ' ' O ' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -167.08 76.61 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.904 -1.122 . . . . 0.0 110.12 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -88.97 156.88 18.61 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.8 pt -145.98 146.77 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.925 -1.11 . . . . 0.0 111.629 -178.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -128.98 165.98 20.07 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 78.3 t -149.14 143.61 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.653 -1.279 . . . . 0.0 110.339 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.75 163.94 30.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.2 t -140.91 141.14 34.58 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.07 -1.019 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.42 113.69 3.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 108.821 179.569 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 mm . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -42.75 121.34 2.14 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.708 1.606 . . . . 0.0 112.31 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 9' ' ' LYS . 19.5 mtmm -66.13 -32.59 74.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 12' ' ' SER . 9.7 m-20 -76.87 111.4 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.463 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 1.8 mppt? -60.87 -0.95 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.0 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.6 t -111.21 42.75 1.59 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -142.92 133.38 24.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 5.4 t -58.75 120.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.44 -0.787 . . . . 0.0 111.263 -178.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.12 -9.63 27.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.22 140.35 3.15 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 90.2 m-85 -94.44 125.22 38.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -1.213 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 tp -95.29 143.04 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -148.07 138.81 23.07 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.712 -1.242 . . . . 0.0 110.936 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.857 HD12 HD21 ' A' ' 75' ' ' LEU . 14.0 mt -149.84 128.32 5.99 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.12 -44.06 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.825 1.683 . . . . 0.0 112.241 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -50.2 -28.3 7.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -113.4 7.07 17.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p30 43.54 30.25 0.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 109.888 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.12 145.2 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.102 0.953 . . . . 0.0 109.795 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -163.02 87.97 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -138.1 159.95 66.22 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.592 -0.693 . . . . 0.0 110.952 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.444 ' CB ' HG13 ' A' ' 14' ' ' VAL . 92.5 Cg_endo -76.52 159.19 35.97 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.982 2.455 . . . . 0.0 113.229 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -135.64 98.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.52 170.74 14.68 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.119 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.46 164.21 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.072 1.848 . . . . 0.0 112.048 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.67 171.92 13.05 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.7 Cg_endo -78.56 120.37 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.758 2.305 . . . . 0.0 111.187 179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -41.6 87.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.235 0.54 . . . . 0.0 110.643 -179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.7 p -108.57 123.56 36.93 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.26 -43.57 7.74 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.804 1.669 . . . . 0.0 112.257 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.73 -16.49 61.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.081 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.6 HE21 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -97.07 -69.51 0.75 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.417 -0.802 . . . . 0.0 109.702 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.6 ' N ' HE21 ' A' ' 38' ' ' GLN . 22.5 mt -45.01 -18.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 109.796 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 38' ' ' GLN . 16.5 m-20 -62.15 -24.87 67.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -83.2 -13.7 54.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.69 -124.23 1.35 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.64 159.34 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.575 -0.956 . . . . 0.0 109.963 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.521 ' CB ' HE22 ' A' ' 38' ' ' GLN . 6.9 p -161.66 164.93 28.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 108.937 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.87 162.32 5.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.604 -1.31 . . . . 0.0 109.205 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -83.21 -9.09 59.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.387 -0.82 . . . . 0.0 109.366 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.53 144.31 29.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.147 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.98 -25.99 68.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -87.8 3.9 46.44 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.917 -1.114 . . . . 0.0 110.677 -178.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' OE1' ' OG ' ' A' ' 58' ' ' SER . 6.0 tp10 -64.93 157.59 27.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.339 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -148.0 -179.84 7.2 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.949 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -91.11 17.19 8.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 13.0 p-10 -141.16 -0.73 1.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.492 -0.755 . . . . 0.0 110.178 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' ASN . 48.6 t0 -57.89 114.58 2.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.733 -1.229 . . . . 0.0 108.998 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -43.07 -20.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.439 -0.788 . . . . 0.0 109.479 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.3 p-10 -134.96 104.09 5.83 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.43 156.06 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' ALA . 50.7 p -141.66 102.08 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 109.133 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.545 HG22 ' N ' ' A' ' 60' ' ' ALA . 94.8 mt -97.98 162.03 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.545 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -145.08 134.18 22.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.44 158.77 27.61 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.754 -1.213 . . . . 0.0 110.209 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 72' ' ' PHE . 10.7 m-70 -71.49 -179.84 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.952 . . . . 0.0 109.913 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.79 80.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -87.94 107.53 18.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 109.118 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 65' ' ' ILE . 8.3 mt -58.46 -29.35 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 110.141 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.36 12.63 5.18 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.791 . . . . 0.0 109.429 -178.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 69' ' ' ASN . 96.6 mtt180 -150.76 64.55 6.48 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -40.14 -19.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.701 2.268 . . . . 0.0 112.534 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' ARG . 28.6 p30 -98.29 28.72 3.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.605 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.9 t80 -89.68 -153.69 0.29 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.851 -1.156 . . . . 0.0 109.754 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -72.88 -96.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.619 -0.676 . . . . 0.0 111.322 -178.731 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.4 t80 -91.63 37.11 0.95 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.765 . . . . 0.0 110.327 -177.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -77.37 -49.04 15.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.859 -1.151 . . . . 0.0 109.706 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ALA . 19.1 m-20 -93.79 -19.99 20.51 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.644 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD21 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -52.93 -29.18 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.804 -1.185 . . . . 0.0 108.869 -179.481 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 140' ' ' LYS . 34.9 pttt -80.6 -6.71 58.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 108.287 179.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -83.68 -21.0 32.54 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -55.71 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -0.756 . . . . 0.0 109.396 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -155.13 152.95 30.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 108.708 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -50.14 108.08 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 109.678 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 97' ' ' MET . . . 137.44 -16.37 3.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.5 m -66.5 -172.73 0.17 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -1.157 . . . . 0.0 108.355 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.9 mmm -129.34 176.79 7.67 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.12 108.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 109.242 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -95.49 105.81 17.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 110.389 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -94.98 111.74 23.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -107.15 143.87 34.71 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.28 -0.887 . . . . 0.0 110.997 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.3 p -168.13 129.57 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.541 -0.725 . . . . 0.0 109.531 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 -105.53 1.6 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.31 22.16 2.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.321 -1.105 . . . . 0.0 109.218 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.27 138.73 35.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -119.91 138.94 53.13 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.677 0.751 . . . . 0.0 110.721 -179.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.42 170.68 9.76 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -146.57 128.52 15.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.126 -0.983 . . . . 0.0 110.385 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -128.41 172.74 10.83 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 98' ' ' THR . 16.5 ttpt -141.85 117.24 10.19 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.17 -0.956 . . . . 0.0 108.941 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.436 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 51.3 mtt -50.61 89.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.517 -0.74 . . . . 0.0 109.478 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -118.89 25.71 10.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.1 m -174.41 138.14 0.53 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.02 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.556 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.7 m-20 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.556 ' C ' ' O ' ' A' ' 118' ' ' ASP . 4.4 mmmt -21.23 131.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 CA-C-N 118.662 0.664 . . . . 0.0 110.34 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -135.69 179.95 6.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.909 -176.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.91 107.41 4.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.075 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 m -94.27 129.96 40.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.47 149.71 29.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.873 . . . . 0.0 109.209 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 124' ' ' ILE . 12.4 mt -142.36 140.5 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 109.125 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -93.57 167.36 11.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.929 -1.107 . . . . 0.0 108.6 178.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.8 m -146.27 128.69 15.92 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.026 -1.047 . . . . 0.0 109.794 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -174.69 131.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.081 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 62.78 67.18 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.522 -0.736 . . . . 0.0 109.117 -179.824 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.09 128.41 35.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.943 -1.098 . . . . 0.0 109.51 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 10.4 t-20 -85.18 114.34 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 109.457 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.95 -3.09 58.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.849 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 51.2 mtmt -81.65 -46.56 14.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.6 p -96.13 -17.2 21.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 109.298 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.3 36.72 23.24 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.99 158.5 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -1.159 . . . . 0.0 109.528 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLU . 64.0 m95 -61.1 112.09 1.96 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.161 -0.962 . . . . 0.0 108.553 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.2 tp10 -39.01 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.163 0.506 . . . . 0.0 110.37 -179.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.39 150.8 19.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 0.0 109.087 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -172.75 156.94 3.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.984 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 55.1 mtmt -130.11 162.95 27.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.03 130.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.466 -0.771 . . . . 0.0 111.273 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 -123.22 165.29 17.16 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.29 147.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.732 -1.23 . . . . 0.0 110.507 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.06 141.1 31.19 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 147' ' ' VAL . 12.0 t -98.68 146.52 25.78 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.244 -0.91 . . . . 0.0 109.918 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.46 34.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 145' ' ' THR . 2.2 t . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.037 -1.039 . . . . 0.0 109.016 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.52 129.68 11.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.53 1.487 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -79.0 -18.92 52.8 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.054 -1.029 . . . . 0.0 108.971 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 28.1 t0 -78.15 101.43 7.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -58.29 -2.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.0 109.806 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 12.6 t -108.95 40.52 1.8 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.458 -0.776 . . . . 0.0 109.578 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -146.46 139.91 25.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.16 119.41 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.858 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.71 -17.12 21.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.71 -169.18 34.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.45 121.69 8.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.312 -1.11 . . . . 0.0 109.041 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.53 143.02 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.39 134.51 22.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.006 -1.059 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.4 mt -145.04 126.55 7.77 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.1 Cg_endo -76.68 -43.24 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.559 1.506 . . . . 0.0 111.375 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 15.7 t0 -53.58 -12.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.354 -0.841 . . . . 0.0 109.124 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -133.45 11.02 4.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.0 109.336 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 p30 41.89 34.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.633 -0.667 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -91.29 144.86 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.543 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -165.76 83.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -140.37 160.27 60.27 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 111.128 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.53 164.91 25.69 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 123.026 2.484 . . . . 0.0 113.0 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.59 107.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -72.56 155.59 90.94 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.821 -1.174 . . . . 0.0 109.515 -179.499 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.5 118.93 1.93 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.139 1.893 . . . . 0.0 111.668 178.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.3 -174.76 41.84 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.22 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 35' ' ' THR . 97.9 Cg_endo -80.7 117.63 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.77 2.313 . . . . 0.0 111.331 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -47.89 85.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.311 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.1 p -104.64 153.96 38.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 37.6 Cg_endo -65.57 -45.18 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.95 1.766 . . . . 0.0 111.616 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.43 -27.65 69.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.312 -0.868 . . . . 0.0 110.271 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.526 ' OE1' ' CD2' ' A' ' 30' ' ' TYR . 0.7 OUTLIER -82.73 -65.34 1.02 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.308 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' N ' ' NE2' ' A' ' 38' ' ' GLN . 17.5 mt -44.74 -17.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.9 m120 -58.23 -28.95 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.1 mtt180 -83.51 -15.35 49.73 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 160.25 -137.62 5.12 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.4 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.2 t -105.98 160.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.504 -0.998 . . . . 0.0 110.269 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 t -155.75 156.66 35.22 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 32.1 m-85 -56.29 171.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.591 -1.318 . . . . 0.0 109.38 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -84.33 -9.06 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.597 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -151.77 145.57 25.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.99 -26.74 68.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.707 . . . . 0.0 110.972 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.67 HD22 ' N ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -86.57 1.08 52.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.856 -1.152 . . . . 0.0 109.886 -179.061 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.67 ' N ' HD22 ' A' ' 49' ' ' ASN . 9.4 tp10 -64.16 150.26 46.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.647 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 53' ' ' ASP . 51.8 p -147.48 159.77 43.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -71.54 4.31 3.19 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 51' ' ' SER . 25.9 m-20 -112.57 -7.49 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t0 -60.32 114.02 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.003 -1.061 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.778 HE22 HE21 ' A' ' 120' ' ' GLN . 0.4 OUTLIER -47.72 -17.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 109.036 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.3 t-20 -133.04 104.74 6.68 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -95.05 150.66 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.1 p -144.41 115.21 7.77 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 60' ' ' ALA . 78.5 mt -110.53 164.47 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.828 0.823 . . . . 0.0 110.629 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.577 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -141.92 139.15 32.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.66 153.36 25.12 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.895 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.719 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 20.7 m-70 -72.54 177.02 4.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.714 -0.874 . . . . 0.0 109.48 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.82 82.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.968 . . . . 0.0 109.416 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.461 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 10.3 m-85 -89.59 118.79 29.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.26 -0.9 . . . . 0.0 109.348 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mm -60.76 -23.05 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -0.817 . . . . 0.0 110.161 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -86.59 14.2 7.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 69' ' ' ASN . 39.3 mtm-85 -150.76 74.36 8.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.569 -0.707 . . . . 0.0 109.243 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.13 13.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 123.403 2.735 . . . . 0.0 113.617 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -147.64 60.95 1.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 108.465 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -146.24 102.1 3.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.1 -1.0 . . . . 0.0 110.838 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.719 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 7.3 mt-30 58.46 -115.13 0.8 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.724 -0.61 . . . . 0.0 112.038 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.3 m-85 -95.17 19.36 10.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.097 -1.002 . . . . 0.0 110.938 -177.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -59.94 -20.11 55.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.422 -1.424 . . . . 0.0 109.492 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.641 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 7.0 m-20 -121.92 -18.41 7.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 109.834 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.699 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.4 tm? -53.51 -39.24 64.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.894 -1.129 . . . . 0.0 108.287 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -65.27 -3.19 3.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -96.89 -29.37 13.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.01 -177.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.44 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -160.27 179.09 8.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.375 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -49.58 149.9 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 109.104 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.81 -13.45 24.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 39.3 m -61.96 100.26 0.15 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.412 -1.052 . . . . 0.0 108.349 179.448 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mmm -67.35 170.07 7.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.669 -179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 t -145.16 110.95 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 109.194 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.19 108.45 19.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.826 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -94.71 111.9 23.65 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -100.74 146.24 27.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 89' ' ' GLY . 14.9 t -132.93 167.64 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.654 -0.653 . . . . 0.0 109.264 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 88' ' ' VAL . . . -45.23 -32.88 3.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.4 ' ND2' ' C ' ' A' ' 89' ' ' GLY . 7.2 m-80 -153.97 47.62 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.913 -1.345 . . . . 0.0 110.274 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -171.95 121.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.064 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 92' ' ' THR . 12.6 t -125.1 125.93 44.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.437 HH12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.37 175.51 9.22 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.545 -0.722 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -145.38 132.74 20.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.176 -0.953 . . . . 0.0 110.24 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 13.1 m-85 -102.93 -177.15 3.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.489 -0.757 . . . . 0.0 108.967 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -141.56 110.74 6.3 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.37 -0.831 . . . . 0.0 109.349 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.6 tpp -48.37 114.47 0.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -146.47 26.25 1.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 108.703 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 m -170.24 124.11 0.72 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 84.3 mt . . . . . 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 0.0 109.841 -179.038 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.0 t0 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 118' ' ' ASP . 20.5 tptt -17.11 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 122.361 1.077 . . . . 0.0 111.153 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.778 HE21 HE22 ' A' ' 55' ' ' GLN . 13.2 mt-30 -93.76 173.61 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.106 -177.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.95 98.31 2.43 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.3 m -92.09 91.73 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.4 147.34 48.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.001 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.518 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 47.0 mt -136.97 149.32 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.325 -0.86 . . . . 0.0 109.782 -179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.23 158.81 15.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.0 137.87 23.82 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.927 -1.108 . . . . 0.0 109.603 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.3 t0 178.39 138.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 6.4 t0 65.1 60.09 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -64.59 121.78 15.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.161 -0.962 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 12.1 p30 -85.55 126.72 34.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.934 -1.104 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.06 6.11 41.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 109.471 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -76.68 -58.81 3.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.33 -0.856 . . . . 0.0 109.118 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 48.8 p -97.87 -4.37 36.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.365 -0.834 . . . . 0.0 109.245 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.04 46.99 33.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.7 t -146.91 167.27 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -1.1 . . . . 0.0 109.459 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 137' ' ' GLU . 70.4 m95 -72.32 113.63 9.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.194 -0.941 . . . . 0.0 108.944 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' TRP . 36.9 tt0 -36.25 -63.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.114 0.483 . . . . 0.0 110.733 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -139.2 149.85 44.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 109.163 179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -173.96 139.63 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.746 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.53 -179.58 6.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.862 . . . . 0.0 109.21 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.0 tt -151.31 144.7 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 8.9 m-85 -137.54 166.57 23.57 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 88.1 t -146.74 148.57 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.977 -1.077 . . . . 0.0 110.084 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.92 179.95 6.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.442 -0.786 . . . . 0.0 109.011 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.2 t -153.63 146.64 24.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.048 -1.032 . . . . 0.0 110.087 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.52 139.36 57.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 109.444 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.528 -179.992 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 mt . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -42.14 132.73 4.6 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.76 1.64 . . . . 0.0 112.442 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -83.85 -17.44 40.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 12' ' ' SER . 54.8 m-20 -77.01 106.63 8.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.58 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.58 -5.82 0.41 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 10' ' ' ASP . 67.4 p -110.83 42.14 1.67 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -146.6 134.17 20.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 16' ' ' GLY . 38.3 t -61.64 133.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 111.097 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.97 -7.68 24.84 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.599 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 171.65 -168.73 41.85 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.564 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 44.3 m-85 -146.88 126.81 13.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.937 -1.331 . . . . 0.0 109.679 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.93 141.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -145.27 137.01 25.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.92 -1.112 . . . . 0.0 110.431 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.731 HD12 HD21 ' A' ' 75' ' ' LEU . 9.8 mt -146.67 128.77 7.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 73.9 Cg_endo -75.39 -42.87 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.614 1.543 . . . . 0.0 111.403 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -54.13 -11.62 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.858 . . . . 0.0 108.959 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -131.5 6.49 4.44 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 42.19 31.72 0.27 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.648 -0.658 . . . . 0.0 109.935 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.99 147.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.061 0.934 . . . . 0.0 109.977 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -164.32 84.49 0.43 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -134.73 159.25 72.87 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.54 -0.725 . . . . 0.0 110.728 -176.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.88 159.51 15.98 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.974 2.45 . . . . 0.0 112.88 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.27 111.34 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 7.6 m-85 -74.41 148.76 86.14 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.855 -1.153 . . . . 0.0 109.765 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.72 112.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.254 1.969 . . . . 0.0 111.96 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.07 -176.12 43.27 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.472 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.7 Cg_endo -79.74 110.57 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 123.045 2.496 . . . . 0.0 111.501 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -42.63 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.418 0.628 . . . . 0.0 111.443 -178.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.562 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -104.18 173.25 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.992 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.22 -28.44 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.693 1.595 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.86 -35.57 80.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.48 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.653 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -81.6 -67.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 110.41 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 38' ' ' GLN . 33.5 mt -42.75 -25.14 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.059 -1.026 . . . . 0.0 110.232 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.03 -24.81 67.29 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -96.14 -17.72 20.65 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 177.57 -133.15 2.14 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.894 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.482 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.1 t -125.82 159.44 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.534 -0.98 . . . . 0.0 109.572 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.653 ' CB ' HE22 ' A' ' 38' ' ' GLN . 4.2 p -155.97 163.0 40.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.231 -0.918 . . . . 0.0 108.833 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 39.9 m-85 -59.43 169.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 109.19 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.66 -14.36 54.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -144.62 146.38 32.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.28 -0.887 . . . . 0.0 110.067 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -23.82 67.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.678 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -87.53 2.49 50.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 2.8 tm-20 -63.56 156.37 26.71 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.498 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.509 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 5.0 m -145.73 178.13 8.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.984 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -87.33 14.79 7.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 108.324 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -140.44 0.86 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.678 . . . . 0.0 109.904 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 14.3 t0 -56.77 118.7 5.16 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.823 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.714 HE22 ' N ' ' A' ' 119' ' ' LYS . 41.5 tp60 -37.52 -24.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.029 0.442 . . . . 0.0 110.322 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 54' ' ' ASP . 18.9 t-20 -133.68 117.27 16.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.354 -0.841 . . . . 0.0 108.944 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.44 HD13 ' OE2' ' A' ' 50' ' ' GLU . 37.3 mm -92.72 142.85 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 108.597 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.5 p -140.67 109.69 6.12 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 60' ' ' ALA . 90.6 mt -111.15 161.2 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.646 0.736 . . . . 0.0 110.486 -178.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -137.8 130.41 29.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.96 154.91 25.66 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 72' ' ' PHE . 15.9 m-70 -72.61 170.45 14.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.588 -0.948 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.94 82.42 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 108.97 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.62 114.99 23.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 0.0 108.799 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 65' ' ' ILE . 6.7 mt -56.68 -29.91 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 109.948 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.82 16.24 2.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.602 -178.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.557 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -144.49 69.43 15.41 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.536 -0.728 . . . . 0.0 109.251 179.691 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.42 17.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.068 2.512 . . . . 0.0 113.543 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.557 ' H ' ' C ' ' A' ' 67' ' ' ARG . 37.0 m-80 -148.95 62.77 1.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.926 -1.108 . . . . 0.0 108.558 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -133.3 -154.04 0.58 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 109.77 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 79.4 mt-30 -57.77 -98.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.539 -0.726 . . . . 0.0 111.19 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.7 m-85 -96.0 27.36 3.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.226 -0.921 . . . . 0.0 110.549 -178.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 73' ' ' THR . 98.2 m -65.76 -12.4 53.66 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.58 -1.325 . . . . 0.0 109.581 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.4 m-20 -128.05 -20.58 3.78 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.269 -0.894 . . . . 0.0 110.47 -179.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.731 HD21 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -53.65 -33.57 55.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 108.278 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -71.44 -9.56 58.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -87.76 -24.49 23.78 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.377 0.608 . . . . 0.0 109.468 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 171.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.659 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -144.77 167.14 23.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 109.221 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -49.42 138.6 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.42 -20.96 47.01 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -62.43 100.52 0.18 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.368 -1.078 . . . . 0.0 108.119 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.28 173.17 0.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -178.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 t -143.13 113.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 109.069 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -95.15 102.6 14.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -95.71 112.08 23.88 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 88' ' ' VAL . 33.5 mtmt -96.59 152.12 18.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.236 -0.915 . . . . 0.0 111.251 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.574 HG21 HH12 ' A' ' 93' ' ' ARG . 76.6 t -156.15 93.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.49 -105.83 1.09 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -118.3 38.84 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.472 -1.016 . . . . 0.0 109.577 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -146.05 108.5 4.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.915 . . . . 0.0 108.828 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 92' ' ' THR . 12.8 t -110.39 119.54 39.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.505 -0.747 . . . . 0.0 110.387 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.574 HH12 HG21 ' A' ' 88' ' ' VAL . 2.2 mpt_? -95.22 172.54 8.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 109.308 179.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -144.41 146.9 32.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.858 -179.661 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 12.8 m-85 -137.52 177.92 7.5 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -140.63 107.69 5.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 109.721 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 81' ' ' GLY . 64.7 mtp -51.86 120.68 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -153.09 28.66 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.264 -0.897 . . . . 0.0 108.904 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.2 t -166.46 121.58 1.16 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 61.3 mt . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.444 -0.785 . . . . 0.0 110.192 -178.207 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 119' ' ' LYS . 8.0 m-20 . . . . . 0 N--CA 1.497 1.895 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.714 ' N ' HE22 ' A' ' 55' ' ' GLN . 85.6 mttt -34.89 131.31 0.38 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.69 -0.631 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.79 162.24 38.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.052 -1.03 . . . . 0.0 110.263 -178.443 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.456 HD11 ' CD1' ' A' ' 95' ' ' TYR . 12.4 mt -109.18 120.47 42.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.706 -0.621 . . . . 0.0 110.497 -178.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m -98.35 87.37 3.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.95 140.84 49.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.413 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -138.16 131.42 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -95.8 164.92 12.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.086 -1.009 . . . . 0.0 108.695 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 97.7 m -145.77 149.06 33.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.118 -0.989 . . . . 0.0 109.873 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 0.7 OUTLIER 176.79 132.09 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.306 -0.871 . . . . 0.0 109.35 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.8 OUTLIER 58.7 75.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.98 126.21 26.92 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.47 117.69 24.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.039 -1.038 . . . . 0.0 109.363 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -85.63 1.9 47.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.353 -0.842 . . . . 0.0 109.686 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -80.79 -55.88 4.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.6 p -94.66 -10.72 30.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.2 41.59 21.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.77 157.34 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 109.508 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.428 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.1 m95 -61.36 113.2 2.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.167 -0.958 . . . . 0.0 108.596 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' TRP . 35.2 tt0 -35.93 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.378 0.608 . . . . 0.0 110.759 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -100.33 150.95 22.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 108.95 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -173.55 144.66 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.948 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -106.37 173.2 6.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.1 mt -145.69 130.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.09 -1.007 . . . . 0.0 109.868 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -128.32 168.43 15.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.4 t -149.57 147.71 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.778 -1.201 . . . . 0.0 110.978 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.12 175.48 9.58 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -146.75 139.15 24.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.929 -1.107 . . . . 0.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 15.8 tm-20 -60.75 112.51 2.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 10.9 m . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.845 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -65.79 143.15 57.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.571 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.527 ' O ' ' NE2' ' A' ' 2' ' ' GLN . . . -71.13 166.33 21.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 0.0 109.394 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -152.14 58.16 2.49 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.234 -0.916 . . . . 0.0 109.809 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.44 -160.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.395 2.063 . . . . 0.0 111.502 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -94.7 72.54 3.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.989 -1.069 . . . . 0.0 109.995 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 7' ' ' ILE . 9.5 mt -89.22 113.43 56.31 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.6 122.46 6.46 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.647 1.564 . . . . 0.0 112.324 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -59.48 -7.55 1.46 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 12' ' ' SER . 2.6 m-20 -77.31 94.95 4.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.275 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.5 mtmm -57.21 -5.68 0.31 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.261 -0.9 . . . . 0.0 109.793 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 10' ' ' ASP . 18.3 t -110.55 40.5 1.97 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.551 -0.718 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -142.36 135.73 28.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.77 120.04 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.448 -0.783 . . . . 0.0 110.36 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.95 -19.98 19.1 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.28 -168.12 32.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.61 126.73 9.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.213 -1.169 . . . . 0.0 109.464 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.01 146.08 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.489 ' OE2' ' N ' ' A' ' 20' ' ' ILE . 8.8 tp10 -146.13 127.5 14.92 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.041 -1.037 . . . . 0.0 109.703 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' N ' ' OE2' ' A' ' 19' ' ' GLU . 44.7 mt -144.28 127.6 8.76 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.94 -46.19 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.726 1.617 . . . . 0.0 111.644 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -49.97 -25.33 3.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.79 9.03 10.62 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.485 -0.759 . . . . 0.0 109.397 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 42.27 38.75 1.24 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.424 0.63 . . . . 0.0 109.998 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.42 HG23 ' OE1' ' A' ' 27' ' ' GLU . 4.4 mt -92.72 146.44 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.88 0.848 . . . . 0.0 109.536 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -164.64 80.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' OE1' HG23 ' A' ' 25' ' ' ILE . 3.2 mp0 -132.09 156.16 80.44 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.398 -0.814 . . . . 0.0 111.278 -176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -82.31 164.98 16.84 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.953 2.436 . . . . 0.0 112.332 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.0 127.03 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.385 -0.822 . . . . 0.0 109.066 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 4.9 m-85 -89.77 150.41 43.9 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.919 -1.113 . . . . 0.0 109.594 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -81.81 104.98 1.48 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 122.139 1.893 . . . . 0.0 111.605 178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.08 -176.41 47.64 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.273 -1.442 . . . . 0.0 110.309 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 35' ' ' THR . 73.4 Cg_endo -79.16 117.94 3.92 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.784 2.323 . . . . 0.0 111.101 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.22 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.392 0.615 . . . . 0.0 110.455 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.587 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.8 p -105.69 153.47 39.92 Favored Pre-proline 0 N--CA 1.499 2.019 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.03 -43.15 2.58 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.037 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.82 -21.41 66.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.9 OUTLIER -93.34 -62.39 1.38 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.0 mt -46.26 -18.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.155 -0.965 . . . . 0.0 109.389 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.5 m-20 -63.25 -25.28 68.25 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 89.2 mtt180 -83.27 -17.95 40.82 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 164.94 -130.92 2.27 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.894 -1.146 . . . . 0.0 110.295 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.5 t -115.34 165.36 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.574 -0.956 . . . . 0.0 109.213 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.452 ' CB ' HE22 ' A' ' 38' ' ' GLN . 3.3 t -162.09 159.1 25.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.157 -0.964 . . . . 0.0 109.065 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -58.94 164.85 2.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.84 -1.163 . . . . 0.0 109.396 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -76.79 -21.84 54.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.234 -0.916 . . . . 0.0 109.375 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -138.19 147.42 43.79 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.315 -0.866 . . . . 0.0 110.147 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.68 -24.14 67.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.555 -0.716 . . . . 0.0 111.185 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -86.28 3.39 43.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.867 -1.146 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.87 161.88 20.18 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.048 -1.033 . . . . 0.0 109.3 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.1 m -147.09 173.06 12.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.759 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.5 mp -84.44 17.23 2.71 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -145.52 2.27 0.95 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.46 -0.775 . . . . 0.0 110.359 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' ASN . 50.7 t0 -57.29 126.49 27.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.64 -1.287 . . . . 0.0 109.292 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -42.31 -20.0 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.512 -0.743 . . . . 0.0 109.777 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 54' ' ' ASP . 14.7 t-20 -143.07 104.15 4.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 108.834 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -95.03 119.93 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.104 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.4 p -108.11 122.89 47.81 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 60' ' ' ALA . 68.9 mt -112.5 161.44 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.943 0.878 . . . . 0.0 110.952 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.552 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.62 125.49 25.71 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.86 153.31 21.04 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.622 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' PHE . 19.2 m-70 -74.97 167.8 21.2 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.737 -0.86 . . . . 0.0 109.972 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.06 87.36 1.27 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.198 -0.939 . . . . 0.0 108.913 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -87.26 117.1 25.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 65' ' ' ILE . 17.9 mt -59.85 -29.13 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.786 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -85.32 19.4 2.3 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.444 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -150.05 70.01 9.2 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.748 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.496 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.2 Cg_exo -54.38 18.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 123.236 2.624 . . . . 0.0 113.564 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 17.2 m-80 -148.94 62.31 1.05 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.07 -153.9 0.6 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.459 -0.776 . . . . 0.0 110.068 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -62.46 -89.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.553 -0.717 . . . . 0.0 111.685 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.65 ' CE1' HG22 ' A' ' 125' ' ' THR . 4.9 t80 -95.08 14.1 23.04 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.537 -0.727 . . . . 0.0 110.692 -177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.438 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 95.8 m -65.17 -49.45 69.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.4 -1.438 . . . . 0.0 110.829 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 5.0 m120 -83.1 -19.1 37.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.435 -177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.806 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.8 tm? -53.84 -27.94 32.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.851 -1.155 . . . . 0.0 109.059 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 20.6 mtmm -66.73 -27.83 67.94 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -71.33 -26.06 62.67 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.08 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.3 170.22 0.36 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.549 -0.719 . . . . 0.0 109.728 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -150.06 168.0 25.16 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.264 -0.897 . . . . 0.0 109.069 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 6.5 ttmm -51.32 150.98 3.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 0.0 109.546 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.66 -15.12 32.45 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.452 ' O ' ' SD ' ' A' ' 97' ' ' MET . 25.9 p -63.58 108.08 1.3 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.359 -1.083 . . . . 0.0 108.679 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.464 ' CE ' ' OH ' ' A' ' 85' ' ' TYR . 21.0 ptm -80.65 166.46 21.06 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.049 -1.032 . . . . 0.0 109.452 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.15 175.8 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.316 -0.865 . . . . 0.0 110.108 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' OH ' ' CE ' ' A' ' 83' ' ' MET . 73.8 m-85 -142.54 111.39 6.34 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.381 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -94.3 115.99 28.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -85.93 141.12 29.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.932 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.492 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.6 m -146.64 127.69 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.534 -0.729 . . . . 0.0 109.163 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.57 -115.83 2.06 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -116.16 53.92 0.85 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.606 -0.937 . . . . 0.0 109.399 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -166.84 153.4 8.6 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.0 109.048 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 92' ' ' THR . 9.0 t -131.09 124.9 31.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -0.781 . . . . 0.0 110.397 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.42 174.4 6.7 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 7.5 ptpp? -142.92 154.8 44.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.146 -0.971 . . . . 0.0 110.042 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.542 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 4.1 m-85 -138.25 177.77 7.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -140.23 110.45 6.59 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.22 -0.925 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.452 ' SD ' ' O ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -49.26 135.21 17.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.05 -179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 p -153.11 18.85 0.57 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -0.875 . . . . 0.0 109.991 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.519 ' OG ' ' NE ' ' A' ' 101' ' ' ARG . 0.6 OUTLIER -170.14 87.45 0.13 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.624 -1.297 . . . . 0.0 109.259 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.418 ' CG2' ' OD2' ' A' ' 102' ' ' ASP . 43.4 mm -81.33 136.51 22.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 121.478 -0.764 . . . . 0.0 109.247 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.0 OUTLIER -124.52 -8.85 7.43 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.393 -0.817 . . . . 0.0 109.353 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 103' ' ' VAL . 6.4 p30 -43.64 -16.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.239 -0.913 . . . . 0.0 110.236 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 101' ' ' ARG . 20.5 t -59.5 -112.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -70.65 135.39 85.97 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.31 -34.25 13.07 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.204 1.269 . . . . 0.0 112.292 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' A' ' 106' ' ' THR . 17.8 p -84.85 91.31 7.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 109.614 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -135.39 160.34 38.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.411 -0.805 . . . . 0.0 108.933 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.75 46.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.759 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 107' ' ' ASP . . . -161.7 38.6 0.39 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 t -65.98 -29.09 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 31.1 mt -139.99 -33.39 0.58 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.523 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 45.7 t0 47.62 41.94 14.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.185 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -114.29 -7.57 12.94 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.479 ' N ' ' CD ' ' A' ' 114' ' ' GLN . 2.2 mp0 -103.03 -9.21 19.96 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -64.68 -155.68 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -156.91 42.54 0.54 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -95.99 -121.61 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.252 -1.146 . . . . 0.0 109.434 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.3 m-20 -118.82 169.74 9.6 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.32 -0.863 . . . . 0.0 108.773 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 118' ' ' ASP . 37.5 mtmt -38.52 150.63 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.423 ' OE1' ' OD1' ' A' ' 112' ' ' ASP . 7.0 pt20 -154.7 157.37 37.98 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.183 -0.948 . . . . 0.0 110.053 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.7 tp -121.82 106.73 11.55 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.1 m -91.16 128.03 36.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.933 -1.104 . . . . 0.0 108.785 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 123' ' ' LEU . 9.3 mp -103.43 145.27 30.24 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.22 -0.925 . . . . 0.0 110.161 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 24.6 mt -142.58 139.97 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.374 -0.829 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.65 HG22 ' CE1' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -96.07 166.11 11.92 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.013 -1.054 . . . . 0.0 108.787 178.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.473 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -149.86 102.49 3.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.04 -1.037 . . . . 0.0 109.754 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 1.8 p-10 -156.03 148.03 23.24 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 0.0 109.305 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 60.48 56.85 2.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.377 -0.827 . . . . 0.0 108.802 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -62.05 119.0 8.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.08 -1.013 . . . . 0.0 109.464 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 135' ' ' VAL . 2.6 p-10 -83.92 130.63 34.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.013 -1.054 . . . . 0.0 109.694 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -88.75 5.52 43.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.364 -0.835 . . . . 0.0 109.061 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -71.63 -61.43 1.78 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.464 -0.773 . . . . 0.0 108.936 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 68.6 p -100.49 -1.42 35.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 109.342 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.85 49.72 33.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 130' ' ' ASN . 5.1 t -146.99 168.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -1.065 . . . . 0.0 109.417 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 91.6 m95 -73.82 113.64 11.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -40.28 -77.54 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.591 -0.693 . . . . 0.0 109.929 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -84.36 150.49 25.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.077 -1.015 . . . . 0.0 108.584 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.9 mtm180 -151.03 79.48 1.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.862 -1.149 . . . . 0.0 110.562 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 125' ' ' THR . 10.8 mtpt -75.2 148.72 39.3 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.463 ' H ' ' HA ' ' A' ' 102' ' ' ASP . 11.9 pt -135.87 149.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 122.12 0.962 . . . . 0.0 110.902 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -144.09 143.86 31.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 99' ' ' SER . 4.7 p -136.89 149.13 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.897 -1.127 . . . . 0.0 110.938 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -130.89 -178.03 4.63 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.7 t -148.05 148.54 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.002 -1.061 . . . . 0.0 109.651 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -51.11 144.03 9.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.325 -0.86 . . . . 0.0 109.223 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.485 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.1 t -91.97 -153.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.346 -0.846 . . . . 0.0 109.164 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.485 ' H ' HG12 ' A' ' 147' ' ' VAL . 84.3 mttt . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.45 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.476 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -154.56 146.67 23.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.259 -0.901 . . . . 0.0 109.515 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.85 158.36 18.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.249 -0.907 . . . . 0.0 109.702 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.56 ' O ' ' O ' ' A' ' 5' ' ' PRO . 1.6 pttm -71.07 153.43 94.56 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.356 -0.84 . . . . 0.0 109.015 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' O ' ' O ' ' A' ' 4' ' ' LYS . 66.1 Cg_exo -42.52 -125.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.107 0 C-N-CA 123.047 2.498 . . . . 0.0 113.726 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -147.76 116.06 6.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.707 -1.246 . . . . 0.0 110.264 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.3 mm -85.27 114.0 53.69 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 98.9 Cg_exo -42.33 150.58 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.627 1.551 . . . . 0.0 112.004 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -102.08 -11.52 18.8 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.192 -0.942 . . . . 0.0 109.981 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -77.13 103.0 6.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 0.0 109.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -56.5 -13.0 1.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -98.48 30.81 3.06 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.4 -0.812 . . . . 0.0 109.203 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -148.5 140.53 23.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.336 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.624 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 58.5 t -60.65 163.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.351 -0.843 . . . . 0.0 110.72 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -138.51 -3.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 177.34 -175.19 47.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.624 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 69.6 m-85 -149.81 121.46 8.04 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.084 -1.245 . . . . 0.0 110.087 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.8 tt -98.66 143.93 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -146.84 136.03 22.6 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.03 -1.044 . . . . 0.0 110.675 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.492 ' CD1' HD21 ' A' ' 75' ' ' LEU . 51.4 mt -144.88 125.02 7.26 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.5 Cg_endo -76.3 -42.55 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.691 1.594 . . . . 0.0 111.434 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -50.66 -17.24 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.886 . . . . 0.0 109.048 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.488 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -133.82 14.31 3.99 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.513 -0.742 . . . . 0.0 109.209 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.4 p-10 43.75 50.25 6.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.488 HG12 ' HB3' ' A' ' 23' ' ' ALA . 43.3 mm -92.7 142.79 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.645 0.736 . . . . 0.0 109.888 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 pttm -168.97 81.35 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -142.0 158.49 61.81 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.214 -0.929 . . . . 0.0 110.738 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' A' ' 14' ' ' VAL . 40.8 Cg_endo -86.07 169.74 8.68 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 123.184 2.589 . . . . 0.0 113.105 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -129.56 137.14 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.599 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 24.6 m-85 -92.41 149.84 39.0 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 120.907 -1.121 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' CB ' ' O ' ' A' ' 8' ' ' PRO . 50.3 Cg_endo -81.46 79.37 3.25 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.806 2.338 . . . . 0.0 111.802 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.76 177.5 39.58 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.954 -1.593 . . . . 0.0 110.865 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 91.2 Cg_endo -79.86 121.66 4.62 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.824 2.349 . . . . 0.0 111.182 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -40.85 87.75 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.906 -0.496 . . . . 0.0 110.918 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -111.54 167.28 9.32 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.52 -45.36 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.739 1.626 . . . . 0.0 111.833 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.482 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -62.28 -17.03 57.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.392 -0.817 . . . . 0.0 109.856 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.599 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -96.98 -69.36 0.76 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.233 -0.917 . . . . 0.0 108.642 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' A' ' 34' ' ' ALA . 42.2 mt -41.35 -24.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.799 -0.563 . . . . 0.0 110.51 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 38' ' ' GLN . 31.3 m-20 -63.61 -25.13 68.09 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.436 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.4 mtp180 -84.49 -14.58 48.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' C ' HE21 ' A' ' 71' ' ' GLN . . . 156.51 -143.92 10.22 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.882 -1.151 . . . . 0.0 110.319 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.636 HG23 ' NE2' ' A' ' 71' ' ' GLN . 3.9 t -88.61 152.88 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.362 -1.081 . . . . 0.0 109.689 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 t -148.81 141.02 24.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 108.967 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -56.45 162.35 2.2 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.022 -1.049 . . . . 0.0 108.944 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.31 -9.98 59.71 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.173 -0.954 . . . . 0.0 108.812 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -145.27 149.55 35.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.466 -0.771 . . . . 0.0 109.526 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.412 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.5 pt-20 -63.39 -41.84 98.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.545 -0.722 . . . . 0.0 111.152 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 8.2 p30 -89.65 17.81 6.11 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.98 -1.075 . . . . 0.0 111.222 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.87 95.77 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.866 -1.146 . . . . 0.0 109.839 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 m -89.75 173.31 8.34 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -82.44 0.13 43.61 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.089 -1.007 . . . . 0.0 108.647 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -101.91 -10.68 19.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.564 -0.71 . . . . 0.0 109.897 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.5 t70 -59.59 113.44 2.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.772 -1.205 . . . . 0.0 108.863 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -46.72 -14.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.133 -0.979 . . . . 0.0 109.56 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.543 HD21 ' C ' ' A' ' 114' ' ' GLN . 3.8 m120 -133.49 97.21 3.89 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -94.23 115.86 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.233 -0.917 . . . . 0.0 108.917 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.8 t -108.63 116.69 32.45 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.697 -0.627 . . . . 0.0 109.351 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 60' ' ' ALA . 92.1 mt -109.37 164.69 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 CA-C-O 121.601 0.715 . . . . 0.0 109.579 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.561 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -138.32 135.25 35.23 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.07 148.78 20.7 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.081 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -74.53 -169.29 0.81 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.639 -0.918 . . . . 0.0 110.07 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.84 99.99 0.47 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.375 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.27 122.45 33.19 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.162 -0.962 . . . . 0.0 108.918 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 65' ' ' ILE . 16.2 mt -64.65 -43.06 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.37 -0.831 . . . . 0.0 110.783 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.26 18.91 2.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.187 -0.945 . . . . 0.0 109.888 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -151.04 75.58 8.16 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 72.9 Cg_exo -51.78 24.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 123.92 3.08 . . . . 0.0 114.642 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.4 m120 -151.7 62.92 0.86 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.791 -1.193 . . . . 0.0 108.55 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.4 ' O ' ' OG1' ' A' ' 73' ' ' THR . 36.8 t80 -141.7 90.24 2.26 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.235 -0.916 . . . . 0.0 110.498 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.636 ' NE2' HG23 ' A' ' 43' ' ' VAL . 1.5 mm100 65.03 -119.23 0.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.764 -0.585 . . . . 0.0 111.556 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.628 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 29.5 t80 -87.44 33.35 0.69 Allowed 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 122.318 1.056 . . . . 0.0 109.142 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 70' ' ' TYR . 21.6 m -69.13 -57.21 5.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.15 -1.594 . . . . 0.0 110.607 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 68' ' ' PRO . 2.1 m-20 -90.43 -13.56 34.63 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.181 -0.949 . . . . 0.0 111.775 -177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 20' ' ' ILE . 2.4 mt -52.38 -29.63 24.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.57 -1.331 . . . . 0.0 108.281 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -74.02 -1.77 21.36 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -99.37 -33.2 10.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.711 -0.618 . . . . 0.0 109.337 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.25 163.23 0.59 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -129.03 162.73 26.97 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -49.06 132.41 19.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.155 -0.966 . . . . 0.0 109.282 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.94 -24.3 15.03 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.3 t -64.36 114.23 4.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.206 -1.173 . . . . 0.0 108.065 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -73.35 -174.11 1.55 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.839 -1.163 . . . . 0.0 109.454 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.584 ' N ' ' SD ' ' A' ' 83' ' ' MET . 21.4 t -146.46 110.75 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.515 ' CD2' ' SD ' ' A' ' 83' ' ' MET . 53.0 m-85 -87.45 102.44 14.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -97.56 117.54 32.07 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -107.75 139.77 41.81 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.414 -0.804 . . . . 0.0 110.112 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 89' ' ' GLY . 7.1 p -168.96 157.41 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.724 . . . . 0.0 109.484 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 88' ' ' VAL . . . 57.85 -96.01 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -154.27 29.8 0.44 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -140.17 -175.25 4.18 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.355 -0.841 . . . . 0.0 109.201 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.7 m -149.83 111.57 4.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.536 ' NH2' ' CD1' ' A' ' 52' ' ' LEU . 7.6 mpt_? -89.07 163.53 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 110.025 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -141.43 122.9 15.0 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.384 -0.823 . . . . 0.0 109.63 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 17.1 m-85 -109.15 175.1 5.58 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.429 -0.794 . . . . 0.0 109.128 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -135.89 111.06 8.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.28 -0.887 . . . . 0.0 109.886 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.9 mtt -50.67 123.23 8.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.123 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 p -149.44 20.07 0.94 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.131 -0.981 . . . . 0.0 109.431 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.1 t -171.37 123.69 0.57 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.691 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 90.3 mt -138.82 128.78 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.315 -0.865 . . . . 0.0 109.493 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 101' ' ' ARG . 3.6 mtt-85 -86.54 -70.8 0.58 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.189 -0.944 . . . . 0.0 108.945 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 51.16 10.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.113 -0.992 . . . . 0.0 109.179 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.774 HG12 ' N ' ' A' ' 104' ' ' LYS . 10.6 t -91.05 -93.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.774 ' N ' HG12 ' A' ' 103' ' ' VAL . 52.0 mtpt -100.0 140.96 21.91 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.06 28.89 0.29 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.207 1.271 . . . . 0.0 111.879 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -178.56 75.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.397 -0.814 . . . . 0.0 109.544 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 106' ' ' THR . 49.5 t0 -61.77 -115.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.15 -0.969 . . . . 0.0 108.81 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.436 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 6.4 m -104.14 22.34 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.33 -0.856 . . . . 0.0 109.126 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.48 103.85 0.84 Allowed Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 94.7 t -67.64 -15.25 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.214 -1.168 . . . . 0.0 108.337 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.4 mt -135.38 54.88 1.9 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -171.74 20.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.469 -0.77 . . . . 0.0 109.097 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 113' ' ' GLU . 10.2 tt0 -156.64 0.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 109.553 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.582 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 3.6 mp0 -94.37 15.73 16.9 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.431 ' N ' HD21 ' A' ' 56' ' ' ASN . 14.9 pttp -96.16 44.55 1.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.78 -92.44 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -145.91 -26.49 0.44 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 49.1 t0 -118.86 168.16 11.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.144 -0.973 . . . . 0.0 108.617 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.468 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 83.0 mttt -60.83 145.08 51.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -143.83 160.58 40.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.057 -1.027 . . . . 0.0 108.953 179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.1 tp -114.87 107.98 16.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.62 -0.675 . . . . 0.0 110.962 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 122' ' ' THR . 6.7 t -97.54 107.72 20.29 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.4 mt -85.0 156.38 21.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.095 -1.003 . . . . 0.0 110.278 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.7 mt -140.37 143.78 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.513 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 0.9 OUTLIER -91.78 155.89 17.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.934 -1.104 . . . . 0.0 108.512 179.288 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.416 ' SG ' ' HB1' ' A' ' 60' ' ' ALA . 2.0 m -149.29 85.03 1.44 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.944 -1.097 . . . . 0.0 109.886 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 20.3 p-10 -142.8 143.88 32.34 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.141 -0.975 . . . . 0.0 109.235 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.34 61.09 0.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.451 -0.78 . . . . 0.0 109.072 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -63.7 119.98 10.94 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.522 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -85.67 123.48 31.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.026 -1.046 . . . . 0.0 109.602 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.7 pm0 -94.82 14.7 20.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.343 -0.848 . . . . 0.0 109.77 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -69.31 -35.5 76.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.0 108.57 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.0 p -140.99 1.92 1.69 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.458 -0.776 . . . . 0.0 109.037 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.76 57.63 3.03 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.3 t -146.99 133.72 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.225 -1.162 . . . . 0.0 109.642 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 53.3 m95 -53.11 113.65 1.19 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.07 -1.019 . . . . 0.0 108.493 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 138' ' ' LYS . 1.0 OUTLIER -36.96 -80.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.291 0.567 . . . . 0.0 110.326 -179.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.479 ' N ' ' CD ' ' A' ' 137' ' ' GLU . 19.2 ptmt -96.87 139.35 33.04 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -151.78 96.49 2.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.891 -1.131 . . . . 0.0 110.569 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.658 ' O ' HD13 ' A' ' 141' ' ' ILE . 40.4 mtpt -86.58 158.49 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.156 -0.965 . . . . 0.0 108.473 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 140' ' ' LYS . 7.9 mm -129.25 140.29 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.544 -0.722 . . . . 0.0 110.286 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 25.8 m-85 -129.49 170.63 13.47 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.1 t -154.06 140.85 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.692 -1.255 . . . . 0.0 110.86 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.24 139.3 40.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.8 t -109.85 137.61 47.39 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.399 -0.813 . . . . 0.0 110.389 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.03 133.55 55.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.535 -0.728 . . . . 0.0 109.547 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 147' ' ' VAL . 8.2 m -91.63 148.17 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 109.327 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.7 pttp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.438 -179.998 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.309 0.575 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -74.43 91.25 2.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.913 . . . . 0.0 109.592 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.19 60.08 2.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.409 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 5' ' ' PRO . 43.7 mttp -146.81 77.26 11.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.323 -0.861 . . . . 0.0 109.431 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' CD ' ' OD1' ' A' ' 53' ' ' ASP . 52.9 Cg_exo -54.58 -140.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.972 2.448 . . . . 0.0 112.495 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -67.37 91.84 0.27 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.765 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mt -149.46 95.57 3.75 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' C ' ' H ' ' A' ' 10' ' ' ASP . 93.1 Cg_endo -83.6 134.18 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.191 1.927 . . . . 0.0 112.432 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -60.21 0.76 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.705 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 12' ' ' SER . 13.2 t70 -76.49 91.18 3.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.639 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -64.76 38.72 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 10' ' ' ASP . 43.3 t -146.9 25.26 1.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 0.0 108.885 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -141.67 141.88 33.36 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.64 118.43 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.66 -0.65 . . . . 0.0 110.885 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.96 -16.81 19.53 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.97 -177.48 38.74 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.67 121.31 8.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.121 -1.223 . . . . 0.0 109.586 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 tt -99.9 142.04 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' CD ' ' NZ ' ' A' ' 87' ' ' LYS . 23.7 mt-10 -146.79 135.24 21.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.968 -1.083 . . . . 0.0 110.737 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.494 HD12 HD23 ' A' ' 75' ' ' LEU . 32.5 mt -144.84 127.06 8.12 Favored Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.41 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.07 -42.75 0.37 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.636 1.557 . . . . 0.0 111.599 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -52.16 -14.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.403 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.495 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -135.63 15.14 3.4 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.42 -0.8 . . . . 0.0 109.136 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 42.41 49.52 4.62 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.718 0.77 . . . . 0.0 109.998 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 23' ' ' ALA . 50.0 mm -91.76 141.1 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.445 ' CG ' ' O ' ' A' ' 25' ' ' ILE . 42.3 mttp -165.9 81.8 0.3 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -143.91 156.58 58.79 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 120.924 -1.11 . . . . 0.0 110.817 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -84.79 165.36 11.84 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.041 2.494 . . . . 0.0 112.531 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.22 119.43 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.565 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 7.9 m-85 -79.37 149.43 72.23 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.817 -1.177 . . . . 0.0 110.207 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.58 88.5 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.479 2.119 . . . . 0.0 111.86 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.31 -179.44 41.23 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.575 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 35' ' ' THR . 85.2 Cg_endo -78.09 119.17 4.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.861 2.374 . . . . 0.0 111.459 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.63 88.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.383 0.611 . . . . 0.0 110.397 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.573 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -112.55 153.47 44.94 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.63 -43.43 10.13 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.09 1.86 . . . . 0.0 111.664 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -63.09 -22.98 67.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.307 -0.871 . . . . 0.0 109.727 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.565 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 7.1 tp60 -89.94 -66.96 0.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.235 -0.916 . . . . 0.0 109.54 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 42' ' ' GLY . 17.2 mt -46.39 -15.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.23 -0.918 . . . . 0.0 109.947 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' GLN . 40.0 m-20 -63.25 -25.19 68.21 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -88.88 -11.24 45.18 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.542 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 158.15 -136.6 4.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 60' ' ' ALA . 2.9 t -108.42 159.03 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.992 . . . . 0.0 109.862 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 p -153.58 156.73 38.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -57.99 175.67 0.19 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.797 -1.189 . . . . 0.0 109.946 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -85.95 -12.18 51.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -147.24 151.12 36.15 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.472 0.653 . . . . 0.0 109.935 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.39 -38.73 92.29 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.6 -0.687 . . . . 0.0 111.34 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -87.38 12.31 12.38 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.897 -1.127 . . . . 0.0 110.643 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -63.31 84.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.987 . . . . 0.0 110.141 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' ASP . 48.2 m -92.56 147.46 22.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 109.03 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.967 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -55.41 -8.77 0.37 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -77.12 -30.82 55.37 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.508 -0.745 . . . . 0.0 109.615 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 15.8 m-20 -62.16 104.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.055 -1.028 . . . . 0.0 109.33 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.31 -16.65 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.48 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 54' ' ' ASP . 27.6 t-20 -117.97 97.86 6.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.646 -0.659 . . . . 0.0 109.223 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.425 ' O ' ' OG1' ' A' ' 122' ' ' THR . 92.2 mt -98.49 150.5 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.376 -0.827 . . . . 0.0 109.325 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 p -140.46 114.45 9.02 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -101.69 161.87 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.326 -0.859 . . . . 0.0 110.362 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.542 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -140.27 131.17 26.02 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.23 154.24 24.89 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.886 -1.149 . . . . 0.0 110.537 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.713 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 19.9 m-70 -71.1 175.52 5.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.68 -0.894 . . . . 0.0 109.063 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.86 89.75 0.66 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.939 . . . . 0.0 109.65 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.05 116.99 28.49 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.2 mm -59.59 -29.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.421 -0.799 . . . . 0.0 110.097 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -87.54 19.51 3.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.153 -0.967 . . . . 0.0 109.219 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.4 OUTLIER -149.71 70.56 9.58 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.536 -0.727 . . . . 0.0 109.191 179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -51.88 14.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 123.442 2.761 . . . . 0.0 113.853 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' H ' ' C ' ' A' ' 67' ' ' ARG . 56.5 m-80 -147.9 60.95 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.216 . . . . 0.0 108.839 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -146.8 103.63 3.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.175 -0.953 . . . . 0.0 110.48 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.713 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 15.0 mt-30 55.81 -115.15 0.9 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.682 -0.636 . . . . 0.0 111.907 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -97.68 30.65 2.87 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 111.13 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.1 m -63.92 -49.16 73.71 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.128 -1.608 . . . . 0.0 109.611 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.602 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.9 m-20 -93.95 -18.23 22.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 110.012 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.69 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.6 tm? -51.05 -39.07 55.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 108.856 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -68.91 -4.71 17.56 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -91.5 -27.99 17.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 162.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 109.742 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.13 166.36 24.34 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.348 -0.845 . . . . 0.0 108.807 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -50.18 137.31 18.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.186 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.44 -28.54 13.19 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -64.19 119.7 10.73 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.407 -1.055 . . . . 0.0 108.269 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.7 mtp -82.96 137.12 34.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.0 -1.063 . . . . 0.0 110.102 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.02 114.12 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.473 -0.767 . . . . 0.0 109.607 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -93.26 102.46 14.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.151 -0.968 . . . . 0.0 109.544 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -97.13 114.63 26.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.338 -0.851 . . . . 0.0 108.755 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' NZ ' ' CD ' ' A' ' 19' ' ' GLU . 23.0 mtmm -106.12 142.08 36.4 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.365 -0.834 . . . . 0.0 110.102 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.94 123.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 47.79 -145.23 5.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 90' ' ' ASN . 28.0 t-20 -85.26 52.1 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.209 -1.171 . . . . 0.0 109.198 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -152.32 157.98 42.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.155 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 m -152.98 148.68 27.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.601 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 177.15 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -144.31 164.1 31.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.028 -1.045 . . . . 0.0 110.526 -179.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.479 ' CD1' ' C ' ' A' ' 94' ' ' LYS . 23.7 m-85 -148.96 108.31 3.95 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -74.39 117.91 16.75 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.132 -0.98 . . . . 0.0 109.27 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.8 mmt -51.75 129.62 26.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.309 -0.869 . . . . 0.0 108.988 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 m -158.16 24.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.178 -0.951 . . . . 0.0 109.227 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.0 t -171.28 132.7 0.81 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 101' ' ' ARG . 64.4 mt -142.1 166.74 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.169 -0.957 . . . . 0.0 109.527 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.624 ' CG ' HH11 ' A' ' 101' ' ' ARG . 2.9 mtt-85 -140.35 -26.74 0.76 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' HA ' ' H ' ' A' ' 141' ' ' ILE . 25.5 t0 42.68 20.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.523 0.678 . . . . 0.0 109.186 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -167.95 141.57 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 105' ' ' PRO . 38.8 tttm -65.66 -62.25 4.71 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.897 -1.127 . . . . 0.0 110.606 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 107' ' ' ASP . 28.0 Cg_exo -23.81 -109.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 123.788 2.992 . . . . 0.0 114.462 179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 107' ' ' ASP . 31.0 p 50.34 -89.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.753 -1.217 . . . . 0.0 109.705 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' OG1' ' A' ' 106' ' ' THR . 50.8 m-20 -96.73 169.35 9.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.199 -0.938 . . . . 0.0 108.935 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 108' ' ' VAL . 15.6 m -72.79 33.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.076 -1.015 . . . . 0.0 108.962 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 154.67 122.16 0.81 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.541 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 60.9 t -68.09 -35.95 73.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.186 -1.185 . . . . 0.0 108.597 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mp -113.08 67.83 0.67 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -173.45 25.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.987 . . . . 0.0 110.187 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -155.02 22.87 0.44 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.866 -1.146 . . . . 0.0 109.701 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 110' ' ' VAL . 5.8 pt20 -146.34 13.79 1.25 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.433 -0.792 . . . . 0.0 109.121 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -80.35 31.81 0.28 Allowed 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.679 -0.638 . . . . 0.0 109.551 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -150.51 8.36 0.74 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -96.65 -125.1 0.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.127 -1.22 . . . . 0.0 108.982 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 118' ' ' ASP . 4.2 m-20 -116.45 168.37 10.21 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -47.37 141.29 4.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.033 -1.042 . . . . 0.0 108.824 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.419 ' OE1' ' OE1' ' A' ' 114' ' ' GLN . 6.8 pt20 -152.84 164.58 37.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 110.572 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.1 tp -127.23 116.59 20.81 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.067 0.46 . . . . 0.0 109.854 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.498 ' H ' ' HG1' ' A' ' 122' ' ' THR . 0.1 OUTLIER -96.05 92.37 6.42 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.07 143.17 54.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.476 -0.765 . . . . 0.0 110.136 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 25.0 mt -140.92 135.62 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.462 -0.774 . . . . 0.0 109.324 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.6 p -96.63 167.04 11.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.058 -1.027 . . . . 0.0 108.521 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 70.8 m -147.03 139.5 24.8 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.022 -1.049 . . . . 0.0 110.124 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 127' ' ' ASP . 1.7 p30 179.59 136.49 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.305 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 61.5 64.01 1.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.47 -0.769 . . . . 0.0 109.201 -179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -62.98 126.5 27.53 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.118 -0.989 . . . . 0.0 109.142 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -85.96 118.36 25.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.038 -1.038 . . . . 0.0 109.509 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.74 -0.56 54.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.425 -0.797 . . . . 0.0 109.918 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -81.77 -50.24 9.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.088 -1.008 . . . . 0.0 109.301 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.7 p -95.13 -10.69 29.88 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.236 -0.915 . . . . 0.0 109.233 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.76 39.94 54.08 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.89 158.89 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.333 -1.098 . . . . 0.0 109.636 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.427 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.8 m95 -62.78 111.76 2.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -35.79 -77.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.064 0.459 . . . . 0.0 110.627 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.446 -0.784 . . . . 0.0 109.227 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -169.79 131.62 1.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.709 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -88.51 166.83 13.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.14 -0.975 . . . . 0.0 108.845 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.474 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 22.6 mt -141.51 144.82 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.095 -1.003 . . . . 0.0 110.583 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 13.1 m-85 -140.1 168.93 18.66 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.6 t -150.05 141.8 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.626 -1.296 . . . . 0.0 110.745 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.19 171.27 14.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.561 ' O ' ' N ' ' A' ' 147' ' ' VAL . 14.4 t -146.87 147.53 30.91 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.84 -1.163 . . . . 0.0 110.93 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -65.17 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.7 t -148.1 175.17 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.181 -0.949 . . . . 0.0 108.99 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.473 ' H ' HG12 ' A' ' 147' ' ' VAL . 41.4 pttt . . . . . 0 N--CA 1.499 2.007 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.377 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -164.41 143.91 7.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.315 -0.866 . . . . 0.0 109.242 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.76 143.67 1.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.606 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' PRO . 45.8 mttt -82.17 154.91 69.82 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' LYS . 99.8 Cg_exo -42.11 172.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.081 1.854 . . . . 0.0 112.062 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -92.32 113.04 25.2 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.907 -1.12 . . . . 0.0 111.252 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' PRO . 6.9 mm -87.82 118.52 69.82 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 7' ' ' ILE . 76.8 Cg_exo -47.27 -174.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.527 1.485 . . . . 0.0 112.509 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -120.66 -26.7 5.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 12' ' ' SER . 30.8 t70 -76.08 101.68 5.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -57.45 -2.67 0.13 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.418 -0.801 . . . . 0.0 110.028 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 10' ' ' ASP . 3.6 p -115.59 43.98 1.97 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.499 -0.75 . . . . 0.0 109.345 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 136.83 30.24 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 t -61.19 108.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.52 -0.738 . . . . 0.0 111.402 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.7 -5.03 49.42 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.43 -170.24 40.96 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.08 126.33 10.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -1.183 . . . . 0.0 109.073 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.5 tp -97.41 140.77 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -146.58 132.54 19.16 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.167 . . . . 0.0 110.748 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.612 ' CD1' HD21 ' A' ' 75' ' ' LEU . 35.6 mt -144.8 120.58 6.02 Favored Pre-proline 0 N--CA 1.492 1.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.94 -37.99 0.97 Allowed 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.629 1.553 . . . . 0.0 111.42 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.32 -19.9 1.48 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.408 -0.807 . . . . 0.0 109.293 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.443 ' O ' ' OD2' ' A' ' 24' ' ' ASP . . . -130.54 5.32 4.72 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.5 -0.75 . . . . 0.0 109.465 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 0.7 OUTLIER 56.16 29.61 15.01 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.831 -0.543 . . . . 0.0 111.372 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.439 ' CD1' ' ND2' ' A' ' 74' ' ' ASN . 1.5 mp -85.33 142.02 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.658 -1.276 . . . . 0.0 108.404 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.3 pttt -165.64 86.3 0.37 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.484 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 16.6 mt-10 -142.13 160.62 54.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.391 -0.818 . . . . 0.0 110.555 -177.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.75 158.18 24.68 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.514 2.143 . . . . 0.0 112.17 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.06 108.39 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.75 166.94 27.01 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 120.948 -1.095 . . . . 0.0 109.11 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -86.1 130.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.486 2.124 . . . . 0.0 112.177 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.02 168.94 30.88 Favored Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.012 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.9 Cg_endo -77.78 121.02 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 111.286 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -39.78 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.33 0.586 . . . . 0.0 110.281 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.578 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.4 p -126.43 152.82 74.68 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.12 -43.0 12.28 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.187 1.924 . . . . 0.0 111.995 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -61.46 -21.98 64.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.576 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -95.29 -69.83 0.74 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.158 -0.964 . . . . 0.0 109.253 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 17.5 mt -45.58 -16.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -62.18 -24.84 67.43 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.6 -15.64 54.06 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.61 -109.69 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.924 -1.131 . . . . 0.0 110.355 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 60' ' ' ALA . 5.0 t -125.52 153.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.505 -0.997 . . . . 0.0 109.758 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 2.7 m -153.79 153.74 32.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -56.78 165.57 1.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.594 -1.317 . . . . 0.0 109.474 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.629 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.05 -5.12 53.22 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -150.9 146.42 26.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.519 -0.738 . . . . 0.0 109.591 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.49 -38.39 87.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.551 -0.718 . . . . 0.0 111.075 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -89.47 15.48 9.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.99 -1.069 . . . . 0.0 111.143 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -62.0 99.06 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.847 -1.158 . . . . 0.0 109.61 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.1 p -91.22 144.28 25.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 108.856 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.039 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -58.99 -7.1 0.95 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 51' ' ' SER . 20.5 t0 -96.01 -13.47 23.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.691 -0.631 . . . . 0.0 109.626 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 56' ' ' ASN . 46.4 t0 -58.97 105.08 0.28 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.02 -1.05 . . . . 0.0 109.382 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.782 HE21 HE21 ' A' ' 120' ' ' GLN . 6.0 tm0? -44.49 -17.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.506 -0.747 . . . . 0.0 109.36 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 54' ' ' ASP . 5.0 t-20 -122.3 92.75 3.79 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.1 mt -93.55 145.8 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.107 -0.996 . . . . 0.0 108.453 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.8 t -142.3 109.17 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 108.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.5 mt -95.27 162.22 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.181 -0.949 . . . . 0.0 110.162 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -134.02 131.78 39.3 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.03 145.47 15.44 Favored Glycine 0 N--CA 1.502 3.057 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.844 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 18.1 m-70 -72.85 -169.95 0.65 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.685 -0.891 . . . . 0.0 109.304 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.48 94.15 0.51 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.35 -0.844 . . . . 0.0 109.619 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -89.44 113.09 24.39 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.224 -0.923 . . . . 0.0 108.887 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 mt -61.07 -31.67 50.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 0.0 110.12 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -84.27 15.47 3.56 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.333 -0.855 . . . . 0.0 109.302 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 69' ' ' ASN . 10.1 tpt180 -151.49 74.23 8.09 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.466 ' C ' ' ND2' ' A' ' 69' ' ' ASN . 76.8 Cg_exo -52.38 24.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.247 0 C-N-CA 123.861 3.041 . . . . 0.0 114.379 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.9 m-80 -151.26 63.44 0.89 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.0 108.551 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.542 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 36.2 t80 -150.77 99.85 2.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.071 -1.018 . . . . 0.0 110.769 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.542 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.8 mt-30 59.66 -122.41 1.1 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.706 . . . . 0.0 111.454 178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.648 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 12.2 t80 -92.75 36.66 1.02 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.402 1.096 . . . . 0.0 109.574 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.7 m -67.05 -56.65 9.18 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 119.908 -1.745 . . . . 0.0 110.299 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.2 p30 -110.82 7.14 21.84 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.232 -0.917 . . . . 0.0 111.409 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.612 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.8 mt -57.8 -15.03 6.95 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.62 -12.35 59.96 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -81.54 -30.41 33.15 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.8 -179.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 81' ' ' GLY . 23.5 mmtp -139.76 153.48 47.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.403 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 9.7 ttmm -51.39 88.63 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.363 -0.835 . . . . 0.0 109.83 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.7 -15.35 0.36 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.5 t -62.86 121.25 13.02 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.335 -1.097 . . . . 0.0 108.119 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtp -70.94 -175.06 1.04 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.336 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -146.51 109.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 109.609 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.39 101.88 14.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.033 -1.042 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.492 ' CE2' ' CG2' ' A' ' 88' ' ' VAL . 16.7 t80 -98.74 112.45 24.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 87' ' ' LYS . 7.0 mtmp? -92.12 146.55 23.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.064 -1.023 . . . . 0.0 110.809 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.513 ' C ' ' H ' ' A' ' 90' ' ' ASN . 68.3 t -139.55 155.25 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.77 41.2 0.25 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.513 ' H ' ' C ' ' A' ' 88' ' ' VAL . 43.1 t30 -160.4 -34.29 0.05 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.229 -1.159 . . . . 0.0 110.028 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.441 ' OE1' ' NH1' ' A' ' 93' ' ' ARG . 29.8 tt0 -172.4 165.9 5.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 92' ' ' THR . 11.0 t -107.14 123.04 47.67 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.472 -0.768 . . . . 0.0 109.58 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.441 ' NH1' ' OE1' ' A' ' 91' ' ' GLU . 5.3 mmt180 -92.94 160.16 15.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 108.737 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -144.87 121.18 10.91 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -114.59 176.76 4.91 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.607 -0.683 . . . . 0.0 109.223 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -136.56 107.21 6.55 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.514 -0.741 . . . . 0.0 109.395 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.445 ' HB3' ' H ' ' A' ' 81' ' ' GLY . 28.5 tpp -49.49 119.29 3.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.052 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -145.37 19.72 1.54 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.096 -1.002 . . . . 0.0 109.744 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.401 ' HB3' HH12 ' A' ' 101' ' ' ARG . 45.7 m -169.54 118.84 0.65 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.158 -0.964 . . . . 0.0 108.784 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 92.3 mt -134.34 151.92 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.554 -0.716 . . . . 0.0 109.669 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.519 ' NH2' ' OE1' ' A' ' 113' ' ' GLU . 10.9 mpt_? -112.66 -65.43 1.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 101' ' ' ARG . 18.5 t70 37.68 54.57 1.5 Allowed 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.339 0.59 . . . . 0.0 110.001 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 103' ' ' VAL . 6.2 p -159.58 40.15 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.385 -0.822 . . . . 0.0 109.253 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 74.11 155.16 0.15 Allowed Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.482 -0.761 . . . . 0.0 109.211 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -35.25 101.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.801 2.334 . . . . 0.0 112.484 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.6 p -88.18 -42.82 12.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.314 -0.866 . . . . 0.0 109.5 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 109' ' ' GLY . 30.3 t70 -98.83 160.79 14.02 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.3 m -73.69 32.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.086 -1.009 . . . . 0.0 108.88 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 157.12 134.4 1.76 Allowed Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.168 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.9 m -69.75 -34.38 60.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.414 -1.051 . . . . 0.0 108.911 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.411 ' O ' ' CG ' ' A' ' 112' ' ' ASP . 19.8 mt -101.13 67.61 1.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.489 -0.757 . . . . 0.0 109.413 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.693 ' N ' HE21 ' A' ' 114' ' ' GLN . 1.8 m-20 -178.22 28.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.519 ' OE1' ' NH2' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -160.88 25.14 0.14 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.693 HE21 ' N ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -137.96 16.94 2.84 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 116' ' ' GLY . 6.8 mtpm? -97.87 35.77 1.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 115' ' ' LYS . . . -48.35 -96.16 0.01 OUTLIER Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -154.79 -32.01 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.155 -1.203 . . . . 0.0 110.647 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -104.99 149.96 25.32 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.207 -0.933 . . . . 0.0 110.442 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -44.86 140.77 2.43 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.782 HE21 HE21 ' A' ' 55' ' ' GLN . 9.0 pt20 -152.21 173.4 15.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.997 -1.064 . . . . 0.0 110.08 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.7 tp -122.87 155.86 35.81 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.45 0.643 . . . . 0.0 110.122 -178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.0 m -141.98 88.96 2.14 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.0 tp -68.77 149.44 49.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.378 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 96.8 mt -140.04 141.99 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.5 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -90.49 156.56 18.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.919 -1.113 . . . . 0.0 108.831 179.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.533 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 23.0 m -148.75 89.82 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.142 -0.973 . . . . 0.0 109.449 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -148.54 146.04 28.13 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.235 -0.916 . . . . 0.0 109.118 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 1.2 m-20 61.29 63.34 1.23 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.306 -0.871 . . . . 0.0 108.835 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -63.24 122.11 15.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -85.17 121.69 28.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.081 -1.012 . . . . 0.0 109.7 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -92.85 13.77 19.43 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.334 -0.853 . . . . 0.0 109.638 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -81.19 -26.16 36.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.136 -0.978 . . . . 0.0 109.244 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 p -141.98 5.59 1.73 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.355 -0.84 . . . . 0.0 109.168 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.23 53.04 23.88 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.481 ' CG1' ' NH2' ' A' ' 139' ' ' ARG . 3.3 t -147.29 139.83 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.218 -1.166 . . . . 0.0 109.856 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 56.9 m95 -56.09 115.39 2.4 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.38 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 12.6 tp10 -39.51 -85.8 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.724 -0.61 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -81.28 146.92 30.16 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.481 ' NH2' ' CG1' ' A' ' 135' ' ' VAL . 26.8 ttm180 -158.76 75.16 0.7 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.872 -1.143 . . . . 0.0 110.482 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.499 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -75.27 163.59 27.33 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.47 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 6.9 mm -134.09 156.11 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 CA-C-O 121.836 0.826 . . . . 0.0 110.426 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 21.3 m-85 -141.75 159.73 41.64 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.2 147.18 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.711 -1.243 . . . . 0.0 111.342 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.17 158.77 43.32 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.21 143.02 50.27 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.15 -0.968 . . . . 0.0 109.92 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 9.1 tm-20 -60.48 135.75 57.84 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.438 -0.789 . . . . 0.0 108.88 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.4 t -136.89 175.84 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.356 -0.84 . . . . 0.0 108.875 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' H ' HG12 ' A' ' 147' ' ' VAL . 58.9 pttt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.085 -1.009 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.376 0.608 . . . . 0.0 109.393 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -69.9 111.32 5.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.163 -0.961 . . . . 0.0 109.624 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.18 154.97 41.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.17 -0.956 . . . . 0.0 109.363 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 5' ' ' PRO . 21.3 pttp -56.15 143.82 62.32 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.14 -0.975 . . . . 0.0 109.159 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.505 ' O ' ' O ' ' A' ' 4' ' ' LYS . 74.6 Cg_exo -49.25 -156.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.225 1.95 . . . . 0.0 113.21 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -67.5 101.66 1.02 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.016 . . . . 0.0 109.909 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.483 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . 11.8 mt -149.75 94.92 3.77 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 0.0 108.964 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.62 172.44 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.275 1.983 . . . . 0.0 112.345 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.57 2.08 12.33 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.57 -0.707 . . . . 0.0 109.514 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 12' ' ' SER . 63.2 t0 -77.21 105.15 8.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 109.317 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -59.98 3.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 110.561 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ASP . 27.2 p -129.24 39.81 3.71 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.259 -0.9 . . . . 0.0 109.82 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -150.42 150.36 31.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.149 -0.969 . . . . 0.0 109.143 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 15' ' ' ALA . 89.0 t -61.04 157.29 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 110.603 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -144.29 -30.09 0.47 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.82 -178.18 28.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -148.06 120.01 8.2 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.267 -1.137 . . . . 0.0 108.963 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.602 HD11 ' CG1' ' A' ' 84' ' ' VAL . 9.8 tp -94.37 143.67 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -147.43 132.55 18.3 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.155 . . . . 0.0 110.914 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.2 mt -145.72 123.71 6.35 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.7 -39.42 0.52 Allowed 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.752 1.635 . . . . 0.0 111.895 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.48 -23.32 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.324 -0.86 . . . . 0.0 109.473 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.461 ' CB ' HD13 ' A' ' 25' ' ' ILE . . . -127.35 4.38 6.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.594 -0.691 . . . . 0.0 109.42 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 1.3 p30 52.38 37.38 22.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.832 -0.542 . . . . 0.0 111.359 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.552 HD11 ' OD1' ' A' ' 74' ' ' ASN . 1.5 mp -86.29 146.01 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.76 -1.212 . . . . 0.0 108.095 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -166.55 82.56 0.26 Allowed 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -139.27 156.91 71.73 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.831 . . . . 0.0 111.646 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -88.0 164.51 7.28 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.82 2.346 . . . . 0.0 113.308 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -129.86 129.72 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.419 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 2.0 m-85 -87.57 152.36 51.81 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 120.877 -1.139 . . . . 0.0 110.179 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.4 97.94 1.17 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.577 2.185 . . . . 0.0 111.43 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.77 -178.27 48.68 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.323 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' A' ' 35' ' ' THR . 99.0 Cg_endo -80.61 117.78 3.41 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.867 2.378 . . . . 0.0 111.018 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.05 88.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.395 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.0 p -107.7 153.63 41.36 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.62 -41.35 11.45 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.191 1.928 . . . . 0.0 112.392 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.43 -22.22 66.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 109.678 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.4 ' O ' ' N ' ' A' ' 40' ' ' ASN . 3.4 tm0? -96.17 -53.74 3.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.9 mt -45.1 -23.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.441 -0.787 . . . . 0.0 109.725 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 38' ' ' GLN . 14.6 m-20 -64.03 -25.67 68.22 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.419 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 88.5 mtt180 -84.35 -16.0 44.45 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.0 -139.61 6.81 Favored Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.682 -1.246 . . . . 0.0 110.782 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.4 t -99.85 159.37 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.46 -1.023 . . . . 0.0 109.792 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 t -155.56 152.97 29.46 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.516 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 54.1 m-85 -58.68 160.21 5.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.522 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -75.39 -6.16 48.61 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.997 . . . . 0.0 109.413 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -154.37 149.56 26.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.285 -0.884 . . . . 0.0 110.181 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -62.99 -35.86 81.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.631 -0.668 . . . . 0.0 111.612 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.509 ' ND2' ' OE2' ' A' ' 48' ' ' GLU . 13.9 p30 -87.88 15.5 7.06 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.858 -1.151 . . . . 0.0 110.979 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 12.0 tm-20 -64.86 145.06 56.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.991 -1.068 . . . . 0.0 109.062 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.465 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 8.4 p -148.44 153.46 38.54 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -67.04 -4.64 10.32 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 51' ' ' SER . 39.2 m-20 -95.06 -17.42 21.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.9 t70 -59.15 115.56 3.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.944 -1.097 . . . . 0.0 108.846 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 9.3 tt0 -46.04 -19.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.224 -0.922 . . . . 0.0 109.607 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.798 HD21 ' HZ3' ' A' ' 115' ' ' LYS . 61.7 t-20 -131.88 113.48 13.51 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.592 -0.692 . . . . 0.0 109.435 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.64 145.19 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.28 -0.888 . . . . 0.0 108.627 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 2.7 p -141.55 104.43 4.56 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.2 mt -103.13 158.83 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.603 -0.686 . . . . 0.0 109.862 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.543 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -126.86 129.06 47.5 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.8 149.05 20.55 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.924 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 126' ' ' CYS . 31.3 m-70 -74.28 -163.54 0.2 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.61 -0.936 . . . . 0.0 110.046 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 63' ' ' THR . 10.0 t -164.34 80.56 0.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.332 -0.855 . . . . 0.0 108.794 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -87.51 108.0 18.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.798 -1.189 . . . . 0.0 109.11 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.99 -29.91 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.378 -0.826 . . . . 0.0 109.911 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -82.38 12.31 4.6 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.805 0.812 . . . . 0.0 109.401 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -146.01 75.39 12.95 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.52 8.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.617 2.878 . . . . 0.0 113.988 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 67' ' ' ARG . 12.2 p30 -142.93 59.36 1.42 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.967 -1.083 . . . . 0.0 108.085 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -143.46 102.91 4.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.381 -0.824 . . . . 0.0 110.177 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.56 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 51.62 -132.85 1.87 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.423 -0.798 . . . . 0.0 110.752 178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.679 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 1.1 t80 -87.65 63.39 7.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.881 1.324 . . . . 0.0 108.779 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.9 m -89.66 -32.69 16.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.657 -1.277 . . . . 0.0 108.377 178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.556 ' OD1' ' N ' ' A' ' 74' ' ' ASN . 3.6 p-10 -140.03 10.06 2.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.362 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -10.53 0.72 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.499 ' N ' ' C ' ' A' ' 74' ' ' ASN . 1.8 ptmm? -85.33 -23.48 28.05 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -67.33 -29.09 68.56 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.36 -157.15 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.43 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.7 ptmt -171.23 162.42 6.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.057 -1.027 . . . . 0.0 109.75 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.6 mttp -52.59 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.256 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 152.56 -25.09 0.85 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.2 t -63.41 113.66 3.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.1 mtp -63.24 -177.5 0.19 Allowed 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.68 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' CG1' HD11 ' A' ' 18' ' ' ILE . 31.6 t -144.87 106.14 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.421 -0.8 . . . . 0.0 109.171 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -92.99 102.43 14.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.171 -0.956 . . . . 0.0 109.931 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -96.12 115.99 28.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -102.91 144.04 31.72 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.304 -0.873 . . . . 0.0 109.983 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 15' ' ' ALA . 2.2 p -169.24 140.29 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.399 -0.813 . . . . 0.0 109.105 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.5 -97.71 0.15 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -149.88 18.9 0.89 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.262 -1.14 . . . . 0.0 109.299 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -132.73 139.82 47.78 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 92' ' ' THR . 12.7 t -112.53 132.35 55.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.439 -0.788 . . . . 0.0 110.287 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HG3' HH11 ' A' ' 93' ' ' ARG . 7.4 mmm-85 -92.93 167.56 11.74 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -148.46 92.76 2.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.9 -1.125 . . . . 0.0 110.497 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -87.7 -178.16 6.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.972 -1.08 . . . . 0.0 108.185 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -138.39 105.33 5.41 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.252 -0.905 . . . . 0.0 109.769 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.416 ' HB3' ' H ' ' A' ' 81' ' ' GLY . 35.7 ttm -50.06 115.11 1.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.504 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -157.59 24.76 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.803 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.436 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.1 m -164.69 119.53 1.39 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 101' ' ' ARG . 71.4 mt -130.49 166.97 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.428 -0.795 . . . . 0.0 109.63 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 101' ' ' ARG . 4.1 mtt-85 -142.02 -71.85 0.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.375 -0.828 . . . . 0.0 109.04 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 101' ' ' ARG . 2.7 p30 40.81 27.45 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.525 0.678 . . . . 0.0 109.645 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 103' ' ' VAL . 9.7 p -145.07 118.26 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 103' ' ' VAL . 11.4 mptt 52.24 97.09 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.117 -0.99 . . . . 0.0 108.628 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.61 74.6 4.25 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.582 1.521 . . . . 0.0 112.249 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 106' ' ' THR . 0.7 OUTLIER -178.22 41.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -82.16 -54.67 5.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -0.969 . . . . 0.0 109.768 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -145.0 33.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.216 -0.928 . . . . 0.0 109.498 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.85 102.04 1.5 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.3 t -68.37 -18.35 23.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.395 -1.061 . . . . 0.0 108.475 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.66 49.12 2.08 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.91 115.39 27.18 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.623 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 1.6 pm0 -87.79 20.49 3.01 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -149.7 24.33 0.87 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.798 ' HZ3' HD21 ' A' ' 56' ' ' ASN . 55.6 mttp -38.58 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.286 0.565 . . . . 0.0 110.191 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . 89.92 3.74 73.16 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -96.28 -138.91 0.26 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.193 -1.18 . . . . 0.0 109.652 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' GLN . 34.7 m-20 -118.81 169.21 10.05 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.154 -0.966 . . . . 0.0 109.226 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 118' ' ' ASP . 42.4 mmtt -41.27 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.3 pm0 -92.5 157.96 16.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.454 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 121' ' ' LEU . 0.3 OUTLIER -114.18 102.66 10.35 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -96.46 134.8 39.18 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.097 -1.002 . . . . 0.0 109.332 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.97 148.06 43.38 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.504 -0.748 . . . . 0.0 109.132 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 63.1 mt -133.77 143.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.43 ' CG2' ' CE2' ' A' ' 72' ' ' PHE . 3.5 p -91.13 153.23 20.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.882 -1.136 . . . . 0.0 109.335 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.515 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 10.6 m -149.31 92.18 1.92 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.327 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.416 ' OD2' ' OD1' ' A' ' 128' ' ' ASP . 6.5 p-10 -149.0 146.85 27.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.353 -0.842 . . . . 0.0 108.898 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.416 ' OD1' ' OD2' ' A' ' 127' ' ' ASP . 1.5 m-20 59.33 63.66 1.52 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.01 124.89 22.25 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.24 -0.912 . . . . 0.0 109.682 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 6.3 t-20 -85.11 115.1 22.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.184 -0.947 . . . . 0.0 109.312 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -83.87 1.21 44.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 65.0 mmtt -79.86 -53.91 6.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.274 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 67.0 p -95.55 -9.8 31.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.246 -0.909 . . . . 0.0 109.38 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.52 42.94 31.81 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.22 152.26 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.299 -1.118 . . . . 0.0 109.62 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.43 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.4 m95 -58.72 114.93 2.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.1 tt0 -38.3 -72.92 0.05 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.68 -0.638 . . . . 0.0 110.567 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -91.01 148.17 22.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.098 -1.001 . . . . 0.0 109.305 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -154.13 93.42 1.62 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.035 -1.041 . . . . 0.0 110.906 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.402 ' CB ' ' HZ3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -94.7 164.59 12.89 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.0 mt -139.38 149.88 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.251 -0.906 . . . . 0.0 110.505 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.2 m-85 -137.27 164.5 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 99' ' ' SER . 72.5 t -152.66 118.98 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 120.655 -1.278 . . . . 0.0 110.997 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -101.81 -176.48 3.14 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.0 t -153.9 131.37 11.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.873 -1.142 . . . . 0.0 110.022 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.54 109.85 1.3 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 147' ' ' VAL . 98.9 t -95.59 -14.65 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.87 0.843 . . . . 0.0 109.667 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.9 mttp . . . . . 0 C--N 1.29 -1.994 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.28 -179.488 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.307 0.575 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.471 ' H ' ' CD ' ' A' ' 2' ' ' GLN . 18.9 mp0 -64.91 150.66 47.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.46 110.8 15.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.636 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.532 ' O ' ' O ' ' A' ' 5' ' ' PRO . 23.3 pttm -55.15 150.72 19.87 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 108.972 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' O ' ' O ' ' A' ' 4' ' ' LYS . 25.7 Cg_exo -36.44 -116.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 123.196 2.597 . . . . 0.0 113.858 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -148.19 109.72 4.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.631 -1.293 . . . . 0.0 110.77 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.537 ' O ' ' O ' ' A' ' 8' ' ' PRO . 5.7 mm -85.43 124.02 72.16 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' A' ' 7' ' ' ILE . 74.2 Cg_exo -49.54 -140.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 121.96 1.773 . . . . 0.0 113.63 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -160.2 -30.81 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.882 -1.136 . . . . 0.0 109.783 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 12' ' ' SER . 26.3 t0 -74.96 112.6 11.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.496 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.1 mtmm -57.8 -4.78 0.32 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.314 -0.866 . . . . 0.0 109.752 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.7 p -111.88 39.73 2.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.549 -0.719 . . . . 0.0 109.585 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.4 143.63 29.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.044 -1.035 . . . . 0.0 109.662 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.3 t -61.83 149.03 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.817 0.817 . . . . 0.0 110.846 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.87 10.45 1.78 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.66 176.05 38.01 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -147.96 117.27 6.92 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.305 -1.114 . . . . 0.0 109.437 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.9 tt -97.76 141.05 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -146.34 138.89 25.29 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.996 -1.065 . . . . 0.0 110.45 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 75' ' ' LEU . 52.4 mt -144.46 125.8 7.89 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.72 -41.14 0.59 Allowed 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.477 1.451 . . . . 0.0 111.333 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -51.79 -16.6 0.72 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.835 . . . . 0.0 109.315 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.523 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.29 14.88 3.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.405 -0.81 . . . . 0.0 109.476 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.4 p-10 43.79 50.09 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.43 -0.794 . . . . 0.0 109.891 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 23' ' ' ALA . 49.6 mm -88.8 144.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.582 0.706 . . . . 0.0 109.664 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 ttmm -168.9 81.25 0.14 Allowed 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -140.83 152.5 65.77 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.239 -0.913 . . . . 0.0 110.33 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.14 166.92 10.95 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.827 2.351 . . . . 0.0 112.633 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 t -133.7 120.44 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -90.99 165.7 21.06 Favored Pre-proline 0 N--CA 1.505 2.297 0 O-C-N 121.004 -1.06 . . . . 0.0 109.432 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -83.12 120.66 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.71 2.273 . . . . 0.0 112.569 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.28 168.46 20.57 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.566 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 69.3 Cg_endo -73.84 123.95 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.831 2.354 . . . . 0.0 111.195 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -42.95 87.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.781 -0.574 . . . . 0.0 110.654 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 4.0 p -112.21 151.65 43.83 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.22 -40.03 9.28 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.15 1.9 . . . . 0.0 111.636 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.61 -23.05 66.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 109.351 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -96.16 -58.92 1.95 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.301 -0.874 . . . . 0.0 108.791 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 34.6 mt -47.13 -12.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.431 -0.793 . . . . 0.0 109.831 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.5 m-20 -60.93 -26.74 67.71 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.427 HH11 ' HB2' ' A' ' 40' ' ' ASN . 12.3 mpt_? -82.31 -16.84 47.88 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.24 -128.77 2.6 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.769 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.517 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 4.5 t -95.93 158.53 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.467 -1.019 . . . . 0.0 110.245 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.8 t -154.96 147.32 23.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.402 -0.811 . . . . 0.0 109.132 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -52.85 170.21 0.08 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.866 -1.146 . . . . 0.0 109.061 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -100.5 9.15 42.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.467 -0.771 . . . . 0.0 109.818 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -167.91 132.24 1.75 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.096 -1.003 . . . . 0.0 109.889 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.414 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 10.2 pt-20 -55.07 -19.41 7.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.71 -0.619 . . . . 0.0 110.422 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.86 25.86 0.89 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.909 -1.119 . . . . 0.0 108.568 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.3 145.56 53.44 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 122.166 0.984 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 53' ' ' ASP . 5.2 p -154.36 144.94 22.3 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 6.4 mt -71.95 10.1 0.79 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.5 OUTLIER -127.76 -1.14 6.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.89 -0.506 . . . . 0.0 110.312 -179.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.551 ' CG ' HE22 ' A' ' 55' ' ' GLN . 4.8 t70 -54.78 118.43 4.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.452 -1.405 . . . . 0.0 108.719 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.786 HE21 ' H ' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -45.52 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.178 -0.951 . . . . 0.0 109.692 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.786 ' H ' HE21 ' A' ' 55' ' ' GLN . 6.7 p-10 -144.88 110.82 5.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -93.31 116.82 35.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.971 -1.081 . . . . 0.0 109.134 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.415 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 27.8 m -107.76 111.53 23.75 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -115.06 162.78 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.562 -0.711 . . . . 0.0 109.165 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.6 121.63 37.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.36 140.37 13.38 Favored Glycine 0 N--CA 1.502 3.077 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.43 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.6 m-70 -73.1 170.33 15.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.441 -1.034 . . . . 0.0 110.027 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.27 78.18 1.37 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.41 -0.806 . . . . 0.0 109.04 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.418 ' N ' ' OG1' ' A' ' 73' ' ' THR . 50.2 m-85 -86.53 110.19 19.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.018 -1.051 . . . . 0.0 109.291 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 65' ' ' ILE . 15.1 mt -57.73 -27.21 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.485 -0.759 . . . . 0.0 110.055 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.9 14.45 3.27 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.321 -0.862 . . . . 0.0 109.128 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 69' ' ' ASN . 80.9 mtt180 -148.21 72.37 11.06 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -56.45 25.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 123.33 2.687 . . . . 0.0 113.443 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 67' ' ' ARG . 11.3 p30 -148.82 25.76 0.93 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 0.0 108.509 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -86.41 -152.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.691 0.758 . . . . 0.0 109.991 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -71.31 -81.89 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.781 -0.575 . . . . 0.0 111.411 -178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 34.4 t80 -94.36 -6.81 43.41 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.023 -1.048 . . . . 0.0 110.116 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.458 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 96.1 m -43.32 -39.52 3.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.96 . . . . 0.0 110.813 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 76' ' ' LYS . 6.0 m120 -94.17 -27.17 16.35 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.841 -1.162 . . . . 0.0 111.44 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' A' ' 20' ' ' ILE . 10.5 mt -51.74 -11.03 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.694 -1.254 . . . . 0.0 109.36 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 74' ' ' ASN . 3.3 ptmt -84.05 -2.71 57.2 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -103.76 -36.97 7.66 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.68 171.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.327 -0.858 . . . . 0.0 110.104 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' O ' ' SD ' ' A' ' 97' ' ' MET . 50.0 mttm -148.09 174.57 11.8 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.426 -0.796 . . . . 0.0 109.37 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -48.13 139.69 8.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.25 -0.906 . . . . 0.0 109.709 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.32 -15.19 62.65 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.406 ' OG ' ' CE ' ' A' ' 97' ' ' MET . 53.2 p -64.22 98.18 0.22 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.262 -1.14 . . . . 0.0 108.486 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.461 ' SD ' ' OH ' ' A' ' 85' ' ' TYR . 11.3 ptm -67.63 178.08 1.79 Allowed 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.32 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.2 t -144.24 117.59 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.364 -0.835 . . . . 0.0 109.671 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' OH ' ' SD ' ' A' ' 83' ' ' MET . 97.9 m-85 -93.82 102.71 14.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.154 -0.966 . . . . 0.0 109.643 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 88' ' ' VAL . 37.1 t80 -95.87 110.83 22.95 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 88' ' ' VAL . 36.3 ttpt -99.69 146.52 26.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 110.405 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 86' ' ' PHE . 20.2 m -156.89 142.03 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.719 -0.613 . . . . 0.0 109.385 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.35 -96.64 0.01 OUTLIER Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.522 ' ND2' ' OE2' ' A' ' 91' ' ' GLU . 4.4 p-10 -140.17 19.2 2.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.261 -1.141 . . . . 0.0 109.296 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.522 ' OE2' ' ND2' ' A' ' 90' ' ' ASN . 4.2 mp0 -120.03 167.11 12.52 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 98.0 m -152.64 118.92 5.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 110.16 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.515 HH11 ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.85 169.86 10.35 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.0 109.626 179.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -143.8 117.29 9.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.185 -0.947 . . . . 0.0 109.876 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.28 176.19 5.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.334 -0.854 . . . . 0.0 109.285 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -138.89 106.44 5.58 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.442 -0.786 . . . . 0.0 109.867 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.451 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 36.7 ttm -48.26 124.93 8.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.085 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.5 m -153.83 0.21 0.22 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.033 -1.042 . . . . 0.0 109.81 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.486 ' O ' ' O ' ' A' ' 143' ' ' VAL . 72.2 m -163.85 112.59 1.21 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.0 pt -139.68 -166.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 121.229 -0.919 . . . . 0.0 110.228 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 101' ' ' ARG . 3.5 mtt-85 -146.6 -74.77 0.21 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.217 -0.927 . . . . 0.0 109.183 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 101' ' ' ARG . 1.7 p30 40.38 24.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.712 0.767 . . . . 0.0 109.323 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.697 ' O ' HG13 ' A' ' 103' ' ' VAL . 9.4 p -154.21 98.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 121.799 0.809 . . . . 0.0 109.069 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 46.65 62.97 10.69 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.765 -1.21 . . . . 0.0 109.254 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -39.53 131.29 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.967 2.445 . . . . 0.0 112.81 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.512 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 30.1 p -75.23 -21.21 58.78 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.492 -0.755 . . . . 0.0 109.351 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 106' ' ' THR . 5.3 t70 83.25 -2.28 1.21 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.84 -0.537 . . . . 0.0 109.921 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.511 HG22 ' OG1' ' A' ' 106' ' ' THR . 3.3 m -79.9 16.4 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.006 -1.059 . . . . 0.0 109.158 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -161.5 44.43 0.39 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.11 -30.28 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 120.973 -1.31 . . . . 0.0 107.743 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.6 mt -137.35 -33.89 0.73 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.476 ' OD1' ' NE2' ' A' ' 120' ' ' GLN . 12.3 t70 50.29 55.57 9.26 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.409 -0.807 . . . . 0.0 109.562 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -108.89 8.11 26.36 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -147.0 1.81 0.77 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.352 0.596 . . . . 0.0 109.657 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 117' ' ' LYS . 54.6 mmtt -75.39 132.68 41.07 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 109.046 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -55.01 85.14 0.01 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 115' ' ' LYS . 58.2 mttp -145.69 -166.67 2.5 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.185 -1.185 . . . . 0.0 109.38 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.478 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.7 t70 -118.22 170.45 8.87 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.478 ' C ' ' O ' ' A' ' 118' ' ' ASP . 66.2 mttm -36.79 132.58 0.64 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.476 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 5.0 pt20 -148.32 -178.14 6.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.159 -0.963 . . . . 0.0 110.455 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.8 tp -134.99 111.31 9.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.0 m -96.04 87.54 4.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.27 -0.893 . . . . 0.0 108.716 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.72 121.04 23.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.12 -0.988 . . . . 0.0 109.145 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 67.2 mt -105.12 140.76 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.464 -0.773 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.2 p -94.76 161.61 14.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.125 -0.985 . . . . 0.0 108.863 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.445 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 21.8 m -148.03 139.51 23.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -175.1 132.95 0.31 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.37 -0.831 . . . . 0.0 109.065 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.1 t0 61.83 66.01 0.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.402 -0.812 . . . . 0.0 109.132 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -61.76 123.56 18.31 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.021 -1.049 . . . . 0.0 109.739 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -87.34 125.49 34.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.157 -0.965 . . . . 0.0 109.672 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -90.71 7.68 38.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.368 -0.833 . . . . 0.0 109.698 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.8 mttp -79.38 -58.65 3.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -0.924 . . . . 0.0 109.077 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.2 p -96.74 -3.9 41.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 109.3 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.79 46.82 35.98 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.1 t -147.15 157.37 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -1.073 . . . . 0.0 109.733 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.445 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.5 m95 -63.79 114.31 3.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 136' ' ' TRP . 31.0 tt0 -36.79 -81.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.244 0.545 . . . . 0.0 110.451 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -64.53 170.16 4.23 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.13 -0.981 . . . . 0.0 108.519 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.529 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -161.86 112.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.914 -1.116 . . . . 0.0 109.983 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.15 155.83 49.09 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.4 pt -150.78 160.52 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.719 -1.238 . . . . 0.0 111.187 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -138.11 157.37 46.46 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 99' ' ' SER . 96.5 t -144.24 111.68 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.863 -1.148 . . . . 0.0 111.551 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -99.3 175.08 6.0 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.1 t -138.88 133.89 32.54 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.035 -1.041 . . . . 0.0 109.706 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -60.22 127.68 33.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.441 -0.787 . . . . 0.0 109.706 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 147' ' ' VAL . 5.0 m -92.14 -169.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.374 -0.829 . . . . 0.0 109.282 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.408 179.881 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 tpp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -78.97 90.69 4.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.386 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.57 117.34 29.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.177 -0.952 . . . . 0.0 109.544 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -46.06 111.81 1.56 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.435 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.36 -141.66 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.018 1.812 . . . . 0.0 111.973 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -66.05 91.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.806 -1.184 . . . . 0.0 110.556 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt -145.62 94.5 5.11 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -47.23 167.39 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.078 1.852 . . . . 0.0 112.5 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -113.81 -12.95 12.66 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 12' ' ' SER . 52.6 t0 -76.87 107.5 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.428 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -57.9 -5.39 0.41 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.404 -0.81 . . . . 0.0 109.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 10' ' ' ASP . 16.5 m -103.68 29.24 5.89 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.445 -0.784 . . . . 0.0 109.808 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -147.16 140.29 25.25 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.154 -0.966 . . . . 0.0 109.418 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 HG12 ' N ' ' A' ' 15' ' ' ALA . 94.8 t -59.91 166.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.71 0.767 . . . . 0.0 110.656 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.634 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -140.3 -34.29 0.54 Allowed 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -160.49 -165.68 17.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 31.3 m-85 -149.41 126.24 11.14 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.983 -1.304 . . . . 0.0 110.438 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -96.31 142.75 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -145.63 146.08 31.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.955 -1.091 . . . . 0.0 110.304 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.5 mt -149.88 131.42 7.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.48 -51.45 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 121.883 1.722 . . . . 0.0 111.752 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -50.55 -29.18 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.412 -0.805 . . . . 0.0 109.321 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.38 3.27 19.61 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.52 -0.738 . . . . 0.0 109.062 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 42.84 41.13 2.4 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.577 0.703 . . . . 0.0 109.894 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 mt -94.82 150.07 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.777 0.799 . . . . 0.0 110.016 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -167.25 83.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -135.8 158.51 73.93 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.512 -0.743 . . . . 0.0 110.351 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.84 161.98 16.13 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 123.008 2.472 . . . . 0.0 113.154 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -126.47 130.82 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.429 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 12.6 m-85 -85.77 148.84 49.65 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.845 -1.159 . . . . 0.0 109.993 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.37 82.73 2.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.647 2.231 . . . . 0.0 111.398 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.64 -173.96 35.48 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.187 -1.482 . . . . 0.0 110.897 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.8 Cg_endo -82.38 121.4 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.961 2.44 . . . . 0.0 111.406 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.53 87.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.851 -0.53 . . . . 0.0 110.576 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.1 p -110.47 151.33 42.64 Favored Pre-proline 0 N--CA 1.499 1.987 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.51 -41.71 6.06 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.227 1.951 . . . . 0.0 112.04 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.64 -21.38 66.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.153 -0.967 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 40' ' ' ASN . 1.6 tt0 -96.73 -60.68 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 42' ' ' GLY . 24.0 mt -45.16 -19.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.69 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.48 ' N ' ' O ' ' A' ' 38' ' ' GLN . 38.7 m-20 -64.35 -26.47 68.49 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.446 HH11 ' HG2' ' A' ' 41' ' ' ARG . 23.4 mtt-85 -79.93 -19.55 47.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 39' ' ' LEU . . . 162.48 -144.12 9.36 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.733 -1.222 . . . . 0.0 110.266 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.515 HG23 HE21 ' A' ' 71' ' ' GLN . 4.1 t -94.75 163.62 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.297 -1.119 . . . . 0.0 108.874 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.459 ' CB ' ' NE2' ' A' ' 38' ' ' GLN . 4.4 t -158.41 155.28 28.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.104 -0.998 . . . . 0.0 109.202 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -60.02 164.84 3.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.075 -1.016 . . . . 0.0 109.419 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -77.81 -19.16 55.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.176 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -141.77 150.5 41.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.397 -0.814 . . . . 0.0 110.248 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -63.44 -36.52 84.01 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.589 -0.694 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -85.17 9.27 15.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.891 -1.131 . . . . 0.0 110.989 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -65.02 138.53 58.41 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 0.0 109.391 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -147.23 169.42 19.41 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.465 -0.772 . . . . 0.0 108.986 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.59 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -72.27 -10.19 59.46 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.92 -29.35 32.35 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.483 -0.761 . . . . 0.0 109.213 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.6 m-20 -64.4 100.7 0.37 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.235 -0.916 . . . . 0.0 109.73 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.518 ' NE2' ' OE1' ' A' ' 114' ' ' GLN . 2.8 pm0 -48.33 -15.92 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.982 -1.074 . . . . 0.0 109.012 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 54' ' ' ASP . 19.6 t30 -110.45 100.04 8.94 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 mm -95.55 148.45 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.212 -0.93 . . . . 0.0 109.548 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -145.82 107.88 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.586 HG22 ' N ' ' A' ' 60' ' ' ALA . 79.1 mt -110.79 165.74 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.588 -0.695 . . . . 0.0 110.134 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.586 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -149.55 138.75 21.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.461 -0.775 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.55 157.73 27.49 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.29 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -73.11 -177.15 2.36 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.302 -1.116 . . . . 0.0 109.818 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.9 81.46 0.43 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -87.85 122.2 31.19 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.318 -0.863 . . . . 0.0 109.533 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 mm -58.9 -26.08 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.269 -0.894 . . . . 0.0 110.748 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -86.72 20.53 2.51 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 109.875 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 69' ' ' ASN . 90.8 mtt180 -150.37 67.87 8.34 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.541 -0.725 . . . . 0.0 109.572 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -48.3 5.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 123.537 2.825 . . . . 0.0 114.124 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -146.13 61.24 1.24 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.89 -1.131 . . . . 0.0 108.638 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -152.86 121.0 6.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 110.509 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.578 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER 54.4 -124.71 2.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.681 -0.637 . . . . 0.0 110.864 178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' CE2' HD13 ' A' ' 75' ' ' LEU . 3.3 m-85 -97.82 12.51 33.68 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 120.72 -1.237 . . . . 0.0 110.15 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.0 m -46.41 -19.93 0.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.911 -1.118 . . . . 0.0 110.311 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 72' ' ' PHE . 5.5 m-20 -121.77 -21.74 6.01 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.442 -0.786 . . . . 0.0 109.971 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 72' ' ' PHE . 5.9 tt -55.96 -25.22 42.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -76.57 -13.64 60.06 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -85.52 -16.43 39.54 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.96 174.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.7 . . . . 0.0 109.827 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 81' ' ' GLY . 53.5 mtmt -150.49 159.21 44.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.259 -0.901 . . . . 0.0 109.114 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -52.84 86.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.917 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 156.2 -22.71 0.51 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.771 -1.732 . . . . 0.0 108.771 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -66.43 121.12 14.59 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.459 -1.024 . . . . 0.0 108.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 18.6 mtm -77.58 -177.82 4.97 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.962 -1.086 . . . . 0.0 109.801 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 85' ' ' TYR . 61.4 t -145.65 159.51 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.408 -0.808 . . . . 0.0 109.444 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' HG12 ' A' ' 84' ' ' VAL . 59.7 m-85 -144.17 102.46 3.87 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.263 -0.898 . . . . 0.0 109.371 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -95.0 113.5 25.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.228 -0.92 . . . . 0.0 108.658 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -102.08 139.1 38.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.3 -0.875 . . . . 0.0 109.707 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 15' ' ' ALA . 2.4 p -162.23 144.22 3.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 49.98 -151.65 4.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.05 -1.62 . . . . 0.0 109.05 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -92.94 59.33 3.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.197 -1.178 . . . . 0.0 109.297 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -168.36 163.37 12.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.335 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 84.8 m -144.86 151.78 39.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.526 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.42 159.38 42.35 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.47 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 37.5 pttt -143.1 164.82 29.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.091 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.557 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 3.1 m-85 -141.31 -174.62 4.07 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -141.95 115.03 8.75 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.16 -0.962 . . . . 0.0 108.964 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.458 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.2 mmt -49.36 110.09 0.33 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 0.0 109.598 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 p -139.46 20.69 2.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.436 -0.79 . . . . 0.0 109.14 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 143' ' ' VAL . 31.1 t -168.63 122.91 0.88 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 85.9 mt -136.02 124.94 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.209 -0.932 . . . . 0.0 109.296 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.503 ' C ' ' N ' ' A' ' 103' ' ' VAL . 22.5 mmm180 -79.42 -71.81 0.43 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 51.08 13.85 0.18 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.022 -1.049 . . . . 0.0 108.184 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.503 ' N ' ' C ' ' A' ' 101' ' ' ARG . 20.2 t -74.59 150.33 7.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.502 ' O ' ' N ' ' A' ' 106' ' ' THR . 46.4 tttp -63.52 -64.99 2.34 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.733 -1.23 . . . . 0.0 109.622 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 107' ' ' ASP . 37.9 Cg_endo -63.4 40.02 0.09 OUTLIER 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.816 1.678 . . . . 0.0 111.057 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.634 ' O ' HG23 ' A' ' 106' ' ' THR . 6.6 t -48.36 93.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.192 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER 171.82 -2.33 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 0.0 110.14 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.467 ' CG2' ' NH2' ' A' ' 101' ' ' ARG . 32.2 m -71.0 16.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.696 -1.252 . . . . 0.0 109.574 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 138.91 22.26 0.4 Allowed Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.4 m -69.14 -34.94 65.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 120.979 -1.306 . . . . 0.0 108.604 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.1 mt -139.16 74.27 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -134.94 -109.27 0.22 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.468 -0.77 . . . . 0.0 109.058 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.571 ' C ' HE21 ' A' ' 114' ' ' GLN . 14.9 pt-20 -81.55 -175.47 5.54 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.187 -0.945 . . . . 0.0 108.775 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.571 HE21 ' C ' ' A' ' 113' ' ' GLU . 5.4 mm-40 -91.01 63.38 5.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.215 -0.928 . . . . 0.0 108.841 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -44.7 -53.22 7.52 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.354 -0.841 . . . . 0.0 109.242 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.578 ' O ' ' NE2' ' A' ' 120' ' ' GLN . . . -60.86 113.43 5.59 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -80.24 -6.59 58.1 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.839 -1.389 . . . . 0.0 108.401 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 120' ' ' GLN . 28.8 m-20 -119.14 136.99 53.9 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.53 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 4.3 mptp? -26.04 87.77 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 122.315 1.055 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 116' ' ' GLY . 5.9 pt20 -89.04 161.16 16.71 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.05 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.405 HD21 HD21 ' A' ' 123' ' ' LEU . 59.7 tp -133.35 109.01 9.06 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.8 m -94.24 92.18 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.181 -0.949 . . . . 0.0 109.909 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.405 HD21 HD21 ' A' ' 121' ' ' LEU . 30.3 mt -74.98 148.02 40.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.915 . . . . 0.0 109.131 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.1 mt -138.74 143.27 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.213 -0.929 . . . . 0.0 109.628 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -105.49 155.67 18.95 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.341 -0.85 . . . . 0.0 108.726 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 127' ' ' ASP . 66.7 m -145.81 155.92 43.23 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.93 -1.106 . . . . 0.0 109.383 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 0.5 OUTLIER 170.49 140.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.277 -0.89 . . . . 0.0 109.56 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.532 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.4 OUTLIER 56.89 63.16 2.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.688 -0.633 . . . . 0.0 109.334 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -61.71 120.57 10.91 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.872 -1.142 . . . . 0.0 108.525 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -85.14 111.41 19.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.873 -1.142 . . . . 0.0 109.896 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.4 4.83 9.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.357 -0.839 . . . . 0.0 109.751 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.34 -53.83 6.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.0 p -96.48 -8.19 32.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.315 -0.866 . . . . 0.0 109.195 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.62 41.37 43.71 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.71 155.55 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.224 -1.162 . . . . 0.0 110.035 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.442 ' O ' ' C ' ' A' ' 137' ' ' GLU . 63.0 m95 -61.85 112.6 2.36 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 136' ' ' TRP . 48.4 tt0 -38.08 -78.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.702 -0.624 . . . . 0.0 110.016 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 10.4 mtpp -89.92 137.91 31.94 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -152.54 108.24 3.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.909 -1.119 . . . . 0.0 110.524 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.518 ' HZ3' ' HB2' ' A' ' 140' ' ' LYS . 3.8 mtmp? -109.84 133.81 52.75 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 17.5 mm -104.81 129.53 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.0 110.895 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -117.4 160.09 21.72 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.5 t -145.72 149.75 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.715 -1.24 . . . . 0.0 110.876 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -145.75 179.3 7.54 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.6 t -161.37 156.38 23.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.575 -1.328 . . . . 0.0 111.309 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 148' ' ' LYS . 41.9 tt0 -60.25 135.05 57.61 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.312 0.577 . . . . 0.0 110.059 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 64.5 t -91.01 -18.33 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 122.01 0.909 . . . . 0.0 109.426 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.425 ' H ' ' HG2' ' A' ' 146' ' ' GLU . 52.1 mmtt . . . . . 0 C--N 1.288 -2.078 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.539 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.328 0.585 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -50.14 143.86 7.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -0.958 . . . . 0.0 109.511 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.37 -170.19 3.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.0 109.263 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -54.65 142.44 52.75 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.915 . . . . 0.0 109.08 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.39 -110.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.299 1.999 . . . . 0.0 111.843 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -101.05 116.26 32.42 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.34 -0.85 . . . . 0.0 109.721 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 mt -149.41 95.06 3.83 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.34 152.43 3.79 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.332 2.022 . . . . 0.0 112.667 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -93.08 -17.08 24.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.265 -0.897 . . . . 0.0 108.885 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 12' ' ' SER . 36.2 t0 -77.58 106.03 9.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.453 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.9 OUTLIER -58.01 -5.45 0.44 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.386 -0.821 . . . . 0.0 109.627 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 10' ' ' ASP . 13.6 t -103.19 39.25 1.6 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.364 -0.835 . . . . 0.0 109.751 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -147.76 132.91 18.33 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.301 -0.874 . . . . 0.0 109.71 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.51 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 38.8 t -61.31 132.21 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 110.515 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.56 -16.3 20.12 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -176.7 -162.76 27.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 87.0 m-85 -148.89 128.78 13.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.251 -1.146 . . . . 0.0 109.687 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.3 tt -98.72 144.67 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -144.27 147.45 33.57 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.874 -1.141 . . . . 0.0 110.75 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mt -149.68 131.88 7.82 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.52 -50.93 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.936 1.757 . . . . 0.0 112.0 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -51.19 -20.98 1.75 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.373 -0.829 . . . . 0.0 109.406 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' HB1' ' OD1' ' A' ' 74' ' ' ASN . . . -118.46 3.31 11.84 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ALA . 1.5 p30 40.91 38.86 0.72 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.542 0.687 . . . . 0.0 109.848 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG23 ' OE2' ' A' ' 27' ' ' GLU . 3.3 mt -98.08 155.05 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.86 0.838 . . . . 0.0 110.47 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -162.49 69.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.467 ' OE2' HG23 ' A' ' 25' ' ' ILE . 11.2 mt-10 -100.56 150.2 36.77 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.582 -0.699 . . . . 0.0 112.495 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -87.98 159.96 7.34 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.844 2.363 . . . . 0.0 111.608 177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.71 130.55 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.117 -0.989 . . . . 0.0 109.646 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -94.42 155.92 39.2 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.881 -1.137 . . . . 0.0 108.888 179.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -81.59 95.12 0.92 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.311 2.007 . . . . 0.0 111.786 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.88 -177.66 39.86 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.336 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 89.0 Cg_endo -81.64 116.99 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.915 2.41 . . . . 0.0 111.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.46 87.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.331 0.586 . . . . 0.0 110.335 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -112.85 153.35 45.19 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.44 -45.04 19.63 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.07 1.847 . . . . 0.0 111.433 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.54 -19.04 64.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -0.874 . . . . 0.0 109.417 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 40' ' ' ASN . 6.7 tp60 -93.02 -69.35 0.75 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.351 -0.843 . . . . 0.0 109.708 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 18.7 mt -45.37 -17.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -0.921 . . . . 0.0 109.754 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 38' ' ' GLN . 13.7 m-20 -61.81 -24.92 67.18 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.415 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.6 mtt180 -85.56 -12.97 50.3 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.76 -110.64 0.45 Allowed Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.737 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.9 t -131.64 156.79 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 121.383 -1.069 . . . . 0.0 109.395 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.7 t -153.04 154.33 34.69 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.228 -0.92 . . . . 0.0 108.749 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -56.31 171.69 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.416 -1.314 . . . . 0.0 108.926 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -78.46 -26.28 46.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 109.517 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -135.15 150.24 50.13 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.451 -0.781 . . . . 0.0 109.635 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.52 -32.77 72.82 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.626 -0.671 . . . . 0.0 111.456 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -85.93 11.32 11.68 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.885 -1.135 . . . . 0.0 110.81 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 58' ' ' SER . 1.4 tt0 -63.96 147.1 52.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.906 -1.121 . . . . 0.0 109.935 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.421 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 2.7 p -147.99 151.76 36.32 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -65.94 -5.52 9.6 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 51' ' ' SER . 13.7 t70 -91.58 -22.51 20.28 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 52.7 m-20 -60.11 100.67 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.199 -0.938 . . . . 0.0 108.861 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.551 HE22 ' H ' ' A' ' 117' ' ' LYS . 9.0 tt0 -42.98 -20.16 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.518 -0.739 . . . . 0.0 109.519 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 22.1 t-20 -116.89 97.64 6.07 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.8 mt -95.8 146.8 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.161 -0.962 . . . . 0.0 109.765 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 46' ' ' ALA . 10.6 m -144.66 109.61 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 mt -108.82 167.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.374 -0.828 . . . . 0.0 109.948 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -142.96 135.17 27.26 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.38 157.9 27.1 Favored Glycine 0 N--CA 1.503 3.127 0 C-N-CA 119.838 -1.172 . . . . 0.0 110.835 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.422 ' H ' ' HG2' ' A' ' 71' ' ' GLN . 25.9 m-70 -73.67 -173.05 1.38 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.608 -0.937 . . . . 0.0 110.562 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -174.9 77.61 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.334 -0.854 . . . . 0.0 109.862 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -88.7 119.05 28.82 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.888 -1.133 . . . . 0.0 108.977 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 65' ' ' ILE . 14.6 mt -61.09 -26.62 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.453 -0.779 . . . . 0.0 110.365 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.15 14.78 2.68 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.628 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' O ' ' N ' ' A' ' 69' ' ' ASN . 83.0 mtt180 -150.77 76.66 8.06 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.675 -0.641 . . . . 0.0 109.407 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.6 12.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.139 0 C-N-CA 123.657 2.905 . . . . 0.0 114.021 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.585 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -146.5 52.62 1.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.892 -1.13 . . . . 0.0 108.125 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 15.7 t80 -136.93 100.72 4.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.411 -0.805 . . . . 0.0 109.96 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 12.1 mp0 54.86 -125.04 2.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.625 -0.672 . . . . 0.0 110.722 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.871 ' CE2' HD13 ' A' ' 75' ' ' LEU . 4.9 m-85 -90.23 34.08 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.685 -1.259 . . . . 0.0 110.092 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.4 m -57.55 -26.65 61.74 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.357 -1.464 . . . . 0.0 109.477 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.4 p30 -140.55 4.15 1.94 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.22 -0.925 . . . . 0.0 109.907 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 72' ' ' PHE . 9.2 tt -55.2 -21.63 14.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.853 -1.154 . . . . 0.0 107.929 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' NZ ' ' O ' ' A' ' 72' ' ' PHE . 14.2 mtmm -82.77 -18.54 40.29 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -62.29 -22.84 66.34 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -54.62 -169.9 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 81' ' ' GLY . 4.5 ptpt -154.58 157.52 38.37 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.162 -0.961 . . . . 0.0 109.223 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.479 ' NZ ' ' CB ' ' A' ' 80' ' ' LYS . 5.3 ttpm? -52.2 88.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 109.543 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 153.42 -14.75 0.64 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -64.42 119.12 9.78 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.545 -0.974 . . . . 0.0 108.774 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 58.3 mmm -73.51 179.89 3.83 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.393 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 85' ' ' TYR . 22.0 t -146.26 161.74 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.152 -0.967 . . . . 0.0 109.231 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.442 ' N ' HG12 ' A' ' 84' ' ' VAL . 77.9 m-85 -147.67 103.13 3.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.345 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -94.58 111.99 23.75 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -95.55 144.83 25.69 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.258 -0.901 . . . . 0.0 110.13 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.6 t -146.1 96.83 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.52 -0.738 . . . . 0.0 109.134 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 48.62 -131.35 21.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -82.22 52.54 2.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.154 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -162.25 143.44 10.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.271 -0.893 . . . . 0.0 109.14 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.4 m -152.87 146.95 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.115 -0.991 . . . . 0.0 109.987 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 177.99 7.87 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.475 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 23.9 pttm -144.28 161.09 39.82 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.091 -1.006 . . . . 0.0 110.351 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 10.9 m-85 -141.35 -179.79 6.34 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -147.13 130.54 16.68 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.935 -1.103 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.443 ' SD ' ' O ' ' A' ' 79' ' ' LYS . 12.9 mtt -48.51 150.86 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.394 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 97' ' ' MET . 14.9 m -166.28 1.34 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.161 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 t -168.5 124.08 0.96 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.25 -0.906 . . . . 0.0 109.141 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.8 mt -137.09 132.0 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 103' ' ' VAL . 82.5 mtt180 -100.62 -66.54 0.9 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.474 -0.766 . . . . 0.0 109.398 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 102' ' ' ASP . 63.9 t0 46.9 17.06 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.221 -0.924 . . . . 0.0 109.214 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 101' ' ' ARG . 53.6 t -134.43 -10.12 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.457 ' NZ ' HH12 ' A' ' 139' ' ' ARG . 6.0 ttmm 55.72 56.53 10.12 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.454 -0.779 . . . . 0.0 109.856 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.0 -54.84 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.861 2.374 . . . . 0.0 111.425 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -84.56 -35.68 22.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.447 -0.783 . . . . 0.0 109.063 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 0.3 OUTLIER 65.54 -58.44 0.3 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.781 -0.574 . . . . 0.0 109.491 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 106' ' ' THR . 31.2 m -95.88 33.74 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.152 -0.967 . . . . 0.0 109.801 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.43 15.12 6.8 Favored Glycine 0 N--CA 1.502 3.078 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.465 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 60.9 t -71.76 -34.67 52.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 120.933 -1.334 . . . . 0.0 108.511 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.407 HD12 ' HB ' ' A' ' 110' ' ' VAL . 1.6 mp -137.07 72.72 1.42 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -172.65 22.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.468 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -163.42 29.19 0.09 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.244 -0.91 . . . . 0.0 109.055 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 110' ' ' VAL . 35.0 mt-30 -134.4 8.93 3.69 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.43 -65.91 0.72 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.18 64.69 4.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.551 ' H ' HE22 ' A' ' 55' ' ' GLN . 33.3 tttt -143.95 -154.51 0.53 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.315 -1.109 . . . . 0.0 108.522 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 119' ' ' LYS . 97.6 m-20 -106.18 160.29 15.44 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.276 -0.89 . . . . 0.0 108.859 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' ASP . 57.5 mttp -44.69 126.78 5.81 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.36 -0.837 . . . . 0.0 109.334 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.589 ' N ' ' OE1' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -149.37 168.24 23.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.335 -0.853 . . . . 0.0 109.983 -179.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 143' ' ' VAL . 26.8 mt -116.71 154.0 31.37 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.552 0.691 . . . . 0.0 110.321 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.0 m -140.48 86.41 2.06 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.45 159.68 19.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.127 -0.983 . . . . 0.0 111.175 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 23.9 mt -140.14 126.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.7 p -90.31 118.7 30.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.767 -1.208 . . . . 0.0 109.025 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 23.1 m -99.1 154.2 18.31 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.619 -0.676 . . . . 0.0 110.129 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.1 t70 179.87 132.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 109.073 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.2 t0 59.76 72.27 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.499 -0.751 . . . . 0.0 109.331 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -65.27 122.27 16.73 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.982 -1.074 . . . . 0.0 109.575 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 10.0 p30 -85.7 129.47 34.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.893 -1.129 . . . . 0.0 109.476 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -91.25 4.84 51.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.298 -0.876 . . . . 0.0 108.962 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -71.96 -62.44 1.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.408 -0.807 . . . . 0.0 109.088 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 p -98.49 -3.16 37.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.472 -0.767 . . . . 0.0 109.314 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.67 47.78 19.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.54 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 2.9 t -146.79 169.57 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -1.076 . . . . 0.0 109.329 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 73.4 m95 -73.2 114.19 11.11 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.177 -0.952 . . . . 0.0 108.943 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.6 tp10 -35.55 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.081 0.467 . . . . 0.0 110.727 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -120.13 150.42 40.64 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.608 -0.682 . . . . 0.0 109.566 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.1 OUTLIER -166.96 164.91 16.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -130.41 133.19 46.17 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.499 -0.75 . . . . 0.0 109.1 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.4 mm -94.54 146.54 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.203 -0.936 . . . . 0.0 109.949 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.46 140.93 25.41 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.533 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 5.9 t -133.07 147.15 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.271 -0.893 . . . . 0.0 110.752 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.41 144.65 33.19 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.7 t -118.3 148.89 42.0 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.278 -0.888 . . . . 0.0 110.295 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 147' ' ' VAL . 7.7 tp10 -61.93 137.24 58.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.62 -0.675 . . . . 0.0 109.407 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.52 ' N ' ' OE1' ' A' ' 146' ' ' GLU . 4.3 m -93.11 -175.46 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.95 . . . . 0.0 109.358 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.427 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 mtm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -159.82 117.98 2.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.892 . . . . 0.0 109.393 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.01 75.48 10.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 109.683 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.8 pttt -67.73 155.86 90.46 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 108.956 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 4' ' ' LYS . 71.0 Cg_exo -50.79 -160.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.053 1.835 . . . . 0.0 112.35 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -99.35 101.95 13.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.087 -1.008 . . . . 0.0 110.067 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.9 mt -88.38 113.39 55.1 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.439 -0.788 . . . . 0.0 109.255 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -44.21 118.94 1.86 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.595 1.53 . . . . 0.0 112.065 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -73.68 -18.61 60.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.945 . . . . 0.0 109.371 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -77.94 106.38 9.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 109.354 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -57.04 -10.6 1.19 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.133 -0.979 . . . . 0.0 109.571 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -94.26 27.2 2.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.186 -0.946 . . . . 0.0 109.771 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -141.52 131.64 24.77 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.317 -0.865 . . . . 0.0 109.481 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 16' ' ' GLY . 44.7 t -61.84 142.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.472 -0.768 . . . . 0.0 110.708 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.55 -23.78 14.97 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.496 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -174.2 -163.25 27.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 16' ' ' GLY . 34.7 m-85 -149.88 130.84 14.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 0.0 109.539 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tt -95.62 144.24 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -146.04 142.09 28.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.037 -1.039 . . . . 0.0 110.343 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 ' CD2' ' A' ' 75' ' ' LEU . 12.5 mt -150.13 132.23 7.87 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.09 -49.28 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.883 1.722 . . . . 0.0 111.882 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -51.75 -30.02 21.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.367 -0.833 . . . . 0.0 109.601 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -106.67 3.29 26.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.371 -0.83 . . . . 0.0 108.895 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.1 p30 43.61 30.19 0.33 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.581 0.705 . . . . 0.0 109.752 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.6 mt -93.28 147.66 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.898 0.856 . . . . 0.0 109.79 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -165.35 84.51 0.37 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -132.84 159.36 72.88 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.327 -0.858 . . . . 0.0 111.052 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.21 163.59 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.273 2.649 . . . . 0.0 113.32 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 m -130.79 132.54 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 42.2 m-85 -87.44 146.18 39.12 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 120.818 -1.176 . . . . 0.0 109.872 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -82.52 88.83 1.23 Allowed 'Trans proline' 0 C--N 1.316 -1.135 0 C-N-CA 121.909 1.739 . . . . 0.0 111.365 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.19 -170.97 34.41 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.522 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 95.6 Cg_endo -81.11 117.97 3.27 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.883 2.389 . . . . 0.0 111.513 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -46.03 87.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.301 0.572 . . . . 0.0 110.724 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.7 OUTLIER -110.6 155.76 41.62 Favored Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 178.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 56.8 Cg_endo -69.93 -44.15 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.223 1.949 . . . . 0.0 112.036 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -62.93 -26.2 68.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.794 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.618 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -84.12 -62.62 1.52 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.159 -0.963 . . . . 0.0 109.039 -179.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -49.28 -11.99 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.135 -0.978 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.3 m120 -61.93 -27.75 69.05 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.433 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 49.2 mtp180 -91.4 -10.88 39.49 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.504 ' C ' HE22 ' A' ' 71' ' ' GLN . . . 164.12 -139.45 5.86 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.259 -1.448 . . . . 0.0 111.109 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.6 t -110.67 164.59 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.438 -1.037 . . . . 0.0 109.329 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -158.86 157.14 30.93 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.182 -0.949 . . . . 0.0 108.623 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.536 ' CE2' ' OE1' ' A' ' 50' ' ' GLU . 46.9 m-85 -58.04 175.92 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.863 -1.148 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -89.0 -3.35 58.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.457 -0.777 . . . . 0.0 109.126 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -153.97 145.82 23.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.287 -0.883 . . . . 0.0 109.966 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -62.49 -31.17 71.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.554 -0.716 . . . . 0.0 110.87 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -86.86 6.94 29.33 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.953 -1.092 . . . . 0.0 110.893 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE1' ' CE2' ' A' ' 45' ' ' PHE . 11.9 tm-20 -61.79 152.19 32.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.78 -1.2 . . . . 0.0 109.33 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' ASP . 76.5 p -146.32 163.38 35.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.017 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -74.54 10.64 1.25 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' SER . 0.9 OUTLIER -124.0 -6.25 7.86 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.838 -0.539 . . . . 0.0 109.751 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 56' ' ' ASN . 9.7 t70 -59.73 113.9 2.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.859 -1.15 . . . . 0.0 109.308 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -45.4 -18.59 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.277 -0.889 . . . . 0.0 109.631 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' OE1' ' A' ' 55' ' ' GLN . 4.0 m120 -133.27 98.66 4.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.498 -0.751 . . . . 0.0 109.051 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 122' ' ' THR . 96.1 mt -96.68 113.31 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.283 -0.886 . . . . 0.0 109.698 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 46' ' ' ALA . 2.5 m -108.6 120.23 41.83 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 60' ' ' ALA . 87.1 mt -107.21 164.45 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.473 -0.767 . . . . 0.0 110.226 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.571 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.99 124.61 23.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.65 152.4 22.07 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 119.932 -1.128 . . . . 0.0 110.748 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.499 ' O ' ' N ' ' A' ' 72' ' ' PHE . 34.0 m-70 -72.72 -179.93 3.32 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.758 -0.848 . . . . 0.0 110.024 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.22 88.45 0.52 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.02 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -87.51 123.68 32.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.042 -1.036 . . . . 0.0 109.06 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 65' ' ' ILE . 6.6 mt -63.76 -33.93 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.563 -0.71 . . . . 0.0 110.589 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -82.97 8.17 13.43 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 110.122 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 69' ' ' ASN . 21.7 mmt180 -140.72 75.28 25.92 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 87.7 Cg_exo -48.64 5.68 0.01 OUTLIER 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 123.621 2.881 . . . . 0.0 113.844 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 67' ' ' ARG . 6.8 p30 -143.64 59.42 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.95 -1.094 . . . . 0.0 108.165 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -134.66 95.97 3.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.582 -0.699 . . . . 0.0 110.355 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.504 HE22 ' C ' ' A' ' 42' ' ' GLY . 1.1 mm100 61.0 -114.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.851 -0.53 . . . . 0.0 111.815 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.649 ' CE2' HG22 ' A' ' 125' ' ' THR . 2.3 t80 -91.93 26.85 2.29 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.138 -0.976 . . . . 0.0 110.803 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.1 m -69.22 -38.74 78.69 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.87 -1.144 . . . . 0.0 110.445 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 15.6 m-20 -108.49 -17.0 14.09 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.226 -0.921 . . . . 0.0 111.072 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' CD2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -53.16 -25.33 13.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.729 -1.232 . . . . 0.0 108.36 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -81.88 -14.35 56.34 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -78.4 -16.57 57.49 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.03 -162.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -174.32 174.97 2.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.247 -0.908 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -48.85 149.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.028 -1.045 . . . . 0.0 109.377 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 -11.27 7.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 57.8 m -62.21 94.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.117 -1.225 . . . . 0.0 108.64 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.1 ptm -66.32 162.19 20.75 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.195 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.82 174.3 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.441 -0.787 . . . . 0.0 109.865 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -144.71 108.83 4.77 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.261 -0.899 . . . . 0.0 110.001 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -95.09 113.37 25.06 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -96.49 144.37 26.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 110.301 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.414 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 18.3 t -143.02 86.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.36 -133.37 42.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -81.86 37.23 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.122 -1.223 . . . . 0.0 109.587 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' OE1' ' O ' ' A' ' 88' ' ' VAL . 21.1 mp0 -138.81 151.98 47.5 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.268 -0.895 . . . . 0.0 108.916 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.6 m -152.97 143.82 22.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.093 -1.005 . . . . 0.0 110.099 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.421 HH11 ' HG3' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -144.33 170.61 15.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.413 -0.805 . . . . 0.0 108.98 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 24.8 pttm -142.87 162.0 36.63 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.194 -0.941 . . . . 0.0 109.769 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 5.9 m-85 -139.35 -175.67 4.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -136.79 110.58 8.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.241 -0.912 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 36.0 tpp -50.89 104.56 0.08 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.431 -0.793 . . . . 0.0 109.05 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -143.84 35.32 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 0.0 109.29 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 143' ' ' VAL . 16.5 t -173.67 131.91 0.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.2 mt -138.64 144.57 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -0.9 . . . . 0.0 109.008 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.0 OUTLIER -119.83 1.04 10.98 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -67.88 45.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 108.757 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 101' ' ' ARG . 7.4 p -157.07 -21.62 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -166.48 62.2 0.7 Allowed Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.558 ' C ' ' H ' ' A' ' 107' ' ' ASP . 89.5 Cg_endo -76.4 -49.21 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.949 2.433 . . . . 0.0 113.053 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.552 HG23 ' C ' ' A' ' 105' ' ' PRO . 1.3 p 69.15 -27.58 0.15 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 105' ' ' PRO . 1.4 m-20 67.6 -43.27 0.46 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.157 -0.965 . . . . 0.0 109.505 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 106' ' ' THR . 26.9 m -76.33 26.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.193 -0.942 . . . . 0.0 109.26 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -153.18 -21.69 0.05 OUTLIER Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.407 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.5 t -67.51 -22.81 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.919 -1.342 . . . . 0.0 108.887 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.8 mt -138.67 79.95 1.76 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.624 -0.672 . . . . 0.0 109.243 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -162.65 -34.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.176 -0.952 . . . . 0.0 109.732 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -179.81 30.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 116' ' ' GLY . 8.9 tt0 -91.55 23.77 3.34 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' C ' HE22 ' A' ' 120' ' ' GLN . 19.8 pttp -50.69 -9.68 0.05 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . 49.87 -97.25 0.01 OUTLIER Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 115' ' ' LYS . 32.5 pttt -146.59 -45.03 0.19 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -1.112 . . . . 0.0 109.564 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -118.73 167.68 11.45 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.487 -0.758 . . . . 0.0 109.525 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 119' ' ' LYS . 12.2 mptt -46.29 162.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.529 HE22 ' C ' ' A' ' 115' ' ' LYS . 3.7 pt20 -157.18 145.0 19.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.11 -0.994 . . . . 0.0 109.154 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.2 tp -103.57 107.56 18.46 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.495 -0.753 . . . . 0.0 110.107 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 57' ' ' ILE . 10.5 m -92.54 146.76 23.43 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.8 mt -130.62 152.24 50.2 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.284 -0.885 . . . . 0.0 110.489 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 32.0 mt -141.3 134.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.649 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.1 p -92.21 160.61 15.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.932 -1.105 . . . . 0.0 108.423 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 56.6 m -144.97 140.1 27.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.06 -1.025 . . . . 0.0 109.943 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 2.0 p30 175.65 139.39 0.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 62.43 58.76 1.65 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.26 -0.9 . . . . 0.0 108.887 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.99 126.62 27.99 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.144 -0.973 . . . . 0.0 109.444 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -85.9 116.99 24.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.131 -0.981 . . . . 0.0 109.695 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -84.18 1.38 44.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -81.22 -52.18 7.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.215 -0.928 . . . . 0.0 109.328 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.6 p -95.65 -15.06 22.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 0.0 109.354 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.27 42.31 15.35 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -147.14 153.24 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.345 -1.091 . . . . 0.0 109.509 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.424 ' O ' ' C ' ' A' ' 137' ' ' GLU . 69.2 m95 -59.25 112.55 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 136' ' ' TRP . 23.1 tt0 -35.24 -84.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.201 0.524 . . . . 0.0 111.003 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -107.06 157.45 17.82 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.394 -0.816 . . . . 0.0 109.473 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -174.84 161.02 2.99 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.882 . . . . 0.0 109.691 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -127.67 153.31 46.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 35.0 mm -115.91 139.12 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 121.583 0.706 . . . . 0.0 110.61 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -136.57 159.12 42.76 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 99' ' ' SER . 59.4 t -148.08 149.29 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.776 -1.202 . . . . 0.0 110.896 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.67 134.24 30.11 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.3 t -95.68 143.43 26.95 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.023 -1.048 . . . . 0.0 110.012 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 3.3 tm-20 -60.22 145.76 46.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.83 . . . . 0.0 109.334 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 1.8 t -91.47 -142.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.172 -0.955 . . . . 0.0 109.337 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.475 ' H ' HG12 ' A' ' 147' ' ' VAL . 41.5 mtmt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.464 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.584 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.6 mpp? . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.348 0.594 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -159.74 91.07 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.841 . . . . 0.0 109.033 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.83 32.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.986 . . . . 0.0 109.812 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.533 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 47.8 pttt -135.62 48.02 2.51 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.413 -0.805 . . . . 0.0 109.967 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 42.4 Cg_endo -66.0 -160.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.637 2.224 . . . . 0.0 111.802 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -79.58 119.62 22.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 0.0 109.617 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 7' ' ' ILE . 11.9 mt -150.58 101.68 3.09 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.307 -0.871 . . . . 0.0 108.813 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -43.85 136.37 7.16 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.844 1.696 . . . . 0.0 112.196 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -87.44 -28.72 21.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.13 -0.981 . . . . 0.0 109.873 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.04 113.28 14.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.807 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -58.2 -11.78 2.97 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.328 -0.857 . . . . 0.0 109.626 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -79.95 21.04 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -147.51 136.16 21.89 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.057 -1.027 . . . . 0.0 109.659 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 15' ' ' ALA . 61.3 t -60.36 161.86 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.699 0.761 . . . . 0.0 110.223 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.553 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -136.13 -9.58 2.01 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -172.05 -179.16 42.8 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.6 120.11 7.44 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.99 -1.3 . . . . 0.0 109.172 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 tt -97.04 140.33 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -146.23 138.89 25.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.105 -0.997 . . . . 0.0 110.081 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' CG2' ' OG ' ' A' ' 82' ' ' SER . 8.3 mt -146.4 127.13 7.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -76.6 -44.22 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.742 1.628 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.24 -17.67 0.75 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.293 -0.88 . . . . 0.0 109.819 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -134.36 17.55 3.69 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.168 -0.958 . . . . 0.0 109.379 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.71 48.4 4.81 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.682 0.753 . . . . 0.0 109.912 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 23' ' ' ALA . 48.3 mm -88.89 141.42 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 121.655 0.741 . . . . 0.0 109.543 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.31 82.69 0.17 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 19.2 mm-40 -143.13 156.78 61.39 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.139 -0.976 . . . . 0.0 110.561 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -83.49 165.72 14.12 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.888 2.392 . . . . 0.0 112.301 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.1 109.23 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -65.84 139.51 96.88 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.705 -1.247 . . . . 0.0 109.1 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.53 109.23 2.59 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.824 1.682 . . . . 0.0 111.904 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.54 -174.47 39.76 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.432 -1.366 . . . . 0.0 110.135 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.562 ' O ' ' N ' ' A' ' 35' ' ' THR . 74.3 Cg_endo -76.75 113.93 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.576 2.184 . . . . 0.0 110.969 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -44.58 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.438 0.637 . . . . 0.0 111.151 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.24 169.35 8.08 Favored Pre-proline 0 N--CA 1.494 1.773 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.56 -27.53 3.29 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 121.632 1.555 . . . . 0.0 112.42 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.48 -33.66 75.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.672 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -89.85 -51.7 5.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.432 -0.792 . . . . 0.0 109.231 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 39' ' ' LEU . 18.8 mt -46.88 -30.45 2.53 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.473 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -65.01 -27.32 68.74 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 38' ' ' GLN . 89.0 mtt180 -84.5 -19.61 32.98 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.67 -140.77 6.35 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.311 -1.424 . . . . 0.0 110.754 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.0 t -107.32 164.69 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.708 -0.878 . . . . 0.0 108.799 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.672 ' CB ' HE22 ' A' ' 38' ' ' GLN . 35.5 t -163.24 157.53 20.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.959 -1.088 . . . . 0.0 109.194 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 37.3 m-85 -59.67 161.86 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.791 -1.193 . . . . 0.0 109.354 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.56 5.28 36.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.164 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -162.39 142.03 9.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.717 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.99 -23.64 67.54 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.645 -0.659 . . . . 0.0 111.529 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -87.1 4.84 40.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.878 -1.139 . . . . 0.0 110.728 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 0.8 OUTLIER -62.68 157.15 21.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.081 -1.012 . . . . 0.0 109.429 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.532 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -143.99 179.51 7.15 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.986 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.3 OUTLIER -83.75 4.24 29.75 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.18 -0.95 . . . . 0.0 108.921 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -146.07 16.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.292 -0.88 . . . . 0.0 110.512 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 56' ' ' ASN . 11.2 t70 -58.26 115.24 2.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.681 -1.262 . . . . 0.0 108.779 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.435 HE22 ' HG3' ' A' ' 114' ' ' GLN . 1.1 pt20 -43.51 -19.36 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.319 -0.863 . . . . 0.0 109.939 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 112' ' ' ASP . 21.6 t-20 -135.17 97.24 3.67 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.6 mt -94.85 151.15 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 0.0 109.347 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 38.7 m -143.64 116.84 8.97 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.7 mt -112.59 162.57 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 121.738 0.78 . . . . 0.0 110.601 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -132.78 131.76 41.48 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.24 148.3 19.98 Favored Glycine 0 N--CA 1.505 3.286 0 C-N-CA 119.784 -1.198 . . . . 0.0 111.323 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.72 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 41.5 m-70 -76.3 -169.89 1.31 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.646 -0.914 . . . . 0.0 110.422 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 63' ' ' THR . 14.7 t -158.82 83.44 0.81 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.75 0.786 . . . . 0.0 108.971 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -88.56 108.51 19.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.712 -1.243 . . . . 0.0 109.462 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.2 mm -60.06 -28.4 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.394 -0.816 . . . . 0.0 110.44 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -86.97 16.52 4.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 69' ' ' ASN . 33.2 ttm180 -150.56 72.99 9.02 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -49.81 14.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.505 2.189 0 C-N-CA 123.909 3.073 . . . . 0.0 114.325 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.568 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.8 p30 -148.47 62.63 1.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.802 -1.186 . . . . 0.0 108.572 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -151.47 98.79 2.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.72 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 4.1 mt-30 60.99 -127.25 0.9 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.513 -0.742 . . . . 0.0 111.179 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.71 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 0.8 OUTLIER -92.01 59.08 3.51 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.682 1.23 . . . . 0.0 109.574 -178.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.7 m -91.17 -24.77 19.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.202 -1.561 . . . . 0.0 108.632 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.491 ' C ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -136.77 -0.97 2.28 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 -178.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -10.22 0.28 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.403 -1.435 . . . . 0.0 108.042 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' N ' ' C ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -77.48 -37.59 50.95 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.27 -27.6 69.13 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.06 -175.83 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -175.11 171.51 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 109.919 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -51.14 101.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.343 -0.848 . . . . 0.0 109.449 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.5 -29.85 2.46 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.444 ' OG ' ' CG2' ' A' ' 20' ' ' ILE . 14.1 t -62.81 108.07 1.11 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 71.2 mtp -62.83 174.99 0.91 Allowed 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.642 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 t -143.09 108.42 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.218 -0.926 . . . . 0.0 109.07 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -90.97 104.91 17.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 109.942 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -94.53 111.94 23.7 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -102.01 144.64 30.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.321 -0.862 . . . . 0.0 110.459 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 15' ' ' ALA . 4.7 p -170.24 128.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.557 -0.714 . . . . 0.0 109.268 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.19 -120.42 19.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -124.19 35.05 4.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.575 -0.956 . . . . 0.0 109.117 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -150.3 133.61 16.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.363 -0.836 . . . . 0.0 108.944 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.8 t -119.01 133.91 55.53 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.674 0.749 . . . . 0.0 110.172 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.4 mmm180 -94.89 172.07 8.38 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -147.53 96.51 2.7 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.915 -1.116 . . . . 0.0 110.226 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 24.7 m-85 -87.57 -173.72 4.47 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.015 -1.053 . . . . 0.0 108.594 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER -150.25 111.55 4.41 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.138 -0.976 . . . . 0.0 109.886 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 60.6 mtp -48.67 117.27 1.95 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.326 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -158.54 21.11 0.23 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.053 -1.029 . . . . 0.0 109.555 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 11.2 p -167.83 86.04 0.22 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.635 -1.291 . . . . 0.0 109.299 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.9 mp -79.28 166.29 2.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.491 ' O ' ' O ' ' A' ' 102' ' ' ASP . 3.4 mmp_? -142.98 -5.45 0.88 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.798 -1.189 . . . . 0.0 109.89 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.566 ' CG ' ' H ' ' A' ' 103' ' ' VAL . 41.5 t0 -58.67 -151.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.234 -0.916 . . . . 0.0 108.896 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.566 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 60.6 t 54.18 -85.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 0.0 109.414 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 102' ' ' ASP . 17.5 tptm -126.8 89.26 52.55 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.65 -103.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.895 1.73 . . . . 0.0 112.028 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 37.6 p 44.51 52.97 7.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.232 -0.918 . . . . 0.0 110.0 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -78.73 -118.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.113 -0.992 . . . . 0.0 108.735 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.61 26.51 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 147.04 106.6 0.46 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.8 t -66.23 -33.66 64.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.279 -1.13 . . . . 0.0 108.082 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 49.1 mt -137.82 76.67 1.59 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.528 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -131.02 179.5 5.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.505 -0.747 . . . . 0.0 109.367 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 14.4 mp0 -60.65 -123.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.401 -0.812 . . . . 0.0 109.498 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.557 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -86.45 86.74 7.34 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.531 ' HB3' ' HZ3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -43.3 -17.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.322 -0.861 . . . . 0.0 110.377 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . 141.12 32.8 0.13 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.416 ' CG ' ' H ' ' A' ' 118' ' ' ASP . 10.0 tptm -143.72 -145.04 0.16 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.254 -1.145 . . . . 0.0 110.495 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.499 ' O ' ' C ' ' A' ' 119' ' ' LYS . 33.2 t0 -118.98 171.6 8.13 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 16.8 ttmm -34.54 132.79 0.28 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.91 175.03 11.63 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.6 tp -128.82 102.97 6.78 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.5 m -93.03 87.24 5.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.185 -0.947 . . . . 0.0 109.151 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.82 152.3 40.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.909 -1.119 . . . . 0.0 109.256 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.9 mt -129.03 151.56 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.669 -0.645 . . . . 0.0 109.29 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.422 HG22 ' CD2' ' A' ' 72' ' ' PHE . 52.0 p -96.37 153.3 17.9 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.154 -0.967 . . . . 0.0 108.568 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 5.0 m -146.77 97.88 2.97 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.968 -1.083 . . . . 0.0 109.799 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 127' ' ' ASP . 2.0 p30 -147.25 136.18 22.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 108.75 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 127' ' ' ASP . 1.5 m-20 70.84 64.14 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.446 -0.784 . . . . 0.0 109.576 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -64.99 125.75 25.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.986 -1.071 . . . . 0.0 109.865 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -86.87 125.74 34.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.135 -0.978 . . . . 0.0 109.399 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.72 4.5 47.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.371 -0.831 . . . . 0.0 109.811 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.67 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 109.408 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.8 p -95.21 -3.14 48.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.358 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.37 45.4 54.88 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.83 165.9 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.252 -1.146 . . . . 0.0 109.24 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.431 ' O ' ' C ' ' A' ' 137' ' ' GLU . 81.4 m95 -68.86 114.38 7.13 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.189 -0.945 . . . . 0.0 108.696 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.3 tp10 -35.42 -86.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.24 0.543 . . . . 0.0 110.325 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -103.76 148.86 25.58 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -157.19 138.9 14.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.792 -1.192 . . . . 0.0 110.618 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -99.76 166.35 11.14 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 102' ' ' ASP . 2.3 mt -138.3 132.84 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.435 -0.79 . . . . 0.0 110.157 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -141.34 147.25 37.8 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.529 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 19.2 t -135.94 132.29 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.077 -1.015 . . . . 0.0 111.296 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -105.15 -178.54 3.68 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.0 t -144.85 141.01 28.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.91 -1.119 . . . . 0.0 109.377 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -57.67 147.27 28.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.81 . . . . 0.0 109.555 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 148' ' ' LYS . 17.8 m -91.43 170.89 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.562 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 147' ' ' VAL . 37.6 pttt . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.47 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.522 ' CG ' HE22 ' A' ' 2' ' ' GLN . 11.9 tpt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.522 HE22 ' CG ' ' A' ' 1' ' ' MET . 6.4 mp0 -71.29 106.36 3.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.967 . . . . 0.0 109.292 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.08 120.08 24.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.384 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 40.7 pttt -141.67 41.39 0.4 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.362 -0.836 . . . . 0.0 110.39 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 29.8 Cg_endo -62.44 -157.86 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.325 2.017 . . . . 0.0 111.72 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -79.99 94.57 5.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.98 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.5 mm -141.89 94.15 7.3 Favored Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.08 168.56 0.36 Allowed 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.466 2.111 . . . . 0.0 112.446 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.09 -14.99 16.87 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.401 -0.812 . . . . 0.0 109.176 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 12' ' ' SER . 0.8 OUTLIER -76.71 107.45 9.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.664 -179.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -60.52 -3.44 0.68 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.0 109.293 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 10' ' ' ASP . 80.9 p -116.69 44.23 2.07 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.532 -0.73 . . . . 0.0 109.497 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -150.46 128.13 11.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.32 -0.862 . . . . 0.0 109.262 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 16' ' ' GLY . 39.2 t -55.33 158.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 111.278 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.501 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -140.7 2.39 1.79 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.633 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 173.68 -175.44 46.33 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 67.3 m-85 -150.34 126.74 10.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.109 -1.23 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.443 ' CD1' HD11 ' A' ' 123' ' ' LEU . 13.3 tt -95.66 147.48 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -149.84 134.88 17.94 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.807 -1.183 . . . . 0.0 110.95 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 84' ' ' VAL . 32.4 mt -145.49 124.79 6.81 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.2 -41.19 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.65 1.567 . . . . 0.0 111.724 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -52.92 -17.95 1.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.289 -0.882 . . . . 0.0 109.6 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' ' CG ' ' A' ' 24' ' ' ASP . . . -130.01 13.49 5.73 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.523 -0.736 . . . . 0.0 109.553 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.8 p30 42.23 36.4 0.72 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.614 -0.679 . . . . 0.0 109.999 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.1 mt -90.58 140.97 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -165.92 86.89 0.36 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -137.62 159.15 70.2 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.474 -0.767 . . . . 0.0 110.441 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HB2' HG22 ' A' ' 14' ' ' VAL . 41.4 Cg_endo -85.58 164.0 10.79 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 123.061 2.507 . . . . 0.0 112.952 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -136.18 113.5 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.53 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -91.29 168.34 13.75 Favored Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.776 -1.202 . . . . 0.0 109.801 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.91 124.49 4.47 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.894 2.396 . . . . 0.0 111.831 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.99 170.55 30.11 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.29 -1.434 . . . . 0.0 110.45 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 35' ' ' THR . 98.5 Cg_endo -78.43 117.29 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.79 2.327 . . . . 0.0 111.256 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.79 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.534 -0.729 . . . . 0.0 109.996 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -122.96 155.41 63.94 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 19.5 Cg_endo -58.25 -48.1 17.16 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.902 1.735 . . . . 0.0 111.191 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -63.01 -19.53 64.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.275 -0.89 . . . . 0.0 109.205 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.536 ' C ' ' H ' ' A' ' 40' ' ' ASN . 19.5 tp60 -89.63 -69.51 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.006 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.1 mt -52.57 -3.8 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 109.943 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 38' ' ' GLN . 16.5 m-20 -59.54 -28.62 67.26 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.906 -1.121 . . . . 0.0 108.744 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' CD ' ' O ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -87.79 -18.94 28.23 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.38 -127.52 1.73 Allowed Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.164 -1.493 . . . . 0.0 111.267 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.53 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.8 t -101.66 157.11 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.538 -0.978 . . . . 0.0 109.97 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.3 m -155.58 151.82 28.02 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -56.53 170.2 0.4 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.751 -1.218 . . . . 0.0 109.829 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.43 -3.39 52.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.822 . . . . 0.0 109.06 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -153.57 150.49 28.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.331 -0.855 . . . . 0.0 109.874 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 13.1 pt-20 -62.73 -40.73 98.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.544 -0.722 . . . . 0.0 111.422 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 6.4 t-20 -88.44 18.64 4.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.921 -1.112 . . . . 0.0 111.226 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.427 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 7.7 tp10 -62.92 139.44 58.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.718 -1.238 . . . . 0.0 109.696 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 53' ' ' ASP . 16.1 m -146.51 152.51 39.1 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.82 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -60.39 -5.66 1.24 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 51' ' ' SER . 5.1 m-20 -75.85 -33.08 60.01 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.677 -0.639 . . . . 0.0 109.679 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 56' ' ' ASN . 51.3 m-20 -59.84 111.22 1.38 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.295 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.589 ' CD ' ' H ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -48.41 -14.87 0.07 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.165 -0.959 . . . . 0.0 108.819 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.6 t30 -125.69 108.02 11.13 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.39 117.65 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.009 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.3 m -108.6 108.96 20.04 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.66 161.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.475 -0.766 . . . . 0.0 109.491 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.54 ' HB1' ' SG ' ' A' ' 126' ' ' CYS . . . -132.61 137.29 46.99 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.21 147.86 19.26 Favored Glycine 0 N--CA 1.5 2.965 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.998 -178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.742 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 18.7 m-70 -75.79 -165.52 0.46 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.885 -0.774 . . . . 0.0 110.278 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.95 88.86 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -88.15 108.97 19.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.055 -1.028 . . . . 0.0 109.084 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.4 mt -57.48 -27.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.465 -0.772 . . . . 0.0 109.872 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.6 12.1 5.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.282 -0.887 . . . . 0.0 109.007 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 69' ' ' ASN . 87.1 mtt180 -150.94 74.79 8.42 Favored Pre-proline 0 C--N 1.299 -1.624 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 80.9 Cg_exo -48.62 7.69 0.01 OUTLIER 'Trans proline' 0 N--CA 1.503 2.078 0 C-N-CA 123.629 2.886 . . . . 0.0 113.927 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 67' ' ' ARG . 44.8 p30 -142.21 58.81 1.47 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 71' ' ' GLN . 61.7 t80 -141.49 100.21 3.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.427 -0.796 . . . . 0.0 110.387 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.742 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 5.1 mt-30 60.75 -124.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.512 -0.742 . . . . 0.0 111.245 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.673 ' CG ' ' O ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -91.95 34.72 0.99 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 122.772 1.272 . . . . 0.0 109.297 -178.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.9 m -73.6 -26.66 60.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 119.421 -2.049 . . . . 0.0 108.855 178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 68' ' ' PRO . 22.0 m-20 -133.55 -4.42 2.94 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.266 -0.897 . . . . 0.0 110.775 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.2 tp -52.9 -23.42 7.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.733 -1.229 . . . . 0.0 108.775 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -2.09 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.949 -1.094 . . . . 0.0 108.388 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.56 -33.55 15.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.76 179.56 0.12 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.171 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -148.84 170.77 17.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.16 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -49.14 149.14 2.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -0.937 . . . . 0.0 109.034 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.3 -23.13 23.15 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.991 -1.643 . . . . 0.0 108.991 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.9 t -62.45 103.08 0.37 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 58.2 mmm -62.01 171.25 1.79 Allowed 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.162 -0.962 . . . . 0.0 110.149 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 20' ' ' ILE . 30.1 t -141.38 110.83 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -90.44 102.44 15.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.871 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -95.42 113.7 25.39 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -85.78 143.22 28.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.101 -0.999 . . . . 0.0 110.565 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 t -148.2 84.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.42 -128.04 27.02 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -95.28 37.36 1.18 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.174 -1.192 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 92' ' ' THR . 1.2 tm-20 -163.17 114.76 1.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.076 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' OE2' ' A' ' 91' ' ' GLU . 9.8 t -107.35 147.1 30.75 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.426 -0.797 . . . . 0.0 110.082 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.415 ' HG3' HH11 ' A' ' 93' ' ' ARG . 9.2 mmm-85 -93.7 172.9 7.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.498 -0.751 . . . . 0.0 109.369 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -146.36 92.94 2.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.105 -0.997 . . . . 0.0 109.999 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.431 ' O ' ' SD ' ' A' ' 83' ' ' MET . 22.7 m-85 -87.38 -176.39 5.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.904 -1.122 . . . . 0.0 108.726 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -147.33 107.93 4.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.239 -0.913 . . . . 0.0 109.428 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 23.9 mtt -48.29 117.83 2.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.282 -0.886 . . . . 0.0 109.559 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.451 ' OG1' HG22 ' A' ' 145' ' ' THR . 10.1 p -142.92 8.55 1.68 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.259 -0.901 . . . . 0.0 109.143 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.424 ' O ' ' O ' ' A' ' 143' ' ' VAL . 30.9 t -164.87 107.98 0.87 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 108.646 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 101' ' ' ARG . 55.5 mt -119.51 166.47 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.522 -0.736 . . . . 0.0 109.544 -178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.556 ' N ' HG22 ' A' ' 100' ' ' ILE . 4.2 mmt-85 -131.11 -84.77 0.51 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 102' ' ' ASP . 8.6 t70 44.53 18.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.467 -0.77 . . . . 0.0 109.217 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 103' ' ' VAL . 4.4 p -151.59 114.34 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.409 -0.807 . . . . 0.0 109.257 -179.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt 45.09 60.55 13.02 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 109.515 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -37.25 102.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.935 2.423 . . . . 0.0 112.509 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 0.7 OUTLIER -57.25 -44.1 83.56 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.309 -0.869 . . . . 0.0 109.841 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 106' ' ' THR . 4.4 t0 85.42 27.87 0.06 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 m -60.11 -6.67 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 157.58 85.37 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 110' ' ' VAL . 2.7 m -68.54 -35.2 69.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.242 -1.152 . . . . 0.0 108.48 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.4 mt -139.29 42.45 2.05 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -92.7 125.28 37.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.104 -0.997 . . . . 0.0 109.647 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 113' ' ' GLU . 1.1 pm0 -90.67 16.98 8.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.568 ' NE2' ' N ' ' A' ' 113' ' ' GLU . 1.7 pm0 -148.47 26.25 0.95 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -48.71 -9.38 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.604 -0.685 . . . . 0.0 110.117 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . 92.43 39.04 5.44 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -137.36 -164.25 1.56 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.494 -1.004 . . . . 0.0 109.415 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 120' ' ' GLN . 14.3 t70 -117.55 169.07 9.83 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.499 ' C ' ' O ' ' A' ' 118' ' ' ASP . 18.7 mmmt -26.93 84.73 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 CA-C-O 121.484 0.659 . . . . 0.0 110.842 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.593 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.8 pm0 -99.36 170.03 8.93 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.585 0.707 . . . . 0.0 110.664 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.97 102.5 8.04 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -94.93 87.55 5.0 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.131 -0.981 . . . . 0.0 109.355 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.443 HD11 ' CD1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -81.5 132.53 35.32 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.89 -1.131 . . . . 0.0 109.367 -179.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 125' ' ' THR . 52.7 mt -113.96 159.86 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.501 0.667 . . . . 0.0 109.534 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 ' CG ' ' A' ' 72' ' ' PHE . 80.8 p -97.2 167.24 11.16 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.281 -0.887 . . . . 0.0 109.62 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.551 ' O ' ' ND1' ' A' ' 62' ' ' HIS . 1.7 m -149.96 84.59 1.4 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.153 -0.967 . . . . 0.0 109.348 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 128' ' ' ASP . 15.0 t70 -148.22 129.0 14.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.976 -1.078 . . . . 0.0 108.953 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 4.5 t0 78.92 60.72 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -66.85 127.71 33.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.817 -1.177 . . . . 0.0 110.067 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -85.79 123.71 31.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.07 -1.019 . . . . 0.0 109.501 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.518 ' N ' HD22 ' A' ' 130' ' ' ASN . 19.0 pt-20 -98.39 8.4 44.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.263 -0.898 . . . . 0.0 109.78 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.597 ' H ' ' ND2' ' A' ' 130' ' ' ASN . 33.3 mtpt -86.89 -20.22 27.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.286 -0.884 . . . . 0.0 109.338 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 72.7 p -140.29 0.69 1.72 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.5 49.04 53.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.72 137.79 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -1.156 . . . . 0.0 109.305 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.435 ' O ' ' C ' ' A' ' 137' ' ' GLU . 51.5 m95 -52.6 112.29 0.8 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.934 -1.104 . . . . 0.0 108.43 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 136' ' ' TRP . 8.2 tp10 -37.6 -81.14 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.904 -0.498 . . . . 0.0 110.174 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -103.67 139.15 39.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.524 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.1 OUTLIER -147.25 114.21 6.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.896 -1.128 . . . . 0.0 110.415 -179.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.492 ' N ' ' CD ' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -95.53 166.69 11.73 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.2 pt -147.95 162.42 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.89 -1.131 . . . . 0.0 110.919 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 5.8 m-85 -137.41 150.49 47.69 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 99' ' ' SER . 21.7 t -132.62 111.73 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.179 -0.951 . . . . 0.0 111.161 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.75 177.59 4.94 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.451 HG22 ' OG1' ' A' ' 98' ' ' THR . 14.7 t -144.66 139.35 27.96 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.978 -1.076 . . . . 0.0 109.726 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -59.08 144.81 44.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 147' ' ' VAL . 9.8 m -90.46 166.23 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.382 -0.824 . . . . 0.0 109.603 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.1 mmmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.455 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mmm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -162.02 167.54 24.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.664 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.65 77.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 109.427 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -45.55 108.8 0.83 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.371 -0.83 . . . . 0.0 109.793 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.15 -148.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.192 1.928 . . . . 0.0 111.918 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -66.92 118.73 10.81 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.896 -1.128 . . . . 0.0 110.839 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.6 mt -152.3 98.38 2.91 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -41.6 155.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.807 1.672 . . . . 0.0 112.525 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -102.65 -19.01 14.97 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.0 109.455 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.9 m-20 -77.22 110.31 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -58.0 -3.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.428 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' ASP . 14.8 t -111.99 41.63 1.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.487 -0.758 . . . . 0.0 109.473 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -149.11 133.79 17.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 16' ' ' GLY . 61.5 t -58.86 161.0 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.405 -0.809 . . . . 0.0 110.95 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -139.97 -0.8 1.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 172.73 -173.71 45.54 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 44.2 m-85 -150.09 128.68 12.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.294 -1.121 . . . . 0.0 109.923 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tt -95.0 146.96 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.753 ' C ' HD12 ' A' ' 20' ' ' ILE . 37.9 tt0 -149.79 119.6 7.08 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.819 -1.175 . . . . 0.0 111.171 -179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 19' ' ' GLU . 1.9 mp -131.52 127.12 21.46 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 23' ' ' ALA . 71.9 Cg_endo -76.37 -42.71 0.35 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.53 1.486 . . . . 0.0 111.483 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 40.8 t0 -52.25 -10.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.423 -0.798 . . . . 0.0 109.473 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 21' ' ' PRO . . . -140.59 15.45 2.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ALA . 2.3 p-10 41.68 49.6 3.8 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.078 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 20' ' ' ILE . 40.2 mm -91.27 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 CA-C-O 121.674 0.749 . . . . 0.0 109.71 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -170.27 80.94 0.1 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -142.03 157.52 63.77 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.07 -1.019 . . . . 0.0 110.536 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -83.03 162.0 15.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 123.099 2.533 . . . . 0.0 113.068 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.92 109.23 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.67 168.77 22.92 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 120.753 -1.217 . . . . 0.0 109.505 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -88.21 117.12 1.01 Allowed 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 122.726 2.284 . . . . 0.0 112.032 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.6 175.92 40.91 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.108 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' THR . 80.6 Cg_endo -78.35 115.52 3.71 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.808 2.339 . . . . 0.0 111.271 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -45.95 88.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.611 -0.681 . . . . 0.0 110.084 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.5 p -120.15 152.99 55.29 Favored Pre-proline 0 N--CA 1.498 1.96 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.39 -41.29 79.57 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.985 1.79 . . . . 0.0 111.745 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.13 -22.84 67.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 109.62 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' NE2' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -90.89 -70.31 0.69 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.111 -0.993 . . . . 0.0 109.489 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 39' ' ' LEU . 16.1 mt -43.87 -20.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 109.916 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 38' ' ' GLN . 19.6 m-20 -60.99 -24.17 65.93 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -90.95 -10.73 41.36 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.46 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 155.1 -115.72 0.68 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.524 ' O ' ' CE1' ' A' ' 30' ' ' TYR . 3.6 t -126.16 154.95 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.595 -0.944 . . . . 0.0 109.917 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.526 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 5.1 m -150.68 155.13 38.72 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 41.7 m-85 -56.28 173.88 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.65 -1.281 . . . . 0.0 109.391 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.01 -13.39 58.9 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -146.31 153.19 40.27 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.269 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -63.71 -41.24 98.13 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.525 -0.734 . . . . 0.0 111.394 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -86.92 12.61 10.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.037 -1.039 . . . . 0.0 111.012 -178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.57 90.78 0.05 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.96 -1.087 . . . . 0.0 109.744 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.499 ' C ' ' H ' ' A' ' 53' ' ' ASP . 17.4 m -89.37 151.64 21.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 108.671 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.4 0.67 1.4 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 51' ' ' SER . 45.3 m-20 -95.88 -14.37 23.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.651 -0.656 . . . . 0.0 109.339 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.9 t0 -58.35 119.28 6.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.039 -1.038 . . . . 0.0 109.571 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.41 HE22 ' HA ' ' A' ' 115' ' ' LYS . 4.5 pt20 -45.99 -14.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.72 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.643 ' ND2' HE22 ' A' ' 114' ' ' GLN . 40.5 t30 -145.56 109.95 4.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 0.0 108.97 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.6 mp -95.29 154.9 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 108.98 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.46 ' OG ' HD11 ' A' ' 124' ' ' ILE . 16.6 t -143.67 123.28 13.27 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG22 ' N ' ' A' ' 60' ' ' ALA . 90.2 mt -110.59 162.23 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.453 -0.779 . . . . 0.0 110.597 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.556 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.97 131.12 26.44 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.29 156.34 26.07 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 119.88 -1.153 . . . . 0.0 110.527 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -72.08 177.02 4.63 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.539 -0.977 . . . . 0.0 109.47 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.5 87.16 0.75 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.297 -0.877 . . . . 0.0 109.65 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -90.13 102.69 15.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.292 -0.88 . . . . 0.0 109.191 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 mt -53.02 -23.69 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.401 -0.812 . . . . 0.0 110.218 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.03 13.96 3.08 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.115 -0.99 . . . . 0.0 109.451 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' ASN . 19.5 ttm-85 -152.66 74.95 7.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 109.282 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.43 20.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 123.911 3.074 . . . . 0.0 114.495 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.587 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.22 62.8 0.9 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.893 -1.129 . . . . 0.0 108.609 179.217 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -151.32 123.53 8.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.097 -1.002 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 61.1 mt-30 40.9 -115.85 0.26 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.812 -0.555 . . . . 0.0 111.357 178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -98.03 9.22 43.34 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.207 -0.933 . . . . 0.0 110.866 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.4 m -49.34 -22.25 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.544 -1.347 . . . . 0.0 109.556 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.0 t-20 -119.57 -22.35 6.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.695 -0.628 . . . . 0.0 109.863 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.676 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.7 tm? -53.26 -35.7 60.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.068 -1.02 . . . . 0.0 108.57 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -72.31 -4.37 29.32 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.308 -0.87 . . . . 0.0 108.689 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -89.81 -28.37 19.36 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.6 -172.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -0.767 . . . . 0.0 109.678 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -162.07 -177.64 5.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.882 . . . . 0.0 109.071 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 82' ' ' SER . 26.9 mtmm -49.78 155.89 0.79 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.005 -1.06 . . . . 0.0 109.288 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.75 -18.86 4.48 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 80' ' ' LYS . 73.7 m -63.89 98.93 0.22 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.327 -1.102 . . . . 0.0 108.437 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 8.7 mtm -62.24 -179.32 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.616 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 20' ' ' ILE . 74.2 t -149.2 108.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.412 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -91.15 102.38 15.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.128 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.431 ' CE2' HG11 ' A' ' 88' ' ' VAL . 43.4 t80 -95.66 111.99 23.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.1 tttp -95.89 134.22 39.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.159 -0.963 . . . . 0.0 111.384 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' A' ' 86' ' ' PHE . 2.0 m -153.33 134.7 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.29 -138.95 26.73 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -101.62 43.98 1.04 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.31 -1.112 . . . . 0.0 109.665 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -162.24 136.44 6.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.958 . . . . 0.0 109.315 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -117.28 140.53 49.44 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.521 -0.737 . . . . 0.0 110.081 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -93.26 168.29 11.19 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.572 -0.705 . . . . 0.0 109.301 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 15.5 pttp -145.8 118.89 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.107 -0.995 . . . . 0.0 109.935 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.51 ' CD2' ' OE1' ' A' ' 146' ' ' GLU . 27.5 m-85 -116.44 168.48 10.12 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -130.22 108.98 10.44 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.239 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.5 tpp -50.89 135.09 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.514 -0.741 . . . . 0.0 109.237 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.5 m -166.28 19.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.883 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.8 t -164.88 92.34 0.59 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 100' ' ' ILE . 2.5 mp -97.7 162.31 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.887 . . . . 0.0 109.498 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 103' ' ' VAL . 74.8 mtt180 -136.33 -86.09 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.476 ' H ' HG13 ' A' ' 141' ' ' ILE . 3.3 p30 44.22 16.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.377 -0.827 . . . . 0.0 109.931 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.636 HG12 ' N ' ' A' ' 104' ' ' LYS . 3.8 t -94.39 -81.99 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.749 ' H ' ' CD ' ' A' ' 105' ' ' PRO . 9.1 ttpt -129.6 -42.76 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.234 0 O-C-N 121.441 -0.787 . . . . 0.0 109.958 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.749 ' CD ' ' H ' ' A' ' 104' ' ' LYS . 20.6 Cg_exo -65.62 66.8 0.37 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.218 1.945 . . . . 0.0 111.299 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 108' ' ' VAL . 22.2 p -89.17 89.64 8.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.101 -1.0 . . . . 0.0 110.714 -178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 109' ' ' GLY . 1.0 OUTLIER 63.07 -1.26 0.52 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.412 -0.805 . . . . 0.0 110.294 178.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 106' ' ' THR . 3.5 m -67.72 2.21 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.87 -1.144 . . . . 0.0 108.145 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 176.87 10.58 0.02 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.881 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.531 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 23.7 t -69.83 -37.51 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 120.636 -1.508 . . . . 0.0 108.334 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.487 HD23 HD22 ' A' ' 56' ' ' ASN . 12.6 mt -98.85 58.48 1.16 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -176.04 23.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.499 -0.751 . . . . 0.0 109.52 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -156.69 14.41 0.29 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.029 -1.044 . . . . 0.0 109.143 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.643 HE22 ' ND2' ' A' ' 56' ' ' ASN . 7.5 mt-30 -101.49 6.05 42.18 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HA ' HE22 ' A' ' 55' ' ' GLN . 56.5 mmtt -75.78 30.06 0.11 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.703 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 114' ' ' GLN . . . -149.69 -14.78 0.09 OUTLIER Glycine 0 N--CA 1.498 2.815 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.655 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -93.27 -147.39 0.24 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.876 -1.367 . . . . 0.0 109.429 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.5 m-20 -116.2 168.87 9.73 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 13.3 mptt -43.38 130.31 4.97 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.243 -0.911 . . . . 0.0 109.448 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.71 172.67 12.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.7 tp -118.51 156.34 29.26 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.661 -0.649 . . . . 0.0 110.019 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.1 m -134.77 88.38 2.43 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.51 145.54 52.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.436 -0.79 . . . . 0.0 110.883 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.46 HD11 ' OG ' ' A' ' 58' ' ' SER . 51.5 mt -138.55 138.26 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.542 -0.724 . . . . 0.0 109.158 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -102.2 156.85 17.3 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 85.5 m -144.76 138.06 26.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.944 -1.098 . . . . 0.0 110.151 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 4.3 t0 178.96 146.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 108.891 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 8.3 t70 60.59 54.3 3.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -61.68 121.25 12.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.159 -0.963 . . . . 0.0 109.116 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -86.25 121.88 29.46 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.757 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.5 pm0 -87.08 6.72 31.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.45 -50.83 9.56 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.4 p -97.67 -14.39 20.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.451 -0.781 . . . . 0.0 108.952 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.02 17.54 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.12 163.47 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -1.141 . . . . 0.0 109.717 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.445 ' O ' ' C ' ' A' ' 137' ' ' GLU . 73.4 m95 -68.24 114.71 6.95 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.5 tp10 -37.18 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.218 0.532 . . . . 0.0 110.181 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -93.94 153.18 18.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -156.51 94.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.852 -1.155 . . . . 0.0 110.71 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -86.79 159.39 19.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.476 HG13 ' H ' ' A' ' 102' ' ' ASP . 9.8 pt -145.82 159.57 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.842 -1.162 . . . . 0.0 110.685 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.4 m-85 -139.95 168.42 19.84 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.19 142.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 120.802 -1.186 . . . . 0.0 110.423 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -140.16 147.85 40.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 147' ' ' VAL . 13.0 t -108.63 140.36 42.12 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.51 ' OE1' ' CD2' ' A' ' 95' ' ' TYR . 3.2 tp10 -65.72 45.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 145' ' ' THR . 1.4 t -146.7 177.93 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.118 -0.988 . . . . 0.0 109.223 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.46 ' H ' HG12 ' A' ' 147' ' ' VAL . 29.3 mmtp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.329 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -66.75 155.48 38.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.902 . . . . 0.0 109.556 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.5 129.89 6.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 0.0 109.482 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -45.84 148.7 1.31 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.91 -152.87 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.43 2.087 . . . . 0.0 111.684 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -68.76 129.17 39.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.023 -1.048 . . . . 0.0 110.258 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.1 mt -150.63 96.56 3.37 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -41.08 143.3 0.7 Allowed 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.304 2.003 . . . . 0.0 113.356 -178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -87.19 -16.24 35.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.148 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 12' ' ' SER . 12.9 m-20 -77.7 105.62 8.98 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -0.859 . . . . 0.0 109.451 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 1.9 mptp? -58.56 -2.46 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.443 -0.786 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.487 ' H ' ' C ' ' A' ' 10' ' ' ASP . 39.7 m -113.94 43.75 1.77 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.537 -0.727 . . . . 0.0 109.409 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.492 ' HZ3' ' HB3' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -143.15 134.41 25.95 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.942 . . . . 0.0 109.04 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.6 t -60.6 115.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.39 -0.818 . . . . 0.0 110.932 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -95.76 -4.53 43.82 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 174.53 -168.85 41.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.54 124.77 10.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.178 -1.189 . . . . 0.0 109.071 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.7 tt -98.91 147.38 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.18 145.95 30.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.01 -1.056 . . . . 0.0 109.828 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -147.86 131.82 8.5 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.42 -52.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.981 1.787 . . . . 0.0 111.833 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -50.88 -26.66 6.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.343 -0.848 . . . . 0.0 109.301 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.55 3.08 17.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.521 -0.737 . . . . 0.0 109.073 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.9 p30 43.39 37.1 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.573 -0.705 . . . . 0.0 109.646 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -92.91 152.19 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 122.214 1.006 . . . . 0.0 110.665 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 pttm -166.07 82.64 0.3 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -132.4 158.69 74.97 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.47 -0.769 . . . . 0.0 110.694 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.67 162.01 21.68 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 123.006 2.47 . . . . 0.0 112.654 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -138.16 104.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -76.65 166.13 47.23 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 120.785 -1.197 . . . . 0.0 109.377 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 15' ' ' ALA . 43.7 Cg_endo -89.77 120.04 0.89 Allowed 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.488 2.126 . . . . 0.0 111.818 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.09 -178.4 43.53 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.432 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.57 ' O ' ' N ' ' A' ' 35' ' ' THR . 88.3 Cg_endo -81.22 116.63 3.06 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.919 2.413 . . . . 0.0 111.712 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.438 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -46.61 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.612 . . . . 0.0 109.765 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.57 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -119.62 153.9 54.43 Favored Pre-proline 0 N--CA 1.497 1.894 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.416 ' O ' ' OD1' ' A' ' 40' ' ' ASN . 22.4 Cg_endo -60.35 -45.12 23.93 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.127 1.884 . . . . 0.0 111.803 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -63.28 -27.8 69.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 109.698 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -86.51 -68.33 0.75 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.7 mt -46.82 -14.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.155 -0.966 . . . . 0.0 109.738 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 38' ' ' GLN . 6.6 m-20 -63.89 -24.96 67.94 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.435 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.3 OUTLIER -80.14 -20.92 43.8 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.085 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.44 ' O ' ' OE1' ' A' ' 71' ' ' GLN . . . 159.29 -119.29 0.88 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.9 t -118.55 157.8 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.605 -0.938 . . . . 0.0 110.102 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -156.63 158.9 37.86 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -56.18 173.37 0.16 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.716 -1.24 . . . . 0.0 109.355 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.1 -14.48 55.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.895 . . . . 0.0 109.139 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -146.78 145.62 29.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 0.0 110.063 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.14 -24.41 67.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.52 -0.737 . . . . 0.0 110.886 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -88.75 3.24 51.63 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 -178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.0 150.3 45.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 109.758 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' OD2' ' A' ' 54' ' ' ASP . 45.9 m -149.04 159.6 44.08 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -69.64 -4.22 18.46 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -99.52 -15.34 18.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.683 . . . . 0.0 109.932 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 51' ' ' SER . 31.2 m-20 -60.14 107.61 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.716 -1.24 . . . . 0.0 109.203 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.666 ' NE2' ' H ' ' A' ' 117' ' ' LYS . 10.8 tt0 -45.75 -18.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.353 -0.842 . . . . 0.0 109.379 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.4 t-20 -127.81 98.31 5.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 58' ' ' SER . 96.6 mt -94.51 154.23 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.186 -0.946 . . . . 0.0 109.277 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 46' ' ' ALA . 58.6 m -145.38 117.59 8.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.2 mt -112.62 158.55 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 110.22 -178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.52 136.61 34.69 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.95 156.38 25.93 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -71.77 178.41 3.65 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.484 -1.009 . . . . 0.0 109.535 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.462 ' CG2' ' OD1' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -163.52 86.51 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.42 -0.8 . . . . 0.0 109.28 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -88.41 119.34 28.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.7 -30.9 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.38 -0.825 . . . . 0.0 110.074 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -82.9 15.94 2.5 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 109.566 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 69' ' ' ASN . 54.7 ttt180 -150.32 70.97 9.17 Favored Pre-proline 0 C--N 1.298 -1.635 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.19 18.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 123.843 3.028 . . . . 0.0 114.36 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -151.2 63.41 0.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.783 -1.198 . . . . 0.0 108.651 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -151.09 110.77 4.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' OE1' ' O ' ' A' ' 42' ' ' GLY . 64.2 mt-30 54.81 -115.5 0.96 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.712 -0.618 . . . . 0.0 111.918 178.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.592 ' CE2' HD13 ' A' ' 75' ' ' LEU . 3.1 m-85 -96.21 10.98 36.07 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.186 -0.946 . . . . 0.0 110.559 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 94.4 m -49.08 -18.01 0.27 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.623 -1.298 . . . . 0.0 109.787 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 4.0 m-20 -122.05 -23.58 5.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.398 -0.814 . . . . 0.0 110.032 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.592 HD13 ' CE2' ' A' ' 72' ' ' PHE . 6.9 tt -54.2 -29.0 44.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.965 -1.084 . . . . 0.0 108.768 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -75.4 -7.2 53.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -88.41 -24.0 23.17 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -50.73 -178.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.584 -0.697 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.23 162.86 40.83 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 ttmm -52.98 133.03 38.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.57 -5.06 66.96 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 83' ' ' MET . 25.8 t -63.33 -161.52 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.055 -1.262 . . . . 0.0 108.174 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.521 ' N ' ' OG ' ' A' ' 82' ' ' SER . 50.1 mmm -142.61 162.27 35.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.908 . . . . 0.0 109.739 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 t -146.15 155.45 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.534 -0.729 . . . . 0.0 109.236 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -140.83 107.9 5.46 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.287 -0.883 . . . . 0.0 109.207 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -95.02 112.28 24.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -97.99 138.98 34.51 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.331 -0.856 . . . . 0.0 110.138 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.7 m -144.06 150.19 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.32 -14.83 0.06 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 88' ' ' VAL . 48.2 t30 -84.02 -58.48 2.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.035 -1.274 . . . . 0.0 109.999 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' H ' HG23 ' A' ' 88' ' ' VAL . 20.1 tt0 -172.08 171.68 4.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.361 -0.837 . . . . 0.0 108.904 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -97.61 149.7 21.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.202 -0.936 . . . . 0.0 110.037 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.65 169.5 17.52 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -142.78 156.49 44.99 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.05 -1.031 . . . . 0.0 110.911 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.527 ' CE2' ' OE1' ' A' ' 146' ' ' GLU . 6.5 m-85 -136.5 -178.07 5.01 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -145.68 116.45 7.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.164 -0.96 . . . . 0.0 109.054 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 40.2 mtt -51.03 111.98 0.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.438 -0.788 . . . . 0.0 109.123 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -140.04 28.98 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.369 -0.832 . . . . 0.0 108.916 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.7 p -178.95 141.91 0.19 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 101' ' ' ARG . 50.3 mt -140.76 164.2 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 104' ' ' LYS . 22.5 mmt180 -140.82 -9.08 1.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.426 -0.796 . . . . 0.0 109.157 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 103' ' ' VAL . 23.4 p30 -45.82 -22.47 0.19 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.228 -0.92 . . . . 0.0 109.713 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.521 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 8.9 p -83.51 -23.9 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.0 109.321 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 101' ' ' ARG . 19.1 pttm -149.36 61.97 5.62 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' A' ' 107' ' ' ASP . 58.6 Cg_endo -72.16 -69.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.392 2.061 . . . . 0.0 112.629 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.502 HG23 ' C ' ' A' ' 105' ' ' PRO . 1.5 p 65.83 -35.95 0.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.277 -0.889 . . . . 0.0 109.548 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.552 ' H ' ' C ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER 71.03 -37.11 0.38 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.486 ' H ' ' C ' ' A' ' 106' ' ' THR . 15.3 m -75.81 25.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 0.0 109.214 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -159.6 -20.63 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.485 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.523 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 12.7 t -67.26 -38.64 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.902 -1.352 . . . . 0.0 108.823 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.9 mt -100.21 63.37 1.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.494 -0.754 . . . . 0.0 109.338 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -172.44 22.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.298 -0.876 . . . . 0.0 109.953 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -175.85 29.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.181 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.545 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 32.1 mt-30 -140.26 17.1 2.42 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.473 ' C ' ' NE2' ' A' ' 55' ' ' GLN . 21.6 pttm -104.82 13.46 31.21 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -128.86 45.15 1.16 Allowed Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.666 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 53.6 mttm -142.92 -131.9 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.316 -1.108 . . . . 0.0 108.795 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -106.77 164.13 12.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.244 -0.91 . . . . 0.0 108.593 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.436 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 4.4 mptp? -46.83 137.54 7.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.218 -0.926 . . . . 0.0 108.54 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.545 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 8.2 pt20 -150.05 152.04 34.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.02 . . . . 0.0 110.528 -178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.7 mt -114.28 117.32 30.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.949 -0.47 . . . . 0.0 110.22 -179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.5 m -92.41 88.17 6.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.0 mt -68.28 138.33 55.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.697 . . . . 0.0 109.986 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.2 mt -137.87 148.31 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.391 -0.818 . . . . 0.0 109.604 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.4 p -102.94 169.01 8.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.427 -0.796 . . . . 0.0 108.907 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 34.5 m -148.49 138.93 22.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.993 -1.067 . . . . 0.0 109.619 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.462 ' OD1' ' CG2' ' A' ' 63' ' ' THR . 0.3 OUTLIER 175.3 140.23 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 0.0 109.078 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 t0 59.86 66.36 1.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -0.806 . . . . 0.0 108.986 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -65.52 127.53 32.23 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 109.668 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -84.77 124.94 32.12 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.027 -1.045 . . . . 0.0 109.759 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.3 6.25 48.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.461 -0.774 . . . . 0.0 109.228 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -88.36 -19.73 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.808 . . . . 0.0 109.681 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.7 p -137.29 -2.36 2.03 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.382 -0.824 . . . . 0.0 109.323 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.42 44.29 59.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 t -146.78 154.34 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.251 -1.146 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.419 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.63 112.99 3.07 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.124 -0.985 . . . . 0.0 108.641 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.3 tp10 -37.96 -82.56 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.93 -0.481 . . . . 0.0 110.691 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' NZ ' ' CB ' ' A' ' 138' ' ' LYS . 0.2 OUTLIER -105.24 140.34 38.54 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.41 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.491 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -170.45 138.84 1.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.248 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -118.9 160.58 21.68 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt -138.89 159.1 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.833 -1.167 . . . . 0.0 110.92 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 4.8 m-85 -132.66 177.45 7.61 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.4 t -150.66 133.61 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.852 -1.155 . . . . 0.0 110.586 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -129.88 169.57 15.03 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 147' ' ' VAL . 12.6 t -139.93 147.33 40.39 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.0 -1.063 . . . . 0.0 110.853 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.527 ' OE1' ' CE2' ' A' ' 95' ' ' TYR . 18.2 tp10 -65.51 48.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.778 -0.576 . . . . 0.0 109.459 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.548 ' N ' ' O ' ' A' ' 145' ' ' THR . 2.0 t -146.64 177.05 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.084 -1.01 . . . . 0.0 108.961 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.532 ' H ' HG12 ' A' ' 147' ' ' VAL . 15.0 pttp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.319 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -82.36 142.52 31.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.842 . . . . 0.0 109.533 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.7 127.33 32.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.915 . . . . 0.0 109.348 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' PRO . 38.4 mmtt -80.91 151.71 70.92 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 109.118 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 4' ' ' LYS . 66.8 Cg_exo -36.9 161.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.359 2.039 . . . . 0.0 112.464 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.507 ' CD ' ' H ' ' A' ' 6' ' ' GLN . 1.2 mp0 -70.73 119.38 14.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.617 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mt -83.59 115.18 58.21 Favored Pre-proline 0 N--CA 1.491 1.579 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -41.39 130.58 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.818 1.679 . . . . 0.0 112.51 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -78.03 -29.27 49.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.503 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 12' ' ' SER . 40.3 m-20 -77.28 112.65 14.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.316 -0.865 . . . . 0.0 109.585 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 0.7 OUTLIER -58.66 -2.59 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.349 -0.845 . . . . 0.0 109.524 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.2 m -105.68 38.84 1.89 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.345 -0.847 . . . . 0.0 109.543 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -142.51 126.37 17.15 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.302 -0.874 . . . . 0.0 109.261 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.497 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 24.9 t -59.62 132.34 24.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.607 -0.683 . . . . 0.0 110.914 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.07 -10.61 21.34 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . 176.16 -161.13 29.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.497 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 66.0 m-85 -148.9 131.58 15.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.768 -1.43 . . . . 0.0 110.179 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -98.16 142.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -145.38 133.26 21.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.996 -1.065 . . . . 0.0 110.166 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 23' ' ' ALA . 53.5 mt -142.63 125.94 9.37 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.98 -44.35 0.21 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.707 1.604 . . . . 0.0 111.956 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -53.17 -20.48 3.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -0.885 . . . . 0.0 109.087 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -121.6 8.33 10.09 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.4 p30 43.15 31.71 0.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.593 -0.692 . . . . 0.0 110.01 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.4 mt -91.08 143.2 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.315 -0.865 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -164.2 85.89 0.46 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -137.4 159.6 68.76 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.463 -0.773 . . . . 0.0 110.624 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.06 162.01 26.28 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.048 2.499 . . . . 0.0 113.036 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 43' ' ' VAL . 3.1 t -139.63 115.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.444 -0.785 . . . . 0.0 109.432 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.442 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -85.73 170.37 13.19 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 120.794 -1.191 . . . . 0.0 108.733 179.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -89.16 130.91 2.1 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.451 2.101 . . . . 0.0 112.194 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 45' ' ' PHE . . . 164.74 175.08 35.17 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.355 -1.402 . . . . 0.0 110.612 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 35' ' ' THR . 61.9 Cg_endo -85.95 128.01 3.17 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.909 2.406 . . . . 0.0 111.589 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.618 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -38.84 88.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.662 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.579 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -118.79 154.13 52.71 Favored Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.76 -41.37 3.05 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.267 1.978 . . . . 0.0 111.89 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -63.08 -21.28 66.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.316 -0.865 . . . . 0.0 109.588 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' N ' ' OE2' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -94.64 -70.08 0.72 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.296 -0.877 . . . . 0.0 109.269 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 39' ' ' LEU . 16.7 mt -44.29 -26.29 0.31 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.449 -0.782 . . . . 0.0 109.855 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -61.11 -24.17 66.05 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 26.9 mtt-85 -89.13 -11.76 42.99 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.32 -122.33 1.14 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.868 -1.158 . . . . 0.0 110.222 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 60' ' ' ALA . 18.2 t -122.3 151.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.61 -0.936 . . . . 0.0 109.094 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.481 ' OG ' ' NE2' ' A' ' 38' ' ' GLN . 1.4 m -151.23 151.01 31.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.916 . . . . 0.0 108.794 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 32' ' ' GLY . 27.7 m-85 -55.4 155.78 4.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.544 -1.348 . . . . 0.0 108.41 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.618 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -83.43 4.88 25.74 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.265 -0.897 . . . . 0.0 109.04 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -149.99 130.83 14.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.403 -0.811 . . . . 0.0 110.109 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -61.76 -22.83 65.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.461 -0.775 . . . . 0.0 110.486 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -88.0 -2.8 58.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.035 -1.041 . . . . 0.0 110.075 -178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -60.45 163.55 5.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.087 -1.008 . . . . 0.0 109.081 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -145.43 -167.97 2.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 108.893 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.682 HD12 ' N ' ' A' ' 52' ' ' LEU . 4.4 mp -95.05 11.64 31.35 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.215 -0.928 . . . . 0.0 109.079 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.92 12.38 0.44 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.143 -0.973 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.576 ' CG ' HE22 ' A' ' 55' ' ' GLN . 19.6 t0 -57.03 120.38 7.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.756 -1.215 . . . . 0.0 108.751 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.713 HE21 ' N ' ' A' ' 56' ' ' ASN . 1.1 pm0 -45.86 -15.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.713 ' N ' HE21 ' A' ' 55' ' ' GLN . 4.8 m120 -136.12 99.32 4.1 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.0 mm -93.26 153.17 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.03 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 t -142.02 103.29 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 60' ' ' ALA . 96.3 mt -100.4 158.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.854 0.835 . . . . 0.0 110.336 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.588 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -138.12 134.7 34.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.86 157.87 27.43 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.684 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 72' ' ' PHE . 14.3 m-70 -76.49 178.4 6.65 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.585 -0.95 . . . . 0.0 110.018 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.48 90.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 108.74 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' N ' ' OG1' ' A' ' 73' ' ' THR . 5.3 m-85 -87.48 110.54 20.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.966 -1.084 . . . . 0.0 109.199 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.2 mm -58.32 -30.68 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -0.849 . . . . 0.0 110.155 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -87.96 19.38 3.61 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.13 -0.981 . . . . 0.0 109.465 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -149.88 74.5 9.33 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.433 -0.792 . . . . 0.0 109.416 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' ' ND2' ' A' ' 74' ' ' ASN . 51.1 Cg_exo -56.06 26.87 0.03 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 123.48 2.787 . . . . 0.0 113.524 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -150.57 29.21 0.69 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.835 -1.166 . . . . 0.0 109.073 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.8 t80 -89.28 -153.2 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.17 -0.956 . . . . 0.0 109.426 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.4 mp0 -71.29 -84.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.711 0.767 . . . . 0.0 110.808 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -94.78 19.45 10.07 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.677 -0.639 . . . . 0.0 109.968 -178.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.491 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 55.5 m -69.74 -38.19 76.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.326 -1.484 . . . . 0.0 109.93 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 77' ' ' ALA . 16.0 m-20 -103.92 -10.28 18.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.182 -0.948 . . . . 0.0 111.46 -177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 72' ' ' PHE . 2.6 mt -53.16 -29.27 30.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.406 -1.433 . . . . 0.0 108.365 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 73' ' ' THR . 10.6 pttp -80.36 -10.44 59.75 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -79.51 -23.37 42.98 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.85 -175.34 0.4 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' GLY . 34.3 mttm -150.53 154.98 38.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.029 -1.045 . . . . 0.0 109.686 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -51.06 96.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 109.734 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.423 ' H ' ' HB2' ' A' ' 97' ' ' MET . . . 150.84 -20.93 1.0 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -66.03 -165.63 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.104 -1.233 . . . . 0.0 108.185 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 45.3 mmm -137.88 171.65 14.11 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.5 t -145.14 108.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 0.0 109.145 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -93.37 109.37 20.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.369 -0.832 . . . . 0.0 109.981 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' O ' ' OG1' ' A' ' 92' ' ' THR . 39.9 t80 -94.76 116.89 29.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -85.24 139.11 31.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 111.115 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.3 m -147.78 124.98 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.53 -132.79 35.06 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.477 ' N ' ' OE2' ' A' ' 91' ' ' GLU . 49.8 t30 -97.95 35.98 1.63 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.163 -1.198 . . . . 0.0 109.832 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.477 ' OE2' ' N ' ' A' ' 90' ' ' ASN . 1.2 pm0 -159.64 170.0 22.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -0.979 . . . . 0.0 108.955 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 86' ' ' PHE . 6.3 t -141.26 150.22 42.33 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.714 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -92.29 175.53 6.81 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -146.87 133.48 19.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.068 -1.02 . . . . 0.0 110.436 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 1.7 m-85 -138.85 126.84 22.42 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.544 ' NZ ' HG21 ' A' ' 147' ' ' VAL . 4.1 ttpm? -93.95 120.39 34.14 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 109.399 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.423 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 85.2 mtp -48.13 120.64 3.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.791 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.522 ' OG1' HG22 ' A' ' 145' ' ' THR . 8.7 p -149.83 31.62 0.7 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.37 -0.831 . . . . 0.0 109.304 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.4 m -171.54 86.95 0.09 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.8 mm -89.13 125.93 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.834 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.503 ' C ' ' H ' ' A' ' 103' ' ' VAL . 23.2 mmt180 -96.67 -116.02 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.463 ' H ' HG13 ' A' ' 141' ' ' ILE . 37.9 t0 58.18 3.6 0.26 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.213 -0.93 . . . . 0.0 109.227 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.941 HG12 ' H ' ' A' ' 104' ' ' LYS . 85.7 t -114.3 -167.35 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.941 ' H ' HG12 ' A' ' 103' ' ' VAL . 1.6 mmmp? -39.36 -55.87 3.01 Favored Pre-proline 0 N--CA 1.499 2.025 0 O-C-N 120.805 -1.185 . . . . 0.0 110.896 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -43.28 88.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.009 1.806 . . . . 0.0 111.741 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.51 ' O ' ' CB ' ' A' ' 107' ' ' ASP . 10.1 p -126.85 94.29 4.0 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.394 -0.816 . . . . 0.0 109.712 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 106' ' ' THR . 3.6 t70 83.38 13.3 0.39 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 108' ' ' VAL . 8.2 m -69.18 3.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 135.34 16.62 0.92 Allowed Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 m -66.91 -24.58 32.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.032 -1.275 . . . . 0.0 108.428 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.8 mt -100.91 33.04 2.94 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 114' ' ' GLN . 30.1 t0 -83.58 121.93 27.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.195 -0.941 . . . . 0.0 109.076 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -61.1 -5.26 1.38 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.031 0.92 . . . . 0.0 108.652 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.711 HE22 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -155.26 74.36 0.9 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 114' ' ' GLN . 1.5 mmmm -41.98 -63.14 0.78 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.178 -0.951 . . . . 0.0 109.71 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.711 ' N ' HE22 ' A' ' 114' ' ' GLN . . . 148.99 -19.61 1.23 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.532 ' NZ ' ' OE1' ' A' ' 120' ' ' GLN . 11.0 pttp -97.9 -106.42 0.18 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.165 -1.197 . . . . 0.0 110.823 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.471 ' O ' ' OE1' ' A' ' 120' ' ' GLN . 2.2 m-20 -121.16 171.18 8.88 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.288 -0.882 . . . . 0.0 109.57 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 118' ' ' ASP . 58.2 mttm -44.7 147.21 0.64 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.532 ' OE1' ' NZ ' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -150.6 150.74 31.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.677 -1.265 . . . . 0.0 110.791 -178.036 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.38 111.9 24.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.88 -0.513 . . . . 0.0 109.753 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.0 m -98.04 120.79 39.06 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.201 -0.937 . . . . 0.0 108.696 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 mp -104.43 147.11 27.92 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.264 -0.897 . . . . 0.0 109.436 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.471 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 77.3 mt -137.89 147.41 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.226 -0.921 . . . . 0.0 110.076 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.452 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.1 p -97.74 155.6 16.94 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 33.9 m -148.63 97.17 2.7 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.954 -1.091 . . . . 0.0 109.658 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.525 ' OD2' ' NZ ' ' A' ' 138' ' ' LYS . 4.9 p-10 -149.39 149.17 30.42 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 61.39 61.23 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.507 -0.745 . . . . 0.0 109.282 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -64.38 118.87 9.34 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -86.72 118.04 25.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.051 -1.03 . . . . 0.0 109.598 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 5.1 pm0 -84.86 10.72 10.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.345 -0.847 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -81.99 -54.53 5.24 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.8 p -96.29 -8.13 33.55 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.87 41.47 33.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -147.21 163.76 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.276 -1.132 . . . . 0.0 109.837 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.443 ' O ' ' C ' ' A' ' 137' ' ' GLU . 71.1 m95 -67.09 116.44 7.91 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 136' ' ' TRP . 16.4 tp10 -37.96 -86.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.778 -0.576 . . . . 0.0 109.893 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' NZ ' ' OD2' ' A' ' 127' ' ' ASP . 1.9 pttp -89.0 152.06 21.92 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.463 ' NH2' HD13 ' A' ' 124' ' ' ILE . 54.8 ttt180 -157.45 89.58 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -79.28 167.99 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.493 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -148.58 151.38 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.756 -1.215 . . . . 0.0 110.023 -179.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 1.3 m-85 -143.09 162.52 35.31 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.1 t -148.68 152.72 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.764 -1.21 . . . . 0.0 110.929 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.41 160.96 38.19 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.522 HG22 ' OG1' ' A' ' 98' ' ' THR . 8.3 t -127.91 135.43 49.98 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.349 -0.844 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.97 105.61 0.6 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.52 -0.738 . . . . 0.0 109.677 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.544 HG21 ' NZ ' ' A' ' 96' ' ' LYS . 1.3 t -93.02 176.97 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.99 . . . . 0.0 108.889 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.419 ' H ' HG12 ' A' ' 147' ' ' VAL . 59.9 mttm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.429 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mmt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.703 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 4.1 mp0 -57.07 114.07 1.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.9 137.43 35.2 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.49 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 57.3 mttp -152.12 52.93 0.99 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.866 . . . . 0.0 109.656 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 60.0 Cg_endo -70.51 -155.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.582 2.188 . . . . 0.0 111.869 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -75.36 96.99 3.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.095 -1.003 . . . . 0.0 110.271 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.3 mt -149.5 94.21 3.94 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -46.37 162.82 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.474 2.116 . . . . 0.0 112.753 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -103.32 -12.41 17.26 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.511 -0.743 . . . . 0.0 109.363 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.533 ' CG ' ' HZ1' ' A' ' 13' ' ' LYS . 2.6 m-20 -77.55 109.06 11.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 11.9 mptt -59.62 -0.32 0.17 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.272 -0.892 . . . . 0.0 109.604 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 10' ' ' ASP . 41.6 m -114.28 36.81 3.58 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.466 -0.771 . . . . 0.0 110.282 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HZ1' ' CG ' ' A' ' 10' ' ' ASP . 2.1 ttmp? -144.18 143.83 31.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.027 -1.046 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.19 145.12 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 110.098 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -144.46 11.79 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.87 173.54 34.45 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.75 119.98 7.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -1.175 . . . . 0.0 109.147 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -97.03 141.5 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -145.09 136.71 25.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.096 -1.003 . . . . 0.0 110.101 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.8 mt -144.37 127.05 8.47 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.9 Cg_endo -75.71 -43.23 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.524 1.483 . . . . 0.0 111.312 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -51.36 -15.24 0.37 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.464 -0.772 . . . . 0.0 109.128 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.1 13.6 3.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.379 -0.826 . . . . 0.0 109.279 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.2 p30 42.46 52.4 4.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.454 -0.779 . . . . 0.0 109.944 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' ' 23' ' ' ALA . 49.8 mm -92.46 146.41 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.864 0.84 . . . . 0.0 110.214 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -169.83 80.28 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -142.9 158.79 58.54 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.131 -0.981 . . . . 0.0 110.526 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -83.54 162.27 14.64 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.995 2.463 . . . . 0.0 112.511 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.9 t -125.52 112.78 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' A' ' 41' ' ' ARG . 5.7 m-85 -73.11 146.48 87.21 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 120.867 -1.146 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -79.93 97.36 1.06 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.571 2.181 . . . . 0.0 111.884 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.19 -174.13 46.49 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.671 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.563 ' O ' ' N ' ' A' ' 35' ' ' THR . 93.7 Cg_endo -80.55 120.97 4.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.839 2.359 . . . . 0.0 111.431 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -45.5 86.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.823 -0.548 . . . . 0.0 110.696 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.1 p -103.67 152.11 38.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 53.5 Cg_endo -68.95 -44.31 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.958 1.772 . . . . 0.0 111.803 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.42 -24.68 67.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.701 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.506 HE22 ' CB ' ' A' ' 44' ' ' SER . 2.8 tt0 -88.59 -59.81 2.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 109.651 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.5 mt -47.29 -15.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -0.972 . . . . 0.0 109.322 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 5.9 m120 -58.63 -29.89 66.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.434 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 85.7 mtt180 -80.38 -19.7 45.76 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.9 -141.7 7.55 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.459 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.1 t -98.36 161.47 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.401 -1.058 . . . . 0.0 109.388 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.506 ' CB ' HE22 ' A' ' 38' ' ' GLN . 11.7 p -158.84 156.97 30.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.072 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -56.06 171.84 0.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -95.46 -2.43 48.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.161 -0.962 . . . . 0.0 109.773 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.97 140.41 18.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.024 -1.048 . . . . 0.0 110.62 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -62.56 -22.84 66.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 110.518 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.69 20.85 2.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.018 -1.051 . . . . 0.0 109.486 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -62.22 145.63 53.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.233 1.016 . . . . 0.0 111.116 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 53' ' ' ASP . 3.3 m -155.33 136.32 13.73 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' CB ' HH22 ' A' ' 93' ' ' ARG . 0.0 OUTLIER -60.87 -4.91 1.11 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' SER . 92.8 m-20 -93.73 -17.8 22.79 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.745 -0.597 . . . . 0.0 109.677 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 56' ' ' ASN . 42.0 t0 -58.94 109.84 0.91 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.777 -1.202 . . . . 0.0 109.286 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -47.56 -12.97 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 109.638 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 54' ' ' ASP . 50.0 t-20 -140.28 104.97 4.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.198 -0.939 . . . . 0.0 109.074 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 58' ' ' SER . 4.0 mp -95.07 159.12 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.293 -0.879 . . . . 0.0 108.716 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.494 ' N ' HG22 ' A' ' 57' ' ' ILE . 2.9 p -145.43 123.15 11.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.3 mt -120.23 160.15 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 CA-C-O 121.679 0.752 . . . . 0.0 110.396 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.49 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -134.28 134.28 41.72 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.94 152.76 22.37 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -71.66 176.48 4.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.528 -0.983 . . . . 0.0 109.272 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.16 90.5 0.59 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.139 -0.976 . . . . 0.0 109.55 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -89.42 111.42 22.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.248 -0.908 . . . . 0.0 109.258 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.0 mm -60.47 -29.19 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.855 . . . . 0.0 110.627 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.44 15.97 4.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.26 -0.9 . . . . 0.0 109.912 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 69' ' ' ASN . 51.5 ttt180 -152.18 77.56 6.77 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.6 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 30.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 123.128 2.552 . . . . 0.0 112.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 67' ' ' ARG . 17.4 m-80 -150.95 63.46 0.91 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.085 -1.009 . . . . 0.0 108.622 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.612 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 3.0 t80 -137.83 -153.76 0.5 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.283 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.612 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 2.4 mp0 -58.43 -99.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.768 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CD2' HD22 ' A' ' 75' ' ' LEU . 3.8 m-30 -94.61 16.61 15.11 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.134 -0.979 . . . . 0.0 110.357 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.8 m -49.14 -24.87 1.85 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.722 -1.236 . . . . 0.0 109.907 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.466 ' C ' ' HB1' ' A' ' 23' ' ' ALA . 2.8 m-20 -115.31 -29.04 6.69 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.763 . . . . 0.0 110.006 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 72' ' ' PHE . 6.7 tt -50.81 -20.89 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.047 -1.033 . . . . 0.0 109.258 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -76.44 -18.1 58.98 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.15 -29.04 31.79 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.526 0.679 . . . . 0.0 109.338 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.67 123.86 7.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.802 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -102.67 177.57 4.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.371 -0.831 . . . . 0.0 109.143 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -51.06 152.49 2.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.135 -0.978 . . . . 0.0 109.248 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.77 -19.72 19.08 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.5 m -62.97 95.66 0.08 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.339 -1.095 . . . . 0.0 108.579 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.8 mtp -64.74 165.75 9.95 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.49 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 0.8 OUTLIER -143.89 121.5 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.948 . . . . 0.0 109.099 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 12.5 m-85 -95.09 110.57 22.49 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.275 -0.891 . . . . 0.0 109.787 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.468 ' CZ ' ' CG2' ' A' ' 88' ' ' VAL . 28.6 t80 -96.15 112.16 23.98 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -96.13 149.85 21.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.295 -0.878 . . . . 0.0 111.034 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' CG2' ' CZ ' ' A' ' 86' ' ' PHE . 74.1 t -155.42 103.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.93 -127.43 31.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -90.29 53.04 2.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.251 -1.146 . . . . 0.0 109.692 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -155.1 146.23 22.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.219 -0.926 . . . . 0.0 109.548 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 60.2 m -151.31 109.94 3.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.523 HH22 ' CB ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -100.83 169.51 8.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.559 -0.713 . . . . 0.0 110.003 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 147.96 41.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.444 -0.785 . . . . 0.0 109.586 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 121' ' ' LEU . 3.3 m-85 -134.1 175.36 9.55 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' THR . 59.5 tttp -131.66 106.7 8.33 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.415 -0.803 . . . . 0.0 109.725 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 27.0 ttm -49.01 98.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 108.876 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -133.65 24.17 4.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.851 . . . . 0.0 109.835 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 143' ' ' VAL . 10.8 t -167.06 121.85 1.06 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.566 HG22 ' N ' ' A' ' 101' ' ' ARG . 65.8 mt -131.48 167.4 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.415 -0.803 . . . . 0.0 110.203 -178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.571 ' NH1' ' N ' ' A' ' 103' ' ' VAL . 4.9 ttt-85 -137.45 -91.11 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' HB3' ' H ' ' A' ' 141' ' ' ILE . 1.9 p30 44.1 19.56 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.953 0.882 . . . . 0.0 108.935 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.571 ' N ' ' NH1' ' A' ' 101' ' ' ARG . 1.7 p -171.32 129.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.538 ' O ' ' O ' ' A' ' 103' ' ' VAL . 16.8 ttmm 59.5 134.52 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 107' ' ' ASP . 30.3 Cg_endo -62.99 8.3 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 CA-C-N 119.727 0.938 . . . . 0.0 112.321 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 104' ' ' LYS . 3.8 p 43.56 -90.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.498 -0.751 . . . . 0.0 109.849 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 105' ' ' PRO . 16.5 m-20 -118.33 144.82 45.58 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.1 41.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.175 -0.953 . . . . 0.0 108.964 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -150.33 55.45 0.47 Allowed Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 110' ' ' VAL . 5.0 m -66.03 -27.3 40.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.011 -1.288 . . . . 0.0 108.089 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.0 mt -137.8 64.81 1.5 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.565 ' CG ' HE22 ' A' ' 114' ' ' GLN . 9.8 t0 -96.12 -141.49 0.27 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.034 -1.041 . . . . 0.0 108.692 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.87 19.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.038 -1.039 . . . . 0.0 109.654 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.565 HE22 ' CG ' ' A' ' 112' ' ' ASP . 1.6 pm0 -152.08 19.97 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.379 -0.826 . . . . 0.0 109.841 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 117' ' ' LYS . 18.6 mmtp -43.05 127.77 4.27 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.378 -0.826 . . . . 0.0 109.61 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.47 58.75 0.18 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 115' ' ' LYS . 25.5 mtpp -143.15 -143.74 0.15 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.235 -1.156 . . . . 0.0 108.886 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 120' ' ' GLN . 2.3 m-20 -118.42 168.95 10.17 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.184 -0.948 . . . . 0.0 108.714 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 118' ' ' ASP . 19.1 ttpp -47.32 96.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.876 -1.14 . . . . 0.0 108.788 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 118' ' ' ASP . 1.1 pm0 -95.89 174.54 6.9 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.844 0.83 . . . . 0.0 110.777 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 ' CE1' ' A' ' 95' ' ' TYR . 94.8 mt -129.08 119.41 24.14 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.5 m -95.26 93.51 7.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 0.0 108.949 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.684 HD22 ' N ' ' A' ' 123' ' ' LEU . 3.1 mm? -76.45 148.34 37.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 16.9 mt -142.32 140.68 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.4 p -97.18 164.84 12.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.232 -0.917 . . . . 0.0 108.691 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.431 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 22.6 m -148.97 140.76 23.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.009 -1.057 . . . . 0.0 109.934 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.6 t70 177.81 142.93 0.1 Allowed 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 2.6 m-20 55.99 63.41 2.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.743 . . . . 0.0 109.101 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -63.34 125.4 24.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.104 -0.998 . . . . 0.0 109.393 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -86.7 124.03 32.52 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.084 -1.01 . . . . 0.0 109.562 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -88.17 4.22 46.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -78.44 -59.93 2.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.164 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.0 p -95.6 -3.21 46.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.279 -0.888 . . . . 0.0 109.335 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.84 46.33 53.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 t -146.78 157.98 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -1.158 . . . . 0.0 109.374 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.437 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.9 m95 -63.86 111.63 2.55 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.165 -0.96 . . . . 0.0 108.596 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 136' ' ' TRP . 74.6 tt0 -32.49 -72.39 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 120.872 0.368 . . . . 0.0 111.309 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -134.03 146.52 50.45 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.269 -0.895 . . . . 0.0 109.853 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.755 ' HE ' ' H ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -167.38 -162.86 0.48 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.121 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -145.88 162.18 38.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.006 -1.058 . . . . 0.0 108.992 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.439 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 3.5 mt -133.78 138.36 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.42 -0.8 . . . . 0.0 109.843 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 2.7 m-85 -128.79 165.76 20.33 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.44 ' O ' ' O ' ' A' ' 99' ' ' SER . 12.8 t -146.38 114.82 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.946 -1.096 . . . . 0.0 110.423 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.23 169.38 9.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 145' ' ' THR . 14.1 t -132.02 127.76 36.9 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.486 -0.759 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 146' ' ' GLU . 3.2 tm-20 -59.0 131.92 52.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.13 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 1.4 t -93.68 176.32 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.239 -0.913 . . . . 0.0 109.075 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.425 ' H ' HG12 ' A' ' 147' ' ' VAL . 66.3 mttm . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.543 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.577 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.2 mpp? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -72.15 158.84 35.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -171.34 42.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -152.04 60.06 3.39 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.263 -0.898 . . . . 0.0 109.023 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.14 -155.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.533 2.155 . . . . 0.0 111.355 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -83.44 71.93 10.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.92 -1.112 . . . . 0.0 109.803 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.6 mt -148.52 108.98 3.59 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.8 179.54 6.19 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.786 1.657 . . . . 0.0 112.313 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -103.77 20.8 17.39 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.469 -0.77 . . . . 0.0 109.578 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 12' ' ' SER . 3.7 m-20 -77.98 101.94 7.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.983 . . . . 0.0 109.563 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 3.5 mptp? -62.29 7.52 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.383 -0.823 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 10' ' ' ASP . 75.6 p -141.37 41.85 1.76 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -147.66 142.0 26.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.023 -1.048 . . . . 0.0 109.827 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 58.3 t -61.35 122.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.595 -0.691 . . . . 0.0 110.67 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.81 -25.3 15.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' C ' ' CD1' ' A' ' 17' ' ' TYR . . . -172.95 -161.64 23.69 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.542 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 13.0 m-85 -147.26 126.97 13.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.132 -1.217 . . . . 0.0 110.156 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -96.04 138.44 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 178.081 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' H ' HD13 ' A' ' 18' ' ' ILE . 22.4 mt-10 -145.23 141.29 28.52 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.652 -1.28 . . . . 0.0 111.836 -177.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.0 mt -148.26 127.26 6.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.431 ' C ' ' N ' ' A' ' 23' ' ' ALA . 73.8 Cg_endo -75.8 -43.65 0.33 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.567 1.511 . . . . 0.0 111.379 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.51 -11.33 0.33 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -0.857 . . . . 0.0 109.364 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.36 11.4 3.82 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.405 -0.809 . . . . 0.0 109.687 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ALA . 3.7 p30 42.26 36.31 0.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.457 -0.777 . . . . 0.0 109.99 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.8 mt -90.18 140.71 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 109.155 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -166.03 86.47 0.35 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -139.79 157.93 68.8 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.415 -0.803 . . . . 0.0 110.5 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -80.96 162.01 20.82 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 123.115 2.544 . . . . 0.0 113.108 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.76 134.43 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 5.3 m-85 -94.48 151.1 39.06 Favored Pre-proline 0 N--CA 1.503 2.191 0 O-C-N 120.869 -1.144 . . . . 0.0 110.56 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.17 82.45 2.48 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.74 2.293 . . . . 0.0 111.442 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 178.84 39.75 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.033 -1.556 . . . . 0.0 111.128 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 35' ' ' THR . 87.3 Cg_endo -78.75 109.53 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.247 2.631 . . . . 0.0 111.284 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -44.09 89.1 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.625 -0.672 . . . . 0.0 111.694 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' PRO . 10.3 p -121.41 152.26 57.56 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.65 -40.13 65.01 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.36 1.374 . . . . 0.0 111.969 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -66.37 -34.66 78.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 111.751 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.575 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -88.64 -26.33 21.94 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.49 -1.381 . . . . 0.0 110.769 -178.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -78.94 -10.88 59.95 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.014 -1.054 . . . . 0.0 108.871 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -56.88 -29.3 62.82 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -79.04 -20.06 49.85 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.33 -135.23 4.75 Favored Glycine 0 N--CA 1.497 2.704 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.9 t -84.79 169.18 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.567 -0.961 . . . . 0.0 110.235 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.575 ' CB ' HE22 ' A' ' 38' ' ' GLN . 1.6 t -167.78 152.97 6.95 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.0 109.096 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.63 155.4 26.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.817 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' SER . . . -72.49 -2.97 21.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -151.86 147.63 26.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.324 -0.86 . . . . 0.0 110.184 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.73 -39.11 93.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.727 -0.608 . . . . 0.0 111.54 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -88.01 20.75 2.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.909 -1.119 . . . . 0.0 111.327 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.09 137.06 58.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.833 -1.167 . . . . 0.0 109.49 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.3 m -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 109.425 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 52' ' ' LEU . 7.5 mp -61.15 -13.92 21.15 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.094 -1.004 . . . . 0.0 108.525 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.55 -27.41 51.57 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.546 -0.721 . . . . 0.0 109.623 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 56' ' ' ASN . 3.4 m-20 -61.78 112.43 2.28 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.155 -0.965 . . . . 0.0 109.862 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -65.9 6.63 0.34 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.292 -0.88 . . . . 0.0 109.083 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 54' ' ' ASP . 46.6 t-20 -147.04 95.14 2.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.7 mt -94.5 115.44 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.505 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -108.71 113.69 26.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.95 155.29 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.56 115.32 23.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.11 145.22 16.07 Favored Glycine 0 N--CA 1.503 3.153 0 N-CA-C 110.666 -0.973 . . . . 0.0 110.666 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' A' ' 72' ' ' PHE . 9.2 m-70 -72.88 175.95 6.11 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.502 -0.999 . . . . 0.0 109.761 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.48 79.73 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -88.01 129.6 35.22 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.064 . . . . 0.0 109.885 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.3 mt -64.33 -34.79 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.531 -0.73 . . . . 0.0 109.935 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -84.04 20.28 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.532 -0.73 . . . . 0.0 109.45 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.0 OUTLIER -149.98 68.2 8.75 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.566 -0.709 . . . . 0.0 109.099 179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 66.7 Cg_exo -52.27 15.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.187 0 C-N-CA 123.481 2.787 . . . . 0.0 113.915 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.2 p30 -151.29 63.75 0.89 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.894 -1.129 . . . . 0.0 108.217 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.498 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 33.5 t80 -148.02 99.42 3.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.11 -0.994 . . . . 0.0 111.275 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 36.7 mt-30 61.01 -110.89 0.45 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.523 ' CE1' HG22 ' A' ' 125' ' ' THR . 35.6 t80 -91.14 0.16 57.59 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.111 -0.993 . . . . 0.0 111.55 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.9 m -49.17 -43.65 42.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.535 -1.353 . . . . 0.0 110.626 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 77' ' ' ALA . 3.8 m120 -94.93 -21.51 18.59 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.027 -1.045 . . . . 0.0 112.028 -177.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.4 tm? -51.07 -32.28 21.64 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.562 -1.336 . . . . 0.0 108.279 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 1.11 2.8 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -105.96 -27.36 11.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.438 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.2 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.845 . . . . 0.0 109.543 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 175.23 5.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 110.02 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -49.37 135.68 17.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.443 -0.786 . . . . 0.0 109.78 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.1 -17.79 55.87 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 m -62.14 107.98 0.98 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.011 -1.288 . . . . 0.0 107.748 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.1 mtp -70.23 176.27 4.02 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.013 -1.054 . . . . 0.0 110.287 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.69 154.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 0.0 109.22 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -145.65 104.88 3.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.946 . . . . 0.0 109.754 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -94.06 111.8 23.56 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -99.21 148.23 24.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.309 -0.869 . . . . 0.0 110.453 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.1 p -167.09 107.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.86 -146.37 48.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -83.54 43.75 0.92 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 0.0 109.62 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.42 150.1 37.14 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.197 -0.94 . . . . 0.0 109.246 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.9 m -150.53 118.85 6.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.267 -0.895 . . . . 0.0 109.704 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmm180 -92.7 164.16 13.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 109.414 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -145.61 118.89 8.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.954 . . . . 0.0 109.587 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 16.7 m-85 -112.36 -171.49 1.86 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -143.61 101.67 3.81 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.16 -0.963 . . . . 0.0 109.65 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 90.6 mtp -48.94 116.58 1.71 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.862 . . . . 0.0 109.326 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.7 t -161.54 29.9 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.089 . . . . 0.0 110.561 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.5 t -163.5 86.31 0.51 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 120.958 -1.089 . . . . 0.0 108.151 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 100' ' ' ILE . 2.1 mp -82.64 158.3 3.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.538 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.1 OUTLIER -142.12 -15.72 0.77 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 141' ' ' ILE . 3.0 p30 -47.69 -30.19 3.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.192 -0.942 . . . . 0.0 109.372 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 11.9 p -82.2 -32.87 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.427 -0.796 . . . . 0.0 109.452 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -130.32 72.33 81.94 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 106' ' ' THR . 94.6 Cg_endo -79.41 -158.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.605 2.203 . . . . 0.0 112.147 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 105' ' ' PRO . 6.1 t 36.34 47.56 0.5 Allowed 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 121.375 0.607 . . . . 0.0 110.624 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.56 -133.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.406 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.5 m -98.38 27.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.327 -0.858 . . . . 0.0 109.706 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 159.06 89.26 0.07 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.41 -31.2 51.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.5 mt -139.65 54.08 1.69 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.51 ' OD2' ' NE2' ' A' ' 114' ' ' GLN . 1.4 m-20 -78.52 115.92 18.55 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 5.3 pt-20 -83.51 16.87 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.51 ' NE2' ' OD2' ' A' ' 112' ' ' ASP . 2.1 pp0? -150.0 28.69 0.75 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 117' ' ' LYS . 84.9 mttt -40.89 140.65 0.7 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.686 -0.634 . . . . 0.0 109.845 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.25 8.25 0.7 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 115' ' ' LYS . 63.9 mmtt -96.64 -145.91 0.29 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.147 -1.208 . . . . 0.0 109.685 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 119' ' ' LYS . 13.1 t70 -118.86 169.71 9.63 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 60.6 mttm -38.05 135.5 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.437 ' OE1' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.73 161.8 39.07 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.892 -1.13 . . . . 0.0 111.104 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.51 103.8 13.39 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.2 m -91.48 152.95 20.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.84 146.8 36.26 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -0.945 . . . . 0.0 109.274 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.7 mt -136.76 142.02 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.523 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.3 p -91.84 169.67 10.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.866 -1.146 . . . . 0.0 108.815 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 19.6 m -147.8 106.41 3.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.08 -1.012 . . . . 0.0 109.803 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 128' ' ' ASP . 10.5 t70 -157.35 144.9 18.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.012 . . . . 0.0 109.335 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.42 ' OD2' ' OD2' ' A' ' 127' ' ' ASP . 70.6 m-20 53.69 64.92 1.67 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.476 -0.765 . . . . 0.0 109.135 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -65.27 124.11 21.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 110.056 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -86.76 127.52 34.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.937 -1.102 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.605 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.8 pm0 -94.6 12.19 28.44 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.454 -0.779 . . . . 0.0 109.649 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -85.61 -57.97 2.85 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 109.073 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.0 p -95.72 -9.95 30.5 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.365 -0.834 . . . . 0.0 109.136 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.83 46.86 9.11 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.1 t -147.05 153.55 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -1.094 . . . . 0.0 109.551 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.426 ' O ' ' C ' ' A' ' 137' ' ' GLU . 72.5 m95 -61.44 112.29 2.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 136' ' ' TRP . 42.5 tt0 -38.68 -83.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.247 0.546 . . . . 0.0 110.326 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -91.38 135.96 33.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.106 -0.996 . . . . 0.0 108.61 179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 139' ' ' ARG . 0.0 OUTLIER -157.04 122.26 4.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.946 -1.096 . . . . 0.0 110.334 -179.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -100.79 164.48 11.83 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 102' ' ' ASP . 29.3 pt -148.35 151.99 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 120.832 -1.168 . . . . 0.0 110.481 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 143' ' ' VAL . 0.1 OUTLIER -147.28 172.2 14.23 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.65 ' N ' ' CD1' ' A' ' 142' ' ' PHE . 43.0 t -147.32 129.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 120.856 -1.153 . . . . 0.0 110.961 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.19 -176.28 3.18 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.0 t -148.26 136.71 21.42 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.745 -1.222 . . . . 0.0 109.426 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -57.24 150.18 18.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.405 -0.809 . . . . 0.0 109.537 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.7 t -90.48 -144.56 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.343 -0.848 . . . . 0.0 109.131 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.502 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.534 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 ttm . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.302 0.572 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -75.46 141.35 43.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.206 -0.934 . . . . 0.0 109.508 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.45 -168.51 1.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.855 . . . . 0.0 109.371 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 5' ' ' PRO . 14.0 mptt -82.09 156.38 69.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 109.006 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' LYS . 90.0 Cg_exo -40.87 174.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.615 2.21 . . . . 0.0 112.835 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -67.24 152.06 46.4 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.118 -0.989 . . . . 0.0 109.386 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.7 mt -83.75 127.57 67.05 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.356 -0.84 . . . . 0.0 108.989 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -40.85 137.49 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 121.56 1.506 . . . . 0.0 112.248 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -82.46 -20.15 37.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.244 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 12' ' ' SER . 67.2 m-20 -77.87 108.89 11.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.48 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -62.68 -1.09 0.74 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 10' ' ' ASP . 22.6 p -120.49 47.33 1.8 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.667 -0.645 . . . . 0.0 109.517 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -144.8 136.04 25.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.3 -0.875 . . . . 0.0 109.274 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -60.47 114.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.472 -0.767 . . . . 0.0 110.995 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.96 -17.33 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.26 -173.0 35.8 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.99 125.0 9.95 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.101 -1.235 . . . . 0.0 109.211 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -97.29 146.88 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -150.6 131.76 14.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.029 -1.045 . . . . 0.0 110.476 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 HD21 ' A' ' 75' ' ' LEU . 26.6 mt -144.29 126.47 8.29 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.45 -41.54 0.44 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.648 1.565 . . . . 0.0 111.572 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -51.38 -16.19 0.52 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.0 109.469 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -136.13 15.32 3.27 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 23' ' ' ALA . 4.2 p-10 44.23 48.51 7.81 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.404 -0.81 . . . . 0.0 109.875 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 23' ' ' ALA . 46.5 mm -90.31 138.64 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.55 -0.719 . . . . 0.0 109.208 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.08 84.03 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -144.67 151.99 51.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.039 -1.038 . . . . 0.0 110.5 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -82.05 161.71 18.12 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.575 2.183 . . . . 0.0 112.155 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.46 102.77 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.69 171.49 12.17 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 120.761 -1.212 . . . . 0.0 109.109 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -86.39 137.11 4.94 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.592 2.194 . . . . 0.0 112.301 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.66 171.62 20.31 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' ' N ' ' A' ' 35' ' ' THR . 92.2 Cg_endo -78.01 117.88 4.28 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.587 2.192 . . . . 0.0 110.767 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -43.04 88.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.698 -0.626 . . . . 0.0 110.338 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -114.6 153.89 46.71 Favored Pre-proline 0 N--CA 1.498 1.959 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -65.05 -41.9 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.944 1.763 . . . . 0.0 112.112 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.04 -23.46 67.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.906 -1.121 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -90.82 -66.82 0.89 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.079 -1.013 . . . . 0.0 109.17 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.3 mt -45.27 -16.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.973 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.2 m-20 -64.2 -24.45 67.68 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' NH1' ' HG2' ' A' ' 41' ' ' ARG . 30.5 mtt-85 -87.34 -10.63 51.69 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 154.67 -129.47 2.59 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.5 t -112.67 156.63 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.613 -0.933 . . . . 0.0 109.907 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.5 m -150.68 154.84 38.18 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -58.56 169.96 0.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.593 -1.317 . . . . 0.0 110.068 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.64 -0.92 49.4 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -154.95 150.67 27.63 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.59 0.71 . . . . 0.0 110.01 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -63.9 -40.28 96.14 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.597 -0.689 . . . . 0.0 111.631 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -87.63 12.76 11.79 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.874 -1.141 . . . . 0.0 111.595 -177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -62.67 101.9 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.786 -1.196 . . . . 0.0 109.519 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 53' ' ' ASP . 8.6 p -93.61 141.85 28.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 109.154 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.668 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -54.85 -9.91 0.41 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 179.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' SER . 7.8 t70 -95.16 -9.91 32.08 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.678 -0.639 . . . . 0.0 109.817 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' ASN . 30.7 t0 -56.35 113.26 1.51 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 120.832 -1.167 . . . . 0.0 109.001 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 1.1 tt0 -41.58 -20.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.693 -0.629 . . . . 0.0 110.186 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 54' ' ' ASP . 15.4 p-10 -137.34 115.21 11.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.27 -0.894 . . . . 0.0 108.772 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -97.72 152.26 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 46' ' ' ALA . 9.3 m -140.66 105.42 4.93 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 60' ' ' ALA . 81.6 mt -100.28 161.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.773 0.797 . . . . 0.0 110.725 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.535 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -139.05 129.84 26.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -137.94 160.14 25.24 Favored Glycine 0 N--CA 1.502 3.054 0 C-N-CA 120.078 -1.058 . . . . 0.0 110.54 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.604 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 19.3 m-70 -77.25 179.11 6.58 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.585 -0.95 . . . . 0.0 109.791 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.426 ' OG1' ' NZ ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -153.49 91.75 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 108.734 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' N ' ' OG1' ' A' ' 73' ' ' THR . 7.3 m-85 -86.51 104.55 16.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.074 -1.016 . . . . 0.0 109.132 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.5 mt -56.83 -32.17 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.0 109.684 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.24 17.05 2.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.426 -0.796 . . . . 0.0 109.059 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.527 ' C ' ' H ' ' A' ' 69' ' ' ASN . 6.3 tpp180 -150.46 72.51 9.09 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.25 25.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 123.297 2.665 . . . . 0.0 113.522 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.527 ' H ' ' C ' ' A' ' 67' ' ' ARG . 18.3 p30 -149.78 39.21 0.78 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.829 -1.17 . . . . 0.0 109.093 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -105.74 -153.57 0.49 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.669 0.747 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.604 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 29.0 mt-30 -64.79 -89.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.657 -0.652 . . . . 0.0 111.776 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 62' ' ' HIS . 0.6 OUTLIER -93.97 22.54 5.64 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.41 -0.806 . . . . 0.0 110.191 -177.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.448 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 92.7 m -72.8 -24.88 60.98 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.306 -1.496 . . . . 0.0 109.951 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -119.37 -13.93 9.23 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.136 -0.977 . . . . 0.0 111.291 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.436 HD21 HD12 ' A' ' 20' ' ' ILE . 7.1 mt -51.74 -19.9 1.87 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.62 -1.3 . . . . 0.0 108.79 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' NZ ' ' OG1' ' A' ' 63' ' ' THR . 12.1 pttm -88.55 -8.4 54.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.242 -0.911 . . . . 0.0 108.563 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -85.69 -21.78 28.16 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -53.4 -174.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 109.362 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 81' ' ' GLY . 45.9 mtmt -150.23 155.23 39.33 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.22 -0.925 . . . . 0.0 109.39 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HZ3' ' HB2' ' A' ' 80' ' ' LYS . 11.0 ttmm -51.4 89.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 148.19 -15.94 1.32 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.029 -1.629 . . . . 0.0 109.029 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.6 m -62.59 114.22 3.44 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.0 ptm -68.9 -179.59 1.52 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.48 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.06 153.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.34 -0.85 . . . . 0.0 109.593 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -132.74 103.28 6.03 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -94.36 111.7 23.46 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ttmm -90.65 150.81 21.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.542 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 90' ' ' ASN . 71.6 t -150.01 151.3 12.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.45 -4.89 0.42 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 88' ' ' VAL . 55.0 m-20 -102.41 -45.96 4.93 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.311 -1.111 . . . . 0.0 110.32 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -171.55 -156.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.985 -1.072 . . . . 0.0 109.106 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 86.4 m -132.88 120.3 21.32 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.345 -0.847 . . . . 0.0 109.941 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.528 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -92.13 171.9 8.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.472 -0.768 . . . . 0.0 109.031 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 8.5 mtmp? -144.84 152.32 40.1 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 11.4 m-85 -139.34 178.57 7.1 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -142.28 105.82 4.66 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.147 -0.971 . . . . 0.0 109.773 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 55.0 mtt -49.33 125.1 10.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.6 t -150.78 19.45 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 143' ' ' VAL . 3.4 p -174.69 122.87 0.26 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 pt -143.86 147.98 19.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.286 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 101' ' ' ARG . 0.0 OUTLIER -98.68 -77.25 0.52 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.0 109.169 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 102' ' ' ASP . 2.7 p30 42.81 33.7 0.51 Allowed 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.579 0.704 . . . . 0.0 109.375 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 104' ' ' LYS . 24.2 t -150.01 -76.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' N ' HG12 ' A' ' 103' ' ' VAL . 53.0 tttp -117.45 82.26 15.07 Favored Pre-proline 0 N--CA 1.496 1.848 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 107' ' ' ASP . 97.8 Cg_exo -43.49 -39.26 9.36 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.309 2.006 . . . . 0.0 112.658 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.7 p -68.48 46.17 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.32 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 105' ' ' PRO . 47.7 t0 -85.03 -83.02 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.253 -0.904 . . . . 0.0 109.729 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 m -112.84 34.96 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.406 -0.809 . . . . 0.0 109.654 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.16 120.2 0.07 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.6 t -67.45 -28.41 42.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.271 -1.135 . . . . 0.0 108.853 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.7 mt -138.16 80.82 1.82 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 20.1 t70 -119.47 -154.9 0.59 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.598 ' C ' HE21 ' A' ' 114' ' ' GLN . 27.2 tt0 -50.43 175.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.981 -1.074 . . . . 0.0 108.268 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.608 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.2 OUTLIER -88.44 68.29 8.78 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 117' ' ' LYS . 8.2 mmtm 1.77 110.37 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.718 0 CA-C-O 121.192 0.52 . . . . 0.0 111.584 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -51.71 80.34 0.01 OUTLIER Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.586 ' N ' ' O ' ' A' ' 115' ' ' LYS . 30.2 ttmt -149.81 -133.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.298 -1.119 . . . . 0.0 108.897 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' GLN . 11.2 m-20 -119.45 169.63 9.86 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HZ2' ' HB2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -37.84 91.23 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 121.907 0.86 . . . . 0.0 109.323 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER -95.47 147.15 23.84 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.411 0.624 . . . . 0.0 110.123 -178.213 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.5 mt -102.74 155.16 18.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.516 -0.74 . . . . 0.0 109.407 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -139.64 87.85 2.2 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.418 ' O ' HG23 ' A' ' 141' ' ' ILE . 9.6 mt -74.04 145.31 44.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 0.0 110.75 -178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.481 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 50.0 mt -139.69 148.31 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.468 -0.77 . . . . 0.0 109.085 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.464 HG22 ' CE1' ' A' ' 72' ' ' PHE . 1.0 OUTLIER -96.59 170.16 9.39 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 179.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.538 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -149.81 95.56 2.33 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -155.39 141.94 18.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 109.485 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.6 55.66 0.99 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.367 -0.833 . . . . 0.0 109.073 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -64.13 123.18 18.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 109.833 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -84.4 122.83 29.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.0 109.302 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -87.53 4.74 42.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.407 -0.808 . . . . 0.0 109.937 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -80.17 -55.85 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.081 -1.012 . . . . 0.0 109.441 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.9 p -95.7 -12.05 26.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.242 -0.911 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 45.55 10.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.7 t -146.96 153.87 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.259 -1.142 . . . . 0.0 109.61 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.538 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 66.0 m95 -61.73 110.69 1.59 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.184 -0.948 . . . . 0.0 108.591 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 136' ' ' TRP . 2.8 tm-20 -42.37 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.487 -0.758 . . . . 0.0 109.859 -179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.53 144.13 27.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 108.248 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.518 HH11 ' HG2' ' A' ' 139' ' ' ARG . 0.5 OUTLIER -161.05 94.33 1.01 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.0 110.548 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -75.1 163.84 27.14 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.457 ' C ' ' CD1' ' A' ' 142' ' ' PHE . 4.2 mt -144.28 155.47 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.058 -1.026 . . . . 0.0 110.791 -178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 141' ' ' ILE . 38.5 m-85 -140.74 165.01 28.66 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 99' ' ' SER . 57.6 t -147.65 148.17 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 120.839 -1.163 . . . . 0.0 110.385 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -141.73 179.24 6.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 13.5 t -143.46 142.71 31.29 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.09 -1.006 . . . . 0.0 109.979 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -56.82 152.32 12.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.37 -0.831 . . . . 0.0 109.608 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.4 m -92.72 168.36 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.378 -0.827 . . . . 0.0 109.297 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.128 -0.983 . . . . 0.0 109.315 179.906 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.553 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -171.39 134.88 0.9 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.131 -0.981 . . . . 0.0 109.636 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.34 60.36 1.99 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.137 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -149.48 64.76 7.41 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.325 -0.86 . . . . 0.0 109.213 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.25 -151.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.808 2.338 . . . . 0.0 111.949 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -67.25 105.15 1.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.007 -1.058 . . . . 0.0 110.589 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mt -150.67 95.09 3.52 Favored Pre-proline 0 N--CA 1.495 1.792 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.26 114.36 0.83 Allowed 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 122.388 2.058 . . . . 0.0 112.916 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -60.03 -11.09 5.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.24 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.494 ' C ' ' H ' ' A' ' 12' ' ' SER . 34.8 m-20 -77.02 100.53 5.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -59.38 0.73 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 10' ' ' ASP . 49.9 m -122.85 39.49 3.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.273 -0.892 . . . . 0.0 109.529 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -142.71 143.58 32.34 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.478 HG12 ' H ' ' A' ' 16' ' ' GLY . 62.8 t -58.23 155.28 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.37 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -141.7 6.62 1.84 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 162.79 -172.8 38.92 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 81.1 m-85 -146.72 125.52 12.66 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -1.071 . . . . 0.0 109.706 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.586 HD11 ' CG1' ' A' ' 84' ' ' VAL . 9.0 tp -95.08 144.25 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -146.98 129.13 15.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.879 -1.138 . . . . 0.0 110.569 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.9 mt -144.76 126.98 8.15 Favored Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.3 Cg_endo -76.9 -42.15 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.673 1.582 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -52.75 -12.96 0.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -134.05 10.74 3.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 p30 40.95 39.86 0.91 Allowed 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.475 0.655 . . . . 0.0 110.121 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.415 HD11 ' H ' ' A' ' 75' ' ' LEU . 7.0 mt -94.7 146.23 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.944 0.878 . . . . 0.0 110.024 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -166.02 83.16 0.3 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -139.96 159.53 64.15 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.388 -0.82 . . . . 0.0 110.645 -177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.47 161.5 22.35 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.946 2.431 . . . . 0.0 112.579 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.5 113.21 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.423 ' OH ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.32 171.29 12.53 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 120.756 -1.215 . . . . 0.0 109.181 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -95.32 136.99 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.546 2.164 . . . . 0.0 112.018 178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 152.72 173.53 22.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.574 ' O ' ' N ' ' A' ' 35' ' ' THR . 57.0 Cg_endo -71.88 115.43 4.3 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.731 2.287 . . . . 0.0 110.785 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.49 86.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.59 -0.694 . . . . 0.0 110.741 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.574 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.9 p -109.0 152.52 42.49 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.527 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 32.7 Cg_endo -63.52 -43.22 18.15 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.072 1.848 . . . . 0.0 112.153 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.07 -27.41 69.37 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.027 -1.045 . . . . 0.0 109.527 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -84.14 -63.72 1.29 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.207 -0.933 . . . . 0.0 109.54 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.6 mt -47.5 -13.74 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.472 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.7 m120 -59.02 -28.13 66.12 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' C ' ' OH ' ' A' ' 30' ' ' TYR . 26.6 mtt-85 -79.84 -17.72 52.57 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 157.17 -101.61 0.21 Allowed Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.59 -1.29 . . . . 0.0 111.057 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 60' ' ' ALA . 4.8 t -135.5 155.14 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -1.073 . . . . 0.0 110.217 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 t -151.22 152.04 32.71 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -56.55 171.32 0.31 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.546 -1.346 . . . . 0.0 109.346 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -80.52 -10.38 59.74 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -149.71 154.68 38.93 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.778 0.799 . . . . 0.0 109.96 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' A' ' 49' ' ' ASN . 17.8 pt-20 -64.48 -43.09 95.25 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 48' ' ' GLU . 31.6 m120 -84.68 10.3 11.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.597 -1.314 . . . . 0.0 111.037 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 58' ' ' SER . 4.5 mm-40 -64.75 96.74 0.19 Allowed 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.27 -0.894 . . . . 0.0 110.354 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.6 p -93.69 175.27 6.8 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -79.92 -10.64 59.8 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -102.19 -4.12 26.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.589 -0.694 . . . . 0.0 109.975 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 56' ' ' ASN . 10.3 t70 -58.72 125.56 23.99 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.848 -1.158 . . . . 0.0 109.337 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.595 HE22 ' N ' ' A' ' 119' ' ' LYS . 34.8 tp60 -39.28 -24.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.73 -0.606 . . . . 0.0 109.956 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 54' ' ' ASP . 52.4 t-20 -151.96 113.87 4.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.941 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 58' ' ' SER . 4.1 mp -96.11 156.04 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.513 ' N ' ' OE2' ' A' ' 50' ' ' GLU . 34.0 t -143.21 123.41 13.73 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 60' ' ' ALA . 73.4 mt -110.9 153.68 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.547 -0.721 . . . . 0.0 110.567 -178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.533 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -133.9 132.56 40.43 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -140.28 157.28 25.5 Favored Glycine 0 N--CA 1.503 3.13 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.995 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -70.61 176.38 4.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.73 -0.865 . . . . 0.0 109.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.586 HG22 ' O ' ' A' ' 63' ' ' THR . 0.9 OUTLIER -159.34 93.83 1.15 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.13 105.51 17.59 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.166 -0.959 . . . . 0.0 108.915 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 65' ' ' ILE . 18.9 mt -59.74 -29.09 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 66' ' ' ASP . 8.2 t70 -84.55 11.22 9.15 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.277 -0.89 . . . . 0.0 109.399 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 69' ' ' ASN . 24.5 ttm180 -151.62 79.75 6.46 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 121.678 -0.639 . . . . 0.0 109.277 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.25 24.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.506 2.235 0 C-N-CA 123.702 2.935 . . . . 0.0 114.357 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 67' ' ' ARG . 40.6 m-80 -151.09 62.77 0.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 0.0 108.597 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.52 ' CD2' ' OE1' ' A' ' 71' ' ' GLN . 15.3 t80 -146.73 102.93 3.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.165 -0.959 . . . . 0.0 110.272 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.541 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 15.2 mp0 55.28 -113.87 0.82 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 111.796 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.4 m-85 -92.42 7.73 41.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.085 -1.01 . . . . 0.0 110.421 -177.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.8 m -47.16 -33.65 5.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.74 -1.225 . . . . 0.0 109.698 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 8.1 m120 -100.28 -28.95 12.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.463 -0.773 . . . . 0.0 110.472 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 77' ' ' ALA . 6.9 tp -54.11 -31.94 53.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.616 -1.303 . . . . 0.0 108.792 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -65.99 -3.28 5.02 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -102.33 -28.5 12.21 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -44.75 168.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.441 -0.787 . . . . 0.0 110.017 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' CB ' ' NZ ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -141.78 160.76 39.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.372 -0.83 . . . . 0.0 108.94 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -49.99 137.08 17.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.03 -1.044 . . . . 0.0 109.312 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.78 -23.94 32.28 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 10.6 m -62.68 115.9 4.71 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.211 -1.17 . . . . 0.0 108.057 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.83 176.7 4.73 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.971 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.586 ' CG1' HD11 ' A' ' 18' ' ' ILE . 13.9 t -142.81 109.27 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.472 -0.768 . . . . 0.0 109.405 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -93.67 102.84 15.02 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -96.99 112.17 24.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -93.89 154.32 17.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.036 -1.04 . . . . 0.0 110.74 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 90' ' ' ASN . 1.6 m -151.15 160.07 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.36 46.38 0.26 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 91' ' ' GLU . 22.7 p30 -160.33 -36.78 0.05 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 109.783 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 90' ' ' ASN . 5.0 tt0 -174.24 -157.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 108.925 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 92' ' ' THR . 7.0 t -141.54 129.76 22.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.228 -0.92 . . . . 0.0 110.048 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -92.12 162.37 14.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.398 -0.813 . . . . 0.0 109.212 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -144.36 93.98 2.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.086 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -93.23 179.34 5.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.076 -1.015 . . . . 0.0 108.8 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 98' ' ' THR . 36.1 ttpt -144.96 114.82 7.34 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 58.3 mtt -48.96 96.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.381 -0.824 . . . . 0.0 109.113 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.6 m -126.03 29.65 5.83 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.579 -0.7 . . . . 0.0 109.538 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -172.3 86.98 0.08 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.15 -0.969 . . . . 0.0 108.499 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 40.4 mm -83.04 147.43 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -145.34 -15.81 0.5 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.008 -1.057 . . . . 0.0 109.883 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 103' ' ' VAL . 29.2 p-10 -43.5 -51.41 6.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.493 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 79.6 t -82.52 130.0 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 109.503 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm 46.9 68.87 3.07 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.328 -0.858 . . . . 0.0 109.439 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.7 -101.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.449 2.099 . . . . 0.0 112.034 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 66.7 p 46.19 50.58 11.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.193 -0.942 . . . . 0.0 109.79 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.43 -163.33 1.04 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.213 -0.929 . . . . 0.0 109.332 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.2 m -78.29 37.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.139 -0.976 . . . . 0.0 109.44 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.99 136.75 5.88 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.6 -43.98 83.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.266 -1.138 . . . . 0.0 108.617 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.5 mt -100.37 62.25 1.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.635 -0.665 . . . . 0.0 109.279 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 12.3 t70 -172.29 21.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.479 -0.763 . . . . 0.0 109.175 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -109.04 -3.63 17.27 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 116' ' ' GLY . 4.9 pp0? -98.7 8.45 44.92 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -47.22 -18.33 0.09 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.285 0.564 . . . . 0.0 109.533 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 114' ' ' GLN . . . -171.28 26.2 0.1 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.76 -151.13 0.32 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.286 -1.126 . . . . 0.0 108.961 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.569 ' C ' HE22 ' A' ' 55' ' ' GLN . 16.7 t70 -115.75 163.18 16.21 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.595 ' N ' HE22 ' A' ' 55' ' ' GLN . 46.4 mttp -43.35 129.81 4.94 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.315 -0.866 . . . . 0.0 109.398 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.589 HE22 HE21 ' A' ' 55' ' ' GLN . 0.1 OUTLIER -148.42 167.43 25.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.0 -1.062 . . . . 0.0 110.117 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 33.7 tp -118.8 122.2 41.83 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.651 -0.656 . . . . 0.0 110.35 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -100.63 94.13 5.94 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.636 ' H ' HD12 ' A' ' 123' ' ' LEU . 5.4 mp -73.78 147.4 43.49 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.222 -0.923 . . . . 0.0 110.244 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.507 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 82.0 mt -138.13 148.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 18.1 p -102.18 165.23 11.26 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.34 -0.85 . . . . 0.0 108.898 178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.9 m -147.51 87.44 1.65 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.976 -1.077 . . . . 0.0 109.273 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 7.1 p30 -130.21 146.34 51.82 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.22 -0.925 . . . . 0.0 110.089 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 54.8 72.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.657 -0.652 . . . . 0.0 109.493 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -67.56 119.96 13.2 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.181 -0.949 . . . . 0.0 109.683 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -88.88 123.11 32.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.779 -1.201 . . . . 0.0 109.711 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 131' ' ' GLU . 1.3 pm0 -93.13 -13.01 29.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.346 -0.847 . . . . 0.0 109.019 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -62.93 -49.72 73.68 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 46.7 p -97.35 -13.34 21.95 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.864 . . . . 0.0 108.775 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.06 38.19 27.02 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.15 162.01 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.444 ' O ' ' C ' ' A' ' 137' ' ' GLU . 78.9 m95 -64.73 113.21 3.62 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 10.6 tp10 -36.99 -81.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.947 -0.471 . . . . 0.0 110.418 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -111.12 137.72 48.44 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.49 113.85 5.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.197 -0.939 . . . . 0.0 109.753 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.48 ' N ' ' OG1' ' A' ' 125' ' ' THR . 44.5 mttm -75.45 166.84 22.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.107 -0.996 . . . . 0.0 108.517 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.488 ' O ' ' N ' ' A' ' 102' ' ' ASP . 10.4 pt -149.6 134.51 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.937 -1.102 . . . . 0.0 110.331 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 0.4 OUTLIER -130.06 169.85 14.76 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 t -145.85 143.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.818 -1.176 . . . . 0.0 110.667 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -132.8 126.24 31.89 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.4 t -94.49 145.65 24.65 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.911 . . . . 0.0 109.46 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -58.41 147.12 32.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 109.45 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.456 ' H ' HG22 ' A' ' 147' ' ' VAL . 5.2 m -90.03 147.3 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.544 -179.943 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.579 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -64.63 152.23 42.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.38 179.31 8.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.325 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' PRO . 20.5 pttm -50.18 127.55 22.18 Favored Pre-proline 0 N--CA 1.486 1.358 0 O-C-N 121.214 -0.929 . . . . 0.0 109.305 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LYS . 90.7 Cg_exo -42.07 176.26 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.382 2.055 . . . . 0.0 113.121 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -71.46 92.98 1.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.473 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.3 mt -86.3 119.3 71.48 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 108.755 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -42.57 156.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.475 1.45 . . . . 0.0 112.179 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -103.38 -23.71 13.54 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 21.5 t0 -76.96 108.13 9.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.124 -0.985 . . . . 0.0 109.668 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -58.28 -3.61 0.28 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.267 -0.895 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 42.3 m -115.27 43.43 2.02 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.487 -0.758 . . . . 0.0 109.349 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -147.6 145.86 29.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.248 -0.907 . . . . 0.0 109.403 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 16' ' ' GLY . 86.5 t -59.72 149.23 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-O 121.857 0.837 . . . . 0.0 110.742 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -141.39 12.46 2.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 160.17 177.07 32.94 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.25 122.5 9.59 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.04 -1.27 . . . . 0.0 109.055 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.7 tt -97.57 151.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -149.48 132.25 15.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 110.045 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 50.3 mt -142.29 125.71 9.57 Favored Pre-proline 0 N--CA 1.496 1.84 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.451 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.2 Cg_endo -76.1 -43.07 0.33 Allowed 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.692 1.595 . . . . 0.0 111.511 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -51.05 -14.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.275 -0.89 . . . . 0.0 108.867 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.451 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.4 12.52 3.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.661 -0.649 . . . . 0.0 109.285 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.6 p-10 43.02 51.86 5.34 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.42 -0.8 . . . . 0.0 109.615 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.6 mm -95.69 147.25 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 122.045 0.926 . . . . 0.0 111.04 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -168.75 80.41 0.14 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 71' ' ' GLN . 10.0 mt-10 -139.3 158.57 68.73 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.299 -0.876 . . . . 0.0 110.944 -176.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -86.25 160.44 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.986 2.457 . . . . 0.0 112.91 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.6 t -132.46 101.7 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.65 171.72 11.19 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.918 -1.114 . . . . 0.0 109.76 -178.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -86.59 116.02 1.34 Allowed 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 123.142 2.561 . . . . 0.0 112.945 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.23 160.99 22.78 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.736 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 35' ' ' THR . 90.3 Cg_endo -76.59 126.77 9.17 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.702 2.268 . . . . 0.0 111.053 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -41.58 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.753 -0.592 . . . . 0.0 110.77 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.576 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.7 p -127.17 149.61 70.02 Favored Pre-proline 0 N--CA 1.499 1.978 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.525 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 19.7 Cg_endo -58.21 -43.04 50.65 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.925 1.75 . . . . 0.0 112.185 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.22 -20.87 65.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.106 -0.996 . . . . 0.0 109.788 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -89.26 -68.63 0.76 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.16 -0.962 . . . . 0.0 109.378 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.2 mt -47.34 -11.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.979 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 38' ' ' GLN . 4.0 m120 -56.84 -28.88 62.24 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 19.9 mmt180 -81.12 -18.31 46.9 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.536 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 147.83 -124.51 1.92 Allowed Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 30' ' ' TYR . 2.3 t -97.6 160.66 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.288 -1.125 . . . . 0.0 109.825 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 p -165.22 153.62 11.78 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.266 -0.896 . . . . 0.0 108.778 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -53.54 167.19 0.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.954 -1.091 . . . . 0.0 108.802 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -100.4 11.14 40.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.394 -0.816 . . . . 0.0 109.055 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -156.16 134.3 11.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.988 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.61 -25.63 68.19 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -87.07 17.29 4.29 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.926 -1.109 . . . . 0.0 110.03 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 51' ' ' SER . 1.7 pp20? -62.43 165.63 5.94 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.732 0.777 . . . . 0.0 110.347 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.533 ' N ' ' OE1' ' A' ' 50' ' ' GLU . 2.1 p -150.77 174.12 13.42 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -83.12 2.74 33.8 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.9 -1.125 . . . . 0.0 108.368 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -154.86 25.02 0.44 Allowed 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.473 -0.767 . . . . 0.0 110.126 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' N ' ' OG ' ' A' ' 51' ' ' SER . 24.2 t70 -56.7 124.04 17.03 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.742 -1.224 . . . . 0.0 108.571 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.483 ' CD ' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -43.77 -22.89 0.06 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.27 -0.894 . . . . 0.0 109.954 -179.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 41.9 t-20 -140.18 97.1 3.16 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 58' ' ' SER . 96.9 mt -94.41 154.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.291 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 57' ' ' ILE . 23.1 p -142.64 120.8 12.19 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 60' ' ' ALA . 79.5 mt -114.59 164.88 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.846 0.831 . . . . 0.0 110.753 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.588 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -141.12 139.87 34.03 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.03 145.08 13.45 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.587 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.694 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 39.0 m-70 -73.16 -172.19 1.05 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.99 . . . . 0.0 109.42 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.23 88.64 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.848 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -89.1 121.82 31.8 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 0.0 108.734 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.401 HG13 ' H ' ' A' ' 65' ' ' ILE . 7.4 mt -61.65 -32.34 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.449 -0.782 . . . . 0.0 110.67 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -83.69 17.45 2.27 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.716 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.563 ' C ' ' H ' ' A' ' 69' ' ' ASN . 53.5 mtp180 -150.11 73.26 9.34 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.56 -0.712 . . . . 0.0 109.393 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -52.57 12.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 123.285 2.657 . . . . 0.0 113.62 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.563 ' H ' ' C ' ' A' ' 67' ' ' ARG . 1.6 p30 -147.15 57.51 1.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.916 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -141.87 112.66 7.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.364 -0.835 . . . . 0.0 109.532 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.694 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 7.5 mt-30 51.85 -127.78 2.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.469 -0.77 . . . . 0.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.419 ' CE2' HD13 ' A' ' 75' ' ' LEU . 5.8 m-30 -93.97 42.5 1.1 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.834 -1.166 . . . . 0.0 110.404 -178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 96.9 m -68.79 -16.48 63.81 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.445 -1.409 . . . . 0.0 109.091 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 14.8 m-20 -125.82 -25.54 3.62 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.582 -0.699 . . . . 0.0 109.99 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.532 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -53.92 -25.29 19.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 0.0 108.591 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 pttt -74.35 -6.06 45.91 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -94.16 -28.61 15.57 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.377 0.608 . . . . 0.0 109.409 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -46.86 173.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.486 -0.759 . . . . 0.0 109.801 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' C ' ' SD ' ' A' ' 97' ' ' MET . 14.6 ptpt -155.37 179.36 9.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.181 -0.95 . . . . 0.0 109.369 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.606 ' HZ1' ' H ' ' A' ' 100' ' ' ILE . 58.1 mmtt -47.4 138.32 7.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.17 -16.05 59.64 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 9.5 t -62.54 97.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.168 -1.195 . . . . 0.0 108.494 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 95' ' ' TYR . 70.3 mmm -62.93 168.28 4.09 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.176 -0.952 . . . . 0.0 109.773 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.8 t -142.32 114.87 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.519 -0.738 . . . . 0.0 109.482 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -95.25 107.29 19.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.114 -0.991 . . . . 0.0 109.614 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 88' ' ' VAL . 41.0 t80 -94.64 112.33 24.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 88' ' ' VAL . 35.6 ttpt -94.18 135.0 36.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.088 -1.007 . . . . 0.0 110.969 -178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 86' ' ' PHE . 4.2 m -157.06 132.31 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 55.96 -148.33 28.25 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -94.61 50.67 1.35 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.195 -1.179 . . . . 0.0 109.749 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -171.24 140.26 1.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.036 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 92' ' ' THR . 15.2 t -120.8 133.14 55.33 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.543 -0.723 . . . . 0.0 110.303 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.537 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -91.8 178.23 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.428 -0.795 . . . . 0.0 109.253 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 15.1 ptpt -145.66 152.3 39.41 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.147 -0.971 . . . . 0.0 109.861 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.497 ' CD1' HD11 ' A' ' 121' ' ' LEU . 26.6 m-85 -141.23 178.79 7.16 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.259 -0.9 . . . . 0.0 108.759 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -143.35 110.34 5.64 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.18 -0.95 . . . . 0.0 109.938 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 79' ' ' LYS . 37.3 ttm -48.19 127.05 12.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 98' ' ' THR . 11.1 m -161.78 25.68 0.12 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.941 -1.1 . . . . 0.0 110.269 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.476 ' N ' ' HZ3' ' A' ' 80' ' ' LYS . 2.2 m -163.27 87.43 0.55 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.672 -1.267 . . . . 0.0 108.636 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.606 ' H ' ' HZ1' ' A' ' 80' ' ' LYS . 1.3 mp -82.49 140.03 16.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.394 -0.816 . . . . 0.0 109.129 -179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.681 HH11 ' NZ ' ' A' ' 115' ' ' LYS . 44.3 mtm180 -137.85 12.92 2.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.476 -0.765 . . . . 0.0 109.302 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 141' ' ' ILE . 2.6 p30 -65.49 47.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.441 -0.787 . . . . 0.0 109.611 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.657 ' O ' HG12 ' A' ' 103' ' ' VAL . 52.9 t -148.91 9.19 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.251 -0.906 . . . . 0.0 108.793 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.8 mttm 58.3 58.14 6.43 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.389 -0.82 . . . . 0.0 109.805 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 106' ' ' THR . 84.2 Cg_endo -78.76 -4.5 14.08 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.661 2.24 . . . . 0.0 112.185 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' PRO . 2.4 t 33.89 59.33 0.56 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.336 0.589 . . . . 0.0 110.596 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -58.5 -72.1 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.1 m -152.02 20.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.9 122.65 1.89 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 110' ' ' VAL . 4.3 m -68.64 -28.89 41.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.273 -1.134 . . . . 0.0 108.658 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.6 mt -138.59 73.87 1.45 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.603 -0.686 . . . . 0.0 109.6 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.568 ' CG ' HE22 ' A' ' 114' ' ' GLN . 25.7 t0 -103.27 -146.45 0.37 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.363 -0.835 . . . . 0.0 108.865 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.558 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 14.0 pt-20 -143.3 25.83 1.68 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.132 -0.98 . . . . 0.0 109.399 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.568 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -144.2 28.37 1.37 Allowed 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.681 ' NZ ' HH11 ' A' ' 101' ' ' ARG . 1.0 OUTLIER -57.59 152.76 14.41 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.783 0.801 . . . . 0.0 110.304 -179.112 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 117' ' ' LYS . . . 46.54 -103.36 0.06 OUTLIER Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 116' ' ' GLY . 81.7 mttt -158.08 -44.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.641 -0.917 . . . . 0.0 110.305 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.491 ' O ' ' C ' ' A' ' 119' ' ' LYS . 3.1 m-20 -118.39 170.92 8.51 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.7 -0.625 . . . . 0.0 109.909 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.555 ' CD ' ' H ' ' A' ' 119' ' ' LYS . 1.6 mptm? -30.89 129.85 0.12 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.256 0.551 . . . . 0.0 110.043 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.532 ' NE2' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -147.3 168.37 21.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.059 -1.025 . . . . 0.0 109.962 -178.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 95' ' ' TYR . 60.7 mt -124.31 111.81 16.25 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.742 -0.598 . . . . 0.0 109.911 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.3 m -91.68 88.07 6.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.041 -1.037 . . . . 0.0 108.243 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 123' ' ' LEU . 6.9 mp -78.16 154.51 31.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.103 -0.998 . . . . 0.0 110.205 -178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 18.4 mt -140.01 148.89 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.481 ' OG1' ' N ' ' A' ' 140' ' ' LYS . 56.2 p -99.03 163.64 12.5 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.6 m -147.34 149.54 33.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.95 -1.094 . . . . 0.0 109.579 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 171.88 130.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.492 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 27.8 t0 60.34 71.24 0.58 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.477 -0.764 . . . . 0.0 109.011 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 130' ' ' ASN . 40.7 t80 -65.1 132.43 49.15 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.655 -1.278 . . . . 0.0 110.026 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.436 ' O ' ' CE1' ' A' ' 129' ' ' TYR . 51.7 t30 -79.64 119.64 22.86 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.982 -1.074 . . . . 0.0 109.351 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -91.97 0.61 57.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.227 -0.92 . . . . 0.0 109.544 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -78.87 -64.66 1.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.1 p -94.84 -7.65 39.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.293 -0.879 . . . . 0.0 109.48 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 53.78 4.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.98 151.4 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.199 -1.177 . . . . 0.0 109.551 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.429 ' O ' ' C ' ' A' ' 137' ' ' GLU . 68.7 m95 -63.39 116.41 5.51 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 128' ' ' ASP . 7.0 mm-40 -37.76 -85.91 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.549 0.69 . . . . 0.0 110.149 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -111.76 156.03 22.59 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -170.16 -160.34 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.137 -0.977 . . . . 0.0 109.963 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.481 ' N ' ' OG1' ' A' ' 125' ' ' THR . 59.7 mttp -152.05 160.46 43.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.543 ' O ' ' N ' ' A' ' 102' ' ' ASP . 17.5 mt -141.69 127.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.131 -0.981 . . . . 0.0 110.201 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.486 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -147.58 149.02 31.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.91 . . . . 0.0 108.715 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 47.4 t -125.47 136.22 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.463 -0.773 . . . . 0.0 111.142 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -106.73 174.85 5.71 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.2 t -140.26 135.95 32.83 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.016 -1.052 . . . . 0.0 109.835 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.87 131.12 49.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.407 -0.808 . . . . 0.0 109.271 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -90.22 146.85 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 20.2 pttp . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.379 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 mmt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -148.86 161.59 41.54 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.187 -0.946 . . . . 0.0 109.279 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.55 162.24 7.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.662 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.42 ' H ' HD11 ' A' ' 52' ' ' LEU . 63.6 mttm -152.15 143.52 15.92 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.273 -0.892 . . . . 0.0 108.987 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -83.4 99.3 0.85 Allowed 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.434 2.09 . . . . 0.0 113.059 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -151.04 72.73 1.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.928 -1.107 . . . . 0.0 109.355 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.6 mt -151.07 93.71 3.61 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.98 -163.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.244 1.963 . . . . 0.0 112.168 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -126.41 -23.17 3.85 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 12' ' ' SER . 16.9 t0 -77.41 114.15 15.94 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.351 -0.843 . . . . 0.0 109.239 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -58.33 -2.55 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.341 -0.85 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 10' ' ' ASP . 24.2 p -112.39 41.78 1.94 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.455 -0.778 . . . . 0.0 109.618 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 ttmm -146.24 137.25 24.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -1.0 . . . . 0.0 109.78 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 16' ' ' GLY . 60.1 t -61.34 159.76 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 121.682 0.753 . . . . 0.0 110.762 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -139.65 1.4 1.91 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.579 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 163.67 -170.39 38.99 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 62.5 m-85 -147.27 125.76 12.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.126 -1.22 . . . . 0.0 110.518 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 tp -95.51 140.13 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -145.15 145.49 31.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.827 -1.17 . . . . 0.0 110.822 -178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.484 ' CD1' HD21 ' A' ' 75' ' ' LEU . 12.6 mt -147.8 129.35 7.31 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.07 -53.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.86 1.707 . . . . 0.0 112.296 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.96 -27.89 6.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -0.934 . . . . 0.0 109.742 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.37 5.91 20.03 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.43 -0.793 . . . . 0.0 109.163 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.4 p30 42.95 35.75 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.738 -0.601 . . . . 0.0 110.395 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 mt -90.5 146.39 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.365 -0.834 . . . . 0.0 109.113 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -166.59 84.47 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.77 158.12 74.72 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.39 -0.819 . . . . 0.0 110.447 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.69 161.61 16.53 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 123.114 2.542 . . . . 0.0 113.083 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 t -125.01 123.35 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.634 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 2.5 m-85 -84.65 152.54 60.23 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.033 -1.042 . . . . 0.0 109.503 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.86 100.61 0.97 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.559 2.173 . . . . 0.0 111.844 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.46 179.12 47.56 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.174 -1.489 . . . . 0.0 110.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.591 ' O ' ' N ' ' A' ' 35' ' ' THR . 71.5 Cg_endo -77.78 120.74 5.22 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.736 2.291 . . . . 0.0 111.097 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -40.33 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.34 0.59 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.591 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.5 p -107.39 153.46 41.22 Favored Pre-proline 0 N--CA 1.498 1.951 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.75 -41.88 7.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.232 1.954 . . . . 0.0 112.435 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -63.71 -19.79 65.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.091 -1.005 . . . . 0.0 110.08 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.634 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 0.0 OUTLIER -94.96 -63.61 1.15 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.101 -0.999 . . . . 0.0 109.117 -179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.08 -24.05 0.13 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.401 -0.812 . . . . 0.0 109.857 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 38' ' ' GLN . 21.4 m-20 -59.88 -24.77 64.53 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.5 mtt180 -89.11 -9.08 52.42 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.64 -136.03 4.99 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.505 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 6.1 t -101.42 157.25 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.485 -1.009 . . . . 0.0 109.586 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -151.74 147.94 27.29 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.277 -0.889 . . . . 0.0 108.85 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -55.13 168.89 0.28 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.187 -0.946 . . . . 0.0 109.864 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' OG ' ' A' ' 58' ' ' SER . . . -92.31 0.42 57.45 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -161.38 142.96 11.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.444 -0.785 . . . . 0.0 108.947 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -59.57 -37.44 78.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.492 -0.755 . . . . 0.0 111.222 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -89.72 -0.25 57.42 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.877 -1.139 . . . . 0.0 111.005 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' A' ' 54' ' ' ASP . 11.3 tp10 -63.24 89.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.853 -1.155 . . . . 0.0 109.749 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.9 m -89.4 177.0 6.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.865 . . . . 0.0 109.347 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.42 HD11 ' H ' ' A' ' 4' ' ' LYS . 2.6 pp -76.84 -8.1 56.7 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.286 -0.884 . . . . 0.0 108.901 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -86.51 -19.39 29.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.764 . . . . 0.0 109.462 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 40.7 t0 -59.43 111.44 1.39 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -44.88 -17.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 6.2 m120 -132.31 100.49 5.02 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.7 mt -94.46 120.65 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.216 -0.928 . . . . 0.0 108.78 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' A' ' 46' ' ' ALA . 3.5 t -108.16 115.15 29.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.5 -0.75 . . . . 0.0 109.165 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.56 HG22 ' N ' ' A' ' 60' ' ' ALA . 61.8 mt -108.55 166.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.51 -0.744 . . . . 0.0 109.563 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.56 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -137.2 132.54 34.03 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.79 148.47 19.99 Favored Glycine 0 N--CA 1.502 3.08 0 C-N-CA 120.028 -1.082 . . . . 0.0 110.434 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' PHE . 17.2 m-70 -72.31 168.06 19.14 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.419 -1.048 . . . . 0.0 110.105 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.28 88.57 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.0 109.352 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.516 ' N ' ' OG1' ' A' ' 73' ' ' THR . 15.7 m-85 -88.19 102.5 14.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.855 -1.153 . . . . 0.0 109.233 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mt -59.09 -29.93 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.32 -0.862 . . . . 0.0 110.094 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.29 12.4 6.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ASN . 23.5 ttm-85 -151.33 77.39 7.42 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.528 -0.732 . . . . 0.0 109.51 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.64 32.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 123.31 2.673 . . . . 0.0 113.319 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' ARG . 19.7 m-80 -149.41 61.11 1.02 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.039 -1.038 . . . . 0.0 108.376 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.5 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 0.3 OUTLIER -130.94 -153.47 0.56 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.632 0.73 . . . . 0.0 109.78 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' OE1' ' N ' ' A' ' 71' ' ' GLN . 0.9 OUTLIER -69.61 -83.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 111.715 -178.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.498 ' CD1' ' O ' ' A' ' 72' ' ' PHE . 28.5 t80 -93.56 -11.64 31.39 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.212 -0.93 . . . . 0.0 110.298 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 64' ' ' PHE . 89.5 m -37.45 -40.71 0.39 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.671 . . . . 0.0 111.124 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 77' ' ' ALA . 2.8 m120 -94.48 -21.61 18.79 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.131 -0.981 . . . . 0.0 111.605 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 20' ' ' ILE . 1.5 mt -53.42 -26.08 18.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.392 -1.443 . . . . 0.0 108.263 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 73' ' ' THR . 9.5 ptpt -75.53 -18.97 59.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -82.09 -14.41 55.83 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.15 -165.06 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.502 -0.749 . . . . 0.0 109.55 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -163.96 164.7 23.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.169 -0.957 . . . . 0.0 109.422 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -52.39 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 155.66 -26.83 0.59 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.9 p -63.07 117.83 7.02 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.352 -1.087 . . . . 0.0 108.252 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.0 mtp -70.91 179.26 2.77 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.97 -1.092 . . . . 0.0 110.008 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.8 t -145.17 111.65 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -93.89 106.33 18.3 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.272 -0.892 . . . . 0.0 110.072 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -94.7 112.5 24.24 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -89.44 151.92 21.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.185 -0.947 . . . . 0.0 111.111 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 90' ' ' ASN . 5.9 t -145.71 45.64 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.36 -80.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 88' ' ' VAL . 1.0 OUTLIER -53.08 -30.93 38.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.403 -1.057 . . . . 0.0 111.1 -179.022 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -170.93 167.49 7.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.725 -1.234 . . . . 0.0 109.665 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 t -131.2 134.22 46.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.501 -0.749 . . . . 0.0 110.183 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.535 HH11 ' HG2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.58 175.25 6.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.625 -0.672 . . . . 0.0 109.276 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -144.57 144.94 31.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.108 -0.995 . . . . 0.0 109.566 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 17.2 m-85 -131.56 177.19 7.7 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.439 -0.788 . . . . 0.0 108.926 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -133.71 104.32 6.28 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 109.601 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.446 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 4.9 mmt -48.59 120.03 3.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.35 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -161.82 28.81 0.12 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.289 -0.882 . . . . 0.0 109.42 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 143' ' ' VAL . 7.7 m -165.58 133.33 2.99 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.8 mt -140.19 130.75 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.279 -0.888 . . . . 0.0 108.674 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 103' ' ' VAL . 19.0 mmm-85 -110.6 13.95 22.48 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.58 -0.7 . . . . 0.0 109.94 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.533 ' HA ' ' H ' ' A' ' 141' ' ' ILE . 73.6 m-20 -42.3 -20.01 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.407 -0.808 . . . . 0.0 109.578 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.557 ' N ' ' O ' ' A' ' 101' ' ' ARG . 53.0 t -68.55 159.66 5.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' N ' HG12 ' A' ' 103' ' ' VAL . 85.6 mttt -48.14 152.62 1.42 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.095 -1.003 . . . . 0.0 108.838 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -34.92 94.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.474 2.116 . . . . 0.0 112.403 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.534 ' OG1' ' NE ' ' A' ' 101' ' ' ARG . 6.4 p -71.85 -27.89 63.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.443 -0.785 . . . . 0.0 109.655 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 109' ' ' GLY . 27.2 t70 -139.96 140.38 36.32 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 m -67.99 43.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.045 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 107' ' ' ASP . . . -146.64 54.46 0.54 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.449 ' H ' HG22 ' A' ' 110' ' ' VAL . 3.9 m -66.49 -19.54 25.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.039 -1.271 . . . . 0.0 108.094 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 mt -139.49 59.82 1.59 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.533 ' OD2' ' NE2' ' A' ' 114' ' ' GLN . 9.8 p-10 -91.44 -135.18 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.925 . . . . 0.0 109.217 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 112' ' ' ASP . 10.6 pt-20 -163.9 16.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 110.058 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.533 ' NE2' ' OD2' ' A' ' 112' ' ' ASP . 1.9 pm0 -153.4 18.48 0.55 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 110.45 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HB3' ' HZ3' ' A' ' 115' ' ' LYS . 7.8 mtpm? -78.44 166.41 22.65 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.991 -1.068 . . . . 0.0 110.226 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.22 -112.4 3.87 Favored Glycine 0 N--CA 1.478 1.447 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -158.04 -54.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.645 -0.915 . . . . 0.0 109.942 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.484 ' O ' ' NE2' ' A' ' 120' ' ' GLN . 70.7 m-20 -118.91 169.88 9.5 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 118' ' ' ASP . 34.2 ttmt -39.66 137.24 0.89 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.485 -0.759 . . . . 0.0 109.656 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -145.75 155.6 43.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.274 -0.891 . . . . 0.0 109.202 -178.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.446 HD11 ' CD1' ' A' ' 95' ' ' TYR . 46.4 mt -103.88 115.91 31.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.441 -0.787 . . . . 0.0 110.185 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.8 m -93.95 87.04 5.23 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.953 -1.092 . . . . 0.0 108.547 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 123' ' ' LEU . 7.5 mp -74.25 154.78 38.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.083 -1.011 . . . . 0.0 110.354 -178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.9 mt -140.02 140.98 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.467 -0.771 . . . . 0.0 108.973 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 ' CZ ' ' A' ' 72' ' ' PHE . 1.3 p -94.24 162.13 13.97 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 109.493 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.433 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 51.3 m -146.9 137.11 23.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -173.3 134.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.123 -0.986 . . . . 0.0 109.387 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 55.09 69.63 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -0.774 . . . . 0.0 108.916 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -62.28 122.11 14.84 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.04 -1.038 . . . . 0.0 109.844 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -84.99 122.42 29.2 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.1 -1.0 . . . . 0.0 109.355 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -86.03 5.89 31.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.294 -0.879 . . . . 0.0 109.749 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -79.93 -57.84 3.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.199 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 p -96.47 -4.27 41.89 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.232 -0.918 . . . . 0.0 109.354 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.53 46.86 53.42 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.66 155.42 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -1.116 . . . . 0.0 109.509 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.433 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 65.1 m95 -63.13 112.15 2.52 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.198 -0.939 . . . . 0.0 108.651 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 136' ' ' TRP . 72.3 tt0 -39.03 -82.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.277 0.561 . . . . 0.0 110.037 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -77.45 120.67 22.77 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -134.98 137.13 42.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.339 -0.851 . . . . 0.0 109.827 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -140.5 134.33 30.51 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.533 ' H ' ' HA ' ' A' ' 102' ' ' ASP . 15.3 mm -99.39 127.67 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.758 0.79 . . . . 0.0 111.22 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.528 ' CE1' ' OD2' ' A' ' 102' ' ' ASP . 27.5 m-85 -129.99 154.52 47.3 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 p -161.88 151.3 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.223 -1.548 . . . . 0.0 111.853 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.39 175.92 7.84 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -138.16 142.38 40.08 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.094 -1.004 . . . . 0.0 110.196 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' VAL . 10.1 tp10 -60.78 137.17 58.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.464 -0.773 . . . . 0.0 109.192 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.526 ' N ' ' OE2' ' A' ' 146' ' ' GLU . 4.6 m -91.59 176.5 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 109.397 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.316 179.993 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mmm . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.268 0.556 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -86.89 173.85 9.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.294 -0.879 . . . . 0.0 109.55 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.54 71.46 0.76 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.331 -0.855 . . . . 0.0 109.185 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -133.18 65.32 72.94 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.434 -0.791 . . . . 0.0 109.728 -179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.22 -156.38 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.544 2.163 . . . . 0.0 112.049 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -71.29 104.14 3.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.054 -1.029 . . . . 0.0 110.275 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 7' ' ' ILE . 15.2 mt -150.29 95.15 3.6 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -44.51 166.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.202 1.935 . . . . 0.0 112.626 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -113.41 -13.25 12.88 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 105.02 7.54 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.157 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -56.44 -11.08 1.1 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.838 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 m -102.48 30.72 4.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.317 -0.864 . . . . 0.0 109.665 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.65 143.51 33.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.325 -0.859 . . . . 0.0 109.205 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.9 t -60.06 150.95 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -144.91 12.04 1.42 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.72 168.44 29.86 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.54 119.66 6.75 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.03 -1.277 . . . . 0.0 109.51 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.9 tt -99.05 141.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -146.2 136.27 23.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.18 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.3 mt -144.1 125.69 8.11 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.425 ' C ' ' N ' ' A' ' 23' ' ' ALA . 74.4 Cg_endo -75.15 -41.26 0.66 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.633 1.555 . . . . 0.0 111.494 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -51.25 -15.42 0.37 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -0.878 . . . . 0.0 109.203 179.549 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 25' ' ' ILE . . . -137.81 15.46 2.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.408 -0.808 . . . . 0.0 109.835 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 4.1 p-10 44.57 50.17 8.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.092 -1.005 . . . . 0.0 109.995 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 23' ' ' ALA . 48.6 mm -92.25 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 121.82 0.819 . . . . 0.0 109.983 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -169.65 82.74 0.12 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 4.9 mm-40 -142.69 150.3 53.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.084 -1.01 . . . . 0.0 110.68 -177.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -86.78 165.05 8.99 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.848 2.365 . . . . 0.0 113.04 179.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.8 t -126.91 122.32 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.626 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 7.6 m-85 -82.59 150.36 62.84 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.007 -1.058 . . . . 0.0 110.247 -179.131 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.87 100.04 1.36 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.6 2.2 . . . . 0.0 111.681 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.26 178.78 45.37 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.158 -1.496 . . . . 0.0 110.616 -179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.583 ' O ' ' N ' ' A' ' 35' ' ' THR . 72.9 Cg_endo -76.49 118.81 5.0 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.755 2.304 . . . . 0.0 111.029 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -42.49 88.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.453 0.644 . . . . 0.0 110.572 -179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.583 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.4 p -113.67 152.43 45.47 Favored Pre-proline 0 N--CA 1.498 1.938 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.5 -40.21 10.91 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.124 1.883 . . . . 0.0 111.945 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -62.24 -20.06 63.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.138 -0.976 . . . . 0.0 109.098 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.626 ' NE2' ' CD2' ' A' ' 30' ' ' TYR . 7.3 tp60 -96.04 -63.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 mt -45.05 -15.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.418 -0.801 . . . . 0.0 110.275 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' GLN . 35.6 m-20 -62.55 -25.14 67.9 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 41' ' ' ARG . 25.2 mtt-85 -88.13 -12.0 45.32 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.09 -135.93 4.78 Favored Glycine 0 N--CA 1.492 2.388 0 C-N-CA 120.021 -1.085 . . . . 0.0 110.408 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.1 t -101.18 160.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.465 -1.021 . . . . 0.0 109.619 -179.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -151.42 152.68 33.4 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 50.4 m-85 -60.32 167.95 2.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.197 . . . . 0.0 109.745 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.16 -8.35 59.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.255 -0.903 . . . . 0.0 109.448 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -152.85 150.95 29.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -62.77 -35.82 81.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.563 -0.71 . . . . 0.0 111.102 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.65 16.42 6.7 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.99 -1.069 . . . . 0.0 110.905 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.535 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 14.5 tm-20 -63.23 98.44 0.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 109.84 179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASP . 1.4 p -95.38 141.74 28.59 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.02 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -61.16 -3.73 0.93 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.756 -1.215 . . . . 0.0 107.881 179.422 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 51' ' ' SER . 23.1 m-20 -91.56 -17.7 25.22 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.594 -0.691 . . . . 0.0 109.861 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' ASN . 38.6 p-10 -60.64 116.99 4.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.861 -1.149 . . . . 0.0 109.576 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.473 HE22 ' NZ ' ' A' ' 115' ' ' LYS . 7.5 pt20 -45.63 -15.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 54' ' ' ASP . 38.2 t30 -132.6 108.58 9.16 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.402 -0.811 . . . . 0.0 109.673 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.0 mt -98.61 117.52 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.463 -0.773 . . . . 0.0 108.951 179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -108.44 114.76 28.85 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 60' ' ' ALA . 61.2 mt -105.47 167.46 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.438 -0.789 . . . . 0.0 109.907 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.587 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -135.07 126.65 28.85 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.85 152.89 23.86 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.68 -178.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.734 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 33.2 m-70 -72.85 -170.46 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.636 -0.92 . . . . 0.0 109.275 179.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -168.17 72.0 0.1 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.93 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.564 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 5.8 m-85 -87.6 114.11 23.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.076 -1.015 . . . . 0.0 109.163 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.8 mm -58.91 -18.42 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.145 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -85.18 13.92 5.77 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 109.184 -179.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.564 ' NH2' ' CG ' ' A' ' 64' ' ' PHE . 59.1 mtm-85 -151.41 74.35 8.13 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.29 14.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.177 0 C-N-CA 123.673 2.915 . . . . 0.0 114.023 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -150.59 62.28 0.94 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.854 -1.154 . . . . 0.0 108.334 179.289 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.444 ' CE2' ' OE1' ' A' ' 71' ' ' GLN . 41.8 t80 -149.72 99.77 2.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.734 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 5.1 mt-30 61.09 -125.49 0.9 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.513 -0.742 . . . . 0.0 111.734 177.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 72' ' ' PHE . 86.2 t80 -92.48 38.88 1.02 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.186 -0.946 . . . . 0.0 110.37 -178.088 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 m -81.58 -65.21 1.04 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.995 -1.066 . . . . 0.0 109.034 179.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.518 ' C ' ' H ' ' A' ' 76' ' ' LYS . 9.9 t-20 -81.18 -24.72 37.32 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.611 -178.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 tp -55.85 -3.89 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.913 -1.117 . . . . 0.0 108.617 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 74' ' ' ASN . 46.1 mtpt -87.03 -21.47 26.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 78' ' ' ALA . . . -80.78 -37.15 30.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -45.43 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.46 -0.775 . . . . 0.0 109.938 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' SD ' ' A' ' 97' ' ' MET . 48.3 mtmt -144.24 172.86 12.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 109.443 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -49.08 153.5 0.92 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.325 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -17.58 31.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.1 t -62.75 97.86 0.11 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.45 -1.029 . . . . 0.0 108.423 179.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 90.1 mtp -55.76 171.63 0.21 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.194 -1.003 . . . . 0.0 109.512 -179.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 t -143.51 113.96 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.444 -0.785 . . . . 0.0 109.492 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -94.92 102.89 14.74 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.196 -0.94 . . . . 0.0 109.438 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -97.54 112.0 24.04 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.235 -0.916 . . . . 0.0 108.571 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -100.25 144.28 29.46 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 15' ' ' ALA . 8.8 p -169.77 140.06 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.654 179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.4 -110.68 3.54 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -137.69 45.89 2.14 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.475 -1.015 . . . . 0.0 109.282 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 92' ' ' THR . 3.9 tm-20 -163.66 138.83 6.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.089 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.445 ' N ' ' CD ' ' A' ' 91' ' ' GLU . 21.6 m -115.13 125.15 53.13 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.459 -0.775 . . . . 0.0 109.801 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 172.43 7.21 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.396 -0.815 . . . . 0.0 108.863 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 17.0 pttm -141.34 150.2 42.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.278 -0.889 . . . . 0.0 109.308 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.554 ' CD1' HD11 ' A' ' 121' ' ' LEU . 15.8 m-85 -138.96 179.39 6.52 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.413 -0.804 . . . . 0.0 109.129 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -134.89 107.88 7.6 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.528 -0.733 . . . . 0.0 109.885 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.47 ' SD ' HD11 ' A' ' 100' ' ' ILE . 31.8 ttm -49.61 128.84 18.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 108.849 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 98' ' ' THR . 73.0 m -159.23 3.56 0.09 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.752 -1.217 . . . . 0.0 110.679 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' VAL . 13.4 t -149.14 122.24 8.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.708 -1.245 . . . . 0.0 107.886 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.49 ' CG2' ' OD2' ' A' ' 102' ' ' ASP . 78.3 mt -140.21 156.1 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.085 -1.01 . . . . 0.0 109.575 -178.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 102' ' ' ASP . 66.7 mtm180 -124.5 -96.11 0.46 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.49 ' OD2' ' CG2' ' A' ' 100' ' ' ILE . 2.8 p30 39.53 35.86 0.2 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.554 -0.716 . . . . 0.0 110.686 179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG12 ' N ' ' A' ' 104' ' ' LYS . 35.3 t -138.52 -83.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.231 -0.918 . . . . 0.0 108.777 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.512 ' N ' HG12 ' A' ' 103' ' ' VAL . 18.0 mmmt -139.99 52.77 3.85 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.285 -0.884 . . . . 0.0 109.321 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 104' ' ' LYS . 73.9 Cg_endo -72.94 -167.77 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.359 2.039 . . . . 0.0 111.488 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 108' ' ' VAL . 22.4 p -103.1 -13.6 16.75 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 109' ' ' GLY . 4.6 t70 66.19 -42.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.545 -0.722 . . . . 0.0 109.65 179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 106' ' ' THR . 18.1 m -76.84 25.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.093 -1.004 . . . . 0.0 109.179 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -135.14 6.94 4.38 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.14 -35.17 70.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.189 -1.183 . . . . 0.0 108.506 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.15 61.27 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.548 -0.72 . . . . 0.0 109.452 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -171.25 4.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.009 -1.057 . . . . 0.0 111.024 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -179.91 26.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.767 -1.208 . . . . 0.0 109.453 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.64 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -103.0 9.5 38.61 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.288 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.59 ' C ' HE22 ' A' ' 120' ' ' GLN . 0.3 OUTLIER -59.07 -19.0 40.24 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.988 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.97 -103.44 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -149.94 -40.08 0.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.322 -1.105 . . . . 0.0 109.508 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -118.59 167.45 11.61 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.494 -0.753 . . . . 0.0 110.353 -178.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -47.04 157.72 0.16 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.59 HE22 ' C ' ' A' ' 115' ' ' LYS . 5.7 pt20 -157.98 161.86 38.16 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.008 -1.058 . . . . 0.0 109.847 -178.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.554 HD11 ' CD1' ' A' ' 95' ' ' TYR . 50.7 mt -114.95 103.39 10.87 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.603 -0.686 . . . . 0.0 110.0 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 51.9 m -99.34 149.2 23.39 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 124' ' ' ILE . 7.4 tt -141.58 157.86 44.57 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.054 -1.029 . . . . 0.0 109.757 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.469 ' N ' HD23 ' A' ' 123' ' ' LEU . 44.9 mt -128.77 150.05 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.447 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.8 p -89.83 163.59 14.97 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.579 -1.325 . . . . 0.0 108.725 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.523 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 4.1 m -146.4 81.94 1.58 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.108 -0.995 . . . . 0.0 109.418 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 14.9 p-10 -137.48 133.97 35.24 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.407 -0.808 . . . . 0.0 109.127 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 69.06 62.01 0.31 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.537 -0.727 . . . . 0.0 109.678 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -62.62 126.23 26.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.273 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -85.89 118.56 25.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.124 -0.985 . . . . 0.0 109.537 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -84.39 1.36 45.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -80.68 -52.91 7.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.442 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.0 p -94.89 -8.28 37.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.27 -0.894 . . . . 0.0 109.39 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.34 41.45 52.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.04 162.56 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.24 -1.153 . . . . 0.0 109.599 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.523 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 68.2 m95 -66.29 114.87 5.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.303 -0.873 . . . . 0.0 108.674 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 136' ' ' TRP . 24.6 tt0 -38.96 -81.92 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.264 0.555 . . . . 0.0 110.13 -179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -83.2 148.25 27.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -148.25 73.89 1.27 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.95 -1.094 . . . . 0.0 110.482 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -76.75 159.01 30.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.919 -1.113 . . . . 0.0 108.225 178.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.74 153.43 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.982 -1.074 . . . . 0.0 111.277 -178.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.487 ' CD1' ' C ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -135.45 171.37 14.55 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 99' ' ' SER . 1.7 p -162.93 117.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.588 -1.32 . . . . 0.0 111.214 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -96.99 177.95 5.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 145' ' ' THR . 15.0 t -147.51 127.93 14.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.762 -1.211 . . . . 0.0 110.131 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -63.89 117.45 6.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.463 -0.773 . . . . 0.0 109.281 179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.0 OUTLIER -93.15 -154.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.194 -0.941 . . . . 0.0 109.087 -179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.488 ' H ' HG12 ' A' ' 147' ' ' VAL . 53.3 mtpt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.799 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.463 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 18.5 mp0 -72.03 142.3 49.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -0.99 . . . . 0.0 109.264 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.87 86.64 4.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.186 -0.946 . . . . 0.0 109.635 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HZ2' ' HB3' ' A' ' 2' ' ' GLN . 28.1 mtmm -151.9 59.91 3.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 0.0 109.279 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.06 -173.66 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.684 2.256 . . . . 0.0 111.919 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.87 81.43 3.44 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.268 -0.895 . . . . 0.0 109.7 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.4 mt -84.23 122.5 75.58 Favored Pre-proline 0 N--CA 1.492 1.625 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.54 167.26 27.54 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 121.257 1.305 . . . . 0.0 112.032 -179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -102.09 -12.78 17.84 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.282 -0.886 . . . . 0.0 109.591 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 12' ' ' SER . 87.1 m-20 -77.16 102.4 6.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.681 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm -58.22 -3.79 0.29 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.288 -0.883 . . . . 0.0 109.368 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 10' ' ' ASP . 15.1 t -115.59 44.63 1.84 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.589 -0.694 . . . . 0.0 109.331 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -141.11 133.28 27.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.341 -0.849 . . . . 0.0 109.445 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.65 107.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.616 -0.678 . . . . 0.0 110.75 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.16 -20.73 19.61 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.44 -173.55 35.71 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -151.41 126.64 9.91 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.008 -1.289 . . . . 0.0 109.74 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.9 tt -99.22 144.6 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -150.33 131.67 14.63 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.874 -1.141 . . . . 0.0 110.622 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 mt -144.25 125.88 8.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.6 Cg_endo -76.09 -41.77 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.654 1.569 . . . . 0.0 111.458 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' OD2' ' OG ' ' A' ' 82' ' ' SER . 47.5 t0 -50.98 -16.23 0.41 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.051 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -135.7 15.98 3.36 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.431 -0.793 . . . . 0.0 109.427 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 4.0 p30 41.78 48.96 3.83 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 109.885 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.4 mm -91.64 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.63 0.729 . . . . 0.0 109.635 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -169.13 84.98 0.14 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -145.48 157.19 52.74 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.063 -1.023 . . . . 0.0 110.33 -177.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.32 165.24 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.85 2.367 . . . . 0.0 112.425 179.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -134.37 112.92 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -85.98 158.31 56.08 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 109.449 -179.289 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.09 133.87 9.04 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.463 2.109 . . . . 0.0 112.398 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.6 176.89 24.0 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.217 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.589 ' O ' ' N ' ' A' ' 35' ' ' THR . 83.1 Cg_endo -79.14 118.01 3.94 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.758 2.305 . . . . 0.0 111.119 179.355 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -42.44 87.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.199 0.523 . . . . 0.0 110.61 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.6 p -108.3 152.89 42.15 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.17 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.19 -42.18 37.44 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.244 1.963 . . . . 0.0 112.092 -179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -62.89 -25.86 68.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.081 -1.012 . . . . 0.0 109.828 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -85.8 -70.11 0.62 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.492 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.434 ' HG ' ' H ' ' A' ' 39' ' ' LEU . 36.1 mt -42.06 -22.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.565 -0.709 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.11 -23.52 66.58 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -87.11 -11.71 49.31 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.81 -106.44 0.29 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 11.3 t -136.02 154.73 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.483 -1.01 . . . . 0.0 109.298 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 t -149.4 156.1 41.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -57.69 173.75 0.28 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.734 -1.228 . . . . 0.0 109.513 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -88.58 -3.24 58.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -155.04 148.61 25.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.524 -0.735 . . . . 0.0 109.902 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -64.62 -29.89 70.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.596 -0.69 . . . . 0.0 111.733 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -88.49 -3.79 58.75 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.707 -1.245 . . . . 0.0 111.449 -177.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.27 114.59 3.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.729 -1.232 . . . . 0.0 109.673 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -91.53 -164.69 1.21 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.534 ' O ' ' NH1' ' A' ' 93' ' ' ARG . 2.2 mp -102.72 17.9 22.7 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -144.42 4.27 1.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' ASN . 68.5 t0 -59.53 118.89 6.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.879 -1.138 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.27 -13.55 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.998 -1.064 . . . . 0.0 109.899 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' ASP . 4.8 t-20 -131.42 93.81 3.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.425 -0.797 . . . . 0.0 109.08 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.1 mt -97.42 145.61 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.242 -0.911 . . . . 0.0 109.425 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' ALA . 1.8 p -142.89 109.36 5.36 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 60' ' ' ALA . 83.8 mt -103.81 159.19 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.664 0.745 . . . . 0.0 110.657 -178.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.513 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -127.36 124.31 38.31 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -131.85 146.04 17.68 Favored Glycine 0 N--CA 1.504 3.219 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -178.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' PHE . 20.6 m-70 -73.16 174.87 7.35 Favored 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.41 -1.053 . . . . 0.0 110.037 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.71 93.56 1.58 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 109.389 179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.06 113.49 24.62 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.16 -0.962 . . . . 0.0 109.074 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 mt -60.47 -34.13 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.213 -0.929 . . . . 0.0 110.051 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -84.94 17.69 2.77 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.931 . . . . 0.0 109.291 -178.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.593 ' O ' ' N ' ' A' ' 69' ' ' ASN . 0.1 OUTLIER -150.66 73.7 8.82 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' O ' ' OD1' ' A' ' 74' ' ' ASN . 63.9 Cg_exo -52.37 23.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.303 0 C-N-CA 123.904 3.069 . . . . 0.0 114.219 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 67' ' ' ARG . 27.3 m-80 -153.55 63.53 0.74 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.603 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 12.8 t80 -148.29 100.46 3.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.102 -0.999 . . . . 0.0 110.953 -178.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.603 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 13.1 mp0 54.39 -109.04 0.46 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.671 -0.643 . . . . 0.0 112.57 177.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.568 ' CE2' HG22 ' A' ' 125' ' ' THR . 41.6 t80 -91.59 8.9 34.44 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.331 -0.855 . . . . 0.0 111.177 -177.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 50.9 m -56.42 -45.35 80.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.465 -1.397 . . . . 0.0 110.921 -179.404 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 5.7 m120 -94.31 -22.09 18.58 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.04 -1.038 . . . . 0.0 111.498 -177.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.712 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.5 tm? -50.37 -36.82 34.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.897 -1.127 . . . . 0.0 108.777 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -60.72 -18.26 53.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -86.12 -23.78 26.5 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.331 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.52 167.61 5.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.412 -0.805 . . . . 0.0 110.0 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -149.66 175.67 11.35 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.86 158.14 0.72 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.86 -29.24 3.81 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.423 ' OG ' ' OD2' ' A' ' 22' ' ' ASP . 61.3 m -62.17 103.74 0.41 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.293 -1.122 . . . . 0.0 108.237 179.371 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.4 mtp -63.36 176.11 0.87 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.777 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.4 t -144.15 114.69 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.482 -0.761 . . . . 0.0 109.17 -179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -93.64 107.29 19.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.193 -0.942 . . . . 0.0 110.22 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -94.99 113.9 25.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -85.69 151.04 24.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.0 110.644 -178.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG21 ' NH1' ' A' ' 93' ' ' ARG . 65.6 t -153.94 116.71 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 46.16 -102.86 0.05 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -125.02 34.98 4.87 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.545 -0.973 . . . . 0.0 109.499 -179.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.84 119.89 5.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 0.0 108.797 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 92' ' ' THR . 12.6 t -111.2 132.87 53.98 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.52 -0.737 . . . . 0.0 110.253 -179.323 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -96.9 179.71 4.86 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.544 -0.723 . . . . 0.0 109.528 179.594 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -144.93 142.47 29.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 0.0 109.879 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 22.7 m-85 -128.82 178.92 6.02 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -135.32 110.36 8.85 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.275 -0.891 . . . . 0.0 109.755 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 5.7 mmt -52.13 118.43 3.49 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 p -151.05 31.21 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.103 -0.998 . . . . 0.0 109.717 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.7 t -164.89 86.38 0.43 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.028 -1.045 . . . . 0.0 109.338 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.7 mp -84.27 135.72 24.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.477 ' NH1' ' CD ' ' A' ' 113' ' ' GLU . 33.0 mtp180 -134.0 -10.45 2.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.334 -0.854 . . . . 0.0 109.581 -179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.519 ' OD2' ' CZ ' ' A' ' 142' ' ' PHE . 0.6 OUTLIER -43.83 -89.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 179.606 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.69 ' O ' HG13 ' A' ' 103' ' ' VAL . 9.7 p 22.37 61.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-O 121.49 0.662 . . . . 0.0 111.573 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 103' ' ' VAL . 31.2 mtmt 61.95 137.81 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.369 -0.832 . . . . 0.0 109.045 -179.361 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -37.16 112.49 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.154 1.903 . . . . 0.0 112.832 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.443 ' OG1' ' N ' ' A' ' 107' ' ' ASP . 17.5 p -80.82 -59.96 2.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.896 . . . . 0.0 108.909 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 109' ' ' GLY . 54.9 m-20 -146.12 147.25 31.36 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.95 42.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.939 . . . . 0.0 109.189 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 107' ' ' ASP . . . -111.97 52.06 0.66 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.7 m -65.34 -24.25 34.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.054 -1.262 . . . . 0.0 107.792 179.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.3 mt -136.15 66.54 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.697 ' N ' HE21 ' A' ' 114' ' ' GLN . 24.0 t70 -175.15 26.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.477 ' CD ' ' NH1' ' A' ' 101' ' ' ARG . 18.0 pt-20 -163.19 29.19 0.09 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.697 HE21 ' N ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -139.54 14.06 2.55 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.612 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 116' ' ' GLY . 86.9 mttt -97.69 28.88 3.59 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 115' ' ' LYS . . . -48.69 -95.77 0.01 OUTLIER Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -154.76 -27.6 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -1.181 . . . . 0.0 110.882 -179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -101.08 143.68 30.91 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.072 -1.017 . . . . 0.0 110.07 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -47.66 139.27 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.543 ' NE2' ' O ' ' A' ' 114' ' ' GLN . 7.8 pt20 -151.61 158.61 43.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.007 -1.058 . . . . 0.0 110.099 -178.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.6 tp -111.22 157.42 20.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.461 0.648 . . . . 0.0 110.214 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.2 m -139.22 88.34 2.26 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.89 147.08 52.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.523 -178.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.8 mt -139.42 141.01 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.568 HG22 ' CE2' ' A' ' 72' ' ' PHE . 1.1 p -94.18 159.42 15.15 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.94 -1.1 . . . . 0.0 109.181 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.551 ' SG ' ' CE2' ' A' ' 136' ' ' TRP . 1.8 m -147.84 100.52 3.21 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.211 -0.931 . . . . 0.0 109.166 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -152.41 144.53 23.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.331 -0.856 . . . . 0.0 109.37 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.0 t0 60.53 58.7 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -62.07 119.41 8.87 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.281 -0.887 . . . . 0.0 109.39 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 11.1 p30 -86.96 124.04 32.72 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.066 -1.021 . . . . 0.0 109.988 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -88.9 14.22 10.92 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -71.5 -31.47 67.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.326 -0.859 . . . . 0.0 109.163 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 22.2 p -140.64 3.2 1.86 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.36 53.1 6.23 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.4 t -146.95 159.42 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.087 -1.243 . . . . 0.0 109.912 -179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.551 ' CE2' ' SG ' ' A' ' 126' ' ' CYS . 70.6 m95 -72.77 116.1 12.86 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.239 -0.913 . . . . 0.0 108.626 178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 136' ' ' TRP . 30.2 tt0 -40.29 -83.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.737 -0.602 . . . . 0.0 109.991 -179.543 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -70.85 165.1 23.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 108.474 179.17 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.532 ' NE ' ' O ' ' A' ' 139' ' ' ARG . 0.4 OUTLIER -167.08 76.61 0.17 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.904 -1.122 . . . . 0.0 110.12 -179.799 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -88.97 156.88 18.61 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.413 ' H ' ' HB3' ' A' ' 102' ' ' ASP . 21.8 pt -145.98 146.77 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.925 -1.11 . . . . 0.0 111.629 -178.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.519 ' CZ ' ' OD2' ' A' ' 102' ' ' ASP . 27.5 m-85 -128.98 165.98 20.07 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 78.3 t -149.14 143.61 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.653 -1.279 . . . . 0.0 110.339 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -138.75 163.94 30.86 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.2 t -140.91 141.14 34.58 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.07 -1.019 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -62.42 113.69 3.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 148' ' ' LYS . 1.7 t -93.85 177.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.091 -1.006 . . . . 0.0 108.821 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.482 ' H ' HG12 ' A' ' 147' ' ' VAL . 73.8 mttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.437 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.6 mtm . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.344 0.593 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -74.0 112.89 10.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.267 -0.895 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.3 -175.22 1.49 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -0.959 . . . . 0.0 109.199 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.502 ' NZ ' ' OD1' ' A' ' 49' ' ' ASN . 94.1 mttt -45.24 107.62 0.67 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.369 -0.832 . . . . 0.0 109.757 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 4' ' ' LYS . 74.9 Cg_exo -49.81 -166.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.043 1.829 . . . . 0.0 112.682 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -80.81 105.43 12.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.067 -1.021 . . . . 0.0 110.06 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 mm -85.0 114.76 57.77 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -42.75 121.34 2.14 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.708 1.606 . . . . 0.0 112.31 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 9' ' ' LYS . 19.5 mtmm -66.13 -32.59 74.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 12' ' ' SER . 9.7 m-20 -76.87 111.4 12.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.463 ' H ' ' HD3' ' A' ' 11' ' ' LYS . 1.8 mppt? -60.87 -0.95 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.353 -0.842 . . . . 0.0 109.0 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 10' ' ' ASP . 8.6 t -111.21 42.75 1.59 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.486 -0.759 . . . . 0.0 109.498 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -142.92 133.38 24.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 17' ' ' TYR . 5.4 t -58.75 120.79 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.44 -0.787 . . . . 0.0 111.263 -178.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -97.12 -9.63 27.57 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.22 140.35 3.15 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 90.2 m-85 -94.44 125.22 38.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.138 -1.213 . . . . 0.0 109.531 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.4 tp -95.29 143.04 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -148.07 138.81 23.07 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.712 -1.242 . . . . 0.0 110.936 -178.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.857 HD12 HD21 ' A' ' 75' ' ' LEU . 14.0 mt -149.84 128.32 5.99 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.12 -44.06 0.28 Allowed 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.825 1.683 . . . . 0.0 112.241 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -50.2 -28.3 7.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.246 -0.909 . . . . 0.0 109.249 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -113.4 7.07 17.48 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 p30 43.54 30.25 0.33 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.577 -0.702 . . . . 0.0 109.888 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.12 145.2 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.102 0.953 . . . . 0.0 109.795 -179.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -163.02 87.97 0.59 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -138.1 159.95 66.22 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.592 -0.693 . . . . 0.0 110.952 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.444 ' CB ' HG13 ' A' ' 14' ' ' VAL . 92.5 Cg_endo -76.52 159.19 35.97 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 122.982 2.455 . . . . 0.0 113.229 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 t -135.64 98.63 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.52 170.74 14.68 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 120.688 -1.258 . . . . 0.0 109.119 -179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -90.46 164.21 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.072 1.848 . . . . 0.0 112.048 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.67 171.92 13.05 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 35' ' ' THR . 96.7 Cg_endo -78.56 120.37 4.78 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.758 2.305 . . . . 0.0 111.187 179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . . . -41.6 87.53 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.235 0.54 . . . . 0.0 110.643 -179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.585 ' N ' ' O ' ' A' ' 33' ' ' PRO . 2.7 p -108.57 123.56 36.93 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -42.26 -43.57 7.74 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.804 1.669 . . . . 0.0 112.257 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -63.73 -16.49 61.26 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.254 -0.904 . . . . 0.0 109.081 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.6 HE21 ' N ' ' A' ' 39' ' ' LEU . 0.0 OUTLIER -97.07 -69.51 0.75 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.417 -0.802 . . . . 0.0 109.702 -179.751 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.6 ' N ' HE21 ' A' ' 38' ' ' GLN . 22.5 mt -45.01 -18.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 109.796 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 38' ' ' GLN . 16.5 m-20 -62.15 -24.87 67.43 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -83.2 -13.7 54.86 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.69 -124.23 1.35 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.64 159.34 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.575 -0.956 . . . . 0.0 109.963 -179.019 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.521 ' CB ' HE22 ' A' ' 38' ' ' GLN . 6.9 p -161.66 164.93 28.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.42 -0.8 . . . . 0.0 108.937 178.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.87 162.32 5.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.604 -1.31 . . . . 0.0 109.205 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . . . -83.21 -9.09 59.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.387 -0.82 . . . . 0.0 109.366 179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.53 144.31 29.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.261 -0.899 . . . . 0.0 110.147 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.98 -25.99 68.64 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 0.0 111.207 -179.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.502 ' OD1' ' NZ ' ' A' ' 4' ' ' LYS . 65.3 t30 -87.8 3.9 46.44 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.917 -1.114 . . . . 0.0 110.677 -178.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' OE1' ' OG ' ' A' ' 58' ' ' SER . 6.0 tp10 -64.93 157.59 27.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 109.339 179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 m -148.0 -179.84 7.2 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.949 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -91.11 17.19 8.41 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.78 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 53' ' ' ASP . 13.0 p-10 -141.16 -0.73 1.42 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.492 -0.755 . . . . 0.0 110.178 -179.51 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' ASN . 48.6 t0 -57.89 114.58 2.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.733 -1.229 . . . . 0.0 108.998 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.513 ' NE2' ' O ' ' A' ' 113' ' ' GLU . 5.4 pt20 -43.07 -20.54 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.439 -0.788 . . . . 0.0 109.479 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' ASP . 12.3 p-10 -134.96 104.09 5.83 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.43 156.06 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.0 -1.063 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' ALA . 50.7 p -141.66 102.08 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.405 -0.809 . . . . 0.0 109.133 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.545 HG22 ' N ' ' A' ' 60' ' ' ALA . 94.8 mt -97.98 162.03 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.396 -0.815 . . . . 0.0 109.858 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.545 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -145.08 134.18 22.7 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.44 158.77 27.61 Favored Glycine 0 N--CA 1.499 2.857 0 C-N-CA 119.754 -1.213 . . . . 0.0 110.209 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 72' ' ' PHE . 10.7 m-70 -71.49 -179.84 2.69 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.952 . . . . 0.0 109.913 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.79 80.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -87.94 107.53 18.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.09 -1.006 . . . . 0.0 109.118 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 65' ' ' ILE . 8.3 mt -58.46 -29.35 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.47 -0.768 . . . . 0.0 110.141 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -83.36 12.63 5.18 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.435 -0.791 . . . . 0.0 109.429 -178.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 69' ' ' ASN . 96.6 mtt180 -150.76 64.55 6.48 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -40.14 -19.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.701 2.268 . . . . 0.0 112.534 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 67' ' ' ARG . 28.6 p30 -98.29 28.72 3.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.605 ' CE2' ' NE2' ' A' ' 71' ' ' GLN . 1.9 t80 -89.68 -153.69 0.29 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.851 -1.156 . . . . 0.0 109.754 -179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.605 ' NE2' ' CE2' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -72.88 -96.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.619 -0.676 . . . . 0.0 111.322 -178.731 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.4 t80 -91.63 37.11 0.95 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.477 -0.765 . . . . 0.0 110.327 -177.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.0 m -77.37 -49.04 15.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.859 -1.151 . . . . 0.0 109.706 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 77' ' ' ALA . 19.1 m-20 -93.79 -19.99 20.51 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.204 -0.935 . . . . 0.0 110.644 -178.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD21 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -52.93 -29.18 27.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.804 -1.185 . . . . 0.0 108.869 -179.481 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 140' ' ' LYS . 34.9 pttt -80.6 -6.71 58.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 108.287 179.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 74' ' ' ASN . . . -83.68 -21.0 32.54 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -55.71 -168.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -0.756 . . . . 0.0 109.396 179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -155.13 152.95 30.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 108.708 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -50.14 108.08 0.2 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.228 -0.92 . . . . 0.0 109.678 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.436 ' H ' ' HB2' ' A' ' 97' ' ' MET . . . 137.44 -16.37 3.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.5 m -66.5 -172.73 0.17 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -1.157 . . . . 0.0 108.355 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 50.9 mmm -129.34 176.79 7.67 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -146.12 108.99 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 109.242 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -95.49 105.81 17.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 0.0 110.389 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -94.98 111.74 23.51 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -107.15 143.87 34.71 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.28 -0.887 . . . . 0.0 110.997 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 88' ' ' VAL . 7.3 p -168.13 129.57 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.541 -0.725 . . . . 0.0 109.531 179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.31 -105.53 1.6 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -140.31 22.16 2.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.321 -1.105 . . . . 0.0 109.218 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.27 138.73 35.23 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -119.91 138.94 53.13 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.677 0.751 . . . . 0.0 110.721 -179.031 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -91.42 170.68 9.76 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -146.57 128.52 15.46 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.126 -0.983 . . . . 0.0 110.385 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -128.41 172.74 10.83 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 98' ' ' THR . 16.5 ttpt -141.85 117.24 10.19 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.17 -0.956 . . . . 0.0 108.941 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.436 ' HB2' ' H ' ' A' ' 81' ' ' GLY . 51.3 mtt -50.61 89.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.517 -0.74 . . . . 0.0 109.478 -179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' LYS . 2.7 m -118.89 25.71 10.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.1 m -174.41 138.14 0.53 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.6 mt -140.77 129.62 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.02 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 103' ' ' VAL . 82.5 mtm180 -104.9 0.8 28.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.53 -0.731 . . . . 0.0 109.671 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 141' ' ' ILE . 15.2 t0 -66.17 55.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.362 -0.836 . . . . 0.0 109.023 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 101' ' ' ARG . 72.8 t -154.87 -75.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.438 -0.789 . . . . 0.0 108.896 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -117.92 60.96 3.7 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' O ' ' OG1' ' A' ' 106' ' ' THR . 13.4 Cg_endo -55.29 88.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.903 1.736 . . . . 0.0 111.84 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 105' ' ' PRO . 3.8 m -166.59 40.24 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.463 -0.773 . . . . 0.0 108.987 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -74.46 -146.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 109.635 -179.812 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.29 25.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.349 -0.845 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . 138.78 132.93 3.01 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 t -67.92 -36.45 75.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.316 -1.108 . . . . 0.0 108.341 179.327 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.4 mt -138.25 73.56 1.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.507 ' CG ' HE21 ' A' ' 114' ' ' GLN . 0.5 OUTLIER -93.45 136.47 33.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.174 -0.954 . . . . 0.0 108.949 -179.659 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.666 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 2.1 pm0 -93.95 18.37 10.65 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.666 ' NE2' ' H ' ' A' ' 113' ' ' GLU . 1.6 pm0 -146.76 31.39 0.96 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.314 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' HE3' ' H ' ' A' ' 112' ' ' ASP . 25.3 mmtp -38.97 -61.32 0.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.771 -0.581 . . . . 0.0 110.288 -179.395 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 135.44 -4.53 4.08 Favored Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.9 tttt -95.64 -145.27 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.156 -1.202 . . . . 0.0 109.554 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.556 ' O ' ' C ' ' A' ' 119' ' ' LYS . 1.7 m-20 -119.25 165.75 13.85 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.556 ' C ' ' O ' ' A' ' 118' ' ' ASP . 4.4 mmmt -21.23 131.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.775 0 CA-C-N 118.662 0.664 . . . . 0.0 110.34 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -135.69 179.95 6.03 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.909 -176.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.2 tp -145.91 107.41 4.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.075 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 m -94.27 129.96 40.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 108.585 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.3 mp -110.47 149.71 29.91 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.873 . . . . 0.0 109.209 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 124' ' ' ILE . 12.4 mt -142.36 140.5 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.34 -0.85 . . . . 0.0 109.125 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -93.57 167.36 11.73 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.929 -1.107 . . . . 0.0 108.6 178.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 63.8 m -146.27 128.69 15.92 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.026 -1.047 . . . . 0.0 109.794 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -174.69 131.69 0.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.973 . . . . 0.0 109.081 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.7 OUTLIER 62.78 67.18 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.522 -0.736 . . . . 0.0 109.117 -179.824 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -64.09 128.41 35.68 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.943 -1.098 . . . . 0.0 109.51 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 132' ' ' LYS . 10.4 t-20 -85.18 114.34 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 0.0 109.457 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -84.95 -3.09 58.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.341 -0.849 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 130' ' ' ASN . 51.2 mtmt -81.65 -46.56 14.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.328 -0.857 . . . . 0.0 109.225 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.6 p -96.13 -17.2 21.04 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.193 -0.942 . . . . 0.0 109.298 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.3 36.72 23.24 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -146.99 158.5 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.23 -1.159 . . . . 0.0 109.528 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.403 ' O ' ' C ' ' A' ' 137' ' ' GLU . 64.0 m95 -61.1 112.09 1.96 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.161 -0.962 . . . . 0.0 108.553 178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 136' ' ' TRP . 9.2 tp10 -39.01 -84.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.163 0.506 . . . . 0.0 110.37 -179.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -94.39 150.8 19.92 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.15 -0.969 . . . . 0.0 109.087 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -172.75 156.94 3.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.206 -0.934 . . . . 0.0 109.984 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 55.1 mtmt -130.11 162.95 27.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' ' 102' ' ' ASP . 5.4 mt -135.03 130.66 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.466 -0.771 . . . . 0.0 111.273 -178.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 -123.22 165.29 17.16 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t -146.29 147.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 120.732 -1.23 . . . . 0.0 110.507 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -143.06 141.1 31.19 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 147' ' ' VAL . 12.0 t -98.68 146.52 25.78 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.244 -0.91 . . . . 0.0 109.918 -179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -65.46 34.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 0.0 109.827 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 145' ' ' THR . 2.2 t -148.0 -138.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.037 -1.039 . . . . 0.0 109.016 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.522 ' H ' HG12 ' A' ' 147' ' ' VAL . 66.8 mttm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.296 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.4 mtt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -74.55 127.95 34.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.882 . . . . 0.0 109.656 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.05 44.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.098 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -152.12 59.4 3.04 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 109.213 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.19 -168.66 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.679 2.252 . . . . 0.0 111.868 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -88.02 78.71 8.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.241 -0.912 . . . . 0.0 109.996 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.4 mt -87.36 113.35 53.56 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.322 -0.861 . . . . 0.0 108.962 179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.52 129.68 11.37 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 121.53 1.487 . . . . 0.0 112.173 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -79.0 -18.92 52.8 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.054 -1.029 . . . . 0.0 108.971 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 12' ' ' SER . 28.1 t0 -78.15 101.43 7.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -58.29 -2.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.259 -0.901 . . . . 0.0 109.806 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 10' ' ' ASP . 12.6 t -108.95 40.52 1.8 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.458 -0.776 . . . . 0.0 109.578 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -146.46 139.91 25.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.3 t -61.16 119.41 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.602 -0.686 . . . . 0.0 110.858 -179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -95.71 -17.12 21.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.71 -169.18 34.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.45 121.69 8.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.312 -1.11 . . . . 0.0 109.041 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.8 tt -96.53 143.02 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -145.39 134.51 22.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.006 -1.059 . . . . 0.0 110.193 -179.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.4 mt -145.04 126.55 7.77 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' ALA . 72.1 Cg_endo -76.68 -43.24 0.28 Allowed 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.559 1.506 . . . . 0.0 111.375 179.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 15.7 t0 -53.58 -12.61 0.5 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.354 -0.841 . . . . 0.0 109.124 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -133.45 11.02 4.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.0 109.336 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 2.7 p30 41.89 34.71 0.46 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.633 -0.667 . . . . 0.0 110.081 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.0 mt -91.29 144.86 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.543 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -165.76 83.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -140.37 160.27 60.27 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.295 -0.878 . . . . 0.0 111.128 -177.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.53 164.91 25.69 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 123.026 2.484 . . . . 0.0 113.0 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.59 107.77 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.526 ' CD2' ' OE1' ' A' ' 38' ' ' GLN . 0.5 OUTLIER -72.56 155.59 90.94 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.821 -1.174 . . . . 0.0 109.515 -179.499 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -85.5 118.93 1.93 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 122.139 1.893 . . . . 0.0 111.668 178.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.3 -174.76 41.84 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.22 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.58 ' O ' ' N ' ' A' ' 35' ' ' THR . 97.9 Cg_endo -80.7 117.63 3.36 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.77 2.313 . . . . 0.0 111.331 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -47.89 85.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.311 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 33' ' ' PRO . 1.1 p -104.64 153.96 38.84 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 37.6 Cg_endo -65.57 -45.18 7.21 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.95 1.766 . . . . 0.0 111.616 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.43 -27.65 69.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.312 -0.868 . . . . 0.0 110.271 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.526 ' OE1' ' CD2' ' A' ' 30' ' ' TYR . 0.7 OUTLIER -82.73 -65.34 1.02 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.308 -179.646 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' N ' ' NE2' ' A' ' 38' ' ' GLN . 17.5 mt -44.74 -17.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.815 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 36' ' ' PRO . 4.9 m120 -58.23 -28.95 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' O ' ' OH ' ' A' ' 30' ' ' TYR . 90.1 mtt180 -83.51 -15.35 49.73 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 160.25 -137.62 5.12 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.88 -1.152 . . . . 0.0 110.4 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 60' ' ' ALA . 3.2 t -105.98 160.0 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.504 -0.998 . . . . 0.0 110.269 -178.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.0 t -155.75 156.66 35.22 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 34' ' ' ALA . 32.1 m-85 -56.29 171.92 0.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.591 -1.318 . . . . 0.0 109.38 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -84.33 -9.06 58.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 109.597 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -151.77 145.57 25.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.569 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.99 -26.74 68.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.57 -0.707 . . . . 0.0 110.972 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.67 HD22 ' N ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -86.57 1.08 52.97 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.856 -1.152 . . . . 0.0 109.886 -179.061 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.67 ' N ' HD22 ' A' ' 49' ' ' ASN . 9.4 tp10 -64.16 150.26 46.06 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.647 179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 53' ' ' ASP . 51.8 p -147.48 159.77 43.34 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -71.54 4.31 3.19 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 51' ' ' SER . 25.9 m-20 -112.57 -7.49 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t0 -60.32 114.02 2.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.003 -1.061 . . . . 0.0 109.536 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.778 HE22 HE21 ' A' ' 120' ' ' GLN . 0.4 OUTLIER -47.72 -17.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 109.036 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' ASP . 32.3 t-20 -133.04 104.74 6.68 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -95.05 150.66 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.19 -0.944 . . . . 0.0 109.761 -179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' ALA . 3.1 p -144.41 115.21 7.77 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 60' ' ' ALA . 78.5 mt -110.53 164.47 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 121.828 0.823 . . . . 0.0 110.629 -178.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.577 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -141.92 139.15 32.46 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -144.66 153.36 25.12 Favored Glycine 0 N--CA 1.499 2.892 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.895 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.719 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 20.7 m-70 -72.54 177.02 4.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.714 -0.874 . . . . 0.0 109.48 179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.82 82.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.15 -0.968 . . . . 0.0 109.416 179.15 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.461 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 10.3 m-85 -89.59 118.79 29.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.26 -0.9 . . . . 0.0 109.348 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.0 mm -60.76 -23.05 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -0.817 . . . . 0.0 110.161 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -86.59 14.2 7.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.288 -0.882 . . . . 0.0 109.53 -179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' C ' ' H ' ' A' ' 69' ' ' ASN . 39.3 mtm-85 -150.76 74.36 8.64 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.569 -0.707 . . . . 0.0 109.243 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.13 13.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 123.403 2.735 . . . . 0.0 113.617 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -147.64 60.95 1.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.991 -1.068 . . . . 0.0 108.465 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -146.24 102.1 3.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.1 -1.0 . . . . 0.0 110.838 -179.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.719 ' NE2' ' H ' ' A' ' 62' ' ' HIS . 7.3 mt-30 58.46 -115.13 0.8 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.724 -0.61 . . . . 0.0 112.038 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 124' ' ' ILE . 3.3 m-85 -95.17 19.36 10.68 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.097 -1.002 . . . . 0.0 110.938 -177.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -59.94 -20.11 55.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.422 -1.424 . . . . 0.0 109.492 -179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.641 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 7.0 m-20 -121.92 -18.41 7.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 109.834 -179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.699 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.4 tm? -53.51 -39.24 64.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.894 -1.129 . . . . 0.0 108.287 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -65.27 -3.19 3.69 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -96.89 -29.37 13.75 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 77' ' ' ALA . . . -52.01 -177.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.44 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' O ' ' OG ' ' A' ' 82' ' ' SER . 13.9 ptpt -160.27 179.09 8.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.375 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HB2' ' HZ2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -49.58 149.9 2.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.16 -0.962 . . . . 0.0 109.104 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.81 -13.45 24.23 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 79' ' ' LYS . 39.3 m -61.96 100.26 0.15 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.412 -1.052 . . . . 0.0 108.349 179.448 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.6 mmm -67.35 170.07 7.9 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.669 -179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.7 t -145.16 110.95 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 109.194 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -90.19 108.45 19.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.826 . . . . 0.0 110.175 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -94.71 111.9 23.65 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -100.74 146.24 27.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.37 -0.831 . . . . 0.0 110.155 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 89' ' ' GLY . 14.9 t -132.93 167.64 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.654 -0.653 . . . . 0.0 109.264 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.5 ' N ' HG12 ' A' ' 88' ' ' VAL . . . -45.23 -32.88 3.78 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.4 ' ND2' ' C ' ' A' ' 89' ' ' GLY . 7.2 m-80 -153.97 47.62 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.913 -1.345 . . . . 0.0 110.274 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -171.95 121.08 0.46 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.145 -0.972 . . . . 0.0 109.064 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 92' ' ' THR . 12.6 t -125.1 125.93 44.53 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.0 110.263 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.437 HH12 ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -132.37 175.51 9.22 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.545 -0.722 . . . . 0.0 109.311 179.689 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -145.38 132.74 20.65 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.176 -0.953 . . . . 0.0 110.24 -179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.463 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 13.1 m-85 -102.93 -177.15 3.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.489 -0.757 . . . . 0.0 108.967 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -141.56 110.74 6.3 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.37 -0.831 . . . . 0.0 109.349 179.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.6 tpp -48.37 114.47 0.96 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.313 -0.867 . . . . 0.0 109.527 -179.868 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 m -146.47 26.25 1.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.884 . . . . 0.0 108.703 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 m -170.24 124.11 0.72 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 84.3 mt -138.34 146.71 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.227 -0.92 . . . . 0.0 109.841 -179.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' A' ' 103' ' ' VAL . 9.9 mpt_? -121.82 -29.21 4.35 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.616 -1.254 . . . . 0.0 107.616 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 50.11 10.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.451 -0.781 . . . . 0.0 109.006 -179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 101' ' ' ARG . 70.0 t -155.4 113.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 30.8 tttm -55.11 -60.43 8.17 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.968 -1.083 . . . . 0.0 109.533 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 34.1 Cg_endo -61.55 78.1 0.09 OUTLIER 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 122.15 1.9 . . . . 0.0 111.873 179.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.78 -73.41 0.6 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 109' ' ' GLY . 7.1 m-20 -84.22 -176.89 6.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 108.718 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.4 m -74.38 29.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.015 -1.053 . . . . 0.0 109.012 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.537 ' O ' ' NE2' ' A' ' 114' ' ' GLN . . . 133.48 109.01 1.09 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.23 -23.84 32.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.189 -1.183 . . . . 0.0 108.373 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.1 mt -138.13 81.33 1.85 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 32.0 t0 -163.68 -20.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.081 -1.012 . . . . 0.0 110.97 -179.488 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -174.7 57.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 109.125 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 109' ' ' GLY . 2.4 mp0 -148.84 19.21 1.01 Allowed 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.406 ' HA ' HE22 ' A' ' 120' ' ' GLN . 17.1 ptmt -85.32 9.27 15.85 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.835 -178.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.39 17.5 58.3 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -96.05 -138.79 0.25 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.123 -1.222 . . . . 0.0 109.338 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 119' ' ' LYS . 25.0 t0 -116.2 145.94 42.71 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' C ' ' O ' ' A' ' 118' ' ' ASP . 20.5 tptt -17.11 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.714 0 CA-C-O 122.361 1.077 . . . . 0.0 111.153 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.778 HE21 HE22 ' A' ' 55' ' ' GLN . 13.2 mt-30 -93.76 173.61 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.106 -177.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.8 tp -151.95 98.31 2.43 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 87.3 m -92.09 91.73 7.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.176 -0.953 . . . . 0.0 110.175 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.4 147.34 48.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.001 179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.518 ' O ' ' CE2' ' A' ' 72' ' ' PHE . 47.0 mt -136.97 149.32 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.325 -0.86 . . . . 0.0 109.782 -179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.23 158.81 15.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.0 137.87 23.82 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.927 -1.108 . . . . 0.0 109.603 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.3 t0 178.39 138.26 0.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 6.4 t0 65.1 60.09 0.81 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -64.59 121.78 15.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.161 -0.962 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 135' ' ' VAL . 12.1 p30 -85.55 126.72 34.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.934 -1.104 . . . . 0.0 109.432 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -89.06 6.11 41.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.371 -0.831 . . . . 0.0 109.471 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -76.68 -58.81 3.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.33 -0.856 . . . . 0.0 109.118 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 48.8 p -97.87 -4.37 36.78 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.365 -0.834 . . . . 0.0 109.245 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.04 46.99 33.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.541 ' O ' ' ND2' ' A' ' 130' ' ' ASN . 3.7 t -146.91 167.27 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.331 -1.1 . . . . 0.0 109.459 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.422 ' O ' ' C ' ' A' ' 137' ' ' GLU . 70.4 m95 -72.32 113.63 9.56 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.194 -0.941 . . . . 0.0 108.944 179.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 136' ' ' TRP . 36.9 tt0 -36.25 -63.78 0.36 Allowed 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.114 0.483 . . . . 0.0 110.733 -179.044 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.451 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 0.5 OUTLIER -139.2 149.85 44.87 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 109.163 179.844 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -173.96 139.63 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 0.0 109.746 -179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -88.53 -179.58 6.09 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.862 . . . . 0.0 109.21 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.0 tt -151.31 144.7 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 8.9 m-85 -137.54 166.57 23.57 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 88.1 t -146.74 148.57 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.977 -1.077 . . . . 0.0 110.084 -179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -142.92 179.95 6.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.442 -0.786 . . . . 0.0 109.011 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.2 t -153.63 146.64 24.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.048 -1.032 . . . . 0.0 110.087 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -59.52 139.36 57.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.371 -0.831 . . . . 0.0 109.444 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.7 m -89.02 159.44 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.511 -0.743 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 mttm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.54 -179.988 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ttt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.61 154.39 4.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.43 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.33 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.557 ' CD ' ' H ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -45.37 107.81 0.7 Allowed Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 109.454 179.933 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' LYS . 82.2 Cg_exo -47.57 -176.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.916 1.744 . . . . 0.0 112.301 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 15.8 mp0 -78.26 98.98 6.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.211 -0.931 . . . . 0.0 110.073 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.1 mt -84.68 114.64 56.57 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -42.14 132.73 4.6 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.76 1.64 . . . . 0.0 112.442 -179.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.9 mtmt -83.85 -17.44 40.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.353 -0.842 . . . . 0.0 109.501 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' C ' ' H ' ' A' ' 12' ' ' SER . 54.8 m-20 -77.01 106.63 8.82 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.58 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -57.58 -5.82 0.41 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.325 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 10' ' ' ASP . 67.4 p -110.83 42.14 1.67 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.508 -0.745 . . . . 0.0 109.362 -179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -146.6 134.17 20.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 109.453 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.599 HG12 ' H ' ' A' ' 16' ' ' GLY . 38.3 t -61.64 133.46 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 111.097 -179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -99.97 -7.68 24.84 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.599 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 171.65 -168.73 41.85 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.564 ' CZ ' HG11 ' A' ' 14' ' ' VAL . 44.3 m-85 -146.88 126.81 13.59 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.937 -1.331 . . . . 0.0 109.679 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 tt -96.93 141.31 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -145.27 137.01 25.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.92 -1.112 . . . . 0.0 110.431 -178.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.731 HD12 HD21 ' A' ' 75' ' ' LEU . 9.8 mt -146.67 128.77 7.64 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 23' ' ' ALA . 73.9 Cg_endo -75.39 -42.87 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.614 1.543 . . . . 0.0 111.403 179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -54.13 -11.62 0.5 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.328 -0.858 . . . . 0.0 108.959 179.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' N ' ' C ' ' A' ' 21' ' ' PRO . . . -131.5 6.49 4.44 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 42.19 31.72 0.27 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.648 -0.658 . . . . 0.0 109.935 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.99 147.55 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.061 0.934 . . . . 0.0 109.977 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -164.32 84.49 0.43 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -134.73 159.25 72.87 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.54 -0.725 . . . . 0.0 110.728 -176.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.88 159.51 15.98 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.974 2.45 . . . . 0.0 112.88 179.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.27 111.34 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CD2' ' O ' ' A' ' 43' ' ' VAL . 7.6 m-85 -74.41 148.76 86.14 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 120.855 -1.153 . . . . 0.0 109.765 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.72 112.07 2.07 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.254 1.969 . . . . 0.0 111.96 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.07 -176.12 43.27 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.472 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.558 ' O ' ' N ' ' A' ' 35' ' ' THR . 84.7 Cg_endo -79.74 110.57 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 123.045 2.496 . . . . 0.0 111.501 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . -42.63 88.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.418 0.628 . . . . 0.0 111.443 -178.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.562 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -104.18 173.25 3.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 177.992 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -84.22 -28.44 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.693 1.595 . . . . 0.0 112.202 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.86 -35.57 80.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 0.0 109.48 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.653 HE22 ' CB ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -81.6 -67.42 0.78 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -0.849 . . . . 0.0 110.41 -179.389 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 38' ' ' GLN . 33.5 mt -42.75 -25.14 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.059 -1.026 . . . . 0.0 110.232 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 38' ' ' GLN . 10.7 m-20 -62.03 -24.81 67.29 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -96.14 -17.72 20.65 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' O ' ' NE2' ' A' ' 71' ' ' GLN . . . 177.57 -133.15 2.14 Favored Glycine 0 N--CA 1.494 2.529 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.894 179.749 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.482 ' O ' ' CD2' ' A' ' 30' ' ' TYR . 3.1 t -125.82 159.44 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.534 -0.98 . . . . 0.0 109.572 -179.032 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.653 ' CB ' HE22 ' A' ' 38' ' ' GLN . 4.2 p -155.97 163.0 40.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.231 -0.918 . . . . 0.0 108.833 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CE1' ' OE1' ' A' ' 50' ' ' GLU . 39.9 m-85 -59.43 169.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.764 -1.21 . . . . 0.0 109.19 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 58' ' ' SER . . . -82.66 -14.36 54.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.175 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -144.62 146.38 32.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.28 -0.887 . . . . 0.0 110.067 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.42 -23.82 67.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.614 -0.678 . . . . 0.0 110.892 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -87.53 2.49 50.57 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.928 -1.107 . . . . 0.0 110.395 -178.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 2.8 tm-20 -63.56 156.37 26.71 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.498 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.509 ' N ' ' CD ' ' A' ' 50' ' ' GLU . 5.0 m -145.73 178.13 8.39 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.984 ' H ' HD22 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -87.33 14.79 7.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 108.324 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -140.44 0.86 1.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.616 -0.678 . . . . 0.0 109.904 -179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 14.3 t0 -56.77 118.7 5.16 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.823 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.714 HE22 ' N ' ' A' ' 119' ' ' LYS . 41.5 tp60 -37.52 -24.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.029 0.442 . . . . 0.0 110.322 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 54' ' ' ASP . 18.9 t-20 -133.68 117.27 16.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.354 -0.841 . . . . 0.0 108.944 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.44 HD13 ' OE2' ' A' ' 50' ' ' GLU . 37.3 mm -92.72 142.85 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.247 -0.908 . . . . 0.0 108.597 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.5 p -140.67 109.69 6.12 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 60' ' ' ALA . 90.6 mt -111.15 161.2 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 121.646 0.736 . . . . 0.0 110.486 -178.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.523 ' N ' HG22 ' A' ' 59' ' ' ILE . . . -137.8 130.41 29.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.96 154.91 25.66 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.495 ' O ' ' N ' ' A' ' 72' ' ' PHE . 15.9 m-70 -72.61 170.45 14.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.588 -0.948 . . . . 0.0 109.634 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.94 82.42 0.72 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.373 -0.83 . . . . 0.0 108.97 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -86.62 114.99 23.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 0.0 108.799 -179.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.417 HG13 ' H ' ' A' ' 65' ' ' ILE . 6.7 mt -56.68 -29.91 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.383 -0.823 . . . . 0.0 109.948 -179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -83.82 16.24 2.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.446 -0.784 . . . . 0.0 109.602 -178.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.557 ' C ' ' H ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -144.49 69.43 15.41 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.536 -0.728 . . . . 0.0 109.251 179.691 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.42 17.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.068 2.512 . . . . 0.0 113.543 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.557 ' H ' ' C ' ' A' ' 67' ' ' ARG . 37.0 m-80 -148.95 62.77 1.05 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.926 -1.108 . . . . 0.0 108.558 179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -133.3 -154.04 0.58 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.553 -0.717 . . . . 0.0 109.77 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 42' ' ' GLY . 79.4 mt-30 -57.77 -98.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.539 -0.726 . . . . 0.0 111.19 -179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 62' ' ' HIS . 4.7 m-85 -96.0 27.36 3.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.226 -0.921 . . . . 0.0 110.549 -178.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 73' ' ' THR . 98.2 m -65.76 -12.4 53.66 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.58 -1.325 . . . . 0.0 109.581 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.4 m-20 -128.05 -20.58 3.78 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.269 -0.894 . . . . 0.0 110.47 -179.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.731 HD21 HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -53.65 -33.57 55.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.809 -1.182 . . . . 0.0 108.278 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -71.44 -9.56 58.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.375 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -87.76 -24.49 23.78 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.377 0.608 . . . . 0.0 109.468 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 171.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.33 -0.856 . . . . 0.0 109.659 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -144.77 167.14 23.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.267 -0.896 . . . . 0.0 109.221 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -49.42 138.6 13.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.399 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 97' ' ' MET . . . 95.42 -20.96 47.01 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -179.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.5 t -62.43 100.52 0.18 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.368 -1.078 . . . . 0.0 108.119 179.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.7 mtp -57.28 173.17 0.26 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 -178.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 t -143.13 113.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 109.069 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -95.15 102.6 14.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.3 -0.875 . . . . 0.0 109.857 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -95.71 112.08 23.88 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' O ' HG23 ' A' ' 88' ' ' VAL . 33.5 mtmt -96.59 152.12 18.94 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.236 -0.915 . . . . 0.0 111.251 -178.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.574 HG21 HH12 ' A' ' 93' ' ' ARG . 76.6 t -156.15 93.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.49 -105.83 1.09 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.2 m-80 -118.3 38.84 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.472 -1.016 . . . . 0.0 109.577 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -146.05 108.5 4.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.235 -0.915 . . . . 0.0 108.828 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 92' ' ' THR . 12.8 t -110.39 119.54 39.53 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.505 -0.747 . . . . 0.0 110.387 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.574 HH12 HG21 ' A' ' 88' ' ' VAL . 2.2 mpt_? -95.22 172.54 8.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.534 -0.729 . . . . 0.0 109.308 179.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 95' ' ' TYR . 0.5 OUTLIER -144.41 146.9 32.76 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.139 -0.976 . . . . 0.0 109.858 -179.661 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 95' ' ' TYR . 12.8 m-85 -137.52 177.92 7.5 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -140.63 107.69 5.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.264 -0.898 . . . . 0.0 109.721 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 81' ' ' GLY . 64.7 mtp -51.86 120.68 5.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.571 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -153.09 28.66 0.51 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.264 -0.897 . . . . 0.0 108.904 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.2 t -166.46 121.58 1.16 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 101' ' ' ARG . 61.3 mt -132.21 166.27 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.444 -0.785 . . . . 0.0 110.192 -178.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.716 ' NH2' ' H ' ' A' ' 107' ' ' ASP . 36.5 ttm180 -141.26 -76.38 0.3 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 p30 41.94 21.39 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.548 -0.72 . . . . 0.0 109.758 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.668 HG13 ' N ' ' A' ' 104' ' ' LYS . 1.7 p -152.37 -155.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.363 -0.835 . . . . 0.0 108.751 -179.418 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.668 ' N ' HG13 ' A' ' 103' ' ' VAL . 57.2 mttm -49.12 151.25 2.46 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.889 -1.132 . . . . 0.0 109.065 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.24 118.4 5.61 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.161 1.908 . . . . 0.0 112.169 -179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 p -80.34 -58.7 3.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 109.257 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.716 ' H ' ' NH2' ' A' ' 101' ' ' ARG . 10.8 t70 -142.62 153.96 43.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.248 -0.907 . . . . 0.0 108.853 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 108' ' ' VAL . 15.3 m -69.78 37.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.926 . . . . 0.0 109.547 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 107' ' ' ASP . . . -91.35 20.94 37.64 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.591 ' CG1' HH12 ' A' ' 101' ' ' ARG . 34.0 m -67.13 -41.2 86.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.211 -1.17 . . . . 0.0 108.679 179.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.524 ' N ' HG23 ' A' ' 110' ' ' VAL . 32.0 mt -135.71 56.59 1.82 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.523 ' OD1' ' ND2' ' A' ' 56' ' ' ASN . 1.2 p30 -84.39 83.9 7.83 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.569 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -103.11 10.05 38.12 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.425 ' NE2' ' N ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -132.43 -2.57 3.44 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.852 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -165.69 -132.64 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.511 179.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.18 -107.63 2.38 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 108.804 -1.719 . . . . 0.0 108.804 -179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -144.05 -102.67 0.12 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.491 -1.005 . . . . 0.0 109.191 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.495 ' O ' ' C ' ' A' ' 119' ' ' LYS . 8.0 m-20 -119.24 171.13 8.51 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.714 ' N ' HE22 ' A' ' 55' ' ' GLN . 85.6 mttt -34.89 131.31 0.38 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.69 -0.631 . . . . 0.0 109.519 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.441 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -145.79 162.24 38.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.052 -1.03 . . . . 0.0 110.263 -178.443 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.456 HD11 ' CD1' ' A' ' 95' ' ' TYR . 12.4 mt -109.18 120.47 42.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.706 -0.621 . . . . 0.0 110.497 -178.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m -98.35 87.37 3.86 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.95 140.84 49.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 110.413 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 31.3 mt -138.16 131.42 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 p -95.8 164.92 12.54 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.086 -1.009 . . . . 0.0 108.695 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 97.7 m -145.77 149.06 33.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.118 -0.989 . . . . 0.0 109.873 -179.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 0.7 OUTLIER 176.79 132.09 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.306 -0.871 . . . . 0.0 109.35 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 128' ' ' ASP . 0.8 OUTLIER 58.7 75.13 0.41 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.98 126.21 26.92 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -85.47 117.69 24.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.039 -1.038 . . . . 0.0 109.363 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -85.63 1.9 47.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.353 -0.842 . . . . 0.0 109.686 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -80.79 -55.88 4.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.531 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.6 p -94.66 -10.72 30.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.2 41.59 21.32 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -146.77 157.34 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.245 -1.15 . . . . 0.0 109.508 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.428 ' O ' ' C ' ' A' ' 137' ' ' GLU . 60.1 m95 -61.36 113.2 2.51 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.167 -0.958 . . . . 0.0 108.596 179.086 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 136' ' ' TRP . 35.2 tt0 -35.93 -84.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.378 0.608 . . . . 0.0 110.759 -178.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -100.33 150.95 22.06 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.414 -0.804 . . . . 0.0 108.95 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -173.55 144.66 1.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.948 -179.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -106.37 173.2 6.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.1 mt -145.69 130.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.09 -1.007 . . . . 0.0 109.868 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -128.32 168.43 15.53 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 96.4 t -149.57 147.71 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.778 -1.201 . . . . 0.0 110.978 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -137.12 175.48 9.58 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.0 t -146.75 139.15 24.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.929 -1.107 . . . . 0.0 110.218 -179.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 147' ' ' VAL . 15.8 tm-20 -60.75 112.51 2.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.43 ' O ' ' OE2' ' A' ' 146' ' ' GLU . 10.9 m -92.93 166.05 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 109.845 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.4 pttt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.416 179.957 . . . . . . . . 0 0 . 1 stop_ save_